<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Death Differ</journal-id><journal-id journal-id-type="iso-abbrev">Cell Death Differ</journal-id><journal-id journal-id-type="pmc-domain-id">1474</journal-id><journal-id journal-id-type="pmc-domain">cddiff</journal-id><journal-title-group><journal-title>Cell Death and Differentiation</journal-title></journal-title-group><issn pub-type="ppub">1350-9047</issn><issn pub-type="epub">1476-5403</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10130819</article-id><article-id pub-id-type="pmcid-ver">PMC10130819.2</article-id><article-id pub-id-type="pmcaid">10130819</article-id><article-id pub-id-type="pmcaiid">10154398</article-id><article-id pub-id-type="pmid">37100955</article-id><article-id pub-id-type="doi">10.1038/s41418-023-01153-w</article-id><article-id pub-id-type="publisher-id">1153</article-id><article-version article-version-type="pmc-version">2</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Apoptotic cell death in disease&#8212;Current understanding of the NCCD 2023</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5918-1841</contrib-id><name name-style="western"><surname>Vitale</surname><given-names initials="I">Ilio</given-names></name><address><email>iliovit@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pietrocola</surname><given-names initials="F">Federico</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guilbaud</surname><given-names initials="E">Emma</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aaronson</surname><given-names initials="SA">Stuart A.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Abrams</surname><given-names initials="JM">John M.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Adam</surname><given-names initials="D">Dieter</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Agostini</surname><given-names initials="M">Massimiliano</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Agostinis</surname><given-names initials="P">Patrizia</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alnemri</surname><given-names initials="ES">Emad S.</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Altucci</surname><given-names initials="L">Lucia</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Amelio</surname><given-names initials="I">Ivano</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Andrews</surname><given-names initials="DW">David W.</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aqeilan</surname><given-names initials="RI">Rami I.</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arama</surname><given-names initials="E">Eli</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baehrecke</surname><given-names initials="EH">Eric H.</given-names></name><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Balachandran</surname><given-names initials="S">Siddharth</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bano</surname><given-names initials="D">Daniele</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barlev</surname><given-names initials="NA">Nickolai A.</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bartek</surname><given-names initials="J">Jiri</given-names></name><xref ref-type="aff" rid="Aff23">23</xref><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bazan</surname><given-names initials="NG">Nicolas G.</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Becker</surname><given-names initials="C">Christoph</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bernassola</surname><given-names initials="F">Francesca</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bertrand</surname><given-names initials="MJM">Mathieu J. M.</given-names></name><xref ref-type="aff" rid="Aff27">27</xref><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bianchi</surname><given-names initials="ME">Marco E.</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blagosklonny</surname><given-names initials="MV">Mikhail V.</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blander</surname><given-names initials="JM">J. Magarian</given-names></name><xref ref-type="aff" rid="Aff31">31</xref><xref ref-type="aff" rid="Aff32">32</xref><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blandino</surname><given-names initials="G">Giovanni</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blomgren</surname><given-names initials="K">Klas</given-names></name><xref ref-type="aff" rid="Aff35">35</xref><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Borner</surname><given-names initials="C">Christoph</given-names></name><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bortner</surname><given-names initials="CD">Carl D.</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bove</surname><given-names initials="P">Pierluigi</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Boya</surname><given-names initials="P">Patricia</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brenner</surname><given-names initials="C">Catherine</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Broz</surname><given-names initials="P">Petr</given-names></name><xref ref-type="aff" rid="Aff41">41</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brunner</surname><given-names initials="T">Thomas</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Damgaard</surname><given-names initials="RB">Rune Busk</given-names></name><xref ref-type="aff" rid="Aff43">43</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Calin</surname><given-names initials="GA">George A.</given-names></name><xref ref-type="aff" rid="Aff44">44</xref><xref ref-type="aff" rid="Aff45">45</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Campanella</surname><given-names initials="M">Michelangelo</given-names></name><xref ref-type="aff" rid="Aff46">46</xref><xref ref-type="aff" rid="Aff47">47</xref><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Candi</surname><given-names initials="E">Eleonora</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carbone</surname><given-names initials="M">Michele</given-names></name><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carmona-Gutierrez</surname><given-names initials="D">Didac</given-names></name><xref ref-type="aff" rid="Aff50">50</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cecconi</surname><given-names initials="F">Francesco</given-names></name><xref ref-type="aff" rid="Aff51">51</xref><xref ref-type="aff" rid="Aff52">52</xref><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chan</surname><given-names initials="FKM">Francis K. -M.</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="GQ">Guo-Qiang</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="Q">Quan</given-names></name><xref ref-type="aff" rid="Aff56">56</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="YH">Youhai H.</given-names></name><xref ref-type="aff" rid="Aff57">57</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cheng</surname><given-names initials="EH">Emily H.</given-names></name><xref ref-type="aff" rid="Aff58">58</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chipuk</surname><given-names initials="JE">Jerry E.</given-names></name><xref ref-type="aff" rid="Aff59">59</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cidlowski</surname><given-names initials="JA">John A.</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ciechanover</surname><given-names initials="A">Aaron</given-names></name><xref ref-type="aff" rid="Aff60">60</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ciliberto</surname><given-names initials="G">Gennaro</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Conrad</surname><given-names initials="M">Marcus</given-names></name><xref ref-type="aff" rid="Aff61">61</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cubillos-Ruiz</surname><given-names initials="JR">Juan R.</given-names></name><xref ref-type="aff" rid="Aff62">62</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Czabotar</surname><given-names initials="PE">Peter E.</given-names></name><xref ref-type="aff" rid="Aff63">63</xref><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>D&#8217;Angiolella</surname><given-names initials="V">Vincenzo</given-names></name><xref ref-type="aff" rid="Aff65">65</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Daugaard</surname><given-names initials="M">Mads</given-names></name><xref ref-type="aff" rid="Aff66">66</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dawson</surname><given-names initials="TM">Ted M.</given-names></name><xref ref-type="aff" rid="Aff67">67</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dawson</surname><given-names initials="VL">Valina L.</given-names></name><xref ref-type="aff" rid="Aff67">67</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>De Maria</surname><given-names initials="R">Ruggero</given-names></name><xref ref-type="aff" rid="Aff52">52</xref><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>De Strooper</surname><given-names initials="B">Bart</given-names></name><xref ref-type="aff" rid="Aff68">68</xref><xref ref-type="aff" rid="Aff69">69</xref><xref ref-type="aff" rid="Aff70">70</xref><xref ref-type="aff" rid="Aff71">71</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Debatin</surname><given-names initials="KM">Klaus-Michael</given-names></name><xref ref-type="aff" rid="Aff72">72</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Deberardinis</surname><given-names initials="RJ">Ralph J.</given-names></name><xref ref-type="aff" rid="Aff73">73</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Degterev</surname><given-names initials="A">Alexei</given-names></name><xref ref-type="aff" rid="Aff74">74</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Del Sal</surname><given-names initials="G">Giannino</given-names></name><xref ref-type="aff" rid="Aff75">75</xref><xref ref-type="aff" rid="Aff76">76</xref><xref ref-type="aff" rid="Aff77">77</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Deshmukh</surname><given-names initials="M">Mohanish</given-names></name><xref ref-type="aff" rid="Aff78">78</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Di Virgilio</surname><given-names initials="F">Francesco</given-names></name><xref ref-type="aff" rid="Aff79">79</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Diederich</surname><given-names initials="M">Marc</given-names></name><xref ref-type="aff" rid="Aff80">80</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dixon</surname><given-names initials="SJ">Scott J.</given-names></name><xref ref-type="aff" rid="Aff81">81</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dynlacht</surname><given-names initials="BD">Brian D.</given-names></name><xref ref-type="aff" rid="Aff82">82</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>El-Deiry</surname><given-names initials="WS">Wafik S.</given-names></name><xref ref-type="aff" rid="Aff83">83</xref><xref ref-type="aff" rid="Aff84">84</xref><xref ref-type="aff" rid="Aff85">85</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Elrod</surname><given-names initials="JW">John W.</given-names></name><xref ref-type="aff" rid="Aff86">86</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Engeland</surname><given-names initials="K">Kurt</given-names></name><xref ref-type="aff" rid="Aff87">87</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fimia</surname><given-names initials="GM">Gian Maria</given-names></name><xref ref-type="aff" rid="Aff88">88</xref><xref ref-type="aff" rid="Aff89">89</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Galassi</surname><given-names initials="C">Claudia</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ganini</surname><given-names initials="C">Carlo</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff90">90</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garcia-Saez</surname><given-names initials="AJ">Ana J.</given-names></name><xref ref-type="aff" rid="Aff91">91</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garg</surname><given-names initials="AD">Abhishek D.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garrido</surname><given-names initials="C">Carmen</given-names></name><xref ref-type="aff" rid="Aff92">92</xref><xref ref-type="aff" rid="Aff93">93</xref><xref ref-type="aff" rid="Aff94">94</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gavathiotis</surname><given-names initials="E">Evripidis</given-names></name><xref ref-type="aff" rid="Aff95">95</xref><xref ref-type="aff" rid="Aff96">96</xref><xref ref-type="aff" rid="Aff97">97</xref><xref ref-type="aff" rid="Aff98">98</xref><xref ref-type="aff" rid="Aff99">99</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gerlic</surname><given-names initials="M">Motti</given-names></name><xref ref-type="aff" rid="Aff100">100</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ghosh</surname><given-names initials="S">Sourav</given-names></name><xref ref-type="aff" rid="Aff101">101</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Green</surname><given-names initials="DR">Douglas R.</given-names></name><xref ref-type="aff" rid="Aff102">102</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Greene</surname><given-names initials="LA">Lloyd A.</given-names></name><xref ref-type="aff" rid="Aff103">103</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gronemeyer</surname><given-names initials="H">Hinrich</given-names></name><xref ref-type="aff" rid="Aff104">104</xref><xref ref-type="aff" rid="Aff105">105</xref><xref ref-type="aff" rid="Aff106">106</xref><xref ref-type="aff" rid="Aff107">107</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>H&#228;cker</surname><given-names initials="G">Georg</given-names></name><xref ref-type="aff" rid="Aff108">108</xref><xref ref-type="aff" rid="Aff109">109</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hajn&#243;czky</surname><given-names initials="G">Gy&#246;rgy</given-names></name><xref ref-type="aff" rid="Aff110">110</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hardwick</surname><given-names initials="JM">J. Marie</given-names></name><xref ref-type="aff" rid="Aff111">111</xref><xref ref-type="aff" rid="Aff112">112</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Haupt</surname><given-names initials="Y">Ygal</given-names></name><xref ref-type="aff" rid="Aff113">113</xref><xref ref-type="aff" rid="Aff114">114</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>He</surname><given-names initials="S">Sudan</given-names></name><xref ref-type="aff" rid="Aff115">115</xref><xref ref-type="aff" rid="Aff116">116</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Heery</surname><given-names initials="DM">David M.</given-names></name><xref ref-type="aff" rid="Aff117">117</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hengartner</surname><given-names initials="MO">Michael O.</given-names></name><xref ref-type="aff" rid="Aff118">118</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hetz</surname><given-names initials="C">Claudio</given-names></name><xref ref-type="aff" rid="Aff119">119</xref><xref ref-type="aff" rid="Aff120">120</xref><xref ref-type="aff" rid="Aff121">121</xref><xref ref-type="aff" rid="Aff122">122</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hildeman</surname><given-names initials="DA">David A.</given-names></name><xref ref-type="aff" rid="Aff123">123</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ichijo</surname><given-names initials="H">Hidenori</given-names></name><xref ref-type="aff" rid="Aff124">124</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Inoue</surname><given-names initials="S">Satoshi</given-names></name><xref ref-type="aff" rid="Aff125">125</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>J&#228;&#228;ttel&#228;</surname><given-names initials="M">Marja</given-names></name><xref ref-type="aff" rid="Aff126">126</xref><xref ref-type="aff" rid="Aff127">127</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Janic</surname><given-names initials="A">Ana</given-names></name><xref ref-type="aff" rid="Aff128">128</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Joseph</surname><given-names initials="B">Bertrand</given-names></name><xref ref-type="aff" rid="Aff129">129</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jost</surname><given-names initials="PJ">Philipp J.</given-names></name><xref ref-type="aff" rid="Aff130">130</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kanneganti</surname><given-names initials="TD">Thirumala-Devi</given-names></name><xref ref-type="aff" rid="Aff102">102</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Karin</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff131">131</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kashkar</surname><given-names initials="H">Hamid</given-names></name><xref ref-type="aff" rid="Aff132">132</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kaufmann</surname><given-names initials="T">Thomas</given-names></name><xref ref-type="aff" rid="Aff133">133</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kelly</surname><given-names initials="GL">Gemma L.</given-names></name><xref ref-type="aff" rid="Aff63">63</xref><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kepp</surname><given-names initials="O">Oliver</given-names></name><xref ref-type="aff" rid="Aff134">134</xref><xref ref-type="aff" rid="Aff135">135</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kimchi</surname><given-names initials="A">Adi</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kitsis</surname><given-names initials="RN">Richard N.</given-names></name><xref ref-type="aff" rid="Aff95">95</xref><xref ref-type="aff" rid="Aff96">96</xref><xref ref-type="aff" rid="Aff97">97</xref><xref ref-type="aff" rid="Aff98">98</xref><xref ref-type="aff" rid="Aff136">136</xref><xref ref-type="aff" rid="Aff137">137</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Klionsky</surname><given-names initials="DJ">Daniel J.</given-names></name><xref ref-type="aff" rid="Aff138">138</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kluck</surname><given-names initials="R">Ruth</given-names></name><xref ref-type="aff" rid="Aff63">63</xref><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Krysko</surname><given-names initials="DV">Dmitri V.</given-names></name><xref ref-type="aff" rid="Aff139">139</xref><xref ref-type="aff" rid="Aff140">140</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kulms</surname><given-names initials="D">Dagmar</given-names></name><xref ref-type="aff" rid="Aff141">141</xref><xref ref-type="aff" rid="Aff142">142</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kumar</surname><given-names initials="S">Sharad</given-names></name><xref ref-type="aff" rid="Aff143">143</xref><xref ref-type="aff" rid="Aff144">144</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lavandero</surname><given-names initials="S">Sergio</given-names></name><xref ref-type="aff" rid="Aff145">145</xref><xref ref-type="aff" rid="Aff146">146</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lavrik</surname><given-names initials="IN">Inna N.</given-names></name><xref ref-type="aff" rid="Aff147">147</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lemasters</surname><given-names initials="JJ">John J.</given-names></name><xref ref-type="aff" rid="Aff148">148</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liccardi</surname><given-names initials="G">Gianmaria</given-names></name><xref ref-type="aff" rid="Aff149">149</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Linkermann</surname><given-names initials="A">Andreas</given-names></name><xref ref-type="aff" rid="Aff150">150</xref><xref ref-type="aff" rid="Aff151">151</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lipton</surname><given-names initials="SA">Stuart A.</given-names></name><xref ref-type="aff" rid="Aff152">152</xref><xref ref-type="aff" rid="Aff153">153</xref><xref ref-type="aff" rid="Aff154">154</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lockshin</surname><given-names initials="RA">Richard A.</given-names></name><xref ref-type="aff" rid="Aff155">155</xref><xref ref-type="aff" rid="Aff156">156</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>L&#243;pez-Ot&#237;n</surname><given-names initials="C">Carlos</given-names></name><xref ref-type="aff" rid="Aff157">157</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Luedde</surname><given-names initials="T">Tom</given-names></name><xref ref-type="aff" rid="Aff158">158</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MacFarlane</surname><given-names initials="M">Marion</given-names></name><xref ref-type="aff" rid="Aff159">159</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Madeo</surname><given-names initials="F">Frank</given-names></name><xref ref-type="aff" rid="Aff50">50</xref><xref ref-type="aff" rid="Aff160">160</xref><xref ref-type="aff" rid="Aff161">161</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Malorni</surname><given-names initials="W">Walter</given-names></name><xref ref-type="aff" rid="Aff162">162</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Manic</surname><given-names initials="G">Gwenola</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mantovani</surname><given-names initials="R">Roberto</given-names></name><xref ref-type="aff" rid="Aff163">163</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marchi</surname><given-names initials="S">Saverio</given-names></name><xref ref-type="aff" rid="Aff164">164</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marine</surname><given-names initials="JC">Jean-Christophe</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff165">165</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Martin</surname><given-names initials="SJ">Seamus J.</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Martinou</surname><given-names initials="JC">Jean-Claude</given-names></name><xref ref-type="aff" rid="Aff167">167</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mastroberardino</surname><given-names initials="PG">Pier G.</given-names></name><xref ref-type="aff" rid="Aff168">168</xref><xref ref-type="aff" rid="Aff169">169</xref><xref ref-type="aff" rid="Aff170">170</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Medema</surname><given-names initials="JP">Jan Paul</given-names></name><xref ref-type="aff" rid="Aff171">171</xref><xref ref-type="aff" rid="Aff172">172</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mehlen</surname><given-names initials="P">Patrick</given-names></name><xref ref-type="aff" rid="Aff173">173</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meier</surname><given-names initials="P">Pascal</given-names></name><xref ref-type="aff" rid="Aff174">174</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Melino</surname><given-names initials="G">Gerry</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Melino</surname><given-names initials="S">Sonia</given-names></name><xref ref-type="aff" rid="Aff175">175</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miao</surname><given-names initials="EA">Edward A.</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moll</surname><given-names initials="UM">Ute M.</given-names></name><xref ref-type="aff" rid="Aff176">176</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mu&#241;oz-Pinedo</surname><given-names initials="C">Cristina</given-names></name><xref ref-type="aff" rid="Aff177">177</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murphy</surname><given-names initials="DJ">Daniel J.</given-names></name><xref ref-type="aff" rid="Aff178">178</xref><xref ref-type="aff" rid="Aff179">179</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Niklison-Chirou</surname><given-names initials="MV">Maria Victoria</given-names></name><xref ref-type="aff" rid="Aff180">180</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Novelli</surname><given-names initials="F">Flavia</given-names></name><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>N&#250;&#241;ez</surname><given-names initials="G">Gabriel</given-names></name><xref ref-type="aff" rid="Aff181">181</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oberst</surname><given-names initials="A">Andrew</given-names></name><xref ref-type="aff" rid="Aff182">182</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ofengeim</surname><given-names initials="D">Dimitry</given-names></name><xref ref-type="aff" rid="Aff183">183</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Opferman</surname><given-names initials="JT">Joseph T.</given-names></name><xref ref-type="aff" rid="Aff184">184</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oren</surname><given-names initials="M">Moshe</given-names></name><xref ref-type="aff" rid="Aff185">185</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pagano</surname><given-names initials="M">Michele</given-names></name><xref ref-type="aff" rid="Aff186">186</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Panaretakis</surname><given-names initials="T">Theocharis</given-names></name><xref ref-type="aff" rid="Aff129">129</xref><xref ref-type="aff" rid="Aff187">187</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pasparakis</surname><given-names initials="M">Manolis</given-names></name><xref ref-type="aff" rid="Aff91">91</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Penninger</surname><given-names initials="JM">Josef M.</given-names></name><xref ref-type="aff" rid="Aff188">188</xref><xref ref-type="aff" rid="Aff189">189</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pentimalli</surname><given-names initials="F">Francesca</given-names></name><xref ref-type="aff" rid="Aff190">190</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pereira</surname><given-names initials="DM">David M.</given-names></name><xref ref-type="aff" rid="Aff191">191</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pervaiz</surname><given-names initials="S">Shazib</given-names></name><xref ref-type="aff" rid="Aff192">192</xref><xref ref-type="aff" rid="Aff193">193</xref><xref ref-type="aff" rid="Aff194">194</xref><xref ref-type="aff" rid="Aff195">195</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peter</surname><given-names initials="ME">Marcus E.</given-names></name><xref ref-type="aff" rid="Aff196">196</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pinton</surname><given-names initials="P">Paolo</given-names></name><xref ref-type="aff" rid="Aff79">79</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Porta</surname><given-names initials="G">Giovanni</given-names></name><xref ref-type="aff" rid="Aff197">197</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prehn</surname><given-names initials="JHM">Jochen H. M.</given-names></name><xref ref-type="aff" rid="Aff198">198</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Puthalakath</surname><given-names initials="H">Hamsa</given-names></name><xref ref-type="aff" rid="Aff199">199</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rabinovich</surname><given-names initials="GA">Gabriel A.</given-names></name><xref ref-type="aff" rid="Aff200">200</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rajalingam</surname><given-names initials="K">Krishnaraj</given-names></name><xref ref-type="aff" rid="Aff201">201</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ravichandran</surname><given-names initials="KS">Kodi S.</given-names></name><xref ref-type="aff" rid="Aff27">27</xref><xref ref-type="aff" rid="Aff202">202</xref><xref ref-type="aff" rid="Aff203">203</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rehm</surname><given-names initials="M">Markus</given-names></name><xref ref-type="aff" rid="Aff204">204</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ricci</surname><given-names initials="JE">Jean-Ehrland</given-names></name><xref ref-type="aff" rid="Aff205">205</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rizzuto</surname><given-names initials="R">Rosario</given-names></name><xref ref-type="aff" rid="Aff206">206</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robinson</surname><given-names initials="N">Nirmal</given-names></name><xref ref-type="aff" rid="Aff143">143</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names initials="CMP">Cecilia M. P.</given-names></name><xref ref-type="aff" rid="Aff207">207</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rotblat</surname><given-names initials="B">Barak</given-names></name><xref ref-type="aff" rid="Aff208">208</xref><xref ref-type="aff" rid="Aff209">209</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rothlin</surname><given-names initials="CV">Carla V.</given-names></name><xref ref-type="aff" rid="Aff210">210</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rubinsztein</surname><given-names initials="DC">David C.</given-names></name><xref ref-type="aff" rid="Aff211">211</xref><xref ref-type="aff" rid="Aff212">212</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rudel</surname><given-names initials="T">Thomas</given-names></name><xref ref-type="aff" rid="Aff213">213</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rufini</surname><given-names initials="A">Alessandro</given-names></name><xref ref-type="aff" rid="Aff163">163</xref><xref ref-type="aff" rid="Aff214">214</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ryan</surname><given-names initials="KM">Kevin M.</given-names></name><xref ref-type="aff" rid="Aff178">178</xref><xref ref-type="aff" rid="Aff179">179</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sarosiek</surname><given-names initials="KA">Kristopher A.</given-names></name><xref ref-type="aff" rid="Aff215">215</xref><xref ref-type="aff" rid="Aff216">216</xref><xref ref-type="aff" rid="Aff217">217</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sawa</surname><given-names initials="A">Akira</given-names></name><xref ref-type="aff" rid="Aff218">218</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sayan</surname><given-names initials="E">Emre</given-names></name><xref ref-type="aff" rid="Aff219">219</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schroder</surname><given-names initials="K">Kate</given-names></name><xref ref-type="aff" rid="Aff220">220</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scorrano</surname><given-names initials="L">Luca</given-names></name><xref ref-type="aff" rid="Aff221">221</xref><xref ref-type="aff" rid="Aff222">222</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sesti</surname><given-names initials="F">Federico</given-names></name><xref ref-type="aff" rid="Aff223">223</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shao</surname><given-names initials="F">Feng</given-names></name><xref ref-type="aff" rid="Aff224">224</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shi</surname><given-names initials="Y">Yufang</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff225">225</xref><xref ref-type="aff" rid="Aff226">226</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sica</surname><given-names initials="GS">Giuseppe S.</given-names></name><xref ref-type="aff" rid="Aff227">227</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Silke</surname><given-names initials="J">John</given-names></name><xref ref-type="aff" rid="Aff63">63</xref><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Simon</surname><given-names initials="HU">Hans-Uwe</given-names></name><xref ref-type="aff" rid="Aff133">133</xref><xref ref-type="aff" rid="Aff228">228</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sistigu</surname><given-names initials="A">Antonella</given-names></name><xref ref-type="aff" rid="Aff229">229</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stephanou</surname><given-names initials="A">Anastasis</given-names></name><xref ref-type="aff" rid="Aff230">230</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stockwell</surname><given-names initials="BR">Brent R.</given-names></name><xref ref-type="aff" rid="Aff231">231</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Strapazzon</surname><given-names initials="F">Flavie</given-names></name><xref ref-type="aff" rid="Aff232">232</xref><xref ref-type="aff" rid="Aff233">233</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Strasser</surname><given-names initials="A">Andreas</given-names></name><xref ref-type="aff" rid="Aff63">63</xref><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="L">Liming</given-names></name><xref ref-type="aff" rid="Aff234">234</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="E">Erwei</given-names></name><xref ref-type="aff" rid="Aff235">235</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="Q">Qiang</given-names></name><xref ref-type="aff" rid="Aff236">236</xref><xref ref-type="aff" rid="Aff237">237</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Szabadkai</surname><given-names initials="G">Gyorgy</given-names></name><xref ref-type="aff" rid="Aff206">206</xref><xref ref-type="aff" rid="Aff238">238</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tait</surname><given-names initials="SWG">Stephen W. G.</given-names></name><xref ref-type="aff" rid="Aff178">178</xref><xref ref-type="aff" rid="Aff179">179</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tang</surname><given-names initials="D">Daolin</given-names></name><xref ref-type="aff" rid="Aff239">239</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tavernarakis</surname><given-names initials="N">Nektarios</given-names></name><xref ref-type="aff" rid="Aff240">240</xref><xref ref-type="aff" rid="Aff241">241</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Troy</surname><given-names initials="CM">Carol M.</given-names></name><xref ref-type="aff" rid="Aff242">242</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Turk</surname><given-names initials="B">Boris</given-names></name><xref ref-type="aff" rid="Aff243">243</xref><xref ref-type="aff" rid="Aff244">244</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Urbano</surname><given-names initials="N">Nicoletta</given-names></name><xref ref-type="aff" rid="Aff245">245</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vandenabeele</surname><given-names initials="P">Peter</given-names></name><xref ref-type="aff" rid="Aff27">27</xref><xref ref-type="aff" rid="Aff28">28</xref><xref ref-type="aff" rid="Aff246">246</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vanden Berghe</surname><given-names initials="T">Tom</given-names></name><xref ref-type="aff" rid="Aff27">27</xref><xref ref-type="aff" rid="Aff28">28</xref><xref ref-type="aff" rid="Aff247">247</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vander Heiden</surname><given-names initials="MG">Matthew G.</given-names></name><xref ref-type="aff" rid="Aff248">248</xref><xref ref-type="aff" rid="Aff249">249</xref><xref ref-type="aff" rid="Aff250">250</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vanderluit</surname><given-names initials="JL">Jacqueline L.</given-names></name><xref ref-type="aff" rid="Aff251">251</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Verkhratsky</surname><given-names initials="A">Alexei</given-names></name><xref ref-type="aff" rid="Aff252">252</xref><xref ref-type="aff" rid="Aff253">253</xref><xref ref-type="aff" rid="Aff254">254</xref><xref ref-type="aff" rid="Aff255">255</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Villunger</surname><given-names initials="A">Andreas</given-names></name><xref ref-type="aff" rid="Aff256">256</xref><xref ref-type="aff" rid="Aff257">257</xref><xref ref-type="aff" rid="Aff258">258</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>von Karstedt</surname><given-names initials="S">Silvia</given-names></name><xref ref-type="aff" rid="Aff259">259</xref><xref ref-type="aff" rid="Aff260">260</xref><xref ref-type="aff" rid="Aff261">261</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Voss</surname><given-names initials="AK">Anne K.</given-names></name><xref ref-type="aff" rid="Aff63">63</xref><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vousden</surname><given-names initials="KH">Karen H.</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vucic</surname><given-names initials="D">Domagoj</given-names></name><xref ref-type="aff" rid="Aff262">262</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vuri</surname><given-names initials="D">Daniela</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wagner</surname><given-names initials="EF">Erwin F.</given-names></name><xref ref-type="aff" rid="Aff263">263</xref><xref ref-type="aff" rid="Aff264">264</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Walczak</surname><given-names initials="H">Henning</given-names></name><xref ref-type="aff" rid="Aff149">149</xref><xref ref-type="aff" rid="Aff260">260</xref><xref ref-type="aff" rid="Aff265">265</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wallach</surname><given-names initials="D">David</given-names></name><xref ref-type="aff" rid="Aff266">266</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="R">Ruoning</given-names></name><xref ref-type="aff" rid="Aff267">267</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Ying</given-names></name><xref ref-type="aff" rid="Aff268">268</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weber</surname><given-names initials="A">Achim</given-names></name><xref ref-type="aff" rid="Aff269">269</xref><xref ref-type="aff" rid="Aff270">270</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wood</surname><given-names initials="W">Will</given-names></name><xref ref-type="aff" rid="Aff271">271</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yamazaki</surname><given-names initials="T">Takahiro</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="HT">Huang-Tian</given-names></name><xref ref-type="aff" rid="Aff268">268</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zakeri</surname><given-names initials="Z">Zahra</given-names></name><xref ref-type="aff" rid="Aff272">272</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zawacka-Pankau</surname><given-names initials="JE">Joanna E.</given-names></name><xref ref-type="aff" rid="Aff273">273</xref><xref ref-type="aff" rid="Aff274">274</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="L">Lin</given-names></name><xref ref-type="aff" rid="Aff275">275</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="H">Haibing</given-names></name><xref ref-type="aff" rid="Aff276">276</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhivotovsky</surname><given-names initials="B">Boris</given-names></name><xref ref-type="aff" rid="Aff129">129</xref><xref ref-type="aff" rid="Aff277">277</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="W">Wenzhao</given-names></name><xref ref-type="aff" rid="Aff236">236</xref><xref ref-type="aff" rid="Aff237">237</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2919-1296</contrib-id><name name-style="western"><surname>Piacentini</surname><given-names initials="M">Mauro</given-names></name><xref ref-type="aff" rid="Aff48">48</xref><xref ref-type="aff" rid="Aff278">278</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9334-4405</contrib-id><name name-style="western"><surname>Kroemer</surname><given-names initials="G">Guido</given-names></name><xref ref-type="aff" rid="Aff134">134</xref><xref ref-type="aff" rid="Aff135">135</xref><xref ref-type="aff" rid="Aff279">279</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2257-8500</contrib-id><name name-style="western"><surname>Galluzzi</surname><given-names initials="L">Lorenzo</given-names></name><address><email>deadoc80@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff33">33</xref><xref ref-type="aff" rid="Aff280">280</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.428948.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1784 6598</institution-id><institution>IIGM - Italian Institute for Genomic Medicine, c/o IRCSS Candiolo, </institution></institution-wrap>Torino, Italy </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.419555.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 7675</institution-id><institution>Candiolo Cancer Institute, FPO -IRCCS, </institution></institution-wrap>Candiolo, Italy </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Department of Biosciences and Nutrition, </institution><institution>Karolinska Institute, </institution></institution-wrap>Huddinge, Sweden </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Radiation Oncology, </institution><institution>Weill Cornell Medical College, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York City, NY USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>Department of Cell Biology, </institution><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX USA </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.9764.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2153 9986</institution-id><institution>Institut f&#252;r Immunologie, </institution><institution>Kiel University, </institution></institution-wrap>Kiel, Germany </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.6530.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2300 0941</institution-id><institution>Department of Experimental Medicine, </institution><institution>University of Rome Tor Vergata, TOR, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution>Department of Cellular and Molecular Medicine, </institution><institution>KU Leuven, </institution></institution-wrap>Leuven, Belgium </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.511459.d</institution-id><institution>VIB Center for Cancer Biology, </institution></institution-wrap>Leuven, Belgium </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.265008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2166 5843</institution-id><institution>Department of Biochemistry and Molecular Biology, </institution><institution>Thomas Jefferson University, </institution></institution-wrap>Philadelphia, PA USA </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.9841.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2200 8888</institution-id><institution>Department of Precision Medicine, </institution><institution>University of Campania Luigi Vanvitelli, </institution></institution-wrap>Naples, Italy </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.428067.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 4674 1402</institution-id><institution>BIOGEM, </institution></institution-wrap>Avellino, Italy </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.9811.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0658 7699</institution-id><institution>Division of Systems Toxicology, Department of Biology, </institution><institution>University of Konstanz, </institution></institution-wrap>Konstanz, Germany </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution>Sunnybrook Research Institute, </institution></institution-wrap>Toronto, ON Canada </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution>Departments of Biochemistry and Medical Biophysics, </institution><institution>University of Toronto, </institution></institution-wrap>Toronto, ON Canada </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.9619.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0538</institution-id><institution>Hebrew University of Jerusalem, Lautenberg Center for Immunology &amp; Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), Faculty of Medicine, </institution></institution-wrap>Jerusalem, Israel </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.13992.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0604 7563</institution-id><institution>Department of Molecular Genetics, </institution><institution>Weizmann Institute of Science, </institution></institution-wrap>Rehovot, Israel </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.168645.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0742 0364</institution-id><institution>Department of Molecular, Cell and Cancer Biology, </institution><institution>University of Massachusetts Chan Medical School, </institution></institution-wrap>Worcester, MA USA </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.249335.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2218 7820</institution-id><institution>Blood Cell Development and Function Program, Fox Chase Cancer Center, </institution></institution-wrap>Philadelphia, PA USA </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution>Deutsches Zentrum f&#252;r Neurodegenerative Erkrankungen (DZNE), </institution></institution-wrap>Bonn, Germany </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.428191.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0495 7803</institution-id><institution>Department of Biomedicine, </institution><institution>Nazarbayev University School of Medicine, </institution></institution-wrap>Astana, Kazakhstan </aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Department of Medical Biochemistry and Biophysics, </institution><institution>Science for Life Laboratory, Karolinska Institute, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.417390.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2175 6024</institution-id><institution>Danish Cancer Society Research Center, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.279863.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 8954 1233</institution-id><institution>Neuroscience Center of Excellence, </institution><institution>School of Medicine, Louisiana State University Health New Orleans, </institution></institution-wrap>New Orleans, LA USA </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution>Department of Medicine 1, </institution><institution>Friedrich-Alexander-University Erlangen-Nuremberg, </institution></institution-wrap>Erlangen, Germany </aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.510970.a</institution-id><institution>VIB-UGent Center for Inflammation Research, </institution></institution-wrap>Ghent, Belgium </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.5342.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2069 7798</institution-id><institution>Department of Biomedical Molecular Biology, </institution><institution>Ghent University, </institution></institution-wrap>Ghent, Belgium </aff><aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.15496.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0439 0892</institution-id><institution>Universit&#224; Vita-Salute San Raffaele, School of Medicine, Milan, Italy and Ospedale San Raffaele IRCSS, </institution></institution-wrap>Milan, Italy </aff><aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.240614.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 8635</institution-id><institution>Roswell Park Comprehensive Cancer Center, </institution></institution-wrap>Buffalo, NY USA </aff><aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Medicine, </institution><institution>Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Microbiology and Immunology, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Sandra and Edward Meyer Cancer Center, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.417520.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1760 5276</institution-id><institution>IRCSS Regina Elena National Cancer Institute, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Department of Women&#8217;s and Children&#8217;s Health, </institution><institution>Karolinska Institute, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.24381.3c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9241 5705</institution-id><institution>Pediatric Hematology and Oncology, </institution><institution>Karolinska University Hospital, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.5963.9</institution-id><institution>Institute of Molecular Medicine and Cell Research, Medical Faculty, </institution><institution>Albert Ludwigs University of Freiburg, </institution></institution-wrap>Freiburg, Germany </aff><aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.280664.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2110 5790</institution-id><institution>Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, </institution></institution-wrap>Durham, NC USA </aff><aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="GRID">grid.418281.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1794 0752</institution-id><institution>Centro de Investigaciones Biologicas Margarita Salas, CSIC, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="GRID">grid.14925.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2284 9388</institution-id><institution>Universit&#233; Paris-Saclay, CNRS, Institut Gustave Roussy, Aspects m&#233;taboliques et syst&#233;miques de l&#8217;oncog&#233;n&#232;se pour de nouvelles approches th&#233;rapeutiques, </institution></institution-wrap>Villejuif, France </aff><aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="GRID">grid.9851.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2165 4204</institution-id><institution>Department of Immunobiology, </institution><institution>University of Lausanne, </institution></institution-wrap>Epalinges, Vaud, Switzerland </aff><aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.9811.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0658 7699</institution-id><institution>Department of Biology, </institution><institution>University of Konstanz, </institution></institution-wrap>Konstanz, Germany </aff><aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.5170.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 8870</institution-id><institution>Department of Biotechnology and Biomedicine, </institution><institution>Technical University of Denmark, </institution></institution-wrap>Kongens Lyngby, Denmark </aff><aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Translational Molecular Pathology, </institution><institution>The University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Center for RNA Interference and Non-Coding RNAs, </institution><institution>The University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="GRID">grid.4464.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2161 2573</institution-id><institution>Department of Comparative Biomedical Sciences, The Royal Veterinary College, </institution><institution>University of London, </institution></institution-wrap>London, UK </aff><aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>UCL Consortium for Mitochondrial Research, </institution></institution-wrap>London, UK </aff><aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="GRID">grid.6530.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2300 0941</institution-id><institution>Department of Biology, </institution><institution>University of Rome Tor Vergata, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="GRID">grid.516097.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0311 6891</institution-id><institution>Thoracic Oncology, </institution><institution>University of Hawaii Cancer Center, </institution></institution-wrap>Honolulu, HI USA </aff><aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="GRID">grid.5110.5</institution-id><institution-id institution-id-type="ISNI">0000000121539003</institution-id><institution>Institute of Molecular Biosciences, NAWI Graz, </institution><institution>University of Graz, </institution></institution-wrap>Graz, Austria </aff><aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="GRID">grid.417390.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2175 6024</institution-id><institution>Cell Stress and Survival Unit, Center for Autophagy, Recycling and Disease (CARD), Danish Cancer Society Research Center, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="GRID">grid.414603.4</institution-id><institution>Fondazione Policlinico Universitario A. Gemelli IRCCS, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="GRID">grid.8142.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 3192</institution-id><institution>Universit&#224; Cattolica del Sacro Cuore, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Department of Immunology, </institution><institution>Duke University School of Medicine, </institution></institution-wrap>Durham, NC USA </aff><aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>State Key Lab of Oncogene and its related gene, Ren-Ji Hospital, </institution><institution>Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>Shanghai, China </aff><aff id="Aff56"><label>56</label><institution-wrap><institution-id institution-id-type="GRID">grid.216938.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 9878 7032</institution-id><institution>College of Life Sciences, </institution><institution>Nankai University, </institution></institution-wrap>Tianjin, China </aff><aff id="Aff57"><label>57</label><institution-wrap><institution-id institution-id-type="GRID">grid.458489.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0483 7922</institution-id><institution>Shenzhen Institute of Advanced Technology (SIAT), </institution></institution-wrap>Shenzhen, Guangdong China </aff><aff id="Aff58"><label>58</label><institution-wrap><institution-id institution-id-type="GRID">grid.51462.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9952</institution-id><institution>Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff59"><label>59</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Oncological Sciences, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff60"><label>60</label><institution-wrap><institution-id institution-id-type="GRID">grid.6451.6</institution-id><institution-id institution-id-type="ISNI">0000000121102151</institution-id><institution>The Technion-Integrated Cancer Center, The Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, </institution></institution-wrap>Haifa, Israel </aff><aff id="Aff61"><label>61</label>Helmholtz Munich, Institute of Metabolism and Cell Death, Neuherberg, Germany </aff><aff id="Aff62"><label>62</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Department of Obstetrics and Gynecology, </institution><institution>Weill Cornell Medical College, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff63"><label>63</label><institution-wrap><institution-id institution-id-type="GRID">grid.1042.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0432 4889</institution-id><institution>The Walter and Eliza Hall Institute of Medical Research, </institution></institution-wrap>Melbourne, Victoria Australia </aff><aff id="Aff64"><label>64</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Department of Medical Biology, </institution><institution>The University of Melbourne, </institution></institution-wrap>Melbourne, Victoria Australia </aff><aff id="Aff65"><label>65</label><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Department of Oncology, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, UK </aff><aff id="Aff66"><label>66</label><institution-wrap><institution-id institution-id-type="GRID">grid.412541.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0684 7796</institution-id><institution>Department of Urologic Sciences, </institution><institution>Vancouver Prostate Centre, </institution></institution-wrap>Vancouver, BC Canada </aff><aff id="Aff67"><label>67</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Institute for Cell Engineering and the Departments of Neurology, Neuroscience and Pharmacology &amp; Molecular Sciences, </institution><institution>Johns Hopkins University School of Medicine, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff68"><label>68</label>VIB Centre for Brain &amp; Disease Research, Leuven, Belgium </aff><aff id="Aff69"><label>69</label><institution-wrap><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution>Department of Neurosciences, </institution><institution>Leuven Brain Institute, KU Leuven, </institution></institution-wrap>Leuven, Belgium </aff><aff id="Aff70"><label>70</label><institution-wrap><institution-id institution-id-type="GRID">grid.451388.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1795 1830</institution-id><institution>The Francis Crick Institute, </institution></institution-wrap>London, UK </aff><aff id="Aff71"><label>71</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>UK Dementia Research Institute at UCL, University College London, </institution></institution-wrap>London, UK </aff><aff id="Aff72"><label>72</label><institution-wrap><institution-id institution-id-type="GRID">grid.410712.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0473 882X</institution-id><institution>Department of Pediatrics and Adolescent Medicine, </institution><institution>Ulm University Medical Center, </institution></institution-wrap>Ulm, Germany </aff><aff id="Aff73"><label>73</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>Howard Hughes Medical Institute and Children&#8217;s Medical Center Research Institute, </institution><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX USA </aff><aff id="Aff74"><label>74</label><institution-wrap><institution-id institution-id-type="GRID">grid.429997.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7531</institution-id><institution>Department of Developmental, </institution><institution>Molecular and Chemical Biology, Tufts University School of Medicine, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff75"><label>75</label><institution-wrap><institution-id institution-id-type="GRID">grid.5133.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 1941 4308</institution-id><institution>Department of Life Sciences, </institution><institution>University of Trieste, </institution></institution-wrap>Trieste, Italy </aff><aff id="Aff76"><label>76</label><institution-wrap><institution-id institution-id-type="GRID">grid.425196.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 4810</institution-id><institution>International Centre for Genetic Engineering and Biotechnology (ICGEB), Area Science Park-Padriciano, </institution></institution-wrap>Trieste, Italy </aff><aff id="Aff77"><label>77</label>IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy </aff><aff id="Aff78"><label>78</label><institution-wrap><institution-id institution-id-type="GRID">grid.410711.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 1034 1720</institution-id><institution>Department of Cell Biology and Physiology, </institution><institution>University of North Carolina, </institution></institution-wrap>Chapel Hill, NC USA </aff><aff id="Aff79"><label>79</label><institution-wrap><institution-id institution-id-type="GRID">grid.8484.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2064</institution-id><institution>Department of Medical Sciences, </institution><institution>University of Ferrara, </institution></institution-wrap>Ferrara, Italy </aff><aff id="Aff80"><label>80</label><institution-wrap><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution>College of Pharmacy, Seoul National University, </institution></institution-wrap>Seoul, South Korea </aff><aff id="Aff81"><label>81</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Department of Biology, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff><aff id="Aff82"><label>82</label><institution-wrap><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution>Department of Pathology, New York University Cancer Institute, </institution><institution>New York University School of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff83"><label>83</label><institution-wrap><institution-id institution-id-type="GRID">grid.40263.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9094</institution-id><institution>Division of Hematology/Oncology, </institution><institution>Brown University and the Lifespan Cancer Institute, </institution></institution-wrap>Providence, RI USA </aff><aff id="Aff84"><label>84</label><institution-wrap><institution-id institution-id-type="GRID">grid.40263.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9094</institution-id><institution>Legorreta Cancer Center at Brown University, The Warren Alpert Medical School, </institution><institution>Brown University, </institution></institution-wrap>Providence, RI USA </aff><aff id="Aff85"><label>85</label><institution-wrap><institution-id institution-id-type="GRID">grid.40263.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9094</institution-id><institution>Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, </institution><institution>Brown University, </institution></institution-wrap>Providence, RI USA </aff><aff id="Aff86"><label>86</label><institution-wrap><institution-id institution-id-type="GRID">grid.264727.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2248 3398</institution-id><institution>Cardiovascular Research Center, </institution><institution>Lewis Katz School of Medicine at Temple University, </institution></institution-wrap>Philadelphia, PA USA </aff><aff id="Aff87"><label>87</label><institution-wrap><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Molecular Oncology, </institution><institution>University of Leipzig, </institution></institution-wrap>Leipzig, Germany </aff><aff id="Aff88"><label>88</label><institution-wrap><institution-id institution-id-type="GRID">grid.414603.4</institution-id><institution>Department of Epidemiology, </institution><institution>Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases &#8216;L. Spallanzani&#8217; IRCCS, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff89"><label>89</label><institution-wrap><institution-id institution-id-type="GRID">grid.7841.a</institution-id><institution>Department of Molecular Medicine, </institution><institution>Sapienza University of Rome, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff90"><label>90</label><institution-wrap><institution-id institution-id-type="GRID">grid.419457.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 0179</institution-id><institution>Biochemistry Laboratory, </institution><institution>Dermopatic Institute of Immaculate (IDI) IRCCS, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff91"><label>91</label><institution-wrap><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>CECAD, Institute of Genetics, </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff92"><label>92</label><institution-wrap><institution-id institution-id-type="GRID">grid.7429.8</institution-id><institution-id institution-id-type="ISNI">0000000121866389</institution-id><institution>INSERM, UMR, </institution></institution-wrap>1231 Dijon, France </aff><aff id="Aff93"><label>93</label><institution-wrap><institution-id institution-id-type="GRID">grid.493090.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 4910 6615</institution-id><institution>Faculty of Medicine, </institution><institution>Universit&#233; de Bourgogne Franche-Comt&#233;, </institution></institution-wrap>Dijon, France </aff><aff id="Aff94"><label>94</label>Anti-cancer Center Georges-Fran&#231;ois Leclerc, Dijon, France </aff><aff id="Aff95"><label>95</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Biochemistry, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff96"><label>96</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Medicine, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff97"><label>97</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Albert Einstein Cancer Center, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff98"><label>98</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Institute for Aging Research, Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff99"><label>99</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff100"><label>100</label><institution-wrap><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution>Department of Clinical Microbiology and Immunology, Sackler school of Medicine, </institution><institution>Tel Aviv university, </institution></institution-wrap>Tel Aviv, Israel </aff><aff id="Aff101"><label>101</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Neurology and Department of Pharmacology, </institution><institution>Yale School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff><aff id="Aff102"><label>102</label><institution-wrap><institution-id institution-id-type="GRID">grid.240871.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0224 711X</institution-id><institution>Department of Immunology, </institution><institution>St Jude Children&#8217;s Research Hospital, </institution></institution-wrap>Memphis, TN USA </aff><aff id="Aff103"><label>103</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Pathology and Cell Biology, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff104"><label>104</label><institution-wrap><institution-id institution-id-type="GRID">grid.420255.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0638 2716</institution-id><institution>Department of Functional Genomics and Cancer, </institution><institution>Institut de G&#233;n&#233;tique et de Biologie Mol&#233;culaire et Cellulaire (IGBMC), </institution></institution-wrap>Illkirch, France </aff><aff id="Aff105"><label>105</label><institution-wrap><institution-id institution-id-type="GRID">grid.4444.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2112 9282</institution-id><institution>Centre National de la Recherche Scientifique, UMR7104, </institution></institution-wrap>Illkirch, France </aff><aff id="Aff106"><label>106</label><institution-wrap><institution-id institution-id-type="GRID">grid.420255.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0638 2716</institution-id><institution>Institut National de la Sant&#233; et de la Recherche M&#233;dicale, </institution></institution-wrap>U1258 Illkirch, France </aff><aff id="Aff107"><label>107</label><institution-wrap><institution-id institution-id-type="GRID">grid.420255.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0638 2716</institution-id><institution>Universit&#233; de Strasbourg, </institution></institution-wrap>Illkirch, France </aff><aff id="Aff108"><label>108</label><institution-wrap><institution-id institution-id-type="GRID">grid.5963.9</institution-id><institution>Faculty of Medicine, Institute of Medical Microbiology and Hygiene, Medical Center, </institution><institution>University of Freiburg, </institution></institution-wrap>Freiburg, Germany </aff><aff id="Aff109"><label>109</label><institution-wrap><institution-id institution-id-type="GRID">grid.5963.9</institution-id><institution>BIOSS Centre for Biological Signalling Studies, </institution><institution>University of Freiburg, </institution></institution-wrap>Freiburg, Germany </aff><aff id="Aff110"><label>110</label><institution-wrap><institution-id institution-id-type="GRID">grid.265008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2166 5843</institution-id><institution>MitoCare Center, Department of Pathology, Anatomy and Cell Biology, </institution><institution>Thomas Jefferson University, </institution></institution-wrap>Philadelphia, PA USA </aff><aff id="Aff111"><label>111</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Department of Molecular Microbiology and Immunology, </institution><institution>Johns Hopkins Bloomberg School of Public Health, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff112"><label>112</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Departments of Molecular Microbiology and Immunology, Pharmacology, Oncology and Neurology, </institution><institution>Johns Hopkins Bloomberg School of Public Health and School of Medicine, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff113"><label>113</label>VITTAIL Ltd, Melbourne, VIC Australia </aff><aff id="Aff114"><label>114</label><institution-wrap><institution-id institution-id-type="GRID">grid.1055.1</institution-id><institution-id institution-id-type="ISNI">0000000403978434</institution-id><institution>Peter MacCallum Cancer Centre, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff115"><label>115</label><institution-wrap><institution-id institution-id-type="GRID">grid.506261.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0706 7839</institution-id><institution>Institute of Systems Medicine, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, </institution></institution-wrap>Beijing, China </aff><aff id="Aff116"><label>116</label><institution-wrap><institution-id institution-id-type="GRID">grid.494590.5</institution-id><institution>Suzhou Institute of Systems Medicine, </institution></institution-wrap>Suzhou, Jiangsu China </aff><aff id="Aff117"><label>117</label><institution-wrap><institution-id institution-id-type="GRID">grid.4563.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8868</institution-id><institution>School of Pharmacy, </institution><institution>University of Nottingham, </institution></institution-wrap>Nottingham, UK </aff><aff id="Aff118"><label>118</label><institution-wrap><institution-id institution-id-type="GRID">grid.451538.e</institution-id><institution>ETH Board, </institution></institution-wrap>Zurich, Switzerland </aff><aff id="Aff119"><label>119</label><institution-wrap><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution>Biomedical Neuroscience Institute, Faculty of Medicine, </institution><institution>University of Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff120"><label>120</label>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile </aff><aff id="Aff121"><label>121</label><institution-wrap><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution>Center for Molecular Studies of the Cell, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, </institution><institution>University of Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff122"><label>122</label><institution-wrap><institution-id institution-id-type="GRID">grid.272799.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8687 5377</institution-id><institution>Buck Institute for Research on Aging, </institution></institution-wrap>Novato, CA USA </aff><aff id="Aff123"><label>123</label><institution-wrap><institution-id institution-id-type="GRID">grid.239573.9</institution-id><institution-id institution-id-type="ISNI">0000 0000 9025 8099</institution-id><institution>Division of Immunobiology, </institution><institution>Cincinnati Children&#8217;s Hospital Medical Center, </institution></institution-wrap>Cincinnati, OH USA </aff><aff id="Aff124"><label>124</label><institution-wrap><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2151 536X</institution-id><institution>Laboratory of Cell Signaling, </institution><institution>The University of Tokyo, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff125"><label>125</label><institution-wrap><institution-id institution-id-type="GRID">grid.272242.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2168 5385</institution-id><institution>National Cancer Center Research Institute, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff126"><label>126</label><institution-wrap><institution-id institution-id-type="GRID">grid.417390.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2175 6024</institution-id><institution>Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff127"><label>127</label><institution-wrap><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution>Department of Cellular and Molecular Medicine, </institution><institution>University of Copenhagen, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff128"><label>128</label><institution-wrap><institution-id institution-id-type="GRID">grid.5612.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2172 2676</institution-id><institution>Department of Medicine and Life Sciences, </institution><institution>Pompeu Fabra University, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff129"><label>129</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Institute of Environmental Medicine, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff130"><label>130</label><institution-wrap><institution-id institution-id-type="GRID">grid.11598.34</institution-id><institution-id institution-id-type="ISNI">0000 0000 8988 2476</institution-id><institution>Clinical Division of Oncology, Department of Internal Medicine, </institution><institution>Medical University of Graz, </institution></institution-wrap>Graz, Austria </aff><aff id="Aff131"><label>131</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Departments of Pharmacology and Pathology, School of Medicine, </institution><institution>University of California San Diego, </institution></institution-wrap>San Diego, CA USA </aff><aff id="Aff132"><label>132</label><institution-wrap><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>CECAD Research Center, Institute for Molecular Immunology, </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff133"><label>133</label><institution-wrap><institution-id institution-id-type="GRID">grid.5734.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 5157</institution-id><institution>Institute of Pharmacology, </institution><institution>University of Bern, </institution></institution-wrap>Bern, Switzerland </aff><aff id="Aff134"><label>134</label><institution-wrap><institution-id institution-id-type="GRID">grid.460789.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4910 6535</institution-id><institution>Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, </institution><institution>Universit&#233; Paris Saclay, </institution></institution-wrap>Villejuif, France </aff><aff id="Aff135"><label>135</label>Centre de Recherche des Cordeliers, Equipe labellis&#233;e par la Ligue contre le cancer, Universit&#233; de Paris, Sorbonne Universit&#233;, Inserm U1138, Institut Universitaire de France, Paris, France </aff><aff id="Aff136"><label>136</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Cell Biology, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff137"><label>137</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Einstein-Mount Sinai Diabetes Research Center, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff138"><label>138</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Life Sciences Institute, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI USA </aff><aff id="Aff139"><label>139</label><institution-wrap><institution-id institution-id-type="GRID">grid.5342.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2069 7798</institution-id><institution>Cell Death Investigation and Therapy Lab, Department of Human Structure and Repair, </institution><institution>Ghent University, </institution></institution-wrap>Ghent, Belgium </aff><aff id="Aff140"><label>140</label><institution-wrap><institution-id institution-id-type="GRID">grid.510942.b</institution-id><institution>Cancer Research Institute Ghent (CRIG), </institution></institution-wrap>Ghent, Belgium </aff><aff id="Aff141"><label>141</label><institution-wrap><institution-id institution-id-type="GRID">grid.4488.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id><institution>Department of Dermatology, </institution><institution>Experimental Dermatology, TU-Dresden, </institution></institution-wrap>Dresden, Germany </aff><aff id="Aff142"><label>142</label><institution-wrap><institution-id institution-id-type="GRID">grid.4488.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id><institution>National Center for Tumor Diseases Dresden, TU-Dresden, </institution></institution-wrap>Dresden, Germany </aff><aff id="Aff143"><label>143</label><institution-wrap><institution-id institution-id-type="GRID">grid.470344.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0450 082X</institution-id><institution>Centre for Cancer Biology, University of South Australia, </institution></institution-wrap>Adelaide, SA Australia </aff><aff id="Aff144"><label>144</label><institution-wrap><institution-id institution-id-type="GRID">grid.1010.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7304</institution-id><institution>Faculty of Health and Medical Sciences, The University of Adelaide, </institution></institution-wrap>Adelaide, SA Australia </aff><aff id="Aff145"><label>145</label><institution-wrap><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution>Universidad de Chile, Facultad Ciencias Quimicas y Farmaceuticas &amp; Facultad Medicina, Advanced Center for Chronic Diseases (ACCDiS), </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff146"><label>146</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>Department of Internal Medicine, Cardiology Division, </institution><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX USA </aff><aff id="Aff147"><label>147</label><institution-wrap><institution-id institution-id-type="GRID">grid.5807.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 1018 4307</institution-id><institution>Translational Inflammation Research, Medical Faculty, </institution><institution>Otto von Guericke University, </institution></institution-wrap>Magdeburg, Germany </aff><aff id="Aff148"><label>148</label><institution-wrap><institution-id institution-id-type="GRID">grid.259828.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2189 3475</institution-id><institution>Departments of Drug Discovery &amp; Biomedical Sciences and Biochemistry &amp; Molecular Biology, </institution><institution>Medical University of South Carolina, </institution></institution-wrap>Charleston, SC USA </aff><aff id="Aff149"><label>149</label><institution-wrap><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Center for Biochemistry, Medical Faculty, </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff150"><label>150</label><institution-wrap><institution-id institution-id-type="GRID">grid.412282.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 1091 2917</institution-id><institution>Division of Nephrology, Department of Internal Medicine 3, </institution><institution>University Hospital Carl Gustav Carus, Technische Universit&#228;t Dresden, </institution></institution-wrap>Dresden, Germany </aff><aff id="Aff151"><label>151</label><institution-wrap><institution-id institution-id-type="GRID">grid.4488.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id><institution>Biotechnology Center, Technische Universit&#228;t Dresden, </institution></institution-wrap>Dresden, Germany </aff><aff id="Aff152"><label>152</label><institution-wrap><institution-id institution-id-type="GRID">grid.214007.0</institution-id><institution-id institution-id-type="ISNI">0000000122199231</institution-id><institution>Neurodegeneration New Medicines Center and Department of Molecular Medicine, The Scripps Research Institute, </institution></institution-wrap>La Jolla, CA USA </aff><aff id="Aff153"><label>153</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Neurosciences, </institution><institution>University of California, San Diego, School of Medicine, </institution></institution-wrap>La Jolla, CA USA </aff><aff id="Aff154"><label>154</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Neurology, </institution><institution>Yale School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff><aff id="Aff155"><label>155</label><institution-wrap><institution-id institution-id-type="GRID">grid.262273.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 3760</institution-id><institution>Department of Biology, </institution><institution>Queens College of the City University of New York, </institution></institution-wrap>Flushing, NY USA </aff><aff id="Aff156"><label>156</label><institution-wrap><institution-id institution-id-type="GRID">grid.264091.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 1954 7928</institution-id><institution>St. John&#8217;s University, </institution></institution-wrap>Jamaica, NY USA </aff><aff id="Aff157"><label>157</label><institution-wrap><institution-id institution-id-type="GRID">grid.10863.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2164 6351</institution-id><institution>Departamento de Bioqu&#237;mica y Biolog&#237;a Molecular, Facultad de Medicina, </institution><institution>Instituto Universitario de Oncolog&#237;a (IUOPA), Universidad de Oviedo, </institution></institution-wrap>Oviedo, Spain </aff><aff id="Aff158"><label>158</label><institution-wrap><institution-id institution-id-type="GRID">grid.411327.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 9917</institution-id><institution>Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, </institution><institution>Heinrich Heine University, </institution></institution-wrap>Duesseldorf, Germany </aff><aff id="Aff159"><label>159</label><institution-wrap><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution>Medical Research Council Toxicology Unit, </institution><institution>University of Cambridge, </institution></institution-wrap>Cambridge, UK </aff><aff id="Aff160"><label>160</label><institution-wrap><institution-id institution-id-type="GRID">grid.452216.6</institution-id><institution>BioTechMed Graz, </institution></institution-wrap>Graz, Austria </aff><aff id="Aff161"><label>161</label><institution-wrap><institution-id institution-id-type="GRID">grid.5110.5</institution-id><institution-id institution-id-type="ISNI">0000000121539003</institution-id><institution>Field of Excellence BioHealth - University of Graz, </institution></institution-wrap>Graz, Austria </aff><aff id="Aff162"><label>162</label><institution-wrap><institution-id institution-id-type="GRID">grid.8142.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 3192</institution-id><institution>Center for Global Health, </institution><institution>Universit&#224; Cattolica del Sacro Cuore, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff163"><label>163</label><institution-wrap><institution-id institution-id-type="GRID">grid.4708.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2822</institution-id><institution>Dipartimento di Bioscienze, </institution><institution>Universit&#224; degli Studi di Milano, </institution></institution-wrap>Milano, Italy </aff><aff id="Aff164"><label>164</label><institution-wrap><institution-id institution-id-type="GRID">grid.7010.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 1017 3210</institution-id><institution>Department of Clinical and Molecular Sciences, </institution><institution>Marche Polytechnic University, </institution></institution-wrap>Ancona, Italy </aff><aff id="Aff165"><label>165</label><institution-wrap><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution>Department of Oncology, </institution><institution>KU Leuven, </institution></institution-wrap>Leuven, Belgium </aff><aff id="Aff166"><label>166</label><institution-wrap><institution-id institution-id-type="GRID">grid.8217.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9705</institution-id><institution>Department of Genetics, </institution><institution>Trinity College, </institution></institution-wrap>Dublin, 2 Ireland </aff><aff id="Aff167"><label>167</label><institution-wrap><institution-id institution-id-type="GRID">grid.8591.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 4988</institution-id><institution>Department of Cell Biology, Faculty of Sciences, </institution><institution>University of Geneva, </institution></institution-wrap>Geneva, Switzerland </aff><aff id="Aff168"><label>168</label>Department of Molecular Genetics, Rotterdam, the Netherlands </aff><aff id="Aff169"><label>169</label>IFOM-ETS The AIRC Institute for Molecular Oncology, Milan, Italy </aff><aff id="Aff170"><label>170</label><institution-wrap><institution-id institution-id-type="GRID">grid.158820.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2611</institution-id><institution>Department of Life, Health, and Environmental Sciences, </institution><institution>University of L&#8217;Aquila, </institution></institution-wrap>L&#8217;Aquila, Italy </aff><aff id="Aff171"><label>171</label><institution-wrap><institution-id institution-id-type="GRID">grid.7177.6</institution-id><institution-id institution-id-type="ISNI">0000000084992262</institution-id><institution>Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, </institution><institution>University of Amsterdam, </institution></institution-wrap>Amsterdam, The Netherlands </aff><aff id="Aff172"><label>172</label><institution-wrap><institution-id institution-id-type="GRID">grid.7177.6</institution-id><institution-id institution-id-type="ISNI">0000000084992262</institution-id><institution>Oncode Institute, Amsterdam UMC, </institution><institution>University of Amsterdam, </institution></institution-wrap>Amsterdam, The Netherlands </aff><aff id="Aff173"><label>173</label><institution-wrap><institution-id institution-id-type="GRID">grid.462282.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 0005</institution-id><institution>Apoptosis, Cancer, and Development Laboratory, Equipe labellis&#233;e &#8216;La Ligue&#8217;, LabEx DEVweCAN, Centre de Recherche en Canc&#233;rologie de Lyon, INSERM U1052-CNRS UMR5286, Centre L&#233;on B&#233;rard, Universit&#233; de Lyon, Universit&#233; Claude Bernard Lyon1, </institution></institution-wrap>Lyon, France </aff><aff id="Aff174"><label>174</label><institution-wrap><institution-id institution-id-type="GRID">grid.18886.3f</institution-id><institution>The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, </institution></institution-wrap>London, UK </aff><aff id="Aff175"><label>175</label><institution-wrap><institution-id institution-id-type="GRID">grid.6530.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2300 0941</institution-id><institution>Department of Chemical Science and Technologies, </institution><institution>University of Rome Tor Vergata, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff176"><label>176</label><institution-wrap><institution-id institution-id-type="GRID">grid.36425.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2216 9681</institution-id><institution>Department of Pathology and Stony Brook Cancer Center, Renaissance School of Medicine, </institution><institution>Stony Brook University, </institution></institution-wrap>Stony Brook, NY USA </aff><aff id="Aff177"><label>177</label><institution-wrap><institution-id institution-id-type="GRID">grid.418284.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0427 2257</institution-id><institution>Institut d&#8217;Investigaci&#243; Biom&#232;dica de Bellvitge (IDIBELL), </institution></institution-wrap>L&#8217;Hospitalet de Llobregat, Spain </aff><aff id="Aff178"><label>178</label><institution-wrap><institution-id institution-id-type="GRID">grid.8756.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 314X</institution-id><institution>School of Cancer Sciences, </institution><institution>University of Glasgow, </institution></institution-wrap>Glasgow, UK </aff><aff id="Aff179"><label>179</label><institution-wrap><institution-id institution-id-type="GRID">grid.23636.32</institution-id><institution-id institution-id-type="ISNI">0000 0000 8821 5196</institution-id><institution>Cancer Research UK Beatson Institute, </institution></institution-wrap>Glasgow, UK </aff><aff id="Aff180"><label>180</label><institution-wrap><institution-id institution-id-type="GRID">grid.7340.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2162 1699</institution-id><institution>Department of Pharmacy &amp; Pharmacology, Centre for Therapeutic Innovation, </institution><institution>University of Bath, </institution></institution-wrap>Bath, UK </aff><aff id="Aff181"><label>181</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Department of Pathology and Rogel Cancer Center, </institution><institution>The University of Michigan, </institution></institution-wrap>Ann Arbor, MI USA </aff><aff id="Aff182"><label>182</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Department of Immunology, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff183"><label>183</label><institution-wrap><institution-id institution-id-type="GRID">grid.417555.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 8814 392X</institution-id><institution>Rare and Neuroscience Therapeutic Area, Sanofi, </institution></institution-wrap>Cambridge, MA USA </aff><aff id="Aff184"><label>184</label><institution-wrap><institution-id institution-id-type="GRID">grid.240871.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0224 711X</institution-id><institution>Department of Cell and Molecular Biology, </institution><institution>St. Jude Children&#8217;s Research Hospital, </institution></institution-wrap>Memphis, TN USA </aff><aff id="Aff185"><label>185</label><institution-wrap><institution-id institution-id-type="GRID">grid.13992.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0604 7563</institution-id><institution>Department of Molecular Cell Biology, </institution><institution>The Weizmann Institute, </institution></institution-wrap>Rehovot, Israel </aff><aff id="Aff186"><label>186</label><institution-wrap><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution>Department of Biochemistry and Molecular Pharmacology, </institution><institution>New York University Grossman School of Medicine and Howard Hughes Medical Institute, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff187"><label>187</label><institution-wrap><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of GU Medical Oncology, </institution><institution>MD Anderson Cancer Center, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff188"><label>188</label><institution-wrap><institution-id institution-id-type="GRID">grid.417521.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0008 2788</institution-id><institution>IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, </institution></institution-wrap>Vienna, Austria </aff><aff id="Aff189"><label>189</label><institution-wrap><institution-id institution-id-type="GRID">grid.17091.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id><institution>Department of Medical Genetics, Life Sciences Institute, </institution><institution>University of British Columbia, </institution></institution-wrap>Vancouver, Canada </aff><aff id="Aff190"><label>190</label>Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy </aff><aff id="Aff191"><label>191</label><institution-wrap><institution-id institution-id-type="GRID">grid.5808.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1503 7226</institution-id><institution>REQUIMTE/LAQV, Laborat&#243;rio de Farmacognosia, Departamento de Qu&#237;mica, Faculdade de Farm&#225;cia, </institution><institution>Universidade do Porto, </institution></institution-wrap>Porto, Portugal </aff><aff id="Aff192"><label>192</label><institution-wrap><institution-id institution-id-type="GRID">grid.4280.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 6431</institution-id><institution>Department of Physiology, YLL School of Medicine, </institution><institution>National University of Singapore, </institution></institution-wrap>Singapore, Singapore </aff><aff id="Aff193"><label>193</label><institution-wrap><institution-id institution-id-type="GRID">grid.4280.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 6431</institution-id><institution>NUS Centre for Cancer Research (N2CR), National University of Singapore, </institution></institution-wrap>Singapore, Singapore </aff><aff id="Aff194"><label>194</label><institution-wrap><institution-id institution-id-type="GRID">grid.440782.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 018X</institution-id><institution>National University Cancer Institute, NUHS, </institution></institution-wrap>Singapore, Singapore </aff><aff id="Aff195"><label>195</label><institution-wrap><institution-id institution-id-type="GRID">grid.4280.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 6431</institution-id><institution>ISEP, NUS Graduate School, National University of Singapore, </institution></institution-wrap>Singapore, Singapore </aff><aff id="Aff196"><label>196</label><institution-wrap><institution-id institution-id-type="GRID">grid.16753.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2299 3507</institution-id><institution>Department of Medicine, Division Hematology/Oncology, </institution><institution>Northwestern University, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff197"><label>197</label><institution-wrap><institution-id institution-id-type="GRID">grid.18147.3b</institution-id><institution-id institution-id-type="ISNI">0000000121724807</institution-id><institution>Center of Genomic Medicine, Department of Medicine and Surgery, </institution><institution>University of Insubria, </institution></institution-wrap>Varese, Italy </aff><aff id="Aff198"><label>198</label><institution-wrap><institution-id institution-id-type="GRID">grid.4912.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0488 7120</institution-id><institution>Department of Physiology and Medical Physics, </institution><institution>Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, </institution></institution-wrap>Dublin 2, Ireland </aff><aff id="Aff199"><label>199</label><institution-wrap><institution-id institution-id-type="GRID">grid.1018.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2342 0938</institution-id><institution>Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, </institution><institution>La Trobe University, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff200"><label>200</label><institution-wrap><institution-id institution-id-type="GRID">grid.423606.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1945 2152</institution-id><institution>Laboratorio de Glicomedicina. Instituto de Biolog&#237;a y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Cient&#237;ficas y T&#233;cnicas (CONICET), </institution></institution-wrap>Buenos Aires, Argentina </aff><aff id="Aff201"><label>201</label><institution-wrap><institution-id institution-id-type="GRID">grid.410607.4</institution-id><institution>Cell Biology Unit, </institution><institution>University Medical Center Mainz, </institution></institution-wrap>Mainz, Germany </aff><aff id="Aff202"><label>202</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>Division of Immunobiology, Department of Pathology and Immunology, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St. Louis, MO USA </aff><aff id="Aff203"><label>203</label><institution-wrap><institution-id institution-id-type="GRID">grid.27755.32</institution-id><institution-id institution-id-type="ISNI">0000 0000 9136 933X</institution-id><institution>Center for Cell Clearance, Department of Microbiology, Immunology, and Cancer Biology, </institution><institution>University of Virginia, </institution></institution-wrap>Charlottesville, VA USA </aff><aff id="Aff204"><label>204</label><institution-wrap><institution-id institution-id-type="GRID">grid.5719.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9713</institution-id><institution>Institute of Cell Biology and Immunology, </institution><institution>University of Stuttgart, </institution></institution-wrap>Stuttgart, Germany </aff><aff id="Aff205"><label>205</label><institution-wrap><institution-id institution-id-type="GRID">grid.462370.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 5402</institution-id><institution>Universit&#233; C&#244;te d&#8217;Azur, INSERM, C3M, Equipe labellis&#233;e Ligue Contre le Cancer, </institution></institution-wrap>Nice, France </aff><aff id="Aff206"><label>206</label><institution-wrap><institution-id institution-id-type="GRID">grid.5608.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3470</institution-id><institution>Department of Biomedical Sciences, </institution><institution>University of Padua, </institution></institution-wrap>Padua, Italy </aff><aff id="Aff207"><label>207</label><institution-wrap><institution-id institution-id-type="GRID">grid.9983.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 4263</institution-id><institution>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, </institution><institution>Universidade de Lisboa, </institution></institution-wrap>Lisbon, Portugal </aff><aff id="Aff208"><label>208</label><institution-wrap><institution-id institution-id-type="GRID">grid.7489.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0511</institution-id><institution>Department of Life sciences, </institution><institution>Ben Gurion University of the Negev, </institution></institution-wrap>Beer Sheva, Israel </aff><aff id="Aff209"><label>209</label>The NIBN, Beer Sheva, Israel </aff><aff id="Aff210"><label>210</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Immunobiology and Department of Pharmacology, </institution><institution>Yale School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff><aff id="Aff211"><label>211</label><institution-wrap><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution>Department of Medical Genetics, </institution><institution>Cambridge Institute for Medical Research, </institution></institution-wrap>Cambridge, UK </aff><aff id="Aff212"><label>212</label><institution-wrap><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution>UK Dementia Research Institute, </institution><institution>University of Cambridge, Cambridge Institute for Medical Research, </institution></institution-wrap>Cambridge, UK </aff><aff id="Aff213"><label>213</label><institution-wrap><institution-id institution-id-type="GRID">grid.8379.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1958 8658</institution-id><institution>Microbiology Biocentre, </institution><institution>University of W&#252;rzburg, </institution></institution-wrap>W&#252;rzburg, Germany </aff><aff id="Aff214"><label>214</label><institution-wrap><institution-id institution-id-type="GRID">grid.9918.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8411</institution-id><institution>University of Leicester, Leicester Cancer Research Centre, </institution></institution-wrap>Leicester, UK </aff><aff id="Aff215"><label>215</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>John B. Little Center for Radiation Sciences, </institution><institution>Harvard School of Public Health, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff216"><label>216</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Systems Biology, Lab of Systems Pharmacology, Harvard Program in Therapeutics Science, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff217"><label>217</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Environmental Health, Molecular and Integrative Physiological Sciences Program, </institution><institution>Harvard School of Public Health, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff218"><label>218</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Johns Hopkins Schizophrenia Center, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff219"><label>219</label><institution-wrap><institution-id institution-id-type="GRID">grid.5491.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9297</institution-id><institution>Faculty of Medicine, Cancer Sciences Unit, </institution><institution>University of Southampton, </institution></institution-wrap>Southampton, UK </aff><aff id="Aff220"><label>220</label><institution-wrap><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Institute for Molecular Bioscience, </institution><institution>The University of Queensland, </institution></institution-wrap>St Lucia, QLD Australia </aff><aff id="Aff221"><label>221</label><institution-wrap><institution-id institution-id-type="GRID">grid.5608.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3470</institution-id><institution>Department of Biology, </institution><institution>University of Padua, </institution></institution-wrap>Padua, Italy </aff><aff id="Aff222"><label>222</label><institution-wrap><institution-id institution-id-type="GRID">grid.428736.c</institution-id><institution>Veneto Institute of Molecular Medicine, </institution></institution-wrap>Padua, Italy </aff><aff id="Aff223"><label>223</label><institution-wrap><institution-id institution-id-type="GRID">grid.430387.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8796</institution-id><institution>Department of Neuroscience and Cell Biology, </institution><institution>Robert Wood Johnson Medical School, </institution></institution-wrap>Rutgers University, NJ USA </aff><aff id="Aff224"><label>224</label><institution-wrap><institution-id institution-id-type="GRID">grid.410717.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0644 5086</institution-id><institution>National Institute of Biological Sciences, </institution></institution-wrap>Beijing, PR China </aff><aff id="Aff225"><label>225</label><institution-wrap><institution-id institution-id-type="GRID">grid.263761.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0198 0694</institution-id><institution>The Third Affiliated Hospital of Soochow University and State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine, </institution><institution>Soochow University, </institution></institution-wrap>Suzhou, Jiangsu China </aff><aff id="Aff226"><label>226</label><institution-wrap><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Shanghai, China </aff><aff id="Aff227"><label>227</label><institution-wrap><institution-id institution-id-type="GRID">grid.6530.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2300 0941</institution-id><institution>Department of Surgical Science, </institution><institution>University Tor Vergata, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff228"><label>228</label><institution-wrap><institution-id institution-id-type="GRID">grid.473452.3</institution-id><institution>Institute of Biochemistry, </institution><institution>Brandenburg Medical School, </institution></institution-wrap>Neuruppin, Germany </aff><aff id="Aff229"><label>229</label><institution-wrap><institution-id institution-id-type="GRID">grid.8142.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 3192</institution-id><institution>Dipartimento di Medicina e Chirurgia Traslazionale, </institution><institution>Universit&#224; Cattolica del Sacro Cuore, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff230"><label>230</label><institution-wrap><institution-id institution-id-type="GRID">grid.440838.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0642 7601</institution-id><institution>European University Cyprus, School of Medicine, </institution></institution-wrap>Nicosia, Cyprus </aff><aff id="Aff231"><label>231</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Biological Sciences and Department of Chemistry, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff232"><label>232</label><institution-wrap><institution-id institution-id-type="GRID">grid.417778.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0692 3437</institution-id><institution>IRCCS Fondazione Santa Lucia, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff233"><label>233</label><institution-wrap><institution-id institution-id-type="GRID">grid.25697.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2172 4233</institution-id><institution>Univ Lyon, Univ Lyon 1, Physiopathologie et G&#233;n&#233;tique du Neurone et du Muscle, UMR5261, U1315, Institut NeuroMyog&#232;ne CNRS, INSERM, </institution></institution-wrap>Lyon, France </aff><aff id="Aff234"><label>234</label><institution-wrap><institution-id institution-id-type="GRID">grid.507739.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0061 254X</institution-id><institution>State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, </institution></institution-wrap>Shanghai, China </aff><aff id="Aff235"><label>235</label><institution-wrap><institution-id institution-id-type="GRID">grid.284723.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 8877 7471</institution-id><institution>Department of Rheumatology and Immunology, The Third Affiliated Hospital, </institution><institution>Southern Medical University, </institution></institution-wrap>Guangzhou, China </aff><aff id="Aff236"><label>236</label><institution-wrap><institution-id institution-id-type="GRID">grid.418873.1</institution-id><institution>Laboratory of Cell Engineering, Institute of Biotechnology, </institution></institution-wrap>Beijing, China </aff><aff id="Aff237"><label>237</label><institution-wrap><institution-id institution-id-type="GRID">grid.506261.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0706 7839</institution-id><institution>Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, </institution></institution-wrap>Beijing, China </aff><aff id="Aff238"><label>238</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Department of Cell and Developmental Biology, Consortium for Mitochondrial Research, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff><aff id="Aff239"><label>239</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>Department of Surgery, </institution><institution>The University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX 75390 USA </aff><aff id="Aff240"><label>240</label><institution-wrap><institution-id institution-id-type="GRID">grid.511959.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0622 9623</institution-id><institution>Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, </institution></institution-wrap>Heraklion, Crete Greece </aff><aff id="Aff241"><label>241</label><institution-wrap><institution-id institution-id-type="GRID">grid.8127.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0576 3437</institution-id><institution>Department of Basic Sciences, School of Medicine, </institution><institution>University of Crete, </institution></institution-wrap>Heraklion, Crete Greece </aff><aff id="Aff242"><label>242</label><institution-wrap><institution-id institution-id-type="GRID">grid.239585.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 2675</institution-id><institution>Departments of Pathology &amp; Cell Biology and Neurology, Taub Institute for Research on Alzheimer&#8217;s Disease and the Aging Brain, </institution><institution>Columbia University Irving Medical Center, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff243"><label>243</label><institution-wrap><institution-id institution-id-type="GRID">grid.11375.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 0706 0012</institution-id><institution>Department of Biochemistry and Molecular and Structural Biology, </institution><institution>J. Stefan Institute, </institution></institution-wrap>Ljubljana, Slovenia </aff><aff id="Aff244"><label>244</label><institution-wrap><institution-id institution-id-type="GRID">grid.8954.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0721 6013</institution-id><institution>Faculty of Chemistry and Chemical Technology, </institution><institution>University of Ljubljana, </institution></institution-wrap>Ljubljana, Slovenia </aff><aff id="Aff245"><label>245</label><institution-wrap><institution-id institution-id-type="GRID">grid.6530.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2300 0941</institution-id><institution>Department of Oncohaematology, </institution><institution>University of Rome Tor Vergata, TOR, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff246"><label>246</label><institution-wrap><institution-id institution-id-type="GRID">grid.5342.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2069 7798</institution-id><institution>Methusalem Program, </institution><institution>Ghent University, </institution></institution-wrap>Ghent, Belgium </aff><aff id="Aff247"><label>247</label><institution-wrap><institution-id institution-id-type="GRID">grid.5284.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0790 3681</institution-id><institution>Infla-Med Centre of Excellence, Department of Biomedical Sciences, </institution><institution>University of Antwerp, </institution></institution-wrap>Antwerp, Belgium </aff><aff id="Aff248"><label>248</label><institution-wrap><institution-id institution-id-type="GRID">grid.516087.d</institution-id><institution>Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, </institution></institution-wrap>Cambridge, MA USA </aff><aff id="Aff249"><label>249</label><institution-wrap><institution-id institution-id-type="GRID">grid.116068.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2341 2786</institution-id><institution>Department of Biology, </institution><institution>Massachusetts Institute of Technology, </institution></institution-wrap>Cambridge, MA USA </aff><aff id="Aff250"><label>250</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Dana-Farber Cancer Institute, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff251"><label>251</label><institution-wrap><institution-id institution-id-type="GRID">grid.25055.37</institution-id><institution-id institution-id-type="ISNI">0000 0000 9130 6822</institution-id><institution>Division of BioMedical Sciences, Memorial University, </institution></institution-wrap>St. John&#8217;s, NL Canada </aff><aff id="Aff252"><label>252</label><institution-wrap><institution-id institution-id-type="GRID">grid.5379.8</institution-id><institution-id institution-id-type="ISNI">0000000121662407</institution-id><institution>Faculty of Biology, Medicine and Health, </institution><institution>The University of Manchester, </institution></institution-wrap>Manchester, UK </aff><aff id="Aff253"><label>253</label><institution-wrap><institution-id institution-id-type="GRID">grid.424810.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0467 2314</institution-id><institution>Achucarro Center for Neuroscience, IKERBASQUE, </institution></institution-wrap>Bilbao, Spain </aff><aff id="Aff254"><label>254</label><institution-wrap><institution-id institution-id-type="GRID">grid.412449.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9678 1884</institution-id><institution>School of Forensic Medicine, </institution><institution>China Medical University, </institution></institution-wrap>Shenyang, China </aff><aff id="Aff255"><label>255</label><institution-wrap><institution-id institution-id-type="GRID">grid.493509.2</institution-id><institution>State Research Institute Centre for Innovative Medicine, </institution></institution-wrap>Vilnius, Lithuania </aff><aff id="Aff256"><label>256</label><institution-wrap><institution-id institution-id-type="GRID">grid.5361.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 8853 2677</institution-id><institution>Institute for Developmental Immunology, Biocenter, </institution><institution>Medical University of Innsbruck, </institution></institution-wrap>Innsbruck, Austria </aff><aff id="Aff257"><label>257</label><institution-wrap><institution-id institution-id-type="GRID">grid.4299.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2169 3852</institution-id><institution>The Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences (OeAW), </institution></institution-wrap>Vienna, Austria </aff><aff id="Aff258"><label>258</label><institution-wrap><institution-id institution-id-type="GRID">grid.511293.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 6104 8403</institution-id><institution>The Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), </institution></institution-wrap>Vienna, Austria </aff><aff id="Aff259"><label>259</label><institution-wrap><institution-id institution-id-type="GRID">grid.411097.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 8852 305X</institution-id><institution>Department of Translational Genomics, </institution><institution>Faculty of Medicine and University Hospital Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff260"><label>260</label><institution-wrap><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>CECAD Cluster of Excellence, </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff261"><label>261</label><institution-wrap><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff262"><label>262</label><institution-wrap><institution-id institution-id-type="GRID">grid.418158.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0534 4718</institution-id><institution>Department of Early Discovery Biochemistry, </institution><institution>Genentech, </institution></institution-wrap>South San Francisco, CA USA </aff><aff id="Aff263"><label>263</label><institution-wrap><institution-id institution-id-type="GRID">grid.22937.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9259 8492</institution-id><institution>Department of Laboratory Medicine, </institution><institution>Medical University of Vienna, </institution></institution-wrap>Vienna, Austria </aff><aff id="Aff264"><label>264</label><institution-wrap><institution-id institution-id-type="GRID">grid.22937.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9259 8492</institution-id><institution>Department of Dermatology, </institution><institution>Medical University of Vienna, </institution></institution-wrap>Vienna, Austria </aff><aff id="Aff265"><label>265</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Centre for Cell Death, Cancer and Inflammation, UCL Cancer Institute, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff><aff id="Aff266"><label>266</label><institution-wrap><institution-id institution-id-type="GRID">grid.13992.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0604 7563</institution-id><institution>Department of Biomolecular Sciences, </institution><institution>The Weizmann Institute of Science, </institution></institution-wrap>Rehovot, Israel </aff><aff id="Aff267"><label>267</label><institution-wrap><institution-id institution-id-type="GRID">grid.261331.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 7943</institution-id><institution>Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children&#8217;s Hospital, </institution><institution>The Ohio State University, </institution></institution-wrap>Columbus, OH USA </aff><aff id="Aff268"><label>268</label><institution-wrap><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>Shanghai Institute of Nutrition and Health, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Shanghai, China </aff><aff id="Aff269"><label>269</label><institution-wrap><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution>University of Zurich and University Hospital Zurich, Department of Pathology and Molecular Pathology, </institution></institution-wrap>Zurich, Switzerland </aff><aff id="Aff270"><label>270</label><institution-wrap><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution>University of Zurich, Institute of Molecular Cancer Research, </institution></institution-wrap>Zurich, Switzerland </aff><aff id="Aff271"><label>271</label><institution-wrap><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution>Centre for Inflammation Research, Queen&#8217;s Medical Research Institute, </institution><institution>University of Edinburgh, </institution></institution-wrap>Edinburgh, UK </aff><aff id="Aff272"><label>272</label><institution-wrap><institution-id institution-id-type="GRID">grid.262273.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 3760</institution-id><institution>Queens College and Graduate Center, City University of New York, </institution></institution-wrap>Flushing, NY USA </aff><aff id="Aff273"><label>273</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Department of Medicine Huddinge, </institution><institution>Karolinska Institute, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff274"><label>274</label><institution-wrap><institution-id institution-id-type="GRID">grid.13339.3b</institution-id><institution-id institution-id-type="ISNI">0000000113287408</institution-id><institution>Department of Biochemistry, Laboratory of Biophysics and p53 protein biology, </institution><institution>Medical University of Warsaw, </institution></institution-wrap>Warsaw, Poland </aff><aff id="Aff275"><label>275</label><institution-wrap><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>Department of Pharmacology &amp; Chemical Biology, UPMC Hillman Cancer Center, </institution><institution>University of Pittsburgh School of Medicine, </institution></institution-wrap>Pittsburgh, PA USA </aff><aff id="Aff276"><label>276</label><institution-wrap><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, </institution><institution>Chinese Academy of Sciences, </institution></institution-wrap>Shanghai, China </aff><aff id="Aff277"><label>277</label><institution-wrap><institution-id institution-id-type="GRID">grid.14476.30</institution-id><institution-id institution-id-type="ISNI">0000 0001 2342 9668</institution-id><institution>Faculty of Medicine, </institution><institution>Lomonosov Moscow State University, </institution></institution-wrap>Moscow, Russia </aff><aff id="Aff278"><label>278</label><institution-wrap><institution-id institution-id-type="GRID">grid.414603.4</institution-id><institution>National Institute for Infectious Diseases IRCCS &#8220;Lazzaro Spallanzani&#8221;, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff279"><label>279</label><institution-wrap><institution-id institution-id-type="GRID">grid.414093.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2183 5849</institution-id><institution>Institut du Cancer Paris CARPEM, Department of Biology, H&#244;pital Europ&#233;en Georges Pompidou, AP-HP, </institution></institution-wrap>Paris, France </aff><aff id="Aff280"><label>280</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Caryl and Israel Englander Institute for Precision Medicine, </institution></institution-wrap>New York, NY USA </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>4</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2023</year></pub-date><volume>30</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">434846</issue-id><fpage>1097</fpage><lpage>1154</lpage><history><date date-type="received"><day>30</day><month>1</month><year>2023</year></date><date date-type="rev-recd"><day>10</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>17</day><month>3</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>27</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-27 17:25:15.670"><day>27</day><month>05</month><year>2024</year></date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10130819</article-id><article-id pub-id-type="doi">10.1038/s41418-023-01153-w</article-id><article-version>1</article-version><pub-date><day>26</day><month>04</month><year>2023</year></pub-date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10154398</article-id><article-id pub-id-type="doi">10.1038/s41418-023-01153-w</article-id><article-version>2</article-version><pub-date><day>26</day><month>04</month><year>2023</year></pub-date></event></pub-history><permissions><copyright-statement>&#169; The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41418_2023_Article_1153.pdf"/><abstract id="Abs1"><p id="Par1">Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have elucidated the key contribution of this process not only to (post-)embryonic development and adult tissue homeostasis, but also to the etiology of multiple human disorders. Consistent with this notion, while defects in the molecular machinery for apoptotic cell death impair organismal development and promote oncogenesis, the unwarranted activation of apoptosis promotes cell loss and tissue damage in the context of various neurological, cardiovascular, renal, hepatic, infectious, neoplastic and inflammatory conditions. Here, the Nomenclature Committee on Cell Death (NCCD) gathered to critically summarize an&#160;abundant pre-clinical literature mechanistically linking the core apoptotic apparatus to organismal homeostasis in the context of disease.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Pathogenesis</kwd><kwd>Medical research</kwd><kwd>Physiology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100005010</institution-id><institution>Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)</institution></institution-wrap></funding-source><award-id>#20417</award-id><award-id>#27685</award-id><principal-award-recipient><name name-style="western"><surname>Vitale</surname><given-names>Ilio</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; ADMC Associazione Differenziamento e Morte Cellulare 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Facts</title><p id="Par2">
<list list-type="bullet"><list-item><p id="Par3">Intrinsic and extrinsic apoptosis are forms of regulated cell death (RCD) promoting the cellular demise along with the activation of proteases of the caspase family.</p></list-item><list-item><p id="Par4">In mammalian organisms, executioner caspases are activated after cells are already committed to die.</p></list-item><list-item><p id="Par5">Apoptosis can be manipulated by genetic or pharmacological means, and multiple genetically engineered animal models and pharmacological tools to modulate apoptosis have been developed.</p></list-item><list-item><p id="Par6">Apoptosis is intimately involved in both (post-)embryonic development and adult tissue homeostasis.</p></list-item><list-item><p id="Par7">Apoptosis deregulation promotes oncogenesis and contributes to the etiology of multiple human disorders, including cardiovascular, hepatic,&#160;renal, inflammatory and neurological conditions.</p></list-item><list-item><p id="Par8">To date, venetoclax is the only apoptosis inducer that has received regulatory approval for use in humans.</p></list-item></list>
</p></sec><sec id="Sec2"><title>Open Questions</title><p id="Par9">
<list list-type="bullet"><list-item><p id="Par10">Will inhibitors of apoptotic caspases with elevated target specificity become available?</p></list-item><list-item><p id="Par11">Will agents specifically conceived to modulate apoptosis enter the clinical practice to treat solid tumors or other human disorders beyond hematological malignancies?</p></list-item><list-item><p id="Par12">Is it conceivable to design combinatorial strategies aimed at inhibiting apoptosis while interrupting compensatory activation of other RCD signaling cascades?</p></list-item><list-item><p id="Par13">Will it be possible to specifically inhibit apoptotic signaling without impacting on other processes dependent on apoptosis regulators such as differentiation, proliferation, and inflammatory reactions?</p></list-item></list>
</p></sec><sec id="Sec3" sec-type="introduction"><title>Introduction</title><p id="Par14">The health and homeostasis of multicellular organisms depend on the tight balance between cell proliferation and cell death. In this context, a large body of experimental evidence has demonstrated the existence of a form of regulated cell death (RCD) that is executed by a genetically programmed process, and hence amenable to manipulation by genetic or pharmacological means [<xref ref-type="bibr" rid="CR1">1</xref>]. Over the past decades, multiple variants of RCD have been characterized at the genetic, biochemical, functional, and immunological level [<xref ref-type="bibr" rid="CR2">2</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>]. For instance, programmed cell death (PCD) has been functionally defined as a modality of RCD activated under purely physiological conditions (i.e., in the absence of perturbations of extracellular or intracellular homeostasis) in the context of embryonic/post-embryonic development or adult tissue homeostasis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Conversely, pathological RCD is invariably initiated in the context of failure to adapt to shifts in extra-cellular or intra-cellular homeostasis, constituting a <italic toggle="yes">de facto</italic> organismal program for the elimination of excessively damaged and/or potentially harmful cells, such as cells infected with pathogens [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. From a biochemical perspective, an increasing number of RCD modalities have been defined by the Nomenclature Committee on Cell Death (NCCD) based on the mechanistic involvement of specific molecular components [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. For instance, apoptotic cell death has been defined as a form of RCD that is promoted&#160;by proteases of the caspase family, namely caspase 3 (CASP3), CASP6 and CASP7, and&#160;initiated by CASP8 and CASP9 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. However, in mammalian organisms, with the exception of CASP8, apoptotic caspases simply accelerate RCD because their activation occurs when cells are already committed to die [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR16">16</xref>]. This means that contrarily to simpler organisms (e.g., <italic toggle="yes">Caenorhabditis</italic>
<italic toggle="yes">elegans</italic>), in which apoptotic caspase elimination fully rescues cells from death, in mammals, apoptotic cell death can at most be retarded but not prevented by pharmacological or genetic strategies inhibiting the activity of these caspases. Mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, and autophagy-dependent cell death represent forms of RCD that involve precise molecular events and hence can also be manipulated with pharmacological or genetic interventions [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>]. Other RCD modalities have been recently identified, such as alkaliptosis [<xref ref-type="bibr" rid="CR20">20</xref>], cuproptosis [<xref ref-type="bibr" rid="CR21">21</xref>] and PANoptosis (involving the simultaneous activation of pyroptosis, apoptosis, and necroptosis) [<xref ref-type="bibr" rid="CR22">22</xref>], and their signal transduction modules are under investigation. The importance of these latter&#160;forms of RCD in health and disease is not yet known.</p><p id="Par15">Along with the identification of key RCD regulators and the advent of modern tools for genetic manipulation, a great experimental effort has been devoted to elucidating the role of RCD in the physiopathology of multi-cellular organisms [<xref ref-type="bibr" rid="CR23">23</xref>]. Thus, various studies in animals (mostly rodents) genetically altered to lack&#160;or over-express components of the apoptotic apparatus (either at the whole-body level or in selected cell/tissue types) have provided formal proof of the relevance, but not always the exquisite requirement, of apoptosis for embryonic and fetal development or adult tissue homeostasis [<xref ref-type="bibr" rid="CR24">24</xref>&#8211;<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par16">Along similar lines, pharmacological and genetic tools aimed at altering apoptotic signaling in pre-clinical disease models revealed the mechanistic contribution of apoptosis to the etiology of various conditions associated with the loss of post-mitotic or (in certain settings) non-post-mitotic cells, including a panel of neurological, cardiovascular, renal, hepatic, and inflammatory disorders [<xref ref-type="bibr" rid="CR24">24</xref>]. Extensive studies over the last five decades highlighted the apoptotic machinery as a major target for the development of new therapeutic interventions [<xref ref-type="bibr" rid="CR27">27</xref>], not only for the induction of cell death in the context of disrupted tissue homeostasis (e.g., for neoplastic diseases) [<xref ref-type="bibr" rid="CR28">28</xref>], but also for the inhibition of cell death in the context of ischemic, degenerative and inflammatory conditions [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. However, while at least one drug designed to induce apoptosis is currently approved for use in humans, namely the BCL2 apoptosis regulator (BCL2) inhibitor venetoclax [<xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref>], which is used alone or in combinatorial regimens for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma and acute myeloid leukemia (AML) [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR38">38</xref>], no other agents specifically conceived to inhibit the apoptotic apparatus have been licensed for clinical practice so far. The broad-spectrum caspase inhibitor emricasan received fast-track designation by the US Food and Drug Administration (FDA) for the treatment of non-alcoholic steatohepatitis in 2016 but demonstrated inconsistent clinical efficacy [<xref ref-type="bibr" rid="CR39">39</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>], and &#8211; as of now&#160;&#8211; is not approved for therapy in humans.</p><p id="Par17">The lack of clinically approved, selective apoptosis inhibitors and the inconclusive performance of emricasan in recent trials reflect several aspects of (apoptotic and non-apoptotic) RCD that began to emerge only recently (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). First, while detecting cell death as well as biomarkers of specific RCD variants in vitro is relatively straightforward [<xref ref-type="bibr" rid="CR42">42</xref>], precise quantification of cell death in vivo in adult tissue remains challenging, at least in part because of rapid disposal of cell corpses by efferocytosis [<xref ref-type="bibr" rid="CR43">43</xref>&#8211;<xref ref-type="bibr" rid="CR46">46</xref>]. Thus, the actual contribution of cell death to the etiology of various human disorders is difficult to quantify by observational approaches [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Second, while for a long-time, specific forms of RCD were considered virtually independent entities, it recently&#160;became clear that the molecular machinery for RCD is composed of highly interconnected modules characterized by substantial redundancy, backup pathways and feedback loops [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Thus, molecules that inhibit one specific form of RCD may ultimately be unable to confer actual cyto- and tissue protection instead only altering the kinetic and biochemical manifestations of death by allowing the engagement of a different RCD sub-routine. For instance, while CASP8 is a major signal transducer in death receptor (DR)-driven apoptosis (see below), it intrinsically inhibits necroptosis induced by DRs and other signaling pathways, such as Toll-like receptor (TLR) signaling [<xref ref-type="bibr" rid="CR51">51</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>], suggesting that caspase inhibition in the context of DR signaling may promote necroptotic cell death [<xref ref-type="bibr" rid="CR54">54</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref>]. Together with a low target specificity and selectivity within the caspase family [<xref ref-type="bibr" rid="CR57">57</xref>], this can explain the inadequate efficacy of emricasan observed in pre-clinical and clinical studies. Third, even in the hypothetical scenario of agents capable of simultaneous inhibition of all (known and unknown) RCD pathways, loss of cellular homeostasis due to failing adaptation to stress generally involve degenerative processes that at some stage cannot be reversed, such as widespread mitochondrial permeabilization and loss of RNA and protein synthesis [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR58">58</xref>&#8211;<xref ref-type="bibr" rid="CR60">60</xref>], i.e., even if all RCD modalities could be blocked effectively, cells might undergo uncontrolled necrotic death. In this setting, cell death may occur as a consequence of an irremediable degeneration of cellular functions that can no longer be rescued pharmacologically or even genetically [<xref ref-type="bibr" rid="CR61">61</xref>]. Supporting these latter notions, accumulating literature indicates that, at least in mammalian systems, perhaps with the exception of CASP8, so-called apoptotic caspases mainly control the kinetics of apoptotic cell death and its immunological manifestations, but not whether cell death ultimately occurs or not [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. This points to the caspase family as a major regulator of organismal homeostasis via control of inflammatory responses [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. The simultaneous inhibition of multiple caspases, as for instance by emricasan, may thus also impact inflammation, as was demonstrated for tumor necrosis factor (TNF)-induced systemic inflammatory respiratory syndrome (SIRS) in vivo for the pan caspase-inhibitor zVAD-fmk [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. To complicate matters, multiple components of the core apoptotic machinery, including caspases and multiple members of the BCL2 family have been reported to regulate a variety of non-apoptotic functions beyond inflammation, such as mitochondrial energy production, Ca<sup>2+</sup> signaling and terminal differentiation [<xref ref-type="bibr" rid="CR65">65</xref>&#8211;<xref ref-type="bibr" rid="CR72">72</xref>]. Structurally, distinguishing between apoptotic and non-apoptotic functions of caspases and the BCL2 family remains challenging. Finally, there is a hitherto unclarified heterogeneity in the regulation of RCD at distinct anatomical sites (possibly linked to micro-environmental features) at distinct stages of cellular differentiation, and in the context of diverse patho-physiological states (e.g., in young <italic toggle="yes">vs</italic>. adult and aged individuals).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>Principal causes of the therapeutic failure of intrinsic or extrinsic apoptosis inhibitors.</title><p>The clinical development and success of agents inhibiting apoptosis is limited by multiple contributory causes, including potential non-apoptotic, accessory or even protective roles of the targeted proteins (exemplified by the involvement of certain BCL2 family members, caspases and death receptors in processes as diverse as inflammation, cell differentiation, cell proliferation and cell survival), the high interconnectivity between RCD pathway (potentially leading to the activation of compensatory RCD variants in response to the inhibition of a specific RCD type), the low specificity and selectivity of the inhibitors developed so far (exemplified by the broad-spectrum caspase inhibitors) and the difficulty to precisely determine and quantify cell death in vivo. RCD regulated cell death.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e5929" position="float" orientation="portrait" xlink:href="41418_2023_1153_Fig1_HTML.jpg"/></fig></p><p id="Par18">All these issues should also be kept under consideration in the context of the present review, in which the NCCD aims at critically discussing a large amount of pre-clinical data in support of a key role for the apoptotic machinery in mammalian diseases. Specifically, the interpretation of results of genetic and pharmacological experiments presented herein should place particular attention on the aforementioned connectivity amongst different RCD variants as well as on discriminating between essential <italic toggle="yes">vs</italic>. accessory aspects of cell death [<xref ref-type="bibr" rid="CR14">14</xref>]. Another issue to be considered is the fact that most conclusions are based on use of knockout/congenic mice which often present other passenger mutations potentially influencing the observed phenotype [<xref ref-type="bibr" rid="CR73">73</xref>]. Our objective is not only to provide a critical summary of the existing literature, but also to offer an updated framework for interpretation of these findings in view of currently accepted models of RCD signaling.</p></sec><sec id="Sec4"><title>Intrinsic apoptosis in disease</title><p id="Par19">There are substantive supporting data from genetic studies to demonstrate that the molecular machinery for intrinsic apoptosis (described in Box&#160;<xref rid="Sec5" ref-type="sec">1</xref> and Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>) is involved in embryonic and fetal development as well as in adult tissue homeostasis. Numerous preclinical studies in animal models of disease demonstrate that intrinsic apoptosis contributes to etiology in various disorders involving the loss of not only post-mitotic, but also non-post-mitotic tissues, including neurological, cardiac, renal, hepatic, autoimmune/inflammatory, oncological, and infectious conditions. However, as discussed above, the interpretation of these results should be taken with caution given the high interconnectivity of RCD pathways and the crosstalk between RCD and inflammatory response. Moreover, the activation of executioner caspases occurs after cells are already committed to intrinsic apoptosis [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Accordingly, caspase inhibition only delays the execution of cell death. In this context, the phenotypes observed under apoptotic caspase-deleted or inhibited conditions may reflect cell-extrinsic effects of caspase activity such as the release of immunomodulatory and cytotoxic signals from dying/dead cells, including damage-associated molecular patterns (DAMPs) or cytokines (this concept is extensively discussed in [<xref ref-type="bibr" rid="CR14">14</xref>]). These phenotypes may also stem from the lack of processes independent of intrinsic (or extrinsic) apoptosis, as, for instance, the lack of CASP3-mediated cleavage of gasdermin E (GSDME) leading to impaired pyroptosis and associated inflammatory response [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>].<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>Molecular machinery of the intrinsic apoptosis.</title><p>Intrinsic apoptosis can be activated by a range of extracellular or intracellular stimuli, including, but not limited to, DNA damage, endoplasmic reticulum (ER) or oxidative stress, growth factor withdrawal or microtubular alterations. The critical step of the intrinsic apoptosis is the activation of the pro-apoptotic effectors of the BCL2 family, BAX, BAK and possibly BOK, which drives the outer membrane permeabilization (MOMP) and commits cells to death. MOMP results in the release from the mitochondrial intermembrane space into the cytosol of proapoptotic proteins, including CYCS and SMAC. CYCS assembles with APAF1, dATP and pro-CASP9 into the apoptosome, leading to the activation of CASP9, which in turn promotes the activation of the executioner caspases CASP3 and CASP7. The activation of the executioner caspases is facilitated by SMAC, which sequesters and/or degrades members of IAP family that inhibit apoptosis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e5978" position="float" orientation="portrait" xlink:href="41418_2023_1153_Fig2_HTML.jpg"/></fig></p><p id="Par20">Below, we will provide details of the pro-apoptotic BCL2 proteins, the anti-apoptotic BCL2 proteins, the components of the apoptosome&#8212;a platform for the activation of initiator caspases composed of cytochrome c, somatic (CYCS), apoptotic peptidase activating factor 1 (APAF1) and pro-CASP9&#8212;and effector caspases in disease. The instances of involvement encompass participation in the pathogenic mechanisms as well as experimental deletion or inhibition as a means of exploring potential utility as treatment targets. The effects of these regulators and effectors of the intrinsic apoptosis pathway on health are described in Box&#160;<xref rid="Sec6" ref-type="sec">2</xref>, Box&#160;<xref rid="Sec7" ref-type="sec">3</xref> and Box&#160;<xref rid="Sec8" ref-type="sec">4</xref>.</p><sec id="Sec5"><boxed-text position="float" orientation="portrait"><label>Box 1 Principle of intrinsic apoptosis</label><p id="Par21">Intrinsic apoptosis is a type of regulated cell death (RCD) initiated by perturbations of the extracellular or intracellular microenvironment including (but not limited to) DNA damage, endoplasmic reticulum or oxidative stress, growth factor withdrawal, and&#160;microtubular alterations. The critical step is mitochondrial outer membrane permeabilization (MOMP) [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR1054">1054</xref>, <xref ref-type="bibr" rid="CR1055">1055</xref>]. MOMP is modulated by the activity of multiple pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family [<xref ref-type="bibr" rid="CR1056">1056</xref>&#8211;<xref ref-type="bibr" rid="CR1060">1060</xref>]. In response to apoptotic stimuli, MOMP leads to the sequential activation of the initiator caspase 9 (CASP9) and then executioner caspases CASP3 and CASP7 [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR1061">1061</xref>&#8211;<xref ref-type="bibr" rid="CR1063">1063</xref>]. Two functionally distinct classes of pro-apoptotic BCL2 proteins have been identified. The first class encompasses the apoptotic activators BCL2 associated X, apoptosis regulator (BAX), BCL2 antagonist/killer 1 (BAK1), and BCL2 family apoptosis regulator (BOK) [<xref ref-type="bibr" rid="CR1064">1064</xref>]. Once activated by apoptotic stimuli, BAX, BAK1 and BOK induce MOMP by generating pores across the outer mitochondrial membrane (OMM) [<xref ref-type="bibr" rid="CR1065">1065</xref>&#8211;<xref ref-type="bibr" rid="CR1069">1069</xref>]. These pro-apoptotic factors promote the release into the cytosol of several apoptogenic factors, including cytochrome c, somatic (CYCS) and diablo IAP-binding mitochondrial protein (DIABLO; also known as second mitochondrial activator of caspases, SMAC) [<xref ref-type="bibr" rid="CR1070">1070</xref>]. CYCS exerts apoptogenic activity by associating with apoptotic peptidase activating factor 1 (APAF1) and pro-CASP9 to generate a complex known as the apoptosome, leading to sequential activation of CASP9 and executioner caspases CASP3 and CASP7 [<xref ref-type="bibr" rid="CR1071">1071</xref>]. DIABLO/SMAC contributes to CASP3 and CASP7 activation by associating with and inhibiting X-linked inhibitor of apoptosis (XIAP) and other members of the inhibitor of apoptosis (IAP) protein family that&#160;restrain caspase activation [<xref ref-type="bibr" rid="CR1072">1072</xref>].</p><p id="Par22">The second class of pro-apoptotic BCL2 proteins (known as BH3-only proteins [<xref ref-type="bibr" rid="CR1073">1073</xref>]) include BCL2 associated agonist of cell death (BAD), BCL2 binding component 3 (BBC3; best known as p53-upregulated modulator of apoptosis, PUMA), BCL2 interacting killer (BIK), BCL2 like 11 (BCL2L11; best known as BIM), Bcl2 modifying factor (BMF), BH3 interacting domain death agonist (BID), BCL2 interacting protein harakiri (HRK, also known as DP5), and phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1; best known as NOXA [<xref ref-type="bibr" rid="CR1074">1074</xref>, <xref ref-type="bibr" rid="CR1075">1075</xref>]). Of these, caspase-cleaved BID (tBID), BIM, PUMA, and NOXA have been reported to also be able to promote BAX and BAK1 activation through a direct interaction with these proteins at mitochondria [<xref ref-type="bibr" rid="CR1076">1076</xref>&#8211;<xref ref-type="bibr" rid="CR1082">1082</xref>]. All BH3-only proteins, including BAD, BIK, BMF and HRK activate BAX and BAK1 indirectly by associating with anti-apoptotic BCL2 family members, thereby blocking the inhibitory binding of the latter to BAX and BAK1 [<xref ref-type="bibr" rid="CR1056">1056</xref>, <xref ref-type="bibr" rid="CR1060">1060</xref>, <xref ref-type="bibr" rid="CR1080">1080</xref>&#8211;<xref ref-type="bibr" rid="CR1084">1084</xref>]. Some BH3-only proteins, particularly BIM, PUMA and tBID, can potently bind and inhibit all anti-apoptotic BCL-2 proteins whereas others bind only some (e.g., NOXA only binds MCL1 and A1) [<xref ref-type="bibr" rid="CR1080">1080</xref>, <xref ref-type="bibr" rid="CR1082">1082</xref>, <xref ref-type="bibr" rid="CR1085">1085</xref>, <xref ref-type="bibr" rid="CR1086">1086</xref>]. It is noteworthy that BAX and BAK1 can induce apoptosis in the absence of all BH3-only proteins when the anti-apoptotic BCL2 proteins are genetically removed or inhibited by BH3 mimetic drugs [<xref ref-type="bibr" rid="CR1082">1082</xref>, <xref ref-type="bibr" rid="CR1083">1083</xref>]. However, BAX and BAK1 activation in the absence of BH3-only proteins occurs at slower kinetics compared to that in the presence of BH3-only proteins [<xref ref-type="bibr" rid="CR1082">1082</xref>]. These findings support the existence of both BH3-dependent and BH3-independent BAX and BAK1&#160;activation mechanisms (in the latter scenario,&#160;BH3-only proteins function as catalysts for BAX and BAK activation) [<xref ref-type="bibr" rid="CR1082">1082</xref>, <xref ref-type="bibr" rid="CR1087">1087</xref>]. In this context, BAX and BAK are also reported to be activated by tumor protein p53 (TP53; best known as p53) in a fashion independent of BH3-only proteins [<xref ref-type="bibr" rid="CR1088">1088</xref>, <xref ref-type="bibr" rid="CR1089">1089</xref>]. The anti-apoptotic members of the BCL2 family encompass BCL2, apoptosis regulator (BCL2), BCL2 like 1 (BCL2L1; best known as BCL-X<sub>L</sub>), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known as A1) [<xref ref-type="bibr" rid="CR1056">1056</xref>&#8211;<xref ref-type="bibr" rid="CR1059">1059</xref>]. The anti-apoptotic activity of these BCL2 proteins mainly involves MOMP inhibition, although, a non-canonical, cellular redox-dependent mechanism of cytoprotection has also&#160;been reported&#160;in cancer cells, at least for BCL2 [<xref ref-type="bibr" rid="CR1090">1090</xref>&#8211;<xref ref-type="bibr" rid="CR1093">1093</xref>]</p></boxed-text></sec><sec id="Sec6"><boxed-text position="float" orientation="portrait"><label>Box 2 Impact of pro-apoptotic BCL2 proteins on health</label><p id="Par23">Deletion of BCL2-associated X protein (<italic toggle="yes">Bax</italic>), BCL2-antagonist/killer 1 (<italic toggle="yes">Bak1</italic>) or BCL2-related ovarian killer (<italic toggle="yes">Bok</italic>) does not significantly affect mouse development [<xref ref-type="bibr" rid="CR1094">1094</xref>&#8211;<xref ref-type="bibr" rid="CR1096">1096</xref>], with the exception of a mild lymphocyte and neuron accumulation in <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup> mice which also exhibit male infertility due to seminiferous tubule malformation [<xref ref-type="bibr" rid="CR166">166</xref>, <xref ref-type="bibr" rid="CR1094">1094</xref>]. Of note, a recent study has demonstrated that such defects in germ cells occur in the fetal period [<xref ref-type="bibr" rid="CR1097">1097</xref>], supporting the requirement for intrinsic apoptosis in testicular development [<xref ref-type="bibr" rid="CR1098">1098</xref>, <xref ref-type="bibr" rid="CR1099">1099</xref>]. Subsequent studies confirmed the role of BAX in neurogenesis, in particular the development of hippocampal and cerebellar neurons, cortical interneurons and astrocytes [<xref ref-type="bibr" rid="CR1100">1100</xref>&#8211;<xref ref-type="bibr" rid="CR1105">1105</xref>]. Accordingly, <italic toggle="yes">Bax</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice exhibit impaired neurological functions manifesting with increased anxiety, depression-like traits, compromised social and sexual behavior, and impaired spatial representation and olfactory system function [<xref ref-type="bibr" rid="CR1106">1106</xref>&#8211;<xref ref-type="bibr" rid="CR1108">1108</xref>]. These mice also show accelerated medulloblastoma formation [<xref ref-type="bibr" rid="CR389">389</xref>], which is in line with the oncosuppressive activity of apoptotic (and non-apoptotic) regulated cell death (RCD) [<xref ref-type="bibr" rid="CR1109">1109</xref>].</p><p id="Par24">Ablation of <italic toggle="yes">Bok</italic> does not compromise the relatively normal development of BAK1- or BAX-deficient mice, although <italic toggle="yes">Bax</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bok</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice exhibit an increased number of mature oocytes [<xref ref-type="bibr" rid="CR1110">1110</xref>]. In contrast, co-deletion of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic> causes perinatal death in the vast majority (more than 90%) of mice, mainly due to multiple developmental abnormalities and feeding difficulties [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR1095">1095</xref>]. Importantly, the developmental defects of <italic toggle="yes">Bax</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bak1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice are exacerbated by additional deletion of <italic toggle="yes">Bok</italic>, underscoring not only some functional redundancy between BAX, BAK1 and BOK, but also a crucial role of pro-apoptotic BCL2 family members in the development of the central nervous system (CNS) and hematopoietic compartment [<xref ref-type="bibr" rid="CR26">26</xref>]. However, since some <italic toggle="yes">Bax</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bak1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> and <italic toggle="yes">Bax</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bak1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bok</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice can reach adulthood [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR1095">1095</xref>], additional systems must be at play to compensate for defects in apoptosis in other organs. In is worth noting that the developmental defects of <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> mice can be further aggravated by deletion of autophagy related 5 (<italic toggle="yes">Atg5</italic>) [<xref ref-type="bibr" rid="CR1111">1111</xref>], which is involved in autophagy as well as in non-canonical vesicular pathways like LC3-associated phagocytosis [<xref ref-type="bibr" rid="CR1112">1112</xref>, <xref ref-type="bibr" rid="CR1113">1113</xref>]. However, whether autophagy-dependent cell death compensates for the apoptotic defects of <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> mice remains to be formally determined [<xref ref-type="bibr" rid="CR1114">1114</xref>, <xref ref-type="bibr" rid="CR1115">1115</xref>].</p><p id="Par25">Further corroborating the relevance of intrinsic apoptosis for proper development, the few surviving <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> mice and <italic toggle="yes">Bax</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bak1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bok</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup>mice display phenotypes related to defective programmed cell death (PCD), including webbed feet (due to the incomplete removal of interdigital webs), imperforate vagina and midline fusion defects including facial cleft [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR1095">1095</xref>]. CNS issues exhibited by these animals include a striking expansion of the tissue regions that harbor the neural stem cell pool [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR1095">1095</xref>] as well as impaired function of the motor [<xref ref-type="bibr" rid="CR1116">1116</xref>] and visual [<xref ref-type="bibr" rid="CR1117">1117</xref>, <xref ref-type="bibr" rid="CR1118">1118</xref>] systems. Although the number of apoptotic cells were reduced to the limit of&#160;detection in embryos lacking BAX, BAK1 and BOK [<xref ref-type="bibr" rid="CR26">26</xref>], anomalies in the urinary tract were conspicuously absent in these animals [<xref ref-type="bibr" rid="CR26">26</xref>]. This sparked a study examining if BID, in addition to linking the death receptor (DR) pathway and the intrinsic apoptotic pathway (Box&#160;<xref rid="Sec18" ref-type="sec">5</xref>), could act in a way similar to BAX and BAK1. Indeed, while loss of BID alone did not lead to anomalies during embryonic and fetal development, additional deletion of <italic toggle="yes">Bid</italic> in <italic toggle="yes">Bax</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bak1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Bok</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup>mice mice revealed a redundant requirement for BID in urogenital tract development [<xref ref-type="bibr" rid="CR1119">1119</xref>]. In its previously recognized role, BID in the form of tBID activates BAX and BAK1, which would not have caused additional anomalies in the absence of BAX and BAK1. Therefore, these results indicate that BID can act in parallel with BAX, BAK1 and BOK. Congruently, full-length BID [<xref ref-type="bibr" rid="CR1119">1119</xref>] or tBID [<xref ref-type="bibr" rid="CR1120">1120</xref>] can mediate mitochondrial permeabilization and cause cytochrome c, somatic (CYCS) release. In this context it is worth considering that BID has been reported to be structurally similar to the multi-BH domain BCL2 family proteins, such as BAX and BCL-X<sub>L</sub> [<xref ref-type="bibr" rid="CR1060">1060</xref>, <xref ref-type="bibr" rid="CR1121">1121</xref>&#8211;<xref ref-type="bibr" rid="CR1123">1123</xref>].</p><p id="Par26">Tissue-specific ablation of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic>, confirmed the crucial role of these proteins in the hematopoietic system, and specifically in the homeostasis and functionality of B cells [<xref ref-type="bibr" rid="CR1124">1124</xref>], T cells [<xref ref-type="bibr" rid="CR1125">1125</xref>], megakaryocytes [<xref ref-type="bibr" rid="CR1126">1126</xref>] and platelets [<xref ref-type="bibr" rid="CR1127">1127</xref>]. Mice reconstituted with fetal liver cells from <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> mice display massive lymphadenopathy and defective T cell proliferation, and the severity of these defects is even more pronounced when <italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bok</italic><sup>&#8722;/&#8722;</sup> fetal liver cells are used for reconstitution, an experimental setting that also reveals signs of autoimmunity [<xref ref-type="bibr" rid="CR1128">1128</xref>&#8211;<xref ref-type="bibr" rid="CR1130">1130</xref>]. Similarly, mice reconstituted with a <italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup> hematopoietic compartment develop a fatal systemic lupus erythematosus (SLE)-like autoimmune disease [<xref ref-type="bibr" rid="CR411">411</xref>]. Moreover, the inducible co-deletion of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic> in lymphocytes of adult mice results in the development of severe autoimmune glomerulonephritis [<xref ref-type="bibr" rid="CR1124">1124</xref>]. Finally, conditional knockout mouse models reveal a crucial contribution of BAX and BAK1 to endothelial cell homeostasis [<xref ref-type="bibr" rid="CR164">164</xref>, <xref ref-type="bibr" rid="CR1131">1131</xref>], but little impact on cardiac and intestinal functions, as shown by the absence of hyperplasia [<xref ref-type="bibr" rid="CR223">223</xref>, <xref ref-type="bibr" rid="CR453">453</xref>]. These results demonstrate that the multi-BH domain pro-apoptotic BCL2 proteins play critical roles for the normal development of multiple tissues, but that, surprisingly, a few mice can reach weaning or even adulthood when all of these effectors of apoptosis are removed [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par27">Amongst BH3-only proteins, BCL2 like 11 (BCL2L11, best known as BIM) appears the most critical for embryonic development and tissue homeostasis, as shown by the fact that approximately 30% of BIM-deficient mice die during embryogenesis [<xref ref-type="bibr" rid="CR410">410</xref>]. Surviving BIM-deficient mice display severe defects in the hematopoietic system including lymphoid hyperplasia and marked splenomegaly, and on a mixed C57BL/6 x 129SV background many of these mice spontaneously develop systemic autoimmunity often resulting in fatal kidney disease [<xref ref-type="bibr" rid="CR410">410</xref>], a condition that can be accelerated by depletion of immunosuppressive CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> regulatory T (T<sub>REG</sub>) cells [<xref ref-type="bibr" rid="CR1132">1132</xref>]. Cells from BIM-deficient mice are profoundly resistant to growth factor deprivation, glucocorticoids, deregulated calcium flux and ER stress [<xref ref-type="bibr" rid="CR410">410</xref>, <xref ref-type="bibr" rid="CR1133">1133</xref>]. Accordingly, BIM-deficient mice also display dysregulated T cell development and homeostasis [<xref ref-type="bibr" rid="CR1134">1134</xref>&#8211;<xref ref-type="bibr" rid="CR1138">1138</xref>] and hence exhibit defective cellular [<xref ref-type="bibr" rid="CR480">480</xref>, <xref ref-type="bibr" rid="CR1139">1139</xref>, <xref ref-type="bibr" rid="CR1140">1140</xref>] and humoral [<xref ref-type="bibr" rid="CR1141">1141</xref>&#8211;<xref ref-type="bibr" rid="CR1143">1143</xref>] immune responses. <italic toggle="yes">Bcl2l11</italic> deletion (loss of BIM) has also been shown to extend the survival of granulocytes [<xref ref-type="bibr" rid="CR1144">1144</xref>] and to perturb the development of mammary glands [<xref ref-type="bibr" rid="CR1145">1145</xref>, <xref ref-type="bibr" rid="CR1146">1146</xref>], gastric epithelium [<xref ref-type="bibr" rid="CR1147">1147</xref>] and the retina [<xref ref-type="bibr" rid="CR1148">1148</xref>]. Moreover, aged BIM-deficient mice show reduced adiposity [<xref ref-type="bibr" rid="CR1149">1149</xref>]. Of note, systemic deletion of <italic toggle="yes">Bax</italic> or <italic toggle="yes">Bak1</italic> exacerbates the hematopoietic dysregulation of BIM-deficient mice [<xref ref-type="bibr" rid="CR1150">1150</xref>]. Conditional knockout systems confirmed a key role for BIM in the hematopoietic system homeostasis [<xref ref-type="bibr" rid="CR1151">1151</xref>&#8211;<xref ref-type="bibr" rid="CR1154">1154</xref>], and revealed a role for BIM in the survival and differentiation of hippocampal neurons [<xref ref-type="bibr" rid="CR1155">1155</xref>]. Finally, myeloid cell-specific deletion of <italic toggle="yes">Bcl2l11</italic> induces a SLE-like disease that resembles the pathology developing in mice that lack BIM in all cells [<xref ref-type="bibr" rid="CR1156">1156</xref>].</p><p id="Par28">Mice lacking BH3 interacting domain death agonist (BID), phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1, best known as NOXA) or BCL2 binding component 3 (BBC3, best known as PUMA) display normal embryonic development [<xref ref-type="bibr" rid="CR278">278</xref>, <xref ref-type="bibr" rid="CR479">479</xref>, <xref ref-type="bibr" rid="CR1157">1157</xref>, <xref ref-type="bibr" rid="CR1158">1158</xref>]. In these studies on BID-deficient mice, substantial reduction in FAS ligand&#160;(FASL)-induced apoptosis was seen in hepatocytes [<xref ref-type="bibr" rid="CR278">278</xref>, <xref ref-type="bibr" rid="CR761">761</xref>], pancreatic cells [<xref ref-type="bibr" rid="CR278">278</xref>, <xref ref-type="bibr" rid="CR1159">1159</xref>, <xref ref-type="bibr" rid="CR1160">1160</xref>] and possibly neurons [<xref ref-type="bibr" rid="CR181">181</xref>, <xref ref-type="bibr" rid="CR1161">1161</xref>]. Moreover, <italic toggle="yes">Bid</italic><sup>&#8722;/&#8722;</sup> mice display a dysregulated myeloid compartment resulting in an increased likelihood of leukemogenesis [<xref ref-type="bibr" rid="CR1161">1161</xref>], as well as cardiac dysfunction [<xref ref-type="bibr" rid="CR1162">1162</xref>]. Conditional gene deletion studies confirmed the relevance of BID in the homeostasis and functionality of hepatocytes and T cells [<xref ref-type="bibr" rid="CR301">301</xref>, <xref ref-type="bibr" rid="CR760">760</xref>, <xref ref-type="bibr" rid="CR1163">1163</xref>].</p><p id="Par29">PUMA contributes to normal ovarian development, as shown by the evidence that two-thirds of the germ cells produced during embryonic development undergo PUMA-mediated cell death shortly after formation [<xref ref-type="bibr" rid="CR1164">1164</xref>]. Moreover, cells from PUMA-deficient mice are profoundly resistant to p53-induced apoptosis triggered by genotoxic drugs, and lymphoid cells are also resistant to glucocorticoids, phorbol ester and growth factor deprivation [<xref ref-type="bibr" rid="CR479">479</xref>, <xref ref-type="bibr" rid="CR1158">1158</xref>, <xref ref-type="bibr" rid="CR1165">1165</xref>&#8211;<xref ref-type="bibr" rid="CR1167">1167</xref>]. Cells from NOXA-deficient mice also showed resistance to DNA damage-inducing drugs, although to a lesser extent compared to cells lacking PUMA [<xref ref-type="bibr" rid="CR479">479</xref>, <xref ref-type="bibr" rid="CR1168">1168</xref>]. Moreover, <italic toggle="yes">Pmaip1</italic><sup>&#8722;/&#8722;</sup> mice (lacking NOXA) show limited stress-induced erythropoiesis [<xref ref-type="bibr" rid="CR1169">1169</xref>]. Germline deletion of the gene encoding PUMA or NOXA also affects humoral immune responses [<xref ref-type="bibr" rid="CR1170">1170</xref>, <xref ref-type="bibr" rid="CR1171">1171</xref>] and increases the abundance of multiple cell types in the retina [<xref ref-type="bibr" rid="CR146">146</xref>].</p><p id="Par30">Co-deletion of two or more genes coding for BH3-only proteins confirmed the pronounced relevance of BIM for development and underscored some degree of functional redundancy in the system. On the one hand, mice lacking both PUMA and NOXA develop normally but their cells are profoundly resistant to genotoxic agents, as much&#160;as cells lacking p53 [<xref ref-type="bibr" rid="CR1172">1172</xref>]. Concomitant loss of PUMA but not the additional loss of NOXA, BAD, BID or BIK increases the severity of hematopoietic defects imposed by the lack of BIM [<xref ref-type="bibr" rid="CR282">282</xref>, <xref ref-type="bibr" rid="CR1173">1173</xref>&#8211;<xref ref-type="bibr" rid="CR1175">1175</xref>]. On the other hand, <italic toggle="yes">Bcl2l11</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bbc3</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bid</italic><sup>&#8722;/&#8722;</sup>and <italic toggle="yes">Bcl2l11</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bbc3</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bid</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Pmaip1</italic><sup>&#8722;/&#8722;</sup> mice displayed perinatal embryonic lethality and increased incidence of developmental defects, including webbed feet, imperforate vagina, and supernumerary neurons similar in extent to those seen in <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> mice [<xref ref-type="bibr" rid="CR1082">1082</xref>, <xref ref-type="bibr" rid="CR1176">1176</xref>]. Of note, triple deficiency of BID, BIM, and PUMA completely abrogates BAX/BAK1-dependent apoptosis in cerebellar granule neurons and T lymphocytes [<xref ref-type="bibr" rid="CR1176">1176</xref>], providing in vivo evidence supporting direct activation of BAX and BAK1 by the BH3-only proteins.</p><p id="Par31">Mice lacking BCL2-associated agonist of cell death (<italic toggle="yes">Bad</italic>), BCL2 interacting killer (<italic toggle="yes">Bik</italic>), BCL2 modifying factor (<italic toggle="yes">Bmf</italic>) and harakiri, BCL2 interacting protein (contains only BH3 domain) (<italic toggle="yes">Hrk</italic>) are viable and develop normally [<xref ref-type="bibr" rid="CR168">168</xref>, <xref ref-type="bibr" rid="CR1177">1177</xref>&#8211;<xref ref-type="bibr" rid="CR1179">1179</xref>]. That said, BAD-deficient mice display a prolonged platelet lifespan [<xref ref-type="bibr" rid="CR1180">1180</xref>], while <italic toggle="yes">Bmf</italic><sup>&#8722;/&#8722;</sup> mice are characterized by mild lymphadenopathy, vaginal atresia [<xref ref-type="bibr" rid="CR1178">1178</xref>, <xref ref-type="bibr" rid="CR1181">1181</xref>] as well as minor defects in mammary gland development and oogenesis [<xref ref-type="bibr" rid="CR1146">1146</xref>, <xref ref-type="bibr" rid="CR1182">1182</xref>]. Interestingly, female <italic toggle="yes">Bmf</italic><sup>&#8722;/&#8722;</sup> mice had significantly more primordial follicles than wild-type control animals associated with an extended fertile life span [<xref ref-type="bibr" rid="CR1183">1183</xref>], while <italic toggle="yes">Bmf</italic><sup>&#8722;/&#8722;</sup> mice developed an accelerated gamma irradiation-induced thymic lymphoma [<xref ref-type="bibr" rid="CR1178">1178</xref>]. Combined deletion of some of the above listed BH3-only protein-coding genes does not cause significant embryonic lethality or developmental abnormalities. Moreover, increased spontaneous tumorigenesis has been documented in <italic toggle="yes">Bad</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bmf</italic><sup>&#8722;/&#8722;</sup> mice [<xref ref-type="bibr" rid="CR1184">1184</xref>]. Conversely, the absence of some of these BH3-only proteins aggravates the defects caused by the loss of <italic toggle="yes">Bcl2l11</italic> (the gene encoding BIM). This applies to: (1) <italic toggle="yes">Bad</italic> co-deletion with <italic toggle="yes">Bcl2l11</italic>, which enhances lymphocyte accumulation [<xref ref-type="bibr" rid="CR1180">1180</xref>], (2) <italic toggle="yes">Bik</italic> co-deletion with <italic toggle="yes">Bcl2l11</italic>, which causes male infertility due to defective spermatogenesis [<xref ref-type="bibr" rid="CR1185">1185</xref>], a phenotype resembling that of BAX-deficient mice, and (3) <italic toggle="yes">Bmf</italic> co-deletion with <italic toggle="yes">Bcl2l11</italic>, which considerably increases the incidence of developmental defects, vaginal atresia, lymphadenopathy, autoimmune glomerulonephritis, and spontaneous development of hematological malignancies [<xref ref-type="bibr" rid="CR1181">1181</xref>, <xref ref-type="bibr" rid="CR1186">1186</xref>, <xref ref-type="bibr" rid="CR1187">1187</xref>].</p></boxed-text></sec><sec id="Sec7"><boxed-text position="float" orientation="portrait"><label>Box 3 Impact of anti-apoptotic BCL2 proteins on health</label><p id="Par32">While myeloid cell leukemia sequence 1 (<italic toggle="yes">Mcl1</italic>) deletion in mice induces embryonic lethality at the blastocyst (embryonic E3) stage prior to implantation [<xref ref-type="bibr" rid="CR1188">1188</xref>, <xref ref-type="bibr" rid="CR1189">1189</xref>], embryos lacking BCL2-like 1 (BCL2L1, best known as BCL-X<sub>L</sub>) die around embryonic day 13.5) with substantial cell depletion in the developing central nervous system (CNS) and erythroid progenitors [<xref ref-type="bibr" rid="CR1190">1190</xref>]. Concomitant deletion of BCL2-associated X protein (<italic toggle="yes">Bax</italic>) or caspase 9 (<italic toggle="yes">Casp9</italic>) considerably limited neuronal cell death genotype caused by the absence of BCL-X<sub>L</sub> [<xref ref-type="bibr" rid="CR1191">1191</xref>, <xref ref-type="bibr" rid="CR1192">1192</xref>]. Concomitant deletion of BCL2 like 11 (<italic toggle="yes">Bcl2l11</italic>, encoding BIM) rescues erythroid progenitor (but not the neuronal) cells from death in BCL-X<sub>L</sub>-deficient mice [<xref ref-type="bibr" rid="CR1193">1193</xref>]. <italic toggle="yes">Bcl2</italic><sup>&#8722;/&#8722;</sup> mice are born but exhibit severe defects in their kidneys, alterations of the CNS, lymphoid cell depletion as well as premature graying of their hair and they succumb to polycystic kidney disease at a young age [<xref ref-type="bibr" rid="CR1194">1194</xref>&#8211;<xref ref-type="bibr" rid="CR1200">1200</xref>]. These defects can all be rescued by concomitant deletion of the gene encoding BIM, and, remarkably, in the case of some defects, the loss of even a single allele of <italic toggle="yes">Bim</italic> is sufficient [<xref ref-type="bibr" rid="CR1194">1194</xref>]. Mice with deletion of B cell leukemia/lymphoma 2 related protein A1a (<italic toggle="yes">Bcl2a1a</italic>, one of three isoforms of BCL2A1 in mice) or loss of all isoforms of BCL2A1 (best known as A1) show no developmental defects but display minor defects in the hematopoietic compartment [<xref ref-type="bibr" rid="CR1201">1201</xref>&#8211;<xref ref-type="bibr" rid="CR1204">1204</xref>]. The absence of BCL2 like 2 (BCL2L2; best known as BCL-W)&#160;results in male infertility due to defective spermatogenesis [<xref ref-type="bibr" rid="CR1205">1205</xref>&#8211;<xref ref-type="bibr" rid="CR1207">1207</xref>].</p><p id="Par33">As opposed to homozygous deletion, haploinsufficiency for genes encoding MCL1 or BCL-X<sub>L</sub> did not result in defects in normal development [<xref ref-type="bibr" rid="CR1188">1188</xref>, <xref ref-type="bibr" rid="CR1190">1190</xref>]. However, <italic toggle="yes">Mcl1</italic><sup>+/-</sup> mice display significant, albeit minor decreases in certain hematopoietic cell types [<xref ref-type="bibr" rid="CR1208">1208</xref>, <xref ref-type="bibr" rid="CR1209">1209</xref>], and poor hematopoietic recovery from stress, such as gamma-radiation or treatment with 5-FU, which can be rescued by deletion of BCL2 binding component 3 (<italic toggle="yes">Bbc3;</italic> encoding PUMA) [<xref ref-type="bibr" rid="CR1209">1209</xref>]. Moreover, the loss of one <italic toggle="yes">Bcl2l1</italic> (encoding BCL-X<sub>L</sub>) allele&#160;limits male fertility due to defects in germ cell development [<xref ref-type="bibr" rid="CR1210">1210</xref>] and shortens platelet lifespan [<xref ref-type="bibr" rid="CR1211">1211</xref>]. Of note, while combined haploinsufficiency for <italic toggle="yes">Mcl1</italic> and <italic toggle="yes">Bcl2</italic>, for <italic toggle="yes">Mcl1</italic> and <italic toggle="yes">Bcl2a1a</italic> or for <italic toggle="yes">Bcl2l1</italic> (encoding BIM)&#160;and <italic toggle="yes">Bcl2</italic> does not markedly affect embryonic development in mice [<xref ref-type="bibr" rid="CR1212">1212</xref>&#8211;<xref ref-type="bibr" rid="CR1214">1214</xref>], <italic toggle="yes">Mcl1</italic><sup>+/&#8722;</sup><italic toggle="yes">Bcl2l1</italic><sup>+/&#8722;</sup> double heterozygote mice display severe developmental defects and die during embryogenesis or early postnatally [<xref ref-type="bibr" rid="CR1213">1213</xref>]. Remarkably, this defect can be rescued by concomitant deletion of a single allele of the gene encoding BIM. These observations suggest that embryonic development is safeguarded by a delicate balance between pro- and anti-apoptotic BCL2 proteins.</p><p id="Par34">Conditional knockout studies confirmed the importance of the different pro-survival BCL2 family members in specific tissues at precise developmental stages. These studies showed that MCL1 is critical for the development and/or maintenance of most (but not all) hematopoietic cell populations including stem and progenitor cells [<xref ref-type="bibr" rid="CR1215">1215</xref>], immature as well as mature B and T lymphocytes [<xref ref-type="bibr" rid="CR1216">1216</xref>&#8211;<xref ref-type="bibr" rid="CR1220">1220</xref>], natural killer (NK) cells [<xref ref-type="bibr" rid="CR1221">1221</xref>], neutrophils [<xref ref-type="bibr" rid="CR1222">1222</xref>, <xref ref-type="bibr" rid="CR1223">1223</xref>], mast cells and basophils [<xref ref-type="bibr" rid="CR1224">1224</xref>], as well as Ig-secreting plasma cells [<xref ref-type="bibr" rid="CR1225">1225</xref>, <xref ref-type="bibr" rid="CR1226">1226</xref>]. Accumulating evidence suggests that the survival of some hematopoietic cell subsets is safeguarded by the combined activity of two or even more anti-apoptotic BCL2 family members [<xref ref-type="bibr" rid="CR1227">1227</xref>]. Conditional deletion of <italic toggle="yes">Bcl2l1</italic> alone (leading to lack of BCL-X<sub>L</sub>) or in combination with loss of <italic toggle="yes">Mcl1</italic> demonstrated functional redundancy between BCL-X<sub>L</sub> and MCL1 in developing lymphocytes [<xref ref-type="bibr" rid="CR1228">1228</xref>, <xref ref-type="bibr" rid="CR1229">1229</xref>] and megakaryocytes [<xref ref-type="bibr" rid="CR1211">1211</xref>, <xref ref-type="bibr" rid="CR1230">1230</xref>&#8211;<xref ref-type="bibr" rid="CR1232">1232</xref>]. Conversely, BCL2 and A1 appear to have overlapping actions in the survival of B cells and neutrophils [<xref ref-type="bibr" rid="CR1212">1212</xref>, <xref ref-type="bibr" rid="CR1233">1233</xref>, <xref ref-type="bibr" rid="CR1234">1234</xref>] but not megakaryocytes and platelets [<xref ref-type="bibr" rid="CR1235">1235</xref>]. Data from chimeric mice confirm the role of these proteins in hematopoiesis [<xref ref-type="bibr" rid="CR1144">1144</xref>, <xref ref-type="bibr" rid="CR1190">1190</xref>, <xref ref-type="bibr" rid="CR1236">1236</xref>, <xref ref-type="bibr" rid="CR1237">1237</xref>]. BCL2 is reported to contribute to the development and homeostasis of the mouse epidermis [<xref ref-type="bibr" rid="CR1238">1238</xref>]. Along similar lines, MCL1 and BCL- X<sub>L</sub> play roles in the development and homeostasis of several tissues including the myocardium [<xref ref-type="bibr" rid="CR1239">1239</xref>, <xref ref-type="bibr" rid="CR1240">1240</xref>], the CNS [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR1241">1241</xref>&#8211;<xref ref-type="bibr" rid="CR1248">1248</xref>], the hepatic parenchyma [<xref ref-type="bibr" rid="CR298">298</xref>, <xref ref-type="bibr" rid="CR845">845</xref>, <xref ref-type="bibr" rid="CR1249">1249</xref>&#8211;<xref ref-type="bibr" rid="CR1251">1251</xref>], vascular endothelium [<xref ref-type="bibr" rid="CR1252">1252</xref>], thymic epithelium [<xref ref-type="bibr" rid="CR1253">1253</xref>], as well as the intestinal [<xref ref-type="bibr" rid="CR1254">1254</xref>], mammary [<xref ref-type="bibr" rid="CR1255">1255</xref>, <xref ref-type="bibr" rid="CR1256">1256</xref>], lung [<xref ref-type="bibr" rid="CR1257">1257</xref>] and renal [<xref ref-type="bibr" rid="CR277">277</xref>] epithelium.</p><p id="Par35">There are substantial differences in the severity of the defects caused by the conditional deletion of different pro-survival BCL2 family genes and between distinct tissues. For instance, conditional deletion of <italic toggle="yes">Mcl1</italic> in mouse hematopoietic stem/progenitor cells [<xref ref-type="bibr" rid="CR1214">1214</xref>], erythroid cells [<xref ref-type="bibr" rid="CR1258">1258</xref>] or T<sub>REG</sub> cells [<xref ref-type="bibr" rid="CR1259">1259</xref>] is lethal. In the latter case, lethality is ascribed to multiorgan autoimmunity caused by the depletion of the pool of T<sub>REG</sub> cells [<xref ref-type="bibr" rid="CR1259">1259</xref>]. Similarly, the megakaryocyte-specific combined deletion of the genes encoding MCL1 and BCL-X<sub>L</sub> provokes embryonic or perinatal lethality [<xref ref-type="bibr" rid="CR1230">1230</xref>], which can be rescued by the absence of BCL2-antagonist/killer 1 (BAK1) [<xref ref-type="bibr" rid="CR1126">1126</xref>]. Similar findings have been obtained upon the ablation of <italic toggle="yes">Mcl1</italic> from the CNS or the myocardium, or the specific removal of the gene encoding BCL-X<sub>L</sub> from the respiratory epithelium, although these experiments did not include rescue approaches [<xref ref-type="bibr" rid="CR1240">1240</xref>&#8211;<xref ref-type="bibr" rid="CR1242">1242</xref>, <xref ref-type="bibr" rid="CR1257">1257</xref>]. The functional overlap between MCL1 and BCL-X<sub>L</sub> appears to be particularly relevant in the CNS and liver [<xref ref-type="bibr" rid="CR1247">1247</xref>, <xref ref-type="bibr" rid="CR1249">1249</xref>]. Of note, the requirement of MCL1 and BCL-X<sub>L</sub> for neurogenesis appears to fluctuate between different stages of differentiation. The neurodevelopmental defects imposed by the deletion of <italic toggle="yes">Mcl1</italic> or <italic toggle="yes">Bcl2l1</italic> can be rescued in the absence of BAX [<xref ref-type="bibr" rid="CR1192">1192</xref>, <xref ref-type="bibr" rid="CR1247">1247</xref>]. The detrimental effects of the hepatocyte-specific ablation of <italic toggle="yes">Bcl2l1</italic> or <italic toggle="yes">Mcl1</italic> can be rescued by deletion of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic> as well as by that of <italic toggle="yes">Bcl2l11</italic> and/or BH3 interacting domain death agonist (<italic toggle="yes">Bid</italic>) [<xref ref-type="bibr" rid="CR1260">1260</xref>, <xref ref-type="bibr" rid="CR1261">1261</xref>]. These observations demonstrate that organogenesis and adult tissue homeostasis depend on the balance between both anti-apoptotic and pro-apoptotic members of the BCL2 family. Further substantiating this notion, the hepatocyte-specific deletion of <italic toggle="yes">Mcl1</italic> promotes spontaneous&#160;hepatic carcinogenesis [<xref ref-type="bibr" rid="CR1262">1262</xref>], as does the deletion of <italic toggle="yes">Mcl1</italic> in intestinal epithelial cells [<xref ref-type="bibr" rid="CR1254">1254</xref>]. These latter findings may appear counterintuitive, as pre-malignant cells are expected to be more susceptible to succumb to environmental stress in the absence of MCL1 or BCL-X<sub>L</sub>. However, both hepatic and intestinal carcinogenesis involve a robust inflammatory component that is exacerbated by tissue damage and cell death [<xref ref-type="bibr" rid="CR1263">1263</xref>]. Moreover, MCL1-deficient tissues show an increased cell turnover, which results in elevated level of replicative stress and genetic instability, potentially promoting carcinogenesis [<xref ref-type="bibr" rid="CR845">845</xref>, <xref ref-type="bibr" rid="CR1254">1254</xref>]. Also, when many cells die, progenitors get mobilized and must divide extensively. This increases the risk of such cells acquiring mutations that may drive neoplastic transformation, as firstly shown in a murine model of radiation induced thymic T cell lymphoma development [<xref ref-type="bibr" rid="CR359">359</xref>, <xref ref-type="bibr" rid="CR360">360</xref>].</p></boxed-text></sec><sec id="Sec8"><boxed-text position="float" orientation="portrait"><label>Box 4 Impact of the apoptosome and apoptotic caspases on health</label><p id="Par36">The whole-body deletion of apoptotic peptidase activating factor 1 (<italic toggle="yes">Apaf1</italic>) or caspase 9 (<italic toggle="yes">Casp9</italic>) is associated with fetal lethality around E14.5&#8211;E16.5 [<xref ref-type="bibr" rid="CR1264">1264</xref>&#8211;<xref ref-type="bibr" rid="CR1266">1266</xref>]. Severe abnormalities in APAF1-deficient fetuses include webbed feet, craniofacial malformations, incomplete neural tube closure and/or excessive brain growth and exencephaly resulting in alteration of the central nervous system (CNS) including in the visual, olfactory, and auditory systems [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR1264">1264</xref>, <xref ref-type="bibr" rid="CR1266">1266</xref>&#8211;<xref ref-type="bibr" rid="CR1269">1269</xref>]. Similar defects in the developing brain result from <italic toggle="yes">Casp9</italic> deletion [<xref ref-type="bibr" rid="CR1189">1189</xref>, <xref ref-type="bibr" rid="CR1266">1266</xref>, <xref ref-type="bibr" rid="CR1270">1270</xref>], a phenotype that was not exacerbated by <italic toggle="yes">Casp2</italic> co-deletion [<xref ref-type="bibr" rid="CR1271">1271</xref>]. The absence of CASP9 did not rescue neuronal defects due p53 hyperactivation in neural crest cells [<xref ref-type="bibr" rid="CR323">323</xref>].</p><p id="Par37">Of note, evidence linking mutations in <italic toggle="yes">APAF1</italic>, <italic toggle="yes">CASP9</italic> and <italic toggle="yes">CASP3</italic> to neural tube defects in humans has been reported [<xref ref-type="bibr" rid="CR1272">1272</xref>, <xref ref-type="bibr" rid="CR1273">1273</xref>]. Mice lacking cytochrome c, somatic (CYCS) die in midgestation [<xref ref-type="bibr" rid="CR1274">1274</xref>], while the deletion of cytochrome c, testis (<italic toggle="yes">Cyct</italic>), which is specifically expressed in male gonads is associated with normal development but male infertility [<xref ref-type="bibr" rid="CR1275">1275</xref>]. The neuron-specific ablation of <italic toggle="yes">Cycs</italic> results in postnatal cell death [<xref ref-type="bibr" rid="CR1276">1276</xref>]. Confirming that the detrimental effects of <italic toggle="yes">Cycs</italic> deletion result from impaired apoptosis, mice expressing a mutant CYCS that retains the ability to shuttle electrons as a component of the mitochondrial respiratory chain but is unable to assemble the apoptosome exhibit perinatal lethality and developmental brain defects similar to APAF1- and CASP9-deficient mice [<xref ref-type="bibr" rid="CR1277">1277</xref>].</p><p id="Par38">Importantly, the genetic background of mouse strains appears to significantly influence the impact of the absence of core components of the apoptotic machinery on embryonic development. Thus, while genetic deletion of <italic toggle="yes">Casp3</italic> in 129S1/SvImJ mice results in embryonic or early postnatal lethality due to the severe defects in brain development that are only partially rescued by concomitant deletion of the gene encoding BCL-X<sub>L</sub>, on a C57BL/6 background <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice develop normally and survive into adulthood [<xref ref-type="bibr" rid="CR1278">1278</xref>&#8211;<xref ref-type="bibr" rid="CR1281">1281</xref>]. A similar impact of genetic background on phenotype has also been observed for <italic toggle="yes">Apaf1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> and <italic toggle="yes">Casp9</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice [<xref ref-type="bibr" rid="CR1282">1282</xref>, <xref ref-type="bibr" rid="CR1283">1283</xref>]. Although <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice reach adulthood on a C57BL/6 background, they exhibit defects in complex brain functions including attention and (in males) social behavior [<xref ref-type="bibr" rid="CR1284">1284</xref>, <xref ref-type="bibr" rid="CR1285">1285</xref>], as well as ear and vestibular dysfunction including hearing loss [<xref ref-type="bibr" rid="CR1286">1286</xref>&#8211;<xref ref-type="bibr" rid="CR1290">1290</xref>], Abnormalities were also seen in the kidney and spleen of aged <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice [<xref ref-type="bibr" rid="CR1291">1291</xref>]. Survival of <italic toggle="yes">Casp3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice to adulthood in C57BL/6 mice was ascribed to the compensatory activation of CASP7 [<xref ref-type="bibr" rid="CR1292">1292</xref>]. The combined ablation of <italic toggle="yes">Casp3</italic> and <italic toggle="yes">Casp7</italic> causes embryonic lethality on the C57BL/6 background, although death is caused by severe cardiac rather than brain defects [<xref ref-type="bibr" rid="CR1293">1293</xref>]. Such phenotypic differences may originate from some degree of substrate selectivity exhibited by CASP3 <italic toggle="yes">vs</italic>. CASP7 [<xref ref-type="bibr" rid="CR444">444</xref>, <xref ref-type="bibr" rid="CR1294">1294</xref>&#8211;<xref ref-type="bibr" rid="CR1297">1297</xref>]. Moreover, a recent study performed in <italic toggle="yes">Casp7</italic><sup>&#8722;/&#8722;</sup> mice indicates that CASP7 acts as a facilitator of the variants of RCD occurring in the context of pore-driven lysis rather than an apoptotic executioner [<xref ref-type="bibr" rid="CR1298">1298</xref>].</p><p id="Par39">Approximately 5% of APAF1-deficient mice develop normally and survive into adulthood, although males are often sterile due to defective spermatogenesis [<xref ref-type="bibr" rid="CR1265">1265</xref>] a phenotype that is reminiscent of mice deficient for BAX, BAK1 and BOK (<italic toggle="yes">i.e</italic>., <italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bok</italic><sup>&#8722;/&#8722;</sup> mice) [<xref ref-type="bibr" rid="CR26">26</xref>]. Of note, rare adult <italic toggle="yes">Apaf1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> male mice that retain fertility display expansion of the lateral brain ventricles coupled with behavioral abnormalities and growth retardation [<xref ref-type="bibr" rid="CR1283">1283</xref>]. Conversely, the rare mice expressing a CYCS variant specifically deficient in apoptotic functions that survive into adulthood exhibit impaired lymphocyte homeostasis [<xref ref-type="bibr" rid="CR1277">1277</xref>]. Whole-body deletion of diablo, IAP-binding mitochondrial protein (<italic toggle="yes">Diablo</italic>, coding for a pro-apoptotic factor also known as SMAC) alone or along with HtrA serine peptidase 2 (<italic toggle="yes">Htra2</italic>) does not result in developmental defects in mice [<xref ref-type="bibr" rid="CR1299">1299</xref>, <xref ref-type="bibr" rid="CR1300">1300</xref>], while the <italic toggle="yes">Diablo</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> genotype accrues the perinatal lethality observed in <italic toggle="yes">Casp3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice [<xref ref-type="bibr" rid="CR1301">1301</xref>]. Mice lacking the X-linked inhibitor of apoptosis (XIAP, the main target of the pro-apoptotic activity of SMAC and HTRA2) are also viable and develop normally, possibly due to functional compensation by other members of the inhibitor of apoptosis protein (IAP) family [<xref ref-type="bibr" rid="CR1302">1302</xref>, <xref ref-type="bibr" rid="CR1303">1303</xref>], but they exhibit mild defects in late pregnancy that do not compromise lactation [<xref ref-type="bibr" rid="CR1302">1302</xref>]. Consistent with this SMAC-mimetic drugs that were designed to induce apoptosis by antagonizing IAPs are quite well tolerated [<xref ref-type="bibr" rid="CR1304">1304</xref>]. <italic toggle="yes">Xiap</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice also show dysregulated innate immune responses [<xref ref-type="bibr" rid="CR1305">1305</xref>], most likely linked to the modulatory role of XIAP in inflammation and necroptosis [<xref ref-type="bibr" rid="CR459">459</xref>, <xref ref-type="bibr" rid="CR462">462</xref>, <xref ref-type="bibr" rid="CR1306">1306</xref>], or to the inability of these animals to resolve infections [<xref ref-type="bibr" rid="CR1307">1307</xref>]. Accordingly, loss-of-function mutations in <italic toggle="yes">XIAP</italic> are associated with X-linked lymphoproliferative syndrome type 2 in humans [<xref ref-type="bibr" rid="CR458">458</xref>&#8211;<xref ref-type="bibr" rid="CR461">461</xref>].</p><p id="Par40">The myocardium-specific deletion of <italic toggle="yes">Casp3</italic> and <italic toggle="yes">Casp7</italic> impairs heart development in mice resulting in myocyte hypertrophy [<xref ref-type="bibr" rid="CR1308">1308</xref>]. The role of APAF1, CASP9 and CASP3 in hematopoiesis remains debated. Specific ablation of <italic toggle="yes">Apaf1</italic> or <italic toggle="yes">Casp9</italic> from the hematopoietic system using lethally irradiated wild-type mice reconstituted with hematopoietic stem/progenitor cells deficient for these factors does not result in alterations in the lymphoid or myeloid cell compartments [<xref ref-type="bibr" rid="CR15">15</xref>]. Likewise, no hematopoietic defects emerge from the whole-body deletion of <italic toggle="yes">Casp3</italic> [<xref ref-type="bibr" rid="CR1293">1293</xref>]. Moreover, mice lacking <italic toggle="yes">Casp9</italic> in the hematopoietic system display a proper generation and functionality of megakaryocytes and platelets [<xref ref-type="bibr" rid="CR1309">1309</xref>]. Moreover, the clearance of <italic toggle="yes">Casp9</italic><sup>&#8722;/&#8722;</sup> thymocytes seems to occur in a caspase-independent fashion [<xref ref-type="bibr" rid="CR1310">1310</xref>]. In the same line, although apoptosis is widely believed to be crucial for epithelial cell death and shedding in the intestine, during steady state, executioner CASP3 and CASP7 are dispensable for intestinal epithelial cell turnover at the top of intestinal villi, intestinal tissue dynamics, microbiome, and immune cell composition, suggesting high redundancy in non-challenged conditions [<xref ref-type="bibr" rid="CR464">464</xref>]. Apparently at odds with these observations, <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice were reported to have abnormally increased numbers of splenic B cells manifesting increased proliferative capacity [<xref ref-type="bibr" rid="CR1311">1311</xref>], as well as a dysregulated activity in bone marrow stromal stem cells that attenuated osteogenic differentiation [<xref ref-type="bibr" rid="CR1312">1312</xref>]. A similar debate revolves around the requirement for APAF1 and caspase activity in thymocyte selection and/or T cell responses [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR1313">1313</xref>&#8211;<xref ref-type="bibr" rid="CR1317">1317</xref>]. Mouse bone marrow chimeras deficient for APAF1 or CASP9 in their hematopoietic cells displayed a defect in hematopoietic stem/progenitor cells that is caused by the aberrant type 1 interferon production caused by the fact that hematopoietic cells undergoing normal programmed cell death do not die in a &#8220;neat&#8221; non-inflammatory manner [<xref ref-type="bibr" rid="CR243">243</xref>, <xref ref-type="bibr" rid="CR1318">1318</xref>]. Taken together, these findings suggest that BAX/BAK1-dependent death of hematopoietic cells does not require caspases, but that caspases are needed to prevent inflammation caused by&#160;cell demolition [<xref ref-type="bibr" rid="CR1319">1319</xref>&#8211;<xref ref-type="bibr" rid="CR1322">1322</xref>]. However, neither the degree of functional redundancy exhibited by CASP3, CASP6 and CASP7, nor the potential for APAF1-independent CASP3 activation has been formally excluded in these studies, most of which involved single genetic alterations.</p></boxed-text></sec><sec id="Sec9"><title>Neurological disorders</title><p id="Par41">Intrinsic apoptotic factors are implicated in the pathophysiology of numerous neurological diseases (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). In a mouse model of amyotrophic lateral sclerosis (ALS), deletion of BCL2-associated X protein (<italic toggle="yes">Bax</italic>) reduces neuronal cell death coupled to attenuated motor dysfunction and neuromuscular degeneration [<xref ref-type="bibr" rid="CR76">76</xref>]. Additional ablation of BCL2-antagonist/killer 1 (<italic toggle="yes">Bak1</italic>) further enhances neuroprotection, resulting in improved overall animal survival [<xref ref-type="bibr" rid="CR77">77</xref>]. Similar protective effects were observed in mice lacking the BH3-only proteins BCL2 like 11 (BCL2L11, best known as BIM) and BCL2 binding component 3 (BBC3, best known as PUMA), as well as in transgenic mice overexpressing BCL2, X-linked inhibitor of apoptosis (XIAP) [<xref ref-type="bibr" rid="CR78">78</xref>&#8211;<xref ref-type="bibr" rid="CR82">82</xref>]. Moreover, intra-cerebroventricular administration of the broad-spectrum inhibitor Z-VAD-FMK protects mice from ALS [<xref ref-type="bibr" rid="CR83">83</xref>], although whether such protection arises from the inhibition of intrinsic apoptosis remains to be formally established. <italic toggle="yes">Bax</italic> deletion also attenuates neuromuscular dysfunctions in a mouse model of congenital muscular dystrophy (another neurodegenerative disease affecting motoneurons) [<xref ref-type="bibr" rid="CR84">84</xref>], while BCL2 overexpression limits neuromuscular disease progression in some (but not all) mouse models of progressive motor neuronopathy and muscular dystrophy [<xref ref-type="bibr" rid="CR85">85</xref>&#8211;<xref ref-type="bibr" rid="CR87">87</xref>]. Finally, genetic or pharmacological inhibition of poly (ADP-ribose) polymerase family, member 1 (PARP1) and PARP2 halts axonal degeneration and improves related motor phenotypes in <italic toggle="yes">C. elegans</italic> models of ALS [<xref ref-type="bibr" rid="CR88">88</xref>].<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>Impact of intrinsic apoptosis players on neurological disorders.</title><p>Intrinsic apoptosis is directly or indirectly involved in the pathogenesis of multiple neurological disorders, including neurodegenerative diseases, brain damage caused by traumatic injury or neurotoxicity as well as neuromuscular and retinal disorders.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e7764" position="float" orientation="portrait" xlink:href="41418_2023_1153_Fig3_HTML.jpg"/></fig></p><p id="Par42">Multiple components of the molecular machinery for intrinsic apoptosis, including BAX, PUMA, BH3 interacting domain death agonist (BID), Harakiri, BCL2 interacting protein (contains only BH3 domain) (HRK), were shown to drive neuronal death in Alzheimer&#8217;s disease (AD) and Parkinson&#8217;s disease (PD) models [<xref ref-type="bibr" rid="CR89">89</xref>&#8211;<xref ref-type="bibr" rid="CR101">101</xref>]. Thus, overexpression of BCL2 decreases the appearance of early pathological markers of AD, such as amyloid precursor protein (APP) and microtubule-associated protein tau (MAPT, best known as tau) cleavage, which depend on caspases [<xref ref-type="bibr" rid="CR102">102</xref>&#8211;<xref ref-type="bibr" rid="CR104">104</xref>], resulting in attenuated neurological defects [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. Some findings indicate a role of apoptotic caspases in the pathogenesis of AD. However, as discussed above, during intrinsic apoptosis, caspases simply accelerate the course of cell death, and, so, such effects may be linked to the release of cytotoxic and pro-inflammatory factors from dying cells. In more detail, pharmacological inhibition of CASP3 reduces early synaptic failure in mouse models of AD, ultimately improving cognitive defects [<xref ref-type="bibr" rid="CR107">107</xref>]. Moreover, expression of a mutated form of amyloid &#946; (an APP cleavage product) or administration of broad-spectrum caspase inhibitors attenuates synaptic defects in models of AD, an effect only partially recapitulated by CASP3-specific inhibitors [<xref ref-type="bibr" rid="CR108">108</xref>]. Along similar lines, deletion of <italic toggle="yes">Casp2</italic> was reported to provide protection from synaptic loss and cognitive decline in a mouse model of AD [<xref ref-type="bibr" rid="CR109">109</xref>]. Such protection may be linked to the generation of a specific tau&#160;cleavage product (&#8710;tau314) by CASP2, which is reported to impair cognitive and synaptic function by promoting the missorting of tau to dendritic spines [<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]. Accordingly, CASP2 inhibitors blocked tau truncation and restored excitatory neurotransmission in mouse models of tauopathies, including AD [<xref ref-type="bibr" rid="CR112">112</xref>, <xref ref-type="bibr" rid="CR113">113</xref>]. A role for CASP4 in AD pathogenesis has also been&#160;reported [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]. Moreover, studies using the&#160;senescence-accelerated OXY5 rat model of AD demonstrated that the treatment with mitochondria-targeted antioxidant SkQ1 improved mitochondrial fitness and slowed down the signs of Alzheimer&#8217;s disease-like pathology in older rats [<xref ref-type="bibr" rid="CR116">116</xref>]. Lack of BIM (due to deletion of <italic toggle="yes">Bcl2l11</italic>) also confers protection to dopaminergic neurons in experimental PD imposed by inhibition of mitochondrial complex I, an effect that depends on BAX activation [<xref ref-type="bibr" rid="CR117">117</xref>]. In addition, genetic deletion or down-regulation of <italic toggle="yes">Casp3</italic>, as well CASP3 inhibition by transgenic, neuron-restricted expression of XIAP, protects mice against pharmacologically induced PD, attenuating both dopaminergic neuron alterations and behavioral deficits [<xref ref-type="bibr" rid="CR118">118</xref>&#8211;<xref ref-type="bibr" rid="CR121">121</xref>]. Whether protection arises from the lack of cell-intrinsic or cell-extrinsic processes dependent on apoptotic caspases has not been investigated. Finally, pharmacological inhibition of CASP3 confers neuroprotection in a rat model of Huntington&#8217;s disease (HD) [<xref ref-type="bibr" rid="CR122">122</xref>&#8211;<xref ref-type="bibr" rid="CR124">124</xref>]. That said, the precise mechanisms whereby components of the molecular apparatus for intrinsic apoptosis influence neurodegeneration need to be further explored. Two studies in clear contradiction to each other reported that, at sublethal doses, pharmacological inhibition of myeloid cell leukemia sequence 1 (MCL1) improved disease outcome in a mouse model of AD with a mechanism independent of apoptosis induction and involving the stimulation of mitophagy [<xref ref-type="bibr" rid="CR125">125</xref>], but that <italic toggle="yes">Mcl1</italic> haploinsufficiency accelerated the degeneration and dysfunctionality of motor neurons in mice [<xref ref-type="bibr" rid="CR126">126</xref>]. Also, there is evidence that necroptosis or ferroptosis rather than apoptosis can be the major contributor in neuronal cell destruction during AD [<xref ref-type="bibr" rid="CR127">127</xref>, <xref ref-type="bibr" rid="CR128">128</xref>]. Finally, although <italic toggle="yes">Bax</italic> deletion prevents the demise of cerebellar granule neurons in a transgenic model of inherited prion disease [<xref ref-type="bibr" rid="CR129">129</xref>], the direct contribution of BAX to neurotoxicity during prion disorders remains a matter of controversy [<xref ref-type="bibr" rid="CR130">130</xref>].</p><p id="Par43">BCL2 family proteins have also been reported to contribute to axonal degeneration and neuronal cell death in animal models of brain trauma, degeneration, or neurotoxicity [<xref ref-type="bibr" rid="CR131">131</xref>&#8211;<xref ref-type="bibr" rid="CR133">133</xref>]. Thus, BAX- or BID-deficient mice, as well as transgenic mice overexpressing BCL2, display increased survival of cortical or hippocampal neurons after experimental traumatic brain injury, as compared to wild-type mice [<xref ref-type="bibr" rid="CR134">134</xref>&#8211;<xref ref-type="bibr" rid="CR137">137</xref>]. Moreover, transgenic BCL2 overexpression protects mouse neurons against the detrimental effects of transection of the sciatic nerve [<xref ref-type="bibr" rid="CR138">138</xref>]. Likewise, BAX deficiency enhances the survival of oligodendrocytes in mice subjected to spinal cord injury [<xref ref-type="bibr" rid="CR139">139</xref>]. Both neuroprotection and functional improvements were observed in rat or mouse models of traumatic spinal cord injury upon local administration of Z-VAD-FMK) and other caspase inhibitors [<xref ref-type="bibr" rid="CR140">140</xref>&#8211;<xref ref-type="bibr" rid="CR142">142</xref>]. However, these findings need to be validated given the low selectivity of these inhibitors among caspases. Of note, in rats, post-traumatic neuroprotection can further be improved by combined inactivation of PARP1 and CASP3 [<xref ref-type="bibr" rid="CR143">143</xref>], suggesting a potential involvement for PARP1-dependent parthanatos in the process.</p><p id="Par44">Deletion of <italic toggle="yes">Bax</italic> (but not the genes encoding BIM, PUMA or BID), as well as <italic toggle="yes">Bax</italic> haploinsufficiency, prevents the death or degeneration of retinal ganglion cells in mice subjected to optic nerve injury [<xref ref-type="bibr" rid="CR144">144</xref>&#8211;<xref ref-type="bibr" rid="CR147">147</xref>]. Moreover, the demise of injured retinal ganglion cells is exacerbated in mice with a conditional loss of <italic toggle="yes">Bcl2l1</italic> (leading to lack of BCL-X<sub>L</sub>) [<xref ref-type="bibr" rid="CR148">148</xref>] and decreased in transgenic mice over-expressing XIAP [<xref ref-type="bibr" rid="CR149">149</xref>] or BCL-X<sub>L</sub> [<xref ref-type="bibr" rid="CR150">150</xref>] in the eye, as well as in rodents treated with an XIAP-derived cell-permeant peptide targeting CASP9 [<xref ref-type="bibr" rid="CR151">151</xref>], or a CASP3-targeting small-interfering RNA (siRNA) [<xref ref-type="bibr" rid="CR152">152</xref>, <xref ref-type="bibr" rid="CR153">153</xref>]. Moreover, transgenic or adenovirus-driven XIAP expression protects the retina in various animal models of retinal disease, degeneration, or ischemia [<xref ref-type="bibr" rid="CR154">154</xref>&#8211;<xref ref-type="bibr" rid="CR159">159</xref>], while a BCL-X<sub>L</sub> inhibitor alleviates pathogenic neo-vascularization during diabetic retinopathy [<xref ref-type="bibr" rid="CR160">160</xref>]. Genetic deletion of <italic toggle="yes">Casp9</italic> from endothelial cells protected retinal ganglion cells from ischemic death, supporting non-cell autonomous functions of CASP9 [<xref ref-type="bibr" rid="CR151">151</xref>]. Of note, CASP7 seems to play a crucial role in retinal ganglion cell death, as demonstrated in a model of optic injury in <italic toggle="yes">Casp7</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice [<xref ref-type="bibr" rid="CR161">161</xref>]. However, both pro-survival (BCL2) and pro-apoptotic (BAK1, BAX and BIM) BCL2 family members contribute to retinal neo-vascularization in response to experimental ischemic retinopathy [<xref ref-type="bibr" rid="CR162">162</xref>&#8211;<xref ref-type="bibr" rid="CR164">164</xref>]. In one of these models, such an effect was linked to an increased survival of endothelial cells in the absence of BAX and BAK1 [<xref ref-type="bibr" rid="CR164">164</xref>]. Persistent endothelial cells promote&#160;indeed rapid tissue re-vascularization, thus preventing the occurrence of a pathogenic excessive neovascularization. Moreover, the inhibition of the intrinsic apoptotic pathway by c-Jun N-terminal kinase 1 (<italic toggle="yes">Jnk1</italic>) deletion&#160;or the administration of a broad-spectrum caspase inhibitor led to reduced choroidal neo-vascularization in the murine model of wet age-related macular degeneration (AMD) [<xref ref-type="bibr" rid="CR165">165</xref>]. These observations may indicate that factors released by dying cells regulate neo-vascularization in the retina or other eye tissues.</p><p id="Par45">Deletion of <italic toggle="yes">Bax</italic>, <italic toggle="yes">Hrk</italic> or <italic toggle="yes">Casp3</italic> as well as transgenic overexpression of XIAP prevents neuronal loss and/or axon degeneration in mouse models of trophic factor deprivation including nerve growth factor (NGF) withdrawal [<xref ref-type="bibr" rid="CR166">166</xref>&#8211;<xref ref-type="bibr" rid="CR168">168</xref>]. Conversely, lack of BIM or PUMA does not limit hippocampal neuronal injury upon experimental excitotoxicity [<xref ref-type="bibr" rid="CR169">169</xref>, <xref ref-type="bibr" rid="CR170">170</xref>]. Moreover, while in vivo delivery of an XIAP fusion protein protects neurons against death induced by glutamate or kainic acid [<xref ref-type="bibr" rid="CR171">171</xref>], kainic acid-mediated neurodegeneration cannot be rescued by the CASP3 inhibitor DEVD-CHO [<xref ref-type="bibr" rid="CR172">172</xref>]. Conversely, BIM appears to be activated during excitotoxicity [<xref ref-type="bibr" rid="CR173">173</xref>], and <italic toggle="yes">Bcl2l11</italic><sup>&#8722;/&#8722;</sup> mice (which lack BIM) display attenuated neuro-degeneration after experimental seizures induced by administration of kainic acid into the amygdala, at least in part because of decreased neuronal cell death in the hippocampus (but not in the neocortex) [<xref ref-type="bibr" rid="CR174">174</xref>]. Moreover, data from knockout mice suggest that experimental seizure-induced neuronal death involves BCL2-associated agonist of cell death (BAD), BCL2 interacting killer (BIK), BCL2 modifying factor (BMF), or PUMA [<xref ref-type="bibr" rid="CR175">175</xref>&#8211;<xref ref-type="bibr" rid="CR178">178</xref>] and that BCL2-like 2 (BCL2L2; best known as BCL-W) may provide neuroprotective, seizure-suppressive functions [<xref ref-type="bibr" rid="CR179">179</xref>]. Confirming a certain degree of functional redundancy, phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1, best known as NOXA) and BID seem dispensable for RCD driven by excitotoxicity, as shown in kainic acid-treated animals [<xref ref-type="bibr" rid="CR180">180</xref>, <xref ref-type="bibr" rid="CR181">181</xref>].</p><p id="Par46">Intrinsic apoptosis is also involved in neuronal apoptosis post-ischemic injury in both developing and adult brains. In a mouse model of neonatal hypoxia-ischemia, neuroprotection was documented upon deletion of <italic toggle="yes">Bax</italic> [<xref ref-type="bibr" rid="CR182">182</xref>], simultaneous absence of BIM and BAD [<xref ref-type="bibr" rid="CR183">183</xref>], or transgenic overexpression of XIAP [<xref ref-type="bibr" rid="CR184">184</xref>]. Conversely, <italic toggle="yes">Xiap</italic><sup>&#8722;/&#8722;</sup> mice are sensitized to neonatal hypoxia-ischemia injury [<xref ref-type="bibr" rid="CR185">185</xref>]. Apparently at odds with these findings, <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice display increased vulnerability to such experimental perturbation, possibly due to complementary over-activation of CASP3-independent pathways [<xref ref-type="bibr" rid="CR186">186</xref>]. Of note, the absence of CASP3, BAX, or PUMA (but not the absence of NOXA, BIM or HRK) also confers neuro-protection to newborn mice acutely exposed to ethanol [<xref ref-type="bibr" rid="CR187">187</xref>&#8211;<xref ref-type="bibr" rid="CR189">189</xref>], while loss of BAX is neuroprotective in newborn mice exposed to isoflurane [<xref ref-type="bibr" rid="CR190">190</xref>] as well as ionizing radiation [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR191">191</xref>]. At the same time, it is interesting to note that BAX-dependent neuronal RCD also contributes to reactive microgliosis during the recovery of the developing brain from acute alcohol exposure [<xref ref-type="bibr" rid="CR192">192</xref>], pointing to an etiological role for activation of microglial cells by dead neurons.</p><p id="Par47"><italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup> mice displayed pronounced neuroprotection when subjected to distinct experimental brain injuries, including middle cerebral artery occlusion [<xref ref-type="bibr" rid="CR193">193</xref>]. A similar protection against experimental ischemic insults has been observed in mice deficient for BMF [<xref ref-type="bibr" rid="CR194">194</xref>], or BID [<xref ref-type="bibr" rid="CR195">195</xref>&#8211;<xref ref-type="bibr" rid="CR197">197</xref>]. Conversely, NOXA seems to be dispensable for neuronal damage induced by experimental ischemic stroke [<xref ref-type="bibr" rid="CR194">194</xref>]. Moreover, the absence of BID fails to protect mice from ischemia-reperfusion, although it limits the associated inflammatory response [<xref ref-type="bibr" rid="CR198">198</xref>]. Transgenic over-expression of BCL2, BCL-X<sub>L</sub> or XIAP as well as inhibition of apoptotic caspases or genetic deletion of <italic toggle="yes">CASP6</italic> ameliorates neuronal survival upon global ischemia, focal ischemia or stroke [<xref ref-type="bibr" rid="CR199">199</xref>&#8211;<xref ref-type="bibr" rid="CR215">215</xref>]. It should be noted, however, that in these settings neuroprotection by inhibition or deletion of caspases may be related to the lack of cell-extrinsic or apoptotic-unrelated roles of caspases. Morevoer, various examples of caspase-independent neuronal death after cerebral ischemia have been reported [<xref ref-type="bibr" rid="CR216">216</xref>&#8211;<xref ref-type="bibr" rid="CR219">219</xref>]. In this context, it is important to note that apoptosis is dynamically regulated during lifespan in the brain [<xref ref-type="bibr" rid="CR24">24</xref>]. Indeed, while immature brain cells express high levels of many BCL2 proteins [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR220">220</xref>, <xref ref-type="bibr" rid="CR221">221</xref>], most of these proteins are downregulated in the adult brain, when most post-mitotic neural cells become resistant to apoptosis [<xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR222">222</xref>]. This may help explain the divergent findings on the mechanisms of neural cell death reported above.</p></sec><sec id="Sec10"><title>Cardiovascular conditions</title><p id="Par48">While a role for RCD in non-reperfused myocardial infarction remains questionable, apoptosis and other cell death programs including necroptosis, MPT-driven necrosis, ferroptosis, pyroptosis and autosis appear to contribute to cardiomyocyte death and tissue damage during myocardial infarction with reperfusion (also referred to as myocardial ischemia-reperfusion injury). However, the relative importance of the specific&#160;RCD mode&#160;and how it interconnects mechanistically and functionally&#160;with other RCD pathways to produce an integrated response remains poorly understood. For example, <italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup>mice with a cardiomyocyte-specific deletion of <italic toggle="yes">Bax</italic> displayed considerably reduced infarct size as compared to their wild-type littermates when subjected to experimental myocardial ischemia-reperfusion, although it remains unclear whether these effects are attributable to reductions in apoptosis or MPT-driven necrosis [<xref ref-type="bibr" rid="CR223">223</xref>&#8211;<xref ref-type="bibr" rid="CR225">225</xref>], a RCD variant shown to participate in the pathogenesis of ischemic stroke [<xref ref-type="bibr" rid="CR226">226</xref>]. Protection against myocardial ischemia-reperfusion has also been reported in transgenic mice overexpressing BCL2 [<xref ref-type="bibr" rid="CR227">227</xref>&#8211;<xref ref-type="bibr" rid="CR229">229</xref>] or a BCL-X<sub>L</sub>-derived peptide [<xref ref-type="bibr" rid="CR230">230</xref>]. Likewise, deletion of <italic toggle="yes">Bbc3</italic> (leading to lack of PUMA) ameliorates myocardial ischemia-reperfusion injury [<xref ref-type="bibr" rid="CR231">231</xref>], ultimately translating into increased survival [<xref ref-type="bibr" rid="CR232">232</xref>]. Moreover, neurotrophin-3 was reported to confer cardioprotection fromischemic and reperfusion injuries by reducing BIM levels [<xref ref-type="bibr" rid="CR233">233</xref>]. Broad spectrum caspase inhibition [<xref ref-type="bibr" rid="CR234">234</xref>&#8211;<xref ref-type="bibr" rid="CR236">236</xref>] and XIAP mimicking peptides [<xref ref-type="bibr" rid="CR237">237</xref>] were shown to modestly reduce myocardial infarct size. Finally, simultaneous deletion of <italic toggle="yes">Casp3</italic> and <italic toggle="yes">Casp7</italic> had no cardioprotective effect during reperfused myocardial infarction [<xref ref-type="bibr" rid="CR238">238</xref>], in line with the notion that the absence of caspases only delays cell death.</p><p id="Par49">In contrast to the large burst of cell death over several hours characterizing myocardial infarction, cardiomyocytes are lost gradually over months to years during heart failure with reduced ejection fraction [<xref ref-type="bibr" rid="CR3">3</xref>]. The role of intrinsic apoptosis in these heart conditions is, however, debated. In a mouse model of cardiomyopathy based on the deletion of desmin (<italic toggle="yes">Des</italic>), the cardiomyocyte-specific over-expression of BCL2 reduces cardiac lesions and hypertrophy coupled to ameliorated cardiac functionality [<xref ref-type="bibr" rid="CR239">239</xref>]. However, despite improved survival, these mice show increased levels of necrosis due to the activation of alternative cell death pathways [<xref ref-type="bibr" rid="CR240">240</xref>]. Moreover, <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice display enhanced vulnerability to experimental cardiomyopathy, at least in part reflecting the inefficient activation of pro-survival AKT serine/threonine kinase 1 (AKT1) signaling [<xref ref-type="bibr" rid="CR241">241</xref>]. As an alternative explanation, the absence of CASP3 may foster RCD-driven inflammation associated with increased type I interferon (IFN) release [<xref ref-type="bibr" rid="CR242">242</xref>&#8211;<xref ref-type="bibr" rid="CR244">244</xref>]. Indeed, experimental data linking dysregulated type I IFN release and cardiac conditions have recently emerged [<xref ref-type="bibr" rid="CR245">245</xref>].</p><p id="Par50">As for therapeutic interventions, cardioprotective effects have been achieved by inhibition of CASP3 in rodent models of myocardial dysfunction induced by endotoxin [<xref ref-type="bibr" rid="CR246">246</xref>], burn injury [<xref ref-type="bibr" rid="CR247">247</xref>] or hypoxia [<xref ref-type="bibr" rid="CR248">248</xref>], although perhaps such effects can be attributed to the lack of cell-extrinsic or apoptosis-unrelated effects of caspase activity. Moreover, inhibition of BAX prevents cardiotoxicity induced by doxorubicin in zebrafish and mice without affecting the anti-neoplastic activity of doxorubicin [<xref ref-type="bibr" rid="CR249">249</xref>]. Similarly, the endothelial cell-specific expression of B cell leukemia/lymphoma 2 related protein A1a (BCL2A1A) promotes survival in a model of allogeneic heart transplantation [<xref ref-type="bibr" rid="CR250">250</xref>].</p><p id="Par51">Finally, the mechanistic links between intrinsic apoptosis and atherosclerosis remain a matter of debate. Indeed, while <italic toggle="yes">Casp3</italic> deletion favors plaque development in mouse models of atherosclerosis [<xref ref-type="bibr" rid="CR251">251</xref>], the absence of DNA fragmentation factor subunit beta (DFFB, best known as CAD)) [<xref ref-type="bibr" rid="CR252">252</xref>] protects mice against the disease. Likewise, while conditional deletion of <italic toggle="yes">Mcl1</italic> in myeloid cells is pro-atherogenic [<xref ref-type="bibr" rid="CR253">253</xref>], genetic or pharmacological inhibition of BCL-X<sub>L</sub> reduces atherosclerosis via a mechanism involving the depletion of platelets [<xref ref-type="bibr" rid="CR254">254</xref>]. Moreover, the macrophage or leukocyte-specific deletion of the gene encoding BIM in mice has modest effects on plaque development, especially in the early phase of atherosclerosis [<xref ref-type="bibr" rid="CR255">255</xref>, <xref ref-type="bibr" rid="CR256">256</xref>]. As the etiology of atherosclerosis involves a major inflammatory component, these apparently discrepant results may reflect (at least in part) the key role of some components of the apoptotic machinery in the control of inflammatory responses.</p></sec><sec id="Sec11"><title>Renal disorders</title><p id="Par52">Germline or kidney-specific deletion of <italic toggle="yes">Bax</italic> attenuates acute kidney damage in mice subjected to experimental renal ischemia/reperfusion [<xref ref-type="bibr" rid="CR257">257</xref>]. A similar nephron-protection has been observed in <italic toggle="yes">Bid</italic><sup>&#8722;/&#8722;</sup> mice [<xref ref-type="bibr" rid="CR258">258</xref>], as well as in transgenic mice specifically expressing BCL-X<sub>L</sub> in the kidney [<xref ref-type="bibr" rid="CR259">259</xref>]. Moreover, the simultaneous deletion of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic> in kidney proximal tubules limits tubular apoptosis and ameliorates kidney inflammation and fibrosis in a mouse model of renal fibrosis based on unilateral ureteral obstruction [<xref ref-type="bibr" rid="CR260">260</xref>, <xref ref-type="bibr" rid="CR261">261</xref>]. Apoptotic caspases also appear to contribute to the etiology of renal conditions, although&#160;this may reflect cell-extrinsic effects of caspase activity. <italic toggle="yes">Casp3</italic> deletion reduces microvascular rarefaction and renal fibrosis in mice subjected to experimental ischemia-reperfusion injury [<xref ref-type="bibr" rid="CR262">262</xref>], resulting in better long-term outcomes [<xref ref-type="bibr" rid="CR263">263</xref>]. Moreover, the lack of CASP3 increases the survival of mice with chronic kidney disease caused by a congenital mutation in cystin 1 (<italic toggle="yes">Cys1</italic>) [<xref ref-type="bibr" rid="CR264">264</xref>]. In this setting, CASP3-deficient mice display increased CASP7 and decreased BCL2 expression, which is in line with recent clinical evidence of constitutive BCL2 down-regulation in patients with polycystic kidney disease [<xref ref-type="bibr" rid="CR265">265</xref>]. Administration of broad-spectrum caspase inhibitors limits kidney damage and improves renal functionality after a variety of experimental insults to kidneys, as observed in animal models of renal ischemia [<xref ref-type="bibr" rid="CR266">266</xref>, <xref ref-type="bibr" rid="CR267">267</xref>], polycystic kidney disease [<xref ref-type="bibr" rid="CR268">268</xref>], glomerulonephritis [<xref ref-type="bibr" rid="CR269">269</xref>], lupus nephritis [<xref ref-type="bibr" rid="CR270">270</xref>] and diabetic renal disease [<xref ref-type="bibr" rid="CR271">271</xref>]. Nonetheless, the specific targeting of apoptotic caspases will reveal whether this effect reflects the inhibition of intrinsic apoptosis. Indeed, these studies do not rule out the involvement of non-apoptotic RCD pathways in the etiology of acute and chronic kidney injury [<xref ref-type="bibr" rid="CR272">272</xref>, <xref ref-type="bibr" rid="CR273">273</xref>]. Moreover, some of the nephron-protective effects of broad-spectrum caspase inhibitors have been linked to decreased post-RCD inflammation rather than the sole inhibition of apoptosis [<xref ref-type="bibr" rid="CR266">266</xref>, <xref ref-type="bibr" rid="CR274">274</xref>]. In this context, Z-VAD-FMK aggravates (rather than ameliorates) renal dysfunction in a mouse model of cisplatin nephrotoxicity, by a mechanism involving the abrogation of cyto-protective autophagy [<xref ref-type="bibr" rid="CR275">275</xref>]. Similarly, Z-VAD-FMK is ineffective in mouse models of osmotic nephrosis and contrast-induced acute kidney injury [<xref ref-type="bibr" rid="CR276">276</xref>], and this may be linked to the ability of Z-VAD-FMK to inhibit CASP8 (and hence promote necroptosis). Finally, acute loss of BCL-X<sub>L</sub> in all tissues of adult mice, except for hematopoietic cells, caused severe renal tubular degeneration leading to fatal anemia due to the loss of erythropoietin production [<xref ref-type="bibr" rid="CR277">277</xref>].</p></sec><sec id="Sec12"><title>Hepatic diseases</title><p id="Par53">Abundant evidence highlights pathogenic roles of apoptosis in acute liver injuries, as well as in alcohol-related and alcohol-unrelated chronic liver disorders. Hepatocytes express high levels of BID, which connects DR signaling to mitochondrial outer membrane permeabilization (MOMP) upon CASP8-dependent cleavage [<xref ref-type="bibr" rid="CR278">278</xref>], and this complicates distinguishing between the intrinsic and extrinsic pathways. Here, we will focus on studies performed in animal models of liver injury unrelated to overt signaling engaged by the Fas cell surface death receptor (FAS; also known as CD95 or APO-1) or TNF receptor superfamily member 1A (TNFRSF1A, best known as TNF-R1), which instead will be discussed in the next section.</p><p id="Par54">Distinct preclinical models of hepatic ischemia-reperfusion injury demonstrated that deletion of <italic toggle="yes">Bcl2l11</italic> (leading to lack of BIM) and/or <italic toggle="yes">Bid</italic> as well as over-expression of BCL2 or administration of pharmacological broad-spectrum caspase inhibition mediate robust hepatoprotective effects [<xref ref-type="bibr" rid="CR279">279</xref>&#8211;<xref ref-type="bibr" rid="CR282">282</xref>]. A similar improvement of hepatocyte survival and liver functionality was observed in rodents specifically expressing a mutated variant of BID in the liver and subjected to warm ischemia/reperfusion injury [<xref ref-type="bibr" rid="CR283">283</xref>]. As for other models of liver injury, BIM-deficient mice are protected against viral hepatitis [<xref ref-type="bibr" rid="CR284">284</xref>]. Moreover, deletion of the genes encoding BIM or PUMA, but not BCL2-related ovarian killer (<italic toggle="yes">Bok</italic>) limits liver injury in mice exposed to the hepatotoxic agent acetaminophen [<xref ref-type="bibr" rid="CR285">285</xref>&#8211;<xref ref-type="bibr" rid="CR287">287</xref>]. Moreover, pre-treatment with Z-VAD-FMK improves the survival of mice subjected to extensive hepatectomy [<xref ref-type="bibr" rid="CR288">288</xref>].</p><p id="Par55">There is contrasting evidence on the role of BID in the etiology of liver conditions unrelated to overt FAS and TNF-R1 signaling. In a model of alcohol-related liver disease, the lack of BID confers some protection against ethanol-induced fibrosis, although mice display persisting signs of inflammation and steatosis [<xref ref-type="bibr" rid="CR289">289</xref>]. Moreover, mice with a hepatocyte-specific deletion of <italic toggle="yes">Bid</italic> present reduced liver inflammation and fibrosis when subjected to a choline-deficient diet to cause non-alcoholic steatohepatitis (NASH) [<xref ref-type="bibr" rid="CR290">290</xref>]. Also, administration of BID-targeting antisense oligonucleotides exerted significant hepatoprotective effects [<xref ref-type="bibr" rid="CR291">291</xref>]. However, BID deficiency fails to ameliorate liver injury and fibrosis upon bile duct ligation (as a model of obstructive cholestasis and chronic liver disease) [<xref ref-type="bibr" rid="CR292">292</xref>]. Of note, in the same experimental model, the liver-specific overexpression of MCL1 but not BCL2 protects animals from hepatic damage [<xref ref-type="bibr" rid="CR293">293</xref>, <xref ref-type="bibr" rid="CR294">294</xref>], suggesting some specificity for MCL1. To add a layer of complexity, conditional deletion of <italic toggle="yes">Xiap</italic> in hepatocytes does not result in liver injury, steatosis, or fibrosis, possibly due to compensatory effects of other inhibitor of apoptosis protein (IAP) isoforms [<xref ref-type="bibr" rid="CR295">295</xref>]. That said, <italic toggle="yes">Xiap</italic><sup>&#8722;/&#8722;</sup> and <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice subjected to diet-induced hepatic steatosis and/or fibrosis, display exacerbated and attenuated liver damage, respectively [<xref ref-type="bibr" rid="CR296">296</xref>, <xref ref-type="bibr" rid="CR297">297</xref>]. These effects have been linked to the modulation of the inflammatory response rather than apoptosis. Finally, genetic co-deletion of <italic toggle="yes">Mcl1</italic> and transformation-related protein 53 (<italic toggle="yes">Trp53</italic>, best known as p53) [<xref ref-type="bibr" rid="CR298">298</xref>], as well as conditional deletion of the genes encoding BCL-X<sub>L</sub> or MCL1, promote fibrosis and/or carcinogenesis, two common final stages of liver disease [<xref ref-type="bibr" rid="CR299">299</xref>]. In this latter study, the additional deletion of <italic toggle="yes">Bak1</italic> limited hepatotoxicity, which is in line with evidence indicating that deletion of <italic toggle="yes">Bid</italic> and/or <italic toggle="yes">Bok</italic> protects mice against experimentally induced hepatocarcinogenesis [<xref ref-type="bibr" rid="CR300">300</xref>&#8211;<xref ref-type="bibr" rid="CR302">302</xref>].</p><p id="Par56">CASP2 was found to be&#160;upregulated in a&#160;mouse model of NASH and in NASH patients, and was implicated in driving lipogenesis and steatohepatitis with a mechanism involving the cleavage of the site-1-protease (S1) followed by the activation of sterol regulatory element binding proteins (SREBP) [<xref ref-type="bibr" rid="CR303">303</xref>]. In this study, the ablation or pharmacological inhibition of CASP2 prevented diet-induced steatosis and NASH progression. Of note, CASP2 deficiency was also reported to protect mice from diet-induced obesity and metabolic syndrome [<xref ref-type="bibr" rid="CR304">304</xref>]. Supporting the etiological contribution of caspase activation to liver disease, the administration of broad-spectrum caspase inhibitors (e.g., emricasan, VX-166) reduced liver injury, inflammation and fibrosis in mice fed a diet rich in fat or deficient in methionine and choline [<xref ref-type="bibr" rid="CR305">305</xref>, <xref ref-type="bibr" rid="CR306">306</xref>]. Along similar lines, emricasan reportedly decreased portal pressure, fibrogenesis and hepatic inflammation, and preserved liver function in rodent models of chronic carbon tetrachloride (CCl<sub>4</sub>)-mediated cirrhosis or cholestasis driven by bile duct ligation [<xref ref-type="bibr" rid="CR307">307</xref>&#8211;<xref ref-type="bibr" rid="CR309">309</xref>]. Preliminary anti-inflammatory effects coupled with improved liver function have also been observed in patients with NASH-related cirrhosis treated with emricasan [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR310">310</xref>]. However, follow-up, randomized clinical studies failed to observe beneficial effects of this agent on portal pressure and clinical outcome [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR311">311</xref>]. At least in part, these findings may reflect the complex interconnection between multiple RCD variants involved in the pathogenesis of NASH. Supporting this possibility, the administration of CASP3-specific inhibitors that abrogate both pro-apoptotic and pro-pyroptotic activities of CASP3 protected mice against acute liver injury caused by bile duct ligation [<xref ref-type="bibr" rid="CR312">312</xref>]. Additional pharmacological and genetic studies specifically targeting intrinsic apoptosis (over other RCD pathways controlled by caspases) are needed to formally ascertain the involvement of this pathway in the etiology of hepatic disorders.</p></sec><sec id="Sec13"><title>Hematological malignancies and solid cancers</title><p id="Par57">The role of intrinsic apoptosis in preventing oncogenesis has been demonstrated in multiple animal models of induced hematological and solid tumors. In particular, a wide range of evidence demonstrates that over-expression of BCL2, BCL-X<sub>L</sub> or MCL-1 accelerates the onset of leukemia and lymphoma induced by over-expression of the MYC proto-oncogene, bHLH transcription factor (MYC) [<xref ref-type="bibr" rid="CR313">313</xref>&#8211;<xref ref-type="bibr" rid="CR317">317</xref>]. Accordingly, the pharmacological inhibition of anti-apoptotic BCL2 proteins is effective against MYC-driven tumors, even when they lack p53 functions [<xref ref-type="bibr" rid="CR318">318</xref>&#8211;<xref ref-type="bibr" rid="CR321">321</xref>]. In this context, p53 has been shown to exert multiple roles in RCD (e.g., [<xref ref-type="bibr" rid="CR322">322</xref>&#8211;<xref ref-type="bibr" rid="CR324">324</xref>]). In particular, it acts as a direct or indirect regulator of the expression of several apoptotic genes [<xref ref-type="bibr" rid="CR325">325</xref>&#8211;<xref ref-type="bibr" rid="CR328">328</xref>] and connects apoptosis induction and cell cycle arrest [<xref ref-type="bibr" rid="CR329">329</xref>]. One main target of p53 is cyclin dependent kinase inhibitor 1A (<italic toggle="yes">CDKN1A</italic>, best known as p21). p53-induced expression of p21&#160;leads to the activation of DREAM and RB/E2F transcriptional repressor complexes, in turn promoting cell cycle arrest by downregulating crucial cell cycle regulators such as cyclins and cyclin-dependent kinases [<xref ref-type="bibr" rid="CR326">326</xref>, <xref ref-type="bibr" rid="CR327">327</xref>, <xref ref-type="bibr" rid="CR330">330</xref>]. However, recent finding indicates that the p53-p21-DREAM or p53-p21-RB/E2F axis can also downregulate CASP2 and CASP8-associated protein 2/FLASH (CASP8AP2), generating a feedback loop centered on p53 that limits rather than promoting the induction of apoptosis [<xref ref-type="bibr" rid="CR326">326</xref>, <xref ref-type="bibr" rid="CR327">327</xref>]. Of note, when analyzing the impact of endogenous proteins, it was shown that the absence of BCL-X<sub>L</sub> but not BCL2 limits the development of lymphoma in transgenic mice expressing MYC under the IgH enhancer (&#917;&#956;-myc mice) [<xref ref-type="bibr" rid="CR331">331</xref>, <xref ref-type="bibr" rid="CR332">332</xref>], thus supporting the therapeutic use of BCL-X<sub>L</sub> inhibitors against these hematological cancers. Along similar lines, MCL1 overexpression [<xref ref-type="bibr" rid="CR317">317</xref>] or <italic toggle="yes">Mcl1</italic> ablation [<xref ref-type="bibr" rid="CR318">318</xref>, <xref ref-type="bibr" rid="CR333">333</xref>, <xref ref-type="bibr" rid="CR334">334</xref>] accelerates and suppresses MYC-driven lymphomagenesis, respectively. Lending further support to the relevance of MCL1, prevalence and onset of MYC-driven lymphoma development were reduced by <italic toggle="yes">Mcl1</italic> haploinsufficiency [<xref ref-type="bibr" rid="CR318">318</xref>, <xref ref-type="bibr" rid="CR334">334</xref>], or B cell-specific deletion of <italic toggle="yes">Mcl1</italic> [<xref ref-type="bibr" rid="CR335">335</xref>]. Of note, loss of one allele of <italic toggle="yes">Mcl1</italic> (but not deletion of the gene encoding BCL-X<sub>L</sub>) also impairs the development of thymic lymphoma in p53-deficient mice [<xref ref-type="bibr" rid="CR336">336</xref>], which possibly explains the limited effect of the BCL-X<sub>L</sub>, BCL2 and BCL-W inhibitor ABT-737 in these models of tumorigenesis [<xref ref-type="bibr" rid="CR337">337</xref>]. The contribution of pro-survival BCL2 proteins in the development of AML has been demonstrated by using mice reconstituted with genetically modified bone marrow cells overexpressing MYC [<xref ref-type="bibr" rid="CR338">338</xref>] and in human Burkitt lymphomas and diffuse large B-cell lymphomas&#160;[<xref ref-type="bibr" rid="CR339">339</xref>]. Notably, the acute genetic removal of <italic toggle="yes">Mcl1</italic> prevents the sustained survival and proliferation of AML driven by diverse oncogenic fusion proteins [<xref ref-type="bibr" rid="CR340">340</xref>]. Accordingly, MCL-1 specific BH3 mimetic drugs, such as <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="S63845">S63845</ext-link>, are able to potently kill a diverse range of lymphoid and myeloid malignant cells in culture and even in tumor transplanted mice [<xref ref-type="bibr" rid="CR341">341</xref>]. Finally, ablation of <italic toggle="yes">Bcl2l2</italic> (leading to lack of BCL-W) limits the development of MYC-mediated B cell lymphoma [<xref ref-type="bibr" rid="CR342">342</xref>].</p><p id="Par58">Numerous&#160;studies demonstrated that the development of MYC-driven lymphoma and leukemia is accelerated in mice lacking the genes encoding BAX [<xref ref-type="bibr" rid="CR343">343</xref>], BIM [<xref ref-type="bibr" rid="CR344">344</xref>, <xref ref-type="bibr" rid="CR345">345</xref>], BAD [<xref ref-type="bibr" rid="CR346">346</xref>], BMF [<xref ref-type="bibr" rid="CR346">346</xref>] or PUMA [<xref ref-type="bibr" rid="CR347">347</xref>&#8211;<xref ref-type="bibr" rid="CR349">349</xref>]. In particular, these studies report that loss of only a single allele of <italic toggle="yes">Bcl2l11</italic> (encoding BIM) accelerates the development of lymphoma and this effect can be reversed following full ablation of <italic toggle="yes">Bcl2l1</italic> (leading to lack of BCL-X<sub>L</sub>) [<xref ref-type="bibr" rid="CR345">345</xref>]. In this context, the presence of all prosurvival BCL2 proteins is shown to limit the impact of BIM in <italic toggle="yes">E&#956;-Myc</italic> transgenic mice [<xref ref-type="bibr" rid="CR350">350</xref>]. Instead, the combined ablation of the genes encoding BIM and p53 or PUMA and p53 accelerates MYC-driven lymphomagenesis [<xref ref-type="bibr" rid="CR351">351</xref>]. This is in line with the evidence that loss of the genes encoding BAX or BIM augmented lymphomagenesis in p53-deficient mice [<xref ref-type="bibr" rid="CR352">352</xref>, <xref ref-type="bibr" rid="CR353">353</xref>]. Of note, PUMA seems to exert a strong tumor-suppressive role in hematological cancers, as shown by the evidence that <italic toggle="yes">Bbc3</italic> deletion accelerates the development of MYC-driven B-cell lymphomas and that <italic toggle="yes">E&#956;-Myc</italic> lymphomas developing in PUMA-proficient mice display downregulated expression of PUMA [<xref ref-type="bibr" rid="CR348">348</xref>, <xref ref-type="bibr" rid="CR349">349</xref>, <xref ref-type="bibr" rid="CR354">354</xref>]. On the contrary, the loss of the gene encoding NOXA does not accelerate MYC-driven lymphomagenesis, and the role of BIK in this murine lymphoma model is debated [<xref ref-type="bibr" rid="CR348">348</xref>, <xref ref-type="bibr" rid="CR355">355</xref>]. Along similar lines, while CASP2 suppresses MYC-induced lymphomagenesis in mice [<xref ref-type="bibr" rid="CR356">356</xref>], the tumor suppressive role of apoptosome components (Box&#160;<xref rid="Sec5" ref-type="sec">1</xref>) is questioned, as shown in lethally irradiated mice reconstituted with <italic toggle="yes">E&#956;-Myc</italic> transgenic APAF1-deficient or CASP9-deficient fetal liver cells which showed no difference in the incidence of lymphoma compared to their wild-type counterparts [<xref ref-type="bibr" rid="CR357">357</xref>]. This is consistent with the notion that APAF1 and caspase-9 function downstream of the commitment to cell death (MOMP) and therefore do not act as tumor suppressors [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par59">Concerning other experimental animal models of hematological malignancies, the absence of PUMA (due to ablation of <italic toggle="yes">Bbc3</italic>) abrogated the development of both myelodysplasia, as shown in transgenic mice expressing a nucleoporin 98 (NUP98)-homeobox D13 (HOXD13) fusion protein [<xref ref-type="bibr" rid="CR358">358</xref>], and thymic T cell lymphoma induced by gamma radiation [<xref ref-type="bibr" rid="CR359">359</xref>, <xref ref-type="bibr" rid="CR360">360</xref>]. The explanation for these surprising findings is based on the fact that the absence of PUMA prevents the extensive death of hematopoietic cells caused by gamma radiation, which causes mobilization and extensive proliferation of hematopoietic stem and progenitor cells, resulting in elevated replication stress and genetic instability and lymphomagenesis. These observations show that inhibition of apoptosis does not only promote the development of hematological malignancies, but in certain conditions can do the exact opposite and prevent lymphoma development. The absence of NOXA, augments the development of chronic lymphocytic leukemia in T cell lymphoma breakpoint 1 (TCL1) transgenic mice [<xref ref-type="bibr" rid="CR361">361</xref>] and accelerates the development of thymic T lymphoma induced by gamma radiation [<xref ref-type="bibr" rid="CR359">359</xref>]. Moreover, conditional deletion of <italic toggle="yes">Bcl2l11</italic> in B cells (leading to the absence of BIM) accelerates the development of mantle cell lymphoma in mice driven by cyclin D1 (CCND1) overexpression [<xref ref-type="bibr" rid="CR362">362</xref>]. Overexpression of MCL1 and/or BCL2 promotes the development of acute myeloid leukemia driven by lysine (K)-specific methyltransferase 2A (KMT2A, best known as MLL) fusion proteins [<xref ref-type="bibr" rid="CR340">340</xref>, <xref ref-type="bibr" rid="CR363">363</xref>] and plasmacytoma driven by ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1) [<xref ref-type="bibr" rid="CR364">364</xref>]. Conversely, the loss of one <italic toggle="yes">Mcl1</italic> allele suppresses the development of T cell lymphoma, as shown in models based on sequential low-dose irradiation or the expression of a transgene encoding an IL2 inducible T cell kinase (ITK)-spleen tyrosine kinase (SYK) fusion protein [<xref ref-type="bibr" rid="CR365">365</xref>]. Finally, the absence of CASP2 accelerates lymphomagenesis in ataxia telangiectasia mutated (ATM)-deficient mice [<xref ref-type="bibr" rid="CR366">366</xref>], but this may be due to the loss of the function of CASP2 in mitotic cell division [<xref ref-type="bibr" rid="CR367">367</xref>]. Lending support to the role of intrinsic apoptosis in hematologic malignancies, the BCL2 inhibitor venetoclax has entered clinical practice for the treatment of CLL as single agent or more effectively in combination with other therapeutic agents [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR35">35</xref>&#8211;<xref ref-type="bibr" rid="CR37">37</xref>]. Combinatorial regimens of BCL2 inhibition with epigenetic modulation have entered center stage in certain settings of AML [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR368">368</xref>]. However, mechanisms of resistance of CLL and AML to venetoclax related to defects in p53 and the apoptotic network or deregulated energy metabolism have been described [<xref ref-type="bibr" rid="CR369">369</xref>&#8211;<xref ref-type="bibr" rid="CR372">372</xref>]. Venetoclax-based regimens also display effectiveness in patients with high-risk myelodysplastic syndromes [<xref ref-type="bibr" rid="CR373">373</xref>], suggesting a potential application of venetoclax to other hematological cancers [<xref ref-type="bibr" rid="CR374">374</xref>, <xref ref-type="bibr" rid="CR375">375</xref>].</p><p id="Par60">Significant work demonstrated a tumor suppressor role of the intrinsic apoptotic pathway in many cancers. For example, BCL2 overexpression accelerates the development of MYC-induced mammary tumorigenesis [<xref ref-type="bibr" rid="CR376">376</xref>]. A similar acceleration of tumor development has been described for the loss of genes encoding BAX, BIM, CASP2 or PUMA in distinct models of breast cancer induced by expression or overexpression of C3(1)/SV40 T-antigen, MYC, or erb-b2 receptor tyrosine kinase 2 (ERBB2, best known as HER2) [<xref ref-type="bibr" rid="CR377">377</xref>&#8211;<xref ref-type="bibr" rid="CR380">380</xref>]. At odds with these results, BCL2 overexpression in the mammary gland suppresses the development of breast tumors driven by the administration of dimethylbenz(a)anthracene [<xref ref-type="bibr" rid="CR381">381</xref>]. This latter finding may be explained in a similar way as was mentioned for the suppression of radiation-induced thymic T cell lymphoma development by over-expression of BCL-2 or loss of PUMA (see above). Conditional deletion of the genes encoding BCL2 or BCL-X<sub>L</sub> in intestinal epithelial cells delays the development of colorectal cancer driven by inflammation [<xref ref-type="bibr" rid="CR382">382</xref>, <xref ref-type="bibr" rid="CR383">383</xref>], which is in line with the evidence that the absence of PUMA (due to <italic toggle="yes">Bbc3</italic> deletion) exacerbates colorectal tumorigenesis as shown in a mouse model of intestinal oncogenesis driven by colitis or APC, WNT signaling pathway regulator (APC) [<xref ref-type="bibr" rid="CR384">384</xref>]. Interestingly, doxorubicin-induced intestinal cytotoxicity requires PUMA but not BIM, whereas the reverse is true for MYC-driven apoptosis in the gut, indicative of differential roles for different BH3-only proteins in this tissue [<xref ref-type="bibr" rid="CR385">385</xref>]. Intriguingly, treatment with BCL-X<sub>L</sub>, but not BCL2-targeting BH3 mimetics is sufficient to prevent intestinal tumorigenesis, suggesting that BCL-X<sub>L</sub> is the crucial mediator of protection of early neoplastic cells in this model [<xref ref-type="bibr" rid="CR386">386</xref>]. In agreement, earlier work showed a pronounced&#160;BCL-X<sub>L</sub> dependency of cell lines derived from both colorectal and non-small cell lung cancers [<xref ref-type="bibr" rid="CR387">387</xref>, <xref ref-type="bibr" rid="CR388">388</xref>]. Moreover, a tumor suppressive effect has been ascribed to BAX and CASP2 in murine models of brain [<xref ref-type="bibr" rid="CR389">389</xref>, <xref ref-type="bibr" rid="CR390">390</xref>] and lung [<xref ref-type="bibr" rid="CR391">391</xref>] oncogenesis, respectively. In line with this evidence, pharmacologic/genetic inhibition of MCL1 delayed tumor development in a mouse model of mutant KRAS-driven adenoma/adenocarcinoma [<xref ref-type="bibr" rid="CR392">392</xref>]. In the same model, tumor progression was promoted by the ablation of pro-apoptotic <italic toggle="yes">Bok</italic> [<xref ref-type="bibr" rid="CR393">393</xref>]. Of note, there is evidence of a certain tissue-specificity in the epigenetic regulation of <italic toggle="yes">Bcl2</italic> and <italic toggle="yes">Mcl1</italic>, such as the epigenetic mechanism centered on the deubiquitinase BRCA1 associated protein 1 (BAP1) [<xref ref-type="bibr" rid="CR394">394</xref>], a tumor suppressor that is frequently mutated in some cancers [<xref ref-type="bibr" rid="CR395">395</xref>] and has been associated with tumor aggressiveness and therapy resistance [<xref ref-type="bibr" rid="CR396">396</xref>, <xref ref-type="bibr" rid="CR397">397</xref>]. Finally, age-related differences in the expression of pro-apoptotic members of the BCL2 family have been linked to the increased sensitivity of neonatal/childhood tissues, relative to adult counterparts, to chemotherapy and radiotherapy. This was causally linked to the&#160;MYC-dependent expression of genes encoding BAX, BID and BIM, both in mice and humans [<xref ref-type="bibr" rid="CR133">133</xref>].</p><p id="Par61">Cancer-specific roles have been attributed to particular BCL2 protein family members. For example, deletion of <italic toggle="yes">Bax</italic> accelerates the development of MYC-induced pancreatic tumors [<xref ref-type="bibr" rid="CR398">398</xref>], which was not seen with ablation of <italic toggle="yes">Bak1</italic> or <italic toggle="yes">Casp3</italic> [<xref ref-type="bibr" rid="CR398">398</xref>, <xref ref-type="bibr" rid="CR399">399</xref>], but was achieved by BCL-X<sub>L</sub> overexpression [<xref ref-type="bibr" rid="CR314">314</xref>, <xref ref-type="bibr" rid="CR400">400</xref>]. Likewise, BOK seems to be crucial in hepatocarcinogenesis, as demonstrated in a mouse model of diethylnitrosamine-induced liver cancer which was accelerated on a <italic toggle="yes">Bok</italic><sup>&#8722;/&#8722;</sup> genetic background [<xref ref-type="bibr" rid="CR300">300</xref>]. Using the same mouse model, accelerated hepatic carcinogenesis has also been&#160;demonstrated for the deletion of the genes encoding PUMA or CASP2 [<xref ref-type="bibr" rid="CR401">401</xref>, <xref ref-type="bibr" rid="CR402">402</xref>]. Conversely, overexpression of BCL2 was shown to limit transforming growth factor alpha&#160;(TGFA)-driven hepatic tumorigenesis [<xref ref-type="bibr" rid="CR403">403</xref>, <xref ref-type="bibr" rid="CR404">404</xref>], perhaps because the death of some cells in the liver causes massive mobilization and proliferation of progenitor cells, leading to acquisition of oncogenic lesions that drive tumorigenesis in a manner similar to radiation-induced thymic lymphoma development (see above). Finally, the transgenic overexpression of BCL-X<sub>L</sub> (but not BCL2) and the keratinocyte-specific deletion of <italic toggle="yes">Bcl2l1</italic> (leading to lack of BCL-X<sub>L</sub>) accelerates or limits, respectively, carcinogen- and/or ultraviolet B (UVB)-induced skin tumorigenesis [<xref ref-type="bibr" rid="CR405">405</xref>&#8211;<xref ref-type="bibr" rid="CR408">408</xref>]. It will be important to investigate and better understand why in specific settings inhibition of apoptotic cell death promotes tumorigenesis whereas it inhibits tumorigenesis in others.</p></sec><sec id="Sec14"><title>Autoimmune and inflammatory diseases</title><p id="Par62">There is substantial evidence linking intrinsic apoptosis to the development and progression of autoimmune diseases. However, the interpretation of these findings should take into consideration the crosstalk between the apoptotic and inflammatory pathways and the fact that apoptotic caspases accelerate cell death as they regulate its immunological manifestations.</p><p id="Par63">The first evidence that defects in the intrinsic apoptosis pathway can cause the development of autoimmune disease was reported when over-expression of BCL-2 in B lymphocytes [<xref ref-type="bibr" rid="CR409">409</xref>] or loss of BIM in all tissues [<xref ref-type="bibr" rid="CR410">410</xref>] was shown to cause a&#160;fatal systemic lupus erythematosus (SLE)-like disease. Consistent with a critical role for the intrinsic apoptotic pathway in preventing autoimmune disease, the combined loss of the genes encoding BAX and BAK1 in hematopoietic cells, achieved by transplantation of lethally irradiated wild-type mice with hematopoietic stem/progenitor cells from the livers of E14.5 <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> embryos also causes a&#160;fatal SLE-like disease [<xref ref-type="bibr" rid="CR411">411</xref>]. In mouse models of rheumatoid arthritis, ablation of the genes encoding BIM, BID or BAD, but not the loss of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic>, accelerated the emergence and increased the duration and severity of this disorder [<xref ref-type="bibr" rid="CR412">412</xref>&#8211;<xref ref-type="bibr" rid="CR414">414</xref>]. Consistent with these findings, administration of a BIM mimetic suppressed inflammatory arthritis in mice [<xref ref-type="bibr" rid="CR415">415</xref>]. Mice deficient for BAX as well as transgenic mice expressing XIAP display increased severity of autoimmune encephalomyelitis induced by immunization with myelin oligodendrocyte glycoprotein (MOG) [<xref ref-type="bibr" rid="CR416">416</xref>, <xref ref-type="bibr" rid="CR417">417</xref>]. Similar results have been obtained in mouse models of autoimmune encephalomyelitis genetically engineered for the&#160;hematopoietic cell-specific deletion of <italic toggle="yes">Bcl2l11</italic> (leading to BIM deficiency), or the neuron-specific overexpression of BCL2 [<xref ref-type="bibr" rid="CR418">418</xref>, <xref ref-type="bibr" rid="CR419">419</xref>]. Consistent with the notion that inhibition of apoptosis can promote the development of auto-immune disease, inhibition of BCL2, BCL-X<sub>L</sub> and BCL-W using the BH3 mimetic ABT-263 substantially reduced pathology in several mouse models of autoimmune disease, including scleroderma [<xref ref-type="bibr" rid="CR420">420</xref>]. In apparent contrast with these results, studies using models of type 1 (autoimmune) or type 2 (non-autoimmune) diabetes revealed that deletion of <italic toggle="yes">Bax</italic> alone or combined loss of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic> [<xref ref-type="bibr" rid="CR421">421</xref>, <xref ref-type="bibr" rid="CR422">422</xref>], deletion of the gene encoding BIM, alone or together with the gene encoding PUMA [<xref ref-type="bibr" rid="CR418">418</xref>, <xref ref-type="bibr" rid="CR423">423</xref>&#8211;<xref ref-type="bibr" rid="CR425">425</xref>] as well as the loss of BMF [<xref ref-type="bibr" rid="CR426">426</xref>], protect pancreatic &#946; cells from autoimmune destruction. Moreover, the absence of BIM prevents the emergence of type 1 diabetes in non-obese diabetic (NOD) mice [<xref ref-type="bibr" rid="CR418">418</xref>, <xref ref-type="bibr" rid="CR423">423</xref>], while ablation of <italic toggle="yes">Trp53</italic> in pancreatic &#946; cells failed to halt cell death in multiple experimental models of diabetes [<xref ref-type="bibr" rid="CR427">427</xref>].</p><p id="Par64">Based on the studies described above, inhibiting or deleting pro-apoptotic proteins or genes can have conflicting effects on autoimmune disease progression. This may depend on the cell type in which the major effect on apoptosis occurs, e.g., the immune cells or their targets. Inhibiting cell death in the target cells would indeed&#160;provide protection and may improve disease outcome, whereas inhibiting cell death in the immune cell may lead to an accumulation of immune cells and aggravation of the autoimmune disease. The distinction could be explored by studying tissue-specific deletion of apoptosis regulator genes.</p><p id="Par65">In this context, there is evidence that inflammatory and autoimmune disorders may derive from increased survival of specific immune cell population. For instance, elevated levels of cytokines such as colony stimulating factor 2 (CSF2, best known as&#160;GM-CSF), interleukin 3 (IL3) and IL5 in immune disorders have been associated with prolonged survival of neutrophils, eosinophils or basophils with a mechanism involving the upregulation of anti-apoptotic proteins MCL1, BCL-X<sub>L</sub> and&#160;baculoviral IAP repeat containing 2 (BIRC2, best known as cIAP2) [<xref ref-type="bibr" rid="CR428">428</xref>&#8211;<xref ref-type="bibr" rid="CR435">435</xref>]. Apoptosis also plays a relevant role in some hemopathies&#160;with inflammatory features, including beta thalassemia [<xref ref-type="bibr" rid="CR436">436</xref>], Diamond-Blackfand anemia [<xref ref-type="bibr" rid="CR437">437</xref>], and in the Cohen syndrome neutropenia [<xref ref-type="bibr" rid="CR438">438</xref>]. BIM, BID and BAD have all been shown to influence survival in mouse models of septic shock, as their targeting confer protective effects from tissue damage of multiple organs [<xref ref-type="bibr" rid="CR439">439</xref>&#8211;<xref ref-type="bibr" rid="CR441">441</xref>], as well as in patients with severe sepsis [<xref ref-type="bibr" rid="CR442">442</xref>]. On the contrary, the role of apoptotic caspases in septic shock is contentious [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR443">443</xref>, <xref ref-type="bibr" rid="CR444">444</xref>]. The precise impact of apoptosis in widespread inflammation during sepsis requires further investigation.</p><p id="Par66">Concerning other inflammatory diseases, while broad-spectrum caspase inhibition reportedly protected rats against severe acute pancreatitis [<xref ref-type="bibr" rid="CR445">445</xref>], activation of intrinsic apoptosis appears to attenuate the severity of this disease by limiting inflammation, as shown in vivo in a pancreatitis mouse model lacking XIAP [<xref ref-type="bibr" rid="CR446">446</xref>]. These data reinforce the notion that inhibiting (apoptotic) cell death may exacerbate unwarranted inflammatory reactions that contribute to the pathology of various autoimmune and inflammatory disorders. In line with this notion, chronic colitis driven by dextran sulfate sodium in mice manifests with increased (rather than decreased) severity in BID- or BIM-deficient hosts as compared to their wild-type littermates, at least in part owing to immune dysregulation [<xref ref-type="bibr" rid="CR447">447</xref>, <xref ref-type="bibr" rid="CR448">448</xref>]. Similarly, inhibition of BCL2 and/or BCL-X<sub>L</sub> reduces inflammation and ameliorates experimental colitis [<xref ref-type="bibr" rid="CR449">449</xref>, <xref ref-type="bibr" rid="CR450">450</xref>], an effect that was abrogated by concomitant deletion of the gene encoding BIM [<xref ref-type="bibr" rid="CR450">450</xref>]. PUMA-deficient mice display reduced levels of apoptosis amongst intestinal epithelial cells but not reduced inflammation in an experimental model of colitis [<xref ref-type="bibr" rid="CR451">451</xref>]. Corroborating the specific relevance of PUMA for intestinal homeostasis, mice deficient for PUMA but not <italic toggle="yes">Bax</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> mice were protected against the gastrointestinal side effects of radiotherapy, at least in part due to increased survival of intestinal stem/progenitor cells [<xref ref-type="bibr" rid="CR452">452</xref>, <xref ref-type="bibr" rid="CR453">453</xref>]. Moreover, the absence of PUMA conferred protection to intestinal epithelial cells in mouse models of hypertensive gastropathy [<xref ref-type="bibr" rid="CR454">454</xref>], ulcerative colitis (UC) [<xref ref-type="bibr" rid="CR455">455</xref>] and intestinal ischemia/reperfusion [<xref ref-type="bibr" rid="CR456">456</xref>]. In the latter model, transgenic BCL2 expression limited intestinal epithelial cell death [<xref ref-type="bibr" rid="CR457">457</xref>]. On the other hand, defects in XIAP cause X-linked lymphoproliferative syndrome type&#160;2, with one-third of these patients suffering from severe and therapy-refractory inflammatory bowel disease [<xref ref-type="bibr" rid="CR458">458</xref>&#8211;<xref ref-type="bibr" rid="CR461">461</xref>]. Absence of XIAP also results in enhanced TNF production and TNF-R1/TNF-R2 targeting of TLR5-expressing Paneth cells and dendritic cells&#160;(DCs), leading to ileitis and dysbiosis [<xref ref-type="bibr" rid="CR462">462</xref>]. In this context, it is interesting to note that CASP3- or CASP7-deficient mice display an altered gut microbiome [<xref ref-type="bibr" rid="CR463">463</xref>], which may play a hitherto unexplored role in multiple autoimmune and inflammatory disorders beyond intestinal conditions. However, it has recently been&#160;found that under steady state conditions the&#160;absence of CASP3 and CASP7 in the intestinal epithelial cells apparently neither&#160;affects the microbiome nor causes spontaneous inflammation, suggesting that apoptosis may be dispensable for intestinal epithelium turnover and homeostasis at baseline [<xref ref-type="bibr" rid="CR464">464</xref>].</p></sec><sec id="Sec15"><title>Infectious diseases</title><p id="Par67">Activation of RCD constitutes a protective mechanism against many microbial infections by eliminating infected cells and potentiating pathogen-targeting&#160;immune responses. Accordingly, both viruses and bacteria have developed multiple strategies to overcome or disable host intrinsic apoptosis, thus improving survival of both host cells and the infectious organisms [<xref ref-type="bibr" rid="CR465">465</xref>, <xref ref-type="bibr" rid="CR466">466</xref>]. Mice with loss of one BCL-X<sub>L</sub>-coding allele&#160;displayed reduced pathology and had improved survival rates when challenged with Japanese encephalitis virus (JEV), as compared with wild-type mice. This was attributed to compromised viral propagation within JEV-infected cells succumbing to intrinsic apoptosis [<xref ref-type="bibr" rid="CR467">467</xref>]. There is also evidence of a contribution of BAX and BAK1 to the response to murine cytomegalovirus (MCMV) infection. In particular, the MCMV genome encodes inhibitors of BAK1 (m41.1 protein) and BAX (m38.5 protein) that promote&#160;viral replication by inhibiting the induction of intrinsic apoptosis in infected cells [<xref ref-type="bibr" rid="CR468">468</xref>, <xref ref-type="bibr" rid="CR469">469</xref>]. Supporting the requirement of the inhibition of intrinsic apoptosis for optimal in vivo MCMV dissemination, the titers of m41.1-deficient viruses were higher in salivary glands and other organs in <italic toggle="yes">Bak1</italic><sup>&#8722;/&#8722;</sup> mice as compared to wild-type animals [<xref ref-type="bibr" rid="CR468">468</xref>]. Intrinsic apoptosis also protects against bacterial infections, as demonstrated by the lethal course of disease in <italic toggle="yes">Bbc3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice (which lack PUMA) after <italic toggle="yes">Streptococcus pneumoniae</italic> infection [<xref ref-type="bibr" rid="CR470">470</xref>]. Such an effect has been attributed to insufficient immune-mediated bacterial clearance because of an increased neutrophil lifespan in the absence of PUMA-mediated apoptosis.</p><p id="Par68">However, in other contexts, excessive activation of the intrinsic apoptosis pathway has been reported to drive, rather than prevent, microbial disease pathogenesis and lethality. For example, loss of <italic toggle="yes">Xiap</italic> increased the susceptibility of mice to <italic toggle="yes">Shigella</italic> infection, manifesting with coalescing necrotic areas and a high bacterial burden in the liver, an effect that was associated with an inefficient immune-mediated resolution of the bacterial infection [<xref ref-type="bibr" rid="CR471">471</xref>]. Of note,&#160;at least part of this effect may be due to the requirement for XIAP to activate NOD signaling, rather than its ability to inhibit caspases [<xref ref-type="bibr" rid="CR459">459</xref>, <xref ref-type="bibr" rid="CR471">471</xref>, <xref ref-type="bibr" rid="CR472">472</xref>]. Moreover, mice lacking the genes encoding BIM and NOXA (i.e., <italic toggle="yes">Bcl2l11</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Pmaip1</italic><sup>&#8722;/&#8722;</sup> mice) display pronounced resistance to challenge with high doses of <italic toggle="yes">Listeria monocytogenes</italic>, as shown by a decreased bacterial burden and reduced apoptosis induction in the spleen [<xref ref-type="bibr" rid="CR473">473</xref>]. The overexpression of BCL2 in the hematopoietic compartment increase the survival of mice infected with Ebola virus [<xref ref-type="bibr" rid="CR474">474</xref>], while deletion of <italic toggle="yes">Bok</italic> promote resistance of lung epithelial cells to apoptosis induced by SARS-CoV-2 virus membrane (M) protein [<xref ref-type="bibr" rid="CR475">475</xref>]. Intriguingly, this latter&#160;study showed that the SARS-CoV-2 M protein activate BOK to trigger apoptosis in the absence of BAX and BAK1 [<xref ref-type="bibr" rid="CR475">475</xref>]. In another example, conditional deletion of <italic toggle="yes">Casp3</italic> in the murine intestinal epithelium conferred protection from pathogenic <italic toggle="yes">Salmonella enterica</italic>, and this was attributed to a reduction in cell death-induced nutrients that are critical for sustaining bacterial growth [<xref ref-type="bibr" rid="CR476">476</xref>]. Finally, <italic toggle="yes">Casp3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice subjected to intracranial inoculation of reovirus type 3 (strain Dearing) displayed limited injuries in the central nervous system (CNS) and extended survival compared to wild-type mice [<xref ref-type="bibr" rid="CR477">477</xref>]. As discussed above, the interpretation of the infection phenotypes observed in CASP3-, CASP7- and/or CASP9-deficient mice requires particular caution because of the crucial roles of these caspases in modulating immune and inflammatory responses [<xref ref-type="bibr" rid="CR242">242</xref>&#8211;<xref ref-type="bibr" rid="CR244">244</xref>]. That said, there is evidence for a role of specific regulators of apoptosis in the host&#160;response to infection with human herpes simplex virus 1 (HSV-1). On the one hand, a significant accumulation in total leukocyte and CD8<sup>+</sup> T cells was observed in mice deficient for BIM and PUMA upon infection with HSV-1 [<xref ref-type="bibr" rid="CR478">478</xref>], which is in line with a role of these BH3-only proteins in controlling the survival of lymphoid and myeloid cells [<xref ref-type="bibr" rid="CR410">410</xref>, <xref ref-type="bibr" rid="CR479">479</xref>, <xref ref-type="bibr" rid="CR480">480</xref>]. On the other hand, mice deficient for NOXA, BAD or BID were reported to mount a normal CD8<sup>+</sup> T cell immune response to HSV-1 infection [<xref ref-type="bibr" rid="CR478">478</xref>]. Some of these contradictory results may arise from the divergent effects of inhibition or promotion of apoptosis on immune cells versus other cell types affected by the infectious disease, a distinction that cannot be addressed using mice in which apoptotic regulators have been deleted in the germline. In this context, it is noteworthy to note&#160;that the&#160;myeloid cell-specific deletion of the gene encoding BCL-X<sub>L</sub> or its inhibition using BH3 mimetic drugs massively reduced bacterial burden in the lung and extended the survival of mice infected with <italic toggle="yes">Legionella</italic> [<xref ref-type="bibr" rid="CR481">481</xref>]. This indicates that BH3 mimetic drugs might be effective for the treatment of intracellular bacterial infections.</p></sec><sec id="Sec16"><title>Other diseases</title><p id="Par69">Pro-apoptotic BCL2 proteins and caspases have also been implicated in disorders affecting other tissues/organs, such as skeletal muscle and lungs. For instance, the conditional ablation of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic> protected mouse skeletal muscles against pressure-induced injury [<xref ref-type="bibr" rid="CR482">482</xref>]. Similar results have been obtained in rats receiving Z-VAD-FMK after being subjected to muscular compression or blunt injury [<xref ref-type="bibr" rid="CR483">483</xref>, <xref ref-type="bibr" rid="CR484">484</xref>]. Moreover, deletion of <italic toggle="yes">Casp3</italic> or CASP3 inhibition with Ac-DEVD-CHO limited muscular damage and atrophy in experimental models of plaster-mediated immobilization [<xref ref-type="bibr" rid="CR485">485</xref>, <xref ref-type="bibr" rid="CR486">486</xref>]. In mouse models of catabolic disorders, muscle wasting due to protein degradation was decreased by lentiviral expression of XIAP [<xref ref-type="bibr" rid="CR487">487</xref>, <xref ref-type="bibr" rid="CR488">488</xref>], although whether this effect reflects the inhibition of intrinsic apoptosis needs further confirmation. Finally, <italic toggle="yes">Casp3</italic><sup>&#8722;/&#8722;</sup> mice were protected against denervation-induced muscular atrophy [<xref ref-type="bibr" rid="CR489">489</xref>], while expression of a dominant-negative variant of CASP9 improved the neuromuscular activity in a transgenic mouse model of slow-channel syndrome [<xref ref-type="bibr" rid="CR490">490</xref>].</p><p id="Par70">In a mouse model of oxidant-induced lung injury, the tissue-specific ablation of <italic toggle="yes">Bax</italic> and <italic toggle="yes">Bak1</italic> but not that of the genes encoding BID, BIM, NOXA or PUMA protected lung epithelial cells from degeneration [<xref ref-type="bibr" rid="CR491">491</xref>]. Among the anti-apoptotic BCL2 proteins, BCL2 related protein A1 (BCL2A1, best known as A1) seems to exert a crucial role in this setting, as <italic toggle="yes">Bcl2a1</italic> deletion aggravated lung injury in mice subjected to hyperoxia [<xref ref-type="bibr" rid="CR492">492</xref>], while lung-specific overexpression of BCL2 did not confer protection to mice exposed to excessive oxygen supply [<xref ref-type="bibr" rid="CR493">493</xref>]. That said, no critical cytoprotective effect of A1 was seen in acute lung inflammation and peritonitis [<xref ref-type="bibr" rid="CR494">494</xref>]. Intrinsic apoptosis has also been reported to be involved in pulmonary fibrosis [<xref ref-type="bibr" rid="CR495">495</xref>]. <italic toggle="yes">Bid</italic><sup>&#8722;/&#8722;</sup> mice display decreased levels of pulmonary fibrosis after intra-tracheal bleomycin administration&#160;than their wild-type counterparts [<xref ref-type="bibr" rid="CR496">496</xref>]. In apparent contradiction, in the same model of fibrotic pulmonary damage, a&#160;similar degree of&#160;protection was reported in mice lacking <italic toggle="yes">Bcl2</italic> [<xref ref-type="bibr" rid="CR497">497</xref>] or in animals treated with inhibitors of BCL2 [<xref ref-type="bibr" rid="CR497">497</xref>] or caspases [<xref ref-type="bibr" rid="CR498">498</xref>, <xref ref-type="bibr" rid="CR499">499</xref>]. Along similar lines, ablation of <italic toggle="yes">Bid</italic> limited acute lung injury in mice induced by exposure to lipopolysaccharide&#160;(LPS) [<xref ref-type="bibr" rid="CR500">500</xref>]. Moreover, CASP3 depletion using short-hairpin RNAs (shRNAs) protected the lungs of mice subjected to pulmonary ischemia/reperfusion [<xref ref-type="bibr" rid="CR501">501</xref>], a protection further strengthened when necroptosis was concomitantly also suppressed [<xref ref-type="bibr" rid="CR502">502</xref>]. BCL2 overexpression or caspase inhibition protected rodents subjected to lung transplantation [<xref ref-type="bibr" rid="CR503">503</xref>, <xref ref-type="bibr" rid="CR504">504</xref>]. This is in line with the notion that delivery of the caspase inhibitor Z-VAD-FMK to rodents ameliorated lung injury developing as a consequence of severe acute pancreatitis or LPS administration [<xref ref-type="bibr" rid="CR505">505</xref>, <xref ref-type="bibr" rid="CR506">506</xref>] but not as a result of pneumovirus infection [<xref ref-type="bibr" rid="CR507">507</xref>]. In the latter case, lung damage was exacerbated by Z-VAD-FMK, perhaps due to increased inflammation downstream of necroptotic RCD [<xref ref-type="bibr" rid="CR507">507</xref>].</p><p id="Par71">The studies summarized above illustrate that components of the intrinsic apoptosis pathway can be part of the pathogenic mechanism of disease, and, in certain cases, this may offer the opportunity for therapeutic intervention. It is important to note that in many pathogenic processes intrinsic apoptotic cell death is the endpoint, and simply inhibiting it will not be curative. If the cells continue being exposed to the initiating insult, they will likely undergo less regulated forms of cell death. However, inhibiting the intrinsic apoptotic cell death may buy time to control&#160;the factors that are damaging the cells in first place. Ischemia and hypoxia, in cases where the ensuing cell death has a substantial intrinsic apoptotic component, are examples. If cells in the ischemic region were kept alive until adequate circulation was restored, therapeutic benefits might be achieved. Other examples include metabolic disorders, which may be amenable to correction, and traumatic injury, where healing might be supported by inhibiting apoptosis. It would be worth concentrating on inhibiting intrinsic apoptotic cell death in conditions where the initiating tissue insults can be (at least partially) reversed. In contrast, failure to undergo intrinsic apoptosis is the initial pathogenic step or a contributing factor in certain malignancies. Here, the induction of apoptosis, for example by using BH3 mimetic drugs [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], directly&#160;targets pathogenesis.</p></sec></sec><sec id="Sec17"><title>Extrinsic apoptosis in disease</title><p id="Par72">The molecular apparatus for extrinsic apoptosis is described in Box&#160;<xref rid="Sec18" ref-type="sec">5</xref> and illustrated in Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>. Unlike the intrinsic apoptotic pathway, DR-induced apoptosis is not required for embryonic or fetal development but plays a critical role in adult tissue homeostasis, as detailed in Box&#160;<xref rid="Sec19" ref-type="sec">6</xref> and Box&#160;<xref rid="Sec20" ref-type="sec">7</xref>. Of note, various components of the extrinsic pathway of apoptosis are involved in the etiology of multiple human disorders, although (1) with a considerable degree of context-dependency, and (2) with an effect not necessarily linked to the activation of apoptosis but often due to the role of DR signaling in necroptosis and inflammation, as outlined below.<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><title>Molecular machinery of the extrinsic apoptosis pathway.</title><p>Extrinsic apoptosis is initiated by the binding of FASL to FAS or TRAIL to TRAIL-R1 or TRAIL-R2, which promotes the assembly, on the cytoplasmic tail of these death receptors, of a platform known as the DISC. Extrinsic apoptosis is also triggered by the binding of TNF to TNF-R1, which promotes the assembly of the Complex II. The DISC comprises FADD, c-FLIPs and pro-CASP8. Complex II is a platform consisting of FADD and pro-CASP8 in association with either TRADD (complex IIa) or RIPK1 (complex IIb). The assembly of these complexes promotes the activation of CASP8, which mediates CASP3 and CASP7 activation either directly, by catalyzing the proteolytic activation of CASP3 and CASP7 (in type I cells) or indirectly, via the proteolytic activation of the BH3-only protein BID and outer membrane permeabilization (MOMP) (in type II cells). At least in some cells,&#160;extrinsic apoptosis can also be induced by dependence receptors like DCC, NTRK3, PTCH1, or UNC5A-D, which are activated by decreased concentration of the related ligand, as illustrated in the figure. However, the role of this pathway in normal physiology and disease is not yet established.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e9578" position="float" orientation="portrait" xlink:href="41418_2023_1153_Fig4_HTML.jpg"/></fig></p><sec id="Sec18"><boxed-text position="float" orientation="portrait"><label>Box 5 Principles of extrinsic apoptosis</label><p id="Par73">Extrinsic apoptosis is a regulated cell death (RCD) variant frequently triggered by death receptor (DRs) upon binding of a cognate ligand [<xref ref-type="bibr" rid="CR1323">1323</xref>&#8211;<xref ref-type="bibr" rid="CR1325">1325</xref>]. The principal DRs that will be discussed in the review are the Fas cell surface death receptor (FAS; also known as CD95 or APO-1), the TNF receptor superfamily member 1A (TNFRSF1A; best known as TNF-R1), the TNF receptor superfamily member 10a (TNFRSF10A; best known as TRAIL-R1 or DR4) and the TNF receptor superfamily member 10b (TNFRSF10B; best known as TRAIL-R2 or DR5). FAS is activated by the binding of FAS ligand (FASLG; also known as CD95L or APO-1L; FASL in mice), which is primarily expressed by effector immune cells [<xref ref-type="bibr" rid="CR1325">1325</xref>]. TNF-R1 is activated by tumor necrosis factor (TNF), a functionally pleiotropic cytokine expressed in cells in the spleen, thymus and certain other adult tissues [<xref ref-type="bibr" rid="CR1323">1323</xref>]. Of note, while the soluble form of TNF preferentially binds to TNF-R1, the membrane-anchored form mainly interacts with the TNF receptor superfamily member 1B (TNFRSF1B, best known as TNF-R2), which does not have death domain and therefore is not a DR [<xref ref-type="bibr" rid="CR1326">1326</xref>]. Finally, TRAIL-R1 and TRAIL-R2 are specifically activated by the binding of TNF superfamily member 10 (TNFSF10; best known as TRAIL), which is expressed by a variety of cell subtypes of the innate as well as adaptive system, including monocytes, macrophages and effector T cells, as either a soluble or membrane-bound version [<xref ref-type="bibr" rid="CR1327">1327</xref>]. Of note, mice express only one TRAIL receptor (TRAIL-R2, referred in this article as mTRAIL-R) which is equally homologous to human TRAIL-R1 and TRAIL-R2.</p><p id="Par74">Upon ligand binding and trimerization and in certain instances formation of higher order complexes, the engagement of DRs promotes the assembly of multi-protein complexes, such as the death-inducing signaling complex (DISC) and complex II, resulting in the activation of caspase 8 (CASP8) and apoptosis [<xref ref-type="bibr" rid="CR1328">1328</xref>&#8211;<xref ref-type="bibr" rid="CR1331">1331</xref>]. The DISC, which is assembled on the cytoplasmic tail of ligated FAS, TNF-R1, TRAIL-R1 or TRAIL-R2, is comprised of the molecular adaptor Fas-associated death domain protein (FADD), Fas (TNFRSF6)-associated via death domain (FADD), CASP8, and distinct isoforms of CASP8 and FADD like apoptosis regulator (CFLAR; best known as c-FLIP), including alternative splicing variants, the long form c-FLIP<sub>L</sub> and the short form c-FLIP<sub>S</sub>,&#160;and (in human) c-FLIP<sub>R</sub> [<xref ref-type="bibr" rid="CR1332">1332</xref>&#8211;<xref ref-type="bibr" rid="CR1337">1337</xref>]. Of note, c-FLIPs are catalytically inactive CASP8-like molecules acting as a modulator of CASP8 activation. Unlike FAS- and TRAIL-R-associated DISCs, complex II is a cytosolic complex assembled secondarily upon TNF-R1 ligation, in conditions of reduced pro-survival signaling and protein synthesis as for instance upon administration of inhibitor of apoptosis proteins (IAP) blockers&#160;and cycloheximide [<xref ref-type="bibr" rid="CR1338">1338</xref>]. Complex II consists of FADD and CASP8 in association with either TNF-R1-associated death domain protein (TRADD) (complex IIa) or receptor interacting serine/threonine kinase 1 (RIPK1) (complex IIb), which is involved in the modulation of apoptosis and necroptosis [<xref ref-type="bibr" rid="CR1339">1339</xref>]. Upon the recruitment to the DISC (complex I), CASP8 is activated by a process involving CASP8 oligomerization and autoproteolysis. CASP8 then acts as the executor of extrinsic apoptosis by favoring the proteolytic activation of the effector caspases CASP3 and CASP7 [<xref ref-type="bibr" rid="CR1340">1340</xref>]. This direct pathway is sufficient for&#160;the FASLG-driven killing of&#160;thymocytes and mature lymphocytes (so-called type I cells), but the efficient killing of hepatocytes, pancreatic &#946; cells, and most cancer cells (so-called type II cells) requires pathway amplification through the CASP8-dependent proteolytic activation of the BH3-only protein BH3 interacting domain death agonist (BID), leading to engagement of the intrinsic apoptotic pathway [<xref ref-type="bibr" rid="CR278">278</xref>, <xref ref-type="bibr" rid="CR1341">1341</xref>&#8211;<xref ref-type="bibr" rid="CR1346">1346</xref>]. Of note, the absence of X-linked inhibitor of apoptosis (XIAP) converts type II cells into type I cells [<xref ref-type="bibr" rid="CR1160">1160</xref>], indicating that a limited amount of caspase activity is needed for cell killing.</p><p id="Par75">Once activated, CASP8 also cleaves RIPK1 leading to the inhibition of necroptosis and the maintenance of inflammatory homeostasis [<xref ref-type="bibr" rid="CR1347">1347</xref>]. As a further layer of complication, the engagement of DRs by their respective ligands does not necessarily culminate in the activation of the extrinsic apoptosis signaling pathway. Indeed, the engagement of FAS, TRAIL-Rs and TNF-R1 can also result in the activation of pro-survival pathways, which is often -&#160;but not always -&#160;dependent on NF-&#954;B signaling [<xref ref-type="bibr" rid="CR1327">1327</xref>, <xref ref-type="bibr" rid="CR1348">1348</xref>], or, alternatively, in the initiation of inflammatory responses, cell differentiation/activation (as is the case of lymphocytes), and the regulation of other RCD variants, particularly necroptosis and pyroptosis [<xref ref-type="bibr" rid="CR1349">1349</xref>]. The induction of inflammatory chemokines and cytokines downstream of the activation of FAS and TRAIL-Rs is mediated by FADD and CASP8 by a mechanism that can be independent of apoptosis induction [<xref ref-type="bibr" rid="CR872">872</xref>, <xref ref-type="bibr" rid="CR1350">1350</xref>].</p><p id="Par76">Extrinsic apoptosis can be activated by another class of cell surface receptors known as dependence receptor. In this case, cell death is ignited by a decrease in the availability of a specific ligand on which these receptors depend [<xref ref-type="bibr" rid="CR1351">1351</xref>, <xref ref-type="bibr" rid="CR1352">1352</xref>]. Dependence receptors include (but are not limited to) the DCC netrin 1 receptor (DCC) and distinct types of unc-5 netrin receptors (UNC5A, UNC5B, UNC5C, and UNC5D), all of which are bound by netrin 1 (NTN1), and the neurotrophic receptor tyrosine kinase 3 (NTRK3) and patched 1 (PTCH1), which are ligated by neurotrophin and sonic hedgehog (SHH), respectively. The activation of dependence receptors stimulates hitherto poorly characterized signaling cascades often dependent on caspase activation, leading to the induction of cell death [<xref ref-type="bibr" rid="CR838">838</xref>, <xref ref-type="bibr" rid="CR1353">1353</xref>]. Of note,&#160;the relevance of dependence receptor-induced apoptosis for normal physiology and disease remains to be formally established.</p></boxed-text></sec><sec id="Sec19"><boxed-text position="float" orientation="portrait"><label>Box 6 Impact of death receptors on health</label><p id="Par77">A large body of data demonstrates that death receptor (DR) signaling is crucial for the maintenance of adult tissue homeostasis but nor for embryonic development, as demonstrated by the normal appearance of mice lacking caspase 8 and mixed lineage kinase domain like (<italic toggle="yes">Casp8</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Mlkl</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice) or CASP8 and receptor-interacting serine-threonine kinase 3 (<italic toggle="yes">Casp8</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Ripk3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice), before they develop lymphadenopathy and splenomegaly [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR876">876</xref>, <xref ref-type="bibr" rid="CR1354">1354</xref>&#8211;<xref ref-type="bibr" rid="CR1357">1357</xref>]. Mouse strains with spontaneous mutations in Fas (TNF receptor superfamily member 6) (<italic toggle="yes">Fas</italic>) - the so-called <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice &#8211; or Fas ligand (TNF superfamily, member 6) (<italic toggle="yes">Fasl</italic>) - the so-called <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice - are viable but develop progressive lymphoproliferative and systemic lupus erythematosus (SLE)-like disorders [<xref ref-type="bibr" rid="CR543">543</xref>, <xref ref-type="bibr" rid="CR875">875</xref>, <xref ref-type="bibr" rid="CR1358">1358</xref>&#8211;<xref ref-type="bibr" rid="CR1360">1360</xref>]. The severity of these pathologies is greatly influenced by genetic background: fairly mild on a C57BL/6 background but very severe on MRL and NOD backgrounds. That said, mice with heterozygous <italic toggle="yes">Fas</italic> or <italic toggle="yes">Fasl</italic> mutations are normal [<xref ref-type="bibr" rid="CR1360">1360</xref>]. These lymphoproliferative and autoimmune disorders are not accompanied by impaired thymocyte development [<xref ref-type="bibr" rid="CR1361">1361</xref>]. Transgenic overexpression of BCL2 apoptosis regulator (BCL2) [<xref ref-type="bibr" rid="CR1342">1342</xref>] or MCL1, BCL2 family apoptosis regulator (MCL1) [<xref ref-type="bibr" rid="CR1362">1362</xref>] in the lymphocyte compartment of <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice or the absence of BCL2 like 11 (BCL2L11; best known as BIM) [<xref ref-type="bibr" rid="CR1363">1363</xref>] massively exacerbate lymphadenopathy. This is consistent with the notion that intrinsic apoptosis and DR-induced apoptosis are distinct in lymphoid cells and act additively. FAS or FASL deficiency also perturbs the homeostasis or function of other mouse tissues, including (but not limited to) the liver [<xref ref-type="bibr" rid="CR1361">1361</xref>], kidney [<xref ref-type="bibr" rid="CR1364">1364</xref>], retina [<xref ref-type="bibr" rid="CR1365">1365</xref>], pancreas [<xref ref-type="bibr" rid="CR1366">1366</xref>] and intestinal epithelium [<xref ref-type="bibr" rid="CR1367">1367</xref>], but these effects may all be a consequence of the deregulation of the lymphoid system, for example causing excess production of certain cytokines and chemokines.</p><p id="Par78">Conditional deletion of <italic toggle="yes">Fas</italic> and <italic toggle="yes">Fasl</italic> in specific immune cell subsets as well as transgenic expression of FAS in lymphocytes confirms the crucial role of FASL-FAS signaling in the homeostasis of lymphocytes and dendritic cells (DCs) [<xref ref-type="bibr" rid="CR1020">1020</xref>, <xref ref-type="bibr" rid="CR1368">1368</xref>&#8211;<xref ref-type="bibr" rid="CR1371">1371</xref>]. In this context, experiments in <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice deleted of BH3-only protein BCL2 like 11 (<italic toggle="yes">Bcl2l11</italic>, encoding BIM) demonstrate some degree of cooperation between FAS and BIM in preserving the functionality of the immune system [<xref ref-type="bibr" rid="CR1363">1363</xref>]. However, abrogating FAS-FASL signaling ultimately has heterogeneous organismal consequences. The lymphoproliferative disorder caused by <italic toggle="yes">Fas</italic> or <italic toggle="yes">Fasl</italic> deletion confers protection from autoimmune diabetes [<xref ref-type="bibr" rid="CR922">922</xref>]. This may be explained by the fact that the distortion of the T cell repertoire caused by the lymphadenopathy in the <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> and <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice prevents the development of diabetogenic T cells. Finally, FAS appears to exert tumor suppressive effects in lymphoid cells. Indeed, both <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice as well as <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice lacking the T cell compartment have increased incidence of B cell lymphoma [<xref ref-type="bibr" rid="CR816">816</xref>, <xref ref-type="bibr" rid="CR1372">1372</xref>, <xref ref-type="bibr" rid="CR1373">1373</xref>]. Loss of FAS also predisposes humans to B cell&#160;lymphoma (see below).</p><p id="Par79">As for other DRs, mice lacking TNF receptor superfamily member 10b (TNFRSF10B, best known as TRAIL-R2 or mTRAIL-R) or its ligand TNF superfamily member 10 (TNFSF10, beast known as TRAIL) are viable, fertile, and do not spontaneously develop autoimmune diseases [<xref ref-type="bibr" rid="CR883">883</xref>, <xref ref-type="bibr" rid="CR1374">1374</xref>&#8211;<xref ref-type="bibr" rid="CR1376">1376</xref>]. Moreover, these mice exhibit normal immune system development and function [<xref ref-type="bibr" rid="CR1377">1377</xref>&#8211;<xref ref-type="bibr" rid="CR1380">1380</xref>]. Along similar lines, the whole-body deletion of tumor necrosis factor (<italic toggle="yes">Tnf</italic>) does not affect mouse development and fertility [<xref ref-type="bibr" rid="CR1381">1381</xref>, <xref ref-type="bibr" rid="CR1382">1382</xref>]. However, <italic toggle="yes">Tnf</italic><sup>&#8722;/&#8722;</sup> mice often show early hearing loss and, despite presenting with an overtly functional immune system, exhibit abnormally increased susceptibility to spontaneous bacterial infection, which has been ascribed to multiple defects including defective lymphoid organ architecture as well as deficient granuloma and germinal center formation [<xref ref-type="bibr" rid="CR1381">1381</xref>&#8211;<xref ref-type="bibr" rid="CR1385">1385</xref>]. Impaired responses to pathogens have been documented in <italic toggle="yes">Tnf</italic><sup>+/&#8722;</sup> mice [<xref ref-type="bibr" rid="CR1381">1381</xref>] as well as in mice lacking TNF receptor superfamily member 1A (TNFRSF1A, best known as TNF-R1) [<xref ref-type="bibr" rid="CR1383">1383</xref>&#8211;<xref ref-type="bibr" rid="CR1387">1387</xref>]. Conversely, mice overexpressing TNF in cardiomyocytes suffer from lethal dilated cardiomyopathy, demonstrating that balanced TNF signaling is essential for the homeostasis of the cardiac tissue [<xref ref-type="bibr" rid="CR1388">1388</xref>&#8211;<xref ref-type="bibr" rid="CR1390">1390</xref>]. Of note, while the lack of TRAIL enhances the severity of lymphoproliferative and autoimmune disorders in <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice [<xref ref-type="bibr" rid="CR1391">1391</xref>], the lack of TNF attenuates the lymphoproliferative phenotype, extending the survival of <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice [<xref ref-type="bibr" rid="CR1392">1392</xref>]. The latter is probably due to the reduction in TNF-mediated inflammation attenuating lymphadenopathy caused by the absence of FASL. These findings confirm the pleiotropy and redundancy of DR signaling, encompassing not only apoptotic and non-apoptotic regulated cell death (RCD)-related effects, but also various pro-survival and pro-inflammatory modules.</p><p id="Par80">Multiple clinical observations support the role of FAS signaling in human hematopoiesis [<xref ref-type="bibr" rid="CR1393">1393</xref>, <xref ref-type="bibr" rid="CR1394">1394</xref>]. Most patients with autoimmune lymphoproliferative syndrome (ALPS)&#8212;a primary immunodeficiency manifesting with lymphadenopathy, splenomegaly as well as abnorrmal numbers, development and function of lymphocytes &#8212;carry loss-of-function mutations in <italic toggle="yes">FAS</italic> or <italic toggle="yes">FASLG</italic> [<xref ref-type="bibr" rid="CR874">874</xref>, <xref ref-type="bibr" rid="CR1395">1395</xref>&#8211;<xref ref-type="bibr" rid="CR1400">1400</xref>]. ALPS patients also display an increased incidence of non-Hodgkin and Hodgkin lymphoma [<xref ref-type="bibr" rid="CR1401">1401</xref>]. While no mutations in the genes encoding TRAIL, TRAIL-R1 and TRAIL-R2 have so far been linked to human autoimmune diseases, autosomal dominant mutations in <italic toggle="yes">TNFRSF1A</italic> (leading to lack of TNF-R1) have been identified in patients affected by TNF receptor-associated periodic syndrome (TRAPS), characterized by severe abdominal pain, arthralgias, and myalgias [<xref ref-type="bibr" rid="CR1402">1402</xref>&#8211;<xref ref-type="bibr" rid="CR1404">1404</xref>].</p></boxed-text></sec><sec id="Sec20"><boxed-text position="float" orientation="portrait"><label>Box 7 Impact of extrinsic apoptosis complexes and caspases on health</label><p id="Par81">Several signal transducers in the death receptor (DRs) pathway are essential for embryonic development in mice. Thus, deletion of Fas (TNFRSF6)-associated via death domain (<italic toggle="yes">Fadd</italic>), caspase 8 (<italic toggle="yes">Casp8</italic>) or CASP8 and FADD-like apoptosis regulator (<italic toggle="yes">Cflar</italic>, encoding c-FLIP) is embryonic lethal at mid-gestation as a consequence of severe vascular as well as cardiac defects associated with spontaneous intra-abdominal hemorrhage [<xref ref-type="bibr" rid="CR1405">1405</xref>&#8211;<xref ref-type="bibr" rid="CR1410">1410</xref>]. Of note, CASP8-deficient mice also exhibit neural tube defects [<xref ref-type="bibr" rid="CR1409">1409</xref>]. A similar embryonic lethality has also been documented in mice expressing a mutant form of FADD deficient in its death domain [<xref ref-type="bibr" rid="CR1406">1406</xref>]. The absence of other components of DR-associated signaling complexes, such as TNFRSF1A associated via death domain (TRADD) and receptor-interacting serine/threonine kinase 1 (RIPK1), causes different abnormalities. Thus, while <italic toggle="yes">Tradd</italic><sup>&#8722;/&#8722;</sup> mice develop normally and do not display major hematopoietic defects [<xref ref-type="bibr" rid="CR1411">1411</xref>&#8211;<xref ref-type="bibr" rid="CR1413">1413</xref>], <italic toggle="yes">Ripk1</italic><sup>&#8722;/&#8722;</sup> mice die early after birth due to severe multiorgan inflammation [<xref ref-type="bibr" rid="CR1414">1414</xref>, <xref ref-type="bibr" rid="CR1415">1415</xref>]. These findings are attributed to the pleiotropic contribution of RIPK1 and TRADD to a variety of processes beyond apoptosis, most notably necroptotic regulated cell death (RCD) and inflammation. This is exemplified by the observation that the embryonic lethality caused by the absence of CASP8 or FADD can be rescued by the concomitant loss of mixed lineage kinase domain like (MLKL) or receptor-interacting serine-threonine kinase 3 (RIPK3) (see below). Mice lacking baculoviral IAP repeat-containing 3 (BIRC3; best known as cIAP1) and X-linked inhibitor of apoptosis (XIAP), or cIAP1 and BIRC2 (best known as cIAP2), but not mice lacking cIAP2 and XIAP, display embryonic lethality [<xref ref-type="bibr" rid="CR1416">1416</xref>]. These findings indicate specific functional redundancies among the inhibitor of apoptosis protein family. cIAP1/cIAP2-deficient mice display mid-gestation lethality, which can be rescued to birth by the deletion of TNF receptor superfamily member 1A (<italic toggle="yes">Tnfrsf1a</italic>, encoding TNF-R1) but not that of TNF receptor superfamily member 1B (<italic toggle="yes">Tnfrsf1b</italic>, best known as TNF-R2) [<xref ref-type="bibr" rid="CR1416">1416</xref>]. Loss of one allele of <italic toggle="yes">Ripk1</italic> or loss of <italic toggle="yes">Ripk3</italic> prolonged embryonic survival of these mice [<xref ref-type="bibr" rid="CR1416">1416</xref>]. It is noteworthy, that, as discussed above, genetic background effects might contribute to the phenotype, as mice with concomitant knockout of the genes encoding cIAP1 and cIAP2 using mutant alleles generated in C57BL/6 embryonic stem cells die in midgestation [<xref ref-type="bibr" rid="CR1416">1416</xref>], whereas <italic toggle="yes">Birc3</italic><sup>&#8722;/&#8722;</sup> and <italic toggle="yes">Xiap</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> double mutants generated using 129Sv embryonic stem cells are viable [<xref ref-type="bibr" rid="CR1417">1417</xref>].</p><p id="Par82">It was demonstrated that embryonic lethality in <italic toggle="yes">Casp8</italic><sup>&#8722;/&#8722;</sup> and <italic toggle="yes">Fadd</italic><sup>&#8722;/&#8722;</sup> mice is due to excessive necroptosis, reflecting the ability of CASP8 to limit necroptosis downstream of DR activation [<xref ref-type="bibr" rid="CR51">51</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR1354">1354</xref>]. Accordingly, deletion of genes encoding key components of the necroptotic machinery such as RIPK3 or MLKL prevents all developmental defects and embryonic lethality in FADD- or CASP8-deficient embryos [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR876">876</xref>, <xref ref-type="bibr" rid="CR1354">1354</xref>&#8211;<xref ref-type="bibr" rid="CR1357">1357</xref>, <xref ref-type="bibr" rid="CR1418">1418</xref>]. Of note, <italic toggle="yes">Casp8</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Ripk3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> and <italic toggle="yes">Casp8</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Mlkl</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice develop progressive lymphoproliferative disorders that resemble those caused by the absence of FAS or FASL [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR876">876</xref>]. Moreover, embryonic lethality around E10.5 in mice lacking c-FLIP and the perinatal lethality of <italic toggle="yes">Ripk1</italic><sup>&#8722;/&#8722;</sup> mice depend on aberrant activation of both DR-induced apoptosis and DR-induced necroptosis. Indeed, the lethality of these animals can be rescued by concomitant deletion of <italic toggle="yes">Fadd</italic> and <italic toggle="yes">Ripk3</italic>, <italic toggle="yes">Casp8</italic> and <italic toggle="yes">Ripk3</italic>, or <italic toggle="yes">Fadd</italic> and <italic toggle="yes">Mlkl</italic> [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR876">876</xref>, <xref ref-type="bibr" rid="CR1354">1354</xref>&#8211;<xref ref-type="bibr" rid="CR1357">1357</xref>]. Of note, mice with a mutation in <italic toggle="yes">RIPK1</italic>&#160;that prevents its CASP8-mediated cleavage die around E10.5 of embryonic development, and this can be prevented by the combined absence of RIPK3 and CASP8 [<xref ref-type="bibr" rid="CR1347">1347</xref>, <xref ref-type="bibr" rid="CR1419">1419</xref>, <xref ref-type="bibr" rid="CR1420">1420</xref>]. In a heterozygous state, mutations in the gene encoding RIPK1 cause severe auto-inflammation. As an additional layer of complexity, although the deletion of <italic toggle="yes">Tradd</italic> rescues <italic toggle="yes">Ripk1</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Ripk3</italic><sup>&#8722;/&#8722;</sup> embryos from perinatal lethality, triple knockout mice die postnatally [<xref ref-type="bibr" rid="CR1421">1421</xref>, <xref ref-type="bibr" rid="CR1422">1422</xref>]. Moreover, TRADD deficiency does not prevent the embryonic lethality caused by the loss of FADD [<xref ref-type="bibr" rid="CR1422">1422</xref>]. Additional studies confirm the importance of the inter-connectivity between multiple RCD pathways. Mice with a mutation that prevents auto-proteolytic activation of CASP8 develop normally [<xref ref-type="bibr" rid="CR1423">1423</xref>], but akin to complete loss of <italic toggle="yes">CASP8</italic>, mutations in the CASP8 catalytic site result in embryonic lethality around E10.5 due to aberrant necroptosis, phenotype that can be delayed (but not prevented) by <italic toggle="yes">Mlkl</italic> deletion [<xref ref-type="bibr" rid="CR1419">1419</xref>, <xref ref-type="bibr" rid="CR1424">1424</xref>]. While the genetic ablation of <italic toggle="yes">Mlkl</italic> or <italic toggle="yes">Mlkl</italic> plus <italic toggle="yes">Fadd</italic> prevent E10.5 embryonic lethality in these mice, the compound mutant mice die soon after birth, likely due to aberrant inflammation and pyroptosis [<xref ref-type="bibr" rid="CR1425">1425</xref>, <xref ref-type="bibr" rid="CR1426">1426</xref>]. These observations point to the central role for CASP8 in the regulation of multiple RCD variants and inflammatory processes [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par83">The tissue-specific deletion of <italic toggle="yes">Fadd</italic> or <italic toggle="yes">Casp8</italic> in mouse endothelial cells results in an embryonic lethal phenotype that resembles that of germline <italic toggle="yes">Fadd</italic> or <italic toggle="yes">Casp8</italic> deletion [<xref ref-type="bibr" rid="CR596">596</xref>, <xref ref-type="bibr" rid="CR1427">1427</xref>]. Conversely, the absence of FADD in cardiomyocytes or cardiac progenitor cells appears to have no impact on embryonic development [<xref ref-type="bibr" rid="CR1427">1427</xref>]. Again, abrogation of necroptosis rescued the lethal phenotype of endothelial cell specific <italic toggle="yes">Fadd</italic> or <italic toggle="yes">Casp8</italic> deletion [<xref ref-type="bibr" rid="CR1427">1427</xref>], lending additional support to inhibitory role of FADD and CASP8 in necroptotic RCD. FADD, CASP and c-FLIP have also been implicated in hematopoietic homeostasis. However, the abrogation of FADD in specific immune cell subsets in mice via distinct experimental approaches, such as conditional gene deletion, injection of <italic toggle="yes">Fadd</italic><sup>&#8722;/&#8722;</sup> embryonic stem cells into <italic toggle="yes">Rag1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> blastocysts or transgenic expression of a dominant-negative variant of FADD, does not drive lymphoproliferative disorders. Instead, FADD appears to be critical for the proliferation and/or development of T lymphocytes [<xref ref-type="bibr" rid="CR955">955</xref>, <xref ref-type="bibr" rid="CR1428">1428</xref>&#8211;<xref ref-type="bibr" rid="CR1437">1437</xref>] and B cells [<xref ref-type="bibr" rid="CR1438">1438</xref>], most likely by preventing necroptosis through activation of CASP8. Similar conclusions were derived from the analysis of mice with lymphocyte-specific ablation of <italic toggle="yes">Casp8</italic> or <italic toggle="yes">Cflar</italic> [<xref ref-type="bibr" rid="CR1439">1439</xref>&#8211;<xref ref-type="bibr" rid="CR1444">1444</xref>]. A role for CASP8 in T cell proliferation has also emerged from the realization of the anti-proliferative effects of caspase inhibitors [<xref ref-type="bibr" rid="CR1445">1445</xref>]. The T cell-specific deletion of <italic toggle="yes">Casp8</italic> attenuates autoimmunity and improves the survival of mice lacking the BH3-only protein BCL2 like 11 (BCL2L11, best known as BIM) by limiting T cell proliferation and survival [<xref ref-type="bibr" rid="CR1446">1446</xref>]. Apparently at odds with these findings, the conditional deletion of <italic toggle="yes">Casp8</italic> in T cells has also been associated with an age-dependent, lymphoproliferative immune disorder resembling the condition of patients with <italic toggle="yes">CASP8</italic> mutations [<xref ref-type="bibr" rid="CR1447">1447</xref>]. Whether mouse genetic background or other contextual variables (e.g., the mouse microbiota) underlie such apparent discrepancies remains to be elucidated.</p><p id="Par84">The conditional loss of the functions of FADD or CASP8 also revealed a role for these proteins in early hematopoiesis, which may relate to their ability to promote the proliferation and differentiation of hematopoietic stem and progenitor cells by preventing necroptosis [<xref ref-type="bibr" rid="CR596">596</xref>, <xref ref-type="bibr" rid="CR1448">1448</xref>, <xref ref-type="bibr" rid="CR1449">1449</xref>]. Conditional deletion of <italic toggle="yes">Fadd</italic> in myeloid cells resulted in increased myeloid and B cell populations coupled to activation of inflammatory responses [<xref ref-type="bibr" rid="CR1450">1450</xref>]. Along similar lines, the macrophage-restricted deletion of <italic toggle="yes">Casp8</italic> induced a mild systemic inflammatory disease potentially linked to altered macrophage polarization [<xref ref-type="bibr" rid="CR1451">1451</xref>, <xref ref-type="bibr" rid="CR1452">1452</xref>], while the DC-specific deletion of the genes encoding c-FLIP or CASP8 elicited splenomegaly, inflammatory responses and autoimmune disorders [<xref ref-type="bibr" rid="CR1453">1453</xref>&#8211;<xref ref-type="bibr" rid="CR1455">1455</xref>]. These effects all seem to be unrelated to the pro-apoptotic functions of FADD and CASP8 but reflect their ability to prevent necroptosis [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR1434">1434</xref>, <xref ref-type="bibr" rid="CR1450">1450</xref>, <xref ref-type="bibr" rid="CR1451">1451</xref>, <xref ref-type="bibr" rid="CR1456">1456</xref>&#8211;<xref ref-type="bibr" rid="CR1458">1458</xref>]. Corroborating these findings, loss-of-function mutations in <italic toggle="yes">FADD</italic> [<xref ref-type="bibr" rid="CR1459">1459</xref>&#8211;<xref ref-type="bibr" rid="CR1462">1462</xref>], <italic toggle="yes">CASP8</italic> or <italic toggle="yes">CASP10</italic> [<xref ref-type="bibr" rid="CR1463">1463</xref>&#8211;<xref ref-type="bibr" rid="CR1465">1465</xref>] and <italic toggle="yes">TRADD</italic> [<xref ref-type="bibr" rid="CR1466">1466</xref>] have been associated with ALPS-like syndromes and hematological diseases in humans. Of note, patients with ALPS bearing mutations in <italic toggle="yes">FADD</italic> or <italic toggle="yes">CASP8</italic> but not ALPS patients with mutations in <italic toggle="yes">FAS</italic> or <italic toggle="yes">FASLG</italic> also exhibit immunodeficiency coupled with lymphocytic infiltrations in multiple organs, granulomas and/or inflammatory bowel disease [<xref ref-type="bibr" rid="CR1459">1459</xref>, <xref ref-type="bibr" rid="CR1463">1463</xref>, <xref ref-type="bibr" rid="CR1467">1467</xref>&#8211;<xref ref-type="bibr" rid="CR1469">1469</xref>].</p><p id="Par85">Tissue-specific deletion of <italic toggle="yes">Fadd</italic>, <italic toggle="yes">Casp8</italic> and <italic toggle="yes">Cflar</italic> has also revealed a role for these proteins in the homeostasis of the liver, skin and intestine, although severity of the phenotype varies quite considerably, ranging from mild inflammatory responses to embryonic or early postnatal lethality, again likely due to unleashed necroptosis. Conditional deletion of <italic toggle="yes">Cflar</italic> (resulting in lack of c-FLIP) in intestinal epithelial cells, hepatocytes or keratinocytes resulted in embryonic or perinatal lethality due to aberrant activation of cell death [<xref ref-type="bibr" rid="CR1470">1470</xref>&#8211;<xref ref-type="bibr" rid="CR1473">1473</xref>]. The inducible deletion of <italic toggle="yes">Cflar</italic> from the intestinal epithelium of adult mice caused severe inflammation that was often fatal [<xref ref-type="bibr" rid="CR1473">1473</xref>]. These findings are in line with the crucial role of c-FLIP as an inhibitor of necroptosis [<xref ref-type="bibr" rid="CR1354">1354</xref>, <xref ref-type="bibr" rid="CR1474">1474</xref>]. Along similar lines, <italic toggle="yes">Fadd</italic> deletion in epidermal keratinocytes or intestinal epithelial cells causes severe chronic inflammation due to the induction of aberrant necroptosis [<xref ref-type="bibr" rid="CR1475">1475</xref>&#8211;<xref ref-type="bibr" rid="CR1481">1481</xref>]. Accordingly, the removal of FADD (or CASP8) in intestinal epithelial cells resulted in chronic inflammatory colitis and ileitis, which was prevented by concomitant deletion of <italic toggle="yes">Ripk3</italic> or <italic toggle="yes">Mklk</italic> [<xref ref-type="bibr" rid="CR1424">1424</xref>, <xref ref-type="bibr" rid="CR1426">1426</xref>, <xref ref-type="bibr" rid="CR1476">1476</xref>, <xref ref-type="bibr" rid="CR1478">1478</xref>, <xref ref-type="bibr" rid="CR1481">1481</xref>, <xref ref-type="bibr" rid="CR1482">1482</xref>]. In one of these studies, acute deletion of <italic toggle="yes">Casp8</italic> in the gut of adult mice resulted in enterocyte death, leading to disruption of tissue homeostasis, sepsis and death [<xref ref-type="bibr" rid="CR1481">1481</xref>]. In this context, CASP8-deficient enterocytes displayed decreased in vivo survival and migration potential [<xref ref-type="bibr" rid="CR1483">1483</xref>]. Specific deletion of <italic toggle="yes">Casp8</italic> in endothelial cells results in small intestinal hemorrhage and bowel inflammation, suggesting a key role of CASP8 in vascular homeostasis in the small intestine [<xref ref-type="bibr" rid="CR1484">1484</xref>]. Loss of CASP8 catalytic activity specifically in intestinal epithelial cells induced intestinal inflammation similar to absence of CASP8 in the intestinal epithelium [<xref ref-type="bibr" rid="CR1424">1424</xref>]. This intestinal phenotype was aggravated by <italic toggle="yes">Mlkl</italic> deletion, resulting in premature death dependent on the induction of inflammatory responses and pyroptosis [<xref ref-type="bibr" rid="CR1424">1424</xref>]. As an added layer of complexity, deletion of tumor necrosis factor (<italic toggle="yes">Tnf</italic>) or <italic toggle="yes">Tnfrsf1a</italic> (encoding TNF-R1) attenuated colitis, but not ileitis, in mice with an intestinal epithelial cell-specific deletion of <italic toggle="yes">Fadd</italic> or <italic toggle="yes">Casp8</italic> [<xref ref-type="bibr" rid="CR1473">1473</xref>, <xref ref-type="bibr" rid="CR1476">1476</xref>]. A recent study indicated that this effect may also involve the aberrant activation of pyroptosis. Indeed, the CASP8-dependent activation of gasdermin D (GSDMD) appears to promote ileitis in mice with FADD-deficient intestinal epithelial cells [<xref ref-type="bibr" rid="CR1485">1485</xref>]. These results are in line with the crucial involvement of CASP8 and FADD in the activation of inflammation [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR1486">1486</xref>] and indicate that the FADD-CASP8 axis regulates tissue homeostasis by balancing apoptosis, necroptosis, pyroptosis and inflammation.</p></boxed-text></sec><sec id="Sec21"><title>Neurological diseases</title><p id="Par86">Although numerous studies investigated FAS and TNF-R1 signaling in the pathogenesis of multiple neurological diseases, the precise role of extrinsic apoptosis remains unclear (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>). Loss-of-function mutations of Fas ligand (TNF superfamily, member 6) (<italic toggle="yes">Fasl</italic>) as well as <italic toggle="yes">Fas</italic> silencing prevented moto-neuron loss in mouse models of ALS driven by defect in superoxide dismutase 1, soluble (SOD1) [<xref ref-type="bibr" rid="CR508">508</xref>, <xref ref-type="bibr" rid="CR509">509</xref>]. Conversely, the lack of TNF did not affect motor neuron loss and mouse survival in this model [<xref ref-type="bibr" rid="CR510">510</xref>], while signaling via TNF receptor superfamily member 1B (TNFRSF1B, best known as TNF-R2) appeared to mediate neuroprotective effects [<xref ref-type="bibr" rid="CR511">511</xref>]. As an additional layer of complexity, TNF mediates neuroprotective functions in wobbler mice - another mouse model of ALS that carries a point mutation in VPS54 GARP complex subunit (<italic toggle="yes">Vps54</italic>), at least in part by promoting the upregulation of ADAM metallopeptidase domain 8 (ADAM8) [<xref ref-type="bibr" rid="CR512">512</xref>]. CASP8 has not yet been implicated in the pathogenesis of ALS, and non-apoptotic forms of FAS-driven RCD may play a predominant role in this context. For example, FAS stimulation reportedly triggered the demise of motoneurons in mouse models of ALS by aggravating endoplasmic reticulum stress [<xref ref-type="bibr" rid="CR513">513</xref>]. Similarly, cleavage of BID by CASP1 (and not CASP8) appears to contribute to neurodegeneration in transgenic mice expressing a mutant form of human SOD1 [<xref ref-type="bibr" rid="CR514">514</xref>]. However, the precise contributions of endoplasmic reticulum stress and CASP1 in ALS and other motoneuron disorders remain to be elucidated.<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><title>Impact of extrinsic apoptosis players on neurological disorders.</title><p>Death receptor-induced apoptosis is directly or indirectly involved in the pathogenesis of multiple neurological disorders, including neurodegenerative diseases, in brain damage due to traumatic injury or neurotoxicity as well as in neuromuscular and retinal disorders.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e10629" position="float" orientation="portrait" xlink:href="41418_2023_1153_Fig5_HTML.jpg"/></fig></p><p id="Par87">The ability of TNF-R1 signaling to influence neurodegenerative conditions involves not only the induction of extrinsic apoptosis but also the activation of an inflammatory response. In distinct murine models of AD, deletion of <italic toggle="yes">Tnf</italic>, modification of its untranslated region (UTR) as well as pharmacological TNF inhibition reduced plaque formation, resulting in attenuated neurological deficits [<xref ref-type="bibr" rid="CR515">515</xref>&#8211;<xref ref-type="bibr" rid="CR522">522</xref>]. Mechanistic studies in mice and monkeys revealed that TNF-R1 activation stimulates the protein activator of interferon-induced protein kinase EIF2AK2 (PRKRA) network [<xref ref-type="bibr" rid="CR523">523</xref>], which is linked to PD in humans [<xref ref-type="bibr" rid="CR524">524</xref>]. Moreover, TNF-R1 signaling has been shown to favor microglial reactivity during neurodegeneration, culminating in neuronal loss [<xref ref-type="bibr" rid="CR525">525</xref>]. Amelioration of disease was seen in mouse models of AD upon genetic or pharmacological inhibition of TNF-R1 [<xref ref-type="bibr" rid="CR526">526</xref>, <xref ref-type="bibr" rid="CR527">527</xref>]. AD-associated neuroinflammation seems to depend on TNF-induced necroptosis rather than extrinsic apoptosis [<xref ref-type="bibr" rid="CR528">528</xref>, <xref ref-type="bibr" rid="CR529">529</xref>]. Unexpectedly, AD pathogenesis was shown to be enhanced in mice bearing a co-deletion of <italic toggle="yes">Tnfrsf1a</italic> and <italic toggle="yes">Tnfrsf1b</italic> [<xref ref-type="bibr" rid="CR530">530</xref>], a phenotype that appears to impinge on a complex network of mutual interactions between TNF-R1 and TNF-R2 signaling [<xref ref-type="bibr" rid="CR531">531</xref>]. Such a network may also contribute to PD pathogenesis. Genetic ablation of <italic toggle="yes">Tnf</italic> or <italic toggle="yes">Tnfrsf1a</italic> plus <italic toggle="yes">Tnfrsf1b</italic> (leading to the lack of both TNF receptors), as well as pharmacological inhibition of TNF, were reported to protect dopaminergic neurons in murine models of PD following the administration of 1-metil 4-phenyl 1,2,3,6-tetraidro-piridina (MPTP) or 6-hydroxydopamine [<xref ref-type="bibr" rid="CR532">532</xref>&#8211;<xref ref-type="bibr" rid="CR535">535</xref>]. Notably, in the aforementioned experimental settings, TNF is thought to induce neuronal death in vivo by promoting microglia reactivity [<xref ref-type="bibr" rid="CR536">536</xref>] with a complex interaction between TNF-R1 and TNF-R2 signaling [<xref ref-type="bibr" rid="CR537">537</xref>]. Clinical evidence from AD patients subjected to perispinal administration of the TNF blockers infliximab or etanercept suggests that the inhibition of TNF can ameliorate AD [<xref ref-type="bibr" rid="CR538">538</xref>, <xref ref-type="bibr" rid="CR539">539</xref>]. In contrast, a dominant-negative variant of TNF failed to protect mice against neuronal degeneration in a model of HD [<xref ref-type="bibr" rid="CR540">540</xref>], suggesting that this approach may not be viable in patients with HD.</p><p id="Par88">TRAIL/TRAIL-R signaling has also been implicated in the onset and progression of AD [<xref ref-type="bibr" rid="CR541">541</xref>, <xref ref-type="bibr" rid="CR542">542</xref>]. Specifically, in a mouse model of AD, neutralization of TNF superfamily member 10 (TNFSF10, best known as TRAIL) with a monoclonal antibody resulted in decreased neuroinflammation and a reduction in cognitive defects [<xref ref-type="bibr" rid="CR541">541</xref>]. However, these findings were not extensively validated. Similarly, the impact of FASL-FAS signaling on neurodegenerative conditions is debated. Indeed, <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice, which lack FAS [<xref ref-type="bibr" rid="CR543">543</xref>] and to a lesser extent <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice, which lack FASL [<xref ref-type="bibr" rid="CR543">543</xref>], are particularly susceptible to neuronal degeneration driven by MPTP [<xref ref-type="bibr" rid="CR544">544</xref>]. However, contrasting results have been obtained in another study involving FAS-deficient mice treated with MPTP [<xref ref-type="bibr" rid="CR545">545</xref>, <xref ref-type="bibr" rid="CR546">546</xref>]. In this context, FAS-associated factor 1 (Faf1, a FAS binding protein that can initiate or enhance apoptosis) was found to be&#160;increased in midbrain in murine models of PD [<xref ref-type="bibr" rid="CR547">547</xref>]. Moreover, a reduction in Faf1 expression limited MPTP-induced dopaminergic cell loss [<xref ref-type="bibr" rid="CR548">548</xref>]. Such an apparent discrepancy in results may originate from the pleiotropic role of FAS in apoptosis and inflammation and other pro-survival/regenerative signals.</p><p id="Par89">CASP8 activation has been detected in the brain of both AD [<xref ref-type="bibr" rid="CR549">549</xref>] and HD [<xref ref-type="bibr" rid="CR550">550</xref>] patients as well as in dopaminergic neurons of MPTP-treated mice and PD patients, a setting in which BID cleavage has also been documented [<xref ref-type="bibr" rid="CR119">119</xref>]. This is in line with the ability of the broad-spectrum caspase inhibitor Q-VD-OPH to inhibit BID cleavage and mediate neuroprotection in MPTP-treated mice and rats [<xref ref-type="bibr" rid="CR551">551</xref>]. Of note, CASP8 was also reported to promote microglia reactivity potentially leading to neuronal loss [<xref ref-type="bibr" rid="CR552">552</xref>&#8211;<xref ref-type="bibr" rid="CR554">554</xref>]. In this context, genetic loss or pharmacological inhibition of CASP8 attenuated neurotoxicity by reducing microglial reactivity, thus extending survival of neurons, at least in part by stimulating the necroptotic death of activated microglial cells [<xref ref-type="bibr" rid="CR552">552</xref>&#8211;<xref ref-type="bibr" rid="CR554">554</xref>]. Consistent with this notion, <italic toggle="yes">Casp8</italic> deletion in myeloid cells protected mice from MPTP-mediated neurotoxicity [<xref ref-type="bibr" rid="CR555">555</xref>], suggesting that CASP8 inhibitors may be harnessed for the treatment of neurodegenerative conditions. Corroborating this idea, a pharmacological inhibitor of TNF-R1-associated death domain protein (TRADD) protected mice from disease in a model of AD-like proteinopathy driven by mutant tau [<xref ref-type="bibr" rid="CR556">556</xref>]. However, pharmacological inhibition of CASP8 only partially prevented neuronal alterations in other models of AD [<xref ref-type="bibr" rid="CR108">108</xref>], and even exacerbated dopaminergic neuronal necrosis in mice developing PD upon MPTP administration [<xref ref-type="bibr" rid="CR557">557</xref>]. Moreover, rare <italic toggle="yes">CASP8</italic> loss-of-function variants have been associated with AD in a large cohort of patients [<xref ref-type="bibr" rid="CR558">558</xref>]. Thus, the precise contribution of CASP8 signaling to neurodegenerative disorders and whether this relates to its function in driving extrinsic apoptosis, inhibiting necroptosis or promoting inflammatory cytokine production remains to be formally defined. Concerning dependence receptors, Netrin 1 (NTN1) upregulation was shown to confer neuroprotection in murine models of PD, suggesting a potential role of dependence receptors in neurodegenerative disease [<xref ref-type="bibr" rid="CR559">559</xref>].</p><p id="Par90">DR signaling has also been shown to contribute to neuronal death and inflammation in preclinical models of CNS trauma. In a compression model of spinal cord injury, mice with loss of FAS (i.e., <italic toggle="yes">lpr/lpr</italic> mice) as well as mice treated with FASL blockers displayed reduced post-traumatic neuronal degeneration and inflammation coupled to considerable functional improvement [<xref ref-type="bibr" rid="CR560">560</xref>&#8211;<xref ref-type="bibr" rid="CR562">562</xref>]. This beneficial effect also involved reduced engagement of the intrinsic apoptosis pathway [<xref ref-type="bibr" rid="CR563">563</xref>]. Myeloid cell-specific deletion of <italic toggle="yes">Fasl</italic> promoted neuronal regeneration and functional recovery in mice subjected to spinal cord injury [<xref ref-type="bibr" rid="CR564">564</xref>]. A similar functional improvement after spinal injury was observed in mice with conditional deletion of <italic toggle="yes">Tnf</italic> in macrophages and neutrophils, but not in microglia [<xref ref-type="bibr" rid="CR565">565</xref>]. Moreover, neuroprotection and limited neuroinflammation have been documented in <italic toggle="yes">lpr/ lpr</italic> mice subjected to traumatic brain injury [<xref ref-type="bibr" rid="CR566">566</xref>], as well as in mice subjected to experimental spondylotic myelopathy and exposed to FASL-neutralizing antibodies [<xref ref-type="bibr" rid="CR567">567</xref>]. Studies on mice with loss of <italic toggle="yes">Fas</italic> and <italic toggle="yes">Tnfrsf1a</italic> revealed at least some redundancy between FAS and TNF-R1 signaling in the context of experimental brain trauma [<xref ref-type="bibr" rid="CR568">568</xref>&#8211;<xref ref-type="bibr" rid="CR572">572</xref>]. Furthermore, TNF inhibition reduced damage in mice or rats experiencing spinal cord injury [<xref ref-type="bibr" rid="CR573">573</xref>&#8211;<xref ref-type="bibr" rid="CR575">575</xref>], and also reduced the appearance of signs of autonomic dysreflexia, a cardiovascular disease associated with high-level spinal cord injury [<xref ref-type="bibr" rid="CR573">573</xref>, <xref ref-type="bibr" rid="CR576">576</xref>]. Interestingly, some of these studies point to a neuroprotective function for TNF-R2 [<xref ref-type="bibr" rid="CR568">568</xref>, <xref ref-type="bibr" rid="CR570">570</xref>, <xref ref-type="bibr" rid="CR572">572</xref>], which is in line with at least some results from models of ALS [<xref ref-type="bibr" rid="CR511">511</xref>, <xref ref-type="bibr" rid="CR531">531</xref>]. Moreover, several studies question a purely detrimental effect of TNF signaling in these experimental settings [<xref ref-type="bibr" rid="CR577">577</xref>&#8211;<xref ref-type="bibr" rid="CR580">580</xref>]. In particular, TNF was reported to support, at least in part, regeneration and long-term functional recovery in mice exposed to traumatic brain injury [<xref ref-type="bibr" rid="CR578">578</xref>&#8211;<xref ref-type="bibr" rid="CR580">580</xref>]. Conversely, TRAIL neutralization stands out as a promising strategy to promote neuronal regeneration and functional recovery based on mice with spinal cord injuries [<xref ref-type="bibr" rid="CR581">581</xref>, <xref ref-type="bibr" rid="CR582">582</xref>]. In this context, injured neurons seem to undergo Fas-associated via death domain (FADD)- and CASP8-dependent RCD [<xref ref-type="bibr" rid="CR583">583</xref>]. Accordingly, <italic toggle="yes">Casp8</italic> deletion or transgenic expression of a FADD inhibitor (the glycoprotein P45) protected mice after spinal cord injury [<xref ref-type="bibr" rid="CR584">584</xref>, <xref ref-type="bibr" rid="CR585">585</xref>]. Similarly, transgenic expression of a dominant negative mutant of FADD (FADD-DN) limited motoneuron loss in mice undergoing axotomy [<xref ref-type="bibr" rid="CR586">586</xref>].</p><p id="Par91">Components of the molecular apparatus for the extrinsic pathway are associated with disorders of the visual system, again in the context of both exacerbated cell death and inflammation. Thus, in mouse and rat models of optic nerve injury, deletion of <italic toggle="yes">Tnfrsf1a</italic> (encoding TNF-R1) or inhibition of CASP8 with Z-IETD-FMK inhibited the degeneration of retinal ganglion cells [<xref ref-type="bibr" rid="CR587">587</xref>, <xref ref-type="bibr" rid="CR588">588</xref>]. Moreover, the absence of TNF-R1 (but not the absence of TNF-R2) attenuated neurodegeneration in a mouse model of retinal ischemia, despite neuronal survival not being improved [<xref ref-type="bibr" rid="CR589">589</xref>]. Along similar lines, deletion of <italic toggle="yes">Tnf</italic> [<xref ref-type="bibr" rid="CR590">590</xref>] as well as inhibition of FAS [<xref ref-type="bibr" rid="CR591">591</xref>] or TNF [<xref ref-type="bibr" rid="CR592">592</xref>, <xref ref-type="bibr" rid="CR593">593</xref>] protected mice against retinal ganglion cell death in a model of glaucoma. Similar neuroprotective effects were documented for the conditional deletion of <italic toggle="yes">Casp8</italic> in astrocytes or intra-ocular Z-IETD-FMK administration [<xref ref-type="bibr" rid="CR594">594</xref>]. In this context, the conditional inducible ablation of <italic toggle="yes">Casp8</italic> from endothelial cells reduced postnatal retinal angiogenesis and pathological neovascularization in a mouse model of oxygen-induced retinopathy [<xref ref-type="bibr" rid="CR595">595</xref>] (note that ablation of <italic toggle="yes">Casp8</italic> in endothelial cells is embryonically lethal [<xref ref-type="bibr" rid="CR596">596</xref>]; see Box&#160;<xref rid="Sec20" ref-type="sec">7</xref>). Moreover, CASP8 inhibition could prevent experimental neovascularization of the cornea [<xref ref-type="bibr" rid="CR597">597</xref>]. Finally, TRAIL neutralization protected the retinal tissue from damage associated with AD in a mouse model [<xref ref-type="bibr" rid="CR598">598</xref>].</p><p id="Par92">Experimental models of ischemic stroke and hemorrhage revealed a role of DR signaling in the pathophysiology of brain damage. In models of focal ischemia induced by middle cerebral artery occlusion, <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> as well as <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice (deficient for FAS or FASL, respectively) displayed decreased infarct size and neuroinflammation [<xref ref-type="bibr" rid="CR599">599</xref>&#8211;<xref ref-type="bibr" rid="CR601">601</xref>]. Robust neuroprotection was also observed in <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice subjected to neonatal hypoxia-ischemia [<xref ref-type="bibr" rid="CR602">602</xref>], as well as in <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> and <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice subjected to hyperoxia [<xref ref-type="bibr" rid="CR603">603</xref>]. Accordingly, inhibition of FAS or FASL exerted neuroprotective effects in an experimental murine model of stroke [<xref ref-type="bibr" rid="CR604">604</xref>, <xref ref-type="bibr" rid="CR605">605</xref>]. Likewise, TRAIL neutralization limited brain injury in rats and mice subjected to middle cerebral artery occlusion [<xref ref-type="bibr" rid="CR601">601</xref>, <xref ref-type="bibr" rid="CR606">606</xref>] or transient ischemia-reperfusion [<xref ref-type="bibr" rid="CR607">607</xref>]. Moreover, despite some contention in this respect [<xref ref-type="bibr" rid="CR608">608</xref>&#8211;<xref ref-type="bibr" rid="CR611">611</xref>], abrogation of TNF/TNF-R1 signaling by genetic or pharmacological means prevented brain injury in rodent models of intracerebral hemorrhage [<xref ref-type="bibr" rid="CR612">612</xref>] and focal cerebral ischemia [<xref ref-type="bibr" rid="CR613">613</xref>&#8211;<xref ref-type="bibr" rid="CR621">621</xref>]. Further corroborating a pathogenic role of DR signaling, transgene-driven expression of dominant-negative CASP8 mutant and of FADD-like apoptosis regulator (CFLAR; best known as c-FLIP) attenuated brain damage after middle cerebral artery occlusion [<xref ref-type="bibr" rid="CR622">622</xref>, <xref ref-type="bibr" rid="CR623">623</xref>]. This is in line with the ability of CASP8 to drive BID activation upon focal cerebral ischemia [<xref ref-type="bibr" rid="CR196">196</xref>], as well as with the neuroprotective effects afforded by pharmacological CASP8 inhibitors seen in mice experiencing subarachnoid hemorrhage [<xref ref-type="bibr" rid="CR624">624</xref>] or mice and rats subjected to focal cerebral ischemia [<xref ref-type="bibr" rid="CR625">625</xref>, <xref ref-type="bibr" rid="CR626">626</xref>]. Importantly, FADD and CASP8 expression and/or activation have also been associated with ischemic stroke in humans [<xref ref-type="bibr" rid="CR627">627</xref>, <xref ref-type="bibr" rid="CR628">628</xref>].</p><p id="Par93">Perhaps surprisingly, TNF appears to protect mice against experimental seizures, not only through the engagement of TNF-R2 but also through TNF-R1 signaling [<xref ref-type="bibr" rid="CR611">611</xref>, <xref ref-type="bibr" rid="CR629">629</xref>&#8211;<xref ref-type="bibr" rid="CR634">634</xref>] and consequent modulation of NF-&#954;B [<xref ref-type="bibr" rid="CR635">635</xref>, <xref ref-type="bibr" rid="CR636">636</xref>]. Conversely, <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice [<xref ref-type="bibr" rid="CR637">637</xref>], mice with neuron-specific deletion of the gene encoding TNF-R1 [<xref ref-type="bibr" rid="CR638">638</xref>] as well as mice and rats treated with Z-IETD-FMK [<xref ref-type="bibr" rid="CR585">585</xref>, <xref ref-type="bibr" rid="CR639">639</xref>, <xref ref-type="bibr" rid="CR640">640</xref>] display reduced sensitivity to experimental seizures, pointing to a detrimental role for apoptotic DR signaling in this condition. The precise mechanisms through which TNF-R1 signaling promotes anti-apoptotic and anti-inflammatory effects in the context of excitotoxic insults remain unclear.</p></sec><sec id="Sec22"><title>Cardiovascular disorders</title><p id="Par94">Data from preclinical models of ischemic and non-ischemic conditions indicate the involvement of FASL, TRAIL and TNF in the onset and progression of myocardial infarction with reperfusion and other heart diseases. In particular, both <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice (lacking FAS), as well as hearts isolated from these animals, displayed reduced cardiomyocyte death and infarct area upon experimental ischemia-reperfusion [<xref ref-type="bibr" rid="CR641">641</xref>, <xref ref-type="bibr" rid="CR642">642</xref>]. Nonetheless, no protection against ischemia-reperfusion was found in hearts from <italic toggle="yes">Fas</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> or <italic toggle="yes">Fasl</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice [<xref ref-type="bibr" rid="CR643">643</xref>]. However, supporting the therapeutic potential of the inhibition of DR signaling for the management of myocardial infarction, FASL-neutralizing antibodies conferred cardioprotection, limited inflammation, and improved cardiac function in mice experiencing cardiac ischemia-reperfusion [<xref ref-type="bibr" rid="CR644">644</xref>&#8211;<xref ref-type="bibr" rid="CR646">646</xref>]. Likewise, TRAIL blockade protected monkeys, pigs, and rats against experimental infarction by increasing cardiomyocyte survival and reducing inflammation [<xref ref-type="bibr" rid="CR647">647</xref>]. This is in line with the predictive value of TRAIL levels&#160;as a biomarker for heart failure in patients [<xref ref-type="bibr" rid="CR648">648</xref>, <xref ref-type="bibr" rid="CR649">649</xref>]. Of note, TRAIL has also been reported to exert apoptosis-independent roles in cardiomyocyte growth and heart hypertrophy [<xref ref-type="bibr" rid="CR650">650</xref>], as well as in angiogenesis and neovascularization upon experimental hindlimb ischemia [<xref ref-type="bibr" rid="CR651">651</xref>]. Similar to neurological conditions, while TNF-R2 signaling appears to exert cardioprotective effects, the engagement of TNF-R1 drives cardiac hypertrophy, inflammation and cardiomyocyte loss [<xref ref-type="bibr" rid="CR652">652</xref>&#8211;<xref ref-type="bibr" rid="CR659">659</xref>]. The opposite outcome of TNF-R1 <italic toggle="yes">vs</italic> TNF-R2 signaling has been invoked to explain the clinical failure of TNF blocking agents in patients with chronic heart failure [<xref ref-type="bibr" rid="CR660">660</xref>], despite encouraging preliminary findings [<xref ref-type="bibr" rid="CR661">661</xref>, <xref ref-type="bibr" rid="CR662">662</xref>], as well as the&#160;cardiotoxic effects associated with the use of TNF blockers in patients with rheumatoid arthritis [<xref ref-type="bibr" rid="CR663">663</xref>]. Confirming the involvement of extrinsic apoptosis in cardiac diseases, cardiomyocyte-specific deletion of <italic toggle="yes">Fadd</italic> in mice improved cardiomyocyte survival and heart function after ischemia/reperfusion [<xref ref-type="bibr" rid="CR664">664</xref>]. Accordingly, haploinsufficiency of the gene encoding c-FLIP increased infarct area and aggravated cardiac dysfunction in mice experiencing myocardial infarction, while the cardiomyocyte-specific overexpression of c-FLIP attenuated pathology [<xref ref-type="bibr" rid="CR665">665</xref>, <xref ref-type="bibr" rid="CR666">666</xref>]. Cardioprotection has also&#160;been observed in a mouse model of ischemia/reperfusion upon shRNA-mediated CASP8 depletion [<xref ref-type="bibr" rid="CR667">667</xref>] or treatment with the CASP8 inhibitor Q-LETD-OPh [<xref ref-type="bibr" rid="CR668">668</xref>]. Moreover, transplantation of <italic toggle="yes">Casp8</italic><sup>&#8722;/&#8722;</sup> cells did not increase neovascularization in wild-type mice subjected to hindlimb ischemia [<xref ref-type="bibr" rid="CR669">669</xref>], in line with a crucial role of CASP8 in the maintenance of endothelia in healthy conditions [<xref ref-type="bibr" rid="CR596">596</xref>] (see Box&#160;<xref rid="Sec20" ref-type="sec">7</xref>). That said, combined pharmacological inhibition of apoptosis and necroptosis exerted greater cardioprotection than monotherapy in myocardial ischemia-reperfusion injury [<xref ref-type="bibr" rid="CR670">670</xref>], suggesting the involvement of multiple RCD pathways in cardiovascular disorders.</p><p id="Par95">FASL neutralization has been reported to improve cardiomyocyte survival and cardiac function in a model of cirrhotic cardiomyopathy [<xref ref-type="bibr" rid="CR671">671</xref>]. Conversely, a cardioprotective effect of TRAIL and TNF was observed in mice developing cardiomyopathy upon the deletion of apolipoprotein E (<italic toggle="yes">ApoE</italic>) [<xref ref-type="bibr" rid="CR672">672</xref>] or <italic toggle="yes">Des</italic> [<xref ref-type="bibr" rid="CR673">673</xref>], respectively. Both FASL deficiency and administration of CASP8 inhibitors decrease tissue inflammation and aneurysm formation in mice subjected to CaCl<sub>2</sub>-induced abdominal aortic aneurysms [<xref ref-type="bibr" rid="CR674">674</xref>]. A potential role of extrinsic apoptosis in gradual cardiomyocyte attrition during heart failure with reduced fraction has also been reported in a transgenic mouse model of inducible CASP8 overexpression [<xref ref-type="bibr" rid="CR675">675</xref>]. Concerning TNF receptors, deletion of <italic toggle="yes">Tnfrsf1b</italic> resulted in increased cardiomyocyte death and hypertrophy induced by isoproterenol [<xref ref-type="bibr" rid="CR676">676</xref>]. In contrast, deletion of <italic toggle="yes">Tnfrsf1a</italic> (but not <italic toggle="yes">Tnfrsf1b</italic>) was shown to be cardioprotective in murine models of vascular thrombosis [<xref ref-type="bibr" rid="CR677">677</xref>], and heart failure based on angiotensin II administration [<xref ref-type="bibr" rid="CR678">678</xref>]. Similar cardioprotection in this model has been reported after silencing of <italic toggle="yes">Tnfrsf1a</italic> [<xref ref-type="bibr" rid="CR679">679</xref>]. In line with these findings, <italic toggle="yes">Cflar</italic><sup>+/-</sup> mice (which lack one copy of the gene encoding&#160;c-FLIP) displayed increased sensitivity to cardiac injury upon angiotensin II administration [<xref ref-type="bibr" rid="CR680">680</xref>].</p><p id="Par96">FASL and TNF have also been reported to promote cardiac maladaptation and hypertrophy in models of pressure overload [<xref ref-type="bibr" rid="CR681">681</xref>&#8211;<xref ref-type="bibr" rid="CR685">685</xref>]. Consistent with this notion, TNF inhibition [<xref ref-type="bibr" rid="CR686">686</xref>] or transgenic c-FLIP overexpression [<xref ref-type="bibr" rid="CR687">687</xref>] limited experimental heart hypertrophy driven by hypertension. Moreover, treatment with etanercept reduced cardiac fibrosis in a diet-induced mouse model of obesity [<xref ref-type="bibr" rid="CR688">688</xref>]. Conversely, both FAS and TNF receptor superfamily member 10b (TNFRSF10B, best known as TRAIL-R2 or mTRAIL-R) were reported to protect mice against atherosclerosis, at least in part by modulating TNF superfamily member 11 (TNFSF11, best known as RANKL) signaling [<xref ref-type="bibr" rid="CR689">689</xref>&#8211;<xref ref-type="bibr" rid="CR693">693</xref>], while the impact of TNF on experimental atherosclerosis remains a matter of debate [<xref ref-type="bibr" rid="CR694">694</xref>&#8211;<xref ref-type="bibr" rid="CR697">697</xref>]. Finally, pharmacological inhibition of TNF prevented cardiotoxicity induced by doxorubicin in mice [<xref ref-type="bibr" rid="CR698">698</xref>&#8211;<xref ref-type="bibr" rid="CR700">700</xref>]</p></sec><sec id="Sec23"><title>Renal conditions</title><p id="Par97">FASL, TNF and TRAIL have all been implicated in the development of acute kidney injury by driving the activation of both extrinsic apoptosis and inflammation. Loss-of-function mutations in <italic toggle="yes">Fasl</italic>, inhibition or depletion of FASL [<xref ref-type="bibr" rid="CR701">701</xref>&#8211;<xref ref-type="bibr" rid="CR703">703</xref>] as well as <italic toggle="yes">Fas</italic> [<xref ref-type="bibr" rid="CR704">704</xref>] or <italic toggle="yes">Tnf</italic> [<xref ref-type="bibr" rid="CR705">705</xref>] silencing, TNF neutralization [<xref ref-type="bibr" rid="CR706">706</xref>, <xref ref-type="bibr" rid="CR707">707</xref>], or TRAIL blockade [<xref ref-type="bibr" rid="CR708">708</xref>] exerted nephron-protective effects in mouse models of renal ischemia/reperfusion. Generation of chimeric mice reconstituted with spleen cells from <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice (lacking FASL) revealed a particular impact of FASL signaling in the hematopoietic compartment on ischemic acute kidney injury [<xref ref-type="bibr" rid="CR702">702</xref>]. However, some functional overlap between DRs has also been reported. Indeed, while one study suggested that FASL neutralization was more effective than <italic toggle="yes">Tnfrsf1a</italic> deletion (leading to lack of TNF-R1) in preventing renal inflammation and cell death after acute kidney injury [<xref ref-type="bibr" rid="CR701">701</xref>], another study reported that the neutralization of TNF but not FASL prevented tubular apoptosis and renal atrophy upon ischemia/reperfusion injury [<xref ref-type="bibr" rid="CR706">706</xref>].</p><p id="Par98">TRAIL blockade reportedly protects mice against renal damage after full-thickness scald burn, burn of all layers of the skin including epidermis and dermis [<xref ref-type="bibr" rid="CR709">709</xref>], while TNF inhibition limited nephrotoxicity in mice treated with cisplatin [<xref ref-type="bibr" rid="CR710">710</xref>], and acute tubulointerstitial nephritis in cancer patients administered with immune checkpoint inhibitors [<xref ref-type="bibr" rid="CR711">711</xref>]. TNF neutralization also reduces tubulointerstitial fibrosis and renal injury in a mouse model of unilateral urethral obstruction [<xref ref-type="bibr" rid="CR712">712</xref>, <xref ref-type="bibr" rid="CR713">713</xref>]. Contesting these findings, <italic toggle="yes">Tnf</italic><sup>&#8722;/&#8722;</sup> mice showed increased fibrosis at later stages of ureteral obstruction [<xref ref-type="bibr" rid="CR714">714</xref>]. This apparent discrepancy may reflect the distinct contribution of TNF-R1 and TNF-R2 signaling to different stages of renal fibrosis driven by urethral obstruction [<xref ref-type="bibr" rid="CR715">715</xref>]. Conversely, experiments with <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice subjected to unilateral urethral ligation demonstrated a limited impact of FAS signaling to pathology [<xref ref-type="bibr" rid="CR716">716</xref>]. The involvement of CASP8 in acute kidney injury is debated. While <italic toggle="yes">Casp8</italic> and <italic toggle="yes">Casp3</italic> deletion&#160;protected kidneys against damage induced by renal ischemia, increasing the survival of these mice [<xref ref-type="bibr" rid="CR704">704</xref>, <xref ref-type="bibr" rid="CR717">717</xref>], such a nephroprotective effect was not observed after treatment with the broad-spectrum caspase inhibitor Z-VAD-FMK [<xref ref-type="bibr" rid="CR718">718</xref>], potentially due to caspase inhibition promoting necroptosis after DR stimulation. In line with this notion, chemical inhibitors of receptor-interacting serine/threonine kinase 1 (RIPK1) as well as deletion of <italic toggle="yes">Ripk3</italic> exerted robust nephroprotection in mouse models of ischemia/reperfusion [<xref ref-type="bibr" rid="CR718">718</xref>, <xref ref-type="bibr" rid="CR719">719</xref>]. However, combined deletion of <italic toggle="yes">Casp8</italic> and <italic toggle="yes">Ripk3</italic> did not extend the beneficial effects of the genetic loss of <italic toggle="yes">Ripk3</italic> and was associated with a more pronounced demise of tubular epithelial cells by intrinsic apoptosis [<xref ref-type="bibr" rid="CR720">720</xref>].</p><p id="Par99">DR activation has also been associated with chronic kidney disorders, but evidence involving CASP8-mediated apoptotic death is lacking. The conditional deletion of <italic toggle="yes">Tnf</italic> from macrophages [<xref ref-type="bibr" rid="CR721">721</xref>], as well as the administration of TNF inhibitors [<xref ref-type="bibr" rid="CR721">721</xref>&#8211;<xref ref-type="bibr" rid="CR724">724</xref>], were reported to mediate beneficial effects in murine models of diabetic nephropathy. Conversely, the impact of TRAIL on this renal condition remains unclear [<xref ref-type="bibr" rid="CR725">725</xref>&#8211;<xref ref-type="bibr" rid="CR727">727</xref>], like that of TNF on polycystic kidney disease [<xref ref-type="bibr" rid="CR728">728</xref>, <xref ref-type="bibr" rid="CR729">729</xref>]. As for glomerular inflammation, <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice (lacking FASL), as well as wild-type mice treated with TNF blockers, displayed reduced tissue damage during crescentic glomerulonephritis [<xref ref-type="bibr" rid="CR730">730</xref>&#8211;<xref ref-type="bibr" rid="CR733">733</xref>]. Indeed, balanced TNF-R1 and TNF-R2 signaling appeared to be critical for mice to resist experimentally induced glomerulonephritis [<xref ref-type="bibr" rid="CR734">734</xref>&#8211;<xref ref-type="bibr" rid="CR739">739</xref>]. This may explain apparently discrepant findings obtained with TNF-targeting measures.</p></sec><sec id="Sec24"><title>Hepatic disorders</title><p id="Par100">TNF-deficient mice, as well as rodents treated with TNF inhibitors, present with attenuated liver injury and apoptosis upon experimental ischemia/reperfusion, resulting in improved survival [<xref ref-type="bibr" rid="CR740">740</xref>&#8211;<xref ref-type="bibr" rid="CR742">742</xref>]. Of note, this beneficial effect cannot always be recapitulated in <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> and <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice, lacking FAS or FASL, respectively [<xref ref-type="bibr" rid="CR742">742</xref>]. Similarly, FAS inhibition, FASL neutralization, as well as administration of low-dose TNF (as a pre-conditioning maneuver) have been shown to protect the liver against ischemia/reperfusion injury by reducing hepatic cell apoptosis and/or inflammation [<xref ref-type="bibr" rid="CR743">743</xref>&#8211;<xref ref-type="bibr" rid="CR745">745</xref>]. Protection of the liver from ischemia/reperfusion has also been observed in mice deficient for TRAIL [<xref ref-type="bibr" rid="CR746">746</xref>], as well as upon the conditional knockdown of CASP8 or CASP3, the combined deletion of <italic toggle="yes">Casp8</italic> and <italic toggle="yes">Ripk3</italic>, and the transgenic expression of a BID mutant that cannot be cleaved by CASP8 [<xref ref-type="bibr" rid="CR283">283</xref>, <xref ref-type="bibr" rid="CR747">747</xref>, <xref ref-type="bibr" rid="CR748">748</xref>].</p><p id="Par101"><italic toggle="yes">Lpr</italic>/<italic toggle="yes">lpr</italic> mice [<xref ref-type="bibr" rid="CR749">749</xref>], <italic toggle="yes">Tnfsf10</italic><sup>&#8722;/&#8722;</sup> mice (which lack TRAIL) [<xref ref-type="bibr" rid="CR286">286</xref>], as well as animals exposed to TRAIL blockers [<xref ref-type="bibr" rid="CR750">750</xref>], were protected against acetaminophen-induced liver damage, in line with the notion that FAS signaling and TRAIL receptor exacerbate acetaminophen hepatotoxicity [<xref ref-type="bibr" rid="CR751">751</xref>]. Along similar lines, the hepatocyte-specific deletion of the gene encoding c-FLIP enhances liver injury and fibrosis induced by treatment with CCl<sub>4</sub> or thioacetamide [<xref ref-type="bibr" rid="CR752">752</xref>]. Moreover, a large body of evidence demonstrates that the abrogation of extrinsic apoptosis protects mice against fulminant hepatitis and hemorrhage in the liver induced by FASL and TNF. This has been achieved with strategies including (but not limited to) FADD blockade [<xref ref-type="bibr" rid="CR753">753</xref>, <xref ref-type="bibr" rid="CR754">754</xref>], <italic toggle="yes">Casp8</italic> [<xref ref-type="bibr" rid="CR596">596</xref>, <xref ref-type="bibr" rid="CR755">755</xref>, <xref ref-type="bibr" rid="CR756">756</xref>] or <italic toggle="yes">Fadd</italic> [<xref ref-type="bibr" rid="CR757">757</xref>] ablation, and <italic toggle="yes">Casp8</italic> silencing [<xref ref-type="bibr" rid="CR758">758</xref>]. Accordingly, hepatocyte-specific deletion of <italic toggle="yes">Cflar</italic> augments liver damage in mouse model of acute hepatic injury [<xref ref-type="bibr" rid="CR759">759</xref>]. Consistent with the notion that engagement of the intrinsic apoptotic pathway is critical for DR induced cell killing in the liver, <italic toggle="yes">Bid</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice resist fatal hepatitis induced by FAS or TNF [<xref ref-type="bibr" rid="CR278">278</xref>, <xref ref-type="bibr" rid="CR282">282</xref>, <xref ref-type="bibr" rid="CR760">760</xref>, <xref ref-type="bibr" rid="CR761">761</xref>], a protection that is&#160;enhanced by the&#160;concomitant loss of BIM or CASP8 [<xref ref-type="bibr" rid="CR282">282</xref>]. Conditional deletion of the genes encoding BAX, BAK1 or PUMA, as well as overexpression of BCL2, can also protect hepatocytes from FAS-induced killing [<xref ref-type="bibr" rid="CR762">762</xref>&#8211;<xref ref-type="bibr" rid="CR765">765</xref>]. The impact of loss of BAD on TNF-induced hepatitis is controversial [<xref ref-type="bibr" rid="CR766">766</xref>, <xref ref-type="bibr" rid="CR767">767</xref>]. Mice deficient for CASP3 or treated with CASP3 or CASP8 inhibitors have also been shown to be less sensitive to FAS-induced hepatocyte apoptosis [<xref ref-type="bibr" rid="CR768">768</xref>, <xref ref-type="bibr" rid="CR769">769</xref>]. Of note, some degree of functional compensation between caspases and alternative mechanisms of caspase activation have emerged from studies in hepatocytes responding to FAS agonists [<xref ref-type="bibr" rid="CR770">770</xref>]. Finally, FAS and TNF-R1 signaling, as well as FADD activation, are involved in liver regeneration following partial hepatectomy [<xref ref-type="bibr" rid="CR771">771</xref>&#8211;<xref ref-type="bibr" rid="CR775">775</xref>]. In this context, the&#160;liver-specific deletion of <italic toggle="yes">Casp8</italic> resulted in dysregulated hepatocyte proliferation upon partial hepatectomy coupled to the initiation of an inflammatory response [<xref ref-type="bibr" rid="CR776">776</xref>]. It has been suggested that CASP8 modulates liver regeneration by balancing NF-&#954;B activation and necroptosis rather than by inducing apoptosis [<xref ref-type="bibr" rid="CR777">777</xref>].</p><p id="Par102"><italic toggle="yes">Gld</italic>/<italic toggle="yes">gld</italic> mice (lacking FASL) chronically fed with ethanol display reduced liver injury, steatosis and inflammation as compared to wild-type mice, but exhibit signs of incipient fibrosis [<xref ref-type="bibr" rid="CR778">778</xref>]. Some degree of protection against alcohol-induced liver damage has also been documented in mice deficient for the apoptosis-inducing TRAIL receptor mTRAIL-R [<xref ref-type="bibr" rid="CR779">779</xref>] or TNF-R1 (but not TNF-R2) [<xref ref-type="bibr" rid="CR780">780</xref>], as well as in mice receiving a TRAIL-neutralizing antibody [<xref ref-type="bibr" rid="CR781">781</xref>]. Accordingly, the hepatocyte-specific ablation of <italic toggle="yes">Casp8</italic> limited hepatic steatosis in murine models of ethanol administration, although it failed to prevent apoptotic RCD [<xref ref-type="bibr" rid="CR782">782</xref>]. Conversely, apoptosis driven in hepatocytes by chronic ethanol exposure could be abolished by systemic inhibition of CASP3 with Ac-DEVD-FMK [<xref ref-type="bibr" rid="CR783">783</xref>].</p><p id="Par103">The liver-restricted overexpression of FAS induces hepatic steatosis and insulin resistance in mice subjected to a high-fat diet (HFD) [<xref ref-type="bibr" rid="CR784">784</xref>]. In the same experimental setting, hepatoprotection was observed with the hepatocyte-specific ablation of <italic toggle="yes">Fas</italic> or germline deletion of <italic toggle="yes">Bid</italic> [<xref ref-type="bibr" rid="CR784">784</xref>]. Moreover, <italic toggle="yes">Tnf</italic> deletion [<xref ref-type="bibr" rid="CR785">785</xref>, <xref ref-type="bibr" rid="CR786">786</xref>], whole-body deletion of <italic toggle="yes">Tnfrsf1a</italic> (encoding TNF-R1) alone or in combination with the gene encoding TNF-R2 [<xref ref-type="bibr" rid="CR787">787</xref>, <xref ref-type="bibr" rid="CR788">788</xref>] as well as inhibition of TNF [<xref ref-type="bibr" rid="CR789">789</xref>&#8211;<xref ref-type="bibr" rid="CR791">791</xref>] or TNF-R1 [<xref ref-type="bibr" rid="CR792">792</xref>] significantly reduced hepatic steatosis, fibrosis, damage, and metabolic alterations in several diet-induced or genetic models of non-alcoholic fatty liver disease (NAFLD). In apparent contrast with these findings, the hepatocyte-specific deletion of <italic toggle="yes">Tnfrsf1a</italic> failed to protect mice from diet-driven NASH [<xref ref-type="bibr" rid="CR793">793</xref>]. Moreover, <italic toggle="yes">Tnfrsf1a</italic> deletion accelerated the&#160;progression of steatosis to steatohepatitis in mice on&#160;a HFD [<xref ref-type="bibr" rid="CR794">794</xref>]. Taken together, these findings underscore the pleiotropic and context-dependent effects of TNF/TNF-R signaling in NAFLD. The impact of TRAIL on NAFLD is also debated. Indeed, contrasting evidence from experiments with mice deficient for TRAIL or treated with recombinant TRAIL suggests either a detrimental or a beneficial role to TRAIL in NAFLD induced by HFD [<xref ref-type="bibr" rid="CR795">795</xref>&#8211;<xref ref-type="bibr" rid="CR797">797</xref>].</p><p id="Par104">The absence of mTRAIL-R promoted hepatic inflammation and fibrosis in a genetic mouse model of cholestasis [<xref ref-type="bibr" rid="CR798">798</xref>]. Similarly, <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice lacking FAS [<xref ref-type="bibr" rid="CR799">799</xref>&#8211;<xref ref-type="bibr" rid="CR801">801</xref>] as well as TNF-deficient [<xref ref-type="bibr" rid="CR802">802</xref>, <xref ref-type="bibr" rid="CR803">803</xref>] and TRAIL-deficient [<xref ref-type="bibr" rid="CR804">804</xref>, <xref ref-type="bibr" rid="CR805">805</xref>] mice displayed reduced hepatocyte apoptosis and fibrogenesis after experimental cholestasis induced by bile duct ligation. In line with these results, expression of a phosphorylated FADD mimicking mutant attenuated HFD-induced hepatomegaly and steatosis [<xref ref-type="bibr" rid="CR806">806</xref>]. Experiments based on the hepatocyte-specific deletion of <italic toggle="yes">Cflar</italic> (encoding c-FLIP) or transgenic overexpression of c-FLIP revealed a role for this modulator of CASP8 activation as a suppressor of hepatic steatosis and inflammation induced by HFD [<xref ref-type="bibr" rid="CR807">807</xref>]. Moreover, the hepatocyte-specific deletion of <italic toggle="yes">Cflar</italic> in mice resulted in enhanced cholestatic liver injury and inflammatory responses upon bile duct ligation [<xref ref-type="bibr" rid="CR808">808</xref>]. Similarly, the hepatocyte-specific deletion of <italic toggle="yes">Casp8</italic> protected mice against liver injury in models of cholestatic hepatitis caused by the administration of 3,5-diethoxycarbonyl-1,4-dihydrocollidine [<xref ref-type="bibr" rid="CR809">809</xref>], as well as in models of steatosis caused by the feeding of a methionine- and choline-deficient diet [<xref ref-type="bibr" rid="CR810">810</xref>]. A comparable hepatoprotection against obstructive cholestasis has been documented in mice with hepatocyte-specific <italic toggle="yes">Casp8</italic> deletion [<xref ref-type="bibr" rid="CR811">811</xref>]. Furthermore, liver parenchymal cell-specific ablation of the gene encoding FADD prevented RIPK1-dependent but not TNF-R1-, FAS-, and TRAIL-R-dependent hepatocyte apoptosis, chronic liver inflammation and hepato-carcinogenesis in mice with liver-specific deficiency in inhibitor of kappaB kinase gamma (IKBKG, best known as NEMO or IKKgamma) [<xref ref-type="bibr" rid="CR812">812</xref>, <xref ref-type="bibr" rid="CR813">813</xref>]. Finally, decreased BID cleavage has been associated with attenuated liver injury in mouse models of chronic cholestasis [<xref ref-type="bibr" rid="CR814">814</xref>].</p></sec><sec id="Sec25"><title>Hematologic malignancies and solid cancers</title><p id="Par105">Human patients with autoimmune lymphoproliferative syndrome (ALPS) caused by defects in FAS are known to show abnormally increased predisposition to lymphoma development [<xref ref-type="bibr" rid="CR815">815</xref>]. Accordingly, FAS-deficient <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> mice develop a&#160;plasmacytoma-like disease in advanced age [<xref ref-type="bibr" rid="CR816">816</xref>]. TRAIL also seems to exert a tumor suppressive function in lymphomagenesis. The ablation of the gene encoding mTRAIL-R accelerated the development of lymphoma in <italic toggle="yes">E&#956;-Myc</italic> transgenic mice [<xref ref-type="bibr" rid="CR817">817</xref>]. Moreover, deficiency in TRAIL (but not in mTRAIL-R) promoted the development of lymphoma and other tumors in mice with haploinsufficiency for <italic toggle="yes">Trp53</italic> [<xref ref-type="bibr" rid="CR818">818</xref>, <xref ref-type="bibr" rid="CR819">819</xref>]. Interestingly, mice engineered to express exclusively either membrane-bound or secreted FASL showed an increased incidence of spontaneous tumor formation when expressing only soluble FASL, which is unable to induce FAS-mediated apoptosis but may exert pro-inflammatory effects [<xref ref-type="bibr" rid="CR820">820</xref>].</p><p id="Par106">The role of FAS and TRAIL-R in the development of colorectal cancer is controversial. For instance, the loss of FAS was reported to enhance <italic toggle="yes">Apc</italic>&#160;mutation-induced but not inflammation-induced intestinal tumorigenesis [<xref ref-type="bibr" rid="CR821">821</xref>&#8211;<xref ref-type="bibr" rid="CR823">823</xref>]. Along similar lines, while the ablation of <italic toggle="yes">Tnfrsf10b</italic> (leading to lack of mTRAIL-R) in mice did not impact tumorigenesis induced by <italic toggle="yes">Apc</italic> mutations [<xref ref-type="bibr" rid="CR819">819</xref>], the administration of TRAIL suppressed tumorigenesis in a mouse model of colitis-associated colon cancer [<xref ref-type="bibr" rid="CR824">824</xref>]. Despite some contention in this respect [<xref ref-type="bibr" rid="CR825">825</xref>&#8211;<xref ref-type="bibr" rid="CR828">828</xref>], TNF seems to contribute to the development of colorectal cancer, although whether such effects depend on the apoptotic function of TNF needs to be formally established. The administration of TNF blockers [<xref ref-type="bibr" rid="CR829">829</xref>&#8211;<xref ref-type="bibr" rid="CR833">833</xref>] or ablation of <italic toggle="yes">Tnf</italic> [<xref ref-type="bibr" rid="CR834">834</xref>] or <italic toggle="yes">Tnfrsf1a</italic> [<xref ref-type="bibr" rid="CR834">834</xref>, <xref ref-type="bibr" rid="CR835">835</xref>] limits colorectal oncogenesis, as shown in animal models of colorectal cancer induced by colitis, chemicals, or mutations in <italic toggle="yes">Apc</italic>. Finally, loss of the dependence receptor DCC netrin 1 receptor (<italic toggle="yes">Dcc</italic>) accelerates cancer progression in a mouse model of <italic toggle="yes">Apc</italic> mutation-driven colorectal oncogenesis [<xref ref-type="bibr" rid="CR836">836</xref>]. A tumor suppressor role in colorectal cancer has also been described for the dependence neurotrophic tyrosine kinase, receptor, type 3 (NTRK3, best known as TRKC) [<xref ref-type="bibr" rid="CR837">837</xref>]. Of note, the association between gain of dependence receptors ligands (e.g., NTN1) with tumor progression [<xref ref-type="bibr" rid="CR838">838</xref>], may make their targeting a promising anti-cancer approach [<xref ref-type="bibr" rid="CR839">839</xref>].</p><p id="Par107">With regard to other tumor types, both TNF-R1 and FAS display a pro-oncogenic role in hepatic and ovarian oncogenesis. Specifically, conditional deletion of <italic toggle="yes">Fas</italic> in hepatocytes delays carcinogen-driven hepatocarcinogenesis, while <italic toggle="yes">Fas</italic> ablation suppresses the development of ovarian tumors in phosphatase and tensin homolog (PTEN)-deficient&#160;mice bearing mutant&#160;Kirsten rat sarcoma viral oncogene (<italic toggle="yes">Kras</italic>) [<xref ref-type="bibr" rid="CR840">840</xref>]. Likewise, TNF neutralization limits the onset of hepatic cancer driven by experimentally induced cholestatic hepatitis [<xref ref-type="bibr" rid="CR841">841</xref>]. Consistent with these findings, <italic toggle="yes">Casp8</italic><sup>&#8722;/&#8722;</sup> mice are protected against the development of inflammation-driven liver cancer [<xref ref-type="bibr" rid="CR755">755</xref>]. Hyperactivation of CASP8 in the context of RIPK1 and TNF receptor-associated factor 2 (TRAF2) deficiency has indeed&#160;been implicated in the development of hepatocellular carcinoma [<xref ref-type="bibr" rid="CR842">842</xref>], although such effects may be independent of apoptosis induction [<xref ref-type="bibr" rid="CR843">843</xref>, <xref ref-type="bibr" rid="CR844">844</xref>]. In contrast, recent studies show a tumor-suppressive function of CASP8 in the liver and certain other tissues [<xref ref-type="bibr" rid="CR845">845</xref>&#8211;<xref ref-type="bibr" rid="CR848">848</xref>]. In particular, there is evidence of a role of CAPS8 in early tumorigenesis (but not tumor progression) exerted by modulating the DNA damage response [<xref ref-type="bibr" rid="CR845">845</xref>] or the level of chromosomal instability (CIN) [<xref ref-type="bibr" rid="CR846">846</xref>].</p><p id="Par108">Consistent with a pro-tumorigenic effect of TNF, the ablation of <italic toggle="yes">Tnf</italic> or <italic toggle="yes">Tnfrsf1a</italic> or the blockade of TNF in mice conferred protection against carcinogen-induced skin oncogenesis [<xref ref-type="bibr" rid="CR849">849</xref>&#8211;<xref ref-type="bibr" rid="CR854">854</xref>]. In contrast, the impact of genetic and pharmacological inhibition of TNF in UVB-induced skin cancer is debated [<xref ref-type="bibr" rid="CR855">855</xref>, <xref ref-type="bibr" rid="CR856">856</xref>]. Of note, the comparison between TNF-R1- <italic toggle="yes">vs</italic>. TNF-R2-deficient mice revealed a primary role of TNF-R1 in chemically induced skin oncogenesis [<xref ref-type="bibr" rid="CR851">851</xref>]. Furthermore, TNF-R1 deficiency suppresses the development of skin cancer induced by NF-&#954;B inhibition [<xref ref-type="bibr" rid="CR857">857</xref>]. A similar role for TNF-R1 in supporting tumorigenesis was described in murine models of N-methyl-N-nitrosourea(NMU)/testosterone-induced prostate cancer [<xref ref-type="bibr" rid="CR858">858</xref>] and methylcholanthrene (MCA)-induced fibrosarcoma [<xref ref-type="bibr" rid="CR859">859</xref>]. As opposed to TNF-R1, TNF-R2 shows tumor-suppressive functions in mouse models of tumorigenesis, such as the development of fibrosarcoma triggered by MCA [<xref ref-type="bibr" rid="CR859">859</xref>], and mammary oncogenesis induced by transgenic expression of wingless-type MMTV integration site family, member 1 (<italic toggle="yes">Wnt1</italic>) [<xref ref-type="bibr" rid="CR860">860</xref>]. Moreover, the absence of TNF impairs tumor growth in HER2-driven mammary tumorigenesis in mice [<xref ref-type="bibr" rid="CR861">861</xref>], and TNF neutralization suppresses chemically&#160;induced oral [<xref ref-type="bibr" rid="CR862">862</xref>] and pulmonary [<xref ref-type="bibr" rid="CR863">863</xref>] tumorigenesis. Conversely, TNF overexpression in the airway epithelium enhanced mutant <italic toggle="yes">Kras</italic>-driven lung oncogenesis [<xref ref-type="bibr" rid="CR864">864</xref>].</p><p id="Par109">Pre-clinical evidence points to some tumor type-specificity for the role of TRAIL and its receptor(s) in tumorigenesis. Transgenic expression of TRAIL in the skin delays chemically induced carcinogenesis [<xref ref-type="bibr" rid="CR865">865</xref>]. This effect can be recapitulated in mice lacking TRADD [<xref ref-type="bibr" rid="CR866">866</xref>] but, curiously, not in mTRAIL-R-deficient mice [<xref ref-type="bibr" rid="CR867">867</xref>], with the latter actually showing enhanced lymph node involvement. In support of an anti-tumor function for the TRAIL/TRAIL-R system, TRAIL-deficient mice as well as mice treated with TRAIL blockers displayed increased susceptibility to MCA-induced fibrosarcoma [<xref ref-type="bibr" rid="CR868">868</xref>, <xref ref-type="bibr" rid="CR869">869</xref>]. In a recent study, administration of recombinant TRAIL coupled to inhibition of cyclin-dependent kinase 9 (CDK9) was effective in a wide range of cancers [<xref ref-type="bibr" rid="CR870">870</xref>]. Yet in contrast to this and in support of a tumor-supportive role of endogenous TRAIL, deficiency in mTRAIL-R limits tumor growth and improves survival in mouse models of mutant <italic toggle="yes">Kras</italic>-driven lung and pancreatic tumorigenesis [<xref ref-type="bibr" rid="CR871">871</xref>]. Moreover, malignant cell-specific ablation of genes encoding mTRAIL-R or FADD reduced lung cancer growth and tumor-promoting inflammation [<xref ref-type="bibr" rid="CR872">872</xref>], while systemic ablation of <italic toggle="yes">Tnfsf10</italic> (leading to lack of TRAIL) had no impact on HER2-driven mammary oncogenesis [<xref ref-type="bibr" rid="CR818">818</xref>]. Interestingly, <italic toggle="yes">KRAS</italic> mutations have been shown to promote the switch of FAS and TRAIL receptors from a predominantly death-inducing into a metastasis promoting function [<xref ref-type="bibr" rid="CR873">873</xref>]. Since TRAIL as well as FASL can trigger either apoptosis, necroptosis, inflammation or pro-invasive signaling, cancer-specific preferences for one or the other of these outputs are&#160;likely accounts for the apparently discrepant effects observed in various cancer models.</p></sec><sec id="Sec26"><title>Autoimmune and inflammatory diseases</title><p id="Par110">The interpretation of results on the impact of extrinsic apoptosis in the etiology of autoimmune and inflammatory disease should consider the fact that DR engagement can also result in the initiation of an inflammatory response not related to RCD (<italic toggle="yes">see</italic> Box&#160;<xref rid="Sec19" ref-type="sec">6</xref> and Box&#160;<xref rid="Sec20" ref-type="sec">7</xref>), meaning that DR deregulation may lead to inflammatory diseases independently of the induction of extrinsic apoptosis. The notion that defects in DR signaling can cause autoimmune disease is supported by the observation that <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> as well as <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mutant mice, deficient for FAS or FASL, respectively, as well as humans with defects in FAS develop&#160;an SLE-like autoimmune disease accompanied by lymphadenopathy, splenomegaly and hepatomegaly [<xref ref-type="bibr" rid="CR874">874</xref>, <xref ref-type="bibr" rid="CR875">875</xref>]. A critical role for loss of CASP8-mediated apoptosis in this disease was demonstrated by the observation that a&#160;similar condition is seen in mice lacking <italic toggle="yes">Casp8</italic> and also <italic toggle="yes">Ripk3</italic> or <italic toggle="yes">Mlkl</italic> (to prevent necroptosis) [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR876">876</xref>]. However, the roles of DRs in autoimmune disease are complex. TRAIL/TRAIL-R signaling was reported to protect mice and rats against autoimmune encephalomyelitis [<xref ref-type="bibr" rid="CR877">877</xref>&#8211;<xref ref-type="bibr" rid="CR882">882</xref>], autoimmune arthritis [<xref ref-type="bibr" rid="CR883">883</xref>&#8211;<xref ref-type="bibr" rid="CR887">887</xref>] and type I diabetes [<xref ref-type="bibr" rid="CR690">690</xref>, <xref ref-type="bibr" rid="CR883">883</xref>, <xref ref-type="bibr" rid="CR888">888</xref>&#8211;<xref ref-type="bibr" rid="CR891">891</xref>]. Perhaps surprisingly, the presence of FAS and TNF-R1 is associated with the development of certain autoimmune conditions. Indeed, both <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> lacking FAS and <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice lacking FASL, as well as TNF-R1-deficient mice, appear to be protected against experimental encephalomyelitis [<xref ref-type="bibr" rid="CR892">892</xref>&#8211;<xref ref-type="bibr" rid="CR895">895</xref>]. Similar results were obtained in mice with <italic toggle="yes">Tnf</italic> deletion in monocytes and macrophages, but not in mice lacking TNF in microglial cells [<xref ref-type="bibr" rid="CR896">896</xref>]. Protection against experimentally induced autoimmune conditions were also found in mice subjected to neutralization of TNF or TNF-R1 inhibition [<xref ref-type="bibr" rid="CR897">897</xref>&#8211;<xref ref-type="bibr" rid="CR904">904</xref>]. FAS-independent mechanisms also appear to support the pathogenesis of experimental autoimmune encephalomyelitis [<xref ref-type="bibr" rid="CR892">892</xref>, <xref ref-type="bibr" rid="CR905">905</xref>], with some studies pointing to a protective role for FAS-induced RCD amongst lymphocytes in this disease model [<xref ref-type="bibr" rid="CR906">906</xref>]. Moreover, FAS engagement was reported to differentially contribute to the initiation <italic toggle="yes">vs</italic>. the recovery from autoimmune encephalomyelitis [<xref ref-type="bibr" rid="CR907">907</xref>, <xref ref-type="bibr" rid="CR908">908</xref>]. In particular, FASL expression in astrocytes appears to promote recovery from experimental autoimmune encephalomyelitis, as shown by persisting demyelination and paralysis of mice with an astrocyte restricted deletion of <italic toggle="yes">Fasl</italic> [<xref ref-type="bibr" rid="CR907">907</xref>]. Finally, at least in some studies, <italic toggle="yes">Tnf</italic> deletion or TNF neutralization failed to attenuate the severity of autoimmune encephalomyelitis once the disease was established [<xref ref-type="bibr" rid="CR909">909</xref>, <xref ref-type="bibr" rid="CR910">910</xref>].</p><p id="Par111">Mice with defects in FASL or TNF signaling are protected against arthritis induced by immunization with xenogeneic type II collagen in complete Freund&#8217;s adjuvant [<xref ref-type="bibr" rid="CR911">911</xref>&#8211;<xref ref-type="bibr" rid="CR914">914</xref>]. Similar protection was observed in mice transplanted with mesenchymal stem cells engineered to express TNF inhibitors [<xref ref-type="bibr" rid="CR915">915</xref>]. In keeping with this evidence, the myeloid cell specific deletion of <italic toggle="yes">Fas</italic> or the administration of antibodies that target both TNF and chemokine (C-X-C motif) ligand 10 (CXCL10) resulted in accelerated disease resolution in a model of rheumatoid arthritis induced by K/BxN serum transfer [<xref ref-type="bibr" rid="CR916">916</xref>, <xref ref-type="bibr" rid="CR917">917</xref>]. Genetic loss of <italic toggle="yes">Fas</italic> or pharmacological inhibition of FAS conferred protection against autoimmune diabetes in specific animal models, including NOD mice [<xref ref-type="bibr" rid="CR918">918</xref>&#8211;<xref ref-type="bibr" rid="CR923">923</xref>]. However, whether the impact of FAS on the pathogenesis of autoimmune diabetes depends on its role in the death of pancreatic &#946;-cell [<xref ref-type="bibr" rid="CR918">918</xref>] or its role in inflammation (e.g., in the context of insulitis) remains a matter of debate [<xref ref-type="bibr" rid="CR921">921</xref>]. Other studies found no role for FAS in diabetes [<xref ref-type="bibr" rid="CR924">924</xref>&#8211;<xref ref-type="bibr" rid="CR926">926</xref>]. TNF neutralization is effective only in a limited sub-group of patients with inflammatory bowel disease [<xref ref-type="bibr" rid="CR927">927</xref>, <xref ref-type="bibr" rid="CR928">928</xref>]. This is in line with the finding that deletion of the gene encoding TNF-R1 exacerbated colitis in IL10-deficient mice [<xref ref-type="bibr" rid="CR929">929</xref>]. A similar protection was ascribed to TRAIL/TRAIL-R signaling in a dextran sodium sulfate-induced model of colitis [<xref ref-type="bibr" rid="CR930">930</xref>, <xref ref-type="bibr" rid="CR931">931</xref>]. Finally, it has been suggested that FASL and TNF signaling contribute to the pathogenesis of acute pancreatitis [<xref ref-type="bibr" rid="CR932">932</xref>, <xref ref-type="bibr" rid="CR933">933</xref>]. A similar detrimental role has been proposed for TNF in autoimmune neuritis [<xref ref-type="bibr" rid="CR934">934</xref>&#8211;<xref ref-type="bibr" rid="CR936">936</xref>], although there is also some contention [<xref ref-type="bibr" rid="CR937">937</xref>], as well as in spondylarthritis [<xref ref-type="bibr" rid="CR938">938</xref>] and psoriasis [<xref ref-type="bibr" rid="CR939">939</xref>]. Conversely, mTRAIL-R appears to mediate beneficial effects in autoimmune thyroiditis [<xref ref-type="bibr" rid="CR940">940</xref>&#8211;<xref ref-type="bibr" rid="CR944">944</xref>] At least in part, these findings reflect the pleiotropic effects of whole-body inhibition of DRs signaling, which concomitantly impacts both the target (i.e., parenchymal) and the perpetrator (i.e., immune cells) of damage.</p><p id="Par112">Some experimental evidence links CASP8 activation to autoimmune and inflammatory disorders. In a recent study using a chemically-induced model of intestinal inflammation, the selective absence of CASP8 in intestinal epithelial cells decreased their survival, also resulting in gut barrier dysfunction and chronic inflammation [<xref ref-type="bibr" rid="CR945">945</xref>]. Of note, in this setting, inflammation can occur via a mechanism independent of the induction of necroptosis (which is inhibited by CASP8) and involving the activation of RIPK1 and RNA sensor RIG-I (RIGI; best known as RIG-I) [<xref ref-type="bibr" rid="CR946">946</xref>, <xref ref-type="bibr" rid="CR947">947</xref>]. Along similar lines, chronic proliferative dermatitis in mice deficient for components of the linear ubiquitin chain assembly complex (LUBAC) has been associated with an increased keratinocyte apoptosis mediated by the engagement of TNF-R1 and the activation of the RIPK1- and/or FADD-CASP8 cascade [<xref ref-type="bibr" rid="CR948">948</xref>&#8211;<xref ref-type="bibr" rid="CR952">952</xref>]. Importantly, in this mouse model of an inflammatory disease the relevant contributions of cell death versus inflammatory signalling from TNF-R1 were genetically dissected demonstrating that excess apoptosis/necroptosis drove different elements of the inflammatory response depending on the affected tissue. In a mouse model of autoimmune encephalomyelitis, the oligodendrocyte-specific deletion of <italic toggle="yes">Fadd</italic> reduced demyelination and this was accompanied by limited immune cell infiltration in the spinal cord [<xref ref-type="bibr" rid="CR953">953</xref>]. Likewise, experimental autoimmune encephalomyelitis could be prevented by transgenic expression of FADD-DN (dominant negative form of FADD) in T cells [<xref ref-type="bibr" rid="CR954">954</xref>], but it must be noted that this reflects the death of&#160;activated T cells [<xref ref-type="bibr" rid="CR955">955</xref>]. Therefore, this protective effect is due to the removal of T cells that would cause tissue destruction. Activation of CASP8 was identified in the microglia of patients with multiple sclerosis [<xref ref-type="bibr" rid="CR956">956</xref>]. Moreover, transgenic expression of FADD-DN or <italic toggle="yes">Casp8</italic> ablation in pancreatic &#946; cells protects mice from autoimmune diabetes [<xref ref-type="bibr" rid="CR957">957</xref>]. Finally,&#160;BID appears to be dispensable for the development of diabetes in NOD mice [<xref ref-type="bibr" rid="CR958">958</xref>].</p><p id="Par113">There are also contrasting observations on the impact of DR-induced apoptosis on the development and resolution of autoimmune rheumatoid arthritis. The absence of c-FLIP (due to <italic toggle="yes">Cflar</italic> deletion) increased disease severity but limited disease resolution in mice experiencing arthritis upon intraperitoneal injection of serum from K/BxN mice [<xref ref-type="bibr" rid="CR959">959</xref>]. In the same model, deletion of <italic toggle="yes">Casp8</italic> in all myeloid cells enhanced disease resolution, while deletion of <italic toggle="yes">Casp8</italic> selectively in DCs accelerated disease onset [<xref ref-type="bibr" rid="CR960">960</xref>]. Further experiments are required to unveil the reasons for such cell type specificity in the role of CASP8 in this and (perhaps)&#160;other autoimmune disorders.</p></sec><sec id="Sec27"><title>Infectious diseases</title><p id="Par114">Extrinsic apoptosis is reported to act as an anti-infective mechanism. FAS-deficient <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic>, FASL-deficient <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> and <italic toggle="yes">Bid</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice exhibit delayed clearance of <italic toggle="yes">Citrobacter rodentium</italic> and increased intestinal pathology [<xref ref-type="bibr" rid="CR961">961</xref>]. Confirming the importance of DR-induced apoptosis, this pathogen was shown to inhibit extrinsic apoptosis of infected enterocytes by expressing specific virulence proteins, such as the&#160;N-acetylglucosamine transferase NleB1, which prevents FADD-mediated recruitment and activation of CASP8 [<xref ref-type="bibr" rid="CR962">962</xref>]. Along similar lines, <italic toggle="yes">Fas</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice have shorter lifespan than wild-type mice after challenge with <italic toggle="yes">L.&#160;monocytogenes</italic>, succumbing to neurolisteriosis. This was proposed to be promoted by an impaired loss of monocytes due to upregulated expression of c-FLIP by the bacterial protein InlB [<xref ref-type="bibr" rid="CR963">963</xref>]. In support of this result, conditional deletion of <italic toggle="yes">Cflar</italic> in myeloid cells improved <italic toggle="yes">L.&#160;monocytogenes</italic> clearance and host survival [<xref ref-type="bibr" rid="CR964">964</xref>]. FAS signaling also conferred protection from infection with (i) human herpes simplex virus 2 (HSV-2), as demonstrated by a decrease in the loss of monocyte and immune cell recruitment at the infection site in <italic toggle="yes">Fas</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> and <italic toggle="yes">Fasl</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice [<xref ref-type="bibr" rid="CR965">965</xref>], and (ii) <italic toggle="yes">C.&#160;rodentium</italic> or lymphocytic choriomeningitis virus, as demonstrated by an increased neutrophil fraction in mice with conditional deletion of <italic toggle="yes">Fas</italic> in the myeloid compartment [<xref ref-type="bibr" rid="CR966">966</xref>].</p><p id="Par115">Supporting an anti-infection role of CASP8, mice lacking RIPK1 kinase activity fail to control systemic <italic toggle="yes">Yersinia</italic> infection, rapidly dying because of excess apoptosis driven by a kinase-independent function of RIPK1 [<xref ref-type="bibr" rid="CR967">967</xref>, <xref ref-type="bibr" rid="CR968">968</xref>]. In line with this finding, <italic toggle="yes">Ripk3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup><italic toggle="yes">Casp8</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> (but not <italic toggle="yes">Ripk3</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup>)&#160;mice die from <italic toggle="yes">Toxoplasma gondii</italic> infection due to acute toxoplasmosis [<xref ref-type="bibr" rid="CR969">969</xref>]. Moreover, the&#160;hepatocyte-specific deficiency for CASP8 facilitates mouse&#160;liver infection by <italic toggle="yes">L.&#160;monocytogenes</italic>, resulting in inflammation and development of necrotic lesions [<xref ref-type="bibr" rid="CR776">776</xref>]. These results also suggest an interconnection of multiple RCD pathways in controlling infection. Indeed, the deletion of Z-DNA binding protein 1 (<italic toggle="yes">Zbp1</italic>), an essential cytoplasmic sensor of Influenza A virus (IAV) Z-RNA required for the activation of MLKL-dependent necroptosis, RIPK1/FADD-dependent apoptosis and NLR family, pyrin domain containing 3 (NLRP3) inflammasome-dependent pyroptosis, as well as co-deletion of the genes encoding MLKL and FADD, causes a defect in the control of IAV infection&#160;and&#160;lethal respiratory failure. These findings support an essential role of apoptosis, necroptosis and pyroptosis in IAV clearance [<xref ref-type="bibr" rid="CR970">970</xref>&#8211;<xref ref-type="bibr" rid="CR974">974</xref>]. Similarly, combined activation of apoptosis and other RCD pathways contribute to the response of mice to <italic toggle="yes">Burkholderia thailandensis</italic> infection [<xref ref-type="bibr" rid="CR975">975</xref>]. Finally, pharmacological or tissue specific genetic deletion of baculoviral IAP repeat-containing 3 (<italic toggle="yes">Birc3</italic>, encoding&#160;cIAP1) and baculoviral IAP repeat-containing 2&#160;(<italic toggle="yes">Birc2</italic>, encoding&#160;cIAP2) results in better control of hepatitis B virus and liver stage malaria parasites due to increased TNF induced death of infected cells [<xref ref-type="bibr" rid="CR976">976</xref>&#8211;<xref ref-type="bibr" rid="CR978">978</xref>].</p><p id="Par116">Experimental evidence also suggests a detrimental role of extrinsic apoptosis during some infections. Mice deficient for both TNF-R1 and TNF-R2 display decreased sensitivity to LPS, suggesting a critical role for TNF in tissue injury during gram-negative bacterial infection [<xref ref-type="bibr" rid="CR979">979</xref>]. Along similar lines, TNF-R1-deficient mice are more resistant than wild-type mice to the cytopathic effects of TNF during Sindbis virus infection, as evidenced by delayed paralysis&#160;and reduced mortality [<xref ref-type="bibr" rid="CR980">980</xref>]. Moreover, ablation of <italic toggle="yes">Ripk1</italic> protected mice from acute liver injury after infection with <italic toggle="yes">L.&#160;monocytogenes</italic> [<xref ref-type="bibr" rid="CR981">981</xref>], while knockout of <italic toggle="yes">Fas</italic> or <italic toggle="yes">Fasl</italic> reduced the effect of toxin A-induced enteritis in mice infected with <italic toggle="yes">Clostridium difficile</italic>, which has been attributed to a reduction in enterocyte loss [<xref ref-type="bibr" rid="CR982">982</xref>]. Additionally, the infectious spleen and kidney necrosis virus (ISKNV) induced tissue damage in zebrafish by activation of DR-induced apoptosis by a viral protein encoding a TRADD interactor [<xref ref-type="bibr" rid="CR983">983</xref>]. Of note, in this study, the absence of CASP8 protected zebrafish from ISKNV infection. Finally, <italic toggle="yes">Ripk3</italic><sup>&#8722;/&#8722;</sup><italic toggle="yes">Casp8</italic><sup>&#8722;/&#8722;</sup> mice exhibit high levels of protection from LPS-induced septic shock [<xref ref-type="bibr" rid="CR984">984</xref>] or a lethal cytokine shock and tissue damage driven by TNF and interferon gamma (IFNG), mirroring that of SARS-CoV-2 [<xref ref-type="bibr" rid="CR985">985</xref>]. This suggests that the several types of RCD can mediate infection-associated pathogenesis, as demonstrated for infection with <italic toggle="yes">Salmonella</italic> [<xref ref-type="bibr" rid="CR50">50</xref>].</p></sec><sec id="Sec28"><title>Other diseases</title><p id="Par117">TNF is reported to impair myogenesis in a mouse model of skeletal muscle regeneration after hindlimb immobilization (hindlimb suspension) [<xref ref-type="bibr" rid="CR986">986</xref>]. Moreover, silencing of TRAIL improved muscle regeneration in mice with acute skeletal muscle injury due to local injection of BaCl<sub>2</sub> [<xref ref-type="bibr" rid="CR987">987</xref>]. An inhibitory role in myogenesis has also been&#160;ascribed to FADD, at least in response to freezing-induced muscle injury [<xref ref-type="bibr" rid="CR988">988</xref>]. In apparent contrast with this result, combined deletion of the genes encoding TNF-R1 and TNF-R2 limited skeletal muscle regeneration after cardiotoxin-induced injury [<xref ref-type="bibr" rid="CR989">989</xref>, <xref ref-type="bibr" rid="CR990">990</xref>], suggesting the relevance of a balance between TNF-R1 and TNF-R2 signaling in this model. TRAIL neutralization increased muscular strength in a mouse model of Duchenne muscular dystrophy [<xref ref-type="bibr" rid="CR991">991</xref>], while other studies associated TRAIL and FASL signaling&#160;to myositis [<xref ref-type="bibr" rid="CR992">992</xref>, <xref ref-type="bibr" rid="CR993">993</xref>].</p><p id="Par118">Activation of DRs has also been implicated in the pathogenesis of acute lung injury. <italic toggle="yes">Fas</italic> silencing as well as TNF neutralization protected mice from lung injury induced by ischemia-reperfusion [<xref ref-type="bibr" rid="CR994">994</xref>, <xref ref-type="bibr" rid="CR995">995</xref>]. Similarly, deletion of <italic toggle="yes">Tnfrsf1a</italic> (encoding TNF-R1) or pharmacological inhibition of TNF-R1 or CASP8 attenuated pulmonary edema formation and improved alveolar epithelial function in a murine model of acute lung injury induced by acid inhalation [<xref ref-type="bibr" rid="CR996">996</xref>, <xref ref-type="bibr" rid="CR997">997</xref>]. A similar protective effect was provided by pharmacological inhibition or genetic deletion of FASL or TNF in a LPS-induced mouse model of acute lung injury [<xref ref-type="bibr" rid="CR998">998</xref>&#8211;<xref ref-type="bibr" rid="CR1004">1004</xref>]. However, in one study FAS signaling was shown to contribute to the resolution of acute lung injury by depleting macrophages [<xref ref-type="bibr" rid="CR1005">1005</xref>]. Using distinct mouse models of acute lung damage following sepsis, it has been shown that abrogation of FAS and TNF-R1 signaling decreases pulmonary apoptosis and ameliorates pathology, with a survival benefit in some settings [<xref ref-type="bibr" rid="CR1006">1006</xref>&#8211;<xref ref-type="bibr" rid="CR1012">1012</xref>]. Hyperoxia-induced lung injury and bleomycin-induced pulmonary fibrosis, a model for cancer therapy-induced lung injury, are also impacted by DR signaling. Thus,&#160;FAS and TNF deficiency exacerbated hyperoxia-induced lung injury and/or inflammation in newborn mice [<xref ref-type="bibr" rid="CR1013">1013</xref>, <xref ref-type="bibr" rid="CR1014">1014</xref>]. In contrast, TNF inhibition conferred protection against hyperoxia-induced lung damage in a murine model [<xref ref-type="bibr" rid="CR1015">1015</xref>&#8211;<xref ref-type="bibr" rid="CR1017">1017</xref>]. Moreover, the absence of TNF-R1 (but not TNF-R2) improved survival in mice subjected to excessive oxygen supply, and this was not linked to decreasing inflammation [<xref ref-type="bibr" rid="CR1018">1018</xref>]. In support of these results, specific ablation of <italic toggle="yes">Fas</italic> in murine fibroblasts or T cells exacerbates pulmonary fibrosis induced by bleomycin [<xref ref-type="bibr" rid="CR1019">1019</xref>, <xref ref-type="bibr" rid="CR1020">1020</xref>]. However, the level of bleomycin-induced pulmonary fibrosis is reduced in FAS-deficient <italic toggle="yes">lpr</italic>/<italic toggle="yes">lpr</italic> or FASL-deficient <italic toggle="yes">gld</italic>/<italic toggle="yes">gld</italic> mice [<xref ref-type="bibr" rid="CR1021">1021</xref>], but remains unchanged in mice treated with FAS-neutralizing agents [<xref ref-type="bibr" rid="CR1022">1022</xref>]. Likewise, contrasting findings support or refute a role for TNF [<xref ref-type="bibr" rid="CR1023">1023</xref>&#8211;<xref ref-type="bibr" rid="CR1025">1025</xref>] and TRAIL [<xref ref-type="bibr" rid="CR1026">1026</xref>, <xref ref-type="bibr" rid="CR1027">1027</xref>] in the onset and resolution of pulmonary fibrosis after administration of bleomycin. TNF neutralization has been reported to attenuate and enhance interstitial pulmonary fibrosis induced by nitrogen mustard [<xref ref-type="bibr" rid="CR1028">1028</xref>] or rituximab [<xref ref-type="bibr" rid="CR1029">1029</xref>]. Finally, FASL, TNF and/or TRAIL have been implicated in infectious or non-infectious lung disorders, including (but not limited to) infection with respiratory syncytial virus (RSV) [<xref ref-type="bibr" rid="CR1030">1030</xref>&#8211;<xref ref-type="bibr" rid="CR1036">1036</xref>], adenovirus type 1 respiratory disease [<xref ref-type="bibr" rid="CR1037">1037</xref>, <xref ref-type="bibr" rid="CR1038">1038</xref>], allergic reaction and asthma [<xref ref-type="bibr" rid="CR1039">1039</xref>&#8211;<xref ref-type="bibr" rid="CR1050">1050</xref>] and idiopathic pneumonia syndrome [<xref ref-type="bibr" rid="CR1051">1051</xref>], as well as to chronic lung diseases (e.g., chronic obstructive pulmonary disease) [<xref ref-type="bibr" rid="CR864">864</xref>, <xref ref-type="bibr" rid="CR1052">1052</xref>, <xref ref-type="bibr" rid="CR1053">1053</xref>].</p><p id="Par119">The studies discussed above illustrate that DR-induced apoptosis is at the heart of many disorders either promoting recovery or exacerbating disease. The active involvement in disease severity and progression makes this pathway a potentially tractable target for therapeutic interventions in a wide range of diseases, typically those with an inflammatory component. However, this effect may be linked to the role of DR signaling in other RCD pathways and in inflammation. Moreover, there is little consensus on the roles of FASL, TNF and/or TRAIL&#160;in these pathologies, highlighting a high complexity of the system that calls for further investigation.</p></sec></sec><sec id="Sec29"><title>Concluding remarks</title><p id="Par120">Abundant preclinical evidence demonstrates that the intrinsic and the extrinsic pathways of apoptosis not only contribute to adult tissue homeostasis and, in the case of the intrinsic pathway, to embryonic development &#8211; the implication of CASP8 in development is mainly linked to its role as necroptosis inhibitor (<italic toggle="yes">see</italic> Box&#160;<xref rid="Sec19" ref-type="sec">6</xref> and Box&#160;<xref rid="Sec20" ref-type="sec">7</xref>) - but also contribute to the pathogenesis of multiple diseases, including various cardiovascular, hepatic, neurological and renal disorders as well as multiple infectious, autoimmune, inflammatory and oncological conditions. However, despite great potential as targets for therapeutic interventions and a considerable research effort dedicated to developing effective approaches, the success of intrinsic or extrinsic apoptosis-targeting agents in clinical settings is so far limited to BH3 mimetic drugs, SMAC mimetics, caspase inhibitors as well as activators or inhibitors of DR signaling, with only one compound, the BCL2&#160;inhibitor venetoclax being&#160;approved for the treatment of patients with CLL or AML.</p><p id="Par121">Rather than mitigating the enthusiasm about the clinical potential of modulators of apoptosis, this challenge suggests the need for a substantial change in the experimental design and re-interpretation of results, at different levels (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). One major issue is that studies evaluating the impact of apoptotic cell death on disease have not always addressed the connections between the core components of the intrinsic and extrinsic apoptotic machinery or their potential interaction and functional overlap with other RCD pathways. Also, the potential activation of alternative RCD modalities as a mechanism to compensate for the inhibition of apoptotic RCD has not always been explored as an approach to achieve superior outcomes. The importance of independent replication of findings that suggest success from targeting a pathway in the treatment of a disease cannot be emphasized enough. Only then can the costly process of clinical translation be approached with confidence and with an increased chance of success. For example, the findings that overexpression of BCL2 or its pro-survival relatives can promote tumorigenesis and can render malignant cells resistant to diverse anti-cancer therapeutics had been reproduced hundreds of times before the initiation of&#160;BH3 mimetic development. This is not yet the case for many of the other studies discussed herein, as best demonstrated by the fact that certain experiments have provided&#160;diametrically opposing results in different laboratories. These questions must be resolved before considering novel&#160;drug development programs&#160;around apoptotic RCD.</p><p id="Par122">Moreover, some regulators of apoptosis and signaling cascades have been reported to exert a variety of functions beyond cell death control, including (but not limited to) inflammation (e.g., multiple caspases and IAPs), cell differentiation (e.g., pro-and anti-apoptotic BCL2 proteins), cell proliferation and survival (e.g., DR engagement). The relevance of these functions is often dependent on cell/tissue type (as it is related to variable expression levels and activation status of other regulators of RCD) and the intensity and duration of the initiating stimulus (as they can direct to a distinct biological outcome, as exemplified by DR ligation). Of note, some of these cell death unrelated functions of bona fide cell death regulators are highly controversial and much more work must be done to verify or discard them. On the one hand, this pleiotropy may result in a variable (even including an antagonistic protective vs. promoting) impact of apoptosis on distinct human diseases, which may&#160;also explain the considerable degree of context-dependency observed during its experimental modulation. On the other&#160;hand, the pathogenic effect of core components of the apoptotic machinery is often mediated by apoptosis-unrelated functions including inflammation, which may point to unexplored targets for the development of new therapeutic approaches.</p><p id="Par123">In our opinion, investigating the molecular cascade of apoptotic cell death in the context of the functional interconnection between apoptotic and non-apoptotic RCD&#160;pathways, for instance by interrupting some of the molecular connections between different RCD signaling cascades, may instigate new advances, ultimately leading to the development of novel, clinically-viable apoptosis modulators for use in multiple disease settings.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors jointly supervised this work: Mauro Piacentini, Guido Kroemer, Lorenzo Galluzzi.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>L.&#160;Galluzzi and I.&#160;Vitale conceived the review&#160;and&#160;wrote the first version of the manuscript with constructive input from all authors. E.&#160;Guilbaud, C.&#160;Galassi and G.&#160;Manic prepared display items under the supervision of L.&#160;Galluzzi and I.&#160;Vitale. I. Vitale, F.&#160;Pietrocola and L.&#160;Galluzzi addressed requests from the Reviewers and Editors of <italic toggle="yes">Cell Death and Differentiation</italic>. All authors approved the final version of the article and figures.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>I.&#160;Vitale is and has been supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 2017 #20417 and IG 2022 #27685) and by&#160;a startup grant from the Italian Institute for Genomic Medicine (Candiolo, Turin, Italy) and Compagnia di San Paolo (Torino, Italy). M.&#160;Piacentini, G.&#160;Melino, S.&#160;Melino, G.&#160;Ciliberto are supported by the Ministro dell&#8217;Universit&#224; (Italy) progetto Heal Italia PE6. L.&#160;Galluzzi is/has been supported (as a PI unless otherwise indicated) by two Breakthrough Level 2 grants from the US DoD BCRP (#BC180476P1; #BC210945), by a Transformative Breast Cancer Consortium Grant from the US DoD BCRP (#W81XWH2120034, PI: Formenti), by a U54 grant from NIH/NCI (#<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="CA274291">CA274291</ext-link>, PI: Deasy, Formenti, Weichselbaum), by the 2019 Laura Ziskin Prize in Translational Research (#ZP-6177, PI: Formenti) from the Stand Up to Cancer (SU2C), by a Mantle Cell Lymphoma Research Initiative (MCL-RI, PI: Chen-Kiang) grant from the Leukemia and Lymphoma Society (LLS), by a Rapid Response Grant from the Functional Genomics Initiative (New York, US), by startup funds from the Dept. of Radiation Oncology at Weill Cornell Medicine (New York, US), by industrial collaborations with Lytix Biopharma (Oslo, Norway), Promontory (New York, US) and Onxeo (Paris, France), as well as by donations from Promontory (New York, US), the Luke Heller TECPR2 Foundation (Boston, US), Sotio a.s. (Prague, Czech Republic), Lytix Biopharma (Oslo, Norway), Onxeo (Paris, France), Ricerchiamo (Brescia, Italy), and Noxopharm (Chatswood, Australia).&#160;G.&#160;Kroemer is supported by the Ligue contre le Cancer (&#233;quipe labellis&#233;e); Agence National de la Recherche (ANR) &#8211; Projets blancs; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Canc&#233;rop&#244;le Ile-de-France; European Research Council Advanced Investigator Grand &#8220;ICD-Cancer&#8221;, Fondation pour la Recherche M&#233;dicale (FRM); a donation by Elior; Equipex Onco-Pheno-Screen; European Joint Programme on Rare Diseases (EJPRD); European Research Council (ICD-Cancer), European Union Horizon 2020 Projects Oncobiome and Crimson; Fondation Carrefour; Institut National du Cancer (INCa); Institut Universitaire de France; LabEx Immuno-Oncology (ANR-18-IDEX-0001); a Cancer Research ASPIRE Award from the Mark Foundation; the RHU Immunolife; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and SIRIC Cancer Research and Personalized Medicine (CARPEM)</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par124">All Editorial Board Members of Cell Death Differentiation, Cell Death Disease, or Cell Death Discovery are included among the authors. A.&#160;Degterev is shareholder in Denali Therapeutics. A.&#160;D.&#160;Garg has received renumeration, honorarium or consultancy fees from Boehringer Ingelheim, Miltenyi Biotec or IsoPlexis. A.&#160;Strasser and P.&#160;E.&#160;Czabotar (PEC) are employees of the Walter and Eliza Hall Institute, which has an agreement with Genentech and AbbVie and receives milestone and royalty payments related to venetoclax. Employees of the Walter and Eliza Hall Institute may be eligible for financial benefits related to these payments. PEC receives such a financial benefit as a result of previous research related to venetoclax. B.&#160;De Strooper (BDS)&#160;has no COI with the content of this paper. Possible perceived COI: BDS is or has been a consultant for Eli Lilly, Biogen, Janssen Pharmaceutica, Eisai, AbbVie and other companies. BDS is also a scientific founder of Augustine Therapeutics and a scientific founder and stockholder of Muna therapeutics. B. R. Stockwell is an inventor on patents and patent applications involving small molecule drug discovery, ferroptosis, and the antibody 3F3-FMA; co-founded and serves as a consultant to Exarta Therapeutics, and ProJenX Inc.; holds equity in Sonata Therapeutics, and serves as a consultant to Weatherwax Biotechnologies Corporation and Akin Gump Strauss Hauer &amp; Feld LLP, and receives research funding from Sumitomo Dainippon Pharma Oncology. C.&#160;M.&#160;Troy has the following patent applications US20200164026, US20190142915, US20150165061, US20140024597. US2020058683, WO2018013519, WO/2020/223212. D.&#160;C.&#160;Rubinsztein serves as a consultant for Alladdin Healthcare Technologies Ltd., Mindrank AI, Nido Biosciences, Drishti Discoveries and PAQ Therapeutics. D.&#160;J.&#160;Murphy receives funding from the Merck Group (Darmstadt, Germany) &amp; Puma Biotechnology (Los Angeles, CA, USA). D.&#160;Ofengeim is employed at SANOFI. JTO serves as a consultant for Anji Pharmaceuticals. J.&#160;T.&#160;Opferman receives research funding from AbbVie. D.&#160;W.&#160;Andrews receives funding for research in apoptosis from Amylyx. F&#160;Di Virgilio is Member of the Scientific Advisory Board (SAB) of Biosceptre Ltd (UK), and a consultant with Axxam SpA (Italy). F.&#160;Madeo has financial interest in TLL, The Longevity Labs and Samsara Therapeutics. P.&#160;Mehlen is founder and shareholder of NETRIS Pharma. G.&#160;A.&#160;Calin is the scientific founder of Ithax Pharmaceuticals. G.&#160;L.&#160;Kelly (GLK) is an employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax. GLK has received research funding from Servier. J.&#160;R.&#160;Cubillos-Ruiz is a scientific consultant for NextRNA Therapeutics, Inc. and Autoimmunity Biologic Solutions, Inc. K.&#160;Rajalingam is a founder and MD of KH Biotec GmbH. CVR is a scientific founder and member of the Scientific Advisory Board (SAB) of Surface Oncology, a member of Janssen Immunology SAB, and a consultant for the Roche Immunology Incubator. C.&#160;V.&#160;Rothlin has received grant support from Mirati Therapeutics. K.&#160;Schroder is a co-inventor on patent applications for NLRP3 inhibitors which have been licensed to Inflazome Ltd, a company headquartered in Dublin, Ireland. Inflazome is developing drugs that target the NLRP3 inflammasome to address unmet clinical needs in inflammatory disease. K.&#160;Schroder served on the Scientific Advisory Board of Inflazome in 2016&#8211;2017, and serves as a consultant to Quench Bio, USA and Novartis, Switzerland. L.&#160;Altucci receives funding for research from Merck and has shares in Epic SRL and CIRCE SRL.&#160;B.&#160;Joseph is cofounder of CERVO Therapeutics AB. M.&#160;Carbone received donations from the UH Foundation through donations from: the Riviera United-4-a Cure, the Melohn Family Endowment, the Honeywell International Inc., the Germaine Hope Brennan Foundation, and the Maurice and Joanna Sullivan Family Foundation. M.&#160;Carbone has a patent issued for BAP1. M.&#160;Carbone and two patents issued for HMGB1. M.&#160;Carbone is a board-certified pathologist who provides consultation for pleural pathology, including medical-legal. M.&#160;Conrad is a co-founder and shareholder of ROSCUE Therapeutics GmbH. M.&#160;Karin received support from Jansen Pharmaceuticals, Merck and Gossamer Bioscience. M.&#160;Karin is founder and member of SAB, Elgia Pharmaceuticals. M.&#160;Pagano is a scientific cofounder of SEED Therapeutics; receives research funding from and is a shareholder in Kymera Therapeutics; and is a consultant for, a member of the scientific advisory board of, and has financial interests in CullGen, SEED Therapeutics, Triana Biomedicines, and Umbra Therapeutics. M.&#160;G.&#160;Vander Heiden is a scientific advisor for Agios Pharmaceuticals, iTeos Therapeutics, Sage Therapeutics, Droia Ventures, and Auron Therapeutics. M.&#160;Oren is a consultant for Quintrigen. O.&#160;Kepp is a co-founder of Samsara Therapeutics. P.&#160;J.&#160;Jost has had a consulting or advisory role, received honoraria, research funding, and/or travel/accommodation expenses from: Ariad, Abbvie, Bayer, Boehringer, Novartis, Pfizer, Servier, Roche, BMS and Celgene, Pierre Fabre, Janssen/Johnson&amp;Johnson, MSD. R.&#160;B.&#160;Damgaard is a scientific advisor for Immagene B.V., Amsterdam, Netherlands. R.&#160;I.&#160;Aqeilan serves as consultant for Mahzi Therapeutics. R.&#160;J.&#160;DeBerardinis is a founder and advisor at Atavistik Bio and serves on the Scientific Advisory Boards of Agios Pharmaceuticals, Vida Ventures, Droia Ventures and Nirogy Therapeutics. R. N.&#160;Ktsis is Co-founder of ASPIDA Therapeutics Inc. S.&#160;A.&#160;Lipton (SAL) discloses that he is the named inventor on worldwide patents for the use of memantine and derivatives for the treatment of neurodegenerative disorders. As per the rules of Harvard University, SAL participates in a Royalty Sharing Agreement with is former institutions, Boston Children&#8217;s Hospital/Harvard Medical School, which licensed these patents to Forest Laboratories and Allergan, now owned by Abbvie. SAL is also a founder of EuMentis Therapeutics, Inc., Adamas Pharmaceuticals, Inc. (now owned by Supernus Pharmaceuticals, Inc.), and a consultant to SNO bio, Inc., Engine Biosciences, Ventus Therapeutics, Inc., Eisai, inc., and Takeda Pharmaceuticals, Inc. S.&#160;Ghosh has received grant support from Mirati Therapeutics. S.&#160;J.&#160;Dixon is a co-founder of Prothegen Inc., and a scientific advisor to Ferro Therapeutics and Hillstream BioPharma. S.&#160;von Karstedt is named inventor on patent applications covering some of the therapeutic concepts pertaining to TRAIL-R blockade in disease. Y.&#160;H.&#160;Chen is a member of the board of advisors for Amshenn Inc. and Binde Inc. T.-D.&#160;Kanneganti is a consultant for Pfizer. T.&#160;Vanden Berghe and P.&#160;Vandenabeele hold patents related to ferrostatin-1 analogues.&#160;D. R. Green consults for Ventus Therapeutics, Inzen Therapeutics, and Horizon Therapeutics.&#160;K. H. Vousden&#160;is on the board of directors and shareholder of Bristol Myers Squibb and on the scientific advisory board (with stock options) of PMV Pharma, RAZE Therapeutics, Volastra Pharmaceuticals and Kovina Therapeutics. She is on the scientific advisory board of Ludwig Cancer and a co-founder and consultant of Faeth Therapeutics. She has been in receipt of research funding from Astex Pharmaceuticals and AstraZeneca and contributed to CRUK Cancer Research Technology filing of patent application WO/2017/144877. W. S. El-Deiry (WSE-D) is founder and shareholder (no research funding) of Oncoceutics/Chimerix, which is developing ONC201/TIC10 as cancer therapeutic. WSE-D is founder and shareholder (no research funding) of p53-Therapeutics, an early-stage company developing small molecules targeting mutant p53. WSE-D founder, and shareholder (no research funding) of SMURF-Therapeutics, an early-stage company developing small molecules targeting hypoxia. WSE-D is Co-Chair in the Executive Committee for Precision Oncology Alliance (no research funding) of Caris Life Sciences. WSE-D receives support from D&amp;D Pharma and AACR-Novocure. WSE-D is the advisory board of Ocean Biomedical. WSE-D is the advisory board of RAIN Therapeutics. G.&#160;Kroemer has been holding research contra.cts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Tollys, and Vascage. G.&#160;Kroemer has been consulting for Reithera. G.&#160;Kroemer is on the Board of Directors of the Bristol Myers Squibb Foundation France. G.&#160;Kroemer is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. G.&#160;Kroemer is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis and metabolic disorders. G.&#160;Kroemer&#8217;s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. L. Galluzzi is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. All other authors have no conflicts to declare.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Vitale</surname><given-names>I</given-names></name><name name-style="western"><surname>Aaronson</surname><given-names>SA</given-names></name><name name-style="western"><surname>Abrams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Adam</surname><given-names>D</given-names></name><name name-style="western"><surname>Agostinis</surname><given-names>P</given-names></name><etal/></person-group><article-title>Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>486</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1038/s41418-017-0012-4</pub-id><pub-id pub-id-type="pmid">29362479</pub-id><pub-id pub-id-type="pmcid">PMC5864239</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name><name name-style="western"><surname>Stockwell</surname><given-names>BR</given-names></name><name name-style="western"><surname>Conrad</surname><given-names>M</given-names></name></person-group><article-title>Ferroptosis: mechanisms, biology and role in disease</article-title><source>Nat Rev Mol Cell Biol</source><year>2021</year><volume>22</volume><fpage>266</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-00324-8</pub-id><pub-id pub-id-type="pmid">33495651</pub-id><pub-id pub-id-type="pmcid">PMC8142022</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del Re</surname><given-names>DP</given-names></name><name name-style="western"><surname>Amgalan</surname><given-names>D</given-names></name><name name-style="western"><surname>Linkermann</surname><given-names>A</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kitsis</surname><given-names>RN</given-names></name></person-group><article-title>Fundamental mechanisms of regulated cell death and implications for heart disease</article-title><source>Physiol Rev</source><year>2019</year><volume>99</volume><fpage>1765</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1152/physrev.00022.2018</pub-id><pub-id pub-id-type="pmid">31364924</pub-id><pub-id pub-id-type="pmcid">PMC6890986</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bock</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Tait</surname><given-names>SWG</given-names></name></person-group><article-title>Mitochondria as multifaceted regulators of cell death</article-title><source>Nat Rev Mol Cell Biol</source><year>2020</year><volume>21</volume><fpage>85</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0173-8</pub-id><pub-id pub-id-type="pmid">31636403</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broz</surname><given-names>P</given-names></name><name name-style="western"><surname>Pelegr&#237;n</surname><given-names>P</given-names></name><name name-style="western"><surname>Shao</surname><given-names>F</given-names></name></person-group><article-title>The gasdermins, a protein family executing cell death and inflammation</article-title><source>Nat Rev Immunol</source><year>2020</year><volume>20</volume><fpage>143</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0228-2</pub-id><pub-id pub-id-type="pmid">31690840</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinlich</surname><given-names>R</given-names></name><name name-style="western"><surname>Oberst</surname><given-names>A</given-names></name><name name-style="western"><surname>Beere</surname><given-names>HM</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>Necroptosis in development, inflammation and disease</article-title><source>Nat Rev Mol Cell Biol</source><year>2017</year><volume>18</volume><fpage>127</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.149</pub-id><pub-id pub-id-type="pmid">27999438</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Buqu&#233;</surname><given-names>A</given-names></name><name name-style="western"><surname>Kepp</surname><given-names>O</given-names></name><name name-style="western"><surname>Zitvogel</surname><given-names>L</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Immunogenic cell death in cancer and infectious disease</article-title><source>Nat Rev Immunol</source><year>2017</year><volume>17</volume><fpage>97</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.107</pub-id><pub-id pub-id-type="pmid">27748397</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>D</given-names></name><name name-style="western"><surname>Kang</surname><given-names>R</given-names></name><name name-style="western"><surname>Berghe</surname><given-names>TV</given-names></name><name name-style="western"><surname>Vandenabeele</surname><given-names>P</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>The molecular machinery of regulated cell death</article-title><source>Cell Res</source><year>2019</year><volume>29</volume><fpage>347</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/s41422-019-0164-5</pub-id><pub-id pub-id-type="pmid">30948788</pub-id><pub-id pub-id-type="pmcid">PMC6796845</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gudipaty</surname><given-names>SA</given-names></name><name name-style="western"><surname>Conner</surname><given-names>CM</given-names></name><name name-style="western"><surname>Rosenblatt</surname><given-names>J</given-names></name><name name-style="western"><surname>Montell</surname><given-names>DJ</given-names></name></person-group><article-title>Unconventional ways to live and die: cell death and survival in development, homeostasis, and disease</article-title><source>Annu Rev Cell Dev Biol</source><year>2018</year><volume>34</volume><fpage>311</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100616-060748</pub-id><pub-id pub-id-type="pmid">30089222</pub-id><pub-id pub-id-type="pmcid">PMC6791364</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bedoui</surname><given-names>S</given-names></name><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Emerging connectivity of programmed cell death pathways and its physiological implications</article-title><source>Nat Rev Mol Cell Biol</source><year>2020</year><volume>21</volume><fpage>678</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0270-8</pub-id><pub-id pub-id-type="pmid">32873928</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Vitale</surname><given-names>I</given-names></name><name name-style="western"><surname>Abrams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Alnemri</surname><given-names>ES</given-names></name><name name-style="western"><surname>Baehrecke</surname><given-names>EH</given-names></name><name name-style="western"><surname>Blagosklonny</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012</article-title><source>Cell Death Differ</source><year>2012</year><volume>19</volume><fpage>107</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.96</pub-id><pub-id pub-id-type="pmid">21760595</pub-id><pub-id pub-id-type="pmcid">PMC3252826</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kesavardhana</surname><given-names>S</given-names></name><name name-style="western"><surname>Malireddi</surname><given-names>RKS</given-names></name><name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><article-title>Caspases in cell death, inflammation, and pyroptosis</article-title><source>Annu Rev Immunol</source><year>2020</year><volume>38</volume><fpage>567</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-073119-095439</pub-id><pub-id pub-id-type="pmid">32017655</pub-id><pub-id pub-id-type="pmcid">PMC7190443</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Dorstyn</surname><given-names>L</given-names></name><name name-style="western"><surname>Lim</surname><given-names>Y</given-names></name></person-group><article-title>The role of caspases as executioners of apoptosis</article-title><source>Biochem Soc Trans</source><year>2022</year><volume>50</volume><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1042/BST20210751</pub-id><pub-id pub-id-type="pmid">34940803</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Bravo-San Pedro</surname><given-names>JM</given-names></name><name name-style="western"><surname>Vitale</surname><given-names>I</given-names></name><name name-style="western"><surname>Aaronson</surname><given-names>SA</given-names></name><name name-style="western"><surname>Abrams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Adam</surname><given-names>D</given-names></name><etal/></person-group><article-title>Essential versus accessory aspects of cell death: recommendations of the NCCD 2015</article-title><source>Cell Death Differ</source><year>2015</year><volume>22</volume><fpage>58</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.137</pub-id><pub-id pub-id-type="pmid">25236395</pub-id><pub-id pub-id-type="pmcid">PMC4262782</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marsden</surname><given-names>VS</given-names></name><name name-style="western"><surname>O&#8217;Connor</surname><given-names>L</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Silke</surname><given-names>J</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>D</given-names></name><name name-style="western"><surname>Ekert</surname><given-names>PG</given-names></name><etal/></person-group><article-title>Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome</article-title><source>Nature</source><year>2002</year><volume>419</volume><fpage>634</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nature01101</pub-id><pub-id pub-id-type="pmid">12374983</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>EH</given-names></name><name name-style="western"><surname>Wei</surname><given-names>MC</given-names></name><name name-style="western"><surname>Weiler</surname><given-names>S</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mak</surname><given-names>TW</given-names></name><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><etal/></person-group><article-title>BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis</article-title><source>Mol Cell</source><year>2001</year><volume>8</volume><fpage>705</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(01)00320-3</pub-id><pub-id pub-id-type="pmid">11583631</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandian</surname><given-names>N</given-names></name><name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><article-title>PANoptosis: a unique innate immune inflammatory cell death modality</article-title><source>J Immunol</source><year>2022</year><volume>209</volume><fpage>1625</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2200508</pub-id><pub-id pub-id-type="pmid">36253067</pub-id><pub-id pub-id-type="pmcid">PMC9586465</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonora</surname><given-names>M</given-names></name><name name-style="western"><surname>Giorgi</surname><given-names>C</given-names></name><name name-style="western"><surname>Pinton</surname><given-names>P</given-names></name></person-group><article-title>Molecular mechanisms and consequences of mitochondrial permeability transition</article-title><source>Nat Rev Mol Cell Biol</source><year>2022</year><volume>23</volume><fpage>266</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/s41580-021-00433-y</pub-id><pub-id pub-id-type="pmid">34880425</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Zeh</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kang</surname><given-names>R</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name><name name-style="western"><surname>Tang</surname><given-names>D</given-names></name></person-group><article-title>Cell death in pancreatic cancer: from pathogenesis to therapy</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2021</year><volume>18</volume><fpage>804</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/s41575-021-00486-6</pub-id><pub-id pub-id-type="pmid">34331036</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>S</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>D</given-names></name><etal/></person-group><article-title>JTC801 Induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice</article-title><source>Gastroenterology</source><year>2018</year><volume>154</volume><fpage>1480</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2017.12.004</pub-id><pub-id pub-id-type="pmid">29248440</pub-id><pub-id pub-id-type="pmcid">PMC5880694</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsvetkov</surname><given-names>P</given-names></name><name name-style="western"><surname>Coy</surname><given-names>S</given-names></name><name name-style="western"><surname>Petrova</surname><given-names>B</given-names></name><name name-style="western"><surname>Dreishpoon</surname><given-names>M</given-names></name><name name-style="western"><surname>Verma</surname><given-names>A</given-names></name><name name-style="western"><surname>Abdusamad</surname><given-names>M</given-names></name><etal/></person-group><article-title>Copper induces cell death by targeting lipoylated TCA cycle proteins</article-title><source>Science</source><year>2022</year><volume>375</volume><fpage>1254</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1126/science.abf0529</pub-id><pub-id pub-id-type="pmid">35298263</pub-id><pub-id pub-id-type="pmcid">PMC9273333</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malireddi</surname><given-names>RKS</given-names></name><name name-style="western"><surname>Kesavardhana</surname><given-names>S</given-names></name><name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><article-title>ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis)</article-title><source>Front Cell Infect Microbiol</source><year>2019</year><volume>9</volume><fpage>406</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2019.00406</pub-id><pub-id pub-id-type="pmid">31850239</pub-id><pub-id pub-id-type="pmcid">PMC6902032</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>The coming decade of cell death research: five riddles</article-title><source>Cell</source><year>2019</year><volume>177</volume><fpage>1094</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.04.024</pub-id><pub-id pub-id-type="pmid">31100266</pub-id><pub-id pub-id-type="pmcid">PMC6534278</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Letai</surname><given-names>A</given-names></name><name name-style="western"><surname>Sarosiek</surname><given-names>K</given-names></name></person-group><article-title>Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins</article-title><source>Nat Rev Mol Cell Biol</source><year>2019</year><volume>20</volume><fpage>175</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0089-8</pub-id><pub-id pub-id-type="pmid">30655609</pub-id><pub-id pub-id-type="pmcid">PMC7325303</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>FFS</given-names></name><name name-style="western"><surname>Brinkmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Voss</surname><given-names>AK</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Some mice lacking intrinsic, as well as death receptor induced apoptosis and necroptosis, can survive to adulthood</article-title><source>Cell Death Dis</source><year>2022</year><volume>13</volume><fpage>317</fpage><pub-id pub-id-type="doi">10.1038/s41419-022-04731-x</pub-id><pub-id pub-id-type="pmid">35393408</pub-id><pub-id pub-id-type="pmcid">PMC8991225</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>FFS</given-names></name><name name-style="western"><surname>Vanyai</surname><given-names>HK</given-names></name><name name-style="western"><surname>Cowan</surname><given-names>AD</given-names></name><name name-style="western"><surname>Delbridge</surname><given-names>ARD</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>L</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><etal/></person-group><article-title>Embryogenesis and adult life in the absence of intrinsic apoptosis effectors BAX, BAK, and BOK</article-title><source>Cell</source><year>2018</year><volume>173</volume><fpage>1217</fpage><lpage>1230.e1217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.04.036</pub-id><pub-id pub-id-type="pmid">29775594</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spetz</surname><given-names>J</given-names></name><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name></person-group><article-title>Preface: life through death-key role of cellular suicide for colonial and organismal homeostasis</article-title><source>Int Rev Cell Mol Biol</source><year>2020</year><volume>352</volume><fpage>xi</fpage><lpage>xv</lpage><pub-id pub-id-type="doi">10.1016/S1937-6448(20)30047-2</pub-id><pub-id pub-id-type="pmid">32334819</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carneiro</surname><given-names>BA</given-names></name><name name-style="western"><surname>El-Deiry</surname><given-names>WS</given-names></name></person-group><article-title>Targeting apoptosis in cancer therapy</article-title><source>Nat Rev Clin Oncol</source><year>2020</year><volume>17</volume><fpage>395</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1038/s41571-020-0341-y</pub-id><pub-id pub-id-type="pmid">32203277</pub-id><pub-id pub-id-type="pmcid">PMC8211386</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderton</surname><given-names>H</given-names></name><name name-style="western"><surname>Wicks</surname><given-names>IP</given-names></name><name name-style="western"><surname>Silke</surname><given-names>J</given-names></name></person-group><article-title>Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease</article-title><source>Nat Rev Rheumatol</source><year>2020</year><volume>16</volume><fpage>496</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1038/s41584-020-0455-8</pub-id><pub-id pub-id-type="pmid">32641743</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>K</given-names></name><name name-style="western"><surname>van Delft</surname><given-names>MF</given-names></name><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name></person-group><article-title>Too much death can kill you: inhibiting intrinsic apoptosis to treat disease</article-title><source>EMBO J</source><year>2021</year><volume>40</volume><fpage>e107341</fpage><pub-id pub-id-type="doi">10.15252/embj.2020107341</pub-id><pub-id pub-id-type="pmid">34037273</pub-id><pub-id pub-id-type="pmcid">PMC8280825</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>N</given-names></name><name name-style="western"><surname>Keating</surname><given-names>M</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>P</given-names></name><name name-style="western"><surname>Ferrajoli</surname><given-names>A</given-names></name><name name-style="western"><surname>Burger</surname><given-names>J</given-names></name><name name-style="western"><surname>Borthakur</surname><given-names>G</given-names></name><etal/></person-group><article-title>Ibrutinib and Venetoclax for First-Line Treatment of CLL</article-title><source>N Engl J Med</source><year>2019</year><volume>380</volume><fpage>2095</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1900574</pub-id><pub-id pub-id-type="pmid">31141631</pub-id><pub-id pub-id-type="pmcid">PMC11827445</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Souers</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Leverson</surname><given-names>JD</given-names></name><name name-style="western"><surname>Boghaert</surname><given-names>ER</given-names></name><name name-style="western"><surname>Ackler</surname><given-names>SL</given-names></name><name name-style="western"><surname>Catron</surname><given-names>ND</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</article-title><source>Nat Med</source><year>2013</year><volume>19</volume><fpage>202</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nm.3048</pub-id><pub-id pub-id-type="pmid">23291630</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diepstraten</surname><given-names>ST</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>MA</given-names></name><name name-style="western"><surname>Czabotar</surname><given-names>PE</given-names></name><name name-style="western"><surname>Lessene</surname><given-names>G</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>GL</given-names></name></person-group><article-title>The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs</article-title><source>Nat Rev Cancer</source><year>2022</year><volume>22</volume><fpage>45</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/s41568-021-00407-4</pub-id><pub-id pub-id-type="pmid">34663943</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merino</surname><given-names>D</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>GL</given-names></name><name name-style="western"><surname>Lessene</surname><given-names>G</given-names></name><name name-style="western"><surname>Wei</surname><given-names>AH</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>AW</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>BH3-Mimetic drugs: blazing the trail for new cancer medicines</article-title><source>Cancer Cell</source><year>2018</year><volume>34</volume><fpage>879</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2018.11.004</pub-id><pub-id pub-id-type="pmid">30537511</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>K</given-names></name><name name-style="western"><surname>Al-Sawaf</surname><given-names>O</given-names></name><name name-style="western"><surname>Bahlo</surname><given-names>J</given-names></name><name name-style="western"><surname>Fink</surname><given-names>AM</given-names></name><name name-style="western"><surname>Tandon</surname><given-names>M</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>M</given-names></name><etal/></person-group><article-title>Venetoclax and obinutuzumab in patients with CLL and coexisting conditions</article-title><source>N Engl J Med</source><year>2019</year><volume>380</volume><fpage>2225</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1815281</pub-id><pub-id pub-id-type="pmid">31166681</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>AW</given-names></name><name name-style="western"><surname>Davids</surname><given-names>MS</given-names></name><name name-style="western"><surname>Pagel</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kahl</surname><given-names>BS</given-names></name><name name-style="western"><surname>Puvvada</surname><given-names>SD</given-names></name><name name-style="western"><surname>Gerecitano</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia</article-title><source>N Engl J Med</source><year>2016</year><volume>374</volume><fpage>311</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1513257</pub-id><pub-id pub-id-type="pmid">26639348</pub-id><pub-id pub-id-type="pmcid">PMC7107002</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seymour</surname><given-names>JF</given-names></name><name name-style="western"><surname>Kipps</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Eichhorst</surname><given-names>B</given-names></name><name name-style="western"><surname>Hillmen</surname><given-names>P</given-names></name><name name-style="western"><surname>D&#8217;Rozario</surname><given-names>J</given-names></name><name name-style="western"><surname>Assouline</surname><given-names>S</given-names></name><etal/></person-group><article-title>Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia</article-title><source>N Engl J Med</source><year>2018</year><volume>378</volume><fpage>1107</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1713976</pub-id><pub-id pub-id-type="pmid">29562156</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiNardo</surname><given-names>CD</given-names></name><name name-style="western"><surname>Jonas</surname><given-names>BA</given-names></name><name name-style="western"><surname>Pullarkat</surname><given-names>V</given-names></name><name name-style="western"><surname>Thirman</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>JS</given-names></name><name name-style="western"><surname>Wei</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><fpage>617</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2012971</pub-id><pub-id pub-id-type="pmid">32786187</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frenette</surname><given-names>CT</given-names></name><name name-style="western"><surname>Morelli</surname><given-names>G</given-names></name><name name-style="western"><surname>Shiffman</surname><given-names>ML</given-names></name><name name-style="western"><surname>Frederick</surname><given-names>RT</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>RA</given-names></name><name name-style="western"><surname>Fallon</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Emricasan improves liver function in patients with cirrhosis and high model for end-stage liver disease scores compared with placebo</article-title><source>Clin Gastroenterol Hepatol</source><year>2019</year><volume>17</volume><fpage>774</fpage><lpage>783.e774</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2018.06.012</pub-id><pub-id pub-id-type="pmid">29913280</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Tsao</surname><given-names>G</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>J</given-names></name><name name-style="western"><surname>Kayali</surname><given-names>Z</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>SA</given-names></name><name name-style="western"><surname>Abdelmalek</surname><given-names>MF</given-names></name><name name-style="western"><surname>Lawitz</surname><given-names>E</given-names></name><etal/></person-group><article-title>Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension</article-title><source>J Hepatol</source><year>2020</year><volume>72</volume><fpage>885</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2019.12.010</pub-id><pub-id pub-id-type="pmid">31870950</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrison</surname><given-names>SA</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jabbar</surname><given-names>A</given-names></name><name name-style="western"><surname>Vemulapalli</surname><given-names>R</given-names></name><name name-style="western"><surname>Younes</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Freilich</surname><given-names>B</given-names></name><etal/></person-group><article-title>A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis</article-title><source>J Hepatol</source><year>2020</year><volume>72</volume><fpage>816</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2019.11.024</pub-id><pub-id pub-id-type="pmid">31887369</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Aaronson</surname><given-names>SA</given-names></name><name name-style="western"><surname>Abrams</surname><given-names>J</given-names></name><name name-style="western"><surname>Alnemri</surname><given-names>ES</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>DW</given-names></name><name name-style="western"><surname>Baehrecke</surname><given-names>EH</given-names></name><etal/></person-group><article-title>Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes</article-title><source>Cell Death Differ</source><year>2009</year><volume>16</volume><fpage>1093</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.44</pub-id><pub-id pub-id-type="pmid">19373242</pub-id><pub-id pub-id-type="pmcid">PMC2757140</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boada-Romero</surname><given-names>E</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>J</given-names></name><name name-style="western"><surname>Heckmann</surname><given-names>BL</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>The clearance of dead cells by efferocytosis</article-title><source>Nat Rev Mol Cell Biol</source><year>2020</year><volume>21</volume><fpage>398</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1038/s41580-020-0232-1</pub-id><pub-id pub-id-type="pmid">32251387</pub-id><pub-id pub-id-type="pmcid">PMC7392086</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothlin</surname><given-names>CV</given-names></name><name name-style="western"><surname>Hille</surname><given-names>TD</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></name></person-group><article-title>Determining the effector response to cell death</article-title><source>Nat Rev Immunol</source><year>2021</year><volume>21</volume><fpage>292</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-00456-0</pub-id><pub-id pub-id-type="pmid">33188303</pub-id><pub-id pub-id-type="pmcid">PMC8102327</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morioka</surname><given-names>S</given-names></name><name name-style="western"><surname>Maueroder</surname><given-names>C</given-names></name><name name-style="western"><surname>Ravichandran</surname><given-names>KS</given-names></name></person-group><article-title>Living on the edge: efferocytosis at the interface of homeostasis and pathology</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>1149</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.04.018</pub-id><pub-id pub-id-type="pmid">31117011</pub-id><pub-id pub-id-type="pmcid">PMC6721617</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raymond</surname><given-names>MH</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tudor</surname><given-names>DR</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>CD</given-names></name><name name-style="western"><surname>Morioka</surname><given-names>S</given-names></name><etal/></person-group><article-title>Live cell tracking of macrophage efferocytosis during Drosophila embryo development in vivo</article-title><source>Science</source><year>2022</year><volume>375</volume><fpage>1182</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1126/science.abl4430</pub-id><pub-id pub-id-type="pmid">35271315</pub-id><pub-id pub-id-type="pmcid">PMC7612538</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nonomura</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hamachi</surname><given-names>M</given-names></name><name name-style="western"><surname>Koike</surname><given-names>M</given-names></name><name name-style="western"><surname>Uchiyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nakazato</surname><given-names>K</given-names></name><etal/></person-group><article-title>Local apoptosis modulates early mammalian brain development through the elimination of morphogen-producing cells</article-title><source>Dev Cell</source><year>2013</year><volume>27</volume><fpage>621</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.11.015</pub-id><pub-id pub-id-type="pmid">24369835</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>MO</given-names></name><name name-style="western"><surname>Sarkisian</surname><given-names>MR</given-names></name><name name-style="western"><surname>Mehal</surname><given-names>WZ</given-names></name><name name-style="western"><surname>Rakic</surname><given-names>P</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name></person-group><article-title>Phosphatidylserine receptor is required for clearance of apoptotic cells</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>1560</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1126/science.1087621</pub-id><pub-id pub-id-type="pmid">14645847</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kist</surname><given-names>M</given-names></name><name name-style="western"><surname>Vucic</surname><given-names>D</given-names></name></person-group><article-title>Cell death pathways: intricate connections and disease implications</article-title><source>EMBO J</source><year>2021</year><volume>40</volume><fpage>e106700</fpage><pub-id pub-id-type="doi">10.15252/embj.2020106700</pub-id><pub-id pub-id-type="pmid">33439509</pub-id><pub-id pub-id-type="pmcid">PMC7917554</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doerflinger</surname><given-names>M</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Whitney</surname><given-names>P</given-names></name><name name-style="western"><surname>Salvamoser</surname><given-names>R</given-names></name><name name-style="western"><surname>Engel</surname><given-names>S</given-names></name><name name-style="western"><surname>Kueh</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Flexible usage and interconnectivity of diverse cell death pathways protect against intracellular infection</article-title><source>Immunity</source><year>2020</year><volume>53</volume><fpage>533</fpage><lpage>47.e537</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.07.004</pub-id><pub-id pub-id-type="pmid">32735843</pub-id><pub-id pub-id-type="pmcid">PMC7500851</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oberst</surname><given-names>A</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>CP</given-names></name><name name-style="western"><surname>Weinlich</surname><given-names>R</given-names></name><name name-style="western"><surname>McCormick</surname><given-names>LL</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>P</given-names></name><name name-style="western"><surname>Pop</surname><given-names>C</given-names></name><etal/></person-group><article-title>Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis</article-title><source>Nature</source><year>2011</year><volume>471</volume><fpage>363</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nature09852</pub-id><pub-id pub-id-type="pmid">21368763</pub-id><pub-id pub-id-type="pmcid">PMC3077893</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Upton</surname><given-names>JW</given-names></name><name name-style="western"><surname>Long</surname><given-names>AB</given-names></name><name name-style="western"><surname>Livingston-Rosanoff</surname><given-names>D</given-names></name><name name-style="western"><surname>Daley-Bauer</surname><given-names>LP</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>R</given-names></name><etal/></person-group><article-title>RIP3 mediates the embryonic lethality of caspase-8-deficient mice</article-title><source>Nature</source><year>2011</year><volume>471</volume><fpage>368</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/nature09857</pub-id><pub-id pub-id-type="pmid">21368762</pub-id><pub-id pub-id-type="pmcid">PMC3060292</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>MA</given-names></name><name name-style="western"><surname>Perez-Jimenez</surname><given-names>E</given-names></name><name name-style="western"><surname>Oberst</surname><given-names>A</given-names></name><name name-style="western"><surname>Ng</surname><given-names>A</given-names></name><name name-style="western"><surname>Massoumi</surname><given-names>R</given-names></name><name name-style="western"><surname>Xavier</surname><given-names>R</given-names></name><etal/></person-group><article-title>Caspase 8 inhibits programmed necrosis by processing CYLD</article-title><source>Nat Cell Biol</source><year>2011</year><volume>13</volume><fpage>1437</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1038/ncb2362</pub-id><pub-id pub-id-type="pmid">22037414</pub-id><pub-id pub-id-type="pmcid">PMC3229661</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cauwels</surname><given-names>A</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>B</given-names></name><name name-style="western"><surname>Waeytens</surname><given-names>A</given-names></name><name name-style="western"><surname>Cuvelier</surname><given-names>C</given-names></name><name name-style="western"><surname>Brouckaert</surname><given-names>P</given-names></name></person-group><article-title>Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2</article-title><source>Nat Immunol</source><year>2003</year><volume>4</volume><fpage>387</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/ni914</pub-id><pub-id pub-id-type="pmid">12652297</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vercammen</surname><given-names>D</given-names></name><name name-style="western"><surname>Brouckaert</surname><given-names>G</given-names></name><name name-style="western"><surname>Denecker</surname><given-names>G</given-names></name><name name-style="western"><surname>Van de Craen</surname><given-names>M</given-names></name><name name-style="western"><surname>Declercq</surname><given-names>W</given-names></name><name name-style="western"><surname>Fiers</surname><given-names>W</given-names></name><etal/></person-group><article-title>Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>919</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1084/jem.188.5.919</pub-id><pub-id pub-id-type="pmid">9730893</pub-id><pub-id pub-id-type="pmcid">PMC2213397</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vercammen</surname><given-names>D</given-names></name><name name-style="western"><surname>Beyaert</surname><given-names>R</given-names></name><name name-style="western"><surname>Denecker</surname><given-names>G</given-names></name><name name-style="western"><surname>Goossens</surname><given-names>V</given-names></name><name name-style="western"><surname>Van Loo</surname><given-names>G</given-names></name><name name-style="western"><surname>Declercq</surname><given-names>W</given-names></name><etal/></person-group><article-title>Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor</article-title><source>J Exp Med</source><year>1998</year><volume>187</volume><fpage>1477</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1084/jem.187.9.1477</pub-id><pub-id pub-id-type="pmid">9565639</pub-id><pub-id pub-id-type="pmcid">PMC2212268</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brumatti</surname><given-names>G</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C</given-names></name><name name-style="western"><surname>Lalaoui</surname><given-names>N</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>NY</given-names></name><name name-style="western"><surname>Navarro</surname><given-names>M</given-names></name><name name-style="western"><surname>Tanzer</surname><given-names>MC</given-names></name><etal/></person-group><article-title>The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia</article-title><source>Sci Transl Med</source><year>2016</year><volume>8</volume><fpage>339ra369</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aad3099</pub-id><pub-id pub-id-type="pmid">27194727</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saelens</surname><given-names>X</given-names></name><name name-style="western"><surname>Kalai</surname><given-names>M</given-names></name><name name-style="western"><surname>Vandenabeele</surname><given-names>P</given-names></name></person-group><article-title>Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>41620</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1074/jbc.M103674200</pub-id><pub-id pub-id-type="pmid">11555640</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tait</surname><given-names>SW</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>Mitochondria and cell death: outer membrane permeabilization and beyond</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>621</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/nrm2952</pub-id><pub-id pub-id-type="pmid">20683470</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chipuk</surname><given-names>JE</given-names></name><name name-style="western"><surname>Mohammed</surname><given-names>JN</given-names></name><name name-style="western"><surname>Gelles</surname><given-names>JD</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Mechanistic connections between mitochondrial biology and regulated cell death</article-title><source>Dev Cell</source><year>2021</year><volume>56</volume><fpage>1221</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.03.033</pub-id><pub-id pub-id-type="pmid">33887204</pub-id><pub-id pub-id-type="pmcid">PMC8102388</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name><name name-style="western"><surname>Victor</surname><given-names>B</given-names></name></person-group><article-title>The pantheon of the fallen: why are there so many forms of cell death?</article-title><source>Trends Cell Biol</source><year>2012</year><volume>22</volume><fpage>555</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2012.08.008</pub-id><pub-id pub-id-type="pmid">22995729</pub-id><pub-id pub-id-type="pmcid">PMC3568685</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davidovich</surname><given-names>P</given-names></name><name name-style="western"><surname>Kearney</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Martin</surname><given-names>SJ</given-names></name></person-group><article-title>Inflammatory outcomes of apoptosis, necrosis and necroptosis</article-title><source>Biol Chem</source><year>2014</year><volume>395</volume><fpage>1163</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1515/hsz-2014-0164</pub-id><pub-id pub-id-type="pmid">25153241</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>L&#243;pez-Soto</surname><given-names>A</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Caspases connect cell-death signaling to organismal homeostasis</article-title><source>Immunity</source><year>2016</year><volume>44</volume><fpage>221</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.01.020</pub-id><pub-id pub-id-type="pmid">26885855</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duprez</surname><given-names>L</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>N</given-names></name><name name-style="western"><surname>Van Hauwermeiren</surname><given-names>F</given-names></name><name name-style="western"><surname>Vandendriessche</surname><given-names>B</given-names></name><name name-style="western"><surname>Goossens</surname><given-names>V</given-names></name><name name-style="western"><surname>Vanden Berghe</surname><given-names>T</given-names></name><etal/></person-group><article-title>RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>908</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.09.020</pub-id><pub-id pub-id-type="pmid">22195746</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glab</surname><given-names>JA</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Puthalakath</surname><given-names>H</given-names></name></person-group><article-title>Bcl-2 family proteins, beyond the veil</article-title><source>Int Rev Cell Mol Biol</source><year>2020</year><volume>351</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/bs.ircmb.2019.12.001</pub-id><pub-id pub-id-type="pmid">32247577</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gross</surname><given-names>A</given-names></name><name name-style="western"><surname>Katz</surname><given-names>SG</given-names></name></person-group><article-title>Non-apoptotic functions of BCL-2 family proteins</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>1348</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.22</pub-id><pub-id pub-id-type="pmid">28234359</pub-id><pub-id pub-id-type="pmcid">PMC5520452</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hollville</surname><given-names>E</given-names></name><name name-style="western"><surname>Deshmukh</surname><given-names>M</given-names></name></person-group><article-title>Physiological functions of non-apoptotic caspase activity in the nervous system</article-title><source>Semin Cell Dev Biol</source><year>2018</year><volume>82</volume><fpage>127</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.11.037</pub-id><pub-id pub-id-type="pmid">29199140</pub-id><pub-id pub-id-type="pmcid">PMC5988915</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakajima</surname><given-names>YI</given-names></name><name name-style="western"><surname>Kuranaga</surname><given-names>E</given-names></name></person-group><article-title>Caspase-dependent non-apoptotic processes in development</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>1422</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.36</pub-id><pub-id pub-id-type="pmid">28524858</pub-id><pub-id pub-id-type="pmcid">PMC5520453</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aram</surname><given-names>L</given-names></name><name name-style="western"><surname>Yacobi-Sharon</surname><given-names>K</given-names></name><name name-style="western"><surname>Arama</surname><given-names>E</given-names></name></person-group><article-title>CDPs: caspase-dependent non-lethal cellular processes</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>1307</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.111</pub-id><pub-id pub-id-type="pmid">28695898</pub-id><pub-id pub-id-type="pmcid">PMC5520448</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feinstein-Rotkopf</surname><given-names>Y</given-names></name><name name-style="western"><surname>Arama</surname><given-names>E</given-names></name></person-group><article-title>Can&#8217;t live without them, can live with them: roles of caspases during vital cellular processes</article-title><source>Apoptosis</source><year>2009</year><volume>14</volume><fpage>980</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1007/s10495-009-0346-6</pub-id><pub-id pub-id-type="pmid">19373560</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perciavalle</surname><given-names>RM</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>DP</given-names></name><name name-style="western"><surname>Koss</surname><given-names>B</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>J</given-names></name><name name-style="western"><surname>Milasta</surname><given-names>S</given-names></name><name name-style="western"><surname>Bathina</surname><given-names>M</given-names></name><etal/></person-group><article-title>Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration</article-title><source>Nat Cell Biol</source><year>2012</year><volume>14</volume><fpage>575</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/ncb2488</pub-id><pub-id pub-id-type="pmid">22544066</pub-id><pub-id pub-id-type="pmcid">PMC3401947</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><name name-style="western"><surname>Tan</surname><given-names>JL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YX</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JL</given-names></name><etal/></person-group><article-title>ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway</article-title><source>J Mol Cell Cardiol</source><year>2015</year><volume>81</volume><fpage>150</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.02.015</pub-id><pub-id pub-id-type="pmid">25731682</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanden Berghe</surname><given-names>T</given-names></name><name name-style="western"><surname>Hulpiau</surname><given-names>P</given-names></name><name name-style="western"><surname>Martens</surname><given-names>L</given-names></name><name name-style="western"><surname>Vandenbroucke</surname><given-names>RE</given-names></name><name name-style="western"><surname>Van Wonterghem</surname><given-names>E</given-names></name><name name-style="western"><surname>Perry</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Passenger mutations confound interpretation of all genetically modified congenic mice</article-title><source>Immunity</source><year>2015</year><volume>43</volume><fpage>200</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.011</pub-id><pub-id pub-id-type="pmid">26163370</pub-id><pub-id pub-id-type="pmcid">PMC4800811</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>He</surname><given-names>H</given-names></name><etal/></person-group><article-title>Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin</article-title><source>Nature</source><year>2017</year><volume>547</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nature22393</pub-id><pub-id pub-id-type="pmid">28459430</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>C</given-names></name><name name-style="western"><surname>Fernandes-Alnemri</surname><given-names>T</given-names></name><name name-style="western"><surname>Mayes</surname><given-names>L</given-names></name><name name-style="western"><surname>Alnemri</surname><given-names>D</given-names></name><name name-style="western"><surname>Cingolani</surname><given-names>G</given-names></name><name name-style="western"><surname>Alnemri</surname><given-names>ES</given-names></name></person-group><article-title>Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>14128</fpage><pub-id pub-id-type="doi">10.1038/ncomms14128</pub-id><pub-id pub-id-type="pmid">28045099</pub-id><pub-id pub-id-type="pmcid">PMC5216131</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gould</surname><given-names>TW</given-names></name><name name-style="western"><surname>Buss</surname><given-names>RR</given-names></name><name name-style="western"><surname>Vinsant</surname><given-names>S</given-names></name><name name-style="western"><surname>Prevette</surname><given-names>D</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>8774</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2315-06.2006</pub-id><pub-id pub-id-type="pmid">16928866</pub-id><pub-id pub-id-type="pmcid">PMC6674380</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reyes</surname><given-names>NA</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>JK</given-names></name><name name-style="western"><surname>Austgen</surname><given-names>K</given-names></name><name name-style="western"><surname>VandenBerg</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Oakes</surname><given-names>SA</given-names></name></person-group><article-title>Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis</article-title><source>J Clin Investig</source><year>2010</year><volume>120</volume><fpage>3673</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1172/JCI42986</pub-id><pub-id pub-id-type="pmid">20890041</pub-id><pub-id pub-id-type="pmcid">PMC2947232</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kostic</surname><given-names>V</given-names></name><name name-style="western"><surname>Jackson-Lewis</surname><given-names>V</given-names></name><name name-style="western"><surname>Dubois-Dauphin</surname><given-names>M</given-names></name><name name-style="western"><surname>Przedborski</surname><given-names>S</given-names></name></person-group><article-title>Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis</article-title><source>Science</source><year>1997</year><volume>277</volume><fpage>559</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1126/science.277.5325.559</pub-id><pub-id pub-id-type="pmid">9228005</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vukosavic</surname><given-names>S</given-names></name><name name-style="western"><surname>Stefanis</surname><given-names>L</given-names></name><name name-style="western"><surname>Jackson-Lewis</surname><given-names>V</given-names></name><name name-style="western"><surname>Gu&#233;gan</surname><given-names>C</given-names></name><name name-style="western"><surname>Romero</surname><given-names>N</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis</article-title><source>J Neurosci</source><year>2000</year><volume>20</volume><fpage>9119</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-24-09119.2000</pub-id><pub-id pub-id-type="pmid">11124989</pub-id><pub-id pub-id-type="pmcid">PMC6773037</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>H</given-names></name><name name-style="western"><surname>Tsukita</surname><given-names>K</given-names></name><name name-style="western"><surname>Iwasato</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tomioka</surname><given-names>M</given-names></name><name name-style="western"><surname>Tateno</surname><given-names>M</given-names></name><etal/></person-group><article-title>The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model</article-title><source>EMBO J</source><year>2003</year><volume>22</volume><fpage>6665</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg634</pub-id><pub-id pub-id-type="pmid">14657037</pub-id><pub-id pub-id-type="pmcid">PMC291829</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wootz</surname><given-names>H</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>I</given-names></name><name name-style="western"><surname>Korhonen</surname><given-names>L</given-names></name><name name-style="western"><surname>Lindholm</surname><given-names>D</given-names></name></person-group><article-title>XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><fpage>1890</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.02.021</pub-id><pub-id pub-id-type="pmid">16566922</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kieran</surname><given-names>D</given-names></name><name name-style="western"><surname>Woods</surname><given-names>I</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Prehn</surname><given-names>JH</given-names></name></person-group><article-title>Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>20606</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1073/pnas.0707906105</pub-id><pub-id pub-id-type="pmid">18077368</pub-id><pub-id pub-id-type="pmcid">PMC2154478</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Ona</surname><given-names>VO</given-names></name><name name-style="western"><surname>Gu&#233;gan</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Jackson-Lewis</surname><given-names>V</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>335</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1126/science.288.5464.335</pub-id><pub-id pub-id-type="pmid">10764647</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girgenrath</surname><given-names>M</given-names></name><name name-style="western"><surname>Dominov</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kostek</surname><given-names>CA</given-names></name><name name-style="western"><surname>Miller</surname><given-names>JB</given-names></name></person-group><article-title>Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy</article-title><source>J Clin Investig</source><year>2004</year><volume>114</volume><fpage>1635</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1172/JCI22928</pub-id><pub-id pub-id-type="pmid">15578095</pub-id><pub-id pub-id-type="pmcid">PMC529286</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>JE</given-names></name><name name-style="western"><surname>Rubinsztein</surname><given-names>DC</given-names></name></person-group><article-title>Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy</article-title><source>Hum Mol Genet</source><year>2011</year><volume>20</volume><fpage>1154</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq559</pub-id><pub-id pub-id-type="pmid">21199860</pub-id><pub-id pub-id-type="pmcid">PMC3043663</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dominov</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kravetz</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ardelt</surname><given-names>M</given-names></name><name name-style="western"><surname>Kostek</surname><given-names>CA</given-names></name><name name-style="western"><surname>Beermann</surname><given-names>ML</given-names></name><name name-style="western"><surname>Miller</surname><given-names>JB</given-names></name></person-group><article-title>Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>1029</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi095</pub-id><pub-id pub-id-type="pmid">15757977</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sagot</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dubois-Dauphin</surname><given-names>M</given-names></name><name name-style="western"><surname>Tan</surname><given-names>SA</given-names></name><name name-style="western"><surname>de Bilbao</surname><given-names>F</given-names></name><name name-style="western"><surname>Aebischer</surname><given-names>P</given-names></name><name name-style="western"><surname>Martinou</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease</article-title><source>J Neurosci</source><year>1995</year><volume>15</volume><fpage>7727</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-11-07727.1995</pub-id><pub-id pub-id-type="pmid">7472523</pub-id><pub-id pub-id-type="pmcid">PMC6578059</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tossing</surname><given-names>G</given-names></name><name name-style="western"><surname>Livernoche</surname><given-names>R</given-names></name><name name-style="western"><surname>Maios</surname><given-names>C</given-names></name><name name-style="western"><surname>Bretonneau</surname><given-names>C</given-names></name><name name-style="western"><surname>Labarre</surname><given-names>A</given-names></name><name name-style="western"><surname>Parker</surname><given-names>JA</given-names></name></person-group><article-title>Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS</article-title><source>Hum Mol Genet</source><year>2022</year><volume>31</volume><fpage>3313</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddac116</pub-id><pub-id pub-id-type="pmid">35594544</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kudo</surname><given-names>W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HP</given-names></name><name name-style="western"><surname>Smith</surname><given-names>MA</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Matsuyama</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HG</given-names></name></person-group><article-title>Inhibition of Bax protects neuronal cells from oligomeric A&#946; neurotoxicity</article-title><source>Cell Death Dis</source><year>2012</year><volume>3</volume><fpage>e309</fpage><pub-id pub-id-type="doi">10.1038/cddis.2012.43</pub-id><pub-id pub-id-type="pmid">22592316</pub-id><pub-id pub-id-type="pmcid">PMC3366077</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bov&#233;</surname><given-names>J</given-names></name><name name-style="western"><surname>Mart&#237;nez-Vicente</surname><given-names>M</given-names></name><name name-style="western"><surname>Dehay</surname><given-names>B</given-names></name><name name-style="western"><surname>Perier</surname><given-names>C</given-names></name><name name-style="western"><surname>Recasens</surname><given-names>A</given-names></name><name name-style="western"><surname>Bombrun</surname><given-names>A</given-names></name><etal/></person-group><article-title>BAX channel activity mediates lysosomal disruption linked to Parkinson disease</article-title><source>Autophagy</source><year>2014</year><volume>10</volume><fpage>889</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.4161/auto.28286</pub-id><pub-id pub-id-type="pmid">24686337</pub-id><pub-id pub-id-type="pmcid">PMC5119069</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vila</surname><given-names>M</given-names></name><name name-style="western"><surname>Jackson-Lewis</surname><given-names>V</given-names></name><name name-style="western"><surname>Vukosavic</surname><given-names>S</given-names></name><name name-style="western"><surname>Djaldetti</surname><given-names>R</given-names></name><name name-style="western"><surname>Liberatore</surname><given-names>G</given-names></name><name name-style="western"><surname>Offen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson&#8217;s disease</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>2837</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1073/pnas.051633998</pub-id><pub-id pub-id-type="pmid">11226327</pub-id><pub-id pub-id-type="pmcid">PMC30226</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>TW</given-names></name><name name-style="western"><surname>Moon</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JE</given-names></name><name name-style="western"><surname>Koh</surname><given-names>HC</given-names></name><name name-style="western"><surname>Rhyu</surname><given-names>IJ</given-names></name><etal/></person-group><article-title>Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson&#8217;s diseases</article-title><source>PloS one</source><year>2011</year><volume>6</volume><fpage>e25346</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0025346</pub-id><pub-id pub-id-type="pmid">22043283</pub-id><pub-id pub-id-type="pmcid">PMC3197195</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>C</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sun</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><etal/></person-group><article-title>Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats</article-title><source>Life Sci</source><year>2016</year><volume>144</volume><fpage>113</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2015.11.019</pub-id><pub-id pub-id-type="pmid">26612350</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>He</surname><given-names>P</given-names></name><name name-style="western"><surname>Adler</surname><given-names>CH</given-names></name><name name-style="western"><surname>Shill</surname><given-names>H</given-names></name><name name-style="western"><surname>Beach</surname><given-names>TG</given-names></name><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><etal/></person-group><article-title>Bid signal pathway components are identified in the temporal cortex with Parkinson disease</article-title><source>Neurology</source><year>2012</year><volume>79</volume><fpage>1767</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182703f76</pub-id><pub-id pub-id-type="pmid">23019260</pub-id><pub-id pub-id-type="pmcid">PMC3475620</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biswas</surname><given-names>SC</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>E</given-names></name><name name-style="western"><surname>Park</surname><given-names>C</given-names></name><name name-style="western"><surname>Malagelada</surname><given-names>C</given-names></name><name name-style="western"><surname>Greene</surname><given-names>LA</given-names></name></person-group><article-title>Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease</article-title><source>Neurochem Res</source><year>2005</year><volume>30</volume><fpage>839</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s11064-005-6877-5</pub-id><pub-id pub-id-type="pmid">16187218</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akhter</surname><given-names>R</given-names></name><name name-style="western"><surname>Saleem</surname><given-names>S</given-names></name><name name-style="western"><surname>Saha</surname><given-names>A</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>SC</given-names></name></person-group><article-title>The pro-apoptotic protein Bmf co-operates with Bim and Puma in neuron death induced by &#946;-amyloid or NGF deprivation</article-title><source>Mol Cell Neurosci</source><year>2018</year><volume>88</volume><fpage>249</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2018.02.011</pub-id><pub-id pub-id-type="pmid">29499358</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imaizumi</surname><given-names>K</given-names></name><name name-style="western"><surname>Morihara</surname><given-names>T</given-names></name><name name-style="western"><surname>Mori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Katayama</surname><given-names>T</given-names></name><name name-style="western"><surname>Tsuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Furuyama</surname><given-names>T</given-names></name><etal/></person-group><article-title>The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>7975</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.12.7975</pub-id><pub-id pub-id-type="pmid">10075695</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Louneva</surname><given-names>N</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>JW</given-names></name><name name-style="western"><surname>Han</surname><given-names>LY</given-names></name><name name-style="western"><surname>Talbot</surname><given-names>K</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>RS</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer&#8217;s disease</article-title><source>Am J Pathol</source><year>2008</year><volume>173</volume><fpage>1488</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2008.080434</pub-id><pub-id pub-id-type="pmid">18818379</pub-id><pub-id pub-id-type="pmcid">PMC2570138</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rohn</surname><given-names>TT</given-names></name><name name-style="western"><surname>Rissman</surname><given-names>RA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>MC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YE</given-names></name><name name-style="western"><surname>Cotman</surname><given-names>CW</given-names></name><name name-style="western"><surname>Head</surname><given-names>E</given-names></name></person-group><article-title>Caspase-9 activation and caspase cleavage of tau in the Alzheimer&#8217;s disease brain</article-title><source>Neurobiol Dis</source><year>2002</year><volume>11</volume><fpage>341</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1006/nbdi.2002.0549</pub-id><pub-id pub-id-type="pmid">12505426</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Hunot</surname><given-names>S</given-names></name><name name-style="western"><surname>Michel</surname><given-names>PP</given-names></name><name name-style="western"><surname>Muriel</surname><given-names>MP</given-names></name><name name-style="western"><surname>Vyas</surname><given-names>S</given-names></name><name name-style="western"><surname>Faucheux</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson&#8217;s disease</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>2875</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1073/pnas.040556597</pub-id><pub-id pub-id-type="pmid">10688892</pub-id><pub-id pub-id-type="pmcid">PMC16023</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><etal/></person-group><article-title>BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer&#8217;s disease pathology</article-title><source>iScience</source><year>2021</year><volume>24</volume><fpage>102942</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2021.102942</pub-id><pub-id pub-id-type="pmid">34430820</pub-id><pub-id pub-id-type="pmcid">PMC8369003</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rissman</surname><given-names>RA</given-names></name><name name-style="western"><surname>Poon</surname><given-names>WW</given-names></name><name name-style="western"><surname>Blurton-Jones</surname><given-names>M</given-names></name><name name-style="western"><surname>Oddo</surname><given-names>S</given-names></name><name name-style="western"><surname>Torp</surname><given-names>R</given-names></name><name name-style="western"><surname>Vitek</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology</article-title><source>J Clin Investig</source><year>2004</year><volume>114</volume><fpage>121</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1172/JCI200420640</pub-id><pub-id pub-id-type="pmid">15232619</pub-id><pub-id pub-id-type="pmcid">PMC437967</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gervais</surname><given-names>FG</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>GS</given-names></name><name name-style="western"><surname>Vaillancourt</surname><given-names>JP</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Involvement of caspases in proteolytic cleavage of Alzheimer&#8217;s amyloid-beta precursor protein and amyloidogenic A beta peptide formation</article-title><source>Cell</source><year>1999</year><volume>97</volume><fpage>395</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80748-5</pub-id><pub-id pub-id-type="pmid">10319819</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>J</given-names></name><name name-style="western"><surname>Lauretti</surname><given-names>E</given-names></name><name name-style="western"><surname>Pratic&#242;</surname><given-names>D</given-names></name></person-group><article-title>Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3&#946; kinase: implications for Alzheimer&#8217;s disease</article-title><source>Mol Psychiatry</source><year>2017</year><volume>22</volume><fpage>1002</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/mp.2016.214</pub-id><pub-id pub-id-type="pmid">28138159</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rohn</surname><given-names>TT</given-names></name><name name-style="western"><surname>Vyas</surname><given-names>V</given-names></name><name name-style="western"><surname>Hernandez-Estrada</surname><given-names>T</given-names></name><name name-style="western"><surname>Nichol</surname><given-names>KE</given-names></name><name name-style="western"><surname>Christie</surname><given-names>LA</given-names></name><name name-style="western"><surname>Head</surname><given-names>E</given-names></name></person-group><article-title>Lack of pathology in a triple transgenic mouse model of Alzheimer&#8217;s disease after overexpression of the anti-apoptotic protein Bcl-2</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>3051</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5620-07.2008</pub-id><pub-id pub-id-type="pmid">18354008</pub-id><pub-id pub-id-type="pmcid">PMC6670712</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumasaka</surname><given-names>DK</given-names></name><name name-style="western"><surname>Galvan</surname><given-names>V</given-names></name><name name-style="western"><surname>Head</surname><given-names>E</given-names></name><name name-style="western"><surname>Rohn</surname><given-names>TT</given-names></name></person-group><article-title>Caspase cleavage of the amyloid precursor protein is prevented after overexpression of bcl-2 in a triple transgenic mouse model of Alzheimer&#8217;s disease</article-title><source>Int J Physiol, Pathophysiol Pharmacol</source><year>2009</year><volume>1</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">20411026</pub-id><pub-id pub-id-type="pmcid">PMC2856934</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Amelio</surname><given-names>M</given-names></name><name name-style="western"><surname>Cavallucci</surname><given-names>V</given-names></name><name name-style="western"><surname>Middei</surname><given-names>S</given-names></name><name name-style="western"><surname>Marchetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Pacioni</surname><given-names>S</given-names></name><name name-style="western"><surname>Ferri</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer&#8217;s disease</article-title><source>Nat Neurosci</source><year>2011</year><volume>14</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1038/nn.2709</pub-id><pub-id pub-id-type="pmid">21151119</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>G</given-names></name><name name-style="western"><surname>Nhan</surname><given-names>HS</given-names></name><name name-style="western"><surname>Tyan</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kawakatsu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Navarro</surname><given-names>M</given-names></name><etal/></person-group><article-title>Caspase activation and caspase-mediated cleavage of APP is associated with amyloid &#946;-protein-induced synapse loss in Alzheimer&#8217;s disease</article-title><source>Cell Rep</source><year>2020</year><volume>31</volume><fpage>107839</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107839</pub-id><pub-id pub-id-type="pmid">32610140</pub-id><pub-id pub-id-type="pmcid">PMC7375398</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pozueta</surname><given-names>J</given-names></name><name name-style="western"><surname>Lefort</surname><given-names>R</given-names></name><name name-style="western"><surname>Ribe</surname><given-names>EM</given-names></name><name name-style="western"><surname>Troy</surname><given-names>CM</given-names></name><name name-style="western"><surname>Arancio</surname><given-names>O</given-names></name><name name-style="western"><surname>Shelanski</surname><given-names>M</given-names></name></person-group><article-title>Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><fpage>1939</fpage><pub-id pub-id-type="doi">10.1038/ncomms2927</pub-id><pub-id pub-id-type="pmid">23748737</pub-id><pub-id pub-id-type="pmcid">PMC4398315</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Troy</surname><given-names>CM</given-names></name><name name-style="western"><surname>Shelanski</surname><given-names>ML</given-names></name></person-group><article-title>Caspase-2 and tau-a toxic partnership?</article-title><source>Nat Med</source><year>2016</year><volume>22</volume><fpage>1207</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nm.4227</pub-id><pub-id pub-id-type="pmid">27824824</pub-id><pub-id pub-id-type="pmcid">PMC9353876</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Kotilinek</surname><given-names>LA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>B</given-names></name><name name-style="western"><surname>Hlynialuk</surname><given-names>C</given-names></name><name name-style="western"><surname>Zahs</surname><given-names>K</given-names></name><name name-style="western"><surname>Ramsden</surname><given-names>M</given-names></name><etal/></person-group><article-title>Caspase-2 cleavage of tau reversibly impairs memory</article-title><source>Nat Med</source><year>2016</year><volume>22</volume><fpage>1268</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1038/nm.4199</pub-id><pub-id pub-id-type="pmid">27723722</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steuer</surname><given-names>EL</given-names></name><name name-style="western"><surname>Kemper</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Hlynialuk</surname><given-names>CJW</given-names></name><name name-style="western"><surname>Leinonen-Wright</surname><given-names>K</given-names></name><name name-style="western"><surname>Montonye</surname><given-names>ML</given-names></name><name name-style="western"><surname>Lapcinski</surname><given-names>IP</given-names></name><etal/></person-group><article-title>Blocking site-specific cleavage of human tau delays progression of disease-related phenotypes in genetically matched tau-transgenic mice modeling frontotemporal dementia</article-title><source>J Neurosci</source><year>2022</year><volume>42</volume><fpage>4737</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0543-22.2022</pub-id><pub-id pub-id-type="pmid">35508385</pub-id><pub-id pub-id-type="pmcid">PMC9186797</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bresinsky</surname><given-names>M</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>JM</given-names></name><name name-style="western"><surname>Vallaster</surname><given-names>B</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P</given-names></name><name name-style="western"><surname>McCue</surname><given-names>WM</given-names></name><name name-style="western"><surname>Fuller</surname><given-names>J</given-names></name><etal/></person-group><article-title>Structure-based design and biological evaluation of novel caspase-2 inhibitors based on the peptide AcVDVAD-CHO and the caspase-2-mediated tau cleavage sequence YKPVD314</article-title><source>ACS Pharmacol Transl Sci</source><year>2022</year><volume>5</volume><fpage>20</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1021/acsptsci.1c00251</pub-id><pub-id pub-id-type="pmid">35059567</pub-id><pub-id pub-id-type="pmcid">PMC8762753</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kajiwara</surname><given-names>Y</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>A</given-names></name><name name-style="western"><surname>Dorr</surname><given-names>N</given-names></name><name name-style="western"><surname>Gama Sosa</surname><given-names>MA</given-names></name><name name-style="western"><surname>Elder</surname><given-names>G</given-names></name><name name-style="western"><surname>Schmeidler</surname><given-names>J</given-names></name><etal/></person-group><article-title>The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits</article-title><source>Hum Mol Genet</source><year>2016</year><volume>25</volume><fpage>4315</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw265</pub-id><pub-id pub-id-type="pmid">27516385</pub-id><pub-id pub-id-type="pmcid">PMC5291199</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Won</surname><given-names>SM</given-names></name><name name-style="western"><surname>Suh</surname><given-names>J</given-names></name><name name-style="western"><surname>Son</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Moon</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Park</surname><given-names>UJ</given-names></name><etal/></person-group><article-title>Induction of the unfolded protein response and cell death pathway in Alzheimer&#8217;s disease, but not in aged Tg2576 mice</article-title><source>Exp Mol Med</source><year>2010</year><volume>42</volume><fpage>386</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.3858/emm.2010.42.5.040</pub-id><pub-id pub-id-type="pmid">20368688</pub-id><pub-id pub-id-type="pmcid">PMC2877248</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolosova</surname><given-names>NG</given-names></name><name name-style="western"><surname>Tyumentsev</surname><given-names>MA</given-names></name><name name-style="western"><surname>Muraleva</surname><given-names>NA</given-names></name><name name-style="western"><surname>Kiseleva</surname><given-names>E</given-names></name><name name-style="western"><surname>Vitovtov</surname><given-names>AO</given-names></name><name name-style="western"><surname>Stefanova</surname><given-names>NA</given-names></name></person-group><article-title>Antioxidant SkQ1 alleviates signs of Alzheimer&#8217;s disease-like pathology in old OXYS rats by reversing mitochondrial deterioration</article-title><source>Curr Alzheimer Res</source><year>2017</year><volume>14</volume><fpage>1283</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.2174/1567205014666170621111033</pub-id><pub-id pub-id-type="pmid">28637402</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perier</surname><given-names>C</given-names></name><name name-style="western"><surname>Bov&#233;</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>DC</given-names></name><name name-style="western"><surname>Dehay</surname><given-names>B</given-names></name><name name-style="western"><surname>Choi</surname><given-names>DK</given-names></name><name name-style="western"><surname>Jackson-Lewis</surname><given-names>V</given-names></name><etal/></person-group><article-title>Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson&#8217;s disease</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>8161</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.0609874104</pub-id><pub-id pub-id-type="pmid">17483459</pub-id><pub-id pub-id-type="pmcid">PMC1876588</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>M</given-names></name><name name-style="western"><surname>Kida</surname><given-names>K</given-names></name><name name-style="western"><surname>Amutuhaire</surname><given-names>W</given-names></name><name name-style="western"><surname>Ichinose</surname><given-names>F</given-names></name><name name-style="western"><surname>Kaneki</surname><given-names>M</given-names></name></person-group><article-title>Gene disruption of caspase-3 prevents MPTP-induced Parkinson&#8217;s disease in mice</article-title><source>Biochem Biophys Res Commun</source><year>2010</year><volume>402</volume><fpage>312</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.10.023</pub-id><pub-id pub-id-type="pmid">20937256</pub-id><pub-id pub-id-type="pmcid">PMC3292898</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viswanath</surname><given-names>V</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Boonplueang</surname><given-names>R</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Stevenson</surname><given-names>FF</given-names></name><name name-style="western"><surname>Yantiri</surname><given-names>F</given-names></name><etal/></person-group><article-title>Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson&#8217;s disease</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>9519</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-24-09519.2001</pub-id><pub-id pub-id-type="pmid">11739563</pub-id><pub-id pub-id-type="pmcid">PMC6763046</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crocker</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Liston</surname><given-names>P</given-names></name><name name-style="western"><surname>Anisman</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Smith</surname><given-names>PD</given-names></name><name name-style="western"><surname>Earl</surname><given-names>N</given-names></name><etal/></person-group><article-title>Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice</article-title><source>Neurobiol Dis</source><year>2003</year><volume>12</volume><fpage>150</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S0969-9961(02)00020-7</pub-id><pub-id pub-id-type="pmid">12667469</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>An</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><etal/></person-group><article-title>Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson&#8217;s disease</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e62905</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0062905</pub-id><pub-id pub-id-type="pmid">23675438</pub-id><pub-id pub-id-type="pmcid">PMC3652845</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toulmond</surname><given-names>S</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Bureau</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ashdown</surname><given-names>H</given-names></name><name name-style="western"><surname>Degen</surname><given-names>S</given-names></name><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>R</given-names></name><etal/></person-group><article-title>Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington&#8217;s disease</article-title><source>Br J Pharmacol</source><year>2004</year><volume>141</volume><fpage>689</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0705662</pub-id><pub-id pub-id-type="pmid">14744804</pub-id><pub-id pub-id-type="pmcid">PMC1574244</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leyva</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Degiacomo</surname><given-names>F</given-names></name><name name-style="western"><surname>Kaltenbach</surname><given-names>LS</given-names></name><name name-style="western"><surname>Holcomb</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N</given-names></name><name name-style="western"><surname>Gafni</surname><given-names>J</given-names></name><etal/></person-group><article-title>Identification and evaluation of small molecule pan-caspase inhibitors in Huntington&#8217;s disease models</article-title><source>Chem Biol</source><year>2010</year><volume>17</volume><fpage>1189</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2010.08.014</pub-id><pub-id pub-id-type="pmid">21095569</pub-id><pub-id pub-id-type="pmcid">PMC3035168</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Ona</surname><given-names>VO</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Ferrante</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Fink</surname><given-names>KB</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease</article-title><source>Nat Med</source><year>2000</year><volume>6</volume><fpage>797</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1038/77528</pub-id><pub-id pub-id-type="pmid">10888929</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cen</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>R</given-names></name><name name-style="western"><surname>He</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer&#8217;s disease mouse model</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><fpage>5731</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19547-6</pub-id><pub-id pub-id-type="pmid">33184293</pub-id><pub-id pub-id-type="pmcid">PMC7665171</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ekholm-Reed</surname><given-names>S</given-names></name><name name-style="western"><surname>Baker</surname><given-names>R</given-names></name><name name-style="western"><surname>Campos</surname><given-names>AR</given-names></name><name name-style="western"><surname>Stouffer</surname><given-names>D</given-names></name><name name-style="western"><surname>Henze</surname><given-names>M</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Reducing Mcl-1 gene dosage induces dopaminergic neuronal loss and motor impairments in Park2 knockout mice</article-title><source>Commun Biol</source><year>2019</year><volume>2</volume><fpage>125</fpage><pub-id pub-id-type="doi">10.1038/s42003-019-0366-x</pub-id><pub-id pub-id-type="pmid">30963113</pub-id><pub-id pub-id-type="pmcid">PMC6449387</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koper</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Van Schoor</surname><given-names>E</given-names></name><name name-style="western"><surname>Ospitalieri</surname><given-names>S</given-names></name><name name-style="western"><surname>Vandenberghe</surname><given-names>R</given-names></name><name name-style="western"><surname>Vandenbulcke</surname><given-names>M</given-names></name><name name-style="western"><surname>von Arnim</surname><given-names>CAF</given-names></name><etal/></person-group><article-title>Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer&#8217;s disease</article-title><source>Acta Neuropathol</source><year>2020</year><volume>139</volume><fpage>463</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1007/s00401-019-02103-y</pub-id><pub-id pub-id-type="pmid">31802237</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hambright</surname><given-names>WS</given-names></name><name name-style="western"><surname>Fonseca</surname><given-names>RS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Na</surname><given-names>R</given-names></name><name name-style="western"><surname>Ran</surname><given-names>Q</given-names></name></person-group><article-title>Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration</article-title><source>Redox Biol</source><year>2017</year><volume>12</volume><fpage>8</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2017.01.021</pub-id><pub-id pub-id-type="pmid">28212525</pub-id><pub-id pub-id-type="pmcid">PMC5312549</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiesa</surname><given-names>R</given-names></name><name name-style="western"><surname>Piccardo</surname><given-names>P</given-names></name><name name-style="western"><surname>Dossena</surname><given-names>S</given-names></name><name name-style="western"><surname>Nowoslawski</surname><given-names>L</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name><name name-style="western"><surname>Ghetti</surname><given-names>B</given-names></name><etal/></person-group><article-title>Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>238</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1073/pnas.0406173102</pub-id><pub-id pub-id-type="pmid">15618403</pub-id><pub-id pub-id-type="pmcid">PMC544044</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steele</surname><given-names>AD</given-names></name><name name-style="western"><surname>King</surname><given-names>OD</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>WS</given-names></name><name name-style="western"><surname>Hetz</surname><given-names>CA</given-names></name><name name-style="western"><surname>Borkowski</surname><given-names>AW</given-names></name><name name-style="western"><surname>Thielen</surname><given-names>P</given-names></name><etal/></person-group><article-title>Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>13022</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3290-07.2007</pub-id><pub-id pub-id-type="pmid">18032675</pub-id><pub-id pub-id-type="pmcid">PMC2588055</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pemberton</surname><given-names>JM</given-names></name><name name-style="western"><surname>Pogmore</surname><given-names>JP</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>DW</given-names></name></person-group><article-title>Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>108</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-00654-2</pub-id><pub-id pub-id-type="pmid">33162554</pub-id><pub-id pub-id-type="pmcid">PMC7852532</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>SK</given-names></name><name name-style="western"><surname>Samantaray</surname><given-names>S</given-names></name><name name-style="western"><surname>Smith</surname><given-names>JA</given-names></name><name name-style="western"><surname>Matzelle</surname><given-names>DD</given-names></name><name name-style="western"><surname>Das</surname><given-names>A</given-names></name><name name-style="western"><surname>Banik</surname><given-names>NL</given-names></name></person-group><article-title>Inhibition of cysteine proteases in acute and chronic spinal cord injury</article-title><source>Neurotherapeutics</source><year>2011</year><volume>8</volume><fpage>180</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s13311-011-0037-1</pub-id><pub-id pub-id-type="pmid">21373949</pub-id><pub-id pub-id-type="pmcid">PMC3101838</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarosiek</surname><given-names>KA</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name><name name-style="western"><surname>Muthalagu</surname><given-names>N</given-names></name><name name-style="western"><surname>Bhola</surname><given-names>PD</given-names></name><name name-style="western"><surname>Chang</surname><given-names>W</given-names></name><name name-style="western"><surname>McBrayer</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Developmental regulation of mitochondrial apoptosis by c-Myc governs age- and tissue-specific sensitivity to cancer therapeutics</article-title><source>Cancer Cell</source><year>2017</year><volume>31</volume><fpage>142</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.11.011</pub-id><pub-id pub-id-type="pmid">28017613</pub-id><pub-id pub-id-type="pmcid">PMC5363285</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tehranian</surname><given-names>R</given-names></name><name name-style="western"><surname>Rose</surname><given-names>ME</given-names></name><name name-style="western"><surname>Vagni</surname><given-names>V</given-names></name><name name-style="western"><surname>Pickrell</surname><given-names>AM</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>RP</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury</article-title><source>J Neurotrauma</source><year>2008</year><volume>25</volume><fpage>755</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1089/neu.2007.0441</pub-id><pub-id pub-id-type="pmid">18627254</pub-id><pub-id pub-id-type="pmcid">PMC2717742</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tehranian</surname><given-names>R</given-names></name><name name-style="western"><surname>Rose</surname><given-names>ME</given-names></name><name name-style="western"><surname>Vagni</surname><given-names>V</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>RP</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name><name name-style="western"><surname>Maits</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury</article-title><source>Brain Res</source><year>2006</year><volume>1101</volume><fpage>126</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.05.049</pub-id><pub-id pub-id-type="pmid">16782076</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bermpohl</surname><given-names>D</given-names></name><name name-style="western"><surname>You</surname><given-names>Z</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Moskowitz</surname><given-names>MA</given-names></name><name name-style="western"><surname>Whalen</surname><given-names>MJ</given-names></name></person-group><article-title>Traumatic brain injury in mice deficient in Bid: effects on histopathology and functional outcome</article-title><source>J Cereb Blood Flow Metab</source><year>2006</year><volume>26</volume><fpage>625</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600258</pub-id><pub-id pub-id-type="pmid">16395279</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raghupathi</surname><given-names>R</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>SC</given-names></name><name name-style="western"><surname>Murai</surname><given-names>H</given-names></name><name name-style="western"><surname>Trusko</surname><given-names>SP</given-names></name><name name-style="western"><surname>Scott</surname><given-names>RW</given-names></name><name name-style="western"><surname>Nishioka</surname><given-names>WK</given-names></name><etal/></person-group><article-title>BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice</article-title><source>J Cereb Blood Flow Metab</source><year>1998</year><volume>18</volume><fpage>1259</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1097/00004647-199811000-00013</pub-id><pub-id pub-id-type="pmid">9809516</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farlie</surname><given-names>PG</given-names></name><name name-style="western"><surname>Dringen</surname><given-names>R</given-names></name><name name-style="western"><surname>Rees</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kannourakis</surname><given-names>G</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>O</given-names></name></person-group><article-title>bcl-2 transgene expression can protect neurons against developmental and induced cell death</article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>4397</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.10.4397</pub-id><pub-id pub-id-type="pmid">7753817</pub-id><pub-id pub-id-type="pmcid">PMC41951</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>H</given-names></name><name name-style="western"><surname>Fazzaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Jacquin</surname><given-names>MF</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>JW</given-names></name></person-group><article-title>Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>8682</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-25-08682.2003</pub-id><pub-id pub-id-type="pmid">14507967</pub-id><pub-id pub-id-type="pmcid">PMC6740425</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barut</surname><given-names>S</given-names></name><name name-style="western"><surname>Unl&#252;</surname><given-names>YA</given-names></name><name name-style="western"><surname>Karao&#287;lan</surname><given-names>A</given-names></name><name name-style="western"><surname>Tun&#231;demir</surname><given-names>M</given-names></name><name name-style="western"><surname>Da&#287;istanli</surname><given-names>FK</given-names></name><name name-style="western"><surname>Ozt&#252;rk</surname><given-names>M</given-names></name><etal/></person-group><article-title>The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats</article-title><source>Surg Neurol</source><year>2005</year><volume>64</volume><fpage>213</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.surneu.2005.03.042</pub-id><pub-id pub-id-type="pmid">16099247</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colak</surname><given-names>A</given-names></name><name name-style="western"><surname>Karao&#287;lan</surname><given-names>A</given-names></name><name name-style="western"><surname>Barut</surname><given-names>S</given-names></name><name name-style="western"><surname>K&#246;kt&#252;rk</surname><given-names>S</given-names></name><name name-style="western"><surname>Akyildiz</surname><given-names>AI</given-names></name><name name-style="western"><surname>Ta&#351;y&#252;rekli</surname><given-names>M</given-names></name></person-group><article-title>Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury</article-title><source>J Neurosurg Spine</source><year>2005</year><volume>2</volume><fpage>327</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.3171/spi.2005.2.3.0327</pub-id><pub-id pub-id-type="pmid">15796358</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Ona</surname><given-names>VO</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Kaul</surname><given-names>M</given-names></name><name name-style="western"><surname>Tenneti</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury</article-title><source>Neuroscience</source><year>2000</year><volume>99</volume><fpage>333</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(00)00173-1</pub-id><pub-id pub-id-type="pmid">10938439</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Combined administration of poly-ADP-ribose polymerase-1 and caspase-3 inhibitors alleviates neuronal apoptosis after spinal cord injury in rats</article-title><source>World Neurosurg</source><year>2019</year><volume>127</volume><fpage>e346</fpage><lpage>e352</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2019.03.116</pub-id><pub-id pub-id-type="pmid">30904799</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donahue</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Maes</surname><given-names>ME</given-names></name><name name-style="western"><surname>Grosser</surname><given-names>JA</given-names></name><name name-style="western"><surname>Nickells</surname><given-names>RW</given-names></name></person-group><article-title>BAX-depleted retinal ganglion cells survive and become quiescent following optic nerve damage</article-title><source>Mol Neurobiol</source><year>2020</year><volume>57</volume><fpage>1070</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1007/s12035-019-01783-7</pub-id><pub-id pub-id-type="pmid">31673950</pub-id><pub-id pub-id-type="pmcid">PMC7035206</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Libby</surname><given-names>RT</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Savinova</surname><given-names>OV</given-names></name><name name-style="western"><surname>Barter</surname><given-names>J</given-names></name><name name-style="western"><surname>Smith</surname><given-names>RS</given-names></name><name name-style="western"><surname>Nickells</surname><given-names>RW</given-names></name><etal/></person-group><article-title>Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage</article-title><source>PLoS Genet</source><year>2005</year><volume>1</volume><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1371/journal.pgen.0010004</pub-id><pub-id pub-id-type="pmid">16103918</pub-id><pub-id pub-id-type="pmcid">PMC1183523</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harder</surname><given-names>JM</given-names></name><name name-style="western"><surname>Libby</surname><given-names>RT</given-names></name></person-group><article-title>BBC3 (PUMA) regulates developmental apoptosis but not axonal injury induced death in the retina</article-title><source>Mol Neurodegener</source><year>2011</year><volume>6</volume><fpage>50</fpage><pub-id pub-id-type="doi">10.1186/1750-1326-6-50</pub-id><pub-id pub-id-type="pmid">21762490</pub-id><pub-id pub-id-type="pmcid">PMC3149592</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harder</surname><given-names>JM</given-names></name><name name-style="western"><surname>Libby</surname><given-names>RT</given-names></name></person-group><article-title>Deficiency in Bim, Bid and Bbc3 (Puma) do not prevent axonal injury induced death</article-title><source>Cell Death Differ</source><year>2013</year><volume>20</volume><fpage>182</fpage><pub-id pub-id-type="doi">10.1038/cdd.2012.119</pub-id><pub-id pub-id-type="pmid">22996683</pub-id><pub-id pub-id-type="pmcid">PMC3524644</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harder</surname><given-names>JM</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Q</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>KA</given-names></name><name name-style="western"><surname>Cherry</surname><given-names>JD</given-names></name><name name-style="western"><surname>Gan</surname><given-names>L</given-names></name><name name-style="western"><surname>Libby</surname><given-names>RT</given-names></name></person-group><article-title>BCL2L1 (BCL-X) promotes survival of adult and developing retinal ganglion cells</article-title><source>Mol Cell Neurosci</source><year>2012</year><volume>51</volume><fpage>53</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2012.07.006</pub-id><pub-id pub-id-type="pmid">22836101</pub-id><pub-id pub-id-type="pmcid">PMC3436941</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visuvanathan</surname><given-names>S</given-names></name><name name-style="western"><surname>Baker</surname><given-names>AN</given-names></name><name name-style="western"><surname>Lagali</surname><given-names>PS</given-names></name><name name-style="western"><surname>Coupland</surname><given-names>SG</given-names></name><name name-style="western"><surname>Miller</surname><given-names>G</given-names></name><name name-style="western"><surname>Hauswirth</surname><given-names>WW</given-names></name><etal/></person-group><article-title>XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma</article-title><source>Gene Ther</source><year>2022</year><volume>29</volume><fpage>147</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1038/s41434-021-00281-7</pub-id><pub-id pub-id-type="pmid">34363035</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donahue</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Fehrman</surname><given-names>RL</given-names></name><name name-style="western"><surname>Gustafson</surname><given-names>JR</given-names></name><name name-style="western"><surname>Nickells</surname><given-names>RW</given-names></name></person-group><article-title>BCLX(L) gene therapy moderates neuropathology in the DBA/2J mouse model of inherited glaucoma</article-title><source>Cell Death Dis</source><year>2021</year><volume>12</volume><fpage>781</fpage><pub-id pub-id-type="doi">10.1038/s41419-021-04068-x</pub-id><pub-id pub-id-type="pmid">34376637</pub-id><pub-id pub-id-type="pmcid">PMC8355227</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avrutsky</surname><given-names>MI</given-names></name><name name-style="western"><surname>Ortiz</surname><given-names>CC</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>KV</given-names></name><name name-style="western"><surname>Potenski</surname><given-names>AM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CW</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><fpage>3173</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-16902-5</pub-id><pub-id pub-id-type="pmid">32576823</pub-id><pub-id pub-id-type="pmcid">PMC7311551</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishikawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Hirata</surname><given-names>A</given-names></name><name name-style="western"><surname>Nakabayashi</surname><given-names>J</given-names></name><name name-style="western"><surname>Iwakiri</surname><given-names>R</given-names></name><name name-style="western"><surname>Okinami</surname><given-names>S</given-names></name></person-group><article-title>Neuroprotective effect of small interfering RNA targeted to caspase-3 on rat retinal ganglion cell loss induced by ischemia and reperfusion injury</article-title><source>Curr Eye Res</source><year>2012</year><volume>37</volume><fpage>907</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.3109/02713683.2012.688161</pub-id><pub-id pub-id-type="pmid">22642649</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tawfik</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Grigartzik</surname><given-names>L</given-names></name><name name-style="western"><surname>Heiduschka</surname><given-names>P</given-names></name><name name-style="western"><surname>Hintz</surname><given-names>W</given-names></name><name name-style="western"><surname>Henrich-Noack</surname><given-names>P</given-names></name><etal/></person-group><article-title>Gene therapy with caspase-3 small interfering RNA-nanoparticles is neuroprotective after optic nerve damage</article-title><source>Neural Regen Res</source><year>2021</year><volume>16</volume><fpage>2534</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.4103/1673-5374.313068</pub-id><pub-id pub-id-type="pmid">33907045</pub-id><pub-id pub-id-type="pmcid">PMC8374570</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wassmer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>De Repentigny</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>D</given-names></name><name name-style="western"><surname>Lagali</surname><given-names>PS</given-names></name><name name-style="western"><surname>Fang</surname><given-names>L</given-names></name><name name-style="western"><surname>Coupland</surname><given-names>SG</given-names></name><etal/></person-group><article-title>XIAP protects retinal ganglion cells in the mutant ND4 mouse model of leber hereditary optic neuropathy</article-title><source>Investig Ophthalmol Vis Sci</source><year>2020</year><volume>61</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1167/iovs.61.8.49</pub-id><pub-id pub-id-type="pmcid">PMC7425697</pub-id><pub-id pub-id-type="pmid">32735323</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wassmer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>BC</given-names></name><name name-style="western"><surname>Coupland</surname><given-names>SG</given-names></name><name name-style="western"><surname>Baker</surname><given-names>AN</given-names></name><name name-style="western"><surname>Hamilton</surname><given-names>J</given-names></name><name name-style="western"><surname>Hauswirth</surname><given-names>WW</given-names></name><etal/></person-group><article-title>Overexpression of the X-linked inhibitor of apoptosis protects against retinal degeneration in a feline model of retinal detachment</article-title><source>Hum Gene Ther</source><year>2017</year><volume>28</volume><fpage>482</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1089/hum.2016.161</pub-id><pub-id pub-id-type="pmid">28335619</pub-id><pub-id pub-id-type="pmcid">PMC5488383</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renwick</surname><given-names>J</given-names></name><name name-style="western"><surname>Narang</surname><given-names>MA</given-names></name><name name-style="western"><surname>Coupland</surname><given-names>SG</given-names></name><name name-style="western"><surname>Xuan</surname><given-names>JY</given-names></name><name name-style="western"><surname>Baker</surname><given-names>AN</given-names></name><name name-style="western"><surname>Brousseau</surname><given-names>J</given-names></name><etal/></person-group><article-title>XIAP-mediated neuroprotection in retinal ischemia</article-title><source>Gene Ther</source><year>2006</year><volume>13</volume><fpage>339</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1038/sj.gt.3302683</pub-id><pub-id pub-id-type="pmid">16307001</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKinnon</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Lehman</surname><given-names>DM</given-names></name><name name-style="western"><surname>Tahzib</surname><given-names>NG</given-names></name><name name-style="western"><surname>Ransom</surname><given-names>NL</given-names></name><name name-style="western"><surname>Reitsamer</surname><given-names>HA</given-names></name><name name-style="western"><surname>Liston</surname><given-names>P</given-names></name><etal/></person-group><article-title>Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model</article-title><source>Mol Ther</source><year>2002</year><volume>5</volume><fpage>780</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1006/mthe.2002.0608</pub-id><pub-id pub-id-type="pmid">12027563</pub-id></element-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zadro-Lamoureux</surname><given-names>LA</given-names></name><name name-style="western"><surname>Zacks</surname><given-names>DN</given-names></name><name name-style="western"><surname>Baker</surname><given-names>AN</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>QD</given-names></name><name name-style="western"><surname>Hauswirth</surname><given-names>WW</given-names></name><name name-style="western"><surname>Tsilfidis</surname><given-names>C</given-names></name></person-group><article-title>XIAP effects on retinal detachment-induced photoreceptor apoptosis [corrected]</article-title><source>Investig Ophthalmol Vis Sci</source><year>2009</year><volume>50</volume><fpage>1448</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1167/iovs.08-2855</pub-id><pub-id pub-id-type="pmid">19060276</pub-id><pub-id pub-id-type="pmcid">PMC3715305</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>J</given-names></name><name name-style="western"><surname>Feathers</surname><given-names>KL</given-names></name><name name-style="western"><surname>Khanna</surname><given-names>H</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>D</given-names></name><name name-style="western"><surname>Tsilfidis</surname><given-names>C</given-names></name><name name-style="western"><surname>Hauswirth</surname><given-names>WW</given-names></name><etal/></person-group><article-title>XIAP therapy increases survival of transplanted rod precursors in a degenerating host retina</article-title><source>Investig Ophthalmol Vis Sci</source><year>2011</year><volume>52</volume><fpage>1567</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1167/iovs.10-5998</pub-id><pub-id pub-id-type="pmid">20926819</pub-id><pub-id pub-id-type="pmcid">PMC3101692</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crespo-Garcia</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsuruda</surname><given-names>PR</given-names></name><name name-style="western"><surname>Dejda</surname><given-names>A</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>RD</given-names></name><name name-style="western"><surname>Fournier</surname><given-names>F</given-names></name><name name-style="western"><surname>Chaney</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition</article-title><source>Cell Metab</source><year>2021</year><volume>33</volume><fpage>818</fpage><lpage>32.e817</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.01.011</pub-id><pub-id pub-id-type="pmid">33548171</pub-id></element-citation></ref><ref id="CR161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choudhury</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AF</given-names></name><name name-style="western"><surname>Pang</surname><given-names>IH</given-names></name></person-group><article-title>Caspase-7: a critical mediator of optic nerve injury-induced retinal ganglion cell death</article-title><source>Mol Neurodegener</source><year>2015</year><volume>10</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.1186/s13024-015-0039-2</pub-id><pub-id pub-id-type="pmid">26306916</pub-id><pub-id pub-id-type="pmcid">PMC4550044</pub-id></element-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Sorenson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Sheibani</surname><given-names>N</given-names></name></person-group><article-title>Attenuation of retinal vascular development and neovascularization during oxygen-induced ischemic retinopathy in Bcl-2&#8722;/&#8722; mice</article-title><source>Dev Biol</source><year>2005</year><volume>279</volume><fpage>205</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.12.017</pub-id><pub-id pub-id-type="pmid">15708569</pub-id></element-citation></ref><ref id="CR163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Fei</surname><given-names>P</given-names></name><name name-style="western"><surname>Sorenson</surname><given-names>CM</given-names></name></person-group><article-title>Bim is responsible for the inherent sensitivity of the developing retinal vasculature to hyperoxia</article-title><source>Dev Biol</source><year>2011</year><volume>349</volume><fpage>296</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.10.034</pub-id><pub-id pub-id-type="pmid">21047504</pub-id><pub-id pub-id-type="pmcid">PMC3021136</pub-id></element-citation></ref><ref id="CR164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grant</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>L</given-names></name><name name-style="western"><surname>Wong</surname><given-names>VH</given-names></name><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yan</surname><given-names>RY</given-names></name><name name-style="western"><surname>Miles</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Blocking endothelial apoptosis revascularizes the retina in a model of ischemic retinopathy</article-title><source>J Clin Investig</source><year>2020</year><volume>130</volume><fpage>4235</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">32427589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI127668</pub-id><pub-id pub-id-type="pmcid">PMC7410052</pub-id></element-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Guma</surname><given-names>M</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>2377</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1073/pnas.1221729110</pub-id><pub-id pub-id-type="pmid">23341606</pub-id><pub-id pub-id-type="pmcid">PMC3568328</pub-id></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deckwerth</surname><given-names>TL</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>JL</given-names></name><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>EM</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Snider</surname><given-names>WD</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>BAX is required for neuronal death after trophic factor deprivation and during development</article-title><source>Neuron</source><year>1996</year><volume>17</volume><fpage>401</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80173-7</pub-id><pub-id pub-id-type="pmid">8816704</pub-id></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unsain</surname><given-names>N</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>JM</given-names></name><name name-style="western"><surname>Parker</surname><given-names>KN</given-names></name><name name-style="western"><surname>Johnstone</surname><given-names>AD</given-names></name><name name-style="western"><surname>Barker</surname><given-names>PA</given-names></name></person-group><article-title>XIAP regulates caspase activity in degenerating axons</article-title><source>Cell Rep</source><year>2013</year><volume>4</volume><fpage>751</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.07.015</pub-id><pub-id pub-id-type="pmid">23954782</pub-id></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imaizumi</surname><given-names>K</given-names></name><name name-style="western"><surname>Benito</surname><given-names>A</given-names></name><name name-style="western"><surname>Kiryu-Seo</surname><given-names>S</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>V</given-names></name><name name-style="western"><surname>Inohara</surname><given-names>N</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>3721</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5101-03.2004</pub-id><pub-id pub-id-type="pmid">15084651</pub-id><pub-id pub-id-type="pmcid">PMC6729341</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theofilas</surname><given-names>P</given-names></name><name name-style="western"><surname>Bedner</surname><given-names>P</given-names></name><name name-style="western"><surname>H&#252;ttmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Theis</surname><given-names>M</given-names></name><name name-style="western"><surname>Steinh&#228;user</surname><given-names>C</given-names></name><name name-style="western"><surname>Frank</surname><given-names>S</given-names></name></person-group><article-title>The proapoptotic BCL-2 homology domain 3-only protein Bim is not critical for acute excitotoxic cell death</article-title><source>J Neuropathol Exp Neurol</source><year>2009</year><volume>68</volume><fpage>102</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1097/NEN.0b013e31819385fd</pub-id><pub-id pub-id-type="pmid">19104441</pub-id></element-citation></ref><ref id="CR170"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunk</surname><given-names>EC</given-names></name><name name-style="western"><surname>K&#246;nig</surname><given-names>HG</given-names></name><name name-style="western"><surname>Prehn</surname><given-names>JHM</given-names></name><name name-style="western"><surname>Kirby</surname><given-names>BP</given-names></name></person-group><article-title>p53 upregulated mediator of apoptosis (Puma) deficiency increases survival of adult neural stem cells generated physiologically in the hippocampus, but does not protect stem cells generated in surplus after an excitotoxic lesion</article-title><source>J Basic Clin Physiol Pharmacol</source><year>2020</year><volume>32</volume><fpage>57</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1515/jbcpp-2020-0109</pub-id><pub-id pub-id-type="pmid">33155994</pub-id></element-citation></ref><ref id="CR171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>B</given-names></name><name name-style="western"><surname>Lu</surname><given-names>C</given-names></name></person-group><article-title>In vivo delivery of a XIAP (BIR3-RING) fusion protein containing the protein transduction domain protects against neuronal death induced by seizures</article-title><source>Exp Neurol</source><year>2006</year><volume>197</volume><fpage>301</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2005.08.021</pub-id><pub-id pub-id-type="pmid">16336964</pub-id></element-citation></ref><ref id="CR172"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tzeng</surname><given-names>TT</given-names></name><name name-style="western"><surname>Tsay</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>L</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>CL</given-names></name><name name-style="western"><surname>Lai</surname><given-names>TH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>FL</given-names></name><etal/></person-group><article-title>Caspase 3 involves in neuroplasticity, microglial activation and neurogenesis in the mice hippocampus after intracerebral injection of kainic acid</article-title><source>J Biomed Sci</source><year>2013</year><volume>20</volume><fpage>90</fpage><pub-id pub-id-type="doi">10.1186/1423-0127-20-90</pub-id><pub-id pub-id-type="pmid">24313976</pub-id><pub-id pub-id-type="pmcid">PMC4028745</pub-id></element-citation></ref><ref id="CR173"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Concannon</surname><given-names>CG</given-names></name><name name-style="western"><surname>Tuffy</surname><given-names>LP</given-names></name><name name-style="western"><surname>Weisov&#225;</surname><given-names>P</given-names></name><name name-style="western"><surname>Bonner</surname><given-names>HP</given-names></name><name name-style="western"><surname>D&#225;vila</surname><given-names>D</given-names></name><name name-style="western"><surname>Bonner</surname><given-names>C</given-names></name><etal/></person-group><article-title>AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis</article-title><source>J Cell Biol</source><year>2010</year><volume>189</volume><fpage>83</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1083/jcb.200909166</pub-id><pub-id pub-id-type="pmid">20351066</pub-id><pub-id pub-id-type="pmcid">PMC2854380</pub-id></element-citation></ref><ref id="CR174"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>BM</given-names></name><name name-style="western"><surname>Engel</surname><given-names>T</given-names></name><name name-style="western"><surname>Paucard</surname><given-names>A</given-names></name><name name-style="western"><surname>Hatazaki</surname><given-names>S</given-names></name><name name-style="western"><surname>Mouri</surname><given-names>G</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>K</given-names></name><etal/></person-group><article-title>Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>459</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.134</pub-id><pub-id pub-id-type="pmid">19779495</pub-id><pub-id pub-id-type="pmcid">PMC2950266</pub-id></element-citation></ref><ref id="CR175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foley</surname><given-names>J</given-names></name><name name-style="western"><surname>Burnham</surname><given-names>V</given-names></name><name name-style="western"><surname>Tedoldi</surname><given-names>M</given-names></name><name name-style="western"><surname>Danial</surname><given-names>NN</given-names></name><name name-style="western"><surname>Yellen</surname><given-names>G</given-names></name></person-group><article-title>BAD knockout provides metabolic seizure resistance in a genetic model of epilepsy with sudden unexplained death in epilepsy</article-title><source>Epilepsia</source><year>2018</year><volume>59</volume><fpage>e1</fpage><lpage>e4</lpage><pub-id pub-id-type="doi">10.1111/epi.13960</pub-id><pub-id pub-id-type="pmid">29171006</pub-id><pub-id pub-id-type="pmcid">PMC5760331</pub-id></element-citation></ref><ref id="CR176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>C</given-names></name><name name-style="western"><surname>Sanz-Rodriguez</surname><given-names>A</given-names></name><name name-style="western"><surname>Jimenez-Pacheco</surname><given-names>A</given-names></name><name name-style="western"><surname>Martinez-Villareal</surname><given-names>J</given-names></name><name name-style="western"><surname>McKiernan</surname><given-names>RC</given-names></name><name name-style="western"><surname>Jimenez-Mateos</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Bmf upregulation through the AMP-activated protein kinase pathway may protect the brain from seizure-induced cell death</article-title><source>Cell Death Dis</source><year>2013</year><volume>4</volume><fpage>e606</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.136</pub-id><pub-id pub-id-type="pmid">23618904</pub-id><pub-id pub-id-type="pmcid">PMC3668628</pub-id></element-citation></ref><ref id="CR177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engel</surname><given-names>T</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>BM</given-names></name><name name-style="western"><surname>Hatazaki</surname><given-names>S</given-names></name><name name-style="western"><surname>Jimenez-Mateos</surname><given-names>EM</given-names></name><name name-style="western"><surname>Concannon</surname><given-names>CG</given-names></name><name name-style="western"><surname>Woods</surname><given-names>I</given-names></name><etal/></person-group><article-title>Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma</article-title><source>FASEB J</source><year>2010</year><volume>24</volume><fpage>853</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1096/fj.09-145870</pub-id><pub-id pub-id-type="pmid">19890018</pub-id><pub-id pub-id-type="pmcid">PMC3231945</pub-id></element-citation></ref><ref id="CR178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engel</surname><given-names>T</given-names></name><name name-style="western"><surname>Hatazaki</surname><given-names>S</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>K</given-names></name><name name-style="western"><surname>Prehn</surname><given-names>JH</given-names></name><name name-style="western"><surname>Henshall</surname><given-names>DC</given-names></name></person-group><article-title>Deletion of Puma protects hippocampal neurons in a model of severe status epilepticus</article-title><source>Neuroscience</source><year>2010</year><volume>168</volume><fpage>443</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.03.057</pub-id><pub-id pub-id-type="pmid">20362645</pub-id><pub-id pub-id-type="pmcid">PMC2877385</pub-id></element-citation></ref><ref id="CR179"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>B</given-names></name><name name-style="western"><surname>Dunleavy</surname><given-names>M</given-names></name><name name-style="western"><surname>Shinoda</surname><given-names>S</given-names></name><name name-style="western"><surname>Schindler</surname><given-names>C</given-names></name><name name-style="western"><surname>Meller</surname><given-names>R</given-names></name><name name-style="western"><surname>Bellver-Estelles</surname><given-names>C</given-names></name><etal/></person-group><article-title>Bcl-w protects hippocampus during experimental status epilepticus</article-title><source>Am J Pathol</source><year>2007</year><volume>171</volume><fpage>1258</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070269</pub-id><pub-id pub-id-type="pmid">17702891</pub-id><pub-id pub-id-type="pmcid">PMC1988875</pub-id></element-citation></ref><ref id="CR180"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichikawa</surname><given-names>N</given-names></name><name name-style="western"><surname>Alves</surname><given-names>M</given-names></name><name name-style="western"><surname>Pfeiffer</surname><given-names>S</given-names></name><name name-style="western"><surname>Langa</surname><given-names>E</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Santana</surname><given-names>YE</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name><etal/></person-group><article-title>Deletion of the BH3-only protein Noxa alters electrographic seizures but does not protect against hippocampal damage after status epilepticus in mice</article-title><source>Cell Death Dis</source><year>2017</year><volume>8</volume><fpage>e2556</fpage><pub-id pub-id-type="doi">10.1038/cddis.2016.301</pub-id><pub-id pub-id-type="pmid">28079889</pub-id><pub-id pub-id-type="pmcid">PMC5457684</pub-id></element-citation></ref><ref id="CR181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engel</surname><given-names>T</given-names></name><name name-style="western"><surname>Caballero-Caballero</surname><given-names>A</given-names></name><name name-style="western"><surname>Schindler</surname><given-names>CK</given-names></name><name name-style="western"><surname>Plesnila</surname><given-names>N</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Prehn</surname><given-names>JH</given-names></name><etal/></person-group><article-title>BH3-only protein Bid is dispensable for seizure-induced neuronal death and the associated nuclear accumulation of apoptosis-inducing factor</article-title><source>J Neurochem</source><year>2010</year><volume>115</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06909.x</pub-id><pub-id pub-id-type="pmid">20646170</pub-id></element-citation></ref><ref id="CR182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>ME</given-names></name><name name-style="western"><surname>Han</surname><given-names>BH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J</given-names></name><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Parsadanian</surname><given-names>M</given-names></name><etal/></person-group><article-title>BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways</article-title><source>Mol Med</source><year>2001</year><volume>7</volume><fpage>644</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1007/BF03401871</pub-id><pub-id pub-id-type="pmid">11778654</pub-id><pub-id pub-id-type="pmcid">PMC1950070</pub-id></element-citation></ref><ref id="CR183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ness</surname><given-names>JM</given-names></name><name name-style="western"><surname>Harvey</surname><given-names>CA</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name></person-group><article-title>Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia</article-title><source>Brain Res</source><year>2006</year><volume>1099</volume><fpage>150</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.04.132</pub-id><pub-id pub-id-type="pmid">16780816</pub-id></element-citation></ref><ref id="CR184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hagberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Korhonen</surname><given-names>L</given-names></name><name name-style="western"><surname>Sandberg</surname><given-names>M</given-names></name><etal/></person-group><article-title>X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia</article-title><source>Neurobiol Dis</source><year>2004</year><volume>16</volume><fpage>179</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2004.01.014</pub-id><pub-id pub-id-type="pmid">15207275</pub-id></element-citation></ref><ref id="CR185"><label>185.</label><mixed-citation publication-type="other">West T, Stump M, Lodygensky G, Neil JJ, Deshmukh M, Holtzman DM. Lack of X-linked inhibitor of apoptosis protein leads to increased apoptosis and tissue loss following neonatal brain injury. ASN Neuro 2009;1:e00004.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/AN20090005</pub-id><pub-id pub-id-type="pmcid">PMC2695579</pub-id><pub-id pub-id-type="pmid">19570023</pub-id></mixed-citation></ref><ref id="CR186"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>T</given-names></name><name name-style="western"><surname>Atzeva</surname><given-names>M</given-names></name><name name-style="western"><surname>Holtzman</surname><given-names>DM</given-names></name></person-group><article-title>Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways</article-title><source>Neurobiol Dis</source><year>2006</year><volume>22</volume><fpage>523</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2005.12.017</pub-id><pub-id pub-id-type="pmid">16480886</pub-id></element-citation></ref><ref id="CR187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>AP</given-names></name><name name-style="western"><surname>Walls</surname><given-names>KC</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Toms</surname><given-names>R</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name></person-group><article-title>The proapoptotic BH3-only, Bcl-2 family member, Puma is critical for acute ethanol-induced neuronal apoptosis</article-title><source>J Neuropathol Exp Neurol</source><year>2009</year><volume>68</volume><fpage>747</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1097/NEN.0b013e3181a9d524</pub-id><pub-id pub-id-type="pmid">19535997</pub-id><pub-id pub-id-type="pmcid">PMC2745204</pub-id></element-citation></ref><ref id="CR188"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>C</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Tenkova</surname><given-names>T</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J</given-names></name><name name-style="western"><surname>Labruyere</surname><given-names>J</given-names></name><name name-style="western"><surname>Qin</surname><given-names>YQ</given-names></name><etal/></person-group><article-title>Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain</article-title><source>Cell Death Differ</source><year>2003</year><volume>10</volume><fpage>1148</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401277</pub-id><pub-id pub-id-type="pmid">14502238</pub-id></element-citation></ref><ref id="CR189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>C</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>BJ</given-names></name><name name-style="western"><surname>West</surname><given-names>T</given-names></name><name name-style="western"><surname>Holtzman</surname><given-names>DM</given-names></name><name name-style="western"><surname>Labruyere</surname><given-names>J</given-names></name><etal/></person-group><article-title>Role of caspase-3 in ethanol-induced developmental neurodegeneration</article-title><source>Neurobiol Dis</source><year>2005</year><volume>20</volume><fpage>608</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2005.04.014</pub-id><pub-id pub-id-type="pmid">15927478</pub-id></element-citation></ref><ref id="CR190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slupe</surname><given-names>AM</given-names></name><name name-style="western"><surname>Villasana</surname><given-names>L</given-names></name><name name-style="western"><surname>Wright</surname><given-names>KM</given-names></name></person-group><article-title>GABAergic neurons are susceptible to BAX-dependent apoptosis following isoflurane exposure in the neonatal period</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><fpage>e0238799</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0238799</pub-id><pub-id pub-id-type="pmid">33434191</pub-id><pub-id pub-id-type="pmcid">PMC7802958</pub-id></element-citation></ref><ref id="CR191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chong</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Murray</surname><given-names>MR</given-names></name><name name-style="western"><surname>Gosink</surname><given-names>EC</given-names></name><name name-style="western"><surname>Russell</surname><given-names>HR</given-names></name><name name-style="western"><surname>Srinivasan</surname><given-names>A</given-names></name><name name-style="western"><surname>Kapsetaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>889</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.2.889</pub-id><pub-id pub-id-type="pmid">10639175</pub-id><pub-id pub-id-type="pmcid">PMC15426</pub-id></element-citation></ref><ref id="CR192"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahlers</surname><given-names>KE</given-names></name><name name-style="western"><surname>Kara&#231;ay</surname><given-names>B</given-names></name><name name-style="western"><surname>Fuller</surname><given-names>L</given-names></name><name name-style="western"><surname>Bonthius</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Dailey</surname><given-names>ME</given-names></name></person-group><article-title>Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration</article-title><source>Glia</source><year>2015</year><volume>63</volume><fpage>1694</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1002/glia.22835</pub-id><pub-id pub-id-type="pmid">25856413</pub-id><pub-id pub-id-type="pmcid">PMC4534325</pub-id></element-citation></ref><ref id="CR193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Orsi</surname><given-names>B</given-names></name><name name-style="western"><surname>Kilbride</surname><given-names>SM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Perez Alvarez</surname><given-names>S</given-names></name><name name-style="western"><surname>Bonner</surname><given-names>HP</given-names></name><name name-style="western"><surname>Pfeiffer</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bax regulates neuronal Ca2+ homeostasis</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><fpage>1706</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2453-14.2015</pub-id><pub-id pub-id-type="pmid">25632145</pub-id><pub-id pub-id-type="pmcid">PMC6795257</pub-id></element-citation></ref><ref id="CR194"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfeiffer</surname><given-names>S</given-names></name><name name-style="western"><surname>Anilkumar</surname><given-names>U</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Ram&#237;rez-Peinado</surname><given-names>S</given-names></name><name name-style="western"><surname>Galindo-Moreno</surname><given-names>J</given-names></name><name name-style="western"><surname>Mu&#241;oz-Pinedo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Analysis of BH3-only proteins upregulated in response to oxygen/glucose deprivation in cortical neurons identifies Bmf but not Noxa as potential mediator of neuronal injury</article-title><source>Cell Death Dis</source><year>2014</year><volume>5</volume><fpage>e1456</fpage><pub-id pub-id-type="doi">10.1038/cddis.2014.426</pub-id><pub-id pub-id-type="pmid">25299781</pub-id><pub-id pub-id-type="pmcid">PMC4237251</pub-id></element-citation></ref><ref id="CR195"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plesnila</surname><given-names>N</given-names></name><name name-style="western"><surname>Zinkel</surname><given-names>S</given-names></name><name name-style="western"><surname>Le</surname><given-names>DA</given-names></name><name name-style="western"><surname>Amin-Hanjani</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><etal/></person-group><article-title>BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>15318</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1073/pnas.261323298</pub-id><pub-id pub-id-type="pmid">11742085</pub-id><pub-id pub-id-type="pmcid">PMC65027</pub-id></element-citation></ref><ref id="CR196"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>XM</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cao</surname><given-names>G</given-names></name><name name-style="western"><surname>Bai</surname><given-names>L</given-names></name><name name-style="western"><surname>Pei</surname><given-names>W</given-names></name><name name-style="western"><surname>Kuharsky</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Bid-mediated mitochondrial pathway is critical to ischemic neuronal apoptosis and focal cerebral ischemia</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>42074</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1074/jbc.M204991200</pub-id><pub-id pub-id-type="pmid">12200426</pub-id></element-citation></ref><ref id="CR197"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plesnila</surname><given-names>N</given-names></name><name name-style="western"><surname>Zinkel</surname><given-names>S</given-names></name><name name-style="western"><surname>Amin-Hanjani</surname><given-names>S</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Moskowitz</surname><given-names>MA</given-names></name></person-group><article-title>Function of BID - a molecule of the bcl-2 family - in ischemic cell death in the brain</article-title><source>Eur Surg Res</source><year>2002</year><volume>34</volume><fpage>37</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1159/000048885</pub-id><pub-id pub-id-type="pmid">11867899</pub-id></element-citation></ref><ref id="CR198"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>NA</given-names></name><name name-style="western"><surname>Bonner</surname><given-names>H</given-names></name><name name-style="western"><surname>Elkj&#230;r</surname><given-names>ML</given-names></name><name name-style="western"><surname>D&#8217;Orsi</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>K&#246;nig</surname><given-names>HG</given-names></name><etal/></person-group><article-title>BID mediates oxygen-glucose deprivation-induced neuronal injury in organotypic hippocampal slice cultures and modulates tissue inflammation in a transient focal cerebral ischemia model without changing lesion volume</article-title><source>Front Cell Neurosci</source><year>2016</year><volume>10</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.3389/fncel.2016.00014</pub-id><pub-id pub-id-type="pmid">26869884</pub-id><pub-id pub-id-type="pmcid">PMC4737886</pub-id></element-citation></ref><ref id="CR199"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitagawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Matsumoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Tsujimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ohtsuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Kuwabara</surname><given-names>K</given-names></name><name name-style="western"><surname>Matsushita</surname><given-names>K</given-names></name><etal/></person-group><article-title>Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice</article-title><source>Stroke</source><year>1998</year><volume>29</volume><fpage>2616</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1161/01.STR.29.12.2616</pub-id><pub-id pub-id-type="pmid">9836775</pub-id></element-citation></ref><ref id="CR200"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>G</given-names></name><name name-style="western"><surname>Pei</surname><given-names>W</given-names></name><name name-style="western"><surname>Ge</surname><given-names>H</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sharp</surname><given-names>FR</given-names></name><etal/></person-group><article-title>In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>5423</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-13-05423.2002</pub-id><pub-id pub-id-type="pmid">12097494</pub-id><pub-id pub-id-type="pmcid">PMC6758230</pub-id></element-citation></ref><ref id="CR201"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilic</surname><given-names>E</given-names></name><name name-style="western"><surname>Hermann</surname><given-names>DM</given-names></name><name name-style="western"><surname>K&#252;gler</surname><given-names>S</given-names></name><name name-style="western"><surname>Kilic</surname><given-names>U</given-names></name><name name-style="western"><surname>Holzm&#252;ller</surname><given-names>H</given-names></name><name name-style="western"><surname>Schmeer</surname><given-names>C</given-names></name><etal/></person-group><article-title>Adenovirus-mediated Bcl-X(L) expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice</article-title><source>Neurobiol Dis</source><year>2002</year><volume>11</volume><fpage>275</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1006/nbdi.2002.0552</pub-id><pub-id pub-id-type="pmid">12505420</pub-id></element-citation></ref><ref id="CR202"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akpan</surname><given-names>N</given-names></name><name name-style="western"><surname>Serrano-Saiz</surname><given-names>E</given-names></name><name name-style="western"><surname>Zacharia</surname><given-names>BE</given-names></name><name name-style="western"><surname>Otten</surname><given-names>ML</given-names></name><name name-style="western"><surname>Ducruet</surname><given-names>AF</given-names></name><name name-style="western"><surname>Snipas</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>8894</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0698-11.2011</pub-id><pub-id pub-id-type="pmid">21677173</pub-id><pub-id pub-id-type="pmcid">PMC3143191</pub-id></element-citation></ref><ref id="CR203"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>YF</given-names></name><name name-style="western"><surname>Lu</surname><given-names>CZ</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>YX</given-names></name><name name-style="western"><surname>Yang</surname><given-names>GY</given-names></name></person-group><article-title>Apoptosis inhibition in ischemic brain by intraperitoneal PTD-BIR3-RING (XIAP)</article-title><source>Neurochem Int</source><year>2006</year><volume>48</volume><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2005.07.008</pub-id><pub-id pub-id-type="pmid">16293346</pub-id></element-citation></ref><ref id="CR204"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trapp</surname><given-names>T</given-names></name><name name-style="western"><surname>Korhonen</surname><given-names>L</given-names></name><name name-style="western"><surname>Besselmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>R</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>EA</given-names></name><name name-style="western"><surname>Lindholm</surname><given-names>D</given-names></name></person-group><article-title>Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia</article-title><source>Mol Cell Neurosci</source><year>2003</year><volume>23</volume><fpage>302</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/S1044-7431(03)00013-7</pub-id><pub-id pub-id-type="pmid">12812761</pub-id></element-citation></ref><ref id="CR205"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F</given-names></name><name name-style="western"><surname>Fukuda</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Fukuda</surname><given-names>H</given-names></name><name name-style="western"><surname>Korhonen</surname><given-names>L</given-names></name><etal/></person-group><article-title>X chromosome-linked inhibitor of apoptosis protein reduces oxidative stress after cerebral irradiation or hypoxia-ischemia through up-regulation of mitochondrial antioxidants</article-title><source>Eur J Neurosci</source><year>2007</year><volume>26</volume><fpage>3402</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05948.x</pub-id><pub-id pub-id-type="pmid">18052985</pub-id></element-citation></ref><ref id="CR206"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Yenari</surname><given-names>MA</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>D</given-names></name><name name-style="western"><surname>Sapolsky</surname><given-names>RM</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>GK</given-names></name></person-group><article-title>Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia</article-title><source>J Cereb Blood Flow Metab</source><year>2005</year><volume>25</volume><fpage>1119</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600111</pub-id><pub-id pub-id-type="pmid">15789032</pub-id></element-citation></ref><ref id="CR207"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Nagayama</surname><given-names>T</given-names></name><name name-style="western"><surname>Jin</surname><given-names>K</given-names></name><name name-style="western"><surname>Stetler</surname><given-names>RA</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>RL</given-names></name><name name-style="western"><surname>Graham</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia</article-title><source>J Neurosci</source><year>1998</year><volume>18</volume><fpage>4914</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-13-04914.1998</pub-id><pub-id pub-id-type="pmid">9634557</pub-id><pub-id pub-id-type="pmcid">PMC6792571</pub-id></element-citation></ref><ref id="CR208"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liang</surname><given-names>W</given-names></name><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Stetler</surname><given-names>RA</given-names></name><name name-style="western"><surname>Vosler</surname><given-names>P</given-names></name><etal/></person-group><article-title>Neuroprotection against hypoxic-ischemic brain injury by inhibiting the apoptotic protease activating factor-1 pathway</article-title><source>Stroke</source><year>2010</year><volume>41</volume><fpage>166</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.109.561852</pub-id><pub-id pub-id-type="pmid">19910549</pub-id><pub-id pub-id-type="pmcid">PMC2799533</pub-id></element-citation></ref><ref id="CR209"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karatas</surname><given-names>H</given-names></name><name name-style="western"><surname>Aktas</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gursoy-Ozdemir</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bodur</surname><given-names>E</given-names></name><name name-style="western"><surname>Yemisci</surname><given-names>M</given-names></name><name name-style="western"><surname>Caban</surname><given-names>S</given-names></name><etal/></person-group><article-title>A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection</article-title><source>J Neurosci</source><year>2009</year><volume>29</volume><fpage>13761</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4246-09.2009</pub-id><pub-id pub-id-type="pmid">19889988</pub-id><pub-id pub-id-type="pmcid">PMC6666719</pub-id></element-citation></ref><ref id="CR210"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Endres</surname><given-names>M</given-names></name><name name-style="western"><surname>Namura</surname><given-names>S</given-names></name><name name-style="western"><surname>Shimizu-Sasamata</surname><given-names>M</given-names></name><name name-style="western"><surname>Waeber</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>G&#243;mez-Isla</surname><given-names>T</given-names></name><etal/></person-group><article-title>Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family</article-title><source>J Cereb Blood Flow Metab</source><year>1998</year><volume>18</volume><fpage>238</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1097/00004647-199803000-00002</pub-id><pub-id pub-id-type="pmid">9498840</pub-id></element-citation></ref><ref id="CR211"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gottron</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Ying</surname><given-names>HS</given-names></name><name name-style="western"><surname>Choi</surname><given-names>DW</given-names></name></person-group><article-title>Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death</article-title><source>Mol Cell Neurosci</source><year>1997</year><volume>9</volume><fpage>159</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1006/mcne.1997.0618</pub-id><pub-id pub-id-type="pmid">9245499</pub-id></element-citation></ref><ref id="CR212"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibata</surname><given-names>M</given-names></name><name name-style="western"><surname>Hisahara</surname><given-names>S</given-names></name><name name-style="western"><surname>Hara</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamawaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Fukuuchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Caspases determine the vulnerability of oligodendrocytes in the ischemic brain</article-title><source>J Clin Investig</source><year>2000</year><volume>106</volume><fpage>643</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1172/JCI10203</pub-id><pub-id pub-id-type="pmid">10974017</pub-id><pub-id pub-id-type="pmcid">PMC381288</pub-id></element-citation></ref><ref id="CR213"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>JH</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Roy</surname><given-names>M</given-names></name><name name-style="western"><surname>Sapolsky</surname><given-names>RM</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>GK</given-names></name></person-group><article-title>Viral caspase inhibitor p35, but not crmA, is neuroprotective in the ischemic penumbra following experimental stroke</article-title><source>Neuroscience</source><year>2007</year><volume>149</volume><fpage>804</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.07.030</pub-id><pub-id pub-id-type="pmid">17945431</pub-id><pub-id pub-id-type="pmcid">PMC2144739</pub-id></element-citation></ref><ref id="CR214"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>JS</given-names></name><name name-style="western"><surname>Prass</surname><given-names>K</given-names></name><name name-style="western"><surname>Dirnagl</surname><given-names>U</given-names></name><name name-style="western"><surname>Meisel</surname><given-names>A</given-names></name><name name-style="western"><surname>Meisel</surname><given-names>C</given-names></name></person-group><article-title>Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH</article-title><source>Exp Neurol</source><year>2007</year><volume>206</volume><fpage>183</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2007.03.032</pub-id><pub-id pub-id-type="pmid">17585906</pub-id></element-citation></ref><ref id="CR215"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Geng</surname><given-names>L</given-names></name></person-group><article-title>Caspase-3 inhibitor prevents the apoptosis of brain tissue in rats with acute cerebral infarction</article-title><source>Exp Ther Med</source><year>2015</year><volume>10</volume><fpage>133</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3892/etm.2015.2462</pub-id><pub-id pub-id-type="pmid">26170924</pub-id><pub-id pub-id-type="pmcid">PMC4487074</pub-id></element-citation></ref><ref id="CR216"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lapchak</surname><given-names>PA</given-names></name><name name-style="western"><surname>Araujo</surname><given-names>DM</given-names></name><name name-style="western"><surname>Weir</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J</given-names></name><name name-style="western"><surname>Zivin</surname><given-names>JA</given-names></name></person-group><article-title>Effects of intrathecal administration of a cell permeant caspase inhibitor, boc-D-fluoromethylketone (BDFMK), on behavioral deficits following spinal cord ischemia: a dose-response analysis</article-title><source>Brain Res</source><year>2003</year><volume>959</volume><fpage>183</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(02)03739-3</pub-id><pub-id pub-id-type="pmid">12493605</pub-id></element-citation></ref><ref id="CR217"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osman</surname><given-names>AM</given-names></name><name name-style="western"><surname>Neumann</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuhn</surname><given-names>HG</given-names></name><name name-style="western"><surname>Blomgren</surname><given-names>K</given-names></name></person-group><article-title>Caspase inhibition impaired the neural stem/progenitor cell response after cortical ischemia in mice</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>2239</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.6803</pub-id><pub-id pub-id-type="pmid">26734998</pub-id><pub-id pub-id-type="pmcid">PMC4823032</pub-id></element-citation></ref><ref id="CR218"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>RZ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Fujihara</surname><given-names>H</given-names></name><name name-style="western"><surname>Taga</surname><given-names>K</given-names></name><name name-style="western"><surname>Qi</surname><given-names>S</given-names></name><name name-style="western"><surname>Naito</surname><given-names>M</given-names></name><etal/></person-group><article-title>Both caspase-dependent and caspase-independent pathways may be involved in hippocampal CA1 neuronal death because of loss of cytochrome c from mitochondria in a rat forebrain ischemia model</article-title><source>J Cereb Blood Flow Metab</source><year>2001</year><volume>21</volume><fpage>529</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1097/00004647-200105000-00007</pub-id><pub-id pub-id-type="pmid">11333363</pub-id></element-citation></ref><ref id="CR219"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moujalled</surname><given-names>D</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Liddell</surname><given-names>JR</given-names></name></person-group><article-title>Molecular mechanisms of cell death in neurological diseases</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>2029</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00814-y</pub-id><pub-id pub-id-type="pmid">34099897</pub-id><pub-id pub-id-type="pmcid">PMC8257776</pub-id></element-citation></ref><ref id="CR220"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crowther</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Gama</surname><given-names>V</given-names></name><name name-style="western"><surname>Bevilacqua</surname><given-names>A</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SX</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>H</given-names></name><name name-style="western"><surname>Deshmukh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma</article-title><source>J Neurosci</source><year>2013</year><volume>33</volume><fpage>18098</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2602-13.2013</pub-id><pub-id pub-id-type="pmid">24227720</pub-id><pub-id pub-id-type="pmcid">PMC3828463</pub-id></element-citation></ref><ref id="CR221"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakaya</surname><given-names>K</given-names></name><name name-style="western"><surname>Hasegawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Flickinger</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kondziolka</surname><given-names>DS</given-names></name><name name-style="western"><surname>Fellows-Mayle</surname><given-names>W</given-names></name><name name-style="western"><surname>Gobbel</surname><given-names>GT</given-names></name></person-group><article-title>Sensitivity to radiation-induced apoptosis and neuron loss declines rapidly in the postnatal mouse neocortex</article-title><source>Int J Radiat Biol</source><year>2005</year><volume>81</volume><fpage>545</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1080/09553000500280492</pub-id><pub-id pub-id-type="pmid">16263658</pub-id></element-citation></ref><ref id="CR222"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kole</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Annis</surname><given-names>RP</given-names></name><name name-style="western"><surname>Deshmukh</surname><given-names>M</given-names></name></person-group><article-title>Mature neurons: equipped for survival</article-title><source>Cell Death Dis</source><year>2013</year><volume>4</volume><fpage>e689</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.220</pub-id><pub-id pub-id-type="pmid">23807218</pub-id><pub-id pub-id-type="pmcid">PMC3702294</pub-id></element-citation></ref><ref id="CR223"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whelan</surname><given-names>RS</given-names></name><name name-style="western"><surname>Konstantinidis</surname><given-names>K</given-names></name><name name-style="western"><surname>Wei</surname><given-names>AC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Reyna</surname><given-names>DE</given-names></name><name name-style="western"><surname>Jha</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bax regulates primary necrosis through mitochondrial dynamics</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>6566</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1073/pnas.1201608109</pub-id><pub-id pub-id-type="pmid">22493254</pub-id><pub-id pub-id-type="pmcid">PMC3340068</pub-id></element-citation></ref><ref id="CR224"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karch</surname><given-names>J</given-names></name><name name-style="western"><surname>Kwong</surname><given-names>JQ</given-names></name><name name-style="western"><surname>Burr</surname><given-names>AR</given-names></name><name name-style="western"><surname>Sargent</surname><given-names>MA</given-names></name><name name-style="western"><surname>Elrod</surname><given-names>JW</given-names></name><name name-style="western"><surname>Peixoto</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice</article-title><source>eLife</source><year>2013</year><volume>2</volume><fpage>e00772</fpage><pub-id pub-id-type="doi">10.7554/eLife.00772</pub-id><pub-id pub-id-type="pmid">23991283</pub-id><pub-id pub-id-type="pmcid">PMC3755340</pub-id></element-citation></ref><ref id="CR225"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hochhauser</surname><given-names>E</given-names></name><name name-style="western"><surname>Cheporko</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yasovich</surname><given-names>N</given-names></name><name name-style="western"><surname>Pinchas</surname><given-names>L</given-names></name><name name-style="western"><surname>Offen</surname><given-names>D</given-names></name><name name-style="western"><surname>Barhum</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Bax deficiency reduces infarct size and improves long-term function after myocardial infarction</article-title><source>Cell Biochem Biophys</source><year>2007</year><volume>47</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1385/CBB:47:1:11</pub-id><pub-id pub-id-type="pmid">17406056</pub-id></element-citation></ref><ref id="CR226"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaseva</surname><given-names>AV</given-names></name><name name-style="western"><surname>Marchenko</surname><given-names>ND</given-names></name><name name-style="western"><surname>Ji</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsirka</surname><given-names>SE</given-names></name><name name-style="western"><surname>Holzmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Moll</surname><given-names>UM</given-names></name></person-group><article-title>p53 opens the mitochondrial permeability transition pore to trigger necrosis</article-title><source>Cell</source><year>2012</year><volume>149</volume><fpage>1536</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.05.014</pub-id><pub-id pub-id-type="pmid">22726440</pub-id><pub-id pub-id-type="pmcid">PMC3383624</pub-id></element-citation></ref><ref id="CR227"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brocheriou</surname><given-names>V</given-names></name><name name-style="western"><surname>Hag&#232;ge</surname><given-names>AA</given-names></name><name name-style="western"><surname>Oubena&#239;ssa</surname><given-names>A</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>M</given-names></name><name name-style="western"><surname>Mallet</surname><given-names>VO</given-names></name><name name-style="western"><surname>Duriez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury</article-title><source>J Gene Med</source><year>2000</year><volume>2</volume><fpage>326</fpage><lpage>33</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1521-2254(200009/10)2:5&amp;#x0003c;326::AID-JGM133&amp;#x0003e;3.0.CO;2-1</pub-id><pub-id pub-id-type="pmid">11045426</pub-id></element-citation></ref><ref id="CR228"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kristen</surname><given-names>AV</given-names></name><name name-style="western"><surname>Ackermann</surname><given-names>K</given-names></name><name name-style="western"><surname>Buss</surname><given-names>S</given-names></name><name name-style="western"><surname>Lehmann</surname><given-names>L</given-names></name><name name-style="western"><surname>Schnabel</surname><given-names>PA</given-names></name><name name-style="western"><surname>Haunstetter</surname><given-names>A</given-names></name><etal/></person-group><article-title>Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion</article-title><source>Cardiovasc Pathol</source><year>2013</year><volume>22</volume><fpage>280</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.carpath.2013.01.004</pub-id><pub-id pub-id-type="pmid">23410819</pub-id></element-citation></ref><ref id="CR229"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chua</surname><given-names>CC</given-names></name><name name-style="western"><surname>Ho</surname><given-names>YS</given-names></name><name name-style="western"><surname>Hamdy</surname><given-names>RC</given-names></name><name name-style="western"><surname>Chua</surname><given-names>BH</given-names></name></person-group><article-title>Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>280</volume><fpage>H2313</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.2001.280.5.H2313</pub-id><pub-id pub-id-type="pmid">11299236</pub-id></element-citation></ref><ref id="CR230"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ono</surname><given-names>M</given-names></name><name name-style="western"><surname>Sawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ryugo</surname><given-names>M</given-names></name><name name-style="western"><surname>Alechine</surname><given-names>AN</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Sugioka</surname><given-names>R</given-names></name><etal/></person-group><article-title>BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts</article-title><source>Eur J Cardiothorac Surg</source><year>2005</year><volume>27</volume><fpage>117</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.ejcts.2004.09.025</pub-id><pub-id pub-id-type="pmid">15621482</pub-id></element-citation></ref><ref id="CR231"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toth</surname><given-names>A</given-names></name><name name-style="western"><surname>Jeffers</surname><given-names>JR</given-names></name><name name-style="western"><surname>Nickson</surname><given-names>P</given-names></name><name name-style="western"><surname>Min</surname><given-names>JY</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>JP</given-names></name><name name-style="western"><surname>Zambetti</surname><given-names>GP</given-names></name><etal/></person-group><article-title>Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2006</year><volume>291</volume><fpage>H52</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01046.2005</pub-id><pub-id pub-id-type="pmid">16399862</pub-id></element-citation></ref><ref id="CR232"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>WL</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chu</surname><given-names>HC</given-names></name></person-group><article-title>Post-conditioning anti-PUMA treatment protects mice against mice heart I/R injury</article-title><source>Eur Rev Med Pharmacol Sci</source><year>2016</year><volume>20</volume><fpage>1623</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">27160138</pub-id></element-citation></ref><ref id="CR233"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bi</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Neurotrophin-3 contributes to benefits of human embryonic stem cell-derived cardiovascular progenitor cells against reperfused myocardial infarction</article-title><source>Stem Cells Transl Med</source><year>2021</year><volume>10</volume><fpage>756</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1002/sctm.20-0456</pub-id><pub-id pub-id-type="pmid">33529481</pub-id><pub-id pub-id-type="pmcid">PMC8046156</pub-id></element-citation></ref><ref id="CR234"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mersmann</surname><given-names>J</given-names></name><name name-style="western"><surname>Zacharowski</surname><given-names>PA</given-names></name><name name-style="western"><surname>Schmitz</surname><given-names>I</given-names></name><name name-style="western"><surname>Zacharowski</surname><given-names>K</given-names></name></person-group><article-title>Caspase inhibitor zVAD.fmk reduces infarct size after myocardial ischaemia and reperfusion in rats but not in mice</article-title><source>Resuscitation</source><year>2008</year><volume>79</volume><fpage>468</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.resuscitation.2008.07.008</pub-id><pub-id pub-id-type="pmid">18805622</pub-id></element-citation></ref><ref id="CR235"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yaoita</surname><given-names>H</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Maehara</surname><given-names>K</given-names></name><name name-style="western"><surname>Maruyama</surname><given-names>Y</given-names></name></person-group><article-title>Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor</article-title><source>Circulation</source><year>1998</year><volume>97</volume><fpage>276</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.97.3.276</pub-id><pub-id pub-id-type="pmid">9462530</pub-id></element-citation></ref><ref id="CR236"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>JQ</given-names></name><name name-style="western"><surname>Radinovic</surname><given-names>S</given-names></name><name name-style="western"><surname>Rezaiefar</surname><given-names>P</given-names></name><name name-style="western"><surname>Black</surname><given-names>SC</given-names></name></person-group><article-title>In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia</article-title><source>Eur J Pharmacol</source><year>2000</year><volume>402</volume><fpage>139</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S0014-2999(00)00477-5</pub-id><pub-id pub-id-type="pmid">10940367</pub-id></element-citation></ref><ref id="CR237"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Souktani</surname><given-names>R</given-names></name><name name-style="western"><surname>Pons</surname><given-names>S</given-names></name><name name-style="western"><surname>Guegan</surname><given-names>C</given-names></name><name name-style="western"><surname>Bouhidel</surname><given-names>O</given-names></name><name name-style="western"><surname>Bruneval</surname><given-names>P</given-names></name><name name-style="western"><surname>Zini</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cardioprotection against myocardial infarction with PTD-BIR3/RING, a XIAP mimicking protein</article-title><source>J Mol Cell Cardiol</source><year>2009</year><volume>46</volume><fpage>713</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.02.005</pub-id><pub-id pub-id-type="pmid">19233193</pub-id></element-citation></ref><ref id="CR238"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inserte</surname><given-names>J</given-names></name><name name-style="western"><surname>Cardona</surname><given-names>M</given-names></name><name name-style="western"><surname>Poncelas-Nozal</surname><given-names>M</given-names></name><name name-style="western"><surname>Hernando</surname><given-names>V</given-names></name><name name-style="western"><surname>Vilardosa</surname><given-names>&#218;</given-names></name><name name-style="western"><surname>Aluja</surname><given-names>D</given-names></name><etal/></person-group><article-title>Studies on the role of apoptosis after transient myocardial ischemia: genetic deletion of the executioner caspases-3 and -7 does not limit infarct size and ventricular remodeling</article-title><source>Basic Res Cardiol</source><year>2016</year><volume>111</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1007/s00395-016-0537-6</pub-id><pub-id pub-id-type="pmid">26924441</pub-id></element-citation></ref><ref id="CR239"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weisleder</surname><given-names>N</given-names></name><name name-style="western"><surname>Taffet</surname><given-names>GE</given-names></name><name name-style="western"><surname>Capetanaki</surname><given-names>Y</given-names></name></person-group><article-title>Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>769</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1073/pnas.0303202101</pub-id><pub-id pub-id-type="pmid">14715896</pub-id><pub-id pub-id-type="pmcid">PMC321756</pub-id></element-citation></ref><ref id="CR240"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maloyan</surname><given-names>A</given-names></name><name name-style="western"><surname>Sayegh</surname><given-names>J</given-names></name><name name-style="western"><surname>Osinska</surname><given-names>H</given-names></name><name name-style="western"><surname>Chua</surname><given-names>BH</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>J</given-names></name></person-group><article-title>Manipulation of death pathways in desmin-related cardiomyopathy</article-title><source>Circ Res</source><year>2010</year><volume>106</volume><fpage>1524</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.212639</pub-id><pub-id pub-id-type="pmid">20360253</pub-id><pub-id pub-id-type="pmcid">PMC2890082</pub-id></element-citation></ref><ref id="CR241"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalil</surname><given-names>H</given-names></name><name name-style="western"><surname>Peltzer</surname><given-names>N</given-names></name><name name-style="western"><surname>Walicki</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Dubuis</surname><given-names>G</given-names></name><name name-style="western"><surname>Gardiol</surname><given-names>N</given-names></name><etal/></person-group><article-title>Caspase-3 protects stressed organs against cell death</article-title><source>Mol Cell Biol</source><year>2012</year><volume>32</volume><fpage>4523</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1128/MCB.00774-12</pub-id><pub-id pub-id-type="pmid">22949508</pub-id><pub-id pub-id-type="pmcid">PMC3486191</pub-id></element-citation></ref><ref id="CR242"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez-Ruiz</surname><given-names>ME</given-names></name><name name-style="western"><surname>Buqu&#233;</surname><given-names>A</given-names></name><name name-style="western"><surname>Hensler</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Bloy</surname><given-names>N</given-names></name><name name-style="western"><surname>Petroni</surname><given-names>G</given-names></name><etal/></person-group><article-title>Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients</article-title><source>Oncoimmunology</source><year>2019</year><volume>8</volume><fpage>e1655964</fpage><pub-id pub-id-type="doi">10.1080/2162402X.2019.1655964</pub-id><pub-id pub-id-type="pmid">31646105</pub-id><pub-id pub-id-type="pmcid">PMC6791460</pub-id></element-citation></ref><ref id="CR243"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>MJ</given-names></name><name name-style="western"><surname>McArthur</surname><given-names>K</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>D</given-names></name><name name-style="western"><surname>Lane</surname><given-names>RM</given-names></name><name name-style="western"><surname>Cambier</surname><given-names>JC</given-names></name><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1549</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.036</pub-id><pub-id pub-id-type="pmid">25525874</pub-id><pub-id pub-id-type="pmcid">PMC4520319</pub-id></element-citation></ref><ref id="CR244"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rongvaux</surname><given-names>A</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>R</given-names></name><name name-style="western"><surname>Harman</surname><given-names>CC</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>West</surname><given-names>AP</given-names></name><name name-style="western"><surname>de Zoete</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1563</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.037</pub-id><pub-id pub-id-type="pmid">25525875</pub-id><pub-id pub-id-type="pmcid">PMC4272443</pub-id></element-citation></ref><ref id="CR245"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>KR</given-names></name><name name-style="western"><surname>Aguirre</surname><given-names>AD</given-names></name><name name-style="western"><surname>Ye</surname><given-names>YX</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Roh</surname><given-names>JD</given-names></name><name name-style="western"><surname>Ng</surname><given-names>RP</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>IRF3 and type I interferons fuel a fatal response to myocardial infarction</article-title><source>Nat Med</source><year>2017</year><volume>23</volume><fpage>1481</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nm.4428</pub-id><pub-id pub-id-type="pmid">29106401</pub-id><pub-id pub-id-type="pmcid">PMC6477926</pub-id></element-citation></ref><ref id="CR246"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fauvel</surname><given-names>H</given-names></name><name name-style="western"><surname>Marchetti</surname><given-names>P</given-names></name><name name-style="western"><surname>Chopin</surname><given-names>C</given-names></name><name name-style="western"><surname>Formstecher</surname><given-names>P</given-names></name><name name-style="western"><surname>Nevi&#232;re</surname><given-names>R</given-names></name></person-group><article-title>Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>280</volume><fpage>H1608</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.2001.280.4.H1608</pub-id><pub-id pub-id-type="pmid">11247771</pub-id></element-citation></ref><ref id="CR247"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlson</surname><given-names>DL</given-names></name><name name-style="western"><surname>Maass</surname><given-names>DL</given-names></name><name name-style="western"><surname>White</surname><given-names>J</given-names></name><name name-style="western"><surname>Sikes</surname><given-names>P</given-names></name><name name-style="western"><surname>Horton</surname><given-names>JW</given-names></name></person-group><article-title>Caspase inhibition reduces cardiac myocyte dyshomeostasis and improves cardiac contractile function after major burn injury</article-title><source>J Appl Physiol</source><year>2007</year><volume>103</volume><fpage>323</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01255.2006</pub-id><pub-id pub-id-type="pmid">17431085</pub-id></element-citation></ref><ref id="CR248"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Araki</surname><given-names>T</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>M</given-names></name><name name-style="western"><surname>Takano</surname><given-names>R</given-names></name><name name-style="western"><surname>Hisahara</surname><given-names>S</given-names></name><name name-style="western"><surname>Imamura</surname><given-names>S</given-names></name><name name-style="western"><surname>Fukuuchi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Conditional expression of anti-apoptotic protein p35 by Cre-mediated DNA recombination in cardiomyocytes from loxP-p35-transgenic mice</article-title><source>Cell Death Differ</source><year>2000</year><volume>7</volume><fpage>485</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400674</pub-id><pub-id pub-id-type="pmid">10800082</pub-id></element-citation></ref><ref id="CR249"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amgalan</surname><given-names>D</given-names></name><name name-style="western"><surname>Garner</surname><given-names>TP</given-names></name><name name-style="western"><surname>Pekson</surname><given-names>R</given-names></name><name name-style="western"><surname>Jia</surname><given-names>XF</given-names></name><name name-style="western"><surname>Yanamandala</surname><given-names>M</given-names></name><name name-style="western"><surname>Paulino</surname><given-names>V</given-names></name><etal/></person-group><article-title>A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy</article-title><source>Nat Cancer</source><year>2020</year><volume>1</volume><fpage>315</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1038/s43018-020-0039-1</pub-id><pub-id pub-id-type="pmid">32776015</pub-id><pub-id pub-id-type="pmcid">PMC7413180</pub-id></element-citation></ref><ref id="CR250"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>LA</given-names></name><name name-style="western"><surname>Meader</surname><given-names>L</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>F</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>M</given-names></name><name name-style="western"><surname>Brady</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lechler</surname><given-names>R</given-names></name><etal/></person-group><article-title>Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance</article-title><source>Clin Exp Immunol</source><year>2017</year><volume>188</volume><fpage>219</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/cei.12931</pub-id><pub-id pub-id-type="pmid">28120329</pub-id><pub-id pub-id-type="pmcid">PMC5383447</pub-id></element-citation></ref><ref id="CR251"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grootaert</surname><given-names>MO</given-names></name><name name-style="western"><surname>Schrijvers</surname><given-names>DM</given-names></name><name name-style="western"><surname>Hermans</surname><given-names>M</given-names></name><name name-style="western"><surname>Van Hoof</surname><given-names>VO</given-names></name><name name-style="western"><surname>De Meyer</surname><given-names>GR</given-names></name><name name-style="western"><surname>Martinet</surname><given-names>W</given-names></name></person-group><article-title>Caspase-3 deletion promotes necrosis in atherosclerotic plaques of ApoE knockout mice</article-title><source>Oxid Med Cell Longev</source><year>2016</year><volume>2016</volume><fpage>3087469</fpage><pub-id pub-id-type="doi">10.1155/2016/3087469</pub-id><pub-id pub-id-type="pmid">27847551</pub-id><pub-id pub-id-type="pmcid">PMC5101396</pub-id></element-citation></ref><ref id="CR252"><label>252.</label><mixed-citation publication-type="other">Chao ML, Guo J, Cheng WL, Zhu XY, She ZG, Huang Z, et al. Loss of caspase-activated DNase protects against atherosclerosis in apolipoprotein E-deficient mice. J Amn Heart Assoc. 2016;5:e004362.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.116.004362</pub-id><pub-id pub-id-type="pmcid">PMC5210397</pub-id><pub-id pub-id-type="pmid">28007744</pub-id></mixed-citation></ref><ref id="CR253"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontaine</surname><given-names>MAC</given-names></name><name name-style="western"><surname>Westra</surname><given-names>MM</given-names></name><name name-style="western"><surname>Bot</surname><given-names>I</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><name name-style="western"><surname>Franssen</surname><given-names>A</given-names></name><name name-style="western"><surname>Bot</surname><given-names>M</given-names></name><etal/></person-group><article-title>Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><fpage>14547</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-51020-3</pub-id><pub-id pub-id-type="pmid">31601924</pub-id><pub-id pub-id-type="pmcid">PMC6787218</pub-id></element-citation></ref><ref id="CR254"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>MKS</given-names></name><name name-style="western"><surname>Kraakman</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Dragoljevic</surname><given-names>D</given-names></name><name name-style="western"><surname>Hanssen</surname><given-names>NMJ</given-names></name><name name-style="western"><surname>Flynn</surname><given-names>MC</given-names></name><name name-style="western"><surname>Al-Sharea</surname><given-names>A</given-names></name><etal/></person-group><article-title>Apoptotic ablation of platelets reduces atherosclerosis in mice with diabetes</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2021</year><volume>41</volume><fpage>1167</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.120.315369</pub-id><pub-id pub-id-type="pmid">33441028</pub-id><pub-id pub-id-type="pmcid">PMC7904582</pub-id></element-citation></ref><ref id="CR255"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Temmerman</surname><given-names>L</given-names></name><name name-style="western"><surname>Westra</surname><given-names>MM</given-names></name><name name-style="western"><surname>Bot</surname><given-names>I</given-names></name><name name-style="western"><surname>van Vlijmen</surname><given-names>BJM</given-names></name><name name-style="western"><surname>van Bree</surname><given-names>N</given-names></name><name name-style="western"><surname>Bot</surname><given-names>M</given-names></name><etal/></person-group><article-title>Leukocyte Bim deficiency does not impact atherogenesis in ldlr (&#8722;/&#8722;) mice, despite a pronounced induction of autoimmune inflammation</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>3086</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-02771-4</pub-id><pub-id pub-id-type="pmid">28596542</pub-id><pub-id pub-id-type="pmcid">PMC5465223</pub-id></element-citation></ref><ref id="CR256"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thorp</surname><given-names>E</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bao</surname><given-names>L</given-names></name><name name-style="western"><surname>Yao</surname><given-names>PM</given-names></name><name name-style="western"><surname>Kuriakose</surname><given-names>G</given-names></name><name name-style="western"><surname>Rong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe&#8722;/&#8722; mice lacking macrophage Bcl-2</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2009</year><volume>29</volume><fpage>169</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.108.176495</pub-id><pub-id pub-id-type="pmid">18988889</pub-id><pub-id pub-id-type="pmcid">PMC2731712</pub-id></element-citation></ref><ref id="CR257"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Dong</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JK</given-names></name><name name-style="western"><surname>Ramesh</surname><given-names>G</given-names></name></person-group><article-title>Dong Z. Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule-specific knockout mouse models</article-title><source>Kidney Int</source><year>2013</year><volume>84</volume><fpage>138</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/ki.2013.68</pub-id><pub-id pub-id-type="pmid">23466994</pub-id><pub-id pub-id-type="pmcid">PMC3686831</pub-id></element-citation></ref><ref id="CR258"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yin</surname><given-names>XM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>MH</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name></person-group><article-title>Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice</article-title><source>Am J Physiol Ren Physiol</source><year>2006</year><volume>290</volume><fpage>F35</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00184.2005</pub-id><pub-id pub-id-type="pmid">16106037</pub-id></element-citation></ref><ref id="CR259"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chien</surname><given-names>CT</given-names></name><name name-style="western"><surname>Shyue</surname><given-names>SK</given-names></name><name name-style="western"><surname>Lai</surname><given-names>MK</given-names></name></person-group><article-title>Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy</article-title><source>Transplantation</source><year>2007</year><volume>84</volume><fpage>1183</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1097/01.tp.0000287334.38933.e3</pub-id><pub-id pub-id-type="pmid">17998875</pub-id></element-citation></ref><ref id="CR260"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mei</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Hao</surname><given-names>J</given-names></name><name name-style="western"><surname>Su</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mei</surname><given-names>C</given-names></name><etal/></person-group><article-title>Double knockout of Bax and Bak from kidney proximal tubules reduces unilateral urethral obstruction associated apoptosis and renal interstitial fibrosis</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>44892</fpage><pub-id pub-id-type="doi">10.1038/srep44892</pub-id><pub-id pub-id-type="pmid">28317867</pub-id><pub-id pub-id-type="pmcid">PMC5357962</pub-id></element-citation></ref><ref id="CR261"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>HS</given-names></name><name name-style="western"><surname>Padanilam</surname><given-names>BJ</given-names></name></person-group><article-title>Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy</article-title><source>Am J Physiol Ren Physiol</source><year>2015</year><volume>309</volume><fpage>F540</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00170.2015</pub-id><pub-id pub-id-type="pmcid">PMC4572396</pub-id><pub-id pub-id-type="pmid">26180237</pub-id></element-citation></ref><ref id="CR262"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>B</given-names></name><name name-style="western"><surname>Lan</surname><given-names>S</given-names></name><name name-style="western"><surname>Dieud&#233;</surname><given-names>M</given-names></name><name name-style="western"><surname>Sabo-Vatasescu</surname><given-names>JP</given-names></name><name name-style="western"><surname>Karakeussian-Rimbaud</surname><given-names>A</given-names></name><name name-style="western"><surname>Turgeon</surname><given-names>J</given-names></name><etal/></person-group><article-title>Caspase-3 is a pivotal regulator of microvascular rarefaction and renal fibrosis after ischemia-reperfusion injury</article-title><source>J Am Soc Nephrol</source><year>2018</year><volume>29</volume><fpage>1900</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1681/ASN.2017050581</pub-id><pub-id pub-id-type="pmid">29925521</pub-id><pub-id pub-id-type="pmcid">PMC6050936</pub-id></element-citation></ref><ref id="CR263"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lan</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B</given-names></name><name name-style="western"><surname>Migneault</surname><given-names>F</given-names></name><name name-style="western"><surname>Turgeon</surname><given-names>J</given-names></name><name name-style="western"><surname>Bourgault</surname><given-names>M</given-names></name><name name-style="western"><surname>Dieud&#233;</surname><given-names>M</given-names></name><etal/></person-group><article-title>Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury</article-title><source>Am J Physiol Ren Physiol</source><year>2021</year><volume>321</volume><fpage>F335</fpage><lpage>f351</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00690.2020</pub-id><pub-id pub-id-type="pmid">34338031</pub-id></element-citation></ref><ref id="CR264"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zafar</surname><given-names>I</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Schrier</surname><given-names>RW</given-names></name><name name-style="western"><surname>Edelstein</surname><given-names>CL</given-names></name></person-group><article-title>Caspase-3 gene deletion prolongs survival in polycystic kidney disease</article-title><source>J Am Soc Nephrology</source><year>2008</year><volume>19</volume><fpage>749</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1681/ASN.2006121378</pub-id><pub-id pub-id-type="pmcid">PMC2390972</pub-id><pub-id pub-id-type="pmid">18272845</pub-id></element-citation></ref><ref id="CR265"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duplomb</surname><given-names>L</given-names></name><name name-style="western"><surname>Droin</surname><given-names>N</given-names></name><name name-style="western"><surname>Bouchot</surname><given-names>O</given-names></name><name name-style="western"><surname>Thauvin-Robinet</surname><given-names>C</given-names></name><name name-style="western"><surname>Bruel</surname><given-names>AL</given-names></name><name name-style="western"><surname>Thevenon</surname><given-names>J</given-names></name><etal/></person-group><article-title>A constitutive BCL2 down-regulation aggravates the phenotype of PKD1-mutant-induced polycystic kidney disease</article-title><source>Hum Mol Genet</source><year>2017</year><volume>26</volume><fpage>4680</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx349</pub-id><pub-id pub-id-type="pmid">28973148</pub-id></element-citation></ref><ref id="CR266"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daemen</surname><given-names>MA</given-names></name><name name-style="western"><surname>van &#8216;t Veer</surname><given-names>C</given-names></name><name name-style="western"><surname>Denecker</surname><given-names>G</given-names></name><name name-style="western"><surname>Heemskerk</surname><given-names>VH</given-names></name><name name-style="western"><surname>Wolfs</surname><given-names>TG</given-names></name><name name-style="western"><surname>Clauss</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation</article-title><source>J Clin Investig</source><year>1999</year><volume>104</volume><fpage>541</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1172/JCI6974</pub-id><pub-id pub-id-type="pmid">10487768</pub-id><pub-id pub-id-type="pmcid">PMC408540</pub-id></element-citation></ref><ref id="CR267"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bral</surname><given-names>M</given-names></name><name name-style="western"><surname>Pawlick</surname><given-names>R</given-names></name><name name-style="western"><surname>Marfil-Garza</surname><given-names>B</given-names></name><name name-style="western"><surname>Dadheech</surname><given-names>N</given-names></name><name name-style="western"><surname>Hefler</surname><given-names>J</given-names></name><name name-style="western"><surname>Thiesen</surname><given-names>A</given-names></name><etal/></person-group><article-title>Pan-caspase inhibitor F573 mitigates liver ischemia reperfusion injury in a murine model</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><fpage>e0224567</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0224567</pub-id><pub-id pub-id-type="pmid">31770375</pub-id><pub-id pub-id-type="pmcid">PMC6879152</pub-id></element-citation></ref><ref id="CR268"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Faubel</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>JC</given-names></name><name name-style="western"><surname>Falk</surname><given-names>SA</given-names></name><name name-style="western"><surname>Schrier</surname><given-names>RW</given-names></name><etal/></person-group><article-title>Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>6954</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.0408518102</pub-id><pub-id pub-id-type="pmid">15863619</pub-id><pub-id pub-id-type="pmcid">PMC1100753</pub-id></element-citation></ref><ref id="CR269"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>B</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>TS</given-names></name><name name-style="western"><surname>Haylor</surname><given-names>JL</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>B</given-names></name><name name-style="western"><surname>Watson</surname><given-names>PF</given-names></name><name name-style="western"><surname>El Kossi</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Effects of caspase inhibition on the progression of experimental glomerulonephritis</article-title><source>Kidney Int</source><year>2003</year><volume>63</volume><fpage>2050</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.2003.00000.x</pub-id><pub-id pub-id-type="pmid">12753292</pub-id></element-citation></ref><ref id="CR270"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seery</surname><given-names>JP</given-names></name><name name-style="western"><surname>Cattell</surname><given-names>V</given-names></name><name name-style="western"><surname>Watt</surname><given-names>FM</given-names></name></person-group><article-title>Cutting edge: amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(beta-o-methyl)-fluoromethylketone</article-title><source>J Immunol</source><year>2001</year><volume>167</volume><fpage>2452</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.5.2452</pub-id><pub-id pub-id-type="pmid">11509582</pub-id></element-citation></ref><ref id="CR271"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>CX</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fan</surname><given-names>QL</given-names></name></person-group><article-title>Caspase-3 promotes diabetic kidney disease through gasdermin E-mediated progression to secondary necrosis during apoptosis</article-title><source>Diabetes Metab Syndr Obes</source><year>2020</year><volume>13</volume><fpage>313</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S242136</pub-id><pub-id pub-id-type="pmid">32104028</pub-id><pub-id pub-id-type="pmcid">PMC7020918</pub-id></element-citation></ref><ref id="CR272"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belavgeni</surname><given-names>A</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>C</given-names></name><name name-style="western"><surname>Stumpf</surname><given-names>J</given-names></name><name name-style="western"><surname>Hugo</surname><given-names>C</given-names></name><name name-style="western"><surname>Linkermann</surname><given-names>A</given-names></name></person-group><article-title>Ferroptosis and Necroptosis in the Kidney</article-title><source>Cell Chem Biol</source><year>2020</year><volume>27</volume><fpage>448</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2020.03.016</pub-id><pub-id pub-id-type="pmid">32302582</pub-id></element-citation></ref><ref id="CR273"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von M&#228;ssenhausen</surname><given-names>A</given-names></name><name name-style="western"><surname>Tonnus</surname><given-names>W</given-names></name><name name-style="western"><surname>Linkermann</surname><given-names>A</given-names></name></person-group><article-title>Cell death pathways drive necroinflammation during acute kidney injury</article-title><source>Nephron</source><year>2018</year><volume>140</volume><fpage>144</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1159/000490807</pub-id><pub-id pub-id-type="pmid">29961062</pub-id></element-citation></ref><ref id="CR274"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Minto</surname><given-names>AW</given-names></name><name name-style="western"><surname>Quigg</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>PN</given-names></name></person-group><article-title>Acute renal failure in endotoxemia is dependent on caspase activation</article-title><source>J Am Soc Nephrology</source><year>2004</year><volume>15</volume><fpage>3093</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1097/01.ASN.0000145530.73247.F5</pub-id><pub-id pub-id-type="pmid">15579512</pub-id></element-citation></ref><ref id="CR275"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herzog</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaushal</surname><given-names>GP</given-names></name></person-group><article-title>zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function</article-title><source>Am J Physiol Ren Physiol</source><year>2012</year><volume>303</volume><fpage>F1239</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00659.2011</pub-id><pub-id pub-id-type="pmcid">PMC3469677</pub-id><pub-id pub-id-type="pmid">22896037</pub-id></element-citation></ref><ref id="CR276"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linkermann</surname><given-names>A</given-names></name><name name-style="western"><surname>Heller</surname><given-names>JO</given-names></name><name name-style="western"><surname>Pr&#243;kai</surname><given-names>A</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>JM</given-names></name><name name-style="western"><surname>De Zen</surname><given-names>F</given-names></name><name name-style="western"><surname>Himmerkus</surname><given-names>N</given-names></name><etal/></person-group><article-title>The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice</article-title><source>J Am Soc Nephrology</source><year>2013</year><volume>24</volume><fpage>1545</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1681/ASN.2012121169</pub-id><pub-id pub-id-type="pmcid">PMC3785275</pub-id><pub-id pub-id-type="pmid">23833261</pub-id></element-citation></ref><ref id="CR277"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinkmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Waring</surname><given-names>P</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>SP</given-names></name><name name-style="western"><surname>Wimmer</surname><given-names>V</given-names></name><name name-style="western"><surname>Cottle</surname><given-names>DL</given-names></name><name name-style="western"><surname>Tham</surname><given-names>MS</given-names></name><etal/></person-group><article-title>BCL-XL exerts a protective role against anemia caused by radiation-induced kidney damage</article-title><source>EMBO J</source><year>2020</year><volume>39</volume><fpage>e105561</fpage><pub-id pub-id-type="doi">10.15252/embj.2020105561</pub-id><pub-id pub-id-type="pmid">33236795</pub-id><pub-id pub-id-type="pmcid">PMC7737616</pub-id></element-citation></ref><ref id="CR278"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>XM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Gross</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zinkel</surname><given-names>S</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>B</given-names></name><etal/></person-group><article-title>Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis</article-title><source>Nature</source><year>1999</year><volume>400</volume><fpage>886</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/23730</pub-id><pub-id pub-id-type="pmid">10476969</pub-id></element-citation></ref><ref id="CR279"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DuBray</surname><given-names>BJ</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Conzen</surname><given-names>KD</given-names></name><name name-style="western"><surname>Upadhya</surname><given-names>GA</given-names></name><name name-style="western"><surname>Gunter</surname><given-names>KL</given-names></name><name name-style="western"><surname>Jia</surname><given-names>J</given-names></name><name name-style="western"><surname>Knolhoff</surname><given-names>BL</given-names></name><etal/></person-group><article-title>BH3-only proteins contribute to steatotic liver ischemia-reperfusion injury</article-title><source>J Surg Res</source><year>2015</year><volume>194</volume><fpage>653</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2014.10.024</pub-id><pub-id pub-id-type="pmid">25483735</pub-id><pub-id pub-id-type="pmcid">PMC4369674</pub-id></element-citation></ref><ref id="CR280"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selzner</surname><given-names>M</given-names></name><name name-style="western"><surname>R&#252;diger</surname><given-names>HA</given-names></name><name name-style="western"><surname>Selzner</surname><given-names>N</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>DW</given-names></name><name name-style="western"><surname>Sindram</surname><given-names>D</given-names></name><name name-style="western"><surname>Clavien</surname><given-names>PA</given-names></name></person-group><article-title>Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion</article-title><source>J Hepatol</source><year>2002</year><volume>36</volume><fpage>218</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S0168-8278(01)00259-8</pub-id><pub-id pub-id-type="pmid">11830333</pub-id></element-citation></ref><ref id="CR281"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cursio</surname><given-names>R</given-names></name><name name-style="western"><surname>Gugenheim</surname><given-names>J</given-names></name><name name-style="western"><surname>Ricci</surname><given-names>JE</given-names></name><name name-style="western"><surname>Crenesse</surname><given-names>D</given-names></name><name name-style="western"><surname>Rostagno</surname><given-names>P</given-names></name><name name-style="western"><surname>Maulon</surname><given-names>L</given-names></name><etal/></person-group><article-title>Caspase inhibition protects from liver injury following ischemia and reperfusion in rats</article-title><source>Transpl Int</source><year>2000</year><volume>13</volume><fpage>S568</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s001470050405</pub-id><pub-id pub-id-type="pmid">11112076</pub-id></element-citation></ref><ref id="CR282"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaufmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Jost</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>M</given-names></name><name name-style="western"><surname>Puthalakath</surname><given-names>H</given-names></name><name name-style="western"><surname>Gugasyan</surname><given-names>R</given-names></name><name name-style="western"><surname>Gerondakis</surname><given-names>S</given-names></name><etal/></person-group><article-title>Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.10.017</pub-id><pub-id pub-id-type="pmid">19119023</pub-id><pub-id pub-id-type="pmcid">PMC2938743</pub-id></element-citation></ref><ref id="CR283"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riddle-Taylor</surname><given-names>E</given-names></name><name name-style="western"><surname>Nagasaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>J</given-names></name><name name-style="western"><surname>Esquivel</surname><given-names>CO</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>OM</given-names></name><name name-style="western"><surname>Krams</surname><given-names>SM</given-names></name></person-group><article-title>Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury</article-title><source>Transplantation</source><year>2007</year><volume>84</volume><fpage>778</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1097/01.tp.0000281555.18782.2b</pub-id><pub-id pub-id-type="pmid">17893612</pub-id><pub-id pub-id-type="pmcid">PMC4084732</pub-id></element-citation></ref><ref id="CR284"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauer</surname><given-names>C</given-names></name><name name-style="western"><surname>Brunner</surname><given-names>T</given-names></name><name name-style="western"><surname>Corazza</surname><given-names>N</given-names></name></person-group><article-title>The proapoptotic Bcl-2 family member Bim plays a central role during the development of virus-induced hepatitis</article-title><source>J Immunol</source><year>2012</year><volume>188</volume><fpage>916</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101864</pub-id><pub-id pub-id-type="pmid">22156338</pub-id></element-citation></ref><ref id="CR285"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Ni</surname><given-names>HM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Ding</surname><given-names>WX</given-names></name><etal/></person-group><article-title>p53 Up-regulated modulator of apoptosis induction mediates acetaminophen-induced necrosis and liver injury in mice</article-title><source>Hepatology</source><year>2019</year><volume>69</volume><fpage>2164</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1002/hep.30422</pub-id><pub-id pub-id-type="pmid">30552702</pub-id><pub-id pub-id-type="pmcid">PMC6461480</pub-id></element-citation></ref><ref id="CR286"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Badmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Keough</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Brunner</surname><given-names>T</given-names></name><name name-style="western"><surname>Corazza</surname><given-names>N</given-names></name></person-group><article-title>Role of TRAIL and the pro-apoptotic Bcl-2 homolog Bim in acetaminophen-induced liver damage</article-title><source>Cell Death Dis</source><year>2011</year><volume>2</volume><fpage>e171</fpage><pub-id pub-id-type="doi">10.1038/cddis.2011.55</pub-id><pub-id pub-id-type="pmid">21654829</pub-id><pub-id pub-id-type="pmcid">PMC3168997</pub-id></element-citation></ref><ref id="CR287"><label>287.</label><mixed-citation publication-type="other">Naim S, Fernandez-Marrero Y, de Brot S, Bachmann D, Kaufmann T. Loss of BOK has a minor impact on acetaminophen overdose-induced liver damage in mice. Int J Mol Sci. 2021;22:3281.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22063281</pub-id><pub-id pub-id-type="pmcid">PMC8004760</pub-id><pub-id pub-id-type="pmid">33807047</pub-id></mixed-citation></ref><ref id="CR288"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>N</given-names></name><name name-style="western"><surname>Iwata</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name><name name-style="western"><surname>Sekino</surname><given-names>T</given-names></name><name name-style="western"><surname>Matsuo</surname><given-names>H</given-names></name><name name-style="western"><surname>Shirahashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Improvement of the survival rate after rat massive hepatectomy due to the reduction of apoptosis by caspase inhibitor</article-title><source>J Gastroenterol Hepatol</source><year>2007</year><volume>22</volume><fpage>2015</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2007.04960.x</pub-id><pub-id pub-id-type="pmid">17559362</pub-id></element-citation></ref><ref id="CR289"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roychowdhury</surname><given-names>S</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>P</given-names></name><name name-style="western"><surname>McMullen</surname><given-names>MR</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>JI</given-names></name><etal/></person-group><article-title>Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation</article-title><source>Alcohol, Clin Exp Res</source><year>2012</year><volume>36</volume><fpage>1139</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1111/j.1530-0277.2011.01720.x</pub-id><pub-id pub-id-type="pmid">22273278</pub-id><pub-id pub-id-type="pmcid">PMC3337974</pub-id></element-citation></ref><ref id="CR290"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>De Mollerat Du Jeu</surname><given-names>X</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>CD</given-names></name><name name-style="western"><surname>Nektaria</surname><given-names>A</given-names></name><name name-style="western"><surname>Feldstein</surname><given-names>AE</given-names></name></person-group><article-title>Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis</article-title><source>J Hepatol</source><year>2016</year><volume>64</volume><fpage>699</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2015.11.002</pub-id><pub-id pub-id-type="pmid">26555271</pub-id><pub-id pub-id-type="pmcid">PMC4761314</pub-id></element-citation></ref><ref id="CR291"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higuchi</surname><given-names>H</given-names></name><name name-style="western"><surname>Miyoshi</surname><given-names>H</given-names></name><name name-style="western"><surname>Bronk</surname><given-names>SF</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Dean</surname><given-names>N</given-names></name><name name-style="western"><surname>Gores</surname><given-names>GJ</given-names></name></person-group><article-title>Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury</article-title><source>J Pharmacol Exp Ther</source><year>2001</year><volume>299</volume><fpage>866</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">11714870</pub-id></element-citation></ref><ref id="CR292"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nalapareddy</surname><given-names>P</given-names></name><name name-style="western"><surname>Sch&#252;ngel</surname><given-names>S</given-names></name><name name-style="western"><surname>Hong</surname><given-names>JY</given-names></name><name name-style="western"><surname>Manns</surname><given-names>MP</given-names></name><name name-style="western"><surname>Jaeschke</surname><given-names>H</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>A</given-names></name></person-group><article-title>The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis</article-title><source>Am J Pathol</source><year>2009</year><volume>175</volume><fpage>1077</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2009.090304</pub-id><pub-id pub-id-type="pmid">19661444</pub-id><pub-id pub-id-type="pmcid">PMC2731126</pub-id></element-citation></ref><ref id="CR293"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kahraman</surname><given-names>A</given-names></name><name name-style="western"><surname>Mott</surname><given-names>JL</given-names></name><name name-style="western"><surname>Bronk</surname><given-names>SF</given-names></name><name name-style="western"><surname>Werneburg</surname><given-names>NW</given-names></name><name name-style="western"><surname>Barreyro</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Guicciardi</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse</article-title><source>Digest Dis Sci</source><year>2009</year><volume>54</volume><fpage>1908</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1007/s10620-008-0583-5</pub-id><pub-id pub-id-type="pmid">19051025</pub-id><pub-id pub-id-type="pmcid">PMC2879585</pub-id></element-citation></ref><ref id="CR294"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>C</given-names></name><name name-style="western"><surname>Mahrouf-Yorgov</surname><given-names>M</given-names></name><name name-style="western"><surname>Mayeuf</surname><given-names>A</given-names></name><name name-style="western"><surname>Robin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mansouri</surname><given-names>A</given-names></name><name name-style="western"><surname>Fromenty</surname><given-names>B</given-names></name><etal/></person-group><article-title>Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease</article-title><source>Lab Investig</source><year>2011</year><volume>91</volume><fpage>273</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2010.163</pub-id><pub-id pub-id-type="pmid">20856227</pub-id></element-citation></ref><ref id="CR295"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Sehrawat</surname><given-names>TS</given-names></name><name name-style="western"><surname>Verma</surname><given-names>VK</given-names></name><name name-style="western"><surname>Navarro-Corcuera</surname><given-names>A</given-names></name><name name-style="western"><surname>Sidhu</surname><given-names>G</given-names></name><name name-style="western"><surname>Mauer</surname><given-names>A</given-names></name><etal/></person-group><article-title>XIAP knockdown in alcohol-associated liver disease models exhibits divergent in vitro and in vivo phenotypes owing to a potential zonal inhibitory role of SMAC</article-title><source>Front Physiol</source><year>2021</year><volume>12</volume><fpage>664222</fpage><pub-id pub-id-type="doi">10.3389/fphys.2021.664222</pub-id><pub-id pub-id-type="pmid">34025452</pub-id><pub-id pub-id-type="pmcid">PMC8138467</pub-id></element-citation></ref><ref id="CR296"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zilu</surname><given-names>S</given-names></name><name name-style="western"><surname>Qian</surname><given-names>H</given-names></name><name name-style="western"><surname>Haibin</surname><given-names>W</given-names></name><name name-style="western"><surname>Chenxu</surname><given-names>G</given-names></name><name name-style="western"><surname>Deshuai</surname><given-names>L</given-names></name><name name-style="western"><surname>Qiang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress</article-title><source>Aging</source><year>2019</year><volume>11</volume><fpage>12177</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.18632/aging.102559</pub-id><pub-id pub-id-type="pmid">31841118</pub-id><pub-id pub-id-type="pmcid">PMC6949096</pub-id></element-citation></ref><ref id="CR297"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thapaliya</surname><given-names>S</given-names></name><name name-style="western"><surname>Wree</surname><given-names>A</given-names></name><name name-style="western"><surname>Povero</surname><given-names>D</given-names></name><name name-style="western"><surname>Inzaugarat</surname><given-names>ME</given-names></name><name name-style="western"><surname>Berk</surname><given-names>M</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>L</given-names></name><etal/></person-group><article-title>Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model</article-title><source>Digest Dis Sci</source><year>2014</year><volume>59</volume><fpage>1197</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1007/s10620-014-3167-6</pub-id><pub-id pub-id-type="pmid">24795036</pub-id><pub-id pub-id-type="pmcid">PMC4512760</pub-id></element-citation></ref><ref id="CR298"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weng</surname><given-names>SY</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Li</surname><given-names>CC</given-names></name><name name-style="western"><surname>Sun</surname><given-names>TP</given-names></name><name name-style="western"><surname>Tung</surname><given-names>SY</given-names></name><name name-style="western"><surname>Yen</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancer</article-title><source>J Hepatol</source><year>2011</year><volume>54</volume><fpage>685</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2010.07.035</pub-id><pub-id pub-id-type="pmid">21146511</pub-id></element-citation></ref><ref id="CR299"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hikita</surname><given-names>H</given-names></name><name name-style="western"><surname>Kodama</surname><given-names>T</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Shigekawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bak deficiency inhibits liver carcinogenesis: a causal link between apoptosis and carcinogenesis</article-title><source>J Hepatol</source><year>2012</year><volume>57</volume><fpage>92</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2012.01.027</pub-id><pub-id pub-id-type="pmid">22414765</pub-id></element-citation></ref><ref id="CR300"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rabachini</surname><given-names>T</given-names></name><name name-style="western"><surname>Fernandez-Marrero</surname><given-names>Y</given-names></name><name name-style="western"><surname>Montani</surname><given-names>M</given-names></name><name name-style="western"><surname>Loforese</surname><given-names>G</given-names></name><name name-style="western"><surname>Sladky</surname><given-names>V</given-names></name><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><etal/></person-group><article-title>BOK promotes chemical-induced hepatocarcinogenesis in mice</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>708</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/s41418-017-0008-0</pub-id><pub-id pub-id-type="pmid">29229991</pub-id><pub-id pub-id-type="pmcid">PMC5864194</pub-id></element-citation></ref><ref id="CR301"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wree</surname><given-names>A</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>CD</given-names></name><name name-style="western"><surname>Font-Burgada</surname><given-names>J</given-names></name><name name-style="western"><surname>Eguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Povero</surname><given-names>D</given-names></name><name name-style="western"><surname>Karin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation</article-title><source>Cell Death Differ</source><year>2015</year><volume>22</volume><fpage>1985</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.46</pub-id><pub-id pub-id-type="pmid">25909884</pub-id><pub-id pub-id-type="pmcid">PMC4816107</pub-id></element-citation></ref><ref id="CR302"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orlik</surname><given-names>J</given-names></name><name name-style="western"><surname>Sch&#252;ngel</surname><given-names>S</given-names></name><name name-style="western"><surname>Buitrago-Molina</surname><given-names>LE</given-names></name><name name-style="western"><surname>Marhenke</surname><given-names>S</given-names></name><name name-style="western"><surname>Geffers</surname><given-names>R</given-names></name><name name-style="western"><surname>Endig</surname><given-names>J</given-names></name><etal/></person-group><article-title>The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice</article-title><source>Hepatology</source><year>2015</year><volume>62</volume><fpage>816</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1002/hep.27888</pub-id><pub-id pub-id-type="pmid">25951810</pub-id></element-citation></ref><ref id="CR303"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JY</given-names></name><name name-style="western"><surname>Garcia-Carbonell</surname><given-names>R</given-names></name><name name-style="western"><surname>Yamachika</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name><name name-style="western"><surname>Dhar</surname><given-names>D</given-names></name><name name-style="western"><surname>Loomba</surname><given-names>R</given-names></name><etal/></person-group><article-title>ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P</article-title><source>Cell</source><year>2018</year><volume>175</volume><fpage>133</fpage><lpage>145.e115</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.08.020</pub-id><pub-id pub-id-type="pmid">30220454</pub-id><pub-id pub-id-type="pmcid">PMC6159928</pub-id></element-citation></ref><ref id="CR304"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Machado</surname><given-names>MV</given-names></name><name name-style="western"><surname>Michelotti</surname><given-names>GA</given-names></name><name name-style="western"><surname>Jewell</surname><given-names>ML</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>TA</given-names></name><name name-style="western"><surname>Xie</surname><given-names>G</given-names></name><name name-style="western"><surname>Premont</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2096</fpage><pub-id pub-id-type="doi">10.1038/cddis.2016.19</pub-id><pub-id pub-id-type="pmid">26890135</pub-id><pub-id pub-id-type="pmcid">PMC5399190</pub-id></element-citation></ref><ref id="CR305"><label>305.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barreyro</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Holod</surname><given-names>S</given-names></name><name name-style="western"><surname>Finocchietto</surname><given-names>PV</given-names></name><name name-style="western"><surname>Camino</surname><given-names>AM</given-names></name><name name-style="western"><surname>Aquino</surname><given-names>JB</given-names></name><name name-style="western"><surname>Avagnina</surname><given-names>A</given-names></name><etal/></person-group><article-title>The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis</article-title><source>Liver Int</source><year>2015</year><volume>35</volume><fpage>953</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1111/liv.12570</pub-id><pub-id pub-id-type="pmid">24750664</pub-id></element-citation></ref><ref id="CR306"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witek</surname><given-names>RP</given-names></name><name name-style="western"><surname>Stone</surname><given-names>WC</given-names></name><name name-style="western"><surname>Karaca</surname><given-names>FG</given-names></name><name name-style="western"><surname>Syn</surname><given-names>WK</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>TA</given-names></name><name name-style="western"><surname>Agboola</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis</article-title><source>Hepatology</source><year>2009</year><volume>50</volume><fpage>1421</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1002/hep.23167</pub-id><pub-id pub-id-type="pmid">19676126</pub-id></element-citation></ref><ref id="CR307"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gracia-Sancho</surname><given-names>J</given-names></name><name name-style="western"><surname>Manicardi</surname><given-names>N</given-names></name><name name-style="western"><surname>Ortega-Ribera</surname><given-names>M</given-names></name><name name-style="western"><surname>Maeso-D&#237;az</surname><given-names>R</given-names></name><name name-style="western"><surname>Guix&#233;-Muntet</surname><given-names>S</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Iglesias</surname><given-names>A</given-names></name><etal/></person-group><article-title>Emricasan ameliorates portal hypertension and liver fibrosis in cirrhotic rats through a hepatocyte-mediated paracrine mechanism</article-title><source>Hepatol Commun</source><year>2019</year><volume>3</volume><fpage>987</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1002/hep4.1360</pub-id><pub-id pub-id-type="pmid">31304452</pub-id><pub-id pub-id-type="pmcid">PMC6601324</pub-id></element-citation></ref><ref id="CR308"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Koyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wree</surname><given-names>A</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>CD</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>R</given-names></name><name name-style="western"><surname>Povero</surname><given-names>D</given-names></name><etal/></person-group><article-title>Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation</article-title><source>J Mol Med</source><year>2018</year><volume>96</volume><fpage>575</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1007/s00109-018-1642-9</pub-id><pub-id pub-id-type="pmid">29728708</pub-id><pub-id pub-id-type="pmcid">PMC6347405</pub-id></element-citation></ref><ref id="CR309"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canbay</surname><given-names>A</given-names></name><name name-style="western"><surname>Feldstein</surname><given-names>A</given-names></name><name name-style="western"><surname>Baskin-Bey</surname><given-names>E</given-names></name><name name-style="western"><surname>Bronk</surname><given-names>SF</given-names></name><name name-style="western"><surname>Gores</surname><given-names>GJ</given-names></name></person-group><article-title>The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse</article-title><source>J Pharmacol Exp Ther</source><year>2004</year><volume>308</volume><fpage>1191</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1124/jpet.103.060129</pub-id><pub-id pub-id-type="pmid">14617689</pub-id></element-citation></ref><ref id="CR310"><label>310.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Tsao</surname><given-names>G</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>M</given-names></name><name name-style="western"><surname>Shiffman</surname><given-names>M</given-names></name><name name-style="western"><surname>Borg</surname><given-names>BB</given-names></name><name name-style="western"><surname>Pyrsopoulos</surname><given-names>N</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>K</given-names></name><etal/></person-group><article-title>Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension</article-title><source>Hepatology</source><year>2019</year><volume>69</volume><fpage>717</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1002/hep.30199</pub-id><pub-id pub-id-type="pmid">30063802</pub-id><pub-id pub-id-type="pmcid">PMC6587783</pub-id></element-citation></ref><ref id="CR311"><label>311.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frenette</surname><given-names>C</given-names></name><name name-style="western"><surname>Kayali</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mena</surname><given-names>E</given-names></name><name name-style="western"><surname>Mantry</surname><given-names>PS</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Neff</surname><given-names>G</given-names></name><etal/></person-group><article-title>Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis</article-title><source>J Hepatol</source><year>2021</year><volume>74</volume><fpage>274</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2020.09.029</pub-id><pub-id pub-id-type="pmid">33038432</pub-id></element-citation></ref><ref id="CR312"><label>312.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>WF</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ding</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Sun</surname><given-names>HY</given-names></name><name name-style="western"><surname>Che</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Gasdermin E-derived caspase-3 inhibitors effectively protect mice from acute hepatic failure</article-title><source>Acta Pharmacol Sin</source><year>2021</year><volume>42</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1038/s41401-020-0434-2</pub-id><pub-id pub-id-type="pmid">32457417</pub-id><pub-id pub-id-type="pmcid">PMC7921426</pub-id></element-citation></ref><ref id="CR313"><label>313.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>H&#246;gstrand</surname><given-names>K</given-names></name><name name-style="western"><surname>Hejll</surname><given-names>E</given-names></name><name name-style="western"><surname>Sander</surname><given-names>B</given-names></name><name name-style="western"><surname>Rozell</surname><given-names>B</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>LG</given-names></name><name name-style="western"><surname>Grandien</surname><given-names>A</given-names></name></person-group><article-title>Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e31366</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0031366</pub-id><pub-id pub-id-type="pmid">22393362</pub-id><pub-id pub-id-type="pmcid">PMC3290626</pub-id></element-citation></ref><ref id="CR314"><label>314.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finch</surname><given-names>A</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>J</given-names></name><name name-style="western"><surname>Shchors</surname><given-names>K</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>A</given-names></name><name name-style="western"><surname>Soucek</surname><given-names>L</given-names></name><name name-style="western"><surname>Dansen</surname><given-names>TB</given-names></name><etal/></person-group><article-title>Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms</article-title><source>Cancer Cell</source><year>2006</year><volume>10</volume><fpage>113</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2006.06.017</pub-id><pub-id pub-id-type="pmid">16904610</pub-id></element-citation></ref><ref id="CR315"><label>315.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swanson</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Kuslak</surname><given-names>SL</given-names></name><name name-style="western"><surname>Fang</surname><given-names>W</given-names></name><name name-style="western"><surname>Tze</surname><given-names>L</given-names></name><name name-style="western"><surname>Gaffney</surname><given-names>P</given-names></name><name name-style="western"><surname>Selby</surname><given-names>S</given-names></name><etal/></person-group><article-title>Fatal acute lymphoblastic leukemia in mice transgenic for B cell-restricted bcl-xL and c-myc</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>6684</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.11.6684</pub-id><pub-id pub-id-type="pmid">15153484</pub-id></element-citation></ref><ref id="CR316"><label>316.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AW</given-names></name><name name-style="western"><surname>Bath</surname><given-names>ML</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name></person-group><article-title>Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2</article-title><source>Nature</source><year>1990</year><volume>348</volume><fpage>331</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1038/348331a0</pub-id><pub-id pub-id-type="pmid">2250704</pub-id></element-citation></ref><ref id="CR317"><label>317.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Bath</surname><given-names>ML</given-names></name><name name-style="western"><surname>Turner</surname><given-names>ML</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>D</given-names></name><etal/></person-group><article-title>Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>3197</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-04-281071</pub-id><pub-id pub-id-type="pmid">20631380</pub-id><pub-id pub-id-type="pmcid">PMC2995351</pub-id></element-citation></ref><ref id="CR318"><label>318.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>GL</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>SP</given-names></name><name name-style="western"><surname>Fitzsimmons</surname><given-names>L</given-names></name><name name-style="western"><surname>Aubrey</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53</article-title><source>Genes Dev</source><year>2014</year><volume>28</volume><fpage>58</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1101/gad.232009.113</pub-id><pub-id pub-id-type="pmid">24395247</pub-id><pub-id pub-id-type="pmcid">PMC3894413</pub-id></element-citation></ref><ref id="CR319"><label>319.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name></person-group><article-title>ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia</article-title><source>Blood</source><year>2013</year><volume>121</volume><fpage>2285</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-01-475855</pub-id><pub-id pub-id-type="pmid">23341542</pub-id><pub-id pub-id-type="pmcid">PMC3606065</pub-id></element-citation></ref><ref id="CR320"><label>320.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice</article-title><source>Cell Death Differ</source><year>2013</year><volume>20</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/cdd.2012.92</pub-id><pub-id pub-id-type="pmid">22814621</pub-id><pub-id pub-id-type="pmcid">PMC3524630</pub-id></element-citation></ref><ref id="CR321"><label>321.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mason</surname><given-names>KD</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Wei</surname><given-names>AH</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><etal/></person-group><article-title>In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>17961</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.0809957105</pub-id><pub-id pub-id-type="pmid">19004807</pub-id><pub-id pub-id-type="pmcid">PMC2582212</pub-id></element-citation></ref><ref id="CR322"><label>322.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Martin</surname><given-names>DR</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>2421</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00760-9</pub-id><pub-id pub-id-type="pmid">33723373</pub-id><pub-id pub-id-type="pmcid">PMC8329176</pub-id></element-citation></ref><ref id="CR323"><label>323.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowen</surname><given-names>ME</given-names></name><name name-style="western"><surname>Mulligan</surname><given-names>AS</given-names></name><name name-style="western"><surname>Sorayya</surname><given-names>A</given-names></name><name name-style="western"><surname>Attardi</surname><given-names>LD</given-names></name></person-group><article-title>Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>2083</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00738-7</pub-id><pub-id pub-id-type="pmid">33574585</pub-id><pub-id pub-id-type="pmcid">PMC8257737</pub-id></element-citation></ref><ref id="CR324"><label>324.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>J</given-names></name><name name-style="western"><surname>Niu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group><article-title>p53-dependent elimination of aneuploid mitotic offspring by entosis</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>799</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-00645-3</pub-id><pub-id pub-id-type="pmid">33110215</pub-id><pub-id pub-id-type="pmcid">PMC7862607</pub-id></element-citation></ref><ref id="CR325"><label>325.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>M</given-names></name><name name-style="western"><surname>Steiner</surname><given-names>L</given-names></name><name name-style="western"><surname>Engeland</surname><given-names>K</given-names></name></person-group><article-title>The transcription factor p53: not a repressor, solely an activator</article-title><source>Cell Cycle</source><year>2014</year><volume>13</volume><fpage>3037</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.4161/15384101.2014.949083</pub-id><pub-id pub-id-type="pmid">25486564</pub-id><pub-id pub-id-type="pmcid">PMC4612452</pub-id></element-citation></ref><ref id="CR326"><label>326.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engeland</surname><given-names>K</given-names></name></person-group><article-title>Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>114</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.172</pub-id><pub-id pub-id-type="pmid">29125603</pub-id><pub-id pub-id-type="pmcid">PMC5729532</pub-id></element-citation></ref><ref id="CR327"><label>327.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engeland</surname><given-names>K</given-names></name></person-group><article-title>Cell cycle regulation: p53-p21-RB signaling</article-title><source>Cell Death Differ</source><year>2022</year><volume>29</volume><fpage>946</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/s41418-022-00988-z</pub-id><pub-id pub-id-type="pmid">35361964</pub-id><pub-id pub-id-type="pmcid">PMC9090780</pub-id></element-citation></ref><ref id="CR328"><label>328.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aubrey</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>GL</given-names></name><name name-style="western"><surname>Janic</surname><given-names>A</given-names></name><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>104</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.169</pub-id><pub-id pub-id-type="pmid">29149101</pub-id><pub-id pub-id-type="pmcid">PMC5729529</pub-id></element-citation></ref><ref id="CR329"><label>329.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogelstein</surname><given-names>B</given-names></name><name name-style="western"><surname>Lane</surname><given-names>D</given-names></name><name name-style="western"><surname>Levine</surname><given-names>AJ</given-names></name></person-group><article-title>Surfing the p53 network</article-title><source>Nature</source><year>2000</year><volume>408</volume><fpage>307</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/35042675</pub-id><pub-id pub-id-type="pmid">11099028</pub-id></element-citation></ref><ref id="CR330"><label>330.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uxa</surname><given-names>S</given-names></name><name name-style="western"><surname>Castillo-Binder</surname><given-names>P</given-names></name><name name-style="western"><surname>Kohler</surname><given-names>R</given-names></name><name name-style="western"><surname>Stangner</surname><given-names>K</given-names></name><name name-style="western"><surname>Muller</surname><given-names>GA</given-names></name><name name-style="western"><surname>Engeland</surname><given-names>K</given-names></name></person-group><article-title>Ki-67 gene expression</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>3357</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00823-x</pub-id><pub-id pub-id-type="pmid">34183782</pub-id><pub-id pub-id-type="pmcid">PMC8629999</pub-id></element-citation></ref><ref id="CR331"><label>331.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name></person-group><article-title>Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice</article-title><source>Blood</source><year>2011</year><volume>118</volume><fpage>6380</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-07-367672</pub-id><pub-id pub-id-type="pmid">21998213</pub-id><pub-id pub-id-type="pmcid">PMC3236120</pub-id></element-citation></ref><ref id="CR332"><label>332.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><name name-style="western"><surname>Puthalakath</surname><given-names>H</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma</article-title><source>Blood</source><year>2007</year><volume>109</volume><fpage>4907</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-10-051847</pub-id><pub-id pub-id-type="pmid">17317859</pub-id><pub-id pub-id-type="pmcid">PMC1885522</pub-id></element-citation></ref><ref id="CR333"><label>333.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Aubrey</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Loss of a single Mcl-1 allele inhibits MYC-driven lymphomagenesis by sensitizing Pro-B cells to apoptosis</article-title><source>Cell Rep</source><year>2016</year><volume>14</volume><fpage>2337</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.039</pub-id><pub-id pub-id-type="pmid">26947081</pub-id></element-citation></ref><ref id="CR334"><label>334.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H</given-names></name><name name-style="western"><surname>Payton</surname><given-names>JE</given-names></name><name name-style="western"><surname>Cain</surname><given-names>J</given-names></name><name name-style="western"><surname>Ley</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia</article-title><source>J Clin Investig</source><year>2010</year><volume>120</volume><fpage>2109</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1172/JCI39964</pub-id><pub-id pub-id-type="pmid">20484815</pub-id><pub-id pub-id-type="pmcid">PMC2877934</pub-id></element-citation></ref><ref id="CR335"><label>335.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>GL</given-names></name><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2132</fpage><pub-id pub-id-type="doi">10.1038/cddis.2016.43</pub-id><pub-id pub-id-type="pmid">26962682</pub-id><pub-id pub-id-type="pmcid">PMC4823944</pub-id></element-citation></ref><ref id="CR336"><label>336.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Valente</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice</article-title><source>Blood</source><year>2014</year><volume>124</volume><fpage>3939</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-09-601567</pub-id><pub-id pub-id-type="pmid">25368374</pub-id></element-citation></ref><ref id="CR337"><label>337.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Waring</surname><given-names>P</given-names></name><name name-style="western"><surname>Happo</surname><given-names>L</given-names></name><name name-style="western"><surname>Cook</surname><given-names>M</given-names></name><name name-style="western"><surname>Mason</surname><given-names>KD</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice</article-title><source>Cell Death Differ</source><year>2012</year><volume>19</volume><fpage>623</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.133</pub-id><pub-id pub-id-type="pmid">21997189</pub-id><pub-id pub-id-type="pmcid">PMC3260394</pub-id></element-citation></ref><ref id="CR338"><label>338.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beverly</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Varmus</surname><given-names>HE</given-names></name></person-group><article-title>MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family</article-title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>1274</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/onc.2008.466</pub-id><pub-id pub-id-type="pmid">19137012</pub-id><pub-id pub-id-type="pmcid">PMC2743088</pub-id></element-citation></ref><ref id="CR339"><label>339.</label><mixed-citation publication-type="other">Diepstraten ST, Chang C, Tai L, Gong JN, Lan P, Dowell AC, et al. BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines. Blood Adv. 2020;4:356&#8211;66.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/bloodadvances.2019000541</pub-id><pub-id pub-id-type="pmcid">PMC6988404</pub-id><pub-id pub-id-type="pmid">31985804</pub-id></mixed-citation></ref><ref id="CR340"><label>340.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glaser</surname><given-names>SP</given-names></name><name name-style="western"><surname>Lee</surname><given-names>EF</given-names></name><name name-style="western"><surname>Trounson</surname><given-names>E</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Wei</surname><given-names>A</given-names></name><name name-style="western"><surname>Fairlie</surname><given-names>WD</given-names></name><etal/></person-group><article-title>Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia</article-title><source>Genes Dev</source><year>2012</year><volume>26</volume><fpage>120</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1101/gad.182980.111</pub-id><pub-id pub-id-type="pmid">22279045</pub-id><pub-id pub-id-type="pmcid">PMC3273836</pub-id></element-citation></ref><ref id="CR341"><label>341.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kotschy</surname><given-names>A</given-names></name><name name-style="western"><surname>Szlavik</surname><given-names>Z</given-names></name><name name-style="western"><surname>Murray</surname><given-names>J</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>J</given-names></name><name name-style="western"><surname>Maragno</surname><given-names>AL</given-names></name><name name-style="western"><surname>Le Toumelin-Braizat</surname><given-names>G</given-names></name><etal/></person-group><article-title>The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models</article-title><source>Nature</source><year>2016</year><volume>538</volume><fpage>477</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/nature19830</pub-id><pub-id pub-id-type="pmid">27760111</pub-id></element-citation></ref><ref id="CR342"><label>342.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>CM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>AS</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>R</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JK</given-names></name><name name-style="western"><surname>Gong</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Eischen</surname><given-names>CM</given-names></name></person-group><article-title>BCL-W has a fundamental role in B cell survival and lymphomagenesis</article-title><source>J Clin Investig</source><year>2017</year><volume>127</volume><fpage>635</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1172/JCI89486</pub-id><pub-id pub-id-type="pmid">28094768</pub-id><pub-id pub-id-type="pmcid">PMC5272186</pub-id></element-citation></ref><ref id="CR343"><label>343.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eischen</surname><given-names>CM</given-names></name><name name-style="western"><surname>Roussel</surname><given-names>MF</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Cleveland</surname><given-names>JL</given-names></name></person-group><article-title>Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis</article-title><source>Mol Cell Biol</source><year>2001</year><volume>21</volume><fpage>7653</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1128/MCB.21.22.7653-7662.2001</pub-id><pub-id pub-id-type="pmid">11604501</pub-id><pub-id pub-id-type="pmcid">PMC99936</pub-id></element-citation></ref><ref id="CR344"><label>344.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Egle</surname><given-names>A</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AW</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name></person-group><article-title>Bim is a suppressor of Myc-induced mouse B cell leukemia</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>6164</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.0401471101</pub-id><pub-id pub-id-type="pmid">15079075</pub-id><pub-id pub-id-type="pmcid">PMC395940</pub-id></element-citation></ref><ref id="CR345"><label>345.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis</article-title><source>Oncogene</source><year>2015</year><volume>34</volume><fpage>1872</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/onc.2014.132</pub-id><pub-id pub-id-type="pmid">24858047</pub-id></element-citation></ref><ref id="CR346"><label>346.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frenzel</surname><given-names>A</given-names></name><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Chmelewskij</surname><given-names>W</given-names></name><name name-style="western"><surname>Ploner</surname><given-names>C</given-names></name><name name-style="western"><surname>Geley</surname><given-names>S</given-names></name><name name-style="western"><surname>Fiegl</surname><given-names>H</given-names></name><etal/></person-group><article-title>Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad</article-title><source>Blood</source><year>2010</year><volume>115</volume><fpage>995</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-03-212670</pub-id><pub-id pub-id-type="pmid">19965635</pub-id><pub-id pub-id-type="pmcid">PMC3272372</pub-id></element-citation></ref><ref id="CR347"><label>347.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hemann</surname><given-names>MT</given-names></name><name name-style="western"><surname>Zilfou</surname><given-names>JT</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Hannon</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Lowe</surname><given-names>SW</given-names></name></person-group><article-title>Suppression of tumorigenesis by the p53 target PUMA</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>9333</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.0403286101</pub-id><pub-id pub-id-type="pmid">15192153</pub-id><pub-id pub-id-type="pmcid">PMC438977</pub-id></element-citation></ref><ref id="CR348"><label>348.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michalak</surname><given-names>EM</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>ES</given-names></name><name name-style="western"><surname>Happo</surname><given-names>L</given-names></name><name name-style="western"><surname>Cragg</surname><given-names>MS</given-names></name><name name-style="western"><surname>Tai</surname><given-names>L</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>GK</given-names></name><etal/></person-group><article-title>Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis</article-title><source>Cell Death Differ</source><year>2009</year><volume>16</volume><fpage>684</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1038/cdd.2008.195</pub-id><pub-id pub-id-type="pmid">19148184</pub-id><pub-id pub-id-type="pmcid">PMC2743939</pub-id></element-citation></ref><ref id="CR349"><label>349.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garrison</surname><given-names>SP</given-names></name><name name-style="western"><surname>Jeffers</surname><given-names>JR</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hall</surname><given-names>MA</given-names></name><name name-style="western"><surname>Rehg</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis</article-title><source>Mol Cell Biol</source><year>2008</year><volume>28</volume><fpage>5391</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1128/MCB.00907-07</pub-id><pub-id pub-id-type="pmid">18573879</pub-id><pub-id pub-id-type="pmcid">PMC2519737</pub-id></element-citation></ref><ref id="CR350"><label>350.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#233;rino</surname><given-names>D</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name></person-group><article-title>Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression</article-title><source>Oncogene</source><year>2012</year><volume>31</volume><fpage>3392</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/onc.2011.508</pub-id><pub-id pub-id-type="pmid">22081075</pub-id><pub-id pub-id-type="pmcid">PMC3361534</pub-id></element-citation></ref><ref id="CR351"><label>351.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Q</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Deng</surname><given-names>C</given-names></name></person-group><article-title>Potential synergism of Bim with p53 in mice with Myc&#8209;induced lymphoma in a mouse lymphoma model</article-title><source>Mol Med Rep</source><year>2012</year><volume>5</volume><fpage>1401</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22446994</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2012.844</pub-id></element-citation></ref><ref id="CR352"><label>352.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Pang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Aubrey</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Tai</surname><given-names>L</given-names></name><etal/></person-group><article-title>RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice</article-title><source>J Exp Med</source><year>2016</year><volume>213</volume><fpage>2039</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1084/jem.20150477</pub-id><pub-id pub-id-type="pmid">27621418</pub-id><pub-id pub-id-type="pmcid">PMC5030795</pub-id></element-citation></ref><ref id="CR353"><label>353.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>GM</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Bax accelerates tumorigenesis in p53-deficient mice</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>659</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">11212265</pub-id></element-citation></ref><ref id="CR354"><label>354.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valente</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Janic</surname><given-names>A</given-names></name></person-group><article-title>Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><fpage>3866</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/onc.2015.457</pub-id><pub-id pub-id-type="pmid">26640149</pub-id></element-citation></ref><ref id="CR355"><label>355.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Happo</surname><given-names>L</given-names></name><name name-style="western"><surname>Phipson</surname><given-names>B</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>GK</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name></person-group><article-title>Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs</article-title><source>Cell Death Dis</source><year>2012</year><volume>3</volume><fpage>e306</fpage><pub-id pub-id-type="doi">10.1038/cddis.2012.42</pub-id><pub-id pub-id-type="pmid">22573037</pub-id><pub-id pub-id-type="pmcid">PMC3366076</pub-id></element-citation></ref><ref id="CR356"><label>356.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>LH</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R</given-names></name><name name-style="western"><surname>Dorstyn</surname><given-names>L</given-names></name><name name-style="western"><surname>Cakouros</surname><given-names>D</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>A tumor suppressor function for caspase-2</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>5336</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1073/pnas.0811928106</pub-id><pub-id pub-id-type="pmid">19279217</pub-id><pub-id pub-id-type="pmcid">PMC2664004</pub-id></element-citation></ref><ref id="CR357"><label>357.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Schuler</surname><given-names>M</given-names></name><name name-style="western"><surname>Marsden</surname><given-names>VS</given-names></name><name name-style="western"><surname>Egle</surname><given-names>A</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>M</given-names></name><name name-style="western"><surname>Nesic</surname><given-names>D</given-names></name><etal/></person-group><article-title>Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation</article-title><source>J Cell Biol</source><year>2004</year><volume>164</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1083/jcb.200310041</pub-id><pub-id pub-id-type="pmid">14709542</pub-id><pub-id pub-id-type="pmcid">PMC2171953</pub-id></element-citation></ref><ref id="CR358"><label>358.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guirguis</surname><given-names>AA</given-names></name><name name-style="western"><surname>Slape</surname><given-names>CI</given-names></name><name name-style="western"><surname>Failla</surname><given-names>LM</given-names></name><name name-style="western"><surname>Saw</surname><given-names>J</given-names></name><name name-style="western"><surname>Tremblay</surname><given-names>CS</given-names></name><name name-style="western"><surname>Powell</surname><given-names>DR</given-names></name><etal/></person-group><article-title>PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia</article-title><source>Cell Death Differ</source><year>2016</year><volume>23</volume><fpage>1049</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.159</pub-id><pub-id pub-id-type="pmid">26742432</pub-id><pub-id pub-id-type="pmcid">PMC4987724</pub-id></element-citation></ref><ref id="CR359"><label>359.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michalak</surname><given-names>EM</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death</article-title><source>Genes Dev</source><year>2010</year><volume>24</volume><fpage>1608</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1101/gad.1940110</pub-id><pub-id pub-id-type="pmid">20679396</pub-id><pub-id pub-id-type="pmcid">PMC2912558</pub-id></element-citation></ref><ref id="CR360"><label>360.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Erlacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Krumschnabel</surname><given-names>G</given-names></name><name name-style="western"><surname>Manzl</surname><given-names>C</given-names></name><name name-style="western"><surname>Tzankov</surname><given-names>A</given-names></name><name name-style="western"><surname>Pinon</surname><given-names>J</given-names></name><etal/></person-group><article-title>Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation</article-title><source>Genes Dev</source><year>2010</year><volume>24</volume><fpage>1602</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1101/gad.1940210</pub-id><pub-id pub-id-type="pmid">20679395</pub-id><pub-id pub-id-type="pmcid">PMC2912557</pub-id></element-citation></ref><ref id="CR361"><label>361.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slinger</surname><given-names>E</given-names></name><name name-style="western"><surname>Wensveen</surname><given-names>FM</given-names></name><name name-style="western"><surname>Guikema</surname><given-names>JE</given-names></name><name name-style="western"><surname>Kater</surname><given-names>AP</given-names></name><name name-style="western"><surname>Eldering</surname><given-names>E</given-names></name></person-group><article-title>Chronic lymphocytic leukemia development is accelerated in mice with deficiency of the pro-apoptotic regulator NOXA</article-title><source>Haematologica</source><year>2016</year><volume>101</volume><fpage>e374</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.3324/haematol.2016.142323</pub-id><pub-id pub-id-type="pmid">27479816</pub-id><pub-id pub-id-type="pmcid">PMC5060034</pub-id></element-citation></ref><ref id="CR362"><label>362.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>SG</given-names></name><name name-style="western"><surname>Labelle</surname><given-names>JL</given-names></name><name name-style="western"><surname>Meng</surname><given-names>H</given-names></name><name name-style="western"><surname>Valeriano</surname><given-names>RP</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>JK</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><etal/></person-group><article-title>Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells</article-title><source>Blood</source><year>2014</year><volume>123</volume><fpage>884</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-04-499079</pub-id><pub-id pub-id-type="pmid">24352880</pub-id><pub-id pub-id-type="pmcid">PMC3916879</pub-id></element-citation></ref><ref id="CR363"><label>363.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anstee</surname><given-names>NS</given-names></name><name name-style="western"><surname>Bilardi</surname><given-names>RA</given-names></name><name name-style="western"><surname>Ng</surname><given-names>AP</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Robati</surname><given-names>M</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice</article-title><source>Cell Death Differ</source><year>2019</year><volume>26</volume><fpage>1316</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/s41418-018-0209-1</pub-id><pub-id pub-id-type="pmid">30470795</pub-id><pub-id pub-id-type="pmcid">PMC6748137</pub-id></element-citation></ref><ref id="CR364"><label>364.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Waring</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name></person-group><article-title>Plasmacytomagenesis in E&#956;-v-abl transgenic mice is accelerated when apoptosis is restrained</article-title><source>Blood</source><year>2014</year><volume>124</volume><fpage>1099</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-04-570770</pub-id><pub-id pub-id-type="pmid">24986687</pub-id><pub-id pub-id-type="pmcid">PMC4133484</pub-id></element-citation></ref><ref id="CR365"><label>365.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spinner</surname><given-names>S</given-names></name><name name-style="western"><surname>Crispatzu</surname><given-names>G</given-names></name><name name-style="western"><surname>Yi</surname><given-names>JH</given-names></name><name name-style="western"><surname>Munkhbaatar</surname><given-names>E</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>P</given-names></name><name name-style="western"><surname>H&#246;ckendorf</surname><given-names>U</given-names></name><etal/></person-group><article-title>Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance</article-title><source>Leukemia</source><year>2016</year><volume>30</volume><fpage>1520</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/leu.2016.49</pub-id><pub-id pub-id-type="pmid">27055871</pub-id></element-citation></ref><ref id="CR366"><label>366.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puccini</surname><given-names>J</given-names></name><name name-style="western"><surname>Shalini</surname><given-names>S</given-names></name><name name-style="western"><surname>Voss</surname><given-names>AK</given-names></name><name name-style="western"><surname>Gatei</surname><given-names>M</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>CH</given-names></name><name name-style="western"><surname>Hiwase</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>19920</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1073/pnas.1311947110</pub-id><pub-id pub-id-type="pmid">24248351</pub-id><pub-id pub-id-type="pmcid">PMC3856814</pub-id></element-citation></ref><ref id="CR367"><label>367.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fava</surname><given-names>LL</given-names></name><name name-style="western"><surname>Schuler</surname><given-names>F</given-names></name><name name-style="western"><surname>Sladky</surname><given-names>V</given-names></name><name name-style="western"><surname>Haschka</surname><given-names>MD</given-names></name><name name-style="western"><surname>Soratroi</surname><given-names>C</given-names></name><name name-style="western"><surname>Eiterer</surname><given-names>L</given-names></name><etal/></person-group><article-title>The PIDDosome activates p53 in response to supernumerary centrosomes</article-title><source>Genes Dev</source><year>2017</year><volume>31</volume><fpage>34</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1101/gad.289728.116</pub-id><pub-id pub-id-type="pmid">28130345</pub-id><pub-id pub-id-type="pmcid">PMC5287111</pub-id></element-citation></ref><ref id="CR368"><label>368.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lachowiez</surname><given-names>C</given-names></name><name name-style="western"><surname>DiNardo</surname><given-names>CD</given-names></name><name name-style="western"><surname>Konopleva</surname><given-names>M</given-names></name></person-group><article-title>Venetoclax in acute myeloid leukemia - current and future directions</article-title><source>Leuk lymphoma</source><year>2020</year><volume>61</volume><fpage>1313</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1080/10428194.2020.1719098</pub-id><pub-id pub-id-type="pmid">32031033</pub-id></element-citation></ref><ref id="CR369"><label>369.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nechiporuk</surname><given-names>T</given-names></name><name name-style="western"><surname>Kurtz</surname><given-names>SE</given-names></name><name name-style="western"><surname>Nikolova</surname><given-names>O</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Jones</surname><given-names>CL</given-names></name><name name-style="western"><surname>D&#8217;Alessandro</surname><given-names>A</given-names></name><etal/></person-group><article-title>The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells</article-title><source>Cancer Discov</source><year>2019</year><volume>9</volume><fpage>910</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-19-0125</pub-id><pub-id pub-id-type="pmid">31048320</pub-id><pub-id pub-id-type="pmcid">PMC6606338</pub-id></element-citation></ref><ref id="CR370"><label>370.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bosc</surname><given-names>C</given-names></name><name name-style="western"><surname>Saland</surname><given-names>E</given-names></name><name name-style="western"><surname>Bousard</surname><given-names>A</given-names></name><name name-style="western"><surname>Gadaud</surname><given-names>N</given-names></name><name name-style="western"><surname>Sabatier</surname><given-names>M</given-names></name><name name-style="western"><surname>Cognet</surname><given-names>G</given-names></name><etal/></person-group><article-title>Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia</article-title><source>Nat Cancer</source><year>2021</year><volume>2</volume><fpage>1204</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/s43018-021-00264-y</pub-id><pub-id pub-id-type="pmid">35122057</pub-id></element-citation></ref><ref id="CR371"><label>371.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thijssen</surname><given-names>R</given-names></name><name name-style="western"><surname>Diepstraten</surname><given-names>ST</given-names></name><name name-style="western"><surname>Moujalled</surname><given-names>D</given-names></name><name name-style="western"><surname>Chew</surname><given-names>E</given-names></name><name name-style="western"><surname>Flensburg</surname><given-names>C</given-names></name><name name-style="western"><surname>Shi</surname><given-names>MX</given-names></name><etal/></person-group><article-title>Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias</article-title><source>Blood</source><year>2021</year><volume>137</volume><fpage>2721</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1182/blood.2020010167</pub-id><pub-id pub-id-type="pmid">33824975</pub-id><pub-id pub-id-type="pmcid">PMC8138548</pub-id></element-citation></ref><ref id="CR372"><label>372.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomalla</surname><given-names>D</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>L</given-names></name><name name-style="western"><surname>Grimm</surname><given-names>C</given-names></name><name name-style="western"><surname>Oliverio</surname><given-names>M</given-names></name><name name-style="western"><surname>Meder</surname><given-names>L</given-names></name><name name-style="western"><surname>Herling</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies</article-title><source>Blood</source><year>2022</year><volume>140</volume><fpage>2113</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1182/blood.2021014304</pub-id><pub-id pub-id-type="pmid">35704690</pub-id></element-citation></ref><ref id="CR373"><label>373.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jilg</surname><given-names>S</given-names></name><name name-style="western"><surname>Reidel</surname><given-names>V</given-names></name><name name-style="western"><surname>M&#252;ller-Thomas</surname><given-names>C</given-names></name><name name-style="western"><surname>K&#246;nig</surname><given-names>J</given-names></name><name name-style="western"><surname>Schauwecker</surname><given-names>J</given-names></name><name name-style="western"><surname>H&#246;ckendorf</surname><given-names>U</given-names></name><etal/></person-group><article-title>Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients</article-title><source>Leukemia</source><year>2016</year><volume>30</volume><fpage>112</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/leu.2015.179</pub-id><pub-id pub-id-type="pmid">26153654</pub-id></element-citation></ref><ref id="CR374"><label>374.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganan-Gomez</surname><given-names>I</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Ma</surname><given-names>F</given-names></name><name name-style="western"><surname>Montalban-Bravo</surname><given-names>G</given-names></name><name name-style="western"><surname>Thongon</surname><given-names>N</given-names></name><name name-style="western"><surname>Marchica</surname><given-names>V</given-names></name><etal/></person-group><article-title>Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy</article-title><source>Nat Med</source><year>2022</year><volume>28</volume><fpage>557</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01696-4</pub-id><pub-id pub-id-type="pmid">35241842</pub-id><pub-id pub-id-type="pmcid">PMC8938266</pub-id></element-citation></ref><ref id="CR375"><label>375.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jilg</surname><given-names>S</given-names></name><name name-style="western"><surname>Hauch</surname><given-names>RT</given-names></name><name name-style="western"><surname>Kauschinger</surname><given-names>J</given-names></name><name name-style="western"><surname>Buschhorn</surname><given-names>L</given-names></name><name name-style="western"><surname>Odinius</surname><given-names>TO</given-names></name><name name-style="western"><surname>Dill</surname><given-names>V</given-names></name><etal/></person-group><article-title>Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose</article-title><source>Exp Hematol Oncol</source><year>2019</year><volume>8</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1186/s40164-019-0133-1</pub-id><pub-id pub-id-type="pmid">31016067</pub-id><pub-id pub-id-type="pmcid">PMC6469098</pub-id></element-citation></ref><ref id="CR376"><label>376.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jager</surname><given-names>R</given-names></name><name name-style="western"><surname>Herzer</surname><given-names>U</given-names></name><name name-style="western"><surname>Schenkel</surname><given-names>J</given-names></name><name name-style="western"><surname>Weiher</surname><given-names>H</given-names></name></person-group><article-title>Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice</article-title><source>Oncogene</source><year>1997</year><volume>15</volume><fpage>1787</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1201353</pub-id><pub-id pub-id-type="pmid">9362445</pub-id></element-citation></ref><ref id="CR377"><label>377.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibata</surname><given-names>MA</given-names></name><name name-style="western"><surname>Liu</surname><given-names>ML</given-names></name><name name-style="western"><surname>Knudson</surname><given-names>MC</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>E</given-names></name><name name-style="western"><surname>Yoshidome</surname><given-names>K</given-names></name><name name-style="western"><surname>Bandey</surname><given-names>T</given-names></name><etal/></person-group><article-title>Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage</article-title><source>EMBO J</source><year>1999</year><volume>18</volume><fpage>2692</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.10.2692</pub-id><pub-id pub-id-type="pmid">10329616</pub-id><pub-id pub-id-type="pmcid">PMC1171351</pub-id></element-citation></ref><ref id="CR378"><label>378.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamerson</surname><given-names>MH</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>MD</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Furth</surname><given-names>PA</given-names></name><name name-style="western"><surname>Dickson</surname><given-names>RB</given-names></name></person-group><article-title>Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice</article-title><source>Br J Cancer</source><year>2004</year><volume>91</volume><fpage>1372</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6602137</pub-id><pub-id pub-id-type="pmid">15354213</pub-id><pub-id pub-id-type="pmcid">PMC2409914</pub-id></element-citation></ref><ref id="CR379"><label>379.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bean</surname><given-names>GR</given-names></name><name name-style="western"><surname>Ganesan</surname><given-names>YT</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Chan</surname><given-names>PM</given-names></name><etal/></person-group><article-title>PUMA and BIM are required for oncogene inactivation-induced apoptosis</article-title><source>Sci Signal</source><year>2013</year><volume>6</volume><fpage>ra20</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2003483</pub-id><pub-id pub-id-type="pmid">23532334</pub-id><pub-id pub-id-type="pmcid">PMC3753585</pub-id></element-citation></ref><ref id="CR380"><label>380.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parsons</surname><given-names>MJ</given-names></name><name name-style="western"><surname>McCormick</surname><given-names>L</given-names></name><name name-style="western"><surname>Janke</surname><given-names>L</given-names></name><name name-style="western"><surname>Howard</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouchier-Hayes</surname><given-names>L</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice</article-title><source>Cell Death Differ</source><year>2013</year><volume>20</volume><fpage>1174</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/cdd.2013.38</pub-id><pub-id pub-id-type="pmid">23645210</pub-id><pub-id pub-id-type="pmcid">PMC3741497</pub-id></element-citation></ref><ref id="CR381"><label>381.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>KL</given-names></name><name name-style="western"><surname>Kittrell</surname><given-names>FS</given-names></name><name name-style="western"><surname>Gay</surname><given-names>JP</given-names></name><name name-style="western"><surname>J&#228;ger</surname><given-names>R</given-names></name><name name-style="western"><surname>Medina</surname><given-names>D</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>JM</given-names></name></person-group><article-title>Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice</article-title><source>Oncogene</source><year>1999</year><volume>18</volume><fpage>6597</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1203099</pub-id><pub-id pub-id-type="pmid">10597264</pub-id></element-citation></ref><ref id="CR382"><label>382.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Heijden</surname><given-names>M</given-names></name><name name-style="western"><surname>Zimberlin</surname><given-names>CD</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>AM</given-names></name><name name-style="western"><surname>Colak</surname><given-names>S</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>R</given-names></name><name name-style="western"><surname>Meijer</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Bcl-2 is a critical mediator of intestinal transformation</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><fpage>10916</fpage><pub-id pub-id-type="doi">10.1038/ncomms10916</pub-id><pub-id pub-id-type="pmid">26956214</pub-id><pub-id pub-id-type="pmcid">PMC4786877</pub-id></element-citation></ref><ref id="CR383"><label>383.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scherr</surname><given-names>AL</given-names></name><name name-style="western"><surname>Gdynia</surname><given-names>G</given-names></name><name name-style="western"><surname>Salou</surname><given-names>M</given-names></name><name name-style="western"><surname>Radhakrishnan</surname><given-names>P</given-names></name><name name-style="western"><surname>Duglova</surname><given-names>K</given-names></name><name name-style="western"><surname>Heller</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bcl-xL is an oncogenic driver in colorectal cancer</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2342</fpage><pub-id pub-id-type="doi">10.1038/cddis.2016.233</pub-id><pub-id pub-id-type="pmid">27537525</pub-id><pub-id pub-id-type="pmcid">PMC5108319</pub-id></element-citation></ref><ref id="CR384"><label>384.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>W</given-names></name><name name-style="western"><surname>Carson-Walter</surname><given-names>EB</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>SF</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>PUMA suppresses intestinal tumorigenesis in mice</article-title><source>Cancer Res</source><year>2009</year><volume>69</volume><fpage>4999</fpage><lpage>5006</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-0262</pub-id><pub-id pub-id-type="pmid">19491259</pub-id><pub-id pub-id-type="pmcid">PMC2872079</pub-id></element-citation></ref><ref id="CR385"><label>385.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muthalagu</surname><given-names>N</given-names></name><name name-style="western"><surname>Junttila</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wiese</surname><given-names>KE</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>E</given-names></name><name name-style="western"><surname>Morton</surname><given-names>J</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>B</given-names></name><etal/></person-group><article-title>BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues</article-title><source>Cell Rep</source><year>2014</year><volume>8</volume><fpage>1347</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.07.057</pub-id><pub-id pub-id-type="pmid">25176652</pub-id><pub-id pub-id-type="pmcid">PMC4231288</pub-id></element-citation></ref><ref id="CR386"><label>386.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramesh</surname><given-names>P</given-names></name><name name-style="western"><surname>Lannagan</surname><given-names>TRM</given-names></name><name name-style="western"><surname>Jackstadt</surname><given-names>R</given-names></name><name name-style="western"><surname>Atencia Taboada</surname><given-names>L</given-names></name><name name-style="western"><surname>Lansu</surname><given-names>N</given-names></name><name name-style="western"><surname>Wirapati</surname><given-names>P</given-names></name><etal/></person-group><article-title>BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>3282</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00816-w</pub-id><pub-id pub-id-type="pmid">34117376</pub-id><pub-id pub-id-type="pmcid">PMC8630104</pub-id></element-citation></ref><ref id="CR387"><label>387.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeuner</surname><given-names>A</given-names></name><name name-style="western"><surname>Francescangeli</surname><given-names>F</given-names></name><name name-style="western"><surname>Contavalli</surname><given-names>P</given-names></name><name name-style="western"><surname>Zapparelli</surname><given-names>G</given-names></name><name name-style="western"><surname>Apuzzo</surname><given-names>T</given-names></name><name name-style="western"><surname>Eramo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer</article-title><source>Cell Death Differ</source><year>2014</year><volume>21</volume><fpage>1877</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.105</pub-id><pub-id pub-id-type="pmid">25034785</pub-id><pub-id pub-id-type="pmcid">PMC4227145</pub-id></element-citation></ref><ref id="CR388"><label>388.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colak</surname><given-names>S</given-names></name><name name-style="western"><surname>Zimberlin</surname><given-names>CD</given-names></name><name name-style="western"><surname>Fessler</surname><given-names>E</given-names></name><name name-style="western"><surname>Hogdal</surname><given-names>L</given-names></name><name name-style="western"><surname>Prasetyanti</surname><given-names>PR</given-names></name><name name-style="western"><surname>Grandela</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells</article-title><source>Cell Death Differ</source><year>2014</year><volume>21</volume><fpage>1170</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.37</pub-id><pub-id pub-id-type="pmid">24682005</pub-id><pub-id pub-id-type="pmcid">PMC4207483</pub-id></element-citation></ref><ref id="CR389"><label>389.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>I</given-names></name><name name-style="western"><surname>Crowther</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Gama</surname><given-names>V</given-names></name><name name-style="western"><surname>Miller</surname><given-names>CR</given-names></name><name name-style="western"><surname>Deshmukh</surname><given-names>M</given-names></name><name name-style="western"><surname>Gershon</surname><given-names>TR</given-names></name></person-group><article-title>Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation</article-title><source>Oncogene</source><year>2013</year><volume>32</volume><fpage>2304</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/onc.2012.248</pub-id><pub-id pub-id-type="pmid">22710714</pub-id><pub-id pub-id-type="pmcid">PMC3449008</pub-id></element-citation></ref><ref id="CR390"><label>390.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>C</given-names></name><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Van Dyke</surname><given-names>T</given-names></name></person-group><article-title>Bax suppresses tumorigenesis and stimulates apoptosis in vivo</article-title><source>Nature</source><year>1997</year><volume>385</volume><fpage>637</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/385637a0</pub-id><pub-id pub-id-type="pmid">9024662</pub-id></element-citation></ref><ref id="CR391"><label>391.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terry</surname><given-names>MR</given-names></name><name name-style="western"><surname>Arya</surname><given-names>R</given-names></name><name name-style="western"><surname>Mukhopadhyay</surname><given-names>A</given-names></name><name name-style="western"><surname>Berrett</surname><given-names>KC</given-names></name><name name-style="western"><surname>Clair</surname><given-names>PM</given-names></name><name name-style="western"><surname>Witt</surname><given-names>B</given-names></name><etal/></person-group><article-title>Caspase-2 impacts lung tumorigenesis and chemotherapy response in vivo</article-title><source>Cell Death Differ</source><year>2015</year><volume>22</volume><fpage>719</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.159</pub-id><pub-id pub-id-type="pmid">25301067</pub-id><pub-id pub-id-type="pmcid">PMC4392070</pub-id></element-citation></ref><ref id="CR392"><label>392.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munkhbaatar</surname><given-names>E</given-names></name><name name-style="western"><surname>Dietzen</surname><given-names>M</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>D</given-names></name><name name-style="western"><surname>Anton</surname><given-names>M</given-names></name><name name-style="western"><surname>Jesinghaus</surname><given-names>M</given-names></name><name name-style="western"><surname>Boxberg</surname><given-names>M</given-names></name><etal/></person-group><article-title>MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><fpage>4527</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-18372-1</pub-id><pub-id pub-id-type="pmid">32913197</pub-id><pub-id pub-id-type="pmcid">PMC7484793</pub-id></element-citation></ref><ref id="CR393"><label>393.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meinhardt</surname><given-names>AL</given-names></name><name name-style="western"><surname>Munkhbaatar</surname><given-names>E</given-names></name><name name-style="western"><surname>H&#246;ckendorf</surname><given-names>U</given-names></name><name name-style="western"><surname>Dietzen</surname><given-names>M</given-names></name><name name-style="western"><surname>Dechant</surname><given-names>M</given-names></name><name name-style="western"><surname>Anton</surname><given-names>M</given-names></name><etal/></person-group><article-title>The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner</article-title><source>Oncogene</source><year>2022</year><volume>41</volume><fpage>1376</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/s41388-021-02161-1</pub-id><pub-id pub-id-type="pmid">35091677</pub-id><pub-id pub-id-type="pmcid">PMC8881215</pub-id></element-citation></ref><ref id="CR394"><label>394.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>M</given-names></name><name name-style="western"><surname>Chaurushiya</surname><given-names>MS</given-names></name><name name-style="western"><surname>Webster</surname><given-names>JD</given-names></name><name name-style="western"><surname>Kummerfeld</surname><given-names>S</given-names></name><name name-style="western"><surname>Reja</surname><given-names>R</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1</article-title><source>Sciene</source><year>2019</year><volume>364</volume><fpage>283</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1126/science.aav4902</pub-id><pub-id pub-id-type="pmid">31000662</pub-id></element-citation></ref><ref id="CR395"><label>395.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carbone</surname><given-names>M</given-names></name><name name-style="western"><surname>Harbour</surname><given-names>JW</given-names></name><name name-style="western"><surname>Brugarolas</surname><given-names>J</given-names></name><name name-style="western"><surname>Bononi</surname><given-names>A</given-names></name><name name-style="western"><surname>Pagano</surname><given-names>I</given-names></name><name name-style="western"><surname>Dey</surname><given-names>A</given-names></name><etal/></person-group><article-title>Biological mechanisms and clinical significance of BAP1 mutations in human cancer</article-title><source>Cancer Discov</source><year>2020</year><volume>10</volume><fpage>1103</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-19-1220</pub-id><pub-id pub-id-type="pmid">32690542</pub-id><pub-id pub-id-type="pmcid">PMC8006752</pub-id></element-citation></ref><ref id="CR396"><label>396.</label><mixed-citation publication-type="other">Novelli F, Bononi A, Wang Q, Bai F, Patergnani S, Kricek F, et al. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene &#215; environment interaction with asbestos. Proc Natl Acad Sci USA. 2021;118:e2111946118.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2111946118</pub-id><pub-id pub-id-type="pmcid">PMC8640737</pub-id><pub-id pub-id-type="pmid">34815344</pub-id></mixed-citation></ref><ref id="CR397"><label>397.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bononi</surname><given-names>A</given-names></name><name name-style="western"><surname>Giorgi</surname><given-names>C</given-names></name><name name-style="western"><surname>Patergnani</surname><given-names>S</given-names></name><name name-style="western"><surname>Larson</surname><given-names>D</given-names></name><name name-style="western"><surname>Verbruggen</surname><given-names>K</given-names></name><name name-style="western"><surname>Tanji</surname><given-names>M</given-names></name><etal/></person-group><article-title>BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation</article-title><source>Nature</source><year>2017</year><volume>546</volume><fpage>549</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nature22798</pub-id><pub-id pub-id-type="pmid">28614305</pub-id><pub-id pub-id-type="pmcid">PMC5581194</pub-id></element-citation></ref><ref id="CR398"><label>398.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dansen</surname><given-names>TB</given-names></name><name name-style="western"><surname>Whitfield</surname><given-names>J</given-names></name><name name-style="western"><surname>Rostker</surname><given-names>F</given-names></name><name name-style="western"><surname>Brown-Swigart</surname><given-names>L</given-names></name><name name-style="western"><surname>Evan</surname><given-names>GI</given-names></name></person-group><article-title>Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivo</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>10890</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1074/jbc.M513655200</pub-id><pub-id pub-id-type="pmid">16464852</pub-id></element-citation></ref><ref id="CR399"><label>399.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radziszewska</surname><given-names>A</given-names></name><name name-style="western"><surname>Schroer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Choi</surname><given-names>D</given-names></name><name name-style="western"><surname>Tajmir</surname><given-names>P</given-names></name><name name-style="western"><surname>Radulovich</surname><given-names>N</given-names></name><name name-style="western"><surname>Ho</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>10947</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1074/jbc.M806960200</pub-id><pub-id pub-id-type="pmid">19213729</pub-id><pub-id pub-id-type="pmcid">PMC2667780</pub-id></element-citation></ref><ref id="CR400"><label>400.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evan</surname><given-names>GI</given-names></name><name name-style="western"><surname>Christophorou</surname><given-names>M</given-names></name><name name-style="western"><surname>Lawlor</surname><given-names>EA</given-names></name><name name-style="western"><surname>Ringshausen</surname><given-names>I</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>J</given-names></name><name name-style="western"><surname>Dansen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy</article-title><source>Cold Spring Harb Symp Quant Biol</source><year>2005</year><volume>70</volume><fpage>263</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1101/sqb.2005.70.054</pub-id><pub-id pub-id-type="pmid">16869762</pub-id></element-citation></ref><ref id="CR401"><label>401.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shalini</surname><given-names>S</given-names></name><name name-style="western"><surname>Nikolic</surname><given-names>A</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>CH</given-names></name><name name-style="western"><surname>Puccini</surname><given-names>J</given-names></name><name name-style="western"><surname>Sladojevic</surname><given-names>N</given-names></name><name name-style="western"><surname>Finnie</surname><given-names>J</given-names></name><etal/></person-group><article-title>Caspase-2 deficiency accelerates chemically induced liver cancer in mice</article-title><source>Cell Death Differ</source><year>2016</year><volume>23</volume><fpage>1727</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.81</pub-id><pub-id pub-id-type="pmid">27518436</pub-id><pub-id pub-id-type="pmcid">PMC5041200</pub-id></element-citation></ref><ref id="CR402"><label>402.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Leibowitz</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice</article-title><source>Hepatology</source><year>2011</year><volume>54</volume><fpage>1249</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1002/hep.24516</pub-id><pub-id pub-id-type="pmid">21725994</pub-id><pub-id pub-id-type="pmcid">PMC3184207</pub-id></element-citation></ref><ref id="CR403"><label>403.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pierce</surname><given-names>RH</given-names></name><name name-style="western"><surname>Vail</surname><given-names>ME</given-names></name><name name-style="western"><surname>Ralph</surname><given-names>L</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>JS</given-names></name><name name-style="western"><surname>Fausto</surname><given-names>N</given-names></name></person-group><article-title>Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci</article-title><source>Am J Pathol</source><year>2002</year><volume>160</volume><fpage>1555</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)61101-7</pub-id><pub-id pub-id-type="pmid">12000706</pub-id><pub-id pub-id-type="pmcid">PMC1850870</pub-id></element-citation></ref><ref id="CR404"><label>404.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vail</surname><given-names>ME</given-names></name><name name-style="western"><surname>Pierce</surname><given-names>RH</given-names></name><name name-style="western"><surname>Fausto</surname><given-names>N</given-names></name></person-group><article-title>Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>594</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">11212255</pub-id></element-citation></ref><ref id="CR405"><label>405.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pena</surname><given-names>JC</given-names></name><name name-style="western"><surname>Rudin</surname><given-names>CM</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name></person-group><article-title>A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas</article-title><source>Cancer Res</source><year>1998</year><volume>58</volume><fpage>2111</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9605754</pub-id></element-citation></ref><ref id="CR406"><label>406.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schenkel</surname><given-names>J</given-names></name><name name-style="western"><surname>Weiher</surname><given-names>H</given-names></name><name name-style="western"><surname>F&#252;rstenberger</surname><given-names>G</given-names></name><name name-style="western"><surname>J&#228;ger</surname><given-names>R</given-names></name></person-group><article-title>Suprabasal BCL-2 expression does not sensitize to chemically-induced skin cancer in transgenic mice</article-title><source>Anticancer Res</source><year>2008</year><volume>28</volume><fpage>2825</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19035317</pub-id></element-citation></ref><ref id="CR407"><label>407.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossiter</surname><given-names>H</given-names></name><name name-style="western"><surname>Beissert</surname><given-names>S</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>C</given-names></name><name name-style="western"><surname>Sch&#246;n</surname><given-names>MP</given-names></name><name name-style="western"><surname>Wienrich</surname><given-names>BG</given-names></name><name name-style="western"><surname>Tschachler</surname><given-names>E</given-names></name><etal/></person-group><article-title>Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>3619</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11325830</pub-id></element-citation></ref><ref id="CR408"><label>408.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Kataoka</surname><given-names>K</given-names></name><name name-style="western"><surname>Sano</surname><given-names>S</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>K</given-names></name><name name-style="western"><surname>Kiguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>DiGiovanni</surname><given-names>J</given-names></name></person-group><article-title>Targeted disruption of Bcl-xL in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis</article-title><source>Mol Carcinogen</source><year>2009</year><volume>48</volume><fpage>873</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1002/mc.20527</pub-id><pub-id pub-id-type="pmcid">PMC4066197</pub-id><pub-id pub-id-type="pmid">19309000</pub-id></element-citation></ref><ref id="CR409"><label>409.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Whittingham</surname><given-names>S</given-names></name><name name-style="western"><surname>Vaux</surname><given-names>DL</given-names></name><name name-style="western"><surname>Bath</surname><given-names>ML</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name><etal/></person-group><article-title>Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease</article-title><source>Proc Natl Acad Sci USA</source><year>1991</year><volume>88</volume><fpage>8661</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.19.8661</pub-id><pub-id pub-id-type="pmid">1924327</pub-id><pub-id pub-id-type="pmcid">PMC52569</pub-id></element-citation></ref><ref id="CR410"><label>410.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>D</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Kay</surname><given-names>TW</given-names></name><name name-style="western"><surname>K&#246;ntgen</surname><given-names>F</given-names></name><etal/></person-group><article-title>Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity</article-title><source>Science</source><year>1999</year><volume>286</volume><fpage>1735</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1126/science.286.5445.1735</pub-id><pub-id pub-id-type="pmid">10576740</pub-id></element-citation></ref><ref id="CR411"><label>411.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mason</surname><given-names>KD</given-names></name><name name-style="western"><surname>Lin</surname><given-names>A</given-names></name><name name-style="western"><surname>Robb</surname><given-names>L</given-names></name><name name-style="western"><surname>Josefsson</surname><given-names>EC</given-names></name><name name-style="western"><surname>Henley</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Gray</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Proapoptotic Bak and Bax guard against fatal systemic and organ-specific autoimmune disease</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>2599</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1073/pnas.1215097110</pub-id><pub-id pub-id-type="pmid">23349374</pub-id><pub-id pub-id-type="pmcid">PMC3574926</pub-id></element-citation></ref><ref id="CR412"><label>412.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scatizzi</surname><given-names>JC</given-names></name><name name-style="western"><surname>Bickel</surname><given-names>E</given-names></name><name name-style="western"><surname>Hutcheson</surname><given-names>J</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Perlman</surname><given-names>H</given-names></name></person-group><article-title>Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis</article-title><source>Arthritis Rheum</source><year>2006</year><volume>54</volume><fpage>3182</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1002/art.22133</pub-id><pub-id pub-id-type="pmid">17009248</pub-id></element-citation></ref><ref id="CR413"><label>413.</label><mixed-citation publication-type="other">Li J, Zhang L, Zheng Y, Shao R, Liang Q, Yu W, et al. BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages. eLife. 2020;9:e56309.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.56309</pub-id><pub-id pub-id-type="pmcid">PMC7714394</pub-id><pub-id pub-id-type="pmid">33270017</pub-id></mixed-citation></ref><ref id="CR414"><label>414.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scatizzi</surname><given-names>JC</given-names></name><name name-style="western"><surname>Hutcheson</surname><given-names>J</given-names></name><name name-style="western"><surname>Bickel</surname><given-names>E</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Perlman</surname><given-names>H</given-names></name></person-group><article-title>Pro-apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis</article-title><source>Arthritis Res Ther</source><year>2007</year><volume>9</volume><fpage>R49</fpage><pub-id pub-id-type="doi">10.1186/ar2204</pub-id><pub-id pub-id-type="pmid">17509138</pub-id><pub-id pub-id-type="pmcid">PMC2206343</pub-id></element-citation></ref><ref id="CR415"><label>415.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scatizzi</surname><given-names>JC</given-names></name><name name-style="western"><surname>Hutcheson</surname><given-names>J</given-names></name><name name-style="western"><surname>Pope</surname><given-names>RM</given-names></name><name name-style="western"><surname>Firestein</surname><given-names>GS</given-names></name><name name-style="western"><surname>Koch</surname><given-names>AE</given-names></name><name name-style="western"><surname>Mavers</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><fpage>441</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1002/art.27198</pub-id><pub-id pub-id-type="pmid">20112357</pub-id><pub-id pub-id-type="pmcid">PMC2848986</pub-id></element-citation></ref><ref id="CR416"><label>416.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>CS</given-names></name><name name-style="western"><surname>Hebb</surname><given-names>AL</given-names></name><name name-style="western"><surname>Blanchard</surname><given-names>MM</given-names></name><name name-style="western"><surname>Crocker</surname><given-names>CE</given-names></name><name name-style="western"><surname>Liston</surname><given-names>P</given-names></name><name name-style="western"><surname>Korneluk</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE)</article-title><source>J Neuroimmunol</source><year>2008</year><volume>203</volume><fpage>79</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.06.030</pub-id><pub-id pub-id-type="pmid">18687476</pub-id></element-citation></ref><ref id="CR417"><label>417.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lev</surname><given-names>N</given-names></name><name name-style="western"><surname>Barhum</surname><given-names>Y</given-names></name><name name-style="western"><surname>Melamed</surname><given-names>E</given-names></name><name name-style="western"><surname>Offen</surname><given-names>D</given-names></name></person-group><article-title>Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice</article-title><source>Neurosci Lett</source><year>2004</year><volume>359</volume><fpage>139</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2004.01.076</pub-id><pub-id pub-id-type="pmid">15050683</pub-id></element-citation></ref><ref id="CR418"><label>418.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ludwinski</surname><given-names>MW</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Hilliard</surname><given-names>B</given-names></name><name name-style="western"><surname>Gong</surname><given-names>S</given-names></name><name name-style="western"><surname>Xue</surname><given-names>F</given-names></name><name name-style="western"><surname>Carmody</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Critical roles of Bim in T cell activation and T cell-mediated autoimmune inflammation in mice</article-title><source>J Clin Investig</source><year>2009</year><volume>119</volume><fpage>1706</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1172/JCI37619</pub-id><pub-id pub-id-type="pmid">19411758</pub-id><pub-id pub-id-type="pmcid">PMC2689102</pub-id></element-citation></ref><ref id="CR419"><label>419.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Offen</surname><given-names>D</given-names></name><name name-style="western"><surname>Kaye</surname><given-names>JF</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>O</given-names></name><name name-style="western"><surname>Merims</surname><given-names>D</given-names></name><name name-style="western"><surname>Coire</surname><given-names>CI</given-names></name><name name-style="western"><surname>Panet</surname><given-names>H</given-names></name><etal/></person-group><article-title>Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE)</article-title><source>J Mol Neurosci</source><year>2000</year><volume>15</volume><fpage>167</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1385/JMN:15:3:167</pub-id><pub-id pub-id-type="pmid">11303781</pub-id></element-citation></ref><ref id="CR420"><label>420.</label><mixed-citation publication-type="other">Lagares D, Santos A, Grasberger PE, Liu F, Probst CK, Rahimi RA, et al. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis. Sci Transl Med. 2017;9:eaal3765.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aal3765</pub-id><pub-id pub-id-type="pmcid">PMC8520471</pub-id><pub-id pub-id-type="pmid">29237758</pub-id></mixed-citation></ref><ref id="CR421"><label>421.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Mao</surname><given-names>LQ</given-names></name><name name-style="western"><surname>Polonsky</surname><given-names>KS</given-names></name><name name-style="western"><surname>Ren</surname><given-names>DC</given-names></name></person-group><article-title>Pancreatic &#946;-cell death due to Pdx-1 deficiency requires multi-BH domain protein Bax but Not Bak</article-title><source>J Biol Chem</source><year>2016</year><volume>291</volume><fpage>13529</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.705293</pub-id><pub-id pub-id-type="pmid">27137932</pub-id><pub-id pub-id-type="pmcid">PMC4919439</pub-id></element-citation></ref><ref id="CR422"><label>422.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>SA</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>LS</given-names></name><name name-style="western"><surname>Pasula</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>YHC</given-names></name><name name-style="western"><surname>Luciani</surname><given-names>DS</given-names></name></person-group><article-title>Bax and Bak jointly control survival and dampen the early unfolded protein response in pancreatic &#946;-cells under glucolipotoxic stress</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><fpage>10986</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-67755-3</pub-id><pub-id pub-id-type="pmid">32620813</pub-id><pub-id pub-id-type="pmcid">PMC7335194</pub-id></element-citation></ref><ref id="CR423"><label>423.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnamurthy</surname><given-names>B</given-names></name><name name-style="western"><surname>Chee</surname><given-names>J</given-names></name><name name-style="western"><surname>Jhala</surname><given-names>G</given-names></name><name name-style="western"><surname>Trivedi</surname><given-names>P</given-names></name><name name-style="western"><surname>Catterall</surname><given-names>T</given-names></name><name name-style="western"><surname>Selck</surname><given-names>C</given-names></name><etal/></person-group><article-title>BIM deficiency protects NOD mice from diabetes by diverting thymocytes to regulatory T cells</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><fpage>3229</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.2337/db14-1851</pub-id><pub-id pub-id-type="pmid">25948683</pub-id></element-citation></ref><ref id="CR424"><label>424.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>D</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Ye</surname><given-names>H</given-names></name><name name-style="western"><surname>Mao</surname><given-names>L</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>EH</given-names></name><etal/></person-group><article-title>Role of BH3-only molecules Bim and Puma in &#946;-cell death in Pdx1 deficiency</article-title><source>Diabetes</source><year>2014</year><volume>63</volume><fpage>2744</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.2337/db13-1513</pub-id><pub-id pub-id-type="pmid">24658302</pub-id><pub-id pub-id-type="pmcid">PMC4113059</pub-id></element-citation></ref><ref id="CR425"><label>425.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>D</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Mao</surname><given-names>L</given-names></name><name name-style="western"><surname>Ye</surname><given-names>H</given-names></name><name name-style="western"><surname>Polonsky</surname><given-names>KS</given-names></name></person-group><article-title>BH3-only molecule Bim mediates &#946;-cell death in IRS2 deficiency</article-title><source>Diabetes</source><year>2014</year><volume>63</volume><fpage>3378</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.2337/db13-1814</pub-id><pub-id pub-id-type="pmid">24760140</pub-id><pub-id pub-id-type="pmcid">PMC4171655</pub-id></element-citation></ref><ref id="CR426"><label>426.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfeiffer</surname><given-names>S</given-names></name><name name-style="western"><surname>Halang</surname><given-names>L</given-names></name><name name-style="western"><surname>D&#252;ssmann</surname><given-names>H</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>MM</given-names></name><name name-style="western"><surname>Prehn</surname><given-names>J</given-names></name></person-group><article-title>BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1&#945;-MODY diabetes</article-title><source>Cell Death Discov</source><year>2015</year><volume>1</volume><fpage>15041</fpage><pub-id pub-id-type="doi">10.1038/cddiscovery.2015.41</pub-id><pub-id pub-id-type="pmid">27551471</pub-id><pub-id pub-id-type="pmcid">PMC4979461</pub-id></element-citation></ref><ref id="CR427"><label>427.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uhlemeyer</surname><given-names>C</given-names></name><name name-style="western"><surname>Muller</surname><given-names>N</given-names></name><name name-style="western"><surname>Rieck</surname><given-names>M</given-names></name><name name-style="western"><surname>Kuboth</surname><given-names>J</given-names></name><name name-style="western"><surname>Schlegel</surname><given-names>C</given-names></name><name name-style="western"><surname>Griess</surname><given-names>K</given-names></name><etal/></person-group><article-title>Selective ablation of P53 in pancreatic beta cells fails to ameliorate glucose metabolism in genetic, dietary and pharmacological models of diabetes mellitus</article-title><source>Mol Metab</source><year>2023</year><volume>67</volume><fpage>101650</fpage><pub-id pub-id-type="doi">10.1016/j.molmet.2022.101650</pub-id><pub-id pub-id-type="pmid">36470401</pub-id><pub-id pub-id-type="pmcid">PMC9791454</pub-id></element-citation></ref><ref id="CR428"><label>428.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rohner</surname><given-names>L</given-names></name><name name-style="western"><surname>Reinhart</surname><given-names>R</given-names></name><name name-style="western"><surname>Hagmann</surname><given-names>B</given-names></name><name name-style="western"><surname>Odermatt</surname><given-names>A</given-names></name><name name-style="western"><surname>Babirye</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>T</given-names></name><etal/></person-group><article-title>Fc&#603;RI cross-linking and IL-3 protect human basophils from intrinsic apoptotic stress</article-title><source>J Allergy Clin Immunol</source><year>2018</year><volume>142</volume><fpage>1647</fpage><lpage>1650.e1643</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2018.06.040</pub-id><pub-id pub-id-type="pmid">30048671</pub-id></element-citation></ref><ref id="CR429"><label>429.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reinhart</surname><given-names>R</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>T</given-names></name></person-group><article-title>IL-4 enhances survival of in vitro-differentiated mouse basophils through transcription-independent signaling downstream of PI3K</article-title><source>Cell Death Dis</source><year>2018</year><volume>9</volume><fpage>713</fpage><pub-id pub-id-type="doi">10.1038/s41419-018-0754-z</pub-id><pub-id pub-id-type="pmid">29915306</pub-id><pub-id pub-id-type="pmcid">PMC6006176</pub-id></element-citation></ref><ref id="CR430"><label>430.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Didichenko</surname><given-names>SA</given-names></name><name name-style="western"><surname>Spiegl</surname><given-names>N</given-names></name><name name-style="western"><surname>Brunner</surname><given-names>T</given-names></name><name name-style="western"><surname>Dahinden</surname><given-names>CA</given-names></name></person-group><article-title>IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils</article-title><source>Blood</source><year>2008</year><volume>112</volume><fpage>3949</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-04-149419</pub-id><pub-id pub-id-type="pmid">18768389</pub-id></element-citation></ref><ref id="CR431"><label>431.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vassina</surname><given-names>EM</given-names></name><name name-style="western"><surname>Yousefi</surname><given-names>S</given-names></name><name name-style="western"><surname>Simon</surname><given-names>D</given-names></name><name name-style="western"><surname>Zwicky</surname><given-names>C</given-names></name><name name-style="western"><surname>Conus</surname><given-names>S</given-names></name><name name-style="western"><surname>Simon</surname><given-names>HU</given-names></name></person-group><article-title>cIAP-2 and survivin contribute to cytokine-mediated delayed eosinophil apoptosis</article-title><source>Eur J Immunol</source><year>2006</year><volume>36</volume><fpage>1975</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1002/eji.200635943</pub-id><pub-id pub-id-type="pmid">16761316</pub-id></element-citation></ref><ref id="CR432"><label>432.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasegawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>C</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>K</given-names></name><name name-style="western"><surname>Nishiki</surname><given-names>S</given-names></name><name name-style="western"><surname>Hino</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia</article-title><source>Blood</source><year>2003</year><volume>101</volume><fpage>1164</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-05-1505</pub-id><pub-id pub-id-type="pmid">12393423</pub-id></element-citation></ref><ref id="CR433"><label>433.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moulding</surname><given-names>DA</given-names></name><name name-style="western"><surname>Quayle</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hart</surname><given-names>CA</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>SW</given-names></name></person-group><article-title>Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival</article-title><source>Blood</source><year>1998</year><volume>92</volume><fpage>2495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1182/blood.V92.7.2495</pub-id><pub-id pub-id-type="pmid">9746790</pub-id></element-citation></ref><ref id="CR434"><label>434.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dibbert</surname><given-names>B</given-names></name><name name-style="western"><surname>Daigle</surname><given-names>I</given-names></name><name name-style="western"><surname>Braun</surname><given-names>D</given-names></name><name name-style="western"><surname>Schranz</surname><given-names>C</given-names></name><name name-style="western"><surname>Weber</surname><given-names>M</given-names></name><name name-style="western"><surname>Blaser</surname><given-names>K</given-names></name><etal/></person-group><article-title>Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5</article-title><source>Blood</source><year>1998</year><volume>92</volume><fpage>778</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1182/blood.V92.3.778</pub-id><pub-id pub-id-type="pmid">9680344</pub-id></element-citation></ref><ref id="CR435"><label>435.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>PX</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P</given-names></name></person-group><article-title>The neutrophil&#8217;s role during health and disease</article-title><source>Physiol Rev</source><year>2019</year><volume>99</volume><fpage>1223</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1152/physrev.00012.2018</pub-id><pub-id pub-id-type="pmid">30758246</pub-id></element-citation></ref><ref id="CR436"><label>436.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arlet</surname><given-names>JB</given-names></name><name name-style="western"><surname>Ribeil</surname><given-names>JA</given-names></name><name name-style="western"><surname>Guillem</surname><given-names>F</given-names></name><name name-style="western"><surname>Negre</surname><given-names>O</given-names></name><name name-style="western"><surname>Hazoume</surname><given-names>A</given-names></name><name name-style="western"><surname>Marcion</surname><given-names>G</given-names></name><etal/></person-group><article-title>HSP70 sequestration by free &#945;-globin promotes ineffective erythropoiesis in &#946;-thalassaemia</article-title><source>Nature</source><year>2014</year><volume>514</volume><fpage>242</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nature13614</pub-id><pub-id pub-id-type="pmid">25156257</pub-id></element-citation></ref><ref id="CR437"><label>437.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gastou</surname><given-names>M</given-names></name><name name-style="western"><surname>Rio</surname><given-names>S</given-names></name><name name-style="western"><surname>Dussiot</surname><given-names>M</given-names></name><name name-style="western"><surname>Karboul</surname><given-names>N</given-names></name><name name-style="western"><surname>Moniz</surname><given-names>H</given-names></name><name name-style="western"><surname>Leblanc</surname><given-names>T</given-names></name><etal/></person-group><article-title>The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70</article-title><source>Blood Adv</source><year>2017</year><volume>1</volume><fpage>1959</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2017008078</pub-id><pub-id pub-id-type="pmid">29296843</pub-id><pub-id pub-id-type="pmcid">PMC5728147</pub-id></element-citation></ref><ref id="CR438"><label>438.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duplomb</surname><given-names>L</given-names></name><name name-style="western"><surname>Rivi&#232;re</surname><given-names>J</given-names></name><name name-style="western"><surname>Jego</surname><given-names>G</given-names></name><name name-style="western"><surname>Da Costa</surname><given-names>R</given-names></name><name name-style="western"><surname>Hammann</surname><given-names>A</given-names></name><name name-style="western"><surname>Racine</surname><given-names>J</given-names></name><etal/></person-group><article-title>Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropenia</article-title><source>J Mol Med</source><year>2019</year><volume>97</volume><fpage>633</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s00109-019-01754-4</pub-id><pub-id pub-id-type="pmid">30843084</pub-id></element-citation></ref><ref id="CR439"><label>439.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwulst</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Muenzer</surname><given-names>JT</given-names></name><name name-style="western"><surname>Peck-Palmer</surname><given-names>OM</given-names></name><name name-style="western"><surname>Chang</surname><given-names>KC</given-names></name><name name-style="western"><surname>Davis</surname><given-names>CG</given-names></name><name name-style="western"><surname>McDonough</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis</article-title><source>Shock</source><year>2008</year><volume>30</volume><fpage>127</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e318162cf17</pub-id><pub-id pub-id-type="pmid">18197142</pub-id></element-citation></ref><ref id="CR440"><label>440.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>CS</given-names></name><name name-style="western"><surname>Venet</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jones</surname><given-names>LN</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>DC</given-names></name><name name-style="western"><surname>Ayala</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival</article-title><source>Shock</source><year>2010</year><volume>34</volume><fpage>150</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e3181cf70fb</pub-id><pub-id pub-id-type="pmid">20023601</pub-id><pub-id pub-id-type="pmcid">PMC2909339</pub-id></element-citation></ref><ref id="CR441"><label>441.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><etal/></person-group><article-title>The BH3-only protein BAD mediates TNF&#945; cytotoxicity despite concurrent activation of IKK and NF-&#954;B in septic shock</article-title><source>Cell Res</source><year>2018</year><volume>28</volume><fpage>701</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1038/s41422-018-0041-7</pub-id><pub-id pub-id-type="pmid">29795446</pub-id><pub-id pub-id-type="pmcid">PMC6028455</pub-id></element-citation></ref><ref id="CR442"><label>442.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weber</surname><given-names>SU</given-names></name><name name-style="western"><surname>Schewe</surname><given-names>JC</given-names></name><name name-style="western"><surname>Lehmann</surname><given-names>LE</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>S</given-names></name><name name-style="western"><surname>Book</surname><given-names>M</given-names></name><name name-style="western"><surname>Klaschik</surname><given-names>S</given-names></name><etal/></person-group><article-title>Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis</article-title><source>Crit Care</source><year>2008</year><volume>12</volume><fpage>R128</fpage><pub-id pub-id-type="doi">10.1186/cc7088</pub-id><pub-id pub-id-type="pmid">18925930</pub-id><pub-id pub-id-type="pmcid">PMC2592767</pub-id></element-citation></ref><ref id="CR443"><label>443.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oberholzer</surname><given-names>C</given-names></name><name name-style="western"><surname>Tschoeke</surname><given-names>SK</given-names></name><name name-style="western"><surname>Moldawer</surname><given-names>LL</given-names></name><name name-style="western"><surname>Oberholzer</surname><given-names>A</given-names></name></person-group><article-title>Local thymic caspase-9 inhibition improves survival during polymicrobial sepsis in mice</article-title><source>J Mol Med</source><year>2006</year><volume>84</volume><fpage>389</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1007/s00109-005-0017-1</pub-id><pub-id pub-id-type="pmid">16453149</pub-id></element-citation></ref><ref id="CR444"><label>444.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>LO</given-names></name><name name-style="western"><surname>Makena</surname><given-names>P</given-names></name><name name-style="western"><surname>Spierings</surname><given-names>DC</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>K</given-names></name><name name-style="western"><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>2742</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-09-178038</pub-id><pub-id pub-id-type="pmid">19168786</pub-id><pub-id pub-id-type="pmcid">PMC2661861</pub-id></element-citation></ref><ref id="CR445"><label>445.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yasuda</surname><given-names>T</given-names></name><name name-style="western"><surname>Takeyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name><name name-style="western"><surname>Shinzeki</surname><given-names>M</given-names></name><name name-style="western"><surname>Kishi</surname><given-names>S</given-names></name><name name-style="western"><surname>Sawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Protective effect of caspase inhibitor on intestinal integrity in experimental severe acute pancreatitis</article-title><source>J Surg Res</source><year>2007</year><volume>138</volume><fpage>300</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2006.09.022</pub-id><pub-id pub-id-type="pmid">17292420</pub-id></element-citation></ref><ref id="CR446"><label>446.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>XD</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chi</surname><given-names>JL</given-names></name><name name-style="western"><surname>Long</surname><given-names>FW</given-names></name><name name-style="western"><surname>Yang</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Deletion Of XIAP reduces the severity of acute pancreatitis via regulation of cell death and nuclear factor-&#954;B activity</article-title><source>Cell Death Dis</source><year>2017</year><volume>8</volume><fpage>e2685</fpage><pub-id pub-id-type="doi">10.1038/cddis.2017.70</pub-id><pub-id pub-id-type="pmid">28300832</pub-id><pub-id pub-id-type="pmcid">PMC5386564</pub-id></element-citation></ref><ref id="CR447"><label>447.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leucht</surname><given-names>K</given-names></name><name name-style="western"><surname>Caj</surname><given-names>M</given-names></name><name name-style="western"><surname>Fried</surname><given-names>M</given-names></name><name name-style="western"><surname>Rogler</surname><given-names>G</given-names></name><name name-style="western"><surname>Hausmann</surname><given-names>M</given-names></name></person-group><article-title>Impaired removal of V&#946;8(+) lymphocytes aggravates colitis in mice deficient for B cell lymphoma-2-interacting mediator of cell death (Bim)</article-title><source>Clin Exp Immunol</source><year>2013</year><volume>173</volume><fpage>493</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1111/cei.12137</pub-id><pub-id pub-id-type="pmid">23668821</pub-id><pub-id pub-id-type="pmcid">PMC3949637</pub-id></element-citation></ref><ref id="CR448"><label>448.</label><mixed-citation publication-type="other">Wicki S, Gurzeler U, Corazza N, Genitsch V, Wong WW, Kaufmann T. Loss of BID delays FASL-induced cell death of mouse neutrophils and aggravates DSS-induced weight loss. Int J Mol Sci. 2018;19:684.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms19030684</pub-id><pub-id pub-id-type="pmcid">PMC5877545</pub-id><pub-id pub-id-type="pmid">29495595</pub-id></mixed-citation></ref><ref id="CR449"><label>449.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weder</surname><given-names>B</given-names></name><name name-style="western"><surname>Mozaffari</surname><given-names>M</given-names></name><name name-style="western"><surname>Biedermann</surname><given-names>L</given-names></name><name name-style="western"><surname>Mamie</surname><given-names>C</given-names></name><name name-style="western"><surname>Moncsek</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>BCL-2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice</article-title><source>Clin Exp Immunol</source><year>2018</year><volume>193</volume><fpage>346</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1111/cei.13151</pub-id><pub-id pub-id-type="pmid">29745420</pub-id><pub-id pub-id-type="pmcid">PMC6150252</pub-id></element-citation></ref><ref id="CR450"><label>450.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lutz</surname><given-names>C</given-names></name><name name-style="western"><surname>Mozaffari</surname><given-names>M</given-names></name><name name-style="western"><surname>Tosevski</surname><given-names>V</given-names></name><name name-style="western"><surname>Caj</surname><given-names>M</given-names></name><name name-style="western"><surname>Cipp&#224;</surname><given-names>P</given-names></name><name name-style="western"><surname>McRae</surname><given-names>BL</given-names></name><etal/></person-group><article-title>Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression</article-title><source>Clin Exp Immunol</source><year>2015</year><volume>181</volume><fpage>343</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1111/cei.12635</pub-id><pub-id pub-id-type="pmid">25845418</pub-id><pub-id pub-id-type="pmcid">PMC4516450</pub-id></element-citation></ref><ref id="CR451"><label>451.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dirisina</surname><given-names>R</given-names></name><name name-style="western"><surname>Katzman</surname><given-names>RB</given-names></name><name name-style="western"><surname>Goretsky</surname><given-names>T</given-names></name><name name-style="western"><surname>Managlia</surname><given-names>E</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>N</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DB</given-names></name><etal/></person-group><article-title>p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis</article-title><source>Gastroenterology</source><year>2011</year><volume>141</volume><fpage>1036</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2011.05.032</pub-id><pub-id pub-id-type="pmid">21699775</pub-id><pub-id pub-id-type="pmcid">PMC3736614</pub-id></element-citation></ref><ref id="CR452"><label>452.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>W</given-names></name><name name-style="western"><surname>Carson-Walter</surname><given-names>EB</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Epperly</surname><given-names>M</given-names></name><name name-style="western"><surname>Greenberger</surname><given-names>JS</given-names></name><name name-style="western"><surname>Zambetti</surname><given-names>GP</given-names></name><etal/></person-group><article-title>PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome</article-title><source>cell Stem Cell</source><year>2008</year><volume>2</volume><fpage>576</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2008.03.009</pub-id><pub-id pub-id-type="pmid">18522850</pub-id><pub-id pub-id-type="pmcid">PMC2892934</pub-id></element-citation></ref><ref id="CR453"><label>453.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirsch</surname><given-names>DG</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>PM</given-names></name><name name-style="western"><surname>di Tomaso</surname><given-names>E</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Hou</surname><given-names>WS</given-names></name><name name-style="western"><surname>Dayton</surname><given-names>T</given-names></name><etal/></person-group><article-title>p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis</article-title><source>Science</source><year>2010</year><volume>327</volume><fpage>593</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1126/science.1166202</pub-id><pub-id pub-id-type="pmid">20019247</pub-id><pub-id pub-id-type="pmcid">PMC2897160</pub-id></element-citation></ref><ref id="CR454"><label>454.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>S</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>M</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Khatoon</surname><given-names>S</given-names></name><etal/></person-group><article-title>PUMA mediates ER stress-induced apoptosis in portal hypertensive gastropathy</article-title><source>Cell Death Dis</source><year>2014</year><volume>5</volume><fpage>e1128</fpage><pub-id pub-id-type="doi">10.1038/cddis.2014.95</pub-id><pub-id pub-id-type="pmid">24625987</pub-id><pub-id pub-id-type="pmcid">PMC3973242</pub-id></element-citation></ref><ref id="CR455"><label>455.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>ME</given-names></name><name name-style="western"><surname>Regueiro</surname><given-names>MD</given-names></name><name name-style="western"><surname>Hartman</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice</article-title><source>J Clin Investig</source><year>2011</year><volume>121</volume><fpage>1722</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1172/JCI42917</pub-id><pub-id pub-id-type="pmid">21490394</pub-id><pub-id pub-id-type="pmcid">PMC3083802</pub-id></element-citation></ref><ref id="CR456"><label>456.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>B</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>T</given-names></name><name name-style="western"><surname>Zambetti</surname><given-names>GP</given-names></name><etal/></person-group><article-title>p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion</article-title><source>Gut</source><year>2007</year><volume>56</volume><fpage>645</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1136/gut.2006.101683</pub-id><pub-id pub-id-type="pmid">17127703</pub-id><pub-id pub-id-type="pmcid">PMC1942137</pub-id></element-citation></ref><ref id="CR457"><label>457.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coopersmith</surname><given-names>CM</given-names></name><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>D</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title>Bcl-2 inhibits ischemia-reperfusion-induced apoptosis in the intestinal epithelium of transgenic mice</article-title><source>Am J Physiol</source><year>1999</year><volume>276</volume><fpage>G677</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">10070044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpgi.1999.276.3.G677</pub-id></element-citation></ref><ref id="CR458"><label>458.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Damgaard</surname><given-names>RB</given-names></name><name name-style="western"><surname>Fiil</surname><given-names>BK</given-names></name><name name-style="western"><surname>Speckmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Yabal</surname><given-names>M</given-names></name><name name-style="western"><surname>zur Stadt</surname><given-names>U</given-names></name><name name-style="western"><surname>Bekker-Jensen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling</article-title><source>EMBO Mol Med</source><year>2013</year><volume>5</volume><fpage>1278</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1002/emmm.201303090</pub-id><pub-id pub-id-type="pmid">23818254</pub-id><pub-id pub-id-type="pmcid">PMC3944466</pub-id></element-citation></ref><ref id="CR459"><label>459.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Damgaard</surname><given-names>RB</given-names></name><name name-style="western"><surname>Nachbur</surname><given-names>U</given-names></name><name name-style="western"><surname>Yabal</surname><given-names>M</given-names></name><name name-style="western"><surname>Wong</surname><given-names>WW</given-names></name><name name-style="western"><surname>Fiil</surname><given-names>BK</given-names></name><name name-style="western"><surname>Kastirr</surname><given-names>M</given-names></name><etal/></person-group><article-title>The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity</article-title><source>Mol Cell</source><year>2012</year><volume>46</volume><fpage>746</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.04.014</pub-id><pub-id pub-id-type="pmid">22607974</pub-id></element-citation></ref><ref id="CR460"><label>460.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Kanegane</surname><given-names>H</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>N</given-names></name><name name-style="western"><surname>Imamura</surname><given-names>T</given-names></name><name name-style="western"><surname>Hamamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Miyashita</surname><given-names>R</given-names></name><etal/></person-group><article-title>Clinical and genetic characteristics of XIAP deficiency in Japan</article-title><source>J Clin Immunol</source><year>2012</year><volume>32</volume><fpage>411</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s10875-011-9638-z</pub-id><pub-id pub-id-type="pmid">22228567</pub-id></element-citation></ref><ref id="CR461"><label>461.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salzer</surname><given-names>U</given-names></name><name name-style="western"><surname>Hagena</surname><given-names>T</given-names></name><name name-style="western"><surname>Webster</surname><given-names>DB</given-names></name><name name-style="western"><surname>Grimbacher</surname><given-names>B</given-names></name></person-group><article-title>Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency</article-title><source>Int Arch Allergy Immunol</source><year>2008</year><volume>147</volume><fpage>147</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1159/000135702</pub-id><pub-id pub-id-type="pmid">18520160</pub-id></element-citation></ref><ref id="CR462"><label>462.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahida</surname><given-names>A</given-names></name><name name-style="western"><surname>Muller</surname><given-names>M</given-names></name><name name-style="western"><surname>Hiergeist</surname><given-names>A</given-names></name><name name-style="western"><surname>Popper</surname><given-names>B</given-names></name><name name-style="western"><surname>Steiger</surname><given-names>K</given-names></name><name name-style="western"><surname>Branca</surname><given-names>C</given-names></name><etal/></person-group><article-title>XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells</article-title><source>Sci Immunol</source><year>2021</year><volume>6</volume><fpage>eabf7235</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.abf7235</pub-id><pub-id pub-id-type="pmid">34739338</pub-id></element-citation></ref><ref id="CR463"><label>463.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinkman</surname><given-names>BM</given-names></name><name name-style="western"><surname>Hildebrand</surname><given-names>F</given-names></name><name name-style="western"><surname>Kubica</surname><given-names>M</given-names></name><name name-style="western"><surname>Goosens</surname><given-names>D</given-names></name><name name-style="western"><surname>Del Favero</surname><given-names>J</given-names></name><name name-style="western"><surname>Declercq</surname><given-names>W</given-names></name><etal/></person-group><article-title>Caspase deficiency alters the murine gut microbiome</article-title><source>Cell Death Dis</source><year>2011</year><volume>2</volume><fpage>e220</fpage><pub-id pub-id-type="doi">10.1038/cddis.2011.101</pub-id><pub-id pub-id-type="pmid">22012254</pub-id><pub-id pub-id-type="pmcid">PMC3219086</pub-id></element-citation></ref><ref id="CR464"><label>464.</label><mixed-citation publication-type="other">Ghazavi F, Huysentruyt J, De Coninck J, Kourula S, Martens S, Hassannia B, et al. Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state. Proc Natl Acad Sci USA. 2022;119:e2024508119.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2024508119</pub-id><pub-id pub-id-type="pmcid">PMC8832966</pub-id><pub-id pub-id-type="pmid">35105800</pub-id></mixed-citation></ref><ref id="CR465"><label>465.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>C</given-names></name><name name-style="western"><surname>Morselli</surname><given-names>E</given-names></name><name name-style="western"><surname>Touat</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Viral control of mitochondrial apoptosis</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000018</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000018</pub-id><pub-id pub-id-type="pmid">18516228</pub-id><pub-id pub-id-type="pmcid">PMC2376094</pub-id></element-citation></ref><ref id="CR466"><label>466.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#252;nther</surname><given-names>SD</given-names></name><name name-style="western"><surname>Fritsch</surname><given-names>M</given-names></name><name name-style="western"><surname>Seeger</surname><given-names>JM</given-names></name><name name-style="western"><surname>Schiffmann</surname><given-names>LM</given-names></name><name name-style="western"><surname>Snipas</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Coutelle</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cytosolic Gram-negative bacteria prevent apoptosis by inhibition of effector caspases through lipopolysaccharide</article-title><source>Nat Microbiol</source><year>2020</year><volume>5</volume><fpage>354</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0620-5</pub-id><pub-id pub-id-type="pmid">31873204</pub-id></element-citation></ref><ref id="CR467"><label>467.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Katoh</surname><given-names>H</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kusakabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Tokunaga</surname><given-names>M</given-names></name><etal/></person-group><article-title>Infection with flaviviruses requires BCLXL for cell survival</article-title><source>PLoS Pathog</source><year>2018</year><volume>14</volume><fpage>e1007299</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1007299</pub-id><pub-id pub-id-type="pmid">30261081</pub-id><pub-id pub-id-type="pmcid">PMC6177207</pub-id></element-citation></ref><ref id="CR468"><label>468.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Handke</surname><given-names>W</given-names></name><name name-style="western"><surname>Luig</surname><given-names>C</given-names></name><name name-style="western"><surname>Popovic</surname><given-names>B</given-names></name><name name-style="western"><surname>Krmpotic</surname><given-names>A</given-names></name><name name-style="western"><surname>Jonjic</surname><given-names>S</given-names></name><name name-style="western"><surname>Brune</surname><given-names>W</given-names></name></person-group><article-title>Viral inhibition of BAK promotes murine cytomegalovirus dissemination to salivary glands</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>3592</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1128/JVI.02657-12</pub-id><pub-id pub-id-type="pmid">23302869</pub-id><pub-id pub-id-type="pmcid">PMC3592122</pub-id></element-citation></ref><ref id="CR469"><label>469.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleming</surname><given-names>P</given-names></name><name name-style="western"><surname>Kvansakul</surname><given-names>M</given-names></name><name name-style="western"><surname>Voigt</surname><given-names>V</given-names></name><name name-style="western"><surname>Kile</surname><given-names>BT</given-names></name><name name-style="western"><surname>Kluck</surname><given-names>RM</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><etal/></person-group><article-title>MCMV-mediated inhibition of the pro-apoptotic Bak protein is required for optimal in vivo replication</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003192</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003192</pub-id><pub-id pub-id-type="pmid">23468630</pub-id><pub-id pub-id-type="pmcid">PMC3585157</pub-id></element-citation></ref><ref id="CR470"><label>470.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garrison</surname><given-names>SP</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>JA</given-names></name><name name-style="western"><surname>H&#228;cker</surname><given-names>H</given-names></name><name name-style="western"><surname>Webby</surname><given-names>R</given-names></name><name name-style="western"><surname>Rehg</surname><given-names>JE</given-names></name><name name-style="western"><surname>Parganas</surname><given-names>E</given-names></name><etal/></person-group><article-title>The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsis</article-title><source>PLoS Pathog</source><year>2010</year><volume>6</volume><fpage>e1001240</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1001240</pub-id><pub-id pub-id-type="pmid">21203486</pub-id><pub-id pub-id-type="pmcid">PMC3009602</pub-id></element-citation></ref><ref id="CR471"><label>471.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andree</surname><given-names>M</given-names></name><name name-style="western"><surname>Seeger</surname><given-names>JM</given-names></name><name name-style="western"><surname>Sch&#252;ll</surname><given-names>S</given-names></name><name name-style="western"><surname>Coutelle</surname><given-names>O</given-names></name><name name-style="western"><surname>Wagner-Stippich</surname><given-names>D</given-names></name><name name-style="western"><surname>Wiegmann</surname><given-names>K</given-names></name><etal/></person-group><article-title>BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella</article-title><source>EMBO J</source><year>2014</year><volume>33</volume><fpage>2171</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.15252/embj.201387244</pub-id><pub-id pub-id-type="pmid">25056906</pub-id><pub-id pub-id-type="pmcid">PMC4282505</pub-id></element-citation></ref><ref id="CR472"><label>472.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stafford</surname><given-names>CA</given-names></name><name name-style="western"><surname>Lawlor</surname><given-names>KE</given-names></name><name name-style="western"><surname>Heim</surname><given-names>VJ</given-names></name><name name-style="western"><surname>Bankovacki</surname><given-names>A</given-names></name><name name-style="western"><surname>Bernardini</surname><given-names>JP</given-names></name><name name-style="western"><surname>Silke</surname><given-names>J</given-names></name><etal/></person-group><article-title>IAPs regulate distinct innate immune pathways to co-ordinate the response to bacterial peptidoglycans</article-title><source>Cell Rep</source><year>2018</year><volume>22</volume><fpage>1496</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.01.024</pub-id><pub-id pub-id-type="pmid">29425505</pub-id></element-citation></ref><ref id="CR473"><label>473.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margaroli</surname><given-names>C</given-names></name><name name-style="western"><surname>Oberle</surname><given-names>S</given-names></name><name name-style="western"><surname>Lavanchy</surname><given-names>C</given-names></name><name name-style="western"><surname>Scherer</surname><given-names>S</given-names></name><name name-style="western"><surname>Rosa</surname><given-names>M</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><etal/></person-group><article-title>Role of proapoptotic BH3-only proteins in Listeria monocytogenes infection</article-title><source>Eur J Immunol</source><year>2016</year><volume>46</volume><fpage>1427</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1002/eji.201545857</pub-id><pub-id pub-id-type="pmid">27064265</pub-id></element-citation></ref><ref id="CR474"><label>474.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bradfute</surname><given-names>SB</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>PE</given-names></name><name name-style="western"><surname>Smith</surname><given-names>MA</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>E</given-names></name><name name-style="western"><surname>McDunn</surname><given-names>JE</given-names></name><name name-style="western"><surname>Hotchkiss</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><fpage>327</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901231</pub-id><pub-id pub-id-type="pmid">20028660</pub-id></element-citation></ref><ref id="CR475"><label>475.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Meng</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Younis</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK</article-title><source>Cell Death Differ</source><year>2022</year><volume>29</volume><fpage>1395</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1038/s41418-022-00928-x</pub-id><pub-id pub-id-type="pmid">35022571</pub-id><pub-id pub-id-type="pmcid">PMC8752586</pub-id></element-citation></ref><ref id="CR476"><label>476.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Medina</surname><given-names>CB</given-names></name><name name-style="western"><surname>Barron</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Karvelyte</surname><given-names>L</given-names></name><name name-style="western"><surname>Aaes</surname><given-names>TL</given-names></name><name name-style="western"><surname>Lambertz</surname><given-names>I</given-names></name><etal/></person-group><article-title>Microbes exploit death-induced nutrient release by gut epithelial cells</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>262</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03785-9</pub-id><pub-id pub-id-type="pmid">34349263</pub-id></element-citation></ref><ref id="CR477"><label>477.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beckham</surname><given-names>JD</given-names></name><name name-style="western"><surname>Tuttle</surname><given-names>KD</given-names></name><name name-style="western"><surname>Tyler</surname><given-names>KL</given-names></name></person-group><article-title>Caspase-3 activation is required for reovirus-induced encephalitis in vivo</article-title><source>J Neurovirol</source><year>2010</year><volume>16</volume><fpage>306</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3109/13550284.2010.499890</pub-id><pub-id pub-id-type="pmid">20626234</pub-id><pub-id pub-id-type="pmcid">PMC3023174</pub-id></element-citation></ref><ref id="CR478"><label>478.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>SF</given-names></name><name name-style="western"><surname>Belz</surname><given-names>GT</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>BH3-only protein Puma contributes to death of antigen-specific T cells during shutdown of an immune response to acute viral infection</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>3035</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1073/pnas.0706913105</pub-id><pub-id pub-id-type="pmid">18287039</pub-id><pub-id pub-id-type="pmcid">PMC2268580</pub-id></element-citation></ref><ref id="CR479"><label>479.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name><name name-style="western"><surname>Michalak</surname><given-names>EM</given-names></name><name name-style="western"><surname>Coultas</surname><given-names>L</given-names></name><name name-style="western"><surname>M&#252;llauer</surname><given-names>F</given-names></name><name name-style="western"><surname>B&#246;ck</surname><given-names>G</given-names></name><name name-style="western"><surname>Ausserlechner</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>1036</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1126/science.1090072</pub-id><pub-id pub-id-type="pmid">14500851</pub-id></element-citation></ref><ref id="CR480"><label>480.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pellegrini</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Robati</surname><given-names>M</given-names></name><name name-style="western"><surname>Belz</surname><given-names>GT</given-names></name><name name-style="western"><surname>Davey</surname><given-names>GM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>1189</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1084/jem.20041328</pub-id><pub-id pub-id-type="pmid">15504823</pub-id><pub-id pub-id-type="pmcid">PMC2211860</pub-id></element-citation></ref><ref id="CR481"><label>481.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Speir</surname><given-names>M</given-names></name><name name-style="western"><surname>Lawlor</surname><given-names>KE</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>SP</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>G</given-names></name><name name-style="western"><surname>Chow</surname><given-names>S</given-names></name><name name-style="western"><surname>Vogrin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis</article-title><source>Nat Microbiol</source><year>2016</year><volume>1</volume><fpage>15034</fpage><pub-id pub-id-type="doi">10.1038/nmicrobiol.2015.34</pub-id><pub-id pub-id-type="pmid">27572165</pub-id></element-citation></ref><ref id="CR482"><label>482.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tam</surname><given-names>BT</given-names></name><name name-style="western"><surname>Yu</surname><given-names>AP</given-names></name><name name-style="western"><surname>Tam</surname><given-names>EW</given-names></name><name name-style="western"><surname>Monks</surname><given-names>DA</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XP</given-names></name><name name-style="western"><surname>Pei</surname><given-names>XM</given-names></name><etal/></person-group><article-title>Ablation of Bax and Bak protects skeletal muscle against pressure-induced injury</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>3689</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-21853-5</pub-id><pub-id pub-id-type="pmid">29487339</pub-id><pub-id pub-id-type="pmcid">PMC5829134</pub-id></element-citation></ref><ref id="CR483"><label>483.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stratos</surname><given-names>I</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Rotter</surname><given-names>R</given-names></name><name name-style="western"><surname>Herlyn</surname><given-names>P</given-names></name><name name-style="western"><surname>Mittlmeier</surname><given-names>T</given-names></name><name name-style="western"><surname>Vollmar</surname><given-names>B</given-names></name></person-group><article-title>Inhibition of caspase mediated apoptosis restores muscle function after crush injury in rat skeletal muscle</article-title><source>Apoptosis</source><year>2012</year><volume>17</volume><fpage>269</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s10495-011-0674-1</pub-id><pub-id pub-id-type="pmid">22089165</pub-id><pub-id pub-id-type="pmcid">PMC3279634</pub-id></element-citation></ref><ref id="CR484"><label>484.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teng</surname><given-names>BT</given-names></name><name name-style="western"><surname>Tam</surname><given-names>EW</given-names></name><name name-style="western"><surname>Benzie</surname><given-names>IF</given-names></name><name name-style="western"><surname>Siu</surname><given-names>PM</given-names></name></person-group><article-title>Protective effect of caspase inhibition on compression-induced muscle damage</article-title><source>J Physiol</source><year>2011</year><volume>58913</volume><fpage>3349</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2011.209619</pub-id><pub-id pub-id-type="pmcid">PMC3145944</pub-id><pub-id pub-id-type="pmid">21540338</pub-id></element-citation></ref><ref id="CR485"><label>485.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talbert</surname><given-names>EE</given-names></name><name name-style="western"><surname>Smuder</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Min</surname><given-names>K</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>OS</given-names></name><name name-style="western"><surname>Powers</surname><given-names>SK</given-names></name></person-group><article-title>Calpain and caspase-3 play required roles in immobilization-induced limb muscle atrophy</article-title><source>J Appl Physiol</source><year>2013</year><volume>114</volume><fpage>1482</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00925.2012</pub-id><pub-id pub-id-type="pmid">23471945</pub-id></element-citation></ref><ref id="CR486"><label>486.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>S</given-names></name><name name-style="western"><surname>Nagashima</surname><given-names>M</given-names></name><name name-style="western"><surname>Khan</surname><given-names>MA</given-names></name><name name-style="western"><surname>Yasuhara</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaneki</surname><given-names>M</given-names></name><name name-style="western"><surname>Martyn</surname><given-names>JA</given-names></name></person-group><article-title>Lack of caspase-3 attenuates immobilization-induced muscle atrophy and loss of tension generation along with mitigation of apoptosis and inflammation</article-title><source>Muscle Nerve</source><year>2013</year><volume>47</volume><fpage>711</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/mus.23642</pub-id><pub-id pub-id-type="pmid">23401051</pub-id><pub-id pub-id-type="pmcid">PMC3634903</pub-id></element-citation></ref><ref id="CR487"><label>487.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>XH</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Du</surname><given-names>J</given-names></name><name name-style="western"><surname>Klein</surname><given-names>JD</given-names></name></person-group><article-title>X-chromosome linked inhibitor of apoptosis protein inhibits muscle proteolysis in insulin-deficient mice</article-title><source>Gene Ther</source><year>2007</year><volume>14</volume><fpage>711</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/sj.gt.3302927</pub-id><pub-id pub-id-type="pmid">17315041</pub-id><pub-id pub-id-type="pmcid">PMC3786557</pub-id></element-citation></ref><ref id="CR488"><label>488.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Du</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Price</surname><given-names>SR</given-names></name><name name-style="western"><surname>Klein</surname><given-names>JD</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XH</given-names></name></person-group><article-title>XIAP reduces muscle proteolysis induced by CKD</article-title><source>J Am Soc Nephrol</source><year>2010</year><volume>21</volume><fpage>1174</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1681/ASN.2009101011</pub-id><pub-id pub-id-type="pmid">20431038</pub-id><pub-id pub-id-type="pmcid">PMC3152227</pub-id></element-citation></ref><ref id="CR489"><label>489.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plant</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Bain</surname><given-names>JR</given-names></name><name name-style="western"><surname>Correa</surname><given-names>JE</given-names></name><name name-style="western"><surname>Woo</surname><given-names>M</given-names></name><name name-style="western"><surname>Batt</surname><given-names>J</given-names></name></person-group><article-title>Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy</article-title><source>J Appl Physiol</source><year>2009</year><volume>107</volume><fpage>224</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.90932.2008</pub-id><pub-id pub-id-type="pmid">19390003</pub-id></element-citation></ref><ref id="CR490"><label>490.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Pytel</surname><given-names>P</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>CM</given-names></name></person-group><article-title>Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome</article-title><source>Hum Mol Genet</source><year>2014</year><volume>23</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt397</pub-id><pub-id pub-id-type="pmid">23943790</pub-id></element-citation></ref><ref id="CR491"><label>491.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budinger</surname><given-names>GR</given-names></name><name name-style="western"><surname>Mutlu</surname><given-names>GM</given-names></name><name name-style="western"><surname>Urich</surname><given-names>D</given-names></name><name name-style="western"><surname>Soberanes</surname><given-names>S</given-names></name><name name-style="western"><surname>Buccellato</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Hawkins</surname><given-names>K</given-names></name><etal/></person-group><article-title>Epithelial cell death is an important contributor to oxidant-mediated acute lung injury</article-title><source>Am J Respir Crit Care Med</source><year>2011</year><volume>183</volume><fpage>1043</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1164/rccm.201002-0181OC</pub-id><pub-id pub-id-type="pmid">20959557</pub-id><pub-id pub-id-type="pmcid">PMC3086743</pub-id></element-citation></ref><ref id="CR492"><label>492.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>CH</given-names></name><name name-style="western"><surname>Waxman</surname><given-names>AB</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CG</given-names></name><name name-style="western"><surname>Link</surname><given-names>H</given-names></name><name name-style="western"><surname>Rabach</surname><given-names>ME</given-names></name><name name-style="western"><surname>Ma</surname><given-names>B</given-names></name><etal/></person-group><article-title>Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury</article-title><source>J Clin Investig</source><year>2005</year><volume>115</volume><fpage>1039</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1172/JCI23004</pub-id><pub-id pub-id-type="pmid">15841185</pub-id><pub-id pub-id-type="pmcid">PMC1070412</pub-id></element-citation></ref><ref id="CR493"><label>493.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#233;trailler-Ruchonnet</surname><given-names>I</given-names></name><name name-style="western"><surname>Pagano</surname><given-names>A</given-names></name><name name-style="western"><surname>Carnesecchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Khatib</surname><given-names>K</given-names></name><name name-style="western"><surname>Herrera</surname><given-names>P</given-names></name><name name-style="western"><surname>Donati</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Bcl-2 overexpression in type II epithelial cells does not prevent hyperoxia-induced acute lung injury in mice</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2010</year><volume>299</volume><fpage>L312</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00212.2009</pub-id><pub-id pub-id-type="pmid">20382751</pub-id></element-citation></ref><ref id="CR494"><label>494.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gangoda</surname><given-names>L</given-names></name><name name-style="western"><surname>Schenk</surname><given-names>RL</given-names></name><name name-style="western"><surname>Best</surname><given-names>SA</given-names></name><name name-style="western"><surname>Nedeva</surname><given-names>C</given-names></name><name name-style="western"><surname>Louis</surname><given-names>C</given-names></name><name name-style="western"><surname>D&#8217;Silva</surname><given-names>DB</given-names></name><etal/></person-group><article-title>Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis</article-title><source>Cell Death Differ</source><year>2022</year><volume>29</volume><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00839-3</pub-id><pub-id pub-id-type="pmid">34304242</pub-id><pub-id pub-id-type="pmcid">PMC8738744</pub-id></element-citation></ref><ref id="CR495"><label>495.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>HR</given-names></name><name name-style="western"><surname>Cho</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CG</given-names></name><name name-style="western"><surname>Homer</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Elias</surname><given-names>JA</given-names></name></person-group><article-title>Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>7723</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1074/jbc.M610764200</pub-id><pub-id pub-id-type="pmid">17209037</pub-id></element-citation></ref><ref id="CR496"><label>496.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budinger</surname><given-names>GR</given-names></name><name name-style="western"><surname>Mutlu</surname><given-names>GM</given-names></name><name name-style="western"><surname>Eisenbart</surname><given-names>J</given-names></name><name name-style="western"><surname>Fuller</surname><given-names>AC</given-names></name><name name-style="western"><surname>Bellmeyer</surname><given-names>AA</given-names></name><name name-style="western"><surname>Baker</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Proapoptotic Bid is required for pulmonary fibrosis</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>4604</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.0507604103</pub-id><pub-id pub-id-type="pmid">16537427</pub-id><pub-id pub-id-type="pmcid">PMC1401229</pub-id></element-citation></ref><ref id="CR497"><label>497.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>L</given-names></name><name name-style="western"><surname>Surolia</surname><given-names>R</given-names></name><name name-style="western"><surname>Larson-Casey</surname><given-names>JL</given-names></name><name name-style="western"><surname>He</surname><given-names>C</given-names></name><name name-style="western"><surname>Davis</surname><given-names>D</given-names></name><name name-style="western"><surname>Kang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling</article-title><source>Cell Death Differ</source><year>2022</year><volume>29</volume><fpage>118</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00840-w</pub-id><pub-id pub-id-type="pmid">34413485</pub-id><pub-id pub-id-type="pmcid">PMC8738732</pub-id></element-citation></ref><ref id="CR498"><label>498.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuwano</surname><given-names>K</given-names></name><name name-style="western"><surname>Kunitake</surname><given-names>R</given-names></name><name name-style="western"><surname>Maeyama</surname><given-names>T</given-names></name><name name-style="western"><surname>Hagimoto</surname><given-names>N</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Matsuba</surname><given-names>T</given-names></name><etal/></person-group><article-title>Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2001</year><volume>280</volume><fpage>L316</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1152/ajplung.2001.280.2.L316</pub-id><pub-id pub-id-type="pmid">11159011</pub-id></element-citation></ref><ref id="CR499"><label>499.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Ibarra-Sunga</surname><given-names>O</given-names></name><name name-style="western"><surname>Verlinski</surname><given-names>L</given-names></name><name name-style="western"><surname>Pick</surname><given-names>R</given-names></name><name name-style="western"><surname>Uhal</surname><given-names>BD</given-names></name></person-group><article-title>Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2000</year><volume>279</volume><fpage>L143</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1152/ajplung.2000.279.1.L143</pub-id><pub-id pub-id-type="pmid">10893213</pub-id></element-citation></ref><ref id="CR500"><label>500.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>HL</given-names></name><name name-style="western"><surname>Akinci</surname><given-names>IO</given-names></name><name name-style="western"><surname>Baker</surname><given-names>CM</given-names></name><name name-style="western"><surname>Urich</surname><given-names>D</given-names></name><name name-style="western"><surname>Bellmeyer</surname><given-names>A</given-names></name><name name-style="western"><surname>Jain</surname><given-names>M</given-names></name><etal/></person-group><article-title>The intrinsic apoptotic pathway is required for lipopolysaccharide-induced lung endothelial cell death</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>1834</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.3.1834</pub-id><pub-id pub-id-type="pmid">17641050</pub-id></element-citation></ref><ref id="CR501"><label>501.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>YX</given-names></name><name name-style="western"><surname>Fan</surname><given-names>H</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>ST</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>YF</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Prevention of lung ischemia-reperfusion injury by short hairpin RNA-mediated caspase-3 gene silencing</article-title><source>J Thorac Cardiovasc Surg</source><year>2010</year><volume>139</volume><fpage>758</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2009.09.027</pub-id><pub-id pub-id-type="pmid">19969310</pub-id></element-citation></ref><ref id="CR502"><label>502.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>B</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Jin</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name></person-group><article-title>Necrostatin-1 synergizes the Pan caspase inhibitor to attenuate lung injury induced by ischemia reperfusion in rats</article-title><source>Mediators Inflamm</source><year>2020</year><volume>2020</volume><fpage>7059304</fpage><pub-id pub-id-type="doi">10.1155/2020/7059304</pub-id><pub-id pub-id-type="pmid">33162831</pub-id><pub-id pub-id-type="pmcid">PMC7604602</pub-id></element-citation></ref><ref id="CR503"><label>503.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooke</surname><given-names>DT</given-names></name><name name-style="western"><surname>Hoyt</surname><given-names>EG</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>RC</given-names></name></person-group><article-title>Overexpression of human Bcl-2 in syngeneic rat donor lungs preserves posttransplant function and reduces intragraft caspase activity and interleukin-1beta production</article-title><source>Transplantation</source><year>2005</year><volume>79</volume><fpage>762</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/01.TP.0000153368.08861.15</pub-id><pub-id pub-id-type="pmid">15818317</pub-id></element-citation></ref><ref id="CR504"><label>504.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quadri</surname><given-names>SM</given-names></name><name name-style="western"><surname>Segall</surname><given-names>L</given-names></name><name name-style="western"><surname>de Perrot</surname><given-names>M</given-names></name><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>V</given-names></name><name name-style="western"><surname>Jones</surname><given-names>N</given-names></name><etal/></person-group><article-title>Caspase inhibition improves ischemia-reperfusion injury after lung transplantation</article-title><source>Am J Transplant</source><year>2005</year><volume>5</volume><fpage>292</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2004.00701.x</pub-id><pub-id pub-id-type="pmid">15643988</pub-id></element-citation></ref><ref id="CR505"><label>505.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Zou</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name><name name-style="western"><surname>Ding</surname><given-names>X</given-names></name><etal/></person-group><article-title>Caspase inhibitor zVAD-fmk protects against acute pancreatitis-associated lung injury via inhibiting inflammation and apoptosis</article-title><source>Pancreatology</source><year>2016</year><volume>16</volume><fpage>733</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2016.06.002</pub-id><pub-id pub-id-type="pmid">27324074</pub-id></element-citation></ref><ref id="CR506"><label>506.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawasaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Kuwano</surname><given-names>K</given-names></name><name name-style="western"><surname>Hagimoto</surname><given-names>N</given-names></name><name name-style="western"><surname>Matsuba</surname><given-names>T</given-names></name><name name-style="western"><surname>Kunitake</surname><given-names>R</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>T</given-names></name><etal/></person-group><article-title>Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor</article-title><source>Am J Pathol</source><year>2000</year><volume>157</volume><fpage>597</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64570-1</pub-id><pub-id pub-id-type="pmid">10934162</pub-id><pub-id pub-id-type="pmcid">PMC1850133</pub-id></element-citation></ref><ref id="CR507"><label>507.</label><mixed-citation publication-type="other">van den Berg E, Bal SM, Kuipers MT, Matute-Bello G, Lutter R, Bos AP, et al. The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice. Physiol Rep. 2015;3:e12332.<pub-id pub-id-type="doi" assigning-authority="pmc">10.14814/phy2.12332</pub-id><pub-id pub-id-type="pmcid">PMC4393166</pub-id><pub-id pub-id-type="pmid">25780096</pub-id></mixed-citation></ref><ref id="CR508"><label>508.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locatelli</surname><given-names>F</given-names></name><name name-style="western"><surname>Corti</surname><given-names>S</given-names></name><name name-style="western"><surname>Papadimitriou</surname><given-names>D</given-names></name><name name-style="western"><surname>Fortunato</surname><given-names>F</given-names></name><name name-style="western"><surname>Del Bo</surname><given-names>R</given-names></name><name name-style="western"><surname>Donadoni</surname><given-names>C</given-names></name><etal/></person-group><article-title>Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice</article-title><source>Ann Neurol</source><year>2007</year><volume>62</volume><fpage>81</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1002/ana.21152</pub-id><pub-id pub-id-type="pmid">17503505</pub-id></element-citation></ref><ref id="CR509"><label>509.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petri</surname><given-names>S</given-names></name><name name-style="western"><surname>Kiaei</surname><given-names>M</given-names></name><name name-style="western"><surname>Wille</surname><given-names>E</given-names></name><name name-style="western"><surname>Calingasan</surname><given-names>NY</given-names></name><name name-style="western"><surname>Flint Beal</surname><given-names>M</given-names></name></person-group><article-title>Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice</article-title><source>J Neurol Sci</source><year>2006</year><volume>251</volume><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2006.08.013</pub-id><pub-id pub-id-type="pmid">17049562</pub-id></element-citation></ref><ref id="CR510"><label>510.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gowing</surname><given-names>G</given-names></name><name name-style="western"><surname>Dequen</surname><given-names>F</given-names></name><name name-style="western"><surname>Soucy</surname><given-names>G</given-names></name><name name-style="western"><surname>Julien</surname><given-names>JP</given-names></name></person-group><article-title>Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>11397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0602-06.2006</pub-id><pub-id pub-id-type="pmid">17079668</pub-id><pub-id pub-id-type="pmcid">PMC6674545</pub-id></element-citation></ref><ref id="CR511"><label>511.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tortarolo</surname><given-names>M</given-names></name><name name-style="western"><surname>Vallarola</surname><given-names>A</given-names></name><name name-style="western"><surname>Lidonnici</surname><given-names>D</given-names></name><name name-style="western"><surname>Battaglia</surname><given-names>E</given-names></name><name name-style="western"><surname>Gensano</surname><given-names>F</given-names></name><name name-style="western"><surname>Spaltro</surname><given-names>G</given-names></name><etal/></person-group><article-title>Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression</article-title><source>J Neurochem</source><year>2015</year><volume>135</volume><fpage>109</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/jnc.13154</pub-id><pub-id pub-id-type="pmid">25940956</pub-id></element-citation></ref><ref id="CR512"><label>512.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartsch</surname><given-names>JW</given-names></name><name name-style="western"><surname>Wildeboer</surname><given-names>D</given-names></name><name name-style="western"><surname>Koller</surname><given-names>G</given-names></name><name name-style="western"><surname>Naus</surname><given-names>S</given-names></name><name name-style="western"><surname>Rittger</surname><given-names>A</given-names></name><name name-style="western"><surname>Moss</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><fpage>12210</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1520-10.2010</pub-id><pub-id pub-id-type="pmid">20826683</pub-id><pub-id pub-id-type="pmcid">PMC6633558</pub-id></element-citation></ref><ref id="CR513"><label>513.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernard-Marissal</surname><given-names>N</given-names></name><name name-style="western"><surname>Moumen</surname><given-names>A</given-names></name><name name-style="western"><surname>Sunyach</surname><given-names>C</given-names></name><name name-style="western"><surname>Pellegrino</surname><given-names>C</given-names></name><name name-style="western"><surname>Dudley</surname><given-names>K</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>4901</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5431-11.2012</pub-id><pub-id pub-id-type="pmid">22492046</pub-id><pub-id pub-id-type="pmcid">PMC6620921</pub-id></element-citation></ref><ref id="CR514"><label>514.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu&#233;gan</surname><given-names>C</given-names></name><name name-style="western"><surname>Vila</surname><given-names>M</given-names></name><name name-style="western"><surname>Teismann</surname><given-names>P</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Ont&#233;niente</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><article-title>Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS</article-title><source>Mol Cell Neurosci</source><year>2002</year><volume>20</volume><fpage>553</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1006/mcne.2002.1136</pub-id><pub-id pub-id-type="pmid">12213439</pub-id></element-citation></ref><ref id="CR515"><label>515.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalovyrna</surname><given-names>N</given-names></name><name name-style="western"><surname>Apokotou</surname><given-names>O</given-names></name><name name-style="western"><surname>Boulekou</surname><given-names>S</given-names></name><name name-style="western"><surname>Paouri</surname><given-names>E</given-names></name><name name-style="western"><surname>Boutou</surname><given-names>A</given-names></name><name name-style="western"><surname>Georgopoulos</surname><given-names>S</given-names></name></person-group><article-title>A 3&#8217;UTR modification of the TNF-&#945; mouse gene increases peripheral TNF-&#945; and modulates the Alzheimer-like phenotype in 5XFAD mice</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><fpage>8670</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-65378-2</pub-id><pub-id pub-id-type="pmid">32457323</pub-id><pub-id pub-id-type="pmcid">PMC7250826</pub-id></element-citation></ref><ref id="CR516"><label>516.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paouri</surname><given-names>E</given-names></name><name name-style="western"><surname>Tzara</surname><given-names>O</given-names></name><name name-style="western"><surname>Zenelak</surname><given-names>S</given-names></name><name name-style="western"><surname>Georgopoulos</surname><given-names>S</given-names></name></person-group><article-title>Genetic deletion of tumor necrosis factor-&#945; attenuates amyloid-&#946; production and decreases amyloid plaque formation and glial response in the 5XFAD model of Alzheimer&#8217;s disease</article-title><source>J Alzheimer&#8217;s Dis</source><year>2017</year><volume>60</volume><fpage>165</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.3233/JAD-170065</pub-id><pub-id pub-id-type="pmid">28826177</pub-id></element-citation></ref><ref id="CR517"><label>517.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paouri</surname><given-names>E</given-names></name><name name-style="western"><surname>Tzara</surname><given-names>O</given-names></name><name name-style="western"><surname>Kartalou</surname><given-names>GI</given-names></name><name name-style="western"><surname>Zenelak</surname><given-names>S</given-names></name><name name-style="western"><surname>Georgopoulos</surname><given-names>S</given-names></name></person-group><article-title>Peripheral tumor necrosis factor-alpha (TNF-&#945;) modulates amyloid pathology by regulating blood-derived immune cells and glial response in the brain of AD/TNF Transgenic Mice</article-title><source>J Neurosci</source><year>2017</year><volume>37</volume><fpage>5155</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2484-16.2017</pub-id><pub-id pub-id-type="pmid">28442538</pub-id><pub-id pub-id-type="pmcid">PMC6596468</pub-id></element-citation></ref><ref id="CR518"><label>518.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tweedie</surname><given-names>D</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>RA</given-names></name><name name-style="western"><surname>Fishman</surname><given-names>K</given-names></name><name name-style="western"><surname>Frankola</surname><given-names>KA</given-names></name><name name-style="western"><surname>Van Praag</surname><given-names>H</given-names></name><name name-style="western"><surname>Holloway</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-&#945; synthesis inhibitor 3,6&#8217;-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer&#8217;s disease</article-title><source>J Neuroinflammation</source><year>2012</year><volume>9</volume><fpage>106</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-9-106</pub-id><pub-id pub-id-type="pmid">22642825</pub-id><pub-id pub-id-type="pmcid">PMC3405480</pub-id></element-citation></ref><ref id="CR519"><label>519.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McAlpine</surname><given-names>FE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JK</given-names></name><name name-style="western"><surname>Harms</surname><given-names>AS</given-names></name><name name-style="western"><surname>Ruhn</surname><given-names>KA</given-names></name><name name-style="western"><surname>Blurton-Jones</surname><given-names>M</given-names></name><name name-style="western"><surname>Hong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Inhibition of soluble TNF signaling in a mouse model of Alzheimer&#8217;s disease prevents pre-plaque amyloid-associated neuropathology</article-title><source>Neurobiol Dis</source><year>2009</year><volume>34</volume><fpage>163</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2009.01.006</pub-id><pub-id pub-id-type="pmid">19320056</pub-id><pub-id pub-id-type="pmcid">PMC2948857</pub-id></element-citation></ref><ref id="CR520"><label>520.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacPherson</surname><given-names>KP</given-names></name><name name-style="western"><surname>Sompol</surname><given-names>P</given-names></name><name name-style="western"><surname>Kannarkat</surname><given-names>GT</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J</given-names></name><name name-style="western"><surname>Sniffen</surname><given-names>L</given-names></name><name name-style="western"><surname>Wildner</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice</article-title><source>Neurobiol Dis</source><year>2017</year><volume>102</volume><fpage>81</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2017.02.010</pub-id><pub-id pub-id-type="pmid">28237313</pub-id><pub-id pub-id-type="pmcid">PMC5464789</pub-id></element-citation></ref><ref id="CR521"><label>521.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabbita</surname><given-names>SP</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>MF</given-names></name><name name-style="western"><surname>Kobritz</surname><given-names>N</given-names></name><name name-style="western"><surname>Eslami</surname><given-names>P</given-names></name><name name-style="western"><surname>Poteshkina</surname><given-names>A</given-names></name><name name-style="western"><surname>Varadarajan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Oral TNF&#945; modulation alters neutrophil infiltration, improves cognition and diminishes tau and amyloid pathology in the 3xTgAD mouse model</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0137305</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0137305</pub-id><pub-id pub-id-type="pmid">26436670</pub-id><pub-id pub-id-type="pmcid">PMC4593589</pub-id></element-citation></ref><ref id="CR522"><label>522.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabbita</surname><given-names>SP</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>MK</given-names></name><name name-style="western"><surname>Eslami</surname><given-names>P</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>MF</given-names></name><name name-style="western"><surname>Kobritz</surname><given-names>NK</given-names></name><name name-style="western"><surname>Tweedie</surname><given-names>D</given-names></name><etal/></person-group><article-title>Early intervention with a small molecule inhibitor for tumor necrosis factor-&#945; prevents cognitive deficits in a triple transgenic mouse model of Alzheimer&#8217;s disease</article-title><source>J Neuroinflammation</source><year>2012</year><volume>9</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-9-99</pub-id><pub-id pub-id-type="pmid">22632257</pub-id><pub-id pub-id-type="pmcid">PMC3403851</pub-id></element-citation></ref><ref id="CR523"><label>523.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lourenco</surname><given-names>MV</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>JR</given-names></name><name name-style="western"><surname>Frozza</surname><given-names>RL</given-names></name><name name-style="western"><surname>Bomfim</surname><given-names>TR</given-names></name><name name-style="western"><surname>Forny-Germano</surname><given-names>L</given-names></name><name name-style="western"><surname>Batista</surname><given-names>AF</given-names></name><etal/></person-group><article-title>TNF-&#945; mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer&#8217;s &#946;-amyloid oligomers in mice and monkeys</article-title><source>Cell Metab</source><year>2013</year><volume>18</volume><fpage>831</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.11.002</pub-id><pub-id pub-id-type="pmid">24315369</pub-id></element-citation></ref><ref id="CR524"><label>524.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camargos</surname><given-names>S</given-names></name><name name-style="western"><surname>Scholz</surname><given-names>S</given-names></name><name name-style="western"><surname>Sim&#243;n-S&#225;nchez</surname><given-names>J</given-names></name><name name-style="western"><surname>Pais&#225;n-Ruiz</surname><given-names>C</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>P</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>D</given-names></name><etal/></person-group><article-title>DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA</article-title><source>Lancet Neurol</source><year>2008</year><volume>7</volume><fpage>207</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(08)70022-X</pub-id><pub-id pub-id-type="pmid">18243799</pub-id></element-citation></ref><ref id="CR525"><label>525.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhaskar</surname><given-names>K</given-names></name><name name-style="western"><surname>Maphis</surname><given-names>N</given-names></name><name name-style="western"><surname>Xu</surname><given-names>G</given-names></name><name name-style="western"><surname>Varvel</surname><given-names>NH</given-names></name><name name-style="western"><surname>Kokiko-Cochran</surname><given-names>ON</given-names></name><name name-style="western"><surname>Weick</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Microglial derived tumor necrosis factor-&#945; drives Alzheimer&#8217;s disease-related neuronal cell cycle events</article-title><source>Neurobiol Dis</source><year>2014</year><volume>62</volume><fpage>273</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2013.10.007</pub-id><pub-id pub-id-type="pmid">24141019</pub-id><pub-id pub-id-type="pmcid">PMC3877710</pub-id></element-citation></ref><ref id="CR526"><label>526.</label><mixed-citation publication-type="other">Steeland S, Gorl&#233; N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, et al. Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer&#8217;s disease. EMBO Mol Med. 2018;10:e8300.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/emmm.201708300</pub-id><pub-id pub-id-type="pmcid">PMC5887909</pub-id><pub-id pub-id-type="pmid">29472246</pub-id></mixed-citation></ref><ref id="CR527"><label>527.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lindholm</surname><given-names>K</given-names></name><name name-style="western"><surname>Berning</surname><given-names>L</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W</given-names></name><name name-style="western"><surname>Lemere</surname><given-names>C</given-names></name><etal/></person-group><article-title>Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer&#8217;s mice</article-title><source>J Cell Biol</source><year>2007</year><volume>178</volume><fpage>829</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1083/jcb.200705042</pub-id><pub-id pub-id-type="pmid">17724122</pub-id><pub-id pub-id-type="pmcid">PMC2064547</pub-id></element-citation></ref><ref id="CR528"><label>528.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jayaraman</surname><given-names>A</given-names></name><name name-style="western"><surname>Htike</surname><given-names>TT</given-names></name><name name-style="western"><surname>James</surname><given-names>R</given-names></name><name name-style="western"><surname>Picon</surname><given-names>C</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>R</given-names></name></person-group><article-title>TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer&#8217;s disease hippocampus</article-title><source>Acta Neuropathol Commun</source><year>2021</year><volume>9</volume><fpage>159</fpage><pub-id pub-id-type="doi">10.1186/s40478-021-01264-w</pub-id><pub-id pub-id-type="pmid">34625123</pub-id><pub-id pub-id-type="pmcid">PMC8501605</pub-id></element-citation></ref><ref id="CR529"><label>529.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><etal/></person-group><article-title>TNF-alpha-dependent neuronal necroptosis regulated in Alzheimer&#8217;s disease by coordination of RIPK1-p62 complex with autophagic UVRAG</article-title><source>Theranostics</source><year>2021</year><volume>11</volume><fpage>9452</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.7150/thno.62376</pub-id><pub-id pub-id-type="pmid">34646380</pub-id><pub-id pub-id-type="pmcid">PMC8490500</pub-id></element-citation></ref><ref id="CR530"><label>530.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montgomery</surname><given-names>SL</given-names></name><name name-style="western"><surname>Mastrangelo</surname><given-names>MA</given-names></name><name name-style="western"><surname>Habib</surname><given-names>D</given-names></name><name name-style="western"><surname>Narrow</surname><given-names>WC</given-names></name><name name-style="western"><surname>Knowlden</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wright</surname><given-names>TW</given-names></name><etal/></person-group><article-title>Ablation of TNF-RI/RII expression in Alzheimer&#8217;s disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-&#945; suppressive therapeutic strategies in the brain</article-title><source>Am J Pathol</source><year>2011</year><volume>179</volume><fpage>2053</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.07.001</pub-id><pub-id pub-id-type="pmid">21835156</pub-id><pub-id pub-id-type="pmcid">PMC3181376</pub-id></element-citation></ref><ref id="CR531"><label>531.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montgomery</surname><given-names>SL</given-names></name><name name-style="western"><surname>Narrow</surname><given-names>WC</given-names></name><name name-style="western"><surname>Mastrangelo</surname><given-names>MA</given-names></name><name name-style="western"><surname>Olschowka</surname><given-names>JA</given-names></name><name name-style="western"><surname>O&#8217;Banion</surname><given-names>MK</given-names></name><name name-style="western"><surname>Bowers</surname><given-names>WJ</given-names></name></person-group><article-title>Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologies</article-title><source>Am J Pathol</source><year>2013</year><volume>182</volume><fpage>2285</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2013.02.030</pub-id><pub-id pub-id-type="pmid">23567638</pub-id><pub-id pub-id-type="pmcid">PMC3668024</pub-id></element-citation></ref><ref id="CR532"><label>532.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferger</surname><given-names>B</given-names></name><name name-style="western"><surname>Leng</surname><given-names>A</given-names></name><name name-style="western"><surname>Mura</surname><given-names>A</given-names></name><name name-style="western"><surname>Hengerer</surname><given-names>B</given-names></name><name name-style="western"><surname>Feldon</surname><given-names>J</given-names></name></person-group><article-title>Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum</article-title><source>J Neurochem</source><year>2004</year><volume>89</volume><fpage>822</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02399.x</pub-id><pub-id pub-id-type="pmid">15140182</pub-id></element-citation></ref><ref id="CR533"><label>533.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sriram</surname><given-names>K</given-names></name><name name-style="western"><surname>Matheson</surname><given-names>JM</given-names></name><name name-style="western"><surname>Benkovic</surname><given-names>SA</given-names></name><name name-style="western"><surname>Miller</surname><given-names>DB</given-names></name><name name-style="western"><surname>Luster</surname><given-names>MI</given-names></name><name name-style="western"><surname>O&#8217;Callaghan</surname><given-names>JP</given-names></name></person-group><article-title>Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson&#8217;s disease</article-title><source>FASEB J</source><year>2002</year><volume>16</volume><fpage>1474</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1096/fj.02-0216fje</pub-id><pub-id pub-id-type="pmid">12205053</pub-id></element-citation></ref><ref id="CR534"><label>534.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>QH</given-names></name><name name-style="western"><surname>Sumbria</surname><given-names>R</given-names></name><name name-style="western"><surname>Hui</surname><given-names>EK</given-names></name><name name-style="western"><surname>Lu</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Boado</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Pardridge</surname><given-names>WM</given-names></name></person-group><article-title>Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor</article-title><source>J Pharmacol Exp Ther</source><year>2011</year><volume>339</volume><fpage>618</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1124/jpet.111.185876</pub-id><pub-id pub-id-type="pmid">21831964</pub-id><pub-id pub-id-type="pmcid">PMC3199996</pub-id></element-citation></ref><ref id="CR535"><label>535.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCoy</surname><given-names>MK</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>TN</given-names></name><name name-style="western"><surname>Ruhn</surname><given-names>KA</given-names></name><name name-style="western"><surname>Szymkowski</surname><given-names>DE</given-names></name><name name-style="western"><surname>Smith</surname><given-names>CG</given-names></name><name name-style="western"><surname>Botterman</surname><given-names>BR</given-names></name><etal/></person-group><article-title>Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson&#8217;s disease</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>9365</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1504-06.2006</pub-id><pub-id pub-id-type="pmid">16971520</pub-id><pub-id pub-id-type="pmcid">PMC3707118</pub-id></element-citation></ref><ref id="CR536"><label>536.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sriram</surname><given-names>K</given-names></name><name name-style="western"><surname>Matheson</surname><given-names>JM</given-names></name><name name-style="western"><surname>Benkovic</surname><given-names>SA</given-names></name><name name-style="western"><surname>Miller</surname><given-names>DB</given-names></name><name name-style="western"><surname>Luster</surname><given-names>MI</given-names></name><name name-style="western"><surname>O&#8217;Callaghan</surname><given-names>JP</given-names></name></person-group><article-title>Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><fpage>670</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1096/fj.05-5106com</pub-id><pub-id pub-id-type="pmid">16581975</pub-id></element-citation></ref><ref id="CR537"><label>537.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>R</given-names></name><name name-style="western"><surname>Naud&#233;</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Maier</surname><given-names>O</given-names></name><name name-style="western"><surname>Nyakas</surname><given-names>C</given-names></name><name name-style="western"><surname>Duffey</surname><given-names>M</given-names></name><etal/></person-group><article-title>Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration</article-title><source>Proc Natl Acad Sci USA</source><year>2016</year><volume>113</volume><fpage>12304</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.1605195113</pub-id><pub-id pub-id-type="pmid">27791020</pub-id><pub-id pub-id-type="pmcid">PMC5087045</pub-id></element-citation></ref><ref id="CR538"><label>538.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>JQ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>BR</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>WW</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>YW</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer&#8217;s disease</article-title><source>J Am Geriatr Soc</source><year>2011</year><volume>59</volume><fpage>1142</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2011.03445.x</pub-id><pub-id pub-id-type="pmid">21668921</pub-id></element-citation></ref><ref id="CR539"><label>539.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tobinick</surname><given-names>EL</given-names></name><name name-style="western"><surname>Gross</surname><given-names>H</given-names></name></person-group><article-title>Rapid cognitive improvement in Alzheimer&#8217;s disease following perispinal etanercept administration</article-title><source>J Neuroinflammation</source><year>2008</year><volume>5</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-5-2</pub-id><pub-id pub-id-type="pmid">18184433</pub-id><pub-id pub-id-type="pmcid">PMC2211476</pub-id></element-citation></ref><ref id="CR540"><label>540.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alto</surname><given-names>LT</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Ruhn</surname><given-names>KA</given-names></name><name name-style="western"><surname>Trevi&#241;o</surname><given-names>I</given-names></name><name name-style="western"><surname>Tansey</surname><given-names>MG</given-names></name></person-group><article-title>AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington&#8217;s disease</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e96544</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0096544</pub-id><pub-id pub-id-type="pmid">24824433</pub-id><pub-id pub-id-type="pmcid">PMC4019512</pub-id></element-citation></ref><ref id="CR541"><label>541.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantarella</surname><given-names>G</given-names></name><name name-style="western"><surname>Di Benedetto</surname><given-names>G</given-names></name><name name-style="western"><surname>Puzzo</surname><given-names>D</given-names></name><name name-style="western"><surname>Privitera</surname><given-names>L</given-names></name><name name-style="western"><surname>Loreto</surname><given-names>C</given-names></name><name name-style="western"><surname>Saccone</surname><given-names>S</given-names></name><etal/></person-group><article-title>Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer&#8217;s disease</article-title><source>Brain</source><year>2015</year><volume>138</volume><fpage>203</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1093/brain/awu318</pub-id><pub-id pub-id-type="pmid">25472798</pub-id><pub-id pub-id-type="pmcid">PMC4441080</pub-id></element-citation></ref><ref id="CR542"><label>542.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uberti</surname><given-names>D</given-names></name><name name-style="western"><surname>Ferrari-Toninelli</surname><given-names>G</given-names></name><name name-style="western"><surname>Bonini</surname><given-names>SA</given-names></name><name name-style="western"><surname>Sarnico</surname><given-names>I</given-names></name><name name-style="western"><surname>Benarese</surname><given-names>M</given-names></name><name name-style="western"><surname>Pizzi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity</article-title><source>Neuropsychopharmacology</source><year>2007</year><volume>32</volume><fpage>872</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1301185</pub-id><pub-id pub-id-type="pmid">16936710</pub-id></element-citation></ref><ref id="CR543"><label>543.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Brannan</surname><given-names>CI</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>NA</given-names></name><name name-style="western"><surname>Copeland</surname><given-names>NG</given-names></name><name name-style="western"><surname>Suda</surname><given-names>T</given-names></name><etal/></person-group><article-title>Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand</article-title><source>Cell</source><year>1994</year><volume>76</volume><fpage>969</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90375-1</pub-id><pub-id pub-id-type="pmid">7511063</pub-id></element-citation></ref><ref id="CR544"><label>544.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landau</surname><given-names>AM</given-names></name><name name-style="western"><surname>Luk</surname><given-names>KC</given-names></name><name name-style="western"><surname>Jones</surname><given-names>ML</given-names></name><name name-style="western"><surname>Siegrist-Johnstone</surname><given-names>R</given-names></name><name name-style="western"><surname>Young</surname><given-names>YK</given-names></name><name name-style="western"><surname>Kouassi</surname><given-names>E</given-names></name><etal/></person-group><article-title>Defective Fas expression exacerbates neurotoxicity in a model of Parkinson&#8217;s disease</article-title><source>J Exp Med</source><year>2005</year><volume>202</volume><fpage>575</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1084/jem.20050163</pub-id><pub-id pub-id-type="pmid">16129703</pub-id><pub-id pub-id-type="pmcid">PMC2212882</pub-id></element-citation></ref><ref id="CR545"><label>545.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>L</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>D</given-names></name><name name-style="western"><surname>Llorens-Bobadilla</surname><given-names>E</given-names></name><name name-style="western"><surname>Saiz-Castro</surname><given-names>G</given-names></name><name name-style="western"><surname>Frank</surname><given-names>T</given-names></name><name name-style="western"><surname>Wieghofer</surname><given-names>P</given-names></name><etal/></person-group><article-title>Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice</article-title><source>J Exp Med</source><year>2015</year><volume>212</volume><fpage>469</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1084/jem.20132423</pub-id><pub-id pub-id-type="pmid">25779632</pub-id><pub-id pub-id-type="pmcid">PMC4387281</pub-id></element-citation></ref><ref id="CR546"><label>546.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayley</surname><given-names>S</given-names></name><name name-style="western"><surname>Crocker</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Smith</surname><given-names>PD</given-names></name><name name-style="western"><surname>Shree</surname><given-names>T</given-names></name><name name-style="western"><surname>Jackson-Lewis</surname><given-names>V</given-names></name><name name-style="western"><surname>Przedborski</surname><given-names>S</given-names></name><etal/></person-group><article-title>Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson&#8217;s disease</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>2045</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4564-03.2004</pub-id><pub-id pub-id-type="pmid">14985447</pub-id><pub-id pub-id-type="pmcid">PMC6730390</pub-id></element-citation></ref><ref id="CR547"><label>547.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Betarbet</surname><given-names>R</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>LR</given-names></name><name name-style="western"><surname>Gearing</surname><given-names>M</given-names></name><name name-style="western"><surname>Hodges</surname><given-names>TR</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lah</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Fas-associated factor 1 and Parkinson&#8217;s disease</article-title><source>Neurobiol Dis</source><year>2008</year><volume>31</volume><fpage>309</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2008.05.006</pub-id><pub-id pub-id-type="pmid">18573343</pub-id><pub-id pub-id-type="pmcid">PMC2615003</pub-id></element-citation></ref><ref id="CR548"><label>548.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sul</surname><given-names>JW</given-names></name><name name-style="western"><surname>Park</surname><given-names>MY</given-names></name><name name-style="western"><surname>Shin</surname><given-names>J</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YR</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>SE</given-names></name><name name-style="western"><surname>Kong</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration</article-title><source>Hum Mol Genet</source><year>2013</year><volume>22</volume><fpage>1558</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt006</pub-id><pub-id pub-id-type="pmid">23307929</pub-id></element-citation></ref><ref id="CR549"><label>549.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rohn</surname><given-names>TT</given-names></name><name name-style="western"><surname>Head</surname><given-names>E</given-names></name><name name-style="western"><surname>Nesse</surname><given-names>WH</given-names></name><name name-style="western"><surname>Cotman</surname><given-names>CW</given-names></name><name name-style="western"><surname>Cribbs</surname><given-names>DH</given-names></name></person-group><article-title>Activation of caspase-8 in the Alzheimer&#8217;s disease brain</article-title><source>Neurobiol Dis</source><year>2001</year><volume>8</volume><fpage>1006</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1006/nbdi.2001.0449</pub-id><pub-id pub-id-type="pmid">11741396</pub-id></element-citation></ref><ref id="CR550"><label>550.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#225;nchez</surname><given-names>I</given-names></name><name name-style="western"><surname>Xu</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Juo</surname><given-names>P</given-names></name><name name-style="western"><surname>Kakizaka</surname><given-names>A</given-names></name><name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Caspase-8 is required for cell death induced by expanded polyglutamine repeats</article-title><source>Neuron</source><year>1999</year><volume>22</volume><fpage>623</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80716-3</pub-id><pub-id pub-id-type="pmid">10197541</pub-id></element-citation></ref><ref id="CR551"><label>551.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Sugama</surname><given-names>S</given-names></name><name name-style="western"><surname>Mischak</surname><given-names>RP</given-names></name><name name-style="western"><surname>Kiaei</surname><given-names>M</given-names></name><name name-style="western"><surname>Bizat</surname><given-names>N</given-names></name><name name-style="western"><surname>Brouillet</surname><given-names>E</given-names></name><etal/></person-group><article-title>A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo</article-title><source>Neurobiol Dis</source><year>2004</year><volume>17</volume><fpage>250</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2004.07.021</pub-id><pub-id pub-id-type="pmid">15474362</pub-id></element-citation></ref><ref id="CR552"><label>552.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viceconte</surname><given-names>N</given-names></name><name name-style="western"><surname>Burguillos</surname><given-names>MA</given-names></name><name name-style="western"><surname>Herrera</surname><given-names>AJ</given-names></name><name name-style="western"><surname>De Pablos</surname><given-names>RM</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>B</given-names></name><name name-style="western"><surname>Venero</surname><given-names>JL</given-names></name></person-group><article-title>Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism</article-title><source>J Neuroinflammation</source><year>2015</year><volume>12</volume><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s12974-014-0228-x</pub-id><pub-id pub-id-type="pmid">25586882</pub-id><pub-id pub-id-type="pmcid">PMC4302615</pub-id></element-citation></ref><ref id="CR553"><label>553.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fricker</surname><given-names>M</given-names></name><name name-style="western"><surname>Vilalta</surname><given-names>A</given-names></name><name name-style="western"><surname>Tolkovsky</surname><given-names>AM</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GC</given-names></name></person-group><article-title>Caspase inhibitors protect neurons by enabling selective necroptosis of inflamed microglia</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>9145</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.427880</pub-id><pub-id pub-id-type="pmid">23386613</pub-id><pub-id pub-id-type="pmcid">PMC3610987</pub-id></element-citation></ref><ref id="CR554"><label>554.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burguillos</surname><given-names>MA</given-names></name><name name-style="western"><surname>Deierborg</surname><given-names>T</given-names></name><name name-style="western"><surname>Kavanagh</surname><given-names>E</given-names></name><name name-style="western"><surname>Persson</surname><given-names>A</given-names></name><name name-style="western"><surname>Hajji</surname><given-names>N</given-names></name><name name-style="western"><surname>Garcia-Quintanilla</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase signalling controls microglia activation and neurotoxicity</article-title><source>Nature</source><year>2011</year><volume>472</volume><fpage>319</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1038/nature09788</pub-id><pub-id pub-id-type="pmid">21389984</pub-id></element-citation></ref><ref id="CR555"><label>555.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kavanagh</surname><given-names>E</given-names></name><name name-style="western"><surname>Burguillos</surname><given-names>MA</given-names></name><name name-style="western"><surname>Carrillo-Jimenez</surname><given-names>A</given-names></name><name name-style="western"><surname>Oliva-Martin</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>M</given-names></name><name name-style="western"><surname>Rodhe</surname><given-names>J</given-names></name><etal/></person-group><article-title>Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model</article-title><source>Aging</source><year>2015</year><volume>7</volume><fpage>673</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.18632/aging.100805</pub-id><pub-id pub-id-type="pmid">26405176</pub-id><pub-id pub-id-type="pmcid">PMC4600625</pub-id></element-citation></ref><ref id="CR556"><label>556.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Jin</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Shan</surname><given-names>B</given-names></name><name name-style="western"><surname>Geng</surname><given-names>J</given-names></name><etal/></person-group><article-title>Modulating TRADD to restore cellular homeostasis and inhibit apoptosis</article-title><source>Nature</source><year>2020</year><volume>587</volume><fpage>133</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2757-z</pub-id><pub-id pub-id-type="pmid">32968279</pub-id></element-citation></ref><ref id="CR557"><label>557.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Troadec</surname><given-names>JD</given-names></name><name name-style="western"><surname>Hunot</surname><given-names>S</given-names></name><name name-style="western"><surname>Kikly</surname><given-names>K</given-names></name><name name-style="western"><surname>Faucheux</surname><given-names>BA</given-names></name><name name-style="western"><surname>Mouatt-Prigent</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson&#8217;s disease, but pathway inhibition results in neuronal necrosis</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>2247</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-07-02247.2001</pub-id><pub-id pub-id-type="pmid">11264300</pub-id><pub-id pub-id-type="pmcid">PMC6762382</pub-id></element-citation></ref><ref id="CR558"><label>558.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rehker</surname><given-names>J</given-names></name><name name-style="western"><surname>Rodhe</surname><given-names>J</given-names></name><name name-style="western"><surname>Nesbitt</surname><given-names>RR</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>EA</given-names></name><name name-style="western"><surname>Martin</surname><given-names>BK</given-names></name><name name-style="western"><surname>Lord</surname><given-names>J</given-names></name><etal/></person-group><article-title>Caspase-8, association with Alzheimer&#8217;s Disease and functional analysis of rare variants</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><fpage>e0185777</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0185777</pub-id><pub-id pub-id-type="pmid">28985224</pub-id><pub-id pub-id-type="pmcid">PMC5630132</pub-id></element-citation></ref><ref id="CR559"><label>559.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jasmin</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>EH</given-names></name><name name-style="western"><surname>Voutilainen</surname><given-names>MH</given-names></name><name name-style="western"><surname>Fombonne</surname><given-names>J</given-names></name><name name-style="western"><surname>Guix</surname><given-names>C</given-names></name><name name-style="western"><surname>Viljakainen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Netrin-1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson&#8217;s disease features</article-title><source>EMBO J</source><year>2021</year><volume>40</volume><fpage>e105537</fpage><pub-id pub-id-type="doi">10.15252/embj.2020105537</pub-id><pub-id pub-id-type="pmid">33351190</pub-id><pub-id pub-id-type="pmcid">PMC7849168</pub-id></element-citation></ref><ref id="CR560"><label>560.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>WR</given-names></name><name name-style="western"><surname>Fehlings</surname><given-names>MG</given-names></name></person-group><article-title>Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application</article-title><source>Acta Neuropathol</source><year>2011</year><volume>122</volume><fpage>747</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/s00401-011-0882-3</pub-id><pub-id pub-id-type="pmid">22038545</pub-id><pub-id pub-id-type="pmcid">PMC3224722</pub-id></element-citation></ref><ref id="CR561"><label>561.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casha</surname><given-names>S</given-names></name><name name-style="western"><surname>Yu</surname><given-names>WR</given-names></name><name name-style="western"><surname>Fehlings</surname><given-names>MG</given-names></name></person-group><article-title>FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury</article-title><source>Exp Neurol</source><year>2005</year><volume>196</volume><fpage>390</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2005.08.020</pub-id><pub-id pub-id-type="pmid">16202410</pub-id></element-citation></ref><ref id="CR562"><label>562.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demjen</surname><given-names>D</given-names></name><name name-style="western"><surname>Klussmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Kleber</surname><given-names>S</given-names></name><name name-style="western"><surname>Zuliani</surname><given-names>C</given-names></name><name name-style="western"><surname>Stieltjes</surname><given-names>B</given-names></name><name name-style="western"><surname>Metzger</surname><given-names>C</given-names></name><etal/></person-group><article-title>Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>389</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/nm1007</pub-id><pub-id pub-id-type="pmid">15004554</pub-id></element-citation></ref><ref id="CR563"><label>563.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>WR</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Fehlings</surname><given-names>TK</given-names></name><name name-style="western"><surname>Fehlings</surname><given-names>MG</given-names></name></person-group><article-title>Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury</article-title><source>Eur J Neurosci</source><year>2009</year><volume>29</volume><fpage>114</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06555.x</pub-id><pub-id pub-id-type="pmid">19120440</pub-id></element-citation></ref><ref id="CR564"><label>564.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Letellier</surname><given-names>E</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Sancho-Martinez</surname><given-names>I</given-names></name><name name-style="western"><surname>Krauth</surname><given-names>S</given-names></name><name name-style="western"><surname>Funke-Kaiser</surname><given-names>A</given-names></name><name name-style="western"><surname>Laudenklos</surname><given-names>S</given-names></name><etal/></person-group><article-title>CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site</article-title><source>Immunity</source><year>2010</year><volume>32</volume><fpage>240</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.01.011</pub-id><pub-id pub-id-type="pmid">20153221</pub-id></element-citation></ref><ref id="CR565"><label>565.</label><mixed-citation publication-type="other">Ellman DG, Lund MC, Nissen M, Nielsen PS, S&#248;rensen C, Lester EB, et al. Conditional ablation of myeloid TNF improves functional outcome and decreases lesion size after spinal cord injury in mice. Cells. 2020;9.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells9112407</pub-id><pub-id pub-id-type="pmcid">PMC7692197</pub-id><pub-id pub-id-type="pmid">33153044</pub-id></mixed-citation></ref><ref id="CR566"><label>566.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ziebell</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bye</surname><given-names>N</given-names></name><name name-style="western"><surname>Semple</surname><given-names>BD</given-names></name><name name-style="western"><surname>Kossmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Morganti-Kossmann</surname><given-names>MC</given-names></name></person-group><article-title>Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury</article-title><source>Brain Res</source><year>2011</year><volume>1414</volume><fpage>94</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2011.07.056</pub-id><pub-id pub-id-type="pmid">21871613</pub-id></element-citation></ref><ref id="CR567"><label>567.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>WR</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Kiehl</surname><given-names>TR</given-names></name><name name-style="western"><surname>Fehlings</surname><given-names>MG</given-names></name></person-group><article-title>Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy</article-title><source>Brain</source><year>2011</year><volume>134</volume><fpage>1277</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1093/brain/awr054</pub-id><pub-id pub-id-type="pmid">21490053</pub-id></element-citation></ref><ref id="CR568"><label>568.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>You</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HH</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>SK</given-names></name><name name-style="western"><surname>Khuman</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice</article-title><source>J Neurotrauma</source><year>2010</year><volume>27</volume><fpage>1037</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1089/neu.2009.1229</pub-id><pub-id pub-id-type="pmid">20205514</pub-id><pub-id pub-id-type="pmcid">PMC2943499</pub-id></element-citation></ref><ref id="CR569"><label>569.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bermpohl</surname><given-names>D</given-names></name><name name-style="western"><surname>You</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lo</surname><given-names>EH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HH</given-names></name><name name-style="western"><surname>Whalen</surname><given-names>MJ</given-names></name></person-group><article-title>TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice</article-title><source>J Cereb Blood Flow Metab</source><year>2007</year><volume>27</volume><fpage>1806</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600487</pub-id><pub-id pub-id-type="pmid">17406655</pub-id></element-citation></ref><ref id="CR570"><label>570.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longhi</surname><given-names>L</given-names></name><name name-style="western"><surname>Perego</surname><given-names>C</given-names></name><name name-style="western"><surname>Ortolano</surname><given-names>F</given-names></name><name name-style="western"><surname>Aresi</surname><given-names>S</given-names></name><name name-style="western"><surname>Fumagalli</surname><given-names>S</given-names></name><name name-style="western"><surname>Zanier</surname><given-names>ER</given-names></name><etal/></person-group><article-title>Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor</article-title><source>J Cereb Blood Flow Metab</source><year>2013</year><volume>33</volume><fpage>1182</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2013.65</pub-id><pub-id pub-id-type="pmid">23611870</pub-id><pub-id pub-id-type="pmcid">PMC3734767</pub-id></element-citation></ref><ref id="CR571"><label>571.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khuman</surname><given-names>J</given-names></name><name name-style="western"><surname>Meehan</surname><given-names>WP</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>U</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice</article-title><source>J Cereb Blood Flow Metab</source><year>2011</year><volume>31</volume><fpage>778</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2010.172</pub-id><pub-id pub-id-type="pmid">20940727</pub-id><pub-id pub-id-type="pmcid">PMC3049532</pub-id></element-citation></ref><ref id="CR572"><label>572.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quintana</surname><given-names>A</given-names></name><name name-style="western"><surname>Giralt</surname><given-names>M</given-names></name><name name-style="western"><surname>Rojas</surname><given-names>S</given-names></name><name name-style="western"><surname>Penkowa</surname><given-names>M</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>IL</given-names></name><name name-style="western"><surname>Hidalgo</surname><given-names>J</given-names></name><etal/></person-group><article-title>Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury</article-title><source>J Neurosci Res</source><year>2005</year><volume>82</volume><fpage>701</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/jnr.20680</pub-id><pub-id pub-id-type="pmid">16267827</pub-id></element-citation></ref><ref id="CR573"><label>573.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mironets</surname><given-names>E</given-names></name><name name-style="western"><surname>Osei-Owusu</surname><given-names>P</given-names></name><name name-style="western"><surname>Bracchi-Ricard</surname><given-names>V</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>R</given-names></name><name name-style="western"><surname>Owens</surname><given-names>EA</given-names></name><name name-style="western"><surname>Ricard</surname><given-names>J</given-names></name><etal/></person-group><article-title>Soluble TNF&#945; signaling within the spinal cord contributes to the development of autonomic dysreflexia and ensuing vascular and immune dysfunction after spinal cord injury</article-title><source>J Neurosci</source><year>2018</year><volume>38</volume><fpage>4146</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2376-17.2018</pub-id><pub-id pub-id-type="pmid">29610439</pub-id><pub-id pub-id-type="pmcid">PMC5963850</pub-id></element-citation></ref><ref id="CR574"><label>574.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baratz</surname><given-names>R</given-names></name><name name-style="western"><surname>Tweedie</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Rubovitch</surname><given-names>V</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W</given-names></name><name name-style="western"><surname>Hoffer</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Transiently lowering tumor necrosis factor-&#945; synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice</article-title><source>J Neuroinflammation</source><year>2015</year><volume>12</volume><fpage>45</fpage><pub-id pub-id-type="doi">10.1186/s12974-015-0237-4</pub-id><pub-id pub-id-type="pmid">25879458</pub-id><pub-id pub-id-type="pmcid">PMC4352276</pub-id></element-citation></ref><ref id="CR575"><label>575.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>KB</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakajima</surname><given-names>H</given-names></name><name name-style="western"><surname>Yayama</surname><given-names>T</given-names></name><name name-style="western"><surname>Hirai</surname><given-names>T</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-&#945; antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury</article-title><source>Spine</source><year>2011</year><volume>36</volume><fpage>1350</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/BRS.0b013e3181f014ec</pub-id><pub-id pub-id-type="pmid">21224756</pub-id></element-citation></ref><ref id="CR576"><label>576.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>ML</given-names></name><name name-style="western"><surname>Mironets</surname><given-names>E</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>TM</given-names></name><name name-style="western"><surname>Crowther</surname><given-names>K</given-names></name><name name-style="western"><surname>Collyer</surname><given-names>E</given-names></name><name name-style="western"><surname>Bethea</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Pharmacological inhibition of soluble tumor necrosis factor-alpha two weeks after high thoracic spinal cord injury does not affect sympathetic hyperreflexia</article-title><source>J Neurotrauma</source><year>2021</year><volume>38</volume><fpage>2186</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1089/neu.2020.7504</pub-id><pub-id pub-id-type="pmid">33397170</pub-id><pub-id pub-id-type="pmcid">PMC8309421</pub-id></element-citation></ref><ref id="CR577"><label>577.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellman</surname><given-names>DG</given-names></name><name name-style="western"><surname>Degn</surname><given-names>M</given-names></name><name name-style="western"><surname>Lund</surname><given-names>MC</given-names></name><name name-style="western"><surname>Clausen</surname><given-names>BH</given-names></name><name name-style="western"><surname>Novrup</surname><given-names>HG</given-names></name><name name-style="western"><surname>Fl&#230;ng</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Genetic ablation of soluble TNF does not affect lesion size and functional recovery after moderate spinal cord injury in mice</article-title><source>Mediators Inflamm</source><year>2016</year><volume>2016</volume><fpage>2684098</fpage><pub-id pub-id-type="doi">10.1155/2016/2684098</pub-id><pub-id pub-id-type="pmid">28070141</pub-id><pub-id pub-id-type="pmcid">PMC5192339</pub-id></element-citation></ref><ref id="CR578"><label>578.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oshima</surname><given-names>T</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Sato</surname><given-names>A</given-names></name><name name-style="western"><surname>Oda</surname><given-names>S</given-names></name><name name-style="western"><surname>Hirasawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>T</given-names></name></person-group><article-title>TNF-alpha contributes to axonal sprouting and functional recovery following traumatic brain injury</article-title><source>Brain Res</source><year>2009</year><volume>1290</volume><fpage>102</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2009.07.022</pub-id><pub-id pub-id-type="pmid">19616519</pub-id></element-citation></ref><ref id="CR579"><label>579.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>GM</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Song</surname><given-names>SK</given-names></name><name name-style="western"><surname>Yan</surname><given-names>P</given-names></name><name name-style="western"><surname>Ku</surname><given-names>G</given-names></name><etal/></person-group><article-title>Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>6617</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-17-06617.2001</pub-id><pub-id pub-id-type="pmid">11517251</pub-id><pub-id pub-id-type="pmcid">PMC6763083</pub-id></element-citation></ref><ref id="CR580"><label>580.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scherbel</surname><given-names>U</given-names></name><name name-style="western"><surname>Raghupathi</surname><given-names>R</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>M</given-names></name><name name-style="western"><surname>Saatman</surname><given-names>KE</given-names></name><name name-style="western"><surname>Trojanowski</surname><given-names>JQ</given-names></name><name name-style="western"><surname>Neugebauer</surname><given-names>E</given-names></name><etal/></person-group><article-title>Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>8721</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.15.8721</pub-id><pub-id pub-id-type="pmid">10411942</pub-id><pub-id pub-id-type="pmcid">PMC17583</pub-id></element-citation></ref><ref id="CR581"><label>581.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantarella</surname><given-names>G</given-names></name><name name-style="western"><surname>Di Benedetto</surname><given-names>G</given-names></name><name name-style="western"><surname>Scollo</surname><given-names>M</given-names></name><name name-style="western"><surname>Paterniti</surname><given-names>I</given-names></name><name name-style="western"><surname>Cuzzocrea</surname><given-names>S</given-names></name><name name-style="western"><surname>Bosco</surname><given-names>P</given-names></name><etal/></person-group><article-title>Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice</article-title><source>Neuropsychopharmacol</source><year>2010</year><volume>35</volume><fpage>1302</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.234</pub-id><pub-id pub-id-type="pmcid">PMC3055339</pub-id><pub-id pub-id-type="pmid">20107429</pub-id></element-citation></ref><ref id="CR582"><label>582.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Mei</surname><given-names>S</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><etal/></person-group><article-title>HIF-1&#945; mediates TRAIL-Induced Neuronal Apoptosis via regulating DcR1 expression following traumatic brain injury</article-title><source>Front Cell Neurosci</source><year>2020</year><volume>14</volume><fpage>192</fpage><pub-id pub-id-type="doi">10.3389/fncel.2020.00192</pub-id><pub-id pub-id-type="pmid">32848609</pub-id><pub-id pub-id-type="pmcid">PMC7416670</pub-id></element-citation></ref><ref id="CR583"><label>583.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sobrido-Came&#225;n</surname><given-names>D</given-names></name><name name-style="western"><surname>Barreiro-Iglesias</surname><given-names>A</given-names></name></person-group><article-title>Role of Caspase-8 and Fas in cell death after spinal cord injury</article-title><source>Front Mol Neurosci</source><year>2018</year><volume>11</volume><fpage>101</fpage><pub-id pub-id-type="doi">10.3389/fnmol.2018.00101</pub-id><pub-id pub-id-type="pmid">29666570</pub-id><pub-id pub-id-type="pmcid">PMC5891576</pub-id></element-citation></ref><ref id="CR584"><label>584.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>TC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Thuret</surname><given-names>S</given-names></name><name name-style="western"><surname>Vilar</surname><given-names>M</given-names></name><name name-style="western"><surname>Gage</surname><given-names>FH</given-names></name><name name-style="western"><surname>Riek</surname><given-names>R</given-names></name><etal/></person-group><article-title>P45 forms a complex with FADD and promotes neuronal cell survival following spinal cord injury</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e69286</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0069286</pub-id><pub-id pub-id-type="pmid">23935974</pub-id><pub-id pub-id-type="pmcid">PMC3720591</pub-id></element-citation></ref><ref id="CR585"><label>585.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krajewska</surname><given-names>M</given-names></name><name name-style="western"><surname>You</surname><given-names>Z</given-names></name><name name-style="western"><surname>Rong</surname><given-names>J</given-names></name><name name-style="western"><surname>Kress</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e24341</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0024341</pub-id><pub-id pub-id-type="pmid">21957448</pub-id><pub-id pub-id-type="pmcid">PMC3174961</pub-id></element-citation></ref><ref id="CR586"><label>586.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugolini</surname><given-names>G</given-names></name><name name-style="western"><surname>Raoul</surname><given-names>C</given-names></name><name name-style="western"><surname>Ferri</surname><given-names>A</given-names></name><name name-style="western"><surname>Haenggeli</surname><given-names>C</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sala&#252;n</surname><given-names>D</given-names></name><etal/></person-group><article-title>Fas/tumor necrosis factor receptor death signaling is required for axotomy-induced death of motoneurons in vivo</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>8526</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-24-08526.2003</pub-id><pub-id pub-id-type="pmid">13679421</pub-id><pub-id pub-id-type="pmcid">PMC6740362</pub-id></element-citation></ref><ref id="CR587"><label>587.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monnier</surname><given-names>PP</given-names></name><name name-style="western"><surname>D&#8217;Onofrio</surname><given-names>PM</given-names></name><name name-style="western"><surname>Magharious</surname><given-names>M</given-names></name><name name-style="western"><surname>Hollander</surname><given-names>AC</given-names></name><name name-style="western"><surname>Tassew</surname><given-names>N</given-names></name><name name-style="western"><surname>Szydlowska</surname><given-names>K</given-names></name><etal/></person-group><article-title>Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>10494</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0148-11.2011</pub-id><pub-id pub-id-type="pmid">21775595</pub-id><pub-id pub-id-type="pmcid">PMC6622648</pub-id></element-citation></ref><ref id="CR588"><label>588.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tezel</surname><given-names>G</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wax</surname><given-names>MB</given-names></name></person-group><article-title>Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice</article-title><source>Brain Res</source><year>2004</year><volume>996</volume><fpage>202</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2003.10.029</pub-id><pub-id pub-id-type="pmid">14697498</pub-id></element-citation></ref><ref id="CR589"><label>589.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontaine</surname><given-names>V</given-names></name><name name-style="western"><surname>Mohand-Said</surname><given-names>S</given-names></name><name name-style="western"><surname>Hanoteau</surname><given-names>N</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>C</given-names></name><name name-style="western"><surname>Pfizenmaier</surname><given-names>K</given-names></name><name name-style="western"><surname>Eisel</surname><given-names>U</given-names></name></person-group><article-title>Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>Rc216</fpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-07-j0001.2002</pub-id><pub-id pub-id-type="pmid">11917000</pub-id><pub-id pub-id-type="pmcid">PMC6758303</pub-id></element-citation></ref><ref id="CR590"><label>590.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakazawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakazawa</surname><given-names>C</given-names></name><name name-style="western"><surname>Matsubara</surname><given-names>A</given-names></name><name name-style="western"><surname>Noda</surname><given-names>K</given-names></name><name name-style="western"><surname>Hisatomi</surname><given-names>T</given-names></name><name name-style="western"><surname>She</surname><given-names>H</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>12633</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2801-06.2006</pub-id><pub-id pub-id-type="pmid">17151265</pub-id><pub-id pub-id-type="pmcid">PMC6674838</pub-id></element-citation></ref><ref id="CR591"><label>591.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnan</surname><given-names>A</given-names></name><name name-style="western"><surname>Kocab</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Zacks</surname><given-names>DN</given-names></name><name name-style="western"><surname>Marshak-Rothstein</surname><given-names>A</given-names></name><name name-style="western"><surname>Gregory-Ksander</surname><given-names>M</given-names></name></person-group><article-title>A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma</article-title><source>J Neuroinflammation</source><year>2019</year><volume>16</volume><fpage>184</fpage><pub-id pub-id-type="doi">10.1186/s12974-019-1576-3</pub-id><pub-id pub-id-type="pmid">31570110</pub-id><pub-id pub-id-type="pmcid">PMC6767653</pub-id></element-citation></ref><ref id="CR592"><label>592.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cueva Vargas</surname><given-names>JL</given-names></name><name name-style="western"><surname>Osswald</surname><given-names>IK</given-names></name><name name-style="western"><surname>Unsain</surname><given-names>N</given-names></name><name name-style="western"><surname>Aurousseau</surname><given-names>MR</given-names></name><name name-style="western"><surname>Barker</surname><given-names>PA</given-names></name><name name-style="western"><surname>Bowie</surname><given-names>D</given-names></name><etal/></person-group><article-title>Soluble tumor necrosis factor alpha promotes retinal ganglion cell death in glaucoma via calcium-permeable AMPA receptor activation</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><fpage>12088</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1273-15.2015</pub-id><pub-id pub-id-type="pmid">26338321</pub-id><pub-id pub-id-type="pmcid">PMC6605307</pub-id></element-citation></ref><ref id="CR593"><label>593.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roh</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Thanos</surname><given-names>A</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SC</given-names></name><name name-style="western"><surname>Vavvas</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Etanercept, a widely used inhibitor of tumor necrosis factor-&#945; (TNF-&#945;), prevents retinal ganglion cell loss in a rat model of glaucoma</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e40065</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0040065</pub-id><pub-id pub-id-type="pmid">22802951</pub-id><pub-id pub-id-type="pmcid">PMC3388998</pub-id></element-citation></ref><ref id="CR594"><label>594.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tezel</surname><given-names>G</given-names></name></person-group><article-title>Regulation of distinct caspase-8 functions in retinal ganglion cells and astroglia in experimental glaucoma</article-title><source>Neurobiol Dis</source><year>2021</year><volume>150</volume><fpage>105258</fpage><pub-id pub-id-type="doi">10.1016/j.nbd.2021.105258</pub-id><pub-id pub-id-type="pmid">33434617</pub-id><pub-id pub-id-type="pmcid">PMC10294121</pub-id></element-citation></ref><ref id="CR595"><label>595.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tisch</surname><given-names>N</given-names></name><name name-style="western"><surname>Freire-Valls</surname><given-names>A</given-names></name><name name-style="western"><surname>Yerbes</surname><given-names>R</given-names></name><name name-style="western"><surname>Paredes</surname><given-names>I</given-names></name><name name-style="western"><surname>La Porta</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Caspase-8 modulates physiological and pathological angiogenesis during retina development</article-title><source>J Clin Investig</source><year>2019</year><volume>129</volume><fpage>5092</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1172/JCI122767</pub-id><pub-id pub-id-type="pmid">31454332</pub-id><pub-id pub-id-type="pmcid">PMC6877326</pub-id></element-citation></ref><ref id="CR596"><label>596.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Ben-Moshe</surname><given-names>T</given-names></name><name name-style="western"><surname>Varfolomeev</surname><given-names>EE</given-names></name><name name-style="western"><surname>Pewzner-Jung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yogev</surname><given-names>N</given-names></name><name name-style="western"><surname>Jurewicz</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-8 serves both apoptotic and nonapoptotic roles</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><fpage>2976</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.5.2976</pub-id><pub-id pub-id-type="pmid">15322156</pub-id></element-citation></ref><ref id="CR597"><label>597.</label><mixed-citation publication-type="other">Tian Y, Li H, Liu X, Xie L, Huang Z, Li W, et al. Pharmacological inhibition of caspase-8 suppresses inflammation-induced angiogenesis in the cornea. Biomolecules. 2020;10:210.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom10020210</pub-id><pub-id pub-id-type="pmcid">PMC7072631</pub-id><pub-id pub-id-type="pmid">32023953</pub-id></mixed-citation></ref><ref id="CR598"><label>598.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgaletto</surname><given-names>C</given-names></name><name name-style="western"><surname>Platania</surname><given-names>CBM</given-names></name><name name-style="western"><surname>Di Benedetto</surname><given-names>G</given-names></name><name name-style="western"><surname>Munaf&#242;</surname><given-names>A</given-names></name><name name-style="western"><surname>Giurdanella</surname><given-names>G</given-names></name><name name-style="western"><surname>Federico</surname><given-names>C</given-names></name><etal/></person-group><article-title>Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer&#8217;s disease</article-title><source>Cell Death Dis</source><year>2021</year><volume>12</volume><fpage>905</fpage><pub-id pub-id-type="doi">10.1038/s41419-021-04165-x</pub-id><pub-id pub-id-type="pmid">34611142</pub-id><pub-id pub-id-type="pmcid">PMC8492692</pub-id></element-citation></ref><ref id="CR599"><label>599.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>HL</given-names></name><name name-style="western"><surname>Li</surname><given-names>XX</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YT</given-names></name><name name-style="western"><surname>Yu</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lao</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Neuronal soluble fas ligand drives M1-microglia polarization after cerebral ischemia</article-title><source>CNS Neurosci Ther</source><year>2016</year><volume>22</volume><fpage>771</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1111/cns.12575</pub-id><pub-id pub-id-type="pmid">27283206</pub-id><pub-id pub-id-type="pmcid">PMC6492913</pub-id></element-citation></ref><ref id="CR600"><label>600.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>FN</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>XM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Chang</surname><given-names>LL</given-names></name><name name-style="western"><surname>Li</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke</article-title><source>Brain Behav Immun</source><year>2012</year><volume>26</volume><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2011.07.235</pub-id><pub-id pub-id-type="pmid">21802508</pub-id></element-citation></ref><ref id="CR601"><label>601.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin-Villalba</surname><given-names>A</given-names></name><name name-style="western"><surname>Herr</surname><given-names>I</given-names></name><name name-style="western"><surname>Jeremias</surname><given-names>I</given-names></name><name name-style="western"><surname>Hahne</surname><given-names>M</given-names></name><name name-style="western"><surname>Brandt</surname><given-names>R</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>J</given-names></name><etal/></person-group><article-title>CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons</article-title><source>J Neurosci</source><year>1999</year><volume>19</volume><fpage>3809</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-10-03809.1999</pub-id><pub-id pub-id-type="pmid">10234013</pub-id><pub-id pub-id-type="pmcid">PMC6782733</pub-id></element-citation></ref><ref id="CR602"><label>602.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>EM</given-names></name><name name-style="western"><surname>Sheldon</surname><given-names>RA</given-names></name><name name-style="western"><surname>Flock</surname><given-names>DL</given-names></name><name name-style="western"><surname>Ferriero</surname><given-names>DM</given-names></name><name name-style="western"><surname>Martin</surname><given-names>LJ</given-names></name><name name-style="western"><surname>O&#8217;Riordan</surname><given-names>DP</given-names></name><etal/></person-group><article-title>Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury</article-title><source>Neurobiol Dis</source><year>2004</year><volume>17</volume><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2004.05.007</pub-id><pub-id pub-id-type="pmid">15350969</pub-id></element-citation></ref><ref id="CR603"><label>603.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dzietko</surname><given-names>M</given-names></name><name name-style="western"><surname>Boos</surname><given-names>V</given-names></name><name name-style="western"><surname>Sifringer</surname><given-names>M</given-names></name><name name-style="western"><surname>Polley</surname><given-names>O</given-names></name><name name-style="western"><surname>Gerstner</surname><given-names>B</given-names></name><name name-style="western"><surname>Genz</surname><given-names>K</given-names></name><etal/></person-group><article-title>A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury</article-title><source>Ann Neurol</source><year>2008</year><volume>64</volume><fpage>664</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1002/ana.21516</pub-id><pub-id pub-id-type="pmid">19107989</pub-id></element-citation></ref><ref id="CR604"><label>604.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ullah</surname><given-names>I</given-names></name><name name-style="western"><surname>Chung</surname><given-names>K</given-names></name><name name-style="western"><surname>Oh</surname><given-names>J</given-names></name><name name-style="western"><surname>Beloor</surname><given-names>J</given-names></name><name name-style="western"><surname>Bae</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>15041</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-33296-z</pub-id><pub-id pub-id-type="pmid">30301943</pub-id><pub-id pub-id-type="pmcid">PMC6178348</pub-id></element-citation></ref><ref id="CR605"><label>605.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin-Villalba</surname><given-names>A</given-names></name><name name-style="western"><surname>Hahne</surname><given-names>M</given-names></name><name name-style="western"><surname>Kleber</surname><given-names>S</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>J</given-names></name><name name-style="western"><surname>Falk</surname><given-names>W</given-names></name><name name-style="western"><surname>Schenkel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke</article-title><source>Cell Death Differ</source><year>2001</year><volume>8</volume><fpage>679</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400882</pub-id><pub-id pub-id-type="pmid">11464212</pub-id></element-citation></ref><ref id="CR606"><label>606.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Jin</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Ren</surname><given-names>C</given-names></name></person-group><article-title>Remote limb preconditioning generates a neuroprotective effect by modulating the extrinsic apoptotic pathway and TRAIL-receptors expression</article-title><source>Cell Mol Neurobiol</source><year>2017</year><volume>37</volume><fpage>169</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/s10571-016-0360-5</pub-id><pub-id pub-id-type="pmid">26971954</pub-id><pub-id pub-id-type="pmcid">PMC11482232</pub-id></element-citation></ref><ref id="CR607"><label>607.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Liang</surname><given-names>X</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia</article-title><source>Neurobiol Dis</source><year>2010</year><volume>39</volume><fpage>138</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2010.03.018</pub-id><pub-id pub-id-type="pmid">20359534</pub-id></element-citation></ref><ref id="CR608"><label>608.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clausen</surname><given-names>BH</given-names></name><name name-style="western"><surname>Degn</surname><given-names>M</given-names></name><name name-style="western"><surname>Sivasaravanaparan</surname><given-names>M</given-names></name><name name-style="western"><surname>Fogtmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>MG</given-names></name><name name-style="western"><surname>Trojanowsky</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>29291</fpage><pub-id pub-id-type="doi">10.1038/srep29291</pub-id><pub-id pub-id-type="pmid">27384243</pub-id><pub-id pub-id-type="pmcid">PMC4935869</pub-id></element-citation></ref><ref id="CR609"><label>609.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambertsen</surname><given-names>KL</given-names></name><name name-style="western"><surname>Clausen</surname><given-names>BH</given-names></name><name name-style="western"><surname>Babcock</surname><given-names>AA</given-names></name><name name-style="western"><surname>Gregersen</surname><given-names>R</given-names></name><name name-style="western"><surname>Fenger</surname><given-names>C</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Microglia protect neurons against ischemia by synthesis of tumor necrosis factor</article-title><source>J Neurosci</source><year>2009</year><volume>29</volume><fpage>1319</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5505-08.2009</pub-id><pub-id pub-id-type="pmid">19193879</pub-id><pub-id pub-id-type="pmcid">PMC6666095</pub-id></element-citation></ref><ref id="CR610"><label>610.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murakami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Saito</surname><given-names>K</given-names></name><name name-style="western"><surname>Hara</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sudo</surname><given-names>K</given-names></name><name name-style="western"><surname>Niwa</surname><given-names>M</given-names></name><etal/></person-group><article-title>Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus</article-title><source>J Neurochem</source><year>2005</year><volume>93</volume><fpage>1616</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03163.x</pub-id><pub-id pub-id-type="pmid">15935078</pub-id></element-citation></ref><ref id="CR611"><label>611.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruce</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Boling</surname><given-names>W</given-names></name><name name-style="western"><surname>Kindy</surname><given-names>MS</given-names></name><name name-style="western"><surname>Peschon</surname><given-names>J</given-names></name><name name-style="western"><surname>Kraemer</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Carpenter</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><fpage>788</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/nm0796-788</pub-id><pub-id pub-id-type="pmid">8673925</pub-id></element-citation></ref><ref id="CR612"><label>612.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>B</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>HN</given-names></name><name name-style="western"><surname>Roulhac-Wilson</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Laskowitz</surname><given-names>DT</given-names></name><name name-style="western"><surname>James</surname><given-names>ML</given-names></name></person-group><article-title>Tumor necrosis factor &#945; antagonism improves neurological recovery in murine intracerebral hemorrhage</article-title><source>J Neuroinflamm</source><year>2013</year><volume>10</volume><fpage>103</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-10-103</pub-id><pub-id pub-id-type="pmcid">PMC3765285</pub-id><pub-id pub-id-type="pmid">23962089</pub-id></element-citation></ref><ref id="CR613"><label>613.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yli-Karjanmaa</surname><given-names>M</given-names></name><name name-style="western"><surname>Clausen</surname><given-names>BH</given-names></name><name name-style="western"><surname>Degn</surname><given-names>M</given-names></name><name name-style="western"><surname>Novrup</surname><given-names>HG</given-names></name><name name-style="western"><surname>Ellman</surname><given-names>DG</given-names></name><name name-style="western"><surname>Toft-Jensen</surname><given-names>P</given-names></name><etal/></person-group><article-title>Topical administration of a soluble TNF inhibitor reduces infarct volume after focal cerebral ischemia in mice</article-title><source>Front Neurosci</source><year>2019</year><volume>13</volume><fpage>781</fpage><pub-id pub-id-type="doi">10.3389/fnins.2019.00781</pub-id><pub-id pub-id-type="pmid">31440125</pub-id><pub-id pub-id-type="pmcid">PMC6692878</pub-id></element-citation></ref><ref id="CR614"><label>614.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madsen</surname><given-names>PM</given-names></name><name name-style="western"><surname>Clausen</surname><given-names>BH</given-names></name><name name-style="western"><surname>Degn</surname><given-names>M</given-names></name><name name-style="western"><surname>Thyssen</surname><given-names>S</given-names></name><name name-style="western"><surname>Kristensen</surname><given-names>LK</given-names></name><name name-style="western"><surname>Svensson</surname><given-names>M</given-names></name><etal/></person-group><article-title>Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia</article-title><source>J Cereb Blood Flow Metab</source><year>2016</year><volume>36</volume><fpage>1553</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1177/0271678X15610339</pub-id><pub-id pub-id-type="pmid">26661199</pub-id><pub-id pub-id-type="pmcid">PMC5012516</pub-id></element-citation></ref><ref id="CR615"><label>615.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>MH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Chio</surname><given-names>CC</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CP</given-names></name><name name-style="western"><surname>Lin</surname><given-names>NK</given-names></name><etal/></person-group><article-title>Inhibition of peripheral TNF-&#945; and downregulation of microglial activation by alpha-lipoic acid and etanercept protect rat brain against ischemic stroke</article-title><source>Mol Neurobiol</source><year>2016</year><volume>53</volume><fpage>4961</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1007/s12035-015-9418-5</pub-id><pub-id pub-id-type="pmid">26374550</pub-id></element-citation></ref><ref id="CR616"><label>616.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clausen</surname><given-names>BH</given-names></name><name name-style="western"><surname>Degn</surname><given-names>M</given-names></name><name name-style="western"><surname>Martin</surname><given-names>NA</given-names></name><name name-style="western"><surname>Couch</surname><given-names>Y</given-names></name><name name-style="western"><surname>Karimi</surname><given-names>L</given-names></name><name name-style="western"><surname>Ormh&#248;j</surname><given-names>M</given-names></name><etal/></person-group><article-title>Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia</article-title><source>J Neuroinflammation</source><year>2014</year><volume>11</volume><fpage>203</fpage><pub-id pub-id-type="doi">10.1186/s12974-014-0203-6</pub-id><pub-id pub-id-type="pmid">25498129</pub-id><pub-id pub-id-type="pmcid">PMC4272527</pub-id></element-citation></ref><ref id="CR617"><label>617.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arango-D&#225;vila</surname><given-names>CA</given-names></name><name name-style="western"><surname>Vera</surname><given-names>A</given-names></name><name name-style="western"><surname>Londo&#241;o</surname><given-names>AC</given-names></name><name name-style="western"><surname>Echeverri</surname><given-names>AF</given-names></name><name name-style="western"><surname>Ca&#241;as</surname><given-names>F</given-names></name><name name-style="western"><surname>Cardozo</surname><given-names>CF</given-names></name><etal/></person-group><article-title>Soluble or soluble/membrane TNF-&#945; inhibitors protect the brain from focal ischemic injury in rats</article-title><source>Int J Neurosci</source><year>2015</year><volume>125</volume><fpage>936</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.3109/00207454.2014.980906</pub-id><pub-id pub-id-type="pmid">25350870</pub-id></element-citation></ref><ref id="CR618"><label>618.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>YM</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lou</surname><given-names>XF</given-names></name><name name-style="western"><surname>Liao</surname><given-names>MH</given-names></name><name name-style="western"><surname>Hong</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles</article-title><source>Biomaterials</source><year>2014</year><volume>35</volume><fpage>530</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.09.093</pub-id><pub-id pub-id-type="pmid">24120040</pub-id></element-citation></ref><ref id="CR619"><label>619.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nawashiro</surname><given-names>H</given-names></name><name name-style="western"><surname>Tasaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Ruetzler</surname><given-names>CA</given-names></name><name name-style="western"><surname>Hallenbeck</surname><given-names>JM</given-names></name></person-group><article-title>TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice</article-title><source>J Cereb Blood Flow Metab</source><year>1997</year><volume>17</volume><fpage>483</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1097/00004647-199705000-00001</pub-id><pub-id pub-id-type="pmid">9183285</pub-id></element-citation></ref><ref id="CR620"><label>620.</label><mixed-citation publication-type="other">Kanazawa T, Kurano T, Ibaraki H, Takashima Y, Suzuki T, Seta Y. Therapeutic effects in a transient middle cerebral artery occlusion rat model by nose-to-brain delivery of anti-TNF-alpha siRNA with cell-penetrating peptide-modified polymer micelles. Pharmaceutics. 2019;11:478.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pharmaceutics11090478</pub-id><pub-id pub-id-type="pmcid">PMC6781507</pub-id><pub-id pub-id-type="pmid">31540164</pub-id></mixed-citation></ref><ref id="CR621"><label>621.</label><mixed-citation publication-type="other">Lin SY, Wang YY, Chang CY, Wu CC, Chen WY, Liao SL, et al. TNF-&#945; receptor inhibitor alleviates metabolic and inflammatory changes in a rat model of ischemic stroke. Antioxidants. 2021;10:851.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antiox10060851</pub-id><pub-id pub-id-type="pmcid">PMC8228519</pub-id><pub-id pub-id-type="pmid">34073455</pub-id></mixed-citation></ref><ref id="CR622"><label>622.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiaohong</surname><given-names>W</given-names></name><name name-style="western"><surname>Jun</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hongmei</surname><given-names>G</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Q</given-names></name></person-group><article-title>CFLAR is a critical regulator of cerebral ischaemia-reperfusion injury through regulating inflammation and endoplasmic reticulum (ER) stress</article-title><source>Biomed Pharmacother</source><year>2019</year><volume>117</volume><fpage>109155</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2019.109155</pub-id><pub-id pub-id-type="pmid">31387178</pub-id></element-citation></ref><ref id="CR623"><label>623.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taoufik</surname><given-names>E</given-names></name><name name-style="western"><surname>Valable</surname><given-names>S</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>ML</given-names></name><name name-style="western"><surname>Divoux</surname><given-names>D</given-names></name><name name-style="western"><surname>Tinel</surname><given-names>A</given-names></name><etal/></person-group><article-title>FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>6633</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1091-07.2007</pub-id><pub-id pub-id-type="pmid">17581950</pub-id><pub-id pub-id-type="pmcid">PMC6672692</pub-id></element-citation></ref><ref id="CR624"><label>624.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>DQ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Li</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H</given-names></name></person-group><article-title>Target inhibition of caspase-8 alleviates brain damage after subarachnoid hemorrhage</article-title><source>Neural Regen Res</source><year>2020</year><volume>15</volume><fpage>1283</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4103/1673-5374.272613</pub-id><pub-id pub-id-type="pmid">31960814</pub-id><pub-id pub-id-type="pmcid">PMC7047790</pub-id></element-citation></ref><ref id="CR625"><label>625.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shabanzadeh</surname><given-names>AP</given-names></name><name name-style="western"><surname>D&#8217;Onofrio</surname><given-names>PM</given-names></name><name name-style="western"><surname>Monnier</surname><given-names>PP</given-names></name><name name-style="western"><surname>Koeberle</surname><given-names>PD</given-names></name></person-group><article-title>Targeting caspase-6 and caspase-8 to promote neuronal survival following ischemic stroke</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1967</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.272</pub-id><pub-id pub-id-type="pmid">26539914</pub-id><pub-id pub-id-type="pmcid">PMC4670918</pub-id></element-citation></ref><ref id="CR626"><label>626.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>S</given-names></name><name name-style="western"><surname>Davis</surname><given-names>DP</given-names></name><name name-style="western"><surname>Drummond</surname><given-names>JC</given-names></name><name name-style="western"><surname>Cole</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Patel</surname><given-names>PM</given-names></name></person-group><article-title>The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia</article-title><source>Anesth Analg</source><year>2006</year><volume>102</volume><fpage>1548</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1213/01.ane.0000202381.40516.8d</pub-id><pub-id pub-id-type="pmid">16632840</pub-id></element-citation></ref><ref id="CR627"><label>627.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muhammad</surname><given-names>IF</given-names></name><name name-style="western"><surname>Born&#233;</surname><given-names>Y</given-names></name><name name-style="western"><surname>Melander</surname><given-names>O</given-names></name><name name-style="western"><surname>Orho-Melander</surname><given-names>M</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>J</given-names></name><name name-style="western"><surname>S&#246;derholm</surname><given-names>M</given-names></name><etal/></person-group><article-title>FADD (Fas-associated protein with death domain), caspase-3, and caspase-8 and incidence of ischemic stroke</article-title><source>Stroke</source><year>2018</year><volume>49</volume><fpage>2224</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.118.022063</pub-id><pub-id pub-id-type="pmid">30354994</pub-id></element-citation></ref><ref id="CR628"><label>628.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodhe</surname><given-names>J</given-names></name><name name-style="western"><surname>Burguillos</surname><given-names>MA</given-names></name><name name-style="western"><surname>de Pablos</surname><given-names>RM</given-names></name><name name-style="western"><surname>Kavanagh</surname><given-names>E</given-names></name><name name-style="western"><surname>Persson</surname><given-names>A</given-names></name><name name-style="western"><surname>Englund</surname><given-names>E</given-names></name><etal/></person-group><article-title>Spatio-temporal activation of caspase-8 in myeloid cells upon ischemic stroke</article-title><source>Acta Neuropathol Commun</source><year>2016</year><volume>4</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.1186/s40478-016-0365-9</pub-id><pub-id pub-id-type="pmid">27566702</pub-id><pub-id pub-id-type="pmcid">PMC5002214</pub-id></element-citation></ref><ref id="CR629"><label>629.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taoufik</surname><given-names>E</given-names></name><name name-style="western"><surname>Petit</surname><given-names>E</given-names></name><name name-style="western"><surname>Divoux</surname><given-names>D</given-names></name><name name-style="western"><surname>Tseveleki</surname><given-names>V</given-names></name><name name-style="western"><surname>Mengozzi</surname><given-names>M</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>ML</given-names></name><etal/></person-group><article-title>TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>6185</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1073/pnas.0801447105</pub-id><pub-id pub-id-type="pmid">18413601</pub-id><pub-id pub-id-type="pmcid">PMC2299225</pub-id></element-citation></ref><ref id="CR630"><label>630.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>MO</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XM</given-names></name><name name-style="western"><surname>Mix</surname><given-names>E</given-names></name><name name-style="western"><surname>Quezada</surname><given-names>HC</given-names></name><name name-style="western"><surname>Jin</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>TNF-alpha receptor 1 deficiency enhances kainic acid-induced hippocampal injury in mice</article-title><source>J Neurosci Res</source><year>2008</year><volume>86</volume><fpage>1608</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/jnr.21600</pub-id><pub-id pub-id-type="pmid">18189316</pub-id></element-citation></ref><ref id="CR631"><label>631.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balosso</surname><given-names>S</given-names></name><name name-style="western"><surname>Ravizza</surname><given-names>T</given-names></name><name name-style="western"><surname>Perego</surname><given-names>C</given-names></name><name name-style="western"><surname>Peschon</surname><given-names>J</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>IL</given-names></name><name name-style="western"><surname>De Simoni</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors</article-title><source>Ann Neurol</source><year>2005</year><volume>57</volume><fpage>804</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1002/ana.20480</pub-id><pub-id pub-id-type="pmid">15852477</pub-id></element-citation></ref><ref id="CR632"><label>632.</label><mixed-citation publication-type="other">Patel DC, Wallis G, Dahle EJ, McElroy PB, Thomson KE, Tesi RJ, et al. Hippocampal TNF&#945; signaling contributes to seizure generation in an infection-induced mouse model of limbic epilepsy. eNeuro. 2017;4:ENEURO.0105-17.2017.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/ENEURO.0105-17.2017</pub-id><pub-id pub-id-type="pmcid">PMC5422919</pub-id><pub-id pub-id-type="pmid">28497109</pub-id></mixed-citation></ref><ref id="CR633"><label>633.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchetti</surname><given-names>L</given-names></name><name name-style="western"><surname>Klein</surname><given-names>M</given-names></name><name name-style="western"><surname>Schlett</surname><given-names>K</given-names></name><name name-style="western"><surname>Pfizenmaier</surname><given-names>K</given-names></name><name name-style="western"><surname>Eisel</surname><given-names>UL</given-names></name></person-group><article-title>Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>32869</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1074/jbc.M311766200</pub-id><pub-id pub-id-type="pmid">15155767</pub-id></element-citation></ref><ref id="CR634"><label>634.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>C</given-names></name><name name-style="western"><surname>Gary</surname><given-names>D</given-names></name><name name-style="western"><surname>Mattson</surname><given-names>M</given-names></name><name name-style="western"><surname>Mackenzie</surname><given-names>A</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>GS</given-names></name></person-group><article-title>Kainic acid-induced naip expression in the hippocampus is blocked in mice lacking TNF receptors</article-title><source>Brain Res Mol Brain Res</source><year>2004</year><volume>123</volume><fpage>126</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.molbrainres.2004.01.009</pub-id><pub-id pub-id-type="pmid">15046874</pub-id></element-citation></ref><ref id="CR635"><label>635.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XM</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>XY</given-names></name><name name-style="western"><surname>Sharkawi</surname><given-names>SS</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Amir</surname><given-names>N</given-names></name><name name-style="western"><surname>Azimullah</surname><given-names>S</given-names></name><etal/></person-group><article-title>Possible protecting role of TNF-&#945; in kainic acid-induced neurotoxicity via down-regulation of NF&#954;B signaling pathway</article-title><source>Curr Alzheimer Res</source><year>2013</year><volume>10</volume><fpage>660</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2174/15672050113109990007</pub-id><pub-id pub-id-type="pmid">23627756</pub-id></element-citation></ref><ref id="CR636"><label>636.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolga</surname><given-names>AM</given-names></name><name name-style="western"><surname>Granic</surname><given-names>I</given-names></name><name name-style="western"><surname>Blank</surname><given-names>T</given-names></name><name name-style="western"><surname>Knaus</surname><given-names>HG</given-names></name><name name-style="western"><surname>Spiess</surname><given-names>J</given-names></name><name name-style="western"><surname>Luiten</surname><given-names>PG</given-names></name><etal/></person-group><article-title>TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels</article-title><source>J Neurochem</source><year>2008</year><volume>107</volume><fpage>1158</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">18823372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1471-4159.2008.05701.x</pub-id></element-citation></ref><ref id="CR637"><label>637.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ettcheto</surname><given-names>M</given-names></name><name name-style="western"><surname>Junyent</surname><given-names>F</given-names></name><name name-style="western"><surname>de Lemos</surname><given-names>L</given-names></name><name name-style="western"><surname>Pallas</surname><given-names>M</given-names></name><name name-style="western"><surname>Folch</surname><given-names>J</given-names></name><name name-style="western"><surname>Beas-Zarate</surname><given-names>C</given-names></name><etal/></person-group><article-title>Mice lacking functional fas death receptors are protected from kainic acid-induced apoptosis in the hippocampus</article-title><source>Mol Neurobiol</source><year>2015</year><volume>52</volume><fpage>120</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s12035-014-8836-0</pub-id><pub-id pub-id-type="pmid">25119776</pub-id></element-citation></ref><ref id="CR638"><label>638.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papazian</surname><given-names>I</given-names></name><name name-style="western"><surname>Tsoukala</surname><given-names>E</given-names></name><name name-style="western"><surname>Boutou</surname><given-names>A</given-names></name><name name-style="western"><surname>Karamita</surname><given-names>M</given-names></name><name name-style="western"><surname>Kambas</surname><given-names>K</given-names></name><name name-style="western"><surname>Iliopoulou</surname><given-names>L</given-names></name><etal/></person-group><article-title>Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKK&#946; promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice</article-title><source>J Neuroinflammation</source><year>2021</year><volume>18</volume><fpage>222</fpage><pub-id pub-id-type="doi">10.1186/s12974-021-02200-4</pub-id><pub-id pub-id-type="pmid">34565380</pub-id><pub-id pub-id-type="pmcid">PMC8466720</pub-id></element-citation></ref><ref id="CR639"><label>639.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Lu</surname><given-names>C</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>B</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name></person-group><article-title>Inhibition of caspase-8 attenuates neuronal death induced by limbic seizures in a cytochrome c-dependent and Smac/DIABLO-independent way</article-title><source>Brain Res</source><year>2006</year><volume>1098</volume><fpage>204</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.04.131</pub-id><pub-id pub-id-type="pmid">16774749</pub-id></element-citation></ref><ref id="CR640"><label>640.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henshall</surname><given-names>DC</given-names></name><name name-style="western"><surname>Bonislawski</surname><given-names>DP</given-names></name><name name-style="western"><surname>Skradski</surname><given-names>SL</given-names></name><name name-style="western"><surname>Lan</surname><given-names>JQ</given-names></name><name name-style="western"><surname>Meller</surname><given-names>R</given-names></name><name name-style="western"><surname>Simon</surname><given-names>RP</given-names></name></person-group><article-title>Cleavage of bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures</article-title><source>Neurobiol Dis</source><year>2001</year><volume>8</volume><fpage>568</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1006/nbdi.2001.0415</pub-id><pub-id pub-id-type="pmid">11493022</pub-id></element-citation></ref><ref id="CR641"><label>641.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>P</given-names></name><name name-style="western"><surname>Sata</surname><given-names>M</given-names></name><name name-style="western"><surname>Lefer</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Factor</surname><given-names>SM</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>K</given-names></name><name name-style="western"><surname>Kitsis</surname><given-names>RN</given-names></name></person-group><article-title>Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2003</year><volume>284</volume><fpage>H456</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00777.2002</pub-id><pub-id pub-id-type="pmid">12414449</pub-id></element-citation></ref><ref id="CR642"><label>642.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeremias</surname><given-names>I</given-names></name><name name-style="western"><surname>Kupatt</surname><given-names>C</given-names></name><name name-style="western"><surname>Martin-Villalba</surname><given-names>A</given-names></name><name name-style="western"><surname>Habazettl</surname><given-names>H</given-names></name><name name-style="western"><surname>Schenkel</surname><given-names>J</given-names></name><name name-style="western"><surname>Boekstegers</surname><given-names>P</given-names></name><etal/></person-group><article-title>Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>915</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.102.8.915</pub-id><pub-id pub-id-type="pmid">10952962</pub-id></element-citation></ref><ref id="CR643"><label>643.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tekin</surname><given-names>D</given-names></name><name name-style="western"><surname>Xi</surname><given-names>L</given-names></name><name name-style="western"><surname>Kukreja</surname><given-names>RC</given-names></name></person-group><article-title>Genetic deletion of fas receptors or Fas ligands does not reduce infarct size after acute global ischemia-reperfusion in isolated mouse heart</article-title><source>Cell Biochem Biophys</source><year>2006</year><volume>44</volume><fpage>111</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1385/CBB:44:1:111</pub-id><pub-id pub-id-type="pmid">16456239</pub-id></element-citation></ref><ref id="CR644"><label>644.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boisgu&#233;rin</surname><given-names>P</given-names></name><name name-style="western"><surname>Covinhes</surname><given-names>A</given-names></name><name name-style="western"><surname>Gallot</surname><given-names>L</given-names></name><name name-style="western"><surname>Barr&#232;re</surname><given-names>C</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>A</given-names></name><name name-style="western"><surname>Busson</surname><given-names>M</given-names></name><etal/></person-group><article-title>A novel therapeutic peptide targeting myocardial reperfusion injury</article-title><source>Cardiovasc Res</source><year>2020</year><volume>116</volume><fpage>633</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvz145</pub-id><pub-id pub-id-type="pmid">31147690</pub-id></element-citation></ref><ref id="CR645"><label>645.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiraishi</surname><given-names>H</given-names></name><name name-style="western"><surname>Toyozaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Tsukamoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Saito</surname><given-names>T</given-names></name><name name-style="western"><surname>Masuda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hiroshima</surname><given-names>K</given-names></name><etal/></person-group><article-title>Antibody binding to fas ligand attenuates inflammatory cell infiltration and cytokine secretion, leading to reduction of myocardial infarct areas and reperfusion injury</article-title><source>Lab Investig</source><year>2002</year><volume>82</volume><fpage>1121</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/01.LAB.0000029148.88524.CE</pub-id><pub-id pub-id-type="pmid">12218072</pub-id></element-citation></ref><ref id="CR646"><label>646.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Covinhes</surname><given-names>A</given-names></name><name name-style="western"><surname>Gallot</surname><given-names>L</given-names></name><name name-style="western"><surname>Barr&#232;re</surname><given-names>C</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>A</given-names></name><name name-style="western"><surname>Sportouch</surname><given-names>C</given-names></name><name name-style="western"><surname>Piot</surname><given-names>C</given-names></name><etal/></person-group><article-title>Anti-apoptotic peptide for long term cardioprotection in a mouse model of myocardial ischemia-reperfusion injury</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><fpage>18116</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-75154-x</pub-id><pub-id pub-id-type="pmid">33093627</pub-id><pub-id pub-id-type="pmcid">PMC7582178</pub-id></element-citation></ref><ref id="CR647"><label>647.</label><mixed-citation publication-type="other">Wang Y, Zhang H, Wang Z, Wei Y, Wang M, Liu M, et al. Blocking the death checkpoint protein TRAIL improves cardiac function after myocardial infarction in monkeys, pigs, and rats. Sci Transl Med. 2020;12:eaaw3172.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aaw3172</pub-id><pub-id pub-id-type="pmcid">PMC9719290</pub-id><pub-id pub-id-type="pmid">32321866</pub-id></mixed-citation></ref><ref id="CR648"><label>648.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattisson</surname><given-names>IY</given-names></name><name name-style="western"><surname>Bj&#246;rkbacka</surname><given-names>H</given-names></name><name name-style="western"><surname>Wigren</surname><given-names>M</given-names></name><name name-style="western"><surname>Edsfeldt</surname><given-names>A</given-names></name><name name-style="western"><surname>Melander</surname><given-names>O</given-names></name><name name-style="western"><surname>Fredrikson</surname><given-names>GN</given-names></name><etal/></person-group><article-title>Elevated markers of death receptor-activated apoptosis are associated with increased risk for development of diabetes and cardiovascular disease</article-title><source>EBioMedicine</source><year>2017</year><volume>26</volume><fpage>187</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2017.11.023</pub-id><pub-id pub-id-type="pmid">29208468</pub-id><pub-id pub-id-type="pmcid">PMC5836474</pub-id></element-citation></ref><ref id="CR649"><label>649.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stenemo</surname><given-names>M</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>C</given-names></name><name name-style="western"><surname>Byberg</surname><given-names>L</given-names></name><name name-style="western"><surname>Sundstr&#246;m</surname><given-names>J</given-names></name><name name-style="western"><surname>Giedraitis</surname><given-names>V</given-names></name><name name-style="western"><surname>Lind</surname><given-names>L</given-names></name><etal/></person-group><article-title>Circulating proteins as predictors of incident heart failure in the elderly</article-title><source>Eur J Heart Fail</source><year>2018</year><volume>20</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1002/ejhf.980</pub-id><pub-id pub-id-type="pmid">28967680</pub-id></element-citation></ref><ref id="CR650"><label>650.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanner</surname><given-names>MA</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>TP</given-names></name><name name-style="western"><surname>Grisanti</surname><given-names>LA</given-names></name></person-group><article-title>Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation</article-title><source>J Mol Cell Cardiol</source><year>2019</year><volume>136</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2019.08.011</pub-id><pub-id pub-id-type="pmid">31473246</pub-id><pub-id pub-id-type="pmcid">PMC12071187</pub-id></element-citation></ref><ref id="CR651"><label>651.</label><mixed-citation publication-type="other">Di Bartolo BA, Cartland SP, Prado-Lourenco L, Griffith TS, Gentile C, Ravindran J, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes angiogenesis and ischemia-induced neovascularization via NADPH oxidase 4 (NOX4) and nitric oxide-dependent mechanisms. J Am Heart Assoc. 2015;4:e002527.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.115.002527</pub-id><pub-id pub-id-type="pmcid">PMC4845240</pub-id><pub-id pub-id-type="pmid">26572549</pub-id></mixed-citation></ref><ref id="CR652"><label>652.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamid</surname><given-names>T</given-names></name><name name-style="western"><surname>Gu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ortines</surname><given-names>RV</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Xuan</surname><given-names>YT</given-names></name><etal/></person-group><article-title>Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation</article-title><source>Circulation</source><year>2009</year><volume>119</volume><fpage>1386</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.802918</pub-id><pub-id pub-id-type="pmid">19255345</pub-id><pub-id pub-id-type="pmcid">PMC2730645</pub-id></element-citation></ref><ref id="CR653"><label>653.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Lau</surname><given-names>WB</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>LY</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-&#945; and lymphotoxin-&#945; mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e60227</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0060227</pub-id><pub-id pub-id-type="pmid">23704873</pub-id><pub-id pub-id-type="pmcid">PMC3660398</pub-id></element-citation></ref><ref id="CR654"><label>654.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>ML</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Crisostomo</surname><given-names>PR</given-names></name><name name-style="western"><surname>Abarbanell</surname><given-names>AM</given-names></name><name name-style="western"><surname>Herrmann</surname><given-names>JL</given-names></name><name name-style="western"><surname>Weil</surname><given-names>BR</given-names></name><etal/></person-group><article-title>TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia</article-title><source>Shock</source><year>2010</year><volume>33</volume><fpage>602</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e3181cc0913</pub-id><pub-id pub-id-type="pmid">19953003</pub-id><pub-id pub-id-type="pmcid">PMC3076044</pub-id></element-citation></ref><ref id="CR655"><label>655.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monden</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kubota</surname><given-names>T</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>T</given-names></name><name name-style="western"><surname>Tsutsumi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawano</surname><given-names>S</given-names></name><name name-style="western"><surname>Ide</surname><given-names>T</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2007</year><volume>293</volume><fpage>H743</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00166.2007</pub-id><pub-id pub-id-type="pmid">17416608</pub-id></element-citation></ref><ref id="CR656"><label>656.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>D</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis</article-title><source>Am J Pathol</source><year>2006</year><volume>169</volume><fpage>1886</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2006.060603</pub-id><pub-id pub-id-type="pmid">17071609</pub-id><pub-id pub-id-type="pmcid">PMC1780200</pub-id></element-citation></ref><ref id="CR657"><label>657.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gouweleeuw</surname><given-names>L</given-names></name><name name-style="western"><surname>Wajant</surname><given-names>H</given-names></name><name name-style="western"><surname>Maier</surname><given-names>O</given-names></name><name name-style="western"><surname>Eisel</surname><given-names>ULM</given-names></name><name name-style="western"><surname>Blankesteijn</surname><given-names>WM</given-names></name><name name-style="western"><surname>Schoemaker</surname><given-names>RG</given-names></name></person-group><article-title>Effects of selective TNFR1 inhibition or TNFR2 stimulation, compared to non-selective TNF inhibition, on (neuro)inflammation and behavior after myocardial infarction in male mice</article-title><source>Brain Behav Immun</source><year>2021</year><volume>93</volume><fpage>156</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2021.01.001</pub-id><pub-id pub-id-type="pmid">33444731</pub-id></element-citation></ref><ref id="CR658"><label>658.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Yin</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Doan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cardioprotective role of tumor necrosis factor receptor-associated factor 2 by suppressing apoptosis and necroptosis</article-title><source>Circulation</source><year>2017</year><volume>136</volume><fpage>729</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.116.026240</pub-id><pub-id pub-id-type="pmid">28572508</pub-id><pub-id pub-id-type="pmcid">PMC5568494</pub-id></element-citation></ref><ref id="CR659"><label>659.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higuchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>McTiernan</surname><given-names>CF</given-names></name><name name-style="western"><surname>Frye</surname><given-names>CB</given-names></name><name name-style="western"><surname>McGowan</surname><given-names>BS</given-names></name><name name-style="western"><surname>Chan</surname><given-names>TO</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>AM</given-names></name></person-group><article-title>Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>1892</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000124227.00670.AB</pub-id><pub-id pub-id-type="pmid">15051641</pub-id></element-citation></ref><ref id="CR660"><label>660.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mann</surname><given-names>DL</given-names></name><name name-style="western"><surname>McMurray</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Packer</surname><given-names>M</given-names></name><name name-style="western"><surname>Swedberg</surname><given-names>K</given-names></name><name name-style="western"><surname>Borer</surname><given-names>JS</given-names></name><name name-style="western"><surname>Colucci</surname><given-names>WS</given-names></name><etal/></person-group><article-title>Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>1594</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000124490.27666.B2</pub-id><pub-id pub-id-type="pmid">15023878</pub-id></element-citation></ref><ref id="CR661"><label>661.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deswal</surname><given-names>A</given-names></name><name name-style="western"><surname>Bozkurt</surname><given-names>B</given-names></name><name name-style="western"><surname>Seta</surname><given-names>Y</given-names></name><name name-style="western"><surname>Parilti-Eiswirth</surname><given-names>S</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>FA</given-names></name><name name-style="western"><surname>Blosch</surname><given-names>C</given-names></name><etal/></person-group><article-title>Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure</article-title><source>Circulation</source><year>1999</year><volume>99</volume><fpage>3224</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.99.25.3224</pub-id><pub-id pub-id-type="pmid">10385494</pub-id></element-citation></ref><ref id="CR662"><label>662.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bozkurt</surname><given-names>B</given-names></name><name name-style="western"><surname>Torre-Amione</surname><given-names>G</given-names></name><name name-style="western"><surname>Warren</surname><given-names>MS</given-names></name><name name-style="western"><surname>Whitmore</surname><given-names>J</given-names></name><name name-style="western"><surname>Soran</surname><given-names>OZ</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure</article-title><source>Circulation</source><year>2001</year><volume>103</volume><fpage>1044</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.103.8.1044</pub-id><pub-id pub-id-type="pmid">11222463</pub-id></element-citation></ref><ref id="CR663"><label>663.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Generali</surname><given-names>E</given-names></name><name name-style="western"><surname>Carrara</surname><given-names>G</given-names></name><name name-style="western"><surname>Kallikourdis</surname><given-names>M</given-names></name><name name-style="western"><surname>Condorelli</surname><given-names>G</given-names></name><name name-style="western"><surname>Bortoluzzi</surname><given-names>A</given-names></name><name name-style="western"><surname>Scir&#232;</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept</article-title><source>Rheumatol Int</source><year>2019</year><volume>39</volume><fpage>239</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1007/s00296-018-4196-9</pub-id><pub-id pub-id-type="pmid">30413926</pub-id></element-citation></ref><ref id="CR664"><label>664.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Huang</surname><given-names>ZM</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>M</given-names></name><name name-style="western"><surname>Shang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>L</given-names></name><name name-style="western"><surname>Brinks</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inhibition of Fas-associated death domain-containing protein (FADD) protects against myocardial ischemia/reperfusion injury in a heart failure mouse model</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e73537</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0073537</pub-id><pub-id pub-id-type="pmid">24058479</pub-id><pub-id pub-id-type="pmcid">PMC3772851</pub-id></element-citation></ref><ref id="CR665"><label>665.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name><name name-style="western"><surname>Moon</surname><given-names>M</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L</given-names></name><name name-style="western"><surname>Nian</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction</article-title><source>Basic Res Cardiol</source><year>2012</year><volume>107</volume><fpage>239</fpage><pub-id pub-id-type="doi">10.1007/s00395-011-0239-z</pub-id><pub-id pub-id-type="pmid">22202974</pub-id></element-citation></ref><ref id="CR666"><label>666.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>YZ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ding</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Cellular FADD-like IL-1&#946;-converting enzyme-inhibitory protein attenuates myocardial ischemia/reperfusion injury via suppressing apoptosis and autophagy simultaneously</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2021</year><volume>31</volume><fpage>1916</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2021.02.026</pub-id><pub-id pub-id-type="pmid">33895078</pub-id></element-citation></ref><ref id="CR667"><label>667.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zou</surname><given-names>X</given-names></name><etal/></person-group><article-title>The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart</article-title><source>Mol Cell Biochem</source><year>2014</year><volume>397</volume><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/s11010-014-2165-5</pub-id><pub-id pub-id-type="pmid">25060909</pub-id></element-citation></ref><ref id="CR668"><label>668.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fauconnier</surname><given-names>J</given-names></name><name name-style="western"><surname>Meli</surname><given-names>AC</given-names></name><name name-style="western"><surname>Thireau</surname><given-names>J</given-names></name><name name-style="western"><surname>Roberge</surname><given-names>S</given-names></name><name name-style="western"><surname>Shan</surname><given-names>J</given-names></name><name name-style="western"><surname>Sassi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>13258</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1073/pnas.1100286108</pub-id><pub-id pub-id-type="pmid">21788490</pub-id><pub-id pub-id-type="pmcid">PMC3156220</pub-id></element-citation></ref><ref id="CR669"><label>669.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scharner</surname><given-names>D</given-names></name><name name-style="western"><surname>R&#246;ssig</surname><given-names>L</given-names></name><name name-style="western"><surname>Carmona</surname><given-names>G</given-names></name><name name-style="western"><surname>Chavakis</surname><given-names>E</given-names></name><name name-style="western"><surname>Urbich</surname><given-names>C</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-8 is involved in neovascularization-promoting progenitor cell functions</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2009</year><volume>29</volume><fpage>571</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.108.182006</pub-id><pub-id pub-id-type="pmid">19122169</pub-id></element-citation></ref><ref id="CR670"><label>670.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koshinuma</surname><given-names>S</given-names></name><name name-style="western"><surname>Miyamae</surname><given-names>M</given-names></name><name name-style="western"><surname>Kaneda</surname><given-names>K</given-names></name><name name-style="western"><surname>Kotani</surname><given-names>J</given-names></name><name name-style="western"><surname>Figueredo</surname><given-names>VM</given-names></name></person-group><article-title>Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury</article-title><source>J Anesth</source><year>2014</year><volume>28</volume><fpage>235</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/s00540-013-1716-3</pub-id><pub-id pub-id-type="pmid">24113863</pub-id></element-citation></ref><ref id="CR671"><label>671.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nam</surname><given-names>SW</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wong</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Feng</surname><given-names>AY</given-names></name><name name-style="western"><surname>Chu</surname><given-names>G</given-names></name><name name-style="western"><surname>Merchant</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice</article-title><source>Clin Sci</source><year>2014</year><volume>127</volume><fpage>519</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1042/CS20130642</pub-id><pub-id pub-id-type="pmid">24712830</pub-id></element-citation></ref><ref id="CR672"><label>672.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toffoli</surname><given-names>B</given-names></name><name name-style="western"><surname>Bernardi</surname><given-names>S</given-names></name><name name-style="western"><surname>Candido</surname><given-names>R</given-names></name><name name-style="western"><surname>Zacchigna</surname><given-names>S</given-names></name><name name-style="western"><surname>Fabris</surname><given-names>B</given-names></name><name name-style="western"><surname>Secchiero</surname><given-names>P</given-names></name></person-group><article-title>TRAIL shows potential cardioprotective activity</article-title><source>Investig N Drugs</source><year>2012</year><volume>30</volume><fpage>1257</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1007/s10637-010-9627-8</pub-id><pub-id pub-id-type="pmid">21197620</pub-id></element-citation></ref><ref id="CR673"><label>673.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papathanasiou</surname><given-names>S</given-names></name><name name-style="western"><surname>Rickelt</surname><given-names>S</given-names></name><name name-style="western"><surname>Soriano</surname><given-names>ME</given-names></name><name name-style="western"><surname>Schips</surname><given-names>TG</given-names></name><name name-style="western"><surname>Maier</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Davos</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-&#945; confers cardioprotection through ectopic expression of keratins K8 and K18</article-title><source>Nat Med</source><year>2015</year><volume>21</volume><fpage>1076</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/nm.3925</pub-id><pub-id pub-id-type="pmid">26280121</pub-id><pub-id pub-id-type="pmcid">PMC5419049</pub-id></element-citation></ref><ref id="CR674"><label>674.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>M</given-names></name><name name-style="western"><surname>Meisinger</surname><given-names>T</given-names></name><name name-style="western"><surname>Batra</surname><given-names>R</given-names></name><name name-style="western"><surname>Suh</surname><given-names>M</given-names></name><name name-style="western"><surname>Greene</surname><given-names>H</given-names></name><etal/></person-group><article-title>CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation</article-title><source>Cardiovasc Res</source><year>2019</year><volume>115</volume><fpage>807</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvy264</pub-id><pub-id pub-id-type="pmid">30428004</pub-id><pub-id pub-id-type="pmcid">PMC6432056</pub-id></element-citation></ref><ref id="CR675"><label>675.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wencker</surname><given-names>D</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>M</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>K</given-names></name><name name-style="western"><surname>Miao</surname><given-names>W</given-names></name><name name-style="western"><surname>Garantziotis</surname><given-names>S</given-names></name><name name-style="western"><surname>Factor</surname><given-names>SM</given-names></name><etal/></person-group><article-title>A mechanistic role for cardiac myocyte apoptosis in heart failure</article-title><source>J Clin Investig</source><year>2003</year><volume>111</volume><fpage>1497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1172/JCI17664</pub-id><pub-id pub-id-type="pmid">12750399</pub-id><pub-id pub-id-type="pmcid">PMC155051</pub-id></element-citation></ref><ref id="CR676"><label>676.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanner</surname><given-names>MA</given-names></name><name name-style="western"><surname>Grisanti</surname><given-names>LA</given-names></name></person-group><article-title>A dual role for death receptor 5 in regulating cardiac fibroblast function</article-title><source>Front Cardiovasc Med</source><year>2021</year><volume>8</volume><fpage>699102</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2021.699102</pub-id><pub-id pub-id-type="pmid">34527710</pub-id><pub-id pub-id-type="pmcid">PMC8437145</pub-id></element-citation></ref><ref id="CR677"><label>677.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pircher</surname><given-names>J</given-names></name><name name-style="western"><surname>Merkle</surname><given-names>M</given-names></name><name name-style="western"><surname>W&#246;rnle</surname><given-names>M</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>A</given-names></name><name name-style="western"><surname>Czermak</surname><given-names>T</given-names></name><name name-style="western"><surname>Stampnik</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2</article-title><source>Arthritis Res Ther</source><year>2012</year><volume>14</volume><fpage>R225</fpage><pub-id pub-id-type="doi">10.1186/ar4064</pub-id><pub-id pub-id-type="pmid">23079185</pub-id><pub-id pub-id-type="pmcid">PMC3580536</pub-id></element-citation></ref><ref id="CR678"><label>678.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duerrschmid</surname><given-names>C</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>JR</given-names></name><name name-style="western"><surname>Reineke</surname><given-names>E</given-names></name><name name-style="western"><surname>Taffet</surname><given-names>GE</given-names></name><name name-style="western"><surname>Trial</surname><given-names>J</given-names></name><name name-style="western"><surname>Entman</surname><given-names>ML</given-names></name><etal/></person-group><article-title>TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis</article-title><source>J Mol Cell Cardiol</source><year>2013</year><volume>57</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.01.006</pub-id><pub-id pub-id-type="pmid">23337087</pub-id><pub-id pub-id-type="pmcid">PMC3593947</pub-id></element-citation></ref><ref id="CR679"><label>679.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woods</surname><given-names>C</given-names></name><name name-style="western"><surname>Marques-Lopes</surname><given-names>J</given-names></name><name name-style="western"><surname>Contoreggi</surname><given-names>NH</given-names></name><name name-style="western"><surname>Milner</surname><given-names>TA</given-names></name><name name-style="western"><surname>Pickel</surname><given-names>VM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><etal/></person-group><article-title>Tumor necrosis factor &#945; receptor type 1 activation in the hypothalamic paraventricular nucleus contributes to glutamate signaling and angiotensin II-dependent hypertension</article-title><source>J Neurosci</source><year>2021</year><volume>41</volume><fpage>1349</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2360-19.2020</pub-id><pub-id pub-id-type="pmid">33303682</pub-id><pub-id pub-id-type="pmcid">PMC7888211</pub-id></element-citation></ref><ref id="CR680"><label>680.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Tang</surname><given-names>QZ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Moon</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L</given-names></name><etal/></person-group><article-title>Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice</article-title><source>Hypertension</source><year>2010</year><volume>56</volume><fpage>1109</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.110.157412</pub-id><pub-id pub-id-type="pmid">20975036</pub-id></element-citation></ref><ref id="CR681"><label>681.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jobe</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Mel&#233;ndez</surname><given-names>GC</given-names></name><name name-style="western"><surname>Levick</surname><given-names>SP</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name><name name-style="western"><surname>Brower</surname><given-names>GL</given-names></name><name name-style="western"><surname>Janicki</surname><given-names>JS</given-names></name></person-group><article-title>TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2009</year><volume>297</volume><fpage>H1462</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00442.2009</pub-id><pub-id pub-id-type="pmid">19666842</pub-id><pub-id pub-id-type="pmcid">PMC2770768</pub-id></element-citation></ref><ref id="CR682"><label>682.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Dawood</surname><given-names>F</given-names></name><name name-style="western"><surname>Zurawska</surname><given-names>U</given-names></name><name name-style="western"><surname>Li</surname><given-names>JY</given-names></name><name name-style="western"><surname>Parker</surname><given-names>T</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state</article-title><source>Circulation</source><year>2007</year><volume>115</volume><fpage>1398</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.643585</pub-id><pub-id pub-id-type="pmid">17353445</pub-id></element-citation></ref><ref id="CR683"><label>683.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Badorff</surname><given-names>C</given-names></name><name name-style="western"><surname>Ruetten</surname><given-names>H</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>S</given-names></name><name name-style="western"><surname>Stahmer</surname><given-names>M</given-names></name><name name-style="western"><surname>Gehring</surname><given-names>D</given-names></name><name name-style="western"><surname>Jung</surname><given-names>F</given-names></name><etal/></person-group><article-title>Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload</article-title><source>J Clin Investig</source><year>2002</year><volume>109</volume><fpage>373</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1172/JCI13779</pub-id><pub-id pub-id-type="pmid">11827997</pub-id><pub-id pub-id-type="pmcid">PMC150855</pub-id></element-citation></ref><ref id="CR684"><label>684.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stamm</surname><given-names>C</given-names></name><name name-style="western"><surname>Friehs</surname><given-names>I</given-names></name><name name-style="western"><surname>Cowan</surname><given-names>DB</given-names></name><name name-style="western"><surname>Moran</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cao-Danh</surname><given-names>H</given-names></name><name name-style="western"><surname>Duebener</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts</article-title><source>Circulation</source><year>2001</year><volume>104</volume><fpage>I350</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1161/hc37t1.094851</pub-id><pub-id pub-id-type="pmid">11568081</pub-id></element-citation></ref><ref id="CR685"><label>685.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Ba</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Gu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yin</surname><given-names>B</given-names></name><etal/></person-group><article-title>Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2</article-title><source>PLoS Biol</source><year>2020</year><volume>18</volume><fpage>e3000967</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.3000967</pub-id><pub-id pub-id-type="pmid">33270628</pub-id><pub-id pub-id-type="pmcid">PMC7714153</pub-id></element-citation></ref><ref id="CR686"><label>686.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattos</surname><given-names>BR</given-names></name><name name-style="western"><surname>Bonacio</surname><given-names>GF</given-names></name><name name-style="western"><surname>Vitorino</surname><given-names>TR</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>VT</given-names></name><name name-style="western"><surname>Amaral</surname><given-names>JH</given-names></name><name name-style="western"><surname>Dellalibera-Joviliano</surname><given-names>R</given-names></name><etal/></person-group><article-title>TNF-&#945; inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure</article-title><source>Biochem Pharmacol</source><year>2020</year><volume>180</volume><fpage>114121</fpage><pub-id pub-id-type="doi">10.1016/j.bcp.2020.114121</pub-id><pub-id pub-id-type="pmid">32592722</pub-id></element-citation></ref><ref id="CR687"><label>687.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giampietri</surname><given-names>C</given-names></name><name name-style="western"><surname>Petrungaro</surname><given-names>S</given-names></name><name name-style="western"><surname>Musumeci</surname><given-names>M</given-names></name><name name-style="western"><surname>Coluccia</surname><given-names>P</given-names></name><name name-style="western"><surname>Antonangeli</surname><given-names>F</given-names></name><name name-style="western"><surname>De Cesaris</surname><given-names>P</given-names></name><etal/></person-group><article-title>c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload</article-title><source>J Hypertens</source><year>2008</year><volume>26</volume><fpage>1008</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1097/HJH.0b013e3282f6a179</pub-id><pub-id pub-id-type="pmid">18398344</pub-id></element-citation></ref><ref id="CR688"><label>688.</label><mixed-citation publication-type="other">Hsu CC, Li Y, Hsu CT, Cheng JT, Lin MH, Cheng KC, et al. Etanercept ameliorates cardiac fibrosis in rats with diet-induced obesity. Pharmaceuticals. 2021;14:320.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ph14040320</pub-id><pub-id pub-id-type="pmcid">PMC8067047</pub-id><pub-id pub-id-type="pmid">33916242</pub-id></mixed-citation></ref><ref id="CR689"><label>689.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Bartolo</surname><given-names>BA</given-names></name><name name-style="western"><surname>Cartland</surname><given-names>SP</given-names></name><name name-style="western"><surname>Harith</surname><given-names>HH</given-names></name><name name-style="western"><surname>Bobryshev</surname><given-names>YV</given-names></name><name name-style="western"><surname>Schoppet</surname><given-names>M</given-names></name><name name-style="western"><surname>Kavurma</surname><given-names>MM</given-names></name></person-group><article-title>TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e74211</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0074211</pub-id><pub-id pub-id-type="pmid">24040204</pub-id><pub-id pub-id-type="pmcid">PMC3764101</pub-id></element-citation></ref><ref id="CR690"><label>690.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Bartolo</surname><given-names>BA</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>MR</given-names></name><name name-style="western"><surname>Cartland</surname><given-names>S</given-names></name><name name-style="western"><surname>Bao</surname><given-names>S</given-names></name><name name-style="western"><surname>Tuch</surname><given-names>BE</given-names></name><etal/></person-group><article-title>TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe &#8722;/&#8722; mice</article-title><source>Diabetologia</source><year>2011</year><volume>54</volume><fpage>3157</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/s00125-011-2308-0</pub-id><pub-id pub-id-type="pmid">21965021</pub-id></element-citation></ref><ref id="CR691"><label>691.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watt</surname><given-names>V</given-names></name><name name-style="western"><surname>Chamberlain</surname><given-names>J</given-names></name><name name-style="western"><surname>Steiner</surname><given-names>T</given-names></name><name name-style="western"><surname>Francis</surname><given-names>S</given-names></name><name name-style="western"><surname>Crossman</surname><given-names>D</given-names></name></person-group><article-title>TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice</article-title><source>Atherosclerosis</source><year>2011</year><volume>215</volume><fpage>348</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2011.01.010</pub-id><pub-id pub-id-type="pmid">21324463</pub-id><pub-id pub-id-type="pmcid">PMC3074084</pub-id></element-citation></ref><ref id="CR692"><label>692.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zadelaar</surname><given-names>AS</given-names></name><name name-style="western"><surname>von der Th&#252;sen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Boesten</surname><given-names>LS</given-names></name><name name-style="western"><surname>Hoeben</surname><given-names>RC</given-names></name><name name-style="western"><surname>Kockx</surname><given-names>MM</given-names></name><name name-style="western"><surname>Versnel</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer</article-title><source>Atherosclerosis</source><year>2005</year><volume>183</volume><fpage>244</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2005.03.044</pub-id><pub-id pub-id-type="pmid">15927188</pub-id></element-citation></ref><ref id="CR693"><label>693.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Sato</surname><given-names>K</given-names></name><name name-style="western"><surname>Aprahamian</surname><given-names>T</given-names></name><name name-style="western"><surname>Brown</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Hutcheson</surname><given-names>J</given-names></name><name name-style="western"><surname>Bialik</surname><given-names>A</given-names></name><etal/></person-group><article-title>Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>1466</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000134402.94963.2f</pub-id><pub-id pub-id-type="pmid">15178561</pub-id></element-citation></ref><ref id="CR694"><label>694.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xanthoulea</surname><given-names>S</given-names></name><name name-style="western"><surname>Thelen</surname><given-names>M</given-names></name><name name-style="western"><surname>P&#246;ttgens</surname><given-names>C</given-names></name><name name-style="western"><surname>Gijbels</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Lutgens</surname><given-names>E</given-names></name><name name-style="western"><surname>de Winther</surname><given-names>MP</given-names></name></person-group><article-title>Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><fpage>e6113</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0006113</pub-id><pub-id pub-id-type="pmid">19582157</pub-id><pub-id pub-id-type="pmcid">PMC2702081</pub-id></element-citation></ref><ref id="CR695"><label>695.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xanthoulea</surname><given-names>S</given-names></name><name name-style="western"><surname>Gijbels</surname><given-names>MJ</given-names></name><name name-style="western"><surname>van der Made</surname><given-names>I</given-names></name><name name-style="western"><surname>Mujcic</surname><given-names>H</given-names></name><name name-style="western"><surname>Thelen</surname><given-names>M</given-names></name><name name-style="western"><surname>Vergouwe</surname><given-names>MN</given-names></name><etal/></person-group><article-title>P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice</article-title><source>Cardiovasc Res</source><year>2008</year><volume>80</volume><fpage>309</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvn193</pub-id><pub-id pub-id-type="pmid">18628255</pub-id></element-citation></ref><ref id="CR696"><label>696.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Peppel</surname><given-names>K</given-names></name><name name-style="western"><surname>Sivashanmugam</surname><given-names>P</given-names></name><name name-style="western"><surname>Orman</surname><given-names>ES</given-names></name><name name-style="western"><surname>Brian</surname><given-names>L</given-names></name><name name-style="western"><surname>Exum</surname><given-names>ST</given-names></name><etal/></person-group><article-title>Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2007</year><volume>27</volume><fpage>1087</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000261548.49790.63</pub-id><pub-id pub-id-type="pmid">17442899</pub-id><pub-id pub-id-type="pmcid">PMC2522308</pub-id></element-citation></ref><ref id="CR697"><label>697.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Br&#229;n&#233;n</surname><given-names>L</given-names></name><name name-style="western"><surname>Hovgaard</surname><given-names>L</given-names></name><name name-style="western"><surname>Nitulescu</surname><given-names>M</given-names></name><name name-style="western"><surname>Bengtsson</surname><given-names>E</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>J</given-names></name><name name-style="western"><surname>Jovinge</surname><given-names>S</given-names></name></person-group><article-title>Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice</article-title><source>Arterioscler Thrombos Vasc Biol</source><year>2004</year><volume>24</volume><fpage>2137</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000143933.20616.1b</pub-id><pub-id pub-id-type="pmid">15345516</pub-id></element-citation></ref><ref id="CR698"><label>698.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyata</surname><given-names>S</given-names></name><name name-style="western"><surname>Takemura</surname><given-names>G</given-names></name><name name-style="western"><surname>Kosai</surname><given-names>K</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Esaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis</article-title><source>Am J Pathol</source><year>2010</year><volume>176</volume><fpage>687</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2010.090222</pub-id><pub-id pub-id-type="pmid">20035047</pub-id><pub-id pub-id-type="pmcid">PMC2808076</pub-id></element-citation></ref><ref id="CR699"><label>699.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>J</given-names></name><name name-style="western"><surname>Azfer</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Kolattukudy</surname><given-names>PE</given-names></name></person-group><article-title>Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice</article-title><source>J Pharmacol Exp Ther</source><year>2009</year><volume>328</volume><fpage>740</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1124/jpet.108.146423</pub-id><pub-id pub-id-type="pmid">19066339</pub-id><pub-id pub-id-type="pmcid">PMC2682255</pub-id></element-citation></ref><ref id="CR700"><label>700.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clayton</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Brunt</surname><given-names>VE</given-names></name><name name-style="western"><surname>Hutton</surname><given-names>DA</given-names></name><name name-style="western"><surname>Casso</surname><given-names>AG</given-names></name><name name-style="western"><surname>Ziemba</surname><given-names>BP</given-names></name><name name-style="western"><surname>Melov</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tumor necrosis factor alpha-mediated inflammation and remodeling of the extracellular matrix underlies aortic stiffening induced by the common chemotherapeutic agent doxorubicin</article-title><source>Hypertension</source><year>2021</year><volume>77</volume><fpage>1581</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.16759</pub-id><pub-id pub-id-type="pmid">33719511</pub-id><pub-id pub-id-type="pmcid">PMC8035245</pub-id></element-citation></ref><ref id="CR701"><label>701.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furuichi</surname><given-names>K</given-names></name><name name-style="western"><surname>Kokubo</surname><given-names>S</given-names></name><name name-style="western"><surname>Hara</surname><given-names>A</given-names></name><name name-style="western"><surname>Imamura</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kitajima</surname><given-names>S</given-names></name><etal/></person-group><article-title>Fas ligand has a greater impact than TNF-&#945; on apoptosis and inflammation in ischemic acute kidney injury</article-title><source>Nephron Extra</source><year>2012</year><volume>2</volume><fpage>27</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1159/000335533</pub-id><pub-id pub-id-type="pmid">22479266</pub-id><pub-id pub-id-type="pmcid">PMC3318938</pub-id></element-citation></ref><ref id="CR702"><label>702.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Jang</surname><given-names>HR</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Womer</surname><given-names>KL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Higbee</surname><given-names>E</given-names></name><etal/></person-group><article-title>Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury</article-title><source>J Am Soc Nephrology</source><year>2011</year><volume>22</volume><fpage>732</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1681/ASN.2010010121</pub-id><pub-id pub-id-type="pmcid">PMC3065228</pub-id><pub-id pub-id-type="pmid">21436290</pub-id></element-citation></ref><ref id="CR703"><label>703.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamar</surname><given-names>P</given-names></name><name name-style="western"><surname>Song</surname><given-names>E</given-names></name><name name-style="western"><surname>K&#246;k&#233;ny</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>N</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>J</given-names></name></person-group><article-title>Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>14883</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.0406421101</pub-id><pub-id pub-id-type="pmid">15466709</pub-id><pub-id pub-id-type="pmcid">PMC522049</pub-id></element-citation></ref><ref id="CR704"><label>704.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Diao</surname><given-names>H</given-names></name><name name-style="western"><surname>Guan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>R</given-names></name><name name-style="western"><surname>Jevnikar</surname><given-names>AM</given-names></name></person-group><article-title>Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury</article-title><source>Am J Transplant</source><year>2006</year><volume>6</volume><fpage>2256</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2006.01478.x</pub-id><pub-id pub-id-type="pmid">16970799</pub-id></element-citation></ref><ref id="CR705"><label>705.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Feng</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XS</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>XF</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Small interfering RNA targeting TNF-&#945; gene significantly attenuates renal ischemia-reperfusion injury in mice</article-title><source>J Huazhong Univ Sci Technol Med Sci</source><year>2016</year><volume>36</volume><fpage>634</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s11596-016-1638-z</pub-id><pub-id pub-id-type="pmid">27752902</pub-id></element-citation></ref><ref id="CR706"><label>706.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adachi</surname><given-names>T</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>N</given-names></name><name name-style="western"><surname>Yagita</surname><given-names>H</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>T</given-names></name></person-group><article-title>Renal atrophy after ischemia-reperfusion injury depends on massive tubular apoptosis induced by TNF&#945; in the later phase</article-title><source>Med Mol Morphol</source><year>2014</year><volume>47</volume><fpage>213</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s00795-013-0067-3</pub-id><pub-id pub-id-type="pmid">24407718</pub-id></element-citation></ref><ref id="CR707"><label>707.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>DE</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>JY</given-names></name><name name-style="western"><surname>Lim</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Na</surname><given-names>KR</given-names></name><name name-style="western"><surname>Shin</surname><given-names>YT</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KW</given-names></name></person-group><article-title>Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury</article-title><source>Transplant Proc</source><year>2009</year><volume>41</volume><fpage>3590</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2009.05.042</pub-id><pub-id pub-id-type="pmid">19917350</pub-id></element-citation></ref><ref id="CR708"><label>708.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adachi</surname><given-names>T</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>N</given-names></name><name name-style="western"><surname>Gondai</surname><given-names>T</given-names></name><name name-style="western"><surname>Yagita</surname><given-names>H</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>T</given-names></name></person-group><article-title>Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury</article-title><source>Acta Histochem Cytochem</source><year>2013</year><volume>46</volume><fpage>161</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1267/ahc.13022</pub-id><pub-id pub-id-type="pmid">24610963</pub-id><pub-id pub-id-type="pmcid">PMC3929614</pub-id></element-citation></ref><ref id="CR709"><label>709.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leng</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name></person-group><article-title>Blocking TRAIL-DR5 signaling with soluble DR5 alleviates acute kidney injury in a severely burned mouse model</article-title><source>Int J Clin Exp Pathol</source><year>2014</year><volume>7</volume><fpage>3460</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">25031778</pub-id><pub-id pub-id-type="pmcid">PMC4097225</pub-id></element-citation></ref><ref id="CR710"><label>710.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramesh</surname><given-names>G</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>WB</given-names></name></person-group><article-title>TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity</article-title><source>J Clin Investig</source><year>2002</year><volume>110</volume><fpage>835</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1172/JCI200215606</pub-id><pub-id pub-id-type="pmid">12235115</pub-id><pub-id pub-id-type="pmcid">PMC151130</pub-id></element-citation></ref><ref id="CR711"><label>711.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mamlouk</surname><given-names>O</given-names></name><name name-style="western"><surname>Selamet</surname><given-names>U</given-names></name><name name-style="western"><surname>Tchakarov</surname><given-names>A</given-names></name><name name-style="western"><surname>Glass</surname><given-names>WF</given-names></name><name name-style="western"><surname>Sheth</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis</article-title><source>Oncoimmunology</source><year>2021</year><volume>10</volume><fpage>1877415</fpage><pub-id pub-id-type="doi">10.1080/2162402X.2021.1877415</pub-id><pub-id pub-id-type="pmid">33643693</pub-id><pub-id pub-id-type="pmcid">PMC7872057</pub-id></element-citation></ref><ref id="CR712"><label>712.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>S</given-names></name><name name-style="western"><surname>Fukasawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Togawa</surname><given-names>A</given-names></name><name name-style="western"><surname>Ohashi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats</article-title><source>Am J Pathol</source><year>2009</year><volume>175</volume><fpage>74</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2009.080884</pub-id><pub-id pub-id-type="pmid">19541932</pub-id><pub-id pub-id-type="pmcid">PMC2708796</pub-id></element-citation></ref><ref id="CR713"><label>713.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misseri</surname><given-names>R</given-names></name><name name-style="western"><surname>Meldrum</surname><given-names>DR</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><name name-style="western"><surname>Dagher</surname><given-names>P</given-names></name><name name-style="western"><surname>Hile</surname><given-names>KL</given-names></name><name name-style="western"><surname>Rink</surname><given-names>RC</given-names></name><etal/></person-group><article-title>TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling</article-title><source>Am J Physiol Ren Physiol</source><year>2005</year><volume>288</volume><fpage>F406</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00099.2004</pub-id><pub-id pub-id-type="pmid">15507546</pub-id></element-citation></ref><ref id="CR714"><label>714.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tanishima</surname><given-names>H</given-names></name><name name-style="western"><surname>Kawakatsu</surname><given-names>M</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>S</given-names></name><name name-style="western"><surname>Hatamura</surname><given-names>I</given-names></name><etal/></person-group><article-title>TNF-alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction</article-title><source>Exp Mol Pathol</source><year>2008</year><volume>85</volume><fpage>207</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.yexmp.2008.08.003</pub-id><pub-id pub-id-type="pmid">18840428</pub-id></element-citation></ref><ref id="CR715"><label>715.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>G</given-names></name><name name-style="western"><surname>Morrissey</surname><given-names>J</given-names></name><name name-style="western"><surname>McCracken</surname><given-names>R</given-names></name><name name-style="western"><surname>Tolley</surname><given-names>T</given-names></name><name name-style="western"><surname>Klahr</surname><given-names>S</given-names></name></person-group><article-title>Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy</article-title><source>Am J Physiol</source><year>1999</year><volume>277</volume><fpage>F766</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">10564241</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.1999.277.5.F766</pub-id></element-citation></ref><ref id="CR716"><label>716.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>J</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>RJ</given-names></name></person-group><article-title>Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction</article-title><source>Am J Physiol</source><year>1999</year><volume>277</volume><fpage>F26</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">10409294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.1999.277.1.F26</pub-id></element-citation></ref><ref id="CR717"><label>717.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><name name-style="western"><surname>Feng</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Vladau</surname><given-names>C</given-names></name><etal/></person-group><article-title>Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8</article-title><source>Transplantation</source><year>2006</year><volume>82</volume><fpage>1728</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1097/01.tp.0000250764.17636.ba</pub-id><pub-id pub-id-type="pmid">17198267</pub-id></element-citation></ref><ref id="CR718"><label>718.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linkermann</surname><given-names>A</given-names></name><name name-style="western"><surname>Br&#228;sen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Himmerkus</surname><given-names>N</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Huber</surname><given-names>TB</given-names></name><name name-style="western"><surname>Kunzendorf</surname><given-names>U</given-names></name><etal/></person-group><article-title>Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</article-title><source>Kidney Int</source><year>2012</year><volume>81</volume><fpage>751</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/ki.2011.450</pub-id><pub-id pub-id-type="pmid">22237751</pub-id></element-citation></ref><ref id="CR719"><label>719.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linkermann</surname><given-names>A</given-names></name><name name-style="western"><surname>Br&#228;sen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Darding</surname><given-names>M</given-names></name><name name-style="western"><surname>Jin</surname><given-names>MK</given-names></name><name name-style="western"><surname>Sanz</surname><given-names>AB</given-names></name><name name-style="western"><surname>Heller</surname><given-names>JO</given-names></name><etal/></person-group><article-title>Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>12024</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.1305538110</pub-id><pub-id pub-id-type="pmid">23818611</pub-id><pub-id pub-id-type="pmcid">PMC3718149</pub-id></element-citation></ref><ref id="CR720"><label>720.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>B</given-names></name><name name-style="western"><surname>Su</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><name name-style="western"><surname>McLeod</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Haig</surname><given-names>A</given-names></name><etal/></person-group><article-title>Loss of receptor interacting protein kinases 3 and caspase-8 augments intrinsic apoptosis in tubular epithelial cell and promote kidney ischaemia-reperfusion injury</article-title><source>Nephrol</source><year>2019</year><volume>24</volume><fpage>661</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/nep.13487</pub-id><pub-id pub-id-type="pmcid">PMC7706480</pub-id><pub-id pub-id-type="pmid">30175514</pub-id></element-citation></ref><ref id="CR721"><label>721.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Awad</surname><given-names>AS</given-names></name><name name-style="western"><surname>You</surname><given-names>H</given-names></name><name name-style="western"><surname>Gao</surname><given-names>T</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>TK</given-names></name><name name-style="western"><surname>Nedospasov</surname><given-names>SA</given-names></name><name name-style="western"><surname>Vacher</surname><given-names>J</given-names></name><etal/></person-group><article-title>Macrophage-derived tumor necrosis factor-&#945; mediates diabetic renal injury</article-title><source>Kidney Int</source><year>2015</year><volume>88</volume><fpage>722</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1038/ki.2015.162</pub-id><pub-id pub-id-type="pmid">26061548</pub-id><pub-id pub-id-type="pmcid">PMC4589442</pub-id></element-citation></ref><ref id="CR722"><label>722.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omote</surname><given-names>K</given-names></name><name name-style="western"><surname>Gohda</surname><given-names>T</given-names></name><name name-style="western"><surname>Murakoshi</surname><given-names>M</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kazuno</surname><given-names>S</given-names></name><name name-style="western"><surname>Fujimura</surname><given-names>T</given-names></name><etal/></person-group><article-title>Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice</article-title><source>Am J Physiol Ren Physiol</source><year>2014</year><volume>306</volume><fpage>F1335</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00509.2013</pub-id><pub-id pub-id-type="pmid">24647715</pub-id></element-citation></ref><ref id="CR723"><label>723.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriwaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Inokuchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Ka</surname><given-names>T</given-names></name><name name-style="western"><surname>Tsutsumi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats</article-title><source>Acta Diabetol</source><year>2007</year><volume>44</volume><fpage>215</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s00592-007-0007-6</pub-id><pub-id pub-id-type="pmid">17767370</pub-id></element-citation></ref><ref id="CR724"><label>724.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>D</given-names></name><name name-style="western"><surname>Liang</surname><given-names>R</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B</given-names></name><name name-style="western"><surname>Hou</surname><given-names>J</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>T</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-&#945; blockade ameliorates diabetic nephropathy in rats</article-title><source>Clin Kidney J</source><year>2021</year><volume>14</volume><fpage>301</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/ckj/sfz137</pub-id><pub-id pub-id-type="pmid">33564432</pub-id><pub-id pub-id-type="pmcid">PMC7857830</pub-id></element-citation></ref><ref id="CR725"><label>725.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cartland</surname><given-names>SP</given-names></name><name name-style="western"><surname>Erlich</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kavurma</surname><given-names>MM</given-names></name></person-group><article-title>TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE&#8722;/&#8722; mice</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e92952</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0092952</pub-id><pub-id pub-id-type="pmid">24667560</pub-id><pub-id pub-id-type="pmcid">PMC3965481</pub-id></element-citation></ref><ref id="CR726"><label>726.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorz</surname><given-names>C</given-names></name><name name-style="western"><surname>Benito-Mart&#237;n</surname><given-names>A</given-names></name><name name-style="western"><surname>Boucherot</surname><given-names>A</given-names></name><name name-style="western"><surname>Ucero</surname><given-names>AC</given-names></name><name name-style="western"><surname>Rastaldi</surname><given-names>MP</given-names></name><name name-style="western"><surname>Henger</surname><given-names>A</given-names></name><etal/></person-group><article-title>The death ligand TRAIL in diabetic nephropathy</article-title><source>J Am Soc Nephrology</source><year>2008</year><volume>19</volume><fpage>904</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1681/ASN.2007050581</pub-id><pub-id pub-id-type="pmcid">PMC2386716</pub-id><pub-id pub-id-type="pmid">18287563</pub-id></element-citation></ref><ref id="CR727"><label>727.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toffoli</surname><given-names>B</given-names></name><name name-style="western"><surname>Tonon</surname><given-names>F</given-names></name><name name-style="western"><surname>Tisato</surname><given-names>V</given-names></name><name name-style="western"><surname>Michelli</surname><given-names>A</given-names></name><name name-style="western"><surname>Zauli</surname><given-names>G</given-names></name><name name-style="western"><surname>Secchiero</surname><given-names>P</given-names></name><etal/></person-group><article-title>TRAIL treatment prevents renal morphological changes and TGF-&#946;-induced mesenchymal transition associated with diabetic nephropathy</article-title><source>Clin Sci</source><year>2020</year><volume>134</volume><fpage>2337</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1042/CS20201004</pub-id><pub-id pub-id-type="pmid">32857135</pub-id></element-citation></ref><ref id="CR728"><label>728.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roix</surname><given-names>J</given-names></name><name name-style="western"><surname>Saha</surname><given-names>S</given-names></name></person-group><article-title>TNF-&#945; blockade is ineffective in animal models of established polycystic kidney disease</article-title><source>BMC Nephrol</source><year>2013</year><volume>14</volume><fpage>233</fpage><pub-id pub-id-type="doi">10.1186/1471-2369-14-233</pub-id><pub-id pub-id-type="pmid">24160989</pub-id><pub-id pub-id-type="pmcid">PMC4231369</pub-id></element-citation></ref><ref id="CR729"><label>729.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Magenheimer</surname><given-names>BS</given-names></name><name name-style="western"><surname>Xia</surname><given-names>S</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>T</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>DP</given-names></name><name name-style="western"><surname>Calvet</surname><given-names>JP</given-names></name><etal/></person-group><article-title>A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease</article-title><source>Nat Med</source><year>2008</year><volume>14</volume><fpage>863</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nm1783</pub-id><pub-id pub-id-type="pmid">18552856</pub-id><pub-id pub-id-type="pmcid">PMC3359869</pub-id></element-citation></ref><ref id="CR730"><label>730.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarzi</surname><given-names>RM</given-names></name><name name-style="western"><surname>Sharp</surname><given-names>PE</given-names></name><name name-style="western"><surname>McDaid</surname><given-names>JP</given-names></name><name name-style="western"><surname>Fossati-Jimack</surname><given-names>L</given-names></name><name name-style="western"><surname>Herbert</surname><given-names>PE</given-names></name><name name-style="western"><surname>Pusey</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Mice with defective Fas ligand are protected from crescentic glomerulonephritis</article-title><source>Kidney Int</source><year>2012</year><volume>81</volume><fpage>170</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ki.2011.319</pub-id><pub-id pub-id-type="pmid">21918502</pub-id></element-citation></ref><ref id="CR731"><label>731.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>SB</given-names></name><name name-style="western"><surname>Cook</surname><given-names>HT</given-names></name><name name-style="western"><surname>Bhangal</surname><given-names>G</given-names></name><name name-style="western"><surname>Smith</surname><given-names>J</given-names></name><name name-style="western"><surname>Tam</surname><given-names>FW</given-names></name><name name-style="western"><surname>Pusey</surname><given-names>CD</given-names></name></person-group><article-title>Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis</article-title><source>Kidney Int</source><year>2005</year><volume>67</volume><fpage>1812</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2005.00279.x</pub-id><pub-id pub-id-type="pmid">15840028</pub-id></element-citation></ref><ref id="CR732"><label>732.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaenker</surname><given-names>M</given-names></name><name name-style="western"><surname>Arbach</surname><given-names>O</given-names></name><name name-style="western"><surname>Helmchen</surname><given-names>U</given-names></name><name name-style="western"><surname>Glorius</surname><given-names>P</given-names></name><name name-style="western"><surname>Ludewig</surname><given-names>S</given-names></name><name name-style="western"><surname>Braasch</surname><given-names>E</given-names></name></person-group><article-title>Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment</article-title><source>Int J tissue React</source><year>2004</year><volume>26</volume><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">15648440</pub-id></element-citation></ref><ref id="CR733"><label>733.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Hir</surname><given-names>M</given-names></name><name name-style="western"><surname>Haas</surname><given-names>C</given-names></name><name name-style="western"><surname>Marino</surname><given-names>M</given-names></name><name name-style="western"><surname>Ryffel</surname><given-names>B</given-names></name></person-group><article-title>Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice</article-title><source>Lab Investig</source><year>1998</year><volume>78</volume><fpage>1625</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">9881962</pub-id></element-citation></ref><ref id="CR734"><label>734.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rudemiller</surname><given-names>NP</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Robinette</surname><given-names>T</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><etal/></person-group><article-title>TNF-&#945; in T lymphocytes attenuates renal injury and fibrosis during nephrotoxic nephritis</article-title><source>Am J Physiol Ren Physiol</source><year>2020</year><volume>318</volume><fpage>F107</fpage><lpage>f116</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00347.2019</pub-id><pub-id pub-id-type="pmcid">PMC6985827</pub-id><pub-id pub-id-type="pmid">31736350</pub-id></element-citation></ref><ref id="CR735"><label>735.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taubitz</surname><given-names>A</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>M</given-names></name><name name-style="western"><surname>Eltrich</surname><given-names>N</given-names></name><name name-style="western"><surname>Lindenmeyer</surname><given-names>MT</given-names></name><name name-style="western"><surname>Vielhauer</surname><given-names>V</given-names></name></person-group><article-title>Distinct contributions of TNF receptor 1 and 2 to TNF-induced glomerular inflammation in mice</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e68167</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0068167</pub-id><pub-id pub-id-type="pmid">23869211</pub-id><pub-id pub-id-type="pmcid">PMC3711912</pub-id></element-citation></ref><ref id="CR736"><label>736.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfeifer</surname><given-names>E</given-names></name><name name-style="western"><surname>Polz</surname><given-names>J</given-names></name><name name-style="western"><surname>Grie&#946;l</surname><given-names>S</given-names></name><name name-style="western"><surname>Mostb&#246;ck</surname><given-names>S</given-names></name><name name-style="western"><surname>Hehlgans</surname><given-names>T</given-names></name><name name-style="western"><surname>M&#228;nnel</surname><given-names>DN</given-names></name></person-group><article-title>Mechanisms of immune complex-mediated experimental glomerulonephritis: possible role of the balance between endogenous TNF and soluble TNF receptor type 2</article-title><source>Eur Cytokine Netw</source><year>2012</year><volume>23</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1684/ecn.2012.0299</pub-id><pub-id pub-id-type="pmid">22449555</pub-id></element-citation></ref><ref id="CR737"><label>737.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vielhauer</surname><given-names>V</given-names></name><name name-style="western"><surname>Stavrakis</surname><given-names>G</given-names></name><name name-style="western"><surname>Mayadas</surname><given-names>TN</given-names></name></person-group><article-title>Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis</article-title><source>J Clin Investig</source><year>2005</year><volume>115</volume><fpage>1199</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1172/JCI200523348</pub-id><pub-id pub-id-type="pmid">15841213</pub-id><pub-id pub-id-type="pmcid">PMC1070636</pub-id></element-citation></ref><ref id="CR738"><label>738.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryffel</surname><given-names>B</given-names></name><name name-style="western"><surname>Eugster</surname><given-names>H</given-names></name><name name-style="western"><surname>Haas</surname><given-names>C</given-names></name><name name-style="western"><surname>Le</surname></name><name name-style="western"><surname>Hir</surname><given-names>M</given-names></name></person-group><article-title>Failure to induce anti-glomerular basement membrane glomerulonephritis in TNF alpha/beta deficient mice</article-title><source>Int J Exp Pathol</source><year>1998</year><volume>79</volume><fpage>453</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2613.1998.00080.x</pub-id><pub-id pub-id-type="pmid">10319026</pub-id><pub-id pub-id-type="pmcid">PMC3220371</pub-id></element-citation></ref><ref id="CR739"><label>739.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#252;ller</surname><given-names>MB</given-names></name><name name-style="western"><surname>Hoppe</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bideak</surname><given-names>A</given-names></name><name name-style="western"><surname>Lux</surname><given-names>M</given-names></name><name name-style="western"><surname>Lindenmeyer</surname><given-names>MT</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>S</given-names></name><etal/></person-group><article-title>Exclusive expression of transmembrane TNF aggravates acute glomerulonephritis despite reduced leukocyte infiltration and inflammation</article-title><source>Kidney Int</source><year>2019</year><volume>95</volume><fpage>75</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2018.08.012</pub-id><pub-id pub-id-type="pmid">30389199</pub-id></element-citation></ref><ref id="CR740"><label>740.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmoud</surname><given-names>MF</given-names></name><name name-style="western"><surname>El Shazly</surname><given-names>SM</given-names></name><name name-style="western"><surname>Barakat</surname><given-names>W</given-names></name></person-group><article-title>Inhibition of TNF-&#945; protects against hepatic ischemia-reperfusion injury in rats via NF-&#954;B dependent pathway</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>2012</year><volume>385</volume><fpage>465</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1007/s00210-012-0729-z</pub-id><pub-id pub-id-type="pmid">22311349</pub-id></element-citation></ref><ref id="CR741"><label>741.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez-Alejandro</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Croome</surname><given-names>KP</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Parfitt</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Reduction of liver ischemia reperfusion injury by silencing of TNF-&#945; gene with shRNA</article-title><source>J Surg Res</source><year>2012</year><volume>176</volume><fpage>614</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2011.10.004</pub-id><pub-id pub-id-type="pmid">22221603</pub-id></element-citation></ref><ref id="CR742"><label>742.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>R&#252;diger</surname><given-names>HA</given-names></name><name name-style="western"><surname>Clavien</surname><given-names>PA</given-names></name></person-group><article-title>Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver</article-title><source>Gastroenterology</source><year>2002</year><volume>122</volume><fpage>202</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1053/gast.2002.30304</pub-id><pub-id pub-id-type="pmid">11781294</pub-id></element-citation></ref><ref id="CR743"><label>743.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Saeedi</surname><given-names>M</given-names></name><name name-style="western"><surname>Steinebrunner</surname><given-names>N</given-names></name><name name-style="western"><surname>Kudsi</surname><given-names>H</given-names></name><name name-style="western"><surname>Halama</surname><given-names>N</given-names></name><name name-style="western"><surname>Mogler</surname><given-names>C</given-names></name><name name-style="western"><surname>B&#252;chler</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure</article-title><source>Cell Death Dis</source><year>2018</year><volume>9</volume><fpage>132</fpage><pub-id pub-id-type="doi">10.1038/s41419-017-0150-0</pub-id><pub-id pub-id-type="pmid">29374146</pub-id><pub-id pub-id-type="pmcid">PMC5833836</pub-id></element-citation></ref><ref id="CR744"><label>744.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakajima</surname><given-names>H</given-names></name><name name-style="western"><surname>Mizuta</surname><given-names>N</given-names></name><name name-style="western"><surname>Fujiwara</surname><given-names>I</given-names></name><name name-style="western"><surname>Sakaguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Ogata</surname><given-names>H</given-names></name><name name-style="western"><surname>Magae</surname><given-names>J</given-names></name><etal/></person-group><article-title>Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver</article-title><source>Apoptosis</source><year>2008</year><volume>13</volume><fpage>1013</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/s10495-008-0234-5</pub-id><pub-id pub-id-type="pmid">18561025</pub-id></element-citation></ref><ref id="CR745"><label>745.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teoh</surname><given-names>N</given-names></name><name name-style="western"><surname>Leclercq</surname><given-names>I</given-names></name><name name-style="western"><surname>Pena</surname><given-names>AD</given-names></name><name name-style="western"><surname>Farrell</surname><given-names>G</given-names></name></person-group><article-title>Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning</article-title><source>Hepatology</source><year>2003</year><volume>37</volume><fpage>118</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1053/jhep.2003.50009</pub-id><pub-id pub-id-type="pmid">12500196</pub-id></element-citation></ref><ref id="CR746"><label>746.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fahrner</surname><given-names>R</given-names></name><name name-style="western"><surname>Trochsler</surname><given-names>M</given-names></name><name name-style="western"><surname>Corazza</surname><given-names>N</given-names></name><name name-style="western"><surname>Graubardt</surname><given-names>N</given-names></name><name name-style="western"><surname>Keogh</surname><given-names>A</given-names></name><name name-style="western"><surname>Candinas</surname><given-names>D</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-related apoptosis-inducing ligand on NK cells protects from hepatic ischemia-reperfusion injury</article-title><source>Transplantation</source><year>2014</year><volume>97</volume><fpage>1102</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/TP.0000000000000101</pub-id><pub-id pub-id-type="pmid">24804996</pub-id></element-citation></ref><ref id="CR747"><label>747.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Contreras</surname><given-names>JL</given-names></name><name name-style="western"><surname>Vilatoba</surname><given-names>M</given-names></name><name name-style="western"><surname>Eckstein</surname><given-names>C</given-names></name><name name-style="western"><surname>Bilbao</surname><given-names>G</given-names></name><name name-style="western"><surname>Anthony Thompson</surname><given-names>J</given-names></name><name name-style="western"><surname>Eckhoff</surname><given-names>DE</given-names></name></person-group><article-title>Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice</article-title><source>Surgery</source><year>2004</year><volume>136</volume><fpage>390</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2004.05.015</pub-id><pub-id pub-id-type="pmid">15300206</pub-id></element-citation></ref><ref id="CR748"><label>748.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolachala</surname><given-names>VL</given-names></name><name name-style="western"><surname>Palle</surname><given-names>SK</given-names></name><name name-style="western"><surname>Shen</surname><given-names>M</given-names></name><name name-style="western"><surname>Shenoi</surname><given-names>A</given-names></name><name name-style="western"><surname>Shayakhmetov</surname><given-names>DM</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>NA</given-names></name></person-group><article-title>Influence of fat on differential receptor interacting serine/threonine protein kinase 1 activity leading to apoptotic cell death in murine liver ischemia reperfusion injury through caspase 8</article-title><source>Hepatol Commun</source><year>2019</year><volume>3</volume><fpage>925</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1002/hep4.1352</pub-id><pub-id pub-id-type="pmid">31334443</pub-id><pub-id pub-id-type="pmcid">PMC6601319</pub-id></element-citation></ref><ref id="CR749"><label>749.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>CD</given-names></name><name name-style="western"><surname>McGill</surname><given-names>MR</given-names></name><name name-style="western"><surname>Farhood</surname><given-names>A</given-names></name><name name-style="western"><surname>Jaeschke</surname><given-names>H</given-names></name></person-group><article-title>Fas receptor-deficient lpr mice are protected against acetaminophen hepatotoxicity due to higher glutathione synthesis and enhanced detoxification of oxidant stress</article-title><source>Food Chem Toxicol</source><year>2013</year><volume>58</volume><fpage>228</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.04.031</pub-id><pub-id pub-id-type="pmid">23628456</pub-id><pub-id pub-id-type="pmcid">PMC3703493</pub-id></element-citation></ref><ref id="CR750"><label>750.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yan</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Xia</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Treatment of acetaminophen-induced liver failure by blocking the death checkpoint protein TRAIL</article-title><source>Biochim Biophys Acta Mol Basis Dis</source><year>2020</year><volume>1866</volume><fpage>165583</fpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2019.165583</pub-id><pub-id pub-id-type="pmid">31676378</pub-id></element-citation></ref><ref id="CR751"><label>751.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tinel</surname><given-names>M</given-names></name><name name-style="western"><surname>Berson</surname><given-names>A</given-names></name><name name-style="western"><surname>Vadrot</surname><given-names>N</given-names></name><name name-style="western"><surname>Descatoire</surname><given-names>V</given-names></name><name name-style="western"><surname>Grodet</surname><given-names>A</given-names></name><name name-style="western"><surname>Feldmann</surname><given-names>G</given-names></name><etal/></person-group><article-title>Subliminal Fas stimulation increases the hepatotoxicity of acetaminophen and bromobenzene in mice</article-title><source>Hepatology</source><year>2004</year><volume>39</volume><fpage>655</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1002/hep.20094</pub-id><pub-id pub-id-type="pmid">14999684</pub-id></element-citation></ref><ref id="CR752"><label>752.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schattenberg</surname><given-names>JM</given-names></name><name name-style="western"><surname>Nagel</surname><given-names>M</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YO</given-names></name><name name-style="western"><surname>Kohl</surname><given-names>T</given-names></name><name name-style="western"><surname>W&#246;rns</surname><given-names>MA</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>T</given-names></name><etal/></person-group><article-title>Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2012</year><volume>303</volume><fpage>G498</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00525.2011</pub-id><pub-id pub-id-type="pmid">22700824</pub-id></element-citation></ref><ref id="CR753"><label>753.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuchmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Varfolomeev</surname><given-names>EE</given-names></name><name name-style="western"><surname>Hermann</surname><given-names>F</given-names></name><name name-style="western"><surname>Rueckert</surname><given-names>F</given-names></name><name name-style="western"><surname>Strand</surname><given-names>D</given-names></name><name name-style="western"><surname>Koehler</surname><given-names>H</given-names></name><etal/></person-group><article-title>Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure</article-title><source>Hepatology</source><year>2003</year><volume>37</volume><fpage>129</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1053/jhep.2003.50011</pub-id><pub-id pub-id-type="pmid">12500197</pub-id></element-citation></ref><ref id="CR754"><label>754.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seino</surname><given-names>K</given-names></name><name name-style="western"><surname>Setoguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ogino</surname><given-names>T</given-names></name><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>H</given-names></name><etal/></person-group><article-title>Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation</article-title><source>Ann Surg</source><year>2001</year><volume>234</volume><fpage>681</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/00000658-200111000-00015</pub-id><pub-id pub-id-type="pmid">11685033</pub-id><pub-id pub-id-type="pmcid">PMC1422094</pub-id></element-citation></ref><ref id="CR755"><label>755.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liedtke</surname><given-names>C</given-names></name><name name-style="western"><surname>Bangen</surname><given-names>JM</given-names></name><name name-style="western"><surname>Freimuth</surname><given-names>J</given-names></name><name name-style="western"><surname>Beraza</surname><given-names>N</given-names></name><name name-style="western"><surname>Lambertz</surname><given-names>D</given-names></name><name name-style="western"><surname>Cubero</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury</article-title><source>Gastroenterology</source><year>2011</year><volume>141</volume><fpage>2176</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2011.08.037</pub-id><pub-id pub-id-type="pmid">21878202</pub-id></element-citation></ref><ref id="CR756"><label>756.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>HM</given-names></name><name name-style="western"><surname>McGill</surname><given-names>MR</given-names></name><name name-style="western"><surname>Chao</surname><given-names>X</given-names></name><name name-style="western"><surname>Woolbright</surname><given-names>BL</given-names></name><name name-style="western"><surname>Jaeschke</surname><given-names>H</given-names></name><name name-style="western"><surname>Ding</surname><given-names>WX</given-names></name></person-group><article-title>Caspase inhibition prevents tumor necrosis factor-&#945;-induced apoptosis and promotes necrotic cell death in mouse hepatocytes in vivo and in vitro</article-title><source>Am J Pathol</source><year>2016</year><volume>186</volume><fpage>2623</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2016.06.009</pub-id><pub-id pub-id-type="pmid">27616656</pub-id><pub-id pub-id-type="pmcid">PMC5222974</pub-id></element-citation></ref><ref id="CR757"><label>757.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wroblewski</surname><given-names>R</given-names></name><name name-style="western"><surname>Armaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Kondylis</surname><given-names>V</given-names></name><name name-style="western"><surname>Pasparakis</surname><given-names>M</given-names></name><name name-style="western"><surname>Walczak</surname><given-names>H</given-names></name><name name-style="western"><surname>Mittr&#252;cker</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Opposing role of tumor necrosis factor receptor 1 signaling in T cell-mediated hepatitis and bacterial infection in mice</article-title><source>Hepatology</source><year>2016</year><volume>64</volume><fpage>508</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/hep.28551</pub-id><pub-id pub-id-type="pmid">26991125</pub-id></element-citation></ref><ref id="CR758"><label>758.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zender</surname><given-names>L</given-names></name><name name-style="western"><surname>Hutker</surname><given-names>S</given-names></name><name name-style="western"><surname>Liedtke</surname><given-names>C</given-names></name><name name-style="western"><surname>Tillmann</surname><given-names>HL</given-names></name><name name-style="western"><surname>Zender</surname><given-names>S</given-names></name><name name-style="western"><surname>Mundt</surname><given-names>B</given-names></name><etal/></person-group><article-title>Caspase 8 small interfering RNA prevents acute liver failure in mice</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>7797</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1073/pnas.1330920100</pub-id><pub-id pub-id-type="pmid">12810955</pub-id><pub-id pub-id-type="pmcid">PMC164667</pub-id></element-citation></ref><ref id="CR759"><label>759.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schattenberg</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>T</given-names></name><name name-style="western"><surname>W&#246;rns</surname><given-names>M</given-names></name><name name-style="western"><surname>Sprinzl</surname><given-names>MF</given-names></name><name name-style="western"><surname>Kreft</surname><given-names>A</given-names></name><name name-style="western"><surname>Kohl</surname><given-names>T</given-names></name><etal/></person-group><article-title>Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo</article-title><source>J Hepatol</source><year>2011</year><volume>55</volume><fpage>1272</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2011.03.008</pub-id><pub-id pub-id-type="pmid">21703207</pub-id></element-citation></ref><ref id="CR760"><label>760.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazic</surname><given-names>M</given-names></name><name name-style="western"><surname>Eguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Berk</surname><given-names>MP</given-names></name><name name-style="western"><surname>Povero</surname><given-names>D</given-names></name><name name-style="western"><surname>Papouchado</surname><given-names>B</given-names></name><name name-style="western"><surname>Mulya</surname><given-names>A</given-names></name><etal/></person-group><article-title>Differential regulation of inflammation and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient mice</article-title><source>J Hepatol</source><year>2014</year><volume>61</volume><fpage>107</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2014.03.028</pub-id><pub-id pub-id-type="pmid">24681344</pub-id><pub-id pub-id-type="pmcid">PMC4712949</pub-id></element-citation></ref><ref id="CR761"><label>761.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaufmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Tai</surname><given-names>L</given-names></name><name name-style="western"><surname>Ekert</surname><given-names>PG</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Norris</surname><given-names>F</given-names></name><name name-style="western"><surname>Lindemann</surname><given-names>RK</given-names></name><etal/></person-group><article-title>The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest</article-title><source>Cell</source><year>2007</year><volume>129</volume><fpage>423</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.03.017</pub-id><pub-id pub-id-type="pmid">17448999</pub-id></element-citation></ref><ref id="CR762"><label>762.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hikita</surname><given-names>H</given-names></name><name name-style="western"><surname>Takehara</surname><given-names>T</given-names></name><name name-style="western"><surname>Kodama</surname><given-names>T</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Shigekawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Hosui</surname><given-names>A</given-names></name><etal/></person-group><article-title>Delayed-onset caspase-dependent massive hepatocyte apoptosis upon Fas activation in Bak/Bax-deficient mice</article-title><source>Hepatology</source><year>2011</year><volume>54</volume><fpage>240</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1002/hep.24305</pub-id><pub-id pub-id-type="pmid">21425311</pub-id></element-citation></ref><ref id="CR763"><label>763.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>I</given-names></name><name name-style="western"><surname>Matsuura</surname><given-names>K</given-names></name><name name-style="western"><surname>Khatib</surname><given-names>K</given-names></name><name name-style="western"><surname>Reed</surname><given-names>JC</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>S</given-names></name><name name-style="western"><surname>Vassalli</surname><given-names>P</given-names></name></person-group><article-title>A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection</article-title><source>J Exp Med</source><year>1996</year><volume>183</volume><fpage>1031</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1084/jem.183.3.1031</pub-id><pub-id pub-id-type="pmid">8642244</pub-id><pub-id pub-id-type="pmcid">PMC2192310</pub-id></element-citation></ref><ref id="CR764"><label>764.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lacronique</surname><given-names>V</given-names></name><name name-style="western"><surname>Mignon</surname><given-names>A</given-names></name><name name-style="western"><surname>Fabre</surname><given-names>M</given-names></name><name name-style="western"><surname>Viollet</surname><given-names>B</given-names></name><name name-style="western"><surname>Rouquet</surname><given-names>N</given-names></name><name name-style="western"><surname>Molina</surname><given-names>T</given-names></name><etal/></person-group><article-title>Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/nm0196-80</pub-id><pub-id pub-id-type="pmid">8564847</pub-id></element-citation></ref><ref id="CR765"><label>765.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Tao</surname><given-names>L</given-names></name><name name-style="western"><surname>Pan</surname><given-names>X</given-names></name><etal/></person-group><article-title>Fas/FasL mediates NF-&#954;Bp65/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis</article-title><source>Cell Death Dis</source><year>2021</year><volume>12</volume><fpage>474</fpage><pub-id pub-id-type="doi">10.1038/s41419-021-03749-x</pub-id><pub-id pub-id-type="pmid">33980818</pub-id><pub-id pub-id-type="pmcid">PMC8115181</pub-id></element-citation></ref><ref id="CR766"><label>766.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inactivation of BAD by IKK inhibits TNF&#945;-induced apoptosis independently of NF-&#954;B activation</article-title><source>Cell</source><year>2013</year><volume>152</volume><fpage>304</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.12.021</pub-id><pub-id pub-id-type="pmid">23332762</pub-id><pub-id pub-id-type="pmcid">PMC3586589</pub-id></element-citation></ref><ref id="CR767"><label>767.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ottina</surname><given-names>E</given-names></name><name name-style="western"><surname>Sochalska</surname><given-names>M</given-names></name><name name-style="western"><surname>Sgonc</surname><given-names>R</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name></person-group><article-title>The BH3-only protein Bad is dispensable for TNF-mediated cell death</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1611</fpage><pub-id pub-id-type="doi">10.1038/cddis.2014.575</pub-id><pub-id pub-id-type="pmid">25611386</pub-id><pub-id pub-id-type="pmcid">PMC4669773</pub-id></element-citation></ref><ref id="CR768"><label>768.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>M</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>A</given-names></name><name name-style="western"><surname>Elia</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>R</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>GS</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes</article-title><source>J Immunol</source><year>1999</year><volume>163</volume><fpage>4909</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.163.9.4909</pub-id><pub-id pub-id-type="pmid">10528193</pub-id></element-citation></ref><ref id="CR769"><label>769.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bajt</surname><given-names>ML</given-names></name><name name-style="western"><surname>Vonderfecht</surname><given-names>SL</given-names></name><name name-style="western"><surname>Jaeschke</surname><given-names>H</given-names></name></person-group><article-title>Differential protection with inhibitors of caspase-8 and caspase-3 in murine models of tumor necrosis factor and Fas receptor-mediated hepatocellular apoptosis</article-title><source>Toxicol Appl Pharmacol</source><year>2001</year><volume>175</volume><fpage>243</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1006/taap.2001.9242</pub-id><pub-id pub-id-type="pmid">11559023</pub-id></element-citation></ref><ref id="CR770"><label>770.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>TS</given-names></name><name name-style="western"><surname>Hunot</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Momoi</surname><given-names>T</given-names></name><name name-style="western"><surname>Srinivasan</surname><given-names>A</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation</article-title><source>Nat Med</source><year>2000</year><volume>6</volume><fpage>1241</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/81343</pub-id><pub-id pub-id-type="pmid">11062535</pub-id></element-citation></ref><ref id="CR771"><label>771.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudo</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Saito</surname><given-names>K</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Ohashi</surname><given-names>H</given-names></name><name name-style="western"><surname>Kato</surname><given-names>T</given-names></name><etal/></person-group><article-title>TNF-alpha and IL-6 signals from the bone marrow derived cells are necessary for normal murine liver regeneration</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1782</volume><fpage>671</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2008.09.010</pub-id><pub-id pub-id-type="pmid">18948191</pub-id></element-citation></ref><ref id="CR772"><label>772.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Desbarats</surname><given-names>J</given-names></name><name name-style="western"><surname>Newell</surname><given-names>MK</given-names></name></person-group><article-title>Fas engagement accelerates liver regeneration after partial hepatectomy</article-title><source>Nat Med</source><year>2000</year><volume>6</volume><fpage>920</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1038/78688</pub-id><pub-id pub-id-type="pmid">10932231</pub-id></element-citation></ref><ref id="CR773"><label>773.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>B</given-names></name><name name-style="western"><surname>Yeoh</surname><given-names>GC</given-names></name></person-group><article-title>TNF/LTalpha double knockout mice display abnormal inflammatory and regenerative responses to acute and chronic liver injury</article-title><source>Cell Tissue Res</source><year>2005</year><volume>319</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/s00441-004-1003-6</pub-id><pub-id pub-id-type="pmid">15592751</pub-id></element-citation></ref><ref id="CR774"><label>774.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taira</surname><given-names>K</given-names></name><name name-style="western"><surname>Hiroyasu</surname><given-names>S</given-names></name><name name-style="western"><surname>Shiraishi</surname><given-names>M</given-names></name><name name-style="western"><surname>Muto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Koji</surname><given-names>T</given-names></name></person-group><article-title>Role of the Fas system in liver regeneration after a partial hepatectomy in rats</article-title><source>Eur Surg Res</source><year>2001</year><volume>33</volume><fpage>334</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1159/000049727</pub-id><pub-id pub-id-type="pmid">11805393</pub-id></element-citation></ref><ref id="CR775"><label>775.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuchmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Ruckert</surname><given-names>F</given-names></name><name name-style="western"><surname>Garcia-Lazaro</surname><given-names>JF</given-names></name><name name-style="western"><surname>Karg</surname><given-names>A</given-names></name><name name-style="western"><surname>Burg</surname><given-names>J</given-names></name><name name-style="western"><surname>Knorr</surname><given-names>N</given-names></name><etal/></person-group><article-title>MORT1/FADD is involved in liver regeneration</article-title><source>World J Gastroenterol</source><year>2005</year><volume>11</volume><fpage>7248</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.3748/wjg.v11.i46.7248</pub-id><pub-id pub-id-type="pmid">16437623</pub-id><pub-id pub-id-type="pmcid">PMC4725154</pub-id></element-citation></ref><ref id="CR776"><label>776.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben Moshe</surname><given-names>T</given-names></name><name name-style="western"><surname>Barash</surname><given-names>H</given-names></name><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kovalenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Gross</surname><given-names>E</given-names></name><etal/></person-group><article-title>Role of caspase-8 in hepatocyte response to infection and injury in mice</article-title><source>Hepatology</source><year>2007</year><volume>45</volume><fpage>1014</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/hep.21495</pub-id><pub-id pub-id-type="pmid">17385212</pub-id></element-citation></ref><ref id="CR777"><label>777.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freimuth</surname><given-names>J</given-names></name><name name-style="western"><surname>Bangen</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lambertz</surname><given-names>D</given-names></name><name name-style="western"><surname>Hu</surname><given-names>W</given-names></name><name name-style="western"><surname>Nevzorova</surname><given-names>YA</given-names></name><name name-style="western"><surname>Sonntag</surname><given-names>R</given-names></name><etal/></person-group><article-title>Loss of caspase-8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation</article-title><source>Hepatology</source><year>2013</year><volume>58</volume><fpage>1779</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1002/hep.26538</pub-id><pub-id pub-id-type="pmid">23728913</pub-id></element-citation></ref><ref id="CR778"><label>778.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isayama</surname><given-names>F</given-names></name><name name-style="western"><surname>Moore</surname><given-names>S</given-names></name><name name-style="western"><surname>Hines</surname><given-names>IN</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>MD</given-names></name></person-group><article-title>Fas regulates macrophage polarization and fibrogenic phenotype in a model of chronic ethanol-induced hepatocellular injury</article-title><source>Am J Pathol</source><year>2016</year><volume>186</volume><fpage>1524</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2016.02.006</pub-id><pub-id pub-id-type="pmid">27102767</pub-id><pub-id pub-id-type="pmcid">PMC4901134</pub-id></element-citation></ref><ref id="CR779"><label>779.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verma</surname><given-names>VK</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Hirsova</surname><given-names>P</given-names></name><name name-style="western"><surname>Mushref</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles</article-title><source>J Hepatol</source><year>2016</year><volume>64</volume><fpage>651</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2015.11.020</pub-id><pub-id pub-id-type="pmid">26632633</pub-id><pub-id pub-id-type="pmcid">PMC4761285</pub-id></element-citation></ref><ref id="CR780"><label>780.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>M</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>MD</given-names></name><name name-style="western"><surname>Kono</surname><given-names>H</given-names></name><name name-style="western"><surname>Bradford</surname><given-names>BU</given-names></name><name name-style="western"><surname>Gallucci</surname><given-names>RM</given-names></name><name name-style="western"><surname>Luster</surname><given-names>MI</given-names></name><etal/></person-group><article-title>Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice</article-title><source>Gastroenterology</source><year>1999</year><volume>117</volume><fpage>942</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(99)70354-9</pub-id><pub-id pub-id-type="pmid">10500078</pub-id></element-citation></ref><ref id="CR781"><label>781.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mundt</surname><given-names>B</given-names></name><name name-style="western"><surname>Wirth</surname><given-names>T</given-names></name><name name-style="western"><surname>Zender</surname><given-names>L</given-names></name><name name-style="western"><surname>Waltemathe</surname><given-names>M</given-names></name><name name-style="western"><surname>Trautwein</surname><given-names>C</given-names></name><name name-style="western"><surname>Manns</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake</article-title><source>Gut</source><year>2005</year><volume>54</volume><fpage>1590</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1136/gut.2004.056929</pub-id><pub-id pub-id-type="pmid">16227360</pub-id><pub-id pub-id-type="pmcid">PMC1774732</pub-id></element-citation></ref><ref id="CR782"><label>782.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hao</surname><given-names>F</given-names></name><name name-style="western"><surname>Cubero</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Ramadori</surname><given-names>P</given-names></name><name name-style="western"><surname>Liao</surname><given-names>L</given-names></name><name name-style="western"><surname>Haas</surname><given-names>U</given-names></name><name name-style="western"><surname>Lambertz</surname><given-names>D</given-names></name><etal/></person-group><article-title>Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice</article-title><source>Cell Death Dis</source><year>2017</year><volume>8</volume><fpage>e3152</fpage><pub-id pub-id-type="doi">10.1038/cddis.2017.532</pub-id><pub-id pub-id-type="pmid">29072704</pub-id><pub-id pub-id-type="pmcid">PMC5680911</pub-id></element-citation></ref><ref id="CR783"><label>783.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Kang</surname><given-names>YJ</given-names></name></person-group><article-title>Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway</article-title><source>Am J Pathol</source><year>2001</year><volume>159</volume><fpage>329</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)61699-9</pub-id><pub-id pub-id-type="pmid">11438480</pub-id><pub-id pub-id-type="pmcid">PMC1850406</pub-id></element-citation></ref><ref id="CR784"><label>784.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Item</surname><given-names>F</given-names></name><name name-style="western"><surname>Wueest</surname><given-names>S</given-names></name><name name-style="western"><surname>Lemos</surname><given-names>V</given-names></name><name name-style="western"><surname>Stein</surname><given-names>S</given-names></name><name name-style="western"><surname>Lucchini</surname><given-names>FC</given-names></name><name name-style="western"><surname>Denzler</surname><given-names>R</given-names></name><etal/></person-group><article-title>Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>480</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-00566-9</pub-id><pub-id pub-id-type="pmid">28883393</pub-id><pub-id pub-id-type="pmcid">PMC5589858</pub-id></element-citation></ref><ref id="CR785"><label>785.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kakino</surname><given-names>S</given-names></name><name name-style="western"><surname>Ohki</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>H</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>X</given-names></name><name name-style="western"><surname>Otabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Hashinaga</surname><given-names>T</given-names></name><etal/></person-group><article-title>Pivotal role of TNF-&#945; in the development and progression of nonalcoholic fatty liver disease in a murine model</article-title><source>Horm Metab Res</source><year>2018</year><volume>50</volume><fpage>80</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1055/s-0043-118666</pub-id><pub-id pub-id-type="pmid">28922680</pub-id></element-citation></ref><ref id="CR786"><label>786.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salles</surname><given-names>J</given-names></name><name name-style="western"><surname>Tardif</surname><given-names>N</given-names></name><name name-style="western"><surname>Landrier</surname><given-names>JF</given-names></name><name name-style="western"><surname>Mothe-Satney</surname><given-names>I</given-names></name><name name-style="western"><surname>Guillet</surname><given-names>C</given-names></name><name name-style="western"><surname>Boue-Vaysse</surname><given-names>C</given-names></name><etal/></person-group><article-title>TNF&#945; gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice</article-title><source>J Nutr Biochem</source><year>2012</year><volume>23</volume><fpage>1685</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2011.12.001</pub-id><pub-id pub-id-type="pmid">22464148</pub-id></element-citation></ref><ref id="CR787"><label>787.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanuri</surname><given-names>G</given-names></name><name name-style="western"><surname>Spruss</surname><given-names>A</given-names></name><name name-style="western"><surname>Wagnerberger</surname><given-names>S</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>SC</given-names></name><name name-style="western"><surname>Bergheim</surname><given-names>I</given-names></name></person-group><article-title>Role of tumor necrosis factor &#945; (TNF&#945;) in the onset of fructose-induced nonalcoholic fatty liver disease in mice</article-title><source>J Nutr Biochem</source><year>2011</year><volume>22</volume><fpage>527</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2010.04.007</pub-id><pub-id pub-id-type="pmid">20801629</pub-id></element-citation></ref><ref id="CR788"><label>788.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomita</surname><given-names>K</given-names></name><name name-style="western"><surname>Tamiya</surname><given-names>G</given-names></name><name name-style="western"><surname>Ando</surname><given-names>S</given-names></name><name name-style="western"><surname>Ohsumi</surname><given-names>K</given-names></name><name name-style="western"><surname>Chiyo</surname><given-names>T</given-names></name><name name-style="western"><surname>Mizutani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice</article-title><source>Gut</source><year>2006</year><volume>55</volume><fpage>415</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1136/gut.2005.071118</pub-id><pub-id pub-id-type="pmid">16174657</pub-id><pub-id pub-id-type="pmcid">PMC1856073</pub-id></element-citation></ref><ref id="CR789"><label>789.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Sousa Rodrigues</surname><given-names>ME</given-names></name><name name-style="western"><surname>Houser</surname><given-names>MC</given-names></name><name name-style="western"><surname>Walker</surname><given-names>DI</given-names></name><name name-style="western"><surname>Jones</surname><given-names>DP</given-names></name><name name-style="western"><surname>Chang</surname><given-names>J</given-names></name><name name-style="western"><surname>Barnum</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer&#8217;s disease associated with obesity, metabolic syndrome, and type 2 diabetes</article-title><source>Alzheimers Res Ther</source><year>2019</year><volume>12</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/s13195-019-0546-4</pub-id><pub-id pub-id-type="pmid">31892368</pub-id><pub-id pub-id-type="pmcid">PMC6937979</pub-id></element-citation></ref><ref id="CR790"><label>790.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ilan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ben</surname><given-names>Ya&#8217;acovA</given-names></name><name name-style="western"><surname>Shabbat</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gingis-Velitski</surname><given-names>S</given-names></name><name name-style="western"><surname>Almon</surname><given-names>E</given-names></name><name name-style="western"><surname>Shaaltiel</surname><given-names>Y</given-names></name></person-group><article-title>Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis</article-title><source>World J Gastroenterol</source><year>2016</year><volume>22</volume><fpage>8760</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3748/wjg.v22.i39.8760</pub-id><pub-id pub-id-type="pmid">27818591</pub-id><pub-id pub-id-type="pmcid">PMC5075550</pub-id></element-citation></ref><ref id="CR791"><label>791.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koca</surname><given-names>SS</given-names></name><name name-style="western"><surname>Bahcecioglu</surname><given-names>IH</given-names></name><name name-style="western"><surname>Poyrazoglu</surname><given-names>OK</given-names></name><name name-style="western"><surname>Ozercan</surname><given-names>IH</given-names></name><name name-style="western"><surname>Sahin</surname><given-names>K</given-names></name><name name-style="western"><surname>Ustundag</surname><given-names>B</given-names></name></person-group><article-title>The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet</article-title><source>Inflammation</source><year>2008</year><volume>31</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/s10753-007-9053-z</pub-id><pub-id pub-id-type="pmid">18066656</pub-id></element-citation></ref><ref id="CR792"><label>792.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wandrer</surname><given-names>F</given-names></name><name name-style="western"><surname>Liebig</surname><given-names>S</given-names></name><name name-style="western"><surname>Marhenke</surname><given-names>S</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>A</given-names></name><name name-style="western"><surname>John</surname><given-names>K</given-names></name><name name-style="western"><surname>Manns</surname><given-names>MP</given-names></name><etal/></person-group><article-title>TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice</article-title><source>Cell Death Dis</source><year>2020</year><volume>11</volume><fpage>212</fpage><pub-id pub-id-type="doi">10.1038/s41419-020-2411-6</pub-id><pub-id pub-id-type="pmid">32235829</pub-id><pub-id pub-id-type="pmcid">PMC7109108</pub-id></element-citation></ref><ref id="CR793"><label>793.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bluemel</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Schnabl</surname><given-names>B</given-names></name></person-group><article-title>Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice</article-title><source>World J Gastroenterol</source><year>2020</year><volume>26</volume><fpage>4933</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.3748/wjg.v26.i33.4933</pub-id><pub-id pub-id-type="pmid">32952340</pub-id><pub-id pub-id-type="pmcid">PMC7476178</pub-id></element-citation></ref><ref id="CR794"><label>794.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambertucci</surname><given-names>F</given-names></name><name name-style="western"><surname>Arboatti</surname><given-names>A</given-names></name><name name-style="western"><surname>Sedlmeier</surname><given-names>MG</given-names></name><name name-style="western"><surname>Moti&#241;o</surname><given-names>O</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>ML</given-names></name><name name-style="western"><surname>Ceballos</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet</article-title><source>J Nutr Biochem</source><year>2018</year><volume>58</volume><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2018.04.013</pub-id><pub-id pub-id-type="pmid">29860102</pub-id></element-citation></ref><ref id="CR795"><label>795.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernardi</surname><given-names>S</given-names></name><name name-style="western"><surname>Toffoli</surname><given-names>B</given-names></name><name name-style="western"><surname>Tisato</surname><given-names>V</given-names></name><name name-style="western"><surname>Bossi</surname><given-names>F</given-names></name><name name-style="western"><surname>Biffi</surname><given-names>S</given-names></name><name name-style="western"><surname>Lorenzon</surname><given-names>A</given-names></name><etal/></person-group><article-title>TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse</article-title><source>Clin Sci</source><year>2018</year><volume>132</volume><fpage>69</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1042/CS20171221</pub-id><pub-id pub-id-type="pmid">29167318</pub-id></element-citation></ref><ref id="CR796"><label>796.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirsova</surname><given-names>P</given-names></name><name name-style="western"><surname>Weng</surname><given-names>P</given-names></name><name name-style="western"><surname>Salim</surname><given-names>W</given-names></name><name name-style="western"><surname>Bronk</surname><given-names>SF</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>TS</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>SH</given-names></name><etal/></person-group><article-title>TRAIL deletion prevents liver, but not adipose tissue, inflammation during murine diet-induced obesity</article-title><source>Hepatol Commun</source><year>2017</year><volume>1</volume><fpage>648</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1002/hep4.1069</pub-id><pub-id pub-id-type="pmid">29124251</pub-id><pub-id pub-id-type="pmcid">PMC5673124</pub-id></element-citation></ref><ref id="CR797"><label>797.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cartland</surname><given-names>SP</given-names></name><name name-style="western"><surname>Harith</surname><given-names>HH</given-names></name><name name-style="western"><surname>Genner</surname><given-names>SW</given-names></name><name name-style="western"><surname>Dang</surname><given-names>L</given-names></name><name name-style="western"><surname>Cogger</surname><given-names>VC</given-names></name><name name-style="western"><surname>Vellozzi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>1898</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-01721-4</pub-id><pub-id pub-id-type="pmid">28507343</pub-id><pub-id pub-id-type="pmcid">PMC5432513</pub-id></element-citation></ref><ref id="CR798"><label>798.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnan</surname><given-names>A</given-names></name><name name-style="western"><surname>Katsumi</surname><given-names>T</given-names></name><name name-style="western"><surname>Guicciardi</surname><given-names>ME</given-names></name><name name-style="western"><surname>Azad</surname><given-names>AI</given-names></name><name name-style="western"><surname>Ozturk</surname><given-names>NB</given-names></name><name name-style="western"><surname>Trussoni</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-related apoptosis-inducing ligand receptor deficiency promotes the ductular reaction, macrophage accumulation, and hepatic fibrosis in the Abcb4(&#8722;/&#8722;) mouse</article-title><source>Am J Pathol</source><year>2020</year><volume>190</volume><fpage>1284</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2020.02.013</pub-id><pub-id pub-id-type="pmid">32240619</pub-id><pub-id pub-id-type="pmcid">PMC7280758</pub-id></element-citation></ref><ref id="CR799"><label>799.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gujral</surname><given-names>JS</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Farhood</surname><given-names>A</given-names></name><name name-style="western"><surname>Jaeschke</surname><given-names>H</given-names></name></person-group><article-title>Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation</article-title><source>Hepatology</source><year>2004</year><volume>40</volume><fpage>998</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1002/hep.1840400431</pub-id><pub-id pub-id-type="pmid">15382126</pub-id></element-citation></ref><ref id="CR800"><label>800.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canbay</surname><given-names>A</given-names></name><name name-style="western"><surname>Higuchi</surname><given-names>H</given-names></name><name name-style="western"><surname>Bronk</surname><given-names>SF</given-names></name><name name-style="western"><surname>Taniai</surname><given-names>M</given-names></name><name name-style="western"><surname>Sebo</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Gores</surname><given-names>GJ</given-names></name></person-group><article-title>Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis</article-title><source>Gastroenterology</source><year>2002</year><volume>123</volume><fpage>1323</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1053/gast.2002.35953</pub-id><pub-id pub-id-type="pmid">12360492</pub-id></element-citation></ref><ref id="CR801"><label>801.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyoshi</surname><given-names>H</given-names></name><name name-style="western"><surname>Rust</surname><given-names>C</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Burgart</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Gores</surname><given-names>GJ</given-names></name></person-group><article-title>Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas</article-title><source>Gastroenterology</source><year>1999</year><volume>117</volume><fpage>669</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(99)70461-0</pub-id><pub-id pub-id-type="pmid">10464144</pub-id></element-citation></ref><ref id="CR802"><label>802.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hoshi</surname><given-names>M</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>I</given-names></name><name name-style="western"><surname>Saibara</surname><given-names>T</given-names></name><name name-style="western"><surname>Moriwaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Kozawa</surname><given-names>O</given-names></name></person-group><article-title>Tumor necrosis factor-&#945; promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells</article-title><source>PloS one</source><year>2013</year><volume>8</volume><fpage>e65251</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0065251</pub-id><pub-id pub-id-type="pmid">23755201</pub-id><pub-id pub-id-type="pmcid">PMC3670853</pub-id></element-citation></ref><ref id="CR803"><label>803.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#228;bele</surname><given-names>E</given-names></name><name name-style="western"><surname>Froh</surname><given-names>M</given-names></name><name name-style="western"><surname>Arteel</surname><given-names>GE</given-names></name><name name-style="western"><surname>Uesugi</surname><given-names>T</given-names></name><name name-style="western"><surname>Hellerbrand</surname><given-names>C</given-names></name><name name-style="western"><surname>Sch&#246;lmerich</surname><given-names>J</given-names></name><etal/></person-group><article-title>TNFalpha is required for cholestasis-induced liver fibrosis in the mouse</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>378</volume><fpage>348</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.10.155</pub-id><pub-id pub-id-type="pmid">18996089</pub-id><pub-id pub-id-type="pmcid">PMC5052129</pub-id></element-citation></ref><ref id="CR804"><label>804.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name><name name-style="western"><surname>Kojima</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ikejima</surname><given-names>K</given-names></name><name name-style="western"><surname>Harada</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamashina</surname><given-names>S</given-names></name><name name-style="western"><surname>Okumura</surname><given-names>K</given-names></name><etal/></person-group><article-title>Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>10895</fpage><lpage>10900</lpage><pub-id pub-id-type="doi">10.1073/pnas.0802702105</pub-id><pub-id pub-id-type="pmid">18667695</pub-id><pub-id pub-id-type="pmcid">PMC2504811</pub-id></element-citation></ref><ref id="CR805"><label>805.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kahraman</surname><given-names>A</given-names></name><name name-style="western"><surname>Barreyro</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Bronk</surname><given-names>SF</given-names></name><name name-style="western"><surname>Werneburg</surname><given-names>NW</given-names></name><name name-style="western"><surname>Mott</surname><given-names>JL</given-names></name><name name-style="western"><surname>Akazawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse</article-title><source>Hepatology</source><year>2008</year><volume>47</volume><fpage>1317</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1002/hep.22136</pub-id><pub-id pub-id-type="pmid">18220275</pub-id><pub-id pub-id-type="pmcid">PMC2570266</pub-id></element-citation></ref><ref id="CR806"><label>806.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zha</surname><given-names>D</given-names></name><name name-style="western"><surname>Gan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cai</surname><given-names>F</given-names></name><name name-style="western"><surname>Du</surname><given-names>P</given-names></name><etal/></person-group><article-title>FADD is a key regulator of lipid metabolism</article-title><source>EMBO Mol Med</source><year>2016</year><volume>8</volume><fpage>895</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.15252/emmm.201505924</pub-id><pub-id pub-id-type="pmid">27357657</pub-id><pub-id pub-id-type="pmcid">PMC4967943</pub-id></element-citation></ref><ref id="CR807"><label>807.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>PX</given-names></name><name name-style="western"><surname>Ji</surname><given-names>YX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>LP</given-names></name><name name-style="western"><surname>Yan</surname><given-names>ZZ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><etal/></person-group><article-title>Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates</article-title><source>Nat Med</source><year>2017</year><volume>23</volume><fpage>439</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/nm.4290</pub-id><pub-id pub-id-type="pmid">28218919</pub-id></element-citation></ref><ref id="CR808"><label>808.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gehrke</surname><given-names>N</given-names></name><name name-style="western"><surname>Nagel</surname><given-names>M</given-names></name><name name-style="western"><surname>Straub</surname><given-names>BK</given-names></name><name name-style="western"><surname>W&#246;rns</surname><given-names>MA</given-names></name><name name-style="western"><surname>Schuchmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Galle</surname><given-names>PR</given-names></name><etal/></person-group><article-title>Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2018</year><volume>314</volume><fpage>G319</fpage><lpage>g333</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00097.2017</pub-id><pub-id pub-id-type="pmid">29191940</pub-id></element-citation></ref><ref id="CR809"><label>809.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaudhary</surname><given-names>K</given-names></name><name name-style="western"><surname>Liedtke</surname><given-names>C</given-names></name><name name-style="western"><surname>Wertenbruch</surname><given-names>S</given-names></name><name name-style="western"><surname>Trautwein</surname><given-names>C</given-names></name><name name-style="western"><surname>Streetz</surname><given-names>KL</given-names></name></person-group><article-title>Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice</article-title><source>J Hepatol</source><year>2013</year><volume>59</volume><fpage>1292</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2013.07.026</pub-id><pub-id pub-id-type="pmid">23928400</pub-id></element-citation></ref><ref id="CR810"><label>810.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hatting</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name><name name-style="western"><surname>Schumacher</surname><given-names>F</given-names></name><name name-style="western"><surname>Sellge</surname><given-names>G</given-names></name><name name-style="western"><surname>Al Masaoudi</surname><given-names>M</given-names></name><name name-style="western"><surname>Ga&#946;ler</surname><given-names>N</given-names></name><etal/></person-group><article-title>Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents</article-title><source>Hepatology</source><year>2013</year><volume>57</volume><fpage>2189</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1002/hep.26271</pub-id><pub-id pub-id-type="pmid">23339067</pub-id></element-citation></ref><ref id="CR811"><label>811.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cubero</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J</given-names></name><name name-style="western"><surname>Liao</surname><given-names>L</given-names></name><name name-style="western"><surname>Su</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name><name name-style="western"><surname>Zoubek</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis</article-title><source>J Hepatol</source><year>2018</year><volume>69</volume><fpage>1326</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2018.08.015</pub-id><pub-id pub-id-type="pmid">30144553</pub-id></element-citation></ref><ref id="CR812"><label>812.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondylis</surname><given-names>V</given-names></name><name name-style="western"><surname>Polykratis</surname><given-names>A</given-names></name><name name-style="western"><surname>Ehlken</surname><given-names>H</given-names></name><name name-style="western"><surname>Ochoa-Callejero</surname><given-names>L</given-names></name><name name-style="western"><surname>Straub</surname><given-names>BK</given-names></name><name name-style="western"><surname>Krishna-Subramanian</surname><given-names>S</given-names></name><etal/></person-group><article-title>NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis</article-title><source>Cancer Cell</source><year>2015</year><volume>28</volume><fpage>582</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2015.10.001</pub-id><pub-id pub-id-type="pmid">26555174</pub-id><pub-id pub-id-type="pmcid">PMC4644221</pub-id></element-citation></ref><ref id="CR813"><label>813.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehlken</surname><given-names>H</given-names></name><name name-style="western"><surname>Krishna-Subramanian</surname><given-names>S</given-names></name><name name-style="western"><surname>Ochoa-Callejero</surname><given-names>L</given-names></name><name name-style="western"><surname>Kondylis</surname><given-names>V</given-names></name><name name-style="western"><surname>Nadi</surname><given-names>NE</given-names></name><name name-style="western"><surname>Straub</surname><given-names>BK</given-names></name><etal/></person-group><article-title>Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout</article-title><source>Cell Death Differ</source><year>2014</year><volume>21</volume><fpage>1721</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.83</pub-id><pub-id pub-id-type="pmid">24971483</pub-id><pub-id pub-id-type="pmcid">PMC4211370</pub-id></element-citation></ref><ref id="CR814"><label>814.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogel</surname><given-names>A</given-names></name><name name-style="western"><surname>Aslan</surname><given-names>JE</given-names></name><name name-style="western"><surname>Willenbring</surname><given-names>H</given-names></name><name name-style="western"><surname>Klein</surname><given-names>C</given-names></name><name name-style="western"><surname>Finegold</surname><given-names>M</given-names></name><name name-style="western"><surname>Mount</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases</article-title><source>Gastroenterology</source><year>2006</year><volume>130</volume><fpage>104</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2005.10.012</pub-id><pub-id pub-id-type="pmid">16401474</pub-id><pub-id pub-id-type="pmcid">PMC1424224</pub-id></element-citation></ref><ref id="CR815"><label>815.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Straus</surname><given-names>SE</given-names></name><name name-style="western"><surname>Jaffe</surname><given-names>ES</given-names></name><name name-style="western"><surname>Puck</surname><given-names>JM</given-names></name><name name-style="western"><surname>Dale</surname><given-names>JK</given-names></name><name name-style="western"><surname>Elkon</surname><given-names>KB</given-names></name><name name-style="western"><surname>R&#246;sen-Wolff</surname><given-names>A</given-names></name><etal/></person-group><article-title>The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis</article-title><source>Blood</source><year>2001</year><volume>98</volume><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1182/blood.V98.1.194</pub-id><pub-id pub-id-type="pmid">11418480</pub-id></element-citation></ref><ref id="CR816"><label>816.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davidson</surname><given-names>WF</given-names></name><name name-style="western"><surname>Giese</surname><given-names>T</given-names></name><name name-style="western"><surname>Fredrickson</surname><given-names>TN</given-names></name></person-group><article-title>Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions</article-title><source>J Exp Med</source><year>1998</year><volume>187</volume><fpage>1825</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1084/jem.187.11.1825</pub-id><pub-id pub-id-type="pmid">9607923</pub-id><pub-id pub-id-type="pmcid">PMC2212316</pub-id></element-citation></ref><ref id="CR817"><label>817.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finnberg</surname><given-names>N</given-names></name><name name-style="western"><surname>Klein-Szanto</surname><given-names>AJ</given-names></name><name name-style="western"><surname>El-Deiry</surname><given-names>WS</given-names></name></person-group><article-title>TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis</article-title><source>J Clin Investig</source><year>2008</year><volume>118</volume><fpage>111</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1172/JCI29900</pub-id><pub-id pub-id-type="pmid">18079962</pub-id><pub-id pub-id-type="pmcid">PMC2129232</pub-id></element-citation></ref><ref id="CR818"><label>818.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zerafa</surname><given-names>N</given-names></name><name name-style="western"><surname>Westwood</surname><given-names>JA</given-names></name><name name-style="western"><surname>Cretney</surname><given-names>E</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>S</given-names></name><name name-style="western"><surname>Waring</surname><given-names>P</given-names></name><name name-style="western"><surname>Iezzi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cutting edge: TRAIL deficiency accelerates hematological malignancies</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>5586</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.9.5586</pub-id><pub-id pub-id-type="pmid">16237043</pub-id></element-citation></ref><ref id="CR819"><label>819.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>HH</given-names></name><name name-style="western"><surname>Diehl</surname><given-names>GE</given-names></name><name name-style="western"><surname>Winoto</surname><given-names>A</given-names></name></person-group><article-title>Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice</article-title><source>Cell Death Differ</source><year>2005</year><volume>12</volume><fpage>94</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401523</pub-id><pub-id pub-id-type="pmid">15514675</pub-id></element-citation></ref><ref id="CR820"><label>820.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LA</surname><given-names>OR</given-names></name><name name-style="western"><surname>Tai</surname><given-names>L</given-names></name><name name-style="western"><surname>Lee</surname><given-names>L</given-names></name><name name-style="western"><surname>Kruse</surname><given-names>EA</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Fairlie</surname><given-names>WD</given-names></name><etal/></person-group><article-title>Membrane-bound Fas ligand only is essential for Fas-induced apoptosis</article-title><source>Nature</source><year>2009</year><volume>461</volume><fpage>659</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nature08402</pub-id><pub-id pub-id-type="pmid">19794494</pub-id><pub-id pub-id-type="pmcid">PMC2785124</pub-id></element-citation></ref><ref id="CR821"><label>821.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guillen-Ahlers</surname><given-names>H</given-names></name><name name-style="western"><surname>Suckow</surname><given-names>MA</given-names></name><name name-style="western"><surname>Castellino</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Ploplis</surname><given-names>VA</given-names></name></person-group><article-title>Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><fpage>e9070</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0009070</pub-id><pub-id pub-id-type="pmid">20140201</pub-id><pub-id pub-id-type="pmcid">PMC2816700</pub-id></element-citation></ref><ref id="CR822"><label>822.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Ashton-Rickardt</surname><given-names>P</given-names></name><name name-style="western"><surname>Turner</surname><given-names>JR</given-names></name><name name-style="western"><surname>Peter</surname><given-names>ME</given-names></name></person-group><article-title>CD95 is cytoprotective for intestinal epithelial cells in colitis</article-title><source>Inflamm Bowel Dis</source><year>2010</year><volume>16</volume><fpage>1063</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1002/ibd.21195</pub-id><pub-id pub-id-type="pmid">20049944</pub-id></element-citation></ref><ref id="CR823"><label>823.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fingleton</surname><given-names>B</given-names></name><name name-style="western"><surname>Carter</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Matrisian</surname><given-names>LM</given-names></name></person-group><article-title>Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><fpage>4800</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4473</pub-id><pub-id pub-id-type="pmid">17510409</pub-id></element-citation></ref><ref id="CR824"><label>824.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YM</given-names></name><name name-style="western"><surname>Park</surname><given-names>JM</given-names></name><name name-style="western"><surname>Han</surname><given-names>YM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KC</given-names></name><name name-style="western"><surname>Hahm</surname><given-names>KB</given-names></name><etal/></person-group><article-title>Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><fpage>1705</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.23083</pub-id><pub-id pub-id-type="pmid">29416724</pub-id><pub-id pub-id-type="pmcid">PMC5788592</pub-id></element-citation></ref><ref id="CR825"><label>825.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopetuso</surname><given-names>LR</given-names></name><name name-style="western"><surname>Petito</surname><given-names>V</given-names></name><name name-style="western"><surname>Zinicola</surname><given-names>T</given-names></name><name name-style="western"><surname>Graziani</surname><given-names>C</given-names></name><name name-style="western"><surname>Gerardi</surname><given-names>V</given-names></name><name name-style="western"><surname>Arena</surname><given-names>V</given-names></name><etal/></person-group><article-title>Infliximab does not increase colonic cancer risk associated to murine chronic colitis</article-title><source>World J Gastroenterol</source><year>2016</year><volume>22</volume><fpage>9727</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.3748/wjg.v22.i44.9727</pub-id><pub-id pub-id-type="pmid">27956796</pub-id><pub-id pub-id-type="pmcid">PMC5124977</pub-id></element-citation></ref><ref id="CR826"><label>826.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Craven</surname><given-names>B</given-names></name><name name-style="western"><surname>Zaric</surname><given-names>V</given-names></name><name name-style="western"><surname>Martin</surname><given-names>A</given-names></name><name name-style="western"><surname>Mureau</surname><given-names>C</given-names></name><name name-style="western"><surname>Egan</surname><given-names>LJ</given-names></name></person-group><article-title>Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in mice</article-title><source>Inflamm Bowel Dis</source><year>2015</year><volume>21</volume><fpage>485</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1097/MIB.0000000000000303</pub-id><pub-id pub-id-type="pmid">25581824</pub-id></element-citation></ref><ref id="CR827"><label>827.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nyboe Andersen</surname><given-names>N</given-names></name><name name-style="western"><surname>Pasternak</surname><given-names>B</given-names></name><name name-style="western"><surname>Basit</surname><given-names>S</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>M</given-names></name><name name-style="western"><surname>Svanstr&#246;m</surname><given-names>H</given-names></name><name name-style="western"><surname>Caspersen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association between tumor necrosis factor-&#945; antagonists and risk of cancer in patients with inflammatory bowel disease</article-title><source>JAMA</source><year>2014</year><volume>311</volume><fpage>2406</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1001/jama.2014.5613</pub-id><pub-id pub-id-type="pmid">24938563</pub-id></element-citation></ref><ref id="CR828"><label>828.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>F</given-names></name><name name-style="western"><surname>Lacey</surname><given-names>MR</given-names></name><name name-style="western"><surname>Bouljihad</surname><given-names>M</given-names></name><name name-style="western"><surname>H&#246;ner Zu Bentrup</surname><given-names>K</given-names></name><name name-style="western"><surname>Fortgang</surname><given-names>IS</given-names></name></person-group><article-title>Tumor necrosis factor receptor 1 functions as a tumor suppressor</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2012</year><volume>302</volume><fpage>G195</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00209.2011</pub-id><pub-id pub-id-type="pmid">22052015</pub-id><pub-id pub-id-type="pmcid">PMC3341116</pub-id></element-citation></ref><ref id="CR829"><label>829.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ba</surname><given-names>H</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Yin</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Suppression of transmembrane tumor necrosis factor alpha processing by a specific antibody protects against colitis-associated cancer</article-title><source>Front Immunol</source><year>2021</year><volume>12</volume><fpage>687874</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2021.687874</pub-id><pub-id pub-id-type="pmid">34675913</pub-id><pub-id pub-id-type="pmcid">PMC8524043</pub-id></element-citation></ref><ref id="CR830"><label>830.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gharaibeh</surname><given-names>RZ</given-names></name><name name-style="western"><surname>Newsome</surname><given-names>RC</given-names></name><name name-style="western"><surname>Jobin</surname><given-names>C</given-names></name></person-group><article-title>Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer</article-title><source>Nat Cancer</source><year>2020</year><volume>1</volume><fpage>723</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1038/s43018-020-0078-7</pub-id><pub-id pub-id-type="pmid">33768208</pub-id><pub-id pub-id-type="pmcid">PMC7990316</pub-id></element-citation></ref><ref id="CR831"><label>831.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Hong</surname><given-names>KS</given-names></name><name name-style="western"><surname>Chung</surname><given-names>JW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Hahm</surname><given-names>KB</given-names></name></person-group><article-title>Prevention of colitis-associated carcinogenesis with infliximab</article-title><source>Cancer Prev Res</source><year>2010</year><volume>3</volume><fpage>1314</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-09-0272</pub-id><pub-id pub-id-type="pmid">20736334</pub-id></element-citation></ref><ref id="CR832"><label>832.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onizawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Nagaishi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kanai</surname><given-names>T</given-names></name><name name-style="western"><surname>Nagano</surname><given-names>K</given-names></name><name name-style="western"><surname>Oshima</surname><given-names>S</given-names></name><name name-style="western"><surname>Nemoto</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2009</year><volume>296</volume><fpage>G850</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00071.2008</pub-id><pub-id pub-id-type="pmid">19179628</pub-id></element-citation></ref><ref id="CR833"><label>833.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>VP</given-names></name><name name-style="western"><surname>Poutahidis</surname><given-names>T</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Z</given-names></name><name name-style="western"><surname>Nambiar</surname><given-names>PR</given-names></name><name name-style="western"><surname>Horwitz</surname><given-names>BH</given-names></name><name name-style="western"><surname>Fox</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3445</pub-id><pub-id pub-id-type="pmid">16397216</pub-id></element-citation></ref><ref id="CR834"><label>834.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oshima</surname><given-names>H</given-names></name><name name-style="western"><surname>Ishikawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Naoi</surname><given-names>K</given-names></name><name name-style="western"><surname>Maeda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Naka</surname><given-names>K</given-names></name><etal/></person-group><article-title>TNF-&#945;/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells</article-title><source>Oncogene</source><year>2014</year><volume>33</volume><fpage>3820</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.356</pub-id><pub-id pub-id-type="pmid">23975421</pub-id></element-citation></ref><ref id="CR835"><label>835.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Popivanova</surname><given-names>BK</given-names></name><name name-style="western"><surname>Kitamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>T</given-names></name><name name-style="western"><surname>Kagaya</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaneko</surname><given-names>S</given-names></name><etal/></person-group><article-title>Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis</article-title><source>J Clin Investig</source><year>2008</year><volume>118</volume><fpage>560</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">18219394</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI32453</pub-id><pub-id pub-id-type="pmcid">PMC2213370</pub-id></element-citation></ref><ref id="CR836"><label>836.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castets</surname><given-names>M</given-names></name><name name-style="western"><surname>Broutier</surname><given-names>L</given-names></name><name name-style="western"><surname>Molin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Brevet</surname><given-names>M</given-names></name><name name-style="western"><surname>Chazot</surname><given-names>G</given-names></name><name name-style="western"><surname>Gadot</surname><given-names>N</given-names></name><etal/></person-group><article-title>DCC constrains tumour progression via its dependence receptor activity</article-title><source>Nature</source><year>2011</year><volume>482</volume><fpage>534</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nature10708</pub-id><pub-id pub-id-type="pmid">22158121</pub-id></element-citation></ref><ref id="CR837"><label>837.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genevois</surname><given-names>AL</given-names></name><name name-style="western"><surname>Ichim</surname><given-names>G</given-names></name><name name-style="western"><surname>Coissieux</surname><given-names>MM</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>MP</given-names></name><name name-style="western"><surname>Lavial</surname><given-names>F</given-names></name><name name-style="western"><surname>Goldschneider</surname><given-names>D</given-names></name><etal/></person-group><article-title>Dependence receptor TrkC is a putative colon cancer tumor suppressor</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>3017</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1073/pnas.1212333110</pub-id><pub-id pub-id-type="pmid">23341610</pub-id><pub-id pub-id-type="pmcid">PMC3581924</pub-id></element-citation></ref><ref id="CR838"><label>838.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Negulescu</surname><given-names>AM</given-names></name><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name></person-group><article-title>Dependence receptors - the dark side awakens</article-title><source>FEBS J</source><year>2018</year><volume>285</volume><fpage>3909</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/febs.14507</pub-id><pub-id pub-id-type="pmid">29776009</pub-id></element-citation></ref><ref id="CR839"><label>839.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grandin</surname><given-names>M</given-names></name><name name-style="western"><surname>Meier</surname><given-names>M</given-names></name><name name-style="western"><surname>Delcros</surname><given-names>JG</given-names></name><name name-style="western"><surname>Nikodemus</surname><given-names>D</given-names></name><name name-style="western"><surname>Reuten</surname><given-names>R</given-names></name><name name-style="western"><surname>Patel</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Structural decoding of the Netrin-1/UNC5 interaction and its therapeutical implications in cancers</article-title><source>Cancer Cell</source><year>2016</year><volume>29</volume><fpage>173</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.01.001</pub-id><pub-id pub-id-type="pmid">26859457</pub-id></element-citation></ref><ref id="CR840"><label>840.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Park</surname><given-names>SM</given-names></name><name name-style="western"><surname>Tumanov</surname><given-names>AV</given-names></name><name name-style="western"><surname>Hau</surname><given-names>A</given-names></name><name name-style="western"><surname>Sawada</surname><given-names>K</given-names></name><name name-style="western"><surname>Feig</surname><given-names>C</given-names></name><etal/></person-group><article-title>CD95 promotes tumour growth</article-title><source>Nature</source><year>2010</year><volume>465</volume><fpage>492</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nature09075</pub-id><pub-id pub-id-type="pmid">20505730</pub-id><pub-id pub-id-type="pmcid">PMC2879093</pub-id></element-citation></ref><ref id="CR841"><label>841.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pikarsky</surname><given-names>E</given-names></name><name name-style="western"><surname>Porat</surname><given-names>RM</given-names></name><name name-style="western"><surname>Stein</surname><given-names>I</given-names></name><name name-style="western"><surname>Abramovitch</surname><given-names>R</given-names></name><name name-style="western"><surname>Amit</surname><given-names>S</given-names></name><name name-style="western"><surname>Kasem</surname><given-names>S</given-names></name><etal/></person-group><article-title>NF-kappaB functions as a tumour promoter in inflammation-associated cancer</article-title><source>Nature</source><year>2004</year><volume>431</volume><fpage>461</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nature02924</pub-id><pub-id pub-id-type="pmid">15329734</pub-id></element-citation></ref><ref id="CR842"><label>842.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>AT</given-names></name><name name-style="western"><surname>Gautheron</surname><given-names>J</given-names></name><name name-style="western"><surname>Feoktistova</surname><given-names>M</given-names></name><name name-style="western"><surname>Roderburg</surname><given-names>C</given-names></name><name name-style="western"><surname>Loosen</surname><given-names>SH</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><etal/></person-group><article-title>RIPK1 suppresses a TRAF2-dependent pathway to liver cancer</article-title><source>Cancer Cell</source><year>2017</year><volume>31</volume><fpage>94</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.11.009</pub-id><pub-id pub-id-type="pmid">28017612</pub-id></element-citation></ref><ref id="CR843"><label>843.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vucur</surname><given-names>M</given-names></name><name name-style="western"><surname>Reisinger</surname><given-names>F</given-names></name><name name-style="western"><surname>Gautheron</surname><given-names>J</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>J</given-names></name><name name-style="western"><surname>Roderburg</surname><given-names>C</given-names></name><name name-style="western"><surname>Cardenas</surname><given-names>DV</given-names></name><etal/></person-group><article-title>RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation</article-title><source>Cell Rep</source><year>2013</year><volume>4</volume><fpage>776</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.07.035</pub-id><pub-id pub-id-type="pmid">23972991</pub-id></element-citation></ref><ref id="CR844"><label>844.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vredevoogd</surname><given-names>DW</given-names></name><name name-style="western"><surname>Kuilman</surname><given-names>T</given-names></name><name name-style="western"><surname>Ligtenberg</surname><given-names>MA</given-names></name><name name-style="western"><surname>Boshuizen</surname><given-names>J</given-names></name><name name-style="western"><surname>Stecker</surname><given-names>KE</given-names></name><name name-style="western"><surname>de Bruijn</surname><given-names>B</given-names></name><etal/></person-group><article-title>Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold</article-title><source>Cell</source><year>2019</year><volume>178</volume><fpage>585</fpage><lpage>599.e515</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.06.014</pub-id><pub-id pub-id-type="pmid">31303383</pub-id></element-citation></ref><ref id="CR845"><label>845.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boege</surname><given-names>Y</given-names></name><name name-style="western"><surname>Malehmir</surname><given-names>M</given-names></name><name name-style="western"><surname>Healy</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bettermann</surname><given-names>K</given-names></name><name name-style="western"><surname>Lorentzen</surname><given-names>A</given-names></name><name name-style="western"><surname>Vucur</surname><given-names>M</given-names></name><etal/></person-group><article-title>A dual role of caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development</article-title><source>Cancer Cell</source><year>2017</year><volume>32</volume><fpage>342</fpage><lpage>359.e310</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2017.08.010</pub-id><pub-id pub-id-type="pmid">28898696</pub-id><pub-id pub-id-type="pmcid">PMC5598544</pub-id></element-citation></ref><ref id="CR846"><label>846.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liccardi</surname><given-names>G</given-names></name><name name-style="western"><surname>Ramos Garcia</surname><given-names>L</given-names></name><name name-style="western"><surname>Tenev</surname><given-names>T</given-names></name><name name-style="western"><surname>Annibaldi</surname><given-names>A</given-names></name><name name-style="western"><surname>Legrand</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>D</given-names></name><etal/></person-group><article-title>RIPK1 and caspase-8 ensure chromosome stability independently of their role in cell death and inflammation</article-title><source>Mol Cell</source><year>2019</year><volume>73</volume><fpage>413</fpage><lpage>428.e417</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.11.010</pub-id><pub-id pub-id-type="pmid">30598363</pub-id><pub-id pub-id-type="pmcid">PMC6375735</pub-id></element-citation></ref><ref id="CR847"><label>847.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hakem</surname><given-names>A</given-names></name><name name-style="western"><surname>El Ghamrasni</surname><given-names>S</given-names></name><name name-style="western"><surname>Maire</surname><given-names>G</given-names></name><name name-style="western"><surname>Lemmers</surname><given-names>B</given-names></name><name name-style="western"><surname>Karaskova</surname><given-names>J</given-names></name><name name-style="western"><surname>Jurisicova</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-8 is essential for maintaining chromosomal stability and suppressing B-cell lymphomagenesis</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>3495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-07-367532</pub-id><pub-id pub-id-type="pmid">22343728</pub-id></element-citation></ref><ref id="CR848"><label>848.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krelin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Appel</surname><given-names>E</given-names></name><name name-style="western"><surname>Kovalenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Wallach</surname><given-names>D</given-names></name></person-group><article-title>Caspase-8 deficiency facilitates cellular transformation in vitro</article-title><source>Cell Death Differ</source><year>2008</year><volume>15</volume><fpage>1350</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/cdd.2008.88</pub-id><pub-id pub-id-type="pmid">18566604</pub-id></element-citation></ref><ref id="CR849"><label>849.</label><mixed-citation publication-type="other">Rodriguez YI, Campos LE, Castro MG, Bannoud N, Blidner AG, Filippa VP, et al. Tumor necrosis factor receptor-1 (p55) deficiency attenuates tumor growth and intratumoral angiogenesis and stimulates CD8(+) T cell function in melanoma. Cells. 2020;9:249.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells9112469</pub-id><pub-id pub-id-type="pmcid">PMC7696624</pub-id><pub-id pub-id-type="pmid">33202705</pub-id></mixed-citation></ref><ref id="CR850"><label>850.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schioppa</surname><given-names>T</given-names></name><name name-style="western"><surname>Moore</surname><given-names>R</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>RG</given-names></name><name name-style="western"><surname>Rosser</surname><given-names>EC</given-names></name><name name-style="western"><surname>Kulbe</surname><given-names>H</given-names></name><name name-style="western"><surname>Nedospasov</surname><given-names>S</given-names></name><etal/></person-group><article-title>B regulatory cells and the tumor-promoting actions of TNF-&#945; during squamous carcinogenesis</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>10662</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.1100994108</pub-id><pub-id pub-id-type="pmid">21670304</pub-id><pub-id pub-id-type="pmcid">PMC3127875</pub-id></element-citation></ref><ref id="CR851"><label>851.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnott</surname><given-names>CH</given-names></name><name name-style="western"><surname>Scott</surname><given-names>KA</given-names></name><name name-style="western"><surname>Moore</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>RG</given-names></name><name name-style="western"><surname>Balkwill</surname><given-names>FR</given-names></name></person-group><article-title>Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>1902</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1207317</pub-id><pub-id pub-id-type="pmid">14661063</pub-id></element-citation></ref><ref id="CR852"><label>852.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>KA</given-names></name><name name-style="western"><surname>Moore</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Arnott</surname><given-names>CH</given-names></name><name name-style="western"><surname>East</surname><given-names>N</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>RG</given-names></name><name name-style="western"><surname>Scallon</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors</article-title><source>Mol Cancer Ther</source><year>2003</year><volume>2</volume><fpage>445</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12748306</pub-id></element-citation></ref><ref id="CR853"><label>853.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suganuma</surname><given-names>M</given-names></name><name name-style="western"><surname>Okabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Marino</surname><given-names>MW</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>A</given-names></name><name name-style="western"><surname>Sueoka</surname><given-names>E</given-names></name><name name-style="western"><surname>Fujiki</surname><given-names>H</given-names></name></person-group><article-title>Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice</article-title><source>Cancer Res</source><year>1999</year><volume>59</volume><fpage>4516</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10493498</pub-id></element-citation></ref><ref id="CR854"><label>854.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Owens</surname><given-names>DM</given-names></name><name name-style="western"><surname>Stamp</surname><given-names>G</given-names></name><name name-style="western"><surname>Arnott</surname><given-names>C</given-names></name><name name-style="western"><surname>Burke</surname><given-names>F</given-names></name><name name-style="western"><surname>East</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis</article-title><source>Nat Med</source><year>1999</year><volume>5</volume><fpage>828</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/10552</pub-id><pub-id pub-id-type="pmid">10395330</pub-id></element-citation></ref><ref id="CR855"><label>855.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cal&#305;skan</surname><given-names>E</given-names></name><name name-style="western"><surname>Gams&#305;zkan</surname><given-names>M</given-names></name><name name-style="western"><surname>Yurekli</surname><given-names>A</given-names></name><name name-style="western"><surname>Botsali</surname><given-names>A</given-names></name><name name-style="western"><surname>Kabalar</surname><given-names>ME</given-names></name><name name-style="western"><surname>Demiriz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Anti-TNF agent etanercept augments UV-induced skin cancer development in SKH-1 mice</article-title><source>J Dermatol Treat</source><year>2021</year><volume>32</volume><fpage>812</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1080/09546634.2019.1708851</pub-id><pub-id pub-id-type="pmid">31868056</pub-id></element-citation></ref><ref id="CR856"><label>856.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>DL</given-names></name><name name-style="western"><surname>Havighurst</surname><given-names>TC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K</given-names></name><etal/></person-group><article-title>Genetic deletion of TNF&#945; inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKC&#949; transgenic mice via inhibition of cell survival signals</article-title><source>Carcinogenesis</source><year>2016</year><volume>37</volume><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgv162</pub-id><pub-id pub-id-type="pmid">26586792</pub-id><pub-id pub-id-type="pmcid">PMC5006113</pub-id></element-citation></ref><ref id="CR857"><label>857.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lind</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rozell</surname><given-names>B</given-names></name><name name-style="western"><surname>Wallin</surname><given-names>RP</given-names></name><name name-style="western"><surname>van Hogerlinden</surname><given-names>M</given-names></name><name name-style="western"><surname>Ljunggren</surname><given-names>HG</given-names></name><name name-style="western"><surname>Toftg&#229;rd</surname><given-names>R</given-names></name><etal/></person-group><article-title>Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>4972</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.0307106101</pub-id><pub-id pub-id-type="pmid">15044707</pub-id><pub-id pub-id-type="pmcid">PMC387358</pub-id></element-citation></ref><ref id="CR858"><label>858.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galheigo</surname><given-names>MR</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>AR</given-names></name><name name-style="western"><surname>Cabral</surname><given-names>&#193;S</given-names></name><name name-style="western"><surname>Faria</surname><given-names>PR</given-names></name><name name-style="western"><surname>Cordeiro</surname><given-names>RS</given-names></name><name name-style="western"><surname>Silva</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Role of the TNF-&#945; receptor type 1 on prostate carcinogenesis in knockout mice</article-title><source>Prostate</source><year>2016</year><volume>76</volume><fpage>917</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1002/pros.23181</pub-id><pub-id pub-id-type="pmid">27018768</pub-id></element-citation></ref><ref id="CR859"><label>859.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sobo-Vujanovic</surname><given-names>A</given-names></name><name name-style="western"><surname>Vujanovic</surname><given-names>L</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>AB</given-names></name><name name-style="western"><surname>Concha-Benavente</surname><given-names>F</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>RL</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inhibition of Soluble tumor necrosis factor prevents chemically induced carcinogenesis in mice</article-title><source>Cancer Immunol Res</source><year>2016</year><volume>4</volume><fpage>441</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1158/2326-6066.CIR-15-0104</pub-id><pub-id pub-id-type="pmid">26896171</pub-id><pub-id pub-id-type="pmcid">PMC4873325</pub-id></element-citation></ref><ref id="CR860"><label>860.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>K</given-names></name><name name-style="western"><surname>Duhacheck-Muggy</surname><given-names>S</given-names></name><name name-style="western"><surname>Ioannidis</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>NT</given-names></name><etal/></person-group><article-title>Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer</article-title><source>Neoplasia</source><year>2021</year><volume>23</volume><fpage>197</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.neo.2020.12.007</pub-id><pub-id pub-id-type="pmid">33383310</pub-id><pub-id pub-id-type="pmcid">PMC7779542</pub-id></element-citation></ref><ref id="CR861"><label>861.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sangaletti</surname><given-names>S</given-names></name><name name-style="western"><surname>Tripodo</surname><given-names>C</given-names></name><name name-style="western"><surname>Ratti</surname><given-names>C</given-names></name><name name-style="western"><surname>Piconese</surname><given-names>S</given-names></name><name name-style="western"><surname>Porcasi</surname><given-names>R</given-names></name><name name-style="western"><surname>Salcedo</surname><given-names>R</given-names></name><etal/></person-group><article-title>Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis</article-title><source>Cancer Res</source><year>2010</year><volume>70</volume><fpage>7764</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-0471</pub-id><pub-id pub-id-type="pmid">20924115</pub-id><pub-id pub-id-type="pmcid">PMC7371347</pub-id></element-citation></ref><ref id="CR862"><label>862.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chadwick</surname><given-names>JW</given-names></name><name name-style="western"><surname>Macdonald</surname><given-names>R</given-names></name><name name-style="western"><surname>Ali</surname><given-names>AA</given-names></name><name name-style="western"><surname>Glogauer</surname><given-names>M</given-names></name><name name-style="western"><surname>Magalhaes</surname><given-names>MA</given-names></name></person-group><article-title>TNF&#945; signaling is increased in progressing oral potentially malignant disorders and regulates malignant transformation in an oral carcinogenesis model</article-title><source>Front Oncol</source><year>2021</year><volume>11</volume><fpage>741013</fpage><pub-id pub-id-type="doi">10.3389/fonc.2021.741013</pub-id><pub-id pub-id-type="pmid">34650923</pub-id><pub-id pub-id-type="pmcid">PMC8507421</pub-id></element-citation></ref><ref id="CR863"><label>863.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karabela</surname><given-names>SP</given-names></name><name name-style="western"><surname>Kairi</surname><given-names>CA</given-names></name><name name-style="western"><surname>Magkouta</surname><given-names>S</given-names></name><name name-style="western"><surname>Psallidas</surname><given-names>I</given-names></name><name name-style="western"><surname>Moschos</surname><given-names>C</given-names></name><name name-style="western"><surname>Stathopoulos</surname><given-names>I</given-names></name><etal/></person-group><article-title>Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice</article-title><source>Neoplasia</source><year>2011</year><volume>13</volume><fpage>1143</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1593/neo.111224</pub-id><pub-id pub-id-type="pmid">22241960</pub-id><pub-id pub-id-type="pmcid">PMC3257189</pub-id></element-citation></ref><ref id="CR864"><label>864.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>L</given-names></name><name name-style="western"><surname>da Silva Caetano</surname><given-names>M</given-names></name><name name-style="western"><surname>Cumpian</surname><given-names>AM</given-names></name><name name-style="western"><surname>Daliri</surname><given-names>S</given-names></name><name name-style="western"><surname>Garza Flores</surname><given-names>A</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Tumor necrosis factor links chronic obstructive pulmonary disease and K-ras mutant lung cancer through induction of an immunosuppressive pro-tumor microenvironment</article-title><source>Oncoimmunology</source><year>2016</year><volume>5</volume><fpage>e1229724</fpage><pub-id pub-id-type="doi">10.1080/2162402X.2016.1229724</pub-id><pub-id pub-id-type="pmid">27853654</pub-id><pub-id pub-id-type="pmcid">PMC5087294</pub-id></element-citation></ref><ref id="CR865"><label>865.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kedinger</surname><given-names>V</given-names></name><name name-style="western"><surname>Muller</surname><given-names>S</given-names></name><name name-style="western"><surname>Gronemeyer</surname><given-names>H</given-names></name></person-group><article-title>Targeted expression of tumor necrosis factor-related apoptosis-inducing ligand TRAIL in skin protects mice against chemical carcinogenesis</article-title><source>Mol Cancer</source><year>2011</year><volume>10</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/1476-4598-10-34</pub-id><pub-id pub-id-type="pmid">21463519</pub-id><pub-id pub-id-type="pmcid">PMC3078898</pub-id></element-citation></ref><ref id="CR866"><label>866.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chio</surname><given-names>II</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Ghazarian</surname><given-names>D</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>J</given-names></name><name name-style="western"><surname>Done</surname><given-names>S</given-names></name><name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name><etal/></person-group><article-title>TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation</article-title><source>Nat Cell Biol</source><year>2012</year><volume>14</volume><fpage>625</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1038/ncb2496</pub-id><pub-id pub-id-type="pmid">22561347</pub-id></element-citation></ref><ref id="CR867"><label>867.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grosse-Wilde</surname><given-names>A</given-names></name><name name-style="western"><surname>Voloshanenko</surname><given-names>O</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>SL</given-names></name><name name-style="western"><surname>Longton</surname><given-names>GM</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>U</given-names></name><name name-style="western"><surname>Csernok</surname><given-names>AI</given-names></name><etal/></person-group><article-title>TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development</article-title><source>J Clin Investig</source><year>2008</year><volume>118</volume><fpage>100</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1172/JCI33061</pub-id><pub-id pub-id-type="pmid">18079967</pub-id><pub-id pub-id-type="pmcid">PMC2129237</pub-id></element-citation></ref><ref id="CR868"><label>868.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Cretney</surname><given-names>E</given-names></name><name name-style="western"><surname>Hayakawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><name name-style="western"><surname>Yagita</surname><given-names>H</given-names></name><etal/></person-group><article-title>Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><fpage>161</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1084/jem.20011171</pub-id><pub-id pub-id-type="pmid">11805143</pub-id><pub-id pub-id-type="pmcid">PMC2193611</pub-id></element-citation></ref><ref id="CR869"><label>869.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cretney</surname><given-names>E</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name><name name-style="western"><surname>Yagita</surname><given-names>H</given-names></name><name name-style="western"><surname>Glaccum</surname><given-names>M</given-names></name><name name-style="western"><surname>Peschon</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>MJ</given-names></name></person-group><article-title>Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>1356</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.3.1356</pub-id><pub-id pub-id-type="pmid">11801676</pub-id></element-citation></ref><ref id="CR870"><label>870.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montinaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Areso Zubiaur</surname><given-names>I</given-names></name><name name-style="western"><surname>Saggau</surname><given-names>J</given-names></name><name name-style="western"><surname>Kretz</surname><given-names>AL</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>RMM</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>O</given-names></name><etal/></person-group><article-title>Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers</article-title><source>Cell Death Differ</source><year>2022</year><volume>29</volume><fpage>492</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00869-x</pub-id><pub-id pub-id-type="pmid">34535764</pub-id><pub-id pub-id-type="pmcid">PMC8901660</pub-id></element-citation></ref><ref id="CR871"><label>871.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Karstedt</surname><given-names>S</given-names></name><name name-style="western"><surname>Conti</surname><given-names>A</given-names></name><name name-style="western"><surname>Nobis</surname><given-names>M</given-names></name><name name-style="western"><surname>Montinaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Hartwig</surname><given-names>T</given-names></name><name name-style="western"><surname>Lemke</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis</article-title><source>Cancer Cell</source><year>2015</year><volume>27</volume><fpage>561</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2015.02.014</pub-id><pub-id pub-id-type="pmid">25843002</pub-id><pub-id pub-id-type="pmcid">PMC6591140</pub-id></element-citation></ref><ref id="CR872"><label>872.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartwig</surname><given-names>T</given-names></name><name name-style="western"><surname>Montinaro</surname><given-names>A</given-names></name><name name-style="western"><surname>von Karstedt</surname><given-names>S</given-names></name><name name-style="western"><surname>Sevko</surname><given-names>A</given-names></name><name name-style="western"><surname>Surinova</surname><given-names>S</given-names></name><name name-style="western"><surname>Chakravarthy</surname><given-names>A</given-names></name><etal/></person-group><article-title>The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2</article-title><source>Mol Cell</source><year>2017</year><volume>65</volume><fpage>730</fpage><lpage>742.e735</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.01.021</pub-id><pub-id pub-id-type="pmid">28212753</pub-id><pub-id pub-id-type="pmcid">PMC5316415</pub-id></element-citation></ref><ref id="CR873"><label>873.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoogwater</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Nijkamp</surname><given-names>MW</given-names></name><name name-style="western"><surname>Smakman</surname><given-names>N</given-names></name><name name-style="western"><surname>Steller</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Emmink</surname><given-names>BL</given-names></name><name name-style="western"><surname>Westendorp</surname><given-names>BF</given-names></name><etal/></person-group><article-title>Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells</article-title><source>Gastroenterology</source><year>2010</year><volume>138</volume><fpage>2357</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2010.02.046</pub-id><pub-id pub-id-type="pmid">20188103</pub-id></element-citation></ref><ref id="CR874"><label>874.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rieux-Laucat</surname><given-names>F</given-names></name><name name-style="western"><surname>Le Deist</surname><given-names>F</given-names></name><name name-style="western"><surname>Hivroz</surname><given-names>C</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>IA</given-names></name><name name-style="western"><surname>Debatin</surname><given-names>KM</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity</article-title><source>Science</source><year>1995</year><volume>268</volume><fpage>1347</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1126/science.7539157</pub-id><pub-id pub-id-type="pmid">7539157</pub-id></element-citation></ref><ref id="CR875"><label>875.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watanabe-Fukunaga</surname><given-names>R</given-names></name><name name-style="western"><surname>Brannan</surname><given-names>CI</given-names></name><name name-style="western"><surname>Copeland</surname><given-names>NG</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>NA</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>S</given-names></name></person-group><article-title>Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis</article-title><source>Nature</source><year>1992</year><volume>356</volume><fpage>314</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/356314a0</pub-id><pub-id pub-id-type="pmid">1372394</pub-id></element-citation></ref><ref id="CR876"><label>876.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez-Diaz</surname><given-names>S</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>CP</given-names></name><name name-style="western"><surname>Lalaoui</surname><given-names>N</given-names></name><name name-style="western"><surname>Tanzer</surname><given-names>MC</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>DA</given-names></name><name name-style="western"><surname>Lin</surname><given-names>A</given-names></name><etal/></person-group><article-title>The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis</article-title><source>Immunity</source><year>2016</year><volume>45</volume><fpage>513</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.07.016</pub-id><pub-id pub-id-type="pmid">27523270</pub-id><pub-id pub-id-type="pmcid">PMC5040700</pub-id></element-citation></ref><ref id="CR877"><label>877.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chyuan</surname><given-names>IT</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>HF</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CS</given-names></name><name name-style="western"><surname>Sung</surname><given-names>CC</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>PN</given-names></name></person-group><article-title>TRAIL-mediated suppression of T cell receptor signaling inhibits T cell activation and inflammation in experimental autoimmune encephalomyelitis</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00015</pub-id><pub-id pub-id-type="pmid">29403497</pub-id><pub-id pub-id-type="pmcid">PMC5786528</pub-id></element-citation></ref><ref id="CR878"><label>878.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikeda</surname><given-names>T</given-names></name><name name-style="western"><surname>Hirata</surname><given-names>S</given-names></name><name name-style="western"><surname>Fukushima</surname><given-names>S</given-names></name><name name-style="western"><surname>Matsunaga</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ito</surname><given-names>T</given-names></name><name name-style="western"><surname>Uchino</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells</article-title><source>J Immunol</source><year>2010</year><volume>185</volume><fpage>5259</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902797</pub-id><pub-id pub-id-type="pmid">20921531</pub-id></element-citation></ref><ref id="CR879"><label>879.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cretney</surname><given-names>E</given-names></name><name name-style="western"><surname>McQualter</surname><given-names>JL</given-names></name><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><name name-style="western"><surname>Yagita</surname><given-names>H</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>CC</given-names></name><name name-style="western"><surname>Grewal</surname><given-names>IS</given-names></name><etal/></person-group><article-title>TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice</article-title><source>Immunol cell Biol</source><year>2005</year><volume>83</volume><fpage>511</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1711.2005.01358.x</pub-id><pub-id pub-id-type="pmid">16174101</pub-id></element-citation></ref><ref id="CR880"><label>880.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razmara</surname><given-names>M</given-names></name><name name-style="western"><surname>Hilliard</surname><given-names>B</given-names></name><name name-style="western"><surname>Ziarani</surname><given-names>AK</given-names></name><name name-style="western"><surname>Murali</surname><given-names>R</given-names></name><name name-style="western"><surname>Yellayi</surname><given-names>S</given-names></name><name name-style="western"><surname>Ghazanfar</surname><given-names>M</given-names></name><etal/></person-group><article-title>Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis</article-title><source>Am J Pathol</source><year>2009</year><volume>174</volume><fpage>460</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2009.080462</pub-id><pub-id pub-id-type="pmid">19147815</pub-id><pub-id pub-id-type="pmcid">PMC2630555</pub-id></element-citation></ref><ref id="CR881"><label>881.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aktas</surname><given-names>O</given-names></name><name name-style="western"><surname>Smorodchenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Brocke</surname><given-names>S</given-names></name><name name-style="western"><surname>Infante-Duarte</surname><given-names>C</given-names></name><name name-style="western"><surname>Schulze Topphoff</surname><given-names>U</given-names></name><name name-style="western"><surname>Vogt</surname><given-names>J</given-names></name><etal/></person-group><article-title>Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL</article-title><source>Neuron</source><year>2005</year><volume>46</volume><fpage>421</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.03.018</pub-id><pub-id pub-id-type="pmid">15882642</pub-id></element-citation></ref><ref id="CR882"><label>882.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hilliard</surname><given-names>B</given-names></name><name name-style="western"><surname>Wilmen</surname><given-names>A</given-names></name><name name-style="western"><surname>Seidel</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>TS</given-names></name><name name-style="western"><surname>G&#246;ke</surname><given-names>R</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis</article-title><source>J Immunol</source><year>2001</year><volume>166</volume><fpage>1314</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.166.2.1314</pub-id><pub-id pub-id-type="pmid">11145715</pub-id></element-citation></ref><ref id="CR883"><label>883.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamhamedi-Cherradi</surname><given-names>SE</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Maguschak</surname><given-names>KA</given-names></name><name name-style="western"><surname>Peschon</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YH</given-names></name></person-group><article-title>Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL&#8722;/&#8722; mice</article-title><source>Nat Immunol</source><year>2003</year><volume>4</volume><fpage>255</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/ni894</pub-id><pub-id pub-id-type="pmid">12577054</pub-id></element-citation></ref><ref id="CR884"><label>884.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>K</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>G&#246;ke</surname><given-names>R</given-names></name><name name-style="western"><surname>Wilmen</surname><given-names>A</given-names></name><name name-style="western"><surname>Seidel</surname><given-names>C</given-names></name><name name-style="western"><surname>G&#246;ke</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>1095</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1084/jem.191.7.1095</pub-id><pub-id pub-id-type="pmid">10748228</pub-id><pub-id pub-id-type="pmcid">PMC2193179</pub-id></element-citation></ref><ref id="CR885"><label>885.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>JS</given-names></name><name name-style="western"><surname>Oh</surname><given-names>Y</given-names></name><name name-style="western"><surname>Park</surname><given-names>O</given-names></name><name name-style="western"><surname>Foss</surname><given-names>CA</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SM</given-names></name><name name-style="western"><surname>Jo</surname><given-names>DG</given-names></name><etal/></person-group><article-title>PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells</article-title><source>J Control Release</source><year>2017</year><volume>267</volume><fpage>163</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2017.10.004</pub-id><pub-id pub-id-type="pmid">29017854</pub-id></element-citation></ref><ref id="CR886"><label>886.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chyuan</surname><given-names>IT</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>HF</given-names></name><name name-style="western"><surname>Liao</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CS</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>PN</given-names></name></person-group><article-title>An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis</article-title><source>Cell Mol Immunol</source><year>2018</year><volume>15</volume><fpage>846</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/cmi.2017.2</pub-id><pub-id pub-id-type="pmid">28392572</pub-id><pub-id pub-id-type="pmcid">PMC6203772</pub-id></element-citation></ref><ref id="CR887"><label>887.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chae</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>TH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>HK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>EY</given-names></name><name name-style="western"><surname>Song</surname><given-names>YW</given-names></name><etal/></person-group><article-title>Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis</article-title><source>J Pharmacol Exp Ther</source><year>2010</year><volume>332</volume><fpage>858</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1124/jpet.109.159517</pub-id><pub-id pub-id-type="pmid">19933369</pub-id></element-citation></ref><ref id="CR888"><label>888.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Joe</surname><given-names>Y</given-names></name><name name-style="western"><surname>Seo</surname><given-names>E</given-names></name><name name-style="western"><surname>Park</surname><given-names>MK</given-names></name><name name-style="western"><surname>Seo</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Systemic delivery of TNF-related apoptosis-inducing ligand (TRAIL) elevates levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and prevents type 1 diabetes in nonobese diabetic mice</article-title><source>Endocrinology</source><year>2010</year><volume>151</volume><fpage>5638</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1210/en.2009-0478</pub-id><pub-id pub-id-type="pmid">21047948</pub-id></element-citation></ref><ref id="CR889"><label>889.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mi</surname><given-names>QS</given-names></name><name name-style="western"><surname>Ly</surname><given-names>D</given-names></name><name name-style="western"><surname>Lamhamedi-Cherradi</surname><given-names>SE</given-names></name><name name-style="western"><surname>Salojin</surname><given-names>KV</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Grattan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>1967</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.2337/diabetes.52.8.1967</pub-id><pub-id pub-id-type="pmid">12882912</pub-id></element-citation></ref><ref id="CR890"><label>890.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bossi</surname><given-names>F</given-names></name><name name-style="western"><surname>Bernardi</surname><given-names>S</given-names></name><name name-style="western"><surname>Zauli</surname><given-names>G</given-names></name><name name-style="western"><surname>Secchiero</surname><given-names>P</given-names></name><name name-style="western"><surname>Fabris</surname><given-names>B</given-names></name></person-group><article-title>TRAIL modulates the immune system and protects against the development of diabetes</article-title><source>J Immunol Res</source><year>2015</year><volume>2015</volume><fpage>680749</fpage><pub-id pub-id-type="doi">10.1155/2015/680749</pub-id><pub-id pub-id-type="pmid">25759846</pub-id><pub-id pub-id-type="pmcid">PMC4352427</pub-id></element-citation></ref><ref id="CR891"><label>891.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamhamedi-Cherradi</surname><given-names>SE</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Tisch</surname><given-names>RM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YH</given-names></name></person-group><article-title>Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>2274</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2337/diabetes.52.9.2274</pub-id><pub-id pub-id-type="pmid">12941766</pub-id></element-citation></ref><ref id="CR892"><label>892.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bachmann</surname><given-names>R</given-names></name><name name-style="western"><surname>Eugster</surname><given-names>HP</given-names></name><name name-style="western"><surname>Frei</surname><given-names>K</given-names></name><name name-style="western"><surname>Fontana</surname><given-names>A</given-names></name><name name-style="western"><surname>Lassmann</surname><given-names>H</given-names></name></person-group><article-title>Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice</article-title><source>Am J Pathol</source><year>1999</year><volume>154</volume><fpage>1417</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)65395-3</pub-id><pub-id pub-id-type="pmid">10329594</pub-id><pub-id pub-id-type="pmcid">PMC1866600</pub-id></element-citation></ref><ref id="CR893"><label>893.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malipiero</surname><given-names>U</given-names></name><name name-style="western"><surname>Frei</surname><given-names>K</given-names></name><name name-style="western"><surname>Spanaus</surname><given-names>KS</given-names></name><name name-style="western"><surname>Agresti</surname><given-names>C</given-names></name><name name-style="western"><surname>Lassmann</surname><given-names>H</given-names></name><name name-style="western"><surname>Hahne</surname><given-names>M</given-names></name><etal/></person-group><article-title>Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice</article-title><source>Eur J Immunol</source><year>1997</year><volume>27</volume><fpage>3151</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1002/eji.1830271211</pub-id><pub-id pub-id-type="pmid">9464800</pub-id></element-citation></ref><ref id="CR894"><label>894.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waldner</surname><given-names>H</given-names></name><name name-style="western"><surname>Sobel</surname><given-names>RA</given-names></name><name name-style="western"><surname>Howard</surname><given-names>E</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group><article-title>Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis</article-title><source>J Immunol</source><year>1997</year><volume>159</volume><fpage>3100</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.159.7.3100</pub-id><pub-id pub-id-type="pmid">9317104</pub-id></element-citation></ref><ref id="CR895"><label>895.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabelko</surname><given-names>KA</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>KA</given-names></name><name name-style="western"><surname>Nahm</surname><given-names>MH</given-names></name><name name-style="western"><surname>Cross</surname><given-names>AH</given-names></name><name name-style="western"><surname>Russell</surname><given-names>JH</given-names></name></person-group><article-title>Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system</article-title><source>J Immunol</source><year>1997</year><volume>159</volume><fpage>3096</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.159.7.3096</pub-id><pub-id pub-id-type="pmid">9317103</pub-id></element-citation></ref><ref id="CR896"><label>896.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shemer</surname><given-names>A</given-names></name><name name-style="western"><surname>Polonsky</surname><given-names>M</given-names></name><name name-style="western"><surname>Gross</surname><given-names>M</given-names></name><name name-style="western"><surname>Mildner</surname><given-names>A</given-names></name><name name-style="western"><surname>Yona</surname><given-names>S</given-names></name><etal/></person-group><article-title>Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation</article-title><source>J Exp Med</source><year>2017</year><volume>214</volume><fpage>905</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1084/jem.20160499</pub-id><pub-id pub-id-type="pmid">28330904</pub-id><pub-id pub-id-type="pmcid">PMC5379969</pub-id></element-citation></ref><ref id="CR897"><label>897.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>SK</given-names></name><name name-style="western"><surname>Fairless</surname><given-names>R</given-names></name><name name-style="western"><surname>Maier</surname><given-names>O</given-names></name><name name-style="western"><surname>Liermann</surname><given-names>PC</given-names></name><name name-style="western"><surname>Pichi</surname><given-names>K</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>R</given-names></name><etal/></person-group><article-title>Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>13628</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-31957-7</pub-id><pub-id pub-id-type="pmid">30206422</pub-id><pub-id pub-id-type="pmcid">PMC6133964</pub-id></element-citation></ref><ref id="CR898"><label>898.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>SK</given-names></name><name name-style="western"><surname>Maier</surname><given-names>O</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>R</given-names></name><name name-style="western"><surname>Fairless</surname><given-names>R</given-names></name><name name-style="western"><surname>Hochmeister</surname><given-names>S</given-names></name><name name-style="western"><surname>Stojic</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e90117</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0090117</pub-id><pub-id pub-id-type="pmid">24587232</pub-id><pub-id pub-id-type="pmcid">PMC3938650</pub-id></element-citation></ref><ref id="CR899"><label>899.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nomura</surname><given-names>T</given-names></name><name name-style="western"><surname>Abe</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kamada</surname><given-names>H</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>H</given-names></name><name name-style="western"><surname>Kayamuro</surname><given-names>H</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>M</given-names></name><etal/></person-group><article-title>Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice</article-title><source>J Control Release</source><year>2011</year><volume>149</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2009.12.015</pub-id><pub-id pub-id-type="pmid">20036293</pub-id></element-citation></ref><ref id="CR900"><label>900.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steeland</surname><given-names>S</given-names></name><name name-style="western"><surname>Van Ryckeghem</surname><given-names>S</given-names></name><name name-style="western"><surname>Van Imschoot</surname><given-names>G</given-names></name><name name-style="western"><surname>De Rycke</surname><given-names>R</given-names></name><name name-style="western"><surname>Toussaint</surname><given-names>W</given-names></name><name name-style="western"><surname>Vanhoutte</surname><given-names>L</given-names></name><etal/></person-group><article-title>TNFR1 inhibition with a Nanobody protects against EAE development in mice</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>13646</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-13984-y</pub-id><pub-id pub-id-type="pmid">29057962</pub-id><pub-id pub-id-type="pmcid">PMC5651799</pub-id></element-citation></ref><ref id="CR901"><label>901.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brambilla</surname><given-names>R</given-names></name><name name-style="western"><surname>Ashbaugh</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Magliozzi</surname><given-names>R</given-names></name><name name-style="western"><surname>Dellarole</surname><given-names>A</given-names></name><name name-style="western"><surname>Karmally</surname><given-names>S</given-names></name><name name-style="western"><surname>Szymkowski</surname><given-names>DE</given-names></name><etal/></person-group><article-title>Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination</article-title><source>Brain</source><year>2011</year><volume>134</volume><fpage>2736</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1093/brain/awr199</pub-id><pub-id pub-id-type="pmid">21908877</pub-id><pub-id pub-id-type="pmcid">PMC3170538</pub-id></element-citation></ref><ref id="CR902"><label>902.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#246;rner</surname><given-names>H</given-names></name><name name-style="western"><surname>Lemckert</surname><given-names>FA</given-names></name><name name-style="western"><surname>Chaudhri</surname><given-names>G</given-names></name><name name-style="western"><surname>Etteldorf</surname><given-names>S</given-names></name><name name-style="western"><surname>Sedgwick</surname><given-names>JD</given-names></name></person-group><article-title>Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system</article-title><source>Eur J Immunol</source><year>1997</year><volume>27</volume><fpage>1973</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1002/eji.1830270822</pub-id><pub-id pub-id-type="pmid">9295034</pub-id></element-citation></ref><ref id="CR903"><label>903.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#246;rner</surname><given-names>H</given-names></name><name name-style="western"><surname>Goodsall</surname><given-names>AL</given-names></name><name name-style="western"><surname>Lemckert</surname><given-names>FA</given-names></name><name name-style="western"><surname>Scallon</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Ghrayeb</surname><given-names>J</given-names></name><name name-style="western"><surname>Ford</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis</article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>11066</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.24.11066</pub-id><pub-id pub-id-type="pmid">7479938</pub-id><pub-id pub-id-type="pmcid">PMC40572</pub-id></element-citation></ref><ref id="CR904"><label>904.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richter</surname><given-names>F</given-names></name><name name-style="western"><surname>Williams</surname><given-names>SK</given-names></name><name name-style="western"><surname>John</surname><given-names>K</given-names></name><name name-style="western"><surname>Huber</surname><given-names>C</given-names></name><name name-style="western"><surname>Vaslin</surname><given-names>C</given-names></name><name name-style="western"><surname>Zanker</surname><given-names>H</given-names></name><etal/></person-group><article-title>The TNFR1 antagonist atrosimab is therapeutic in mouse models of acute and chronic inflammation</article-title><source>Front Immunol</source><year>2021</year><volume>12</volume><fpage>705485</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2021.705485</pub-id><pub-id pub-id-type="pmid">34305946</pub-id><pub-id pub-id-type="pmcid">PMC8294390</pub-id></element-citation></ref><ref id="CR905"><label>905.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dittel</surname><given-names>BN</given-names></name><name name-style="western"><surname>Merchant</surname><given-names>RM</given-names></name><name name-style="western"><surname>Janeway</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group><article-title>Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>6392</fpage><lpage>6400</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.162.11.6392</pub-id><pub-id pub-id-type="pmid">10352252</pub-id></element-citation></ref><ref id="CR906"><label>906.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suvannavejh</surname><given-names>GC</given-names></name><name name-style="western"><surname>Dal Canto</surname><given-names>MC</given-names></name><name name-style="western"><surname>Matis</surname><given-names>LA</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SD</given-names></name></person-group><article-title>Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis</article-title><source>J Clin Investig</source><year>2000</year><volume>105</volume><fpage>223</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1172/JCI8561</pub-id><pub-id pub-id-type="pmid">10642601</pub-id><pub-id pub-id-type="pmcid">PMC377433</pub-id></element-citation></ref><ref id="CR907"><label>907.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Haroon</surname><given-names>F</given-names></name><name name-style="western"><surname>Karray</surname><given-names>S</given-names></name><name name-style="western"><surname>Martina</surname><given-names>D</given-names></name><name name-style="western"><surname>Schl&#252;ter</surname><given-names>D</given-names></name></person-group><article-title>Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis</article-title><source>Eur J Immunol</source><year>2013</year><volume>43</volume><fpage>115</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/eji.201242679</pub-id><pub-id pub-id-type="pmid">23011975</pub-id></element-citation></ref><ref id="CR908"><label>908.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabelko-Downes</surname><given-names>KA</given-names></name><name name-style="western"><surname>Cross</surname><given-names>AH</given-names></name><name name-style="western"><surname>Russell</surname><given-names>JH</given-names></name></person-group><article-title>Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis</article-title><source>J Exp Med</source><year>1999</year><volume>189</volume><fpage>1195</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1084/jem.189.8.1195</pub-id><pub-id pub-id-type="pmid">10209037</pub-id><pub-id pub-id-type="pmcid">PMC2193027</pub-id></element-citation></ref><ref id="CR909"><label>909.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batoulis</surname><given-names>H</given-names></name><name name-style="western"><surname>Recks</surname><given-names>MS</given-names></name><name name-style="western"><surname>Holland</surname><given-names>FO</given-names></name><name name-style="western"><surname>Thomalla</surname><given-names>F</given-names></name><name name-style="western"><surname>Williams</surname><given-names>RO</given-names></name><name name-style="western"><surname>Kuerten</surname><given-names>S</given-names></name></person-group><article-title>Blockade of tumour necrosis factor-&#945; in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology</article-title><source>Clin Exp Immunol</source><year>2014</year><volume>175</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1111/cei.12209</pub-id><pub-id pub-id-type="pmid">24111507</pub-id><pub-id pub-id-type="pmcid">PMC3898553</pub-id></element-citation></ref><ref id="CR910"><label>910.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Marino</surname><given-names>MW</given-names></name><name name-style="western"><surname>Wong</surname><given-names>G</given-names></name><name name-style="western"><surname>Grail</surname><given-names>D</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>A</given-names></name><name name-style="western"><surname>Bettadapura</surname><given-names>J</given-names></name><etal/></person-group><article-title>TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination</article-title><source>Nat Med</source><year>1998</year><volume>4</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/nm0198-078</pub-id><pub-id pub-id-type="pmid">9427610</pub-id></element-citation></ref><ref id="CR911"><label>911.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu-Rapp</surname><given-names>H</given-names></name><name name-style="western"><surname>Hammerm&#252;ller</surname><given-names>A</given-names></name><name name-style="western"><surname>Mix</surname><given-names>E</given-names></name><name name-style="western"><surname>Kreutzer</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Goerlich</surname><given-names>R</given-names></name><name name-style="western"><surname>K&#246;hler</surname><given-names>H</given-names></name><etal/></person-group><article-title>A proinflammatory role for Fas in joints of mice with collagen-induced arthritis</article-title><source>Arthritis Res Ther</source><year>2004</year><volume>6</volume><fpage>R404</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/ar1205</pub-id><pub-id pub-id-type="pmid">15380040</pub-id><pub-id pub-id-type="pmcid">PMC546278</pub-id></element-citation></ref><ref id="CR912"><label>912.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>F</given-names></name><name name-style="western"><surname>Verma</surname><given-names>AH</given-names></name><name name-style="western"><surname>Volk</surname><given-names>A</given-names></name><name name-style="western"><surname>Jones</surname><given-names>B</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>BM</given-names></name><name name-style="western"><surname>Loza</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Combined blockade of TNF-&#945; and IL-17A alleviates progression of collagen-induced arthritis without causing serious infections in mice</article-title><source>J Immunol</source><year>2019</year><volume>202</volume><fpage>2017</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1801436</pub-id><pub-id pub-id-type="pmid">30745461</pub-id><pub-id pub-id-type="pmcid">PMC6424616</pub-id></element-citation></ref><ref id="CR913"><label>913.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>AR</given-names></name><name name-style="western"><surname>Allden</surname><given-names>S</given-names></name><name name-style="western"><surname>Bourne</surname><given-names>T</given-names></name><name name-style="western"><surname>Denis</surname><given-names>MC</given-names></name><name name-style="western"><surname>Kranidioti</surname><given-names>K</given-names></name><name name-style="western"><surname>Okoye</surname><given-names>R</given-names></name><etal/></person-group><article-title>Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNF&#945; in rheumatoid arthritis</article-title><source>J Transl Med</source><year>2014</year><volume>12</volume><fpage>285</fpage><pub-id pub-id-type="doi">10.1186/s12967-014-0285-z</pub-id><pub-id pub-id-type="pmid">25344414</pub-id><pub-id pub-id-type="pmcid">PMC4219128</pub-id></element-citation></ref><ref id="CR914"><label>914.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zalevsky</surname><given-names>J</given-names></name><name name-style="western"><surname>Secher</surname><given-names>T</given-names></name><name name-style="western"><surname>Ezhevsky</surname><given-names>SA</given-names></name><name name-style="western"><surname>Janot</surname><given-names>L</given-names></name><name name-style="western"><surname>Steed</surname><given-names>PM</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>C</given-names></name><etal/></person-group><article-title>Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>1872</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.3.1872</pub-id><pub-id pub-id-type="pmid">17641054</pub-id></element-citation></ref><ref id="CR915"><label>915.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>sTNFRII-Fc modification protects human UC-MSCs against apoptosis/autophagy induced by TNF-&#945; and enhances their efficacy in alleviating inflammatory arthritis</article-title><source>Stem Cell Res Ther</source><year>2021</year><volume>12</volume><fpage>535</fpage><pub-id pub-id-type="doi">10.1186/s13287-021-02602-4</pub-id><pub-id pub-id-type="pmid">34627365</pub-id><pub-id pub-id-type="pmcid">PMC8502322</pub-id></element-citation></ref><ref id="CR916"><label>916.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>QQ</given-names></name><name name-style="western"><surname>Birkett</surname><given-names>R</given-names></name><name name-style="western"><surname>Koessler</surname><given-names>RE</given-names></name><name name-style="western"><surname>Cuda</surname><given-names>CM</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Jin</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Fas signaling in macrophages promotes chronicity in K/BxN serum-induced arthritis</article-title><source>Arthritis Rheumatol</source><year>2014</year><volume>66</volume><fpage>68</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1002/art.38198</pub-id><pub-id pub-id-type="pmid">24431281</pub-id><pub-id pub-id-type="pmcid">PMC5407456</pub-id></element-citation></ref><ref id="CR917"><label>917.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>SE</given-names></name><name name-style="western"><surname>Park</surname><given-names>JK</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HS</given-names></name><name name-style="western"><surname>Park</surname><given-names>YW</given-names></name><name name-style="western"><surname>Park</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Efficacy of novel bispecific antibody targeting TNF-&#945;/CXCL10 in the treatment of experimental arthritis</article-title><source>Transl Res</source><year>2021</year><volume>232</volume><fpage>75</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2021.01.004</pub-id><pub-id pub-id-type="pmid">33453429</pub-id></element-citation></ref><ref id="CR918"><label>918.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itoh</surname><given-names>N</given-names></name><name name-style="western"><surname>Imagawa</surname><given-names>A</given-names></name><name name-style="western"><surname>Hanafusa</surname><given-names>T</given-names></name><name name-style="western"><surname>Waguri</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Iwahashi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice</article-title><source>J Exp Med</source><year>1997</year><volume>186</volume><fpage>613</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1084/jem.186.4.613</pub-id><pub-id pub-id-type="pmid">9254659</pub-id><pub-id pub-id-type="pmcid">PMC2199040</pub-id></element-citation></ref><ref id="CR919"><label>919.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kristan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Costa</surname><given-names>C</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gero</surname><given-names>D</given-names></name><etal/></person-group><article-title>Significant role for Fas in the pathogenesis of autoimmune diabetes</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>2523</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.5.2523</pub-id><pub-id pub-id-type="pmid">10679090</pub-id></element-citation></ref><ref id="CR920"><label>920.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chervonsky</surname><given-names>AV</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wong</surname><given-names>FS</given-names></name><name name-style="western"><surname>Visintin</surname><given-names>I</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><name name-style="western"><surname>Janeway</surname><given-names>CA</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>The role of Fas in autoimmune diabetes</article-title><source>Cell</source><year>1997</year><volume>89</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80178-6</pub-id><pub-id pub-id-type="pmid">9094710</pub-id></element-citation></ref><ref id="CR921"><label>921.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vence</surname><given-names>L</given-names></name><name name-style="western"><surname>Benoist</surname><given-names>C</given-names></name><name name-style="western"><surname>Mathis</surname><given-names>D</given-names></name></person-group><article-title>Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>2797</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.2337/diabetes.53.11.2797</pub-id><pub-id pub-id-type="pmid">15504959</pub-id></element-citation></ref><ref id="CR922"><label>922.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohamood</surname><given-names>AS</given-names></name><name name-style="western"><surname>Guler</surname><given-names>ML</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>D</given-names></name><name name-style="western"><surname>Hess</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically</article-title><source>Am J Pathol</source><year>2007</year><volume>171</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070148</pub-id><pub-id pub-id-type="pmid">17591957</pub-id><pub-id pub-id-type="pmcid">PMC1941609</pub-id></element-citation></ref><ref id="CR923"><label>923.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M</given-names></name><name name-style="western"><surname>Kim</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Park</surname><given-names>TG</given-names></name><name name-style="western"><surname>Ko</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice</article-title><source>J Control Release</source><year>2010</year><volume>143</volume><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2009.12.005</pub-id><pub-id pub-id-type="pmid">20004692</pub-id><pub-id pub-id-type="pmcid">PMC2840072</pub-id></element-citation></ref><ref id="CR924"><label>924.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trivedi</surname><given-names>PM</given-names></name><name name-style="western"><surname>Fynch</surname><given-names>S</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>LM</given-names></name><name name-style="western"><surname>Chee</surname><given-names>J</given-names></name><name name-style="western"><surname>Krishnamurthy</surname><given-names>B</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice</article-title><source>Cell Death Discov</source><year>2019</year><volume>5</volume><fpage>136</fpage><pub-id pub-id-type="doi">10.1038/s41420-019-0217-z</pub-id><pub-id pub-id-type="pmid">31552143</pub-id><pub-id pub-id-type="pmcid">PMC6755132</pub-id></element-citation></ref><ref id="CR925"><label>925.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>D</given-names></name><name name-style="western"><surname>Radziszewska</surname><given-names>A</given-names></name><name name-style="western"><surname>Schroer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Liadis</surname><given-names>N</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Deletion of Fas in the pancreatic beta-cells leads to enhanced insulin secretion</article-title><source>Am J Physiol Endocrinol Metab</source><year>2009</year><volume>297</volume><fpage>E1304</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00217.2009</pub-id><pub-id pub-id-type="pmid">19755672</pub-id></element-citation></ref><ref id="CR926"><label>926.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>HE</given-names></name><name name-style="western"><surname>Darwiche</surname><given-names>R</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kay</surname><given-names>TW</given-names></name></person-group><article-title>Evidence that beta cell death in the nonobese diabetic mouse is Fas independent</article-title><source>J Immunol</source><year>1999</year><volume>163</volume><fpage>1562</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.163.3.1562</pub-id><pub-id pub-id-type="pmid">10415060</pub-id></element-citation></ref><ref id="CR927"><label>927.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biemans</surname><given-names>VBC</given-names></name><name name-style="western"><surname>Sleutjes</surname><given-names>JAM</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>AC</given-names></name><name name-style="western"><surname>Bodelier</surname><given-names>AGL</given-names></name><name name-style="western"><surname>Dijkstra</surname><given-names>G</given-names></name><name name-style="western"><surname>Oldenburg</surname><given-names>B</given-names></name><etal/></person-group><article-title>Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry</article-title><source>Aliment Pharmacol Ther</source><year>2020</year><volume>51</volume><fpage>880</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/apt.15689</pub-id><pub-id pub-id-type="pmid">32237087</pub-id><pub-id pub-id-type="pmcid">PMC7187329</pub-id></element-citation></ref><ref id="CR928"><label>928.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almon</surname><given-names>E</given-names></name><name name-style="western"><surname>Shaaltiel</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sbeit</surname><given-names>W</given-names></name><name name-style="western"><surname>Fich</surname><given-names>A</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>D</given-names></name><name name-style="western"><surname>Waterman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Novel orally administered recombinant anti-TNF alpha fusion protein for the treatment of ulcerative colitis: results from a phase 2a clinical trial</article-title><source>J Clin Gastroenterol</source><year>2021</year><volume>55</volume><fpage>134</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1097/MCG.0000000000001314</pub-id><pub-id pub-id-type="pmid">32501868</pub-id><pub-id pub-id-type="pmcid">PMC7803480</pub-id></element-citation></ref><ref id="CR929"><label>929.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>CY</given-names></name><name name-style="western"><surname>Tam</surname><given-names>SS</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dub&#233;</surname><given-names>PE</given-names></name><name name-style="western"><surname>Alhosh</surname><given-names>R</given-names></name><name name-style="western"><surname>Girish</surname><given-names>N</given-names></name><etal/></person-group><article-title>TNF receptor 1 promotes early-life immunity and protects against colitis in mice</article-title><source>Cell Rep</source><year>2020</year><volume>33</volume><fpage>108275</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108275</pub-id><pub-id pub-id-type="pmid">33086075</pub-id><pub-id pub-id-type="pmcid">PMC7682618</pub-id></element-citation></ref><ref id="CR930"><label>930.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>DP</given-names></name><name name-style="western"><surname>Jin</surname><given-names>YL</given-names></name><name name-style="western"><surname>Hu</surname><given-names>DY</given-names></name><name name-style="western"><surname>Ying</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name></person-group><article-title>Influence of TRAIL deficiency on Th17 cells and colonic microbiota in experimental colitis mouse model</article-title><source>Am J Med Sci</source><year>2021</year><volume>362</volume><fpage>188</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.amjms.2021.04.011</pub-id><pub-id pub-id-type="pmid">33932348</pub-id></element-citation></ref><ref id="CR931"><label>931.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chyuan</surname><given-names>IT</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>HF</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CS</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>PN</given-names></name></person-group><article-title>TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway</article-title><source>Mucosal Immunol</source><year>2019</year><volume>12</volume><fpage>980</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41385-019-0168-y</pub-id><pub-id pub-id-type="pmid">31076664</pub-id><pub-id pub-id-type="pmcid">PMC7746525</pub-id></element-citation></ref><ref id="CR932"><label>932.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>B</given-names></name><name name-style="western"><surname>You</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Sooranna</surname><given-names>SR</given-names></name></person-group><article-title>Overexpression of Fas and FasL is associated with infectious complications and severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes</article-title><source>Inflammation</source><year>2014</year><volume>37</volume><fpage>1202</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-9847-8</pub-id><pub-id pub-id-type="pmid">24566874</pub-id><pub-id pub-id-type="pmcid">PMC4077252</pub-id></element-citation></ref><ref id="CR933"><label>933.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Randhi</surname><given-names>R</given-names></name><name name-style="western"><surname>Damon</surname><given-names>M</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>KJ</given-names></name></person-group><article-title>Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice</article-title><source>BMC Gastroenterol</source><year>2021</year><volume>21</volume><fpage>243</fpage><pub-id pub-id-type="doi">10.1186/s12876-021-01827-0</pub-id><pub-id pub-id-type="pmid">34049483</pub-id><pub-id pub-id-type="pmcid">PMC8161932</pub-id></element-citation></ref><ref id="CR934"><label>934.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XM</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>HL</given-names></name><name name-style="western"><surname>Quezada</surname><given-names>HC</given-names></name><name name-style="western"><surname>Mix</surname><given-names>E</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><etal/></person-group><article-title>TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice</article-title><source>Neurosci Lett</source><year>2010</year><volume>470</volume><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2009.12.045</pub-id><pub-id pub-id-type="pmid">20035831</pub-id></element-citation></ref><ref id="CR935"><label>935.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>JM</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>JD</given-names></name></person-group><article-title>Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation</article-title><source>J Neuroimmunol</source><year>2007</year><volume>183</volume><fpage>118</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2006.11.027</pub-id><pub-id pub-id-type="pmid">17196669</pub-id></element-citation></ref><ref id="CR936"><label>936.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bao</surname><given-names>L</given-names></name><name name-style="western"><surname>Lindgren</surname><given-names>JU</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ljunggren</surname><given-names>HG</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name></person-group><article-title>Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis</article-title><source>Neurobiol Dis</source><year>2003</year><volume>12</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/S0969-9961(02)00007-4</pub-id><pub-id pub-id-type="pmid">12609491</pub-id></element-citation></ref><ref id="CR937"><label>937.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>MO</given-names></name><name name-style="western"><surname>Duan</surname><given-names>RS</given-names></name><name name-style="western"><surname>Quezada</surname><given-names>HC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Mix</surname><given-names>E</given-names></name><name name-style="western"><surname>Jin</surname><given-names>T</given-names></name><etal/></person-group><article-title>Aggravation of experimental autoimmune neuritis in TNF-alpha receptor 1 deficient mice</article-title><source>J Neuroimmunol</source><year>2007</year><volume>186</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2007.02.004</pub-id><pub-id pub-id-type="pmid">17428547</pub-id></element-citation></ref><ref id="CR938"><label>938.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaaij</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rip</surname><given-names>J</given-names></name><name name-style="western"><surname>Jeucken</surname><given-names>KCM</given-names></name><name name-style="western"><surname>Kan</surname><given-names>YY</given-names></name><name name-style="western"><surname>van Rooijen</surname><given-names>CCN</given-names></name><name name-style="western"><surname>Saris</surname><given-names>J</given-names></name><etal/></person-group><article-title>Overexpression of transmembrane TNF drives development of ectopic lymphoid structures in the bone marrow and B cell lineage alterations in experimental spondyloarthritis</article-title><source>J Immunol</source><year>2021</year><volume>207</volume><fpage>2337</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2100512</pub-id><pub-id pub-id-type="pmid">34561228</pub-id></element-citation></ref><ref id="CR939"><label>939.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xi</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Differential role of TNFR1 and TNFR2 in the development of imiquimod-induced mouse psoriasis</article-title><source>J Leukoc Biol</source><year>2021</year><volume>110</volume><fpage>1047</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1002/JLB.2MA0121-082R</pub-id><pub-id pub-id-type="pmid">34494306</pub-id></element-citation></ref><ref id="CR940"><label>940.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title>TRAIL and DR5 promote thyroid follicular cell apoptosis in iodine excess-induced experimental autoimmune thyroiditis in NOD mice</article-title><source>Biol Trace Elem Res</source><year>2011</year><volume>143</volume><fpage>1064</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/s12011-010-8941-5</pub-id><pub-id pub-id-type="pmid">21225479</pub-id></element-citation></ref><ref id="CR941"><label>941.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sharp</surname><given-names>GC</given-names></name><name name-style="western"><surname>Yagita</surname><given-names>H</given-names></name><name name-style="western"><surname>Braley-Mullen</surname><given-names>H</given-names></name></person-group><article-title>A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis</article-title><source>J Pathol</source><year>2008</year><volume>216</volume><fpage>505</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/path.2428</pub-id><pub-id pub-id-type="pmid">18810759</pub-id><pub-id pub-id-type="pmcid">PMC2637621</pub-id></element-citation></ref><ref id="CR942"><label>942.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Sharp</surname><given-names>GC</given-names></name><name name-style="western"><surname>Braley-Mullen</surname><given-names>H</given-names></name></person-group><article-title>Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><fpage>7615</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.12.7615</pub-id><pub-id pub-id-type="pmid">15585889</pub-id></element-citation></ref><ref id="CR943"><label>943.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>GH</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Van Antwerp</surname><given-names>M</given-names></name><name name-style="western"><surname>Baker</surname><given-names>JR</given-names><suffix>Jr</suffix></name></person-group><article-title>Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells</article-title><source>Endocrinology</source><year>2009</year><volume>150</volume><fpage>2000</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1210/en.2008-1389</pub-id><pub-id pub-id-type="pmid">19008314</pub-id><pub-id pub-id-type="pmcid">PMC2659286</pub-id></element-citation></ref><ref id="CR944"><label>944.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>JM</given-names></name><name name-style="western"><surname>Van Antwerp</surname><given-names>M</given-names></name><name name-style="western"><surname>Baker</surname><given-names>JR</given-names><suffix>Jr</suffix></name></person-group><article-title>Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis</article-title><source>Endocrinology</source><year>2005</year><volume>146</volume><fpage>4721</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1210/en.2005-0627</pub-id><pub-id pub-id-type="pmid">16123163</pub-id></element-citation></ref><ref id="CR945"><label>945.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patankar</surname><given-names>JV</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>TM</given-names></name><name name-style="western"><surname>Kantham</surname><given-names>S</given-names></name><name name-style="western"><surname>Acera</surname><given-names>MG</given-names></name><name name-style="western"><surname>Mascia</surname><given-names>F</given-names></name><name name-style="western"><surname>Scheibe</surname><given-names>K</given-names></name><etal/></person-group><article-title>E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis</article-title><source>Nat Cell Biol</source><year>2021</year><volume>23</volume><fpage>796</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00708-8</pub-id><pub-id pub-id-type="pmid">34239062</pub-id></element-citation></ref><ref id="CR946"><label>946.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>JS</given-names></name><name name-style="western"><surname>Yang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kovalenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Wallach</surname><given-names>D</given-names></name></person-group><article-title>Caspase-8 deficiency in mouse embryos triggers chronic RIPK1-dependent activation of inflammatory genes, independently of RIPK3</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>1107</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/s41418-018-0104-9</pub-id><pub-id pub-id-type="pmid">29666472</pub-id><pub-id pub-id-type="pmcid">PMC5988659</pub-id></element-citation></ref><ref id="CR947"><label>947.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajput</surname><given-names>A</given-names></name><name name-style="western"><surname>Kovalenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Bogdanov</surname><given-names>K</given-names></name><name name-style="western"><surname>Yang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JC</given-names></name><etal/></person-group><article-title>RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>340</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.12.018</pub-id><pub-id pub-id-type="pmid">21419663</pub-id></element-citation></ref><ref id="CR948"><label>948.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laurien</surname><given-names>L</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>M</given-names></name><name name-style="western"><surname>Sch&#252;nke</surname><given-names>H</given-names></name><name name-style="western"><surname>Delanghe</surname><given-names>T</given-names></name><name name-style="western"><surname>Wiederstein</surname><given-names>JL</given-names></name><name name-style="western"><surname>Kumari</surname><given-names>S</given-names></name><etal/></person-group><article-title>Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><fpage>1747</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-15466-8</pub-id><pub-id pub-id-type="pmid">32269263</pub-id><pub-id pub-id-type="pmcid">PMC7142081</pub-id></element-citation></ref><ref id="CR949"><label>949.</label><mixed-citation publication-type="other">Rickard JA, Anderton H, Etemadi N, Nachbur U, Darding M, Peltzer N, et al. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. eLife 2014;3:e03464.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.03464</pub-id><pub-id pub-id-type="pmcid">PMC4270099</pub-id><pub-id pub-id-type="pmid">25443632</pub-id></mixed-citation></ref><ref id="CR950"><label>950.</label><mixed-citation publication-type="other">Kumari S, Redouane Y, Lopez-Mosqueda J, Shiraishi R, Romanowska M, Lutzmayer S, et al. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. eLife. 2014;3:e03422.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.03422</pub-id><pub-id pub-id-type="pmcid">PMC4225491</pub-id><pub-id pub-id-type="pmid">25443631</pub-id></mixed-citation></ref><ref id="CR951"><label>951.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berger</surname><given-names>SB</given-names></name><name name-style="western"><surname>Kasparcova</surname><given-names>V</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>S</given-names></name><name name-style="western"><surname>Swift</surname><given-names>B</given-names></name><name name-style="western"><surname>Dare</surname><given-names>L</given-names></name><name name-style="western"><surname>Schaeffer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice</article-title><source>J Immunol</source><year>2014</year><volume>192</volume><fpage>5476</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1400499</pub-id><pub-id pub-id-type="pmid">24821972</pub-id><pub-id pub-id-type="pmcid">PMC4048763</pub-id></element-citation></ref><ref id="CR952"><label>952.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taraborrelli</surname><given-names>L</given-names></name><name name-style="western"><surname>Peltzer</surname><given-names>N</given-names></name><name name-style="western"><surname>Montinaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Kupka</surname><given-names>S</given-names></name><name name-style="western"><surname>Rieser</surname><given-names>E</given-names></name><name name-style="western"><surname>Hartwig</surname><given-names>T</given-names></name><etal/></person-group><article-title>LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><fpage>3910</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-06155-8</pub-id><pub-id pub-id-type="pmid">30254289</pub-id><pub-id pub-id-type="pmcid">PMC6156229</pub-id></element-citation></ref><ref id="CR953"><label>953.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mc Guire</surname><given-names>C</given-names></name><name name-style="western"><surname>Volckaert</surname><given-names>T</given-names></name><name name-style="western"><surname>Wolke</surname><given-names>U</given-names></name><name name-style="western"><surname>Sze</surname><given-names>M</given-names></name><name name-style="western"><surname>de Rycke</surname><given-names>R</given-names></name><name name-style="western"><surname>Waisman</surname><given-names>A</given-names></name><etal/></person-group><article-title>Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination</article-title><source>J Immunol</source><year>2010</year><volume>185</volume><fpage>7646</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000930</pub-id><pub-id pub-id-type="pmid">21068410</pub-id></element-citation></ref><ref id="CR954"><label>954.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Hilliard</surname><given-names>B</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YH</given-names></name></person-group><article-title>Essential roles of the Fas-associated death domain in autoimmune encephalomyelitis</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>4783</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.7.4783</pub-id><pub-id pub-id-type="pmid">16177127</pub-id></element-citation></ref><ref id="CR955"><label>955.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newton</surname><given-names>K</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AW</given-names></name><name name-style="western"><surname>Bath</surname><given-names>ML</given-names></name><name name-style="western"><surname>Smith</surname><given-names>KG</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>706</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.3.706</pub-id><pub-id pub-id-type="pmid">9450996</pub-id><pub-id pub-id-type="pmcid">PMC1170420</pub-id></element-citation></ref><ref id="CR956"><label>956.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation</article-title><source>J Clin Investig</source><year>2018</year><volume>128</volume><fpage>5399</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1172/JCI121901</pub-id><pub-id pub-id-type="pmid">30372424</pub-id><pub-id pub-id-type="pmcid">PMC6264724</pub-id></element-citation></ref><ref id="CR957"><label>957.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allison</surname><given-names>J</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>HE</given-names></name><name name-style="western"><surname>Catterall</surname><given-names>T</given-names></name><name name-style="western"><surname>Kay</surname><given-names>TW</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.1.293</pub-id><pub-id pub-id-type="pmid">15972661</pub-id></element-citation></ref><ref id="CR958"><label>958.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mollah</surname><given-names>ZU</given-names></name><name name-style="western"><surname>Wali</surname><given-names>J</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>MD</given-names></name><name name-style="western"><surname>Krishnamurthy</surname><given-names>B</given-names></name><name name-style="western"><surname>Graham</surname><given-names>KL</given-names></name><name name-style="western"><surname>Fynch</surname><given-names>S</given-names></name><etal/></person-group><article-title>The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouse</article-title><source>Apoptosis</source><year>2011</year><volume>16</volume><fpage>822</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1007/s10495-011-0615-z</pub-id><pub-id pub-id-type="pmid">21644000</pub-id></element-citation></ref><ref id="CR959"><label>959.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>QQ</given-names></name><name name-style="western"><surname>Birkett</surname><given-names>R</given-names></name><name name-style="western"><surname>Doyle</surname><given-names>RE</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>H</given-names></name><name name-style="western"><surname>Shi</surname><given-names>B</given-names></name><etal/></person-group><article-title>Association of increased F4/80(high) macrophages with suppression of serum-transfer arthritis in mice with reduced FLIP in myeloid cells</article-title><source>Arthritis Rheumatol</source><year>2017</year><volume>69</volume><fpage>1762</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1002/art.40151</pub-id><pub-id pub-id-type="pmid">28511285</pub-id><pub-id pub-id-type="pmcid">PMC5575965</pub-id></element-citation></ref><ref id="CR960"><label>960.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dominguez</surname><given-names>S</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>AB</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Bloomfield</surname><given-names>CL</given-names></name><name name-style="western"><surname>Cuda</surname><given-names>CM</given-names></name></person-group><article-title>The caspase-8/RIPK3 signaling axis in antigen presenting cells controls the inflammatory arthritic response</article-title><source>Arthritis Res Ther</source><year>2017</year><volume>19</volume><fpage>224</fpage><pub-id pub-id-type="doi">10.1186/s13075-017-1436-4</pub-id><pub-id pub-id-type="pmid">28978351</pub-id><pub-id pub-id-type="pmcid">PMC5628498</pub-id></element-citation></ref><ref id="CR961"><label>961.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearson</surname><given-names>JS</given-names></name><name name-style="western"><surname>Giogha</surname><given-names>C</given-names></name><name name-style="western"><surname>Ong</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>CL</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>M</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>KS</given-names></name><etal/></person-group><article-title>A type III effector antagonizes death receptor signalling during bacterial gut infection</article-title><source>Nature</source><year>2013</year><volume>501</volume><fpage>247</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/nature12524</pub-id><pub-id pub-id-type="pmid">24025841</pub-id><pub-id pub-id-type="pmcid">PMC3836246</pub-id></element-citation></ref><ref id="CR962"><label>962.</label><mixed-citation publication-type="other">Li S, Zhang L, Yao Q, Li L, Dong N, Rong J, et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 2013;501:242&#8211;6.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12436</pub-id><pub-id pub-id-type="pmid">23955153</pub-id></mixed-citation></ref><ref id="CR963"><label>963.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uchiyama</surname><given-names>R</given-names></name><name name-style="western"><surname>Yonehara</surname><given-names>S</given-names></name><name name-style="western"><surname>Taniguchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Ishido</surname><given-names>S</given-names></name><name name-style="western"><surname>Ishii</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Tsutsui</surname><given-names>H</given-names></name></person-group><article-title>Inflammasome and Fas-mediated IL-1&#946; contributes to Th17/Th1 cell induction in pathogenic bacterial infection in vivo</article-title><source>J Immunol</source><year>2017</year><volume>199</volume><fpage>1122</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601373</pub-id><pub-id pub-id-type="pmid">28674179</pub-id></element-citation></ref><ref id="CR964"><label>964.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maudet</surname><given-names>C</given-names></name><name name-style="western"><surname>Kheloufi</surname><given-names>M</given-names></name><name name-style="western"><surname>Levallois</surname><given-names>S</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Gaultier</surname><given-names>C</given-names></name><etal/></person-group><article-title>Bacterial inhibition of Fas-mediated killing promotes neuroinvasion and persistence</article-title><source>Nature</source><year>2022</year><volume>603</volume><fpage>900</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04505-7</pub-id><pub-id pub-id-type="pmid">35296858</pub-id></element-citation></ref><ref id="CR965"><label>965.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krzyzowska</surname><given-names>M</given-names></name><name name-style="western"><surname>Baska</surname><given-names>P</given-names></name><name name-style="western"><surname>Orlowski</surname><given-names>P</given-names></name><name name-style="western"><surname>Zdanowski</surname><given-names>R</given-names></name><name name-style="western"><surname>Winnicka</surname><given-names>A</given-names></name><name name-style="western"><surname>Eriksson</surname><given-names>K</given-names></name><etal/></person-group><article-title>HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e70308</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0070308</pub-id><pub-id pub-id-type="pmid">23922974</pub-id><pub-id pub-id-type="pmcid">PMC3726399</pub-id></element-citation></ref><ref id="CR966"><label>966.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>CL</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>M</given-names></name><name name-style="western"><surname>Nowell</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>JG</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Fas regulates neutrophil lifespan during viral and bacterial infection</article-title><source>J Leukoc Biol</source><year>2015</year><volume>97</volume><fpage>321</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1189/jlb.3AB1113-594RR</pub-id><pub-id pub-id-type="pmid">25473101</pub-id></element-citation></ref><ref id="CR967"><label>967.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>LW</given-names></name><name name-style="western"><surname>Philip</surname><given-names>NH</given-names></name><name name-style="western"><surname>DeLaney</surname><given-names>A</given-names></name><name name-style="western"><surname>Wynosky-Dolfi</surname><given-names>MA</given-names></name><name name-style="western"><surname>Asklof</surname><given-names>K</given-names></name><name name-style="western"><surname>Gray</surname><given-names>F</given-names></name><etal/></person-group><article-title>RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense</article-title><source>J Exp Med</source><year>2017</year><volume>214</volume><fpage>3171</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1084/jem.20170347</pub-id><pub-id pub-id-type="pmid">28855241</pub-id><pub-id pub-id-type="pmcid">PMC5679171</pub-id></element-citation></ref><ref id="CR968"><label>968.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weng</surname><given-names>D</given-names></name><name name-style="western"><surname>Marty-Roix</surname><given-names>R</given-names></name><name name-style="western"><surname>Ganesan</surname><given-names>S</given-names></name><name name-style="western"><surname>Proulx</surname><given-names>MK</given-names></name><name name-style="western"><surname>Vladimer</surname><given-names>GI</given-names></name><name name-style="western"><surname>Kaiser</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>7391</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.1403477111</pub-id><pub-id pub-id-type="pmid">24799678</pub-id><pub-id pub-id-type="pmcid">PMC4034196</pub-id></element-citation></ref><ref id="CR969"><label>969.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeLaney</surname><given-names>AA</given-names></name><name name-style="western"><surname>Berry</surname><given-names>CT</given-names></name><name name-style="western"><surname>Christian</surname><given-names>DA</given-names></name><name name-style="western"><surname>Hart</surname><given-names>A</given-names></name><name name-style="western"><surname>Bjanes</surname><given-names>E</given-names></name><name name-style="western"><surname>Wynosky-Dolfi</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Caspase-8 promotes c-Rel-dependent inflammatory cytokine expression and resistance against Toxoplasma gondii</article-title><source>Proc Natl Acad Sci USA</source><year>2019</year><volume>116</volume><fpage>11926</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1073/pnas.1820529116</pub-id><pub-id pub-id-type="pmid">31147458</pub-id><pub-id pub-id-type="pmcid">PMC6575527</pub-id></element-citation></ref><ref id="CR970"><label>970.</label><mixed-citation publication-type="other">Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016;1:aag2045.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.aag2045</pub-id><pub-id pub-id-type="pmcid">PMC5131924</pub-id><pub-id pub-id-type="pmid">27917412</pub-id></mixed-citation></ref><ref id="CR971"><label>971.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thapa</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Ingram</surname><given-names>JP</given-names></name><name name-style="western"><surname>Ragan</surname><given-names>KB</given-names></name><name name-style="western"><surname>Nogusa</surname><given-names>S</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>DF</given-names></name><name name-style="western"><surname>Benitez</surname><given-names>AA</given-names></name><etal/></person-group><article-title>DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death</article-title><source>Cell Host Microbe</source><year>2016</year><volume>20</volume><fpage>674</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.09.014</pub-id><pub-id pub-id-type="pmid">27746097</pub-id><pub-id pub-id-type="pmcid">PMC5687825</pub-id></element-citation></ref><ref id="CR972"><label>972.</label><mixed-citation publication-type="other">Oltean T, Van San E, Divert T, Vanden Berghe T, Saelens X, Maelfait J, et al. Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL. Cell Death Dis. 2021;12:471.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-021-03746-0</pub-id><pub-id pub-id-type="pmcid">PMC8113499</pub-id><pub-id pub-id-type="pmid">33976111</pub-id></mixed-citation></ref><ref id="CR973"><label>973.</label><mixed-citation publication-type="other">Nogusa S, Thapa RJ, Dillon CP, Liedmann S, Oguin TH, 3rd, Ingram JP, et al. RIPK3 activates parallel pathways of mlkl-driven necroptosis and fadd-mediated apoptosis to protect against influenza a virus. Cell Host Microbe 2016;20:13&#8211;24.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2016.05.011</pub-id><pub-id pub-id-type="pmcid">PMC5026823</pub-id><pub-id pub-id-type="pmid">27321907</pub-id></mixed-citation></ref><ref id="CR974"><label>974.</label><mixed-citation publication-type="other">Zhang T, Yin C, Boyd DF, Quarato G, Ingram JP, Shubina M, et al. influenza virus z-rnas induce zbp1-mediated necroptosis. Cell 2020;180:1115&#8211;29.e1113.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.02.050</pub-id><pub-id pub-id-type="pmcid">PMC7153753</pub-id><pub-id pub-id-type="pmid">32200799</pub-id></mixed-citation></ref><ref id="CR975"><label>975.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Place</surname><given-names>DE</given-names></name><name name-style="western"><surname>Christgen</surname><given-names>S</given-names></name><name name-style="western"><surname>Tuladhar</surname><given-names>S</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>P</given-names></name><name name-style="western"><surname>Malireddi</surname><given-names>RKS</given-names></name><name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><article-title>Hierarchical cell death program disrupts the intracellular niche required for Burkholderia thailandensis pathogenesis</article-title><source>mBio</source><year>2021</year><volume>12</volume><fpage>e0105921</fpage><pub-id pub-id-type="doi">10.1128/mBio.01059-21</pub-id><pub-id pub-id-type="pmid">34154417</pub-id><pub-id pub-id-type="pmcid">PMC8262894</pub-id></element-citation></ref><ref id="CR976"><label>976.</label><mixed-citation publication-type="other">Ebert G, Preston S, Allison C, Cooney J, Toe JG, Stutz MD, et al. Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proc Natl Acad Sci USA. 2015;112:5797&#8211;802.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1502390112</pub-id><pub-id pub-id-type="pmcid">PMC4426461</pub-id><pub-id pub-id-type="pmid">25902529</pub-id></mixed-citation></ref><ref id="CR977"><label>977.</label><mixed-citation publication-type="other">Ebert G, Allison C, Preston S, Cooney J, Toe JG, Stutz MD, et al. Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. Proc Natl Acad Sci USA. 2015;112:5803&#8211;8.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1502400112</pub-id><pub-id pub-id-type="pmcid">PMC4426438</pub-id><pub-id pub-id-type="pmid">25902530</pub-id></mixed-citation></ref><ref id="CR978"><label>978.</label><mixed-citation publication-type="other">Ebert G, Lopaticki S, O'Neill MT, Steel RWJ, Doerflinger M, Rajasekaran P, et al. targeting the extrinsic pathway of hepatocyte apoptosis promotes clearance of plasmodium liver infection. Cell Rep. 2020;30:4343-4354.e4344.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2020.03.032</pub-id><pub-id pub-id-type="pmid">32234472</pub-id></mixed-citation></ref><ref id="CR979"><label>979.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alikhani</surname><given-names>M</given-names></name><name name-style="western"><surname>Alikhani</surname><given-names>Z</given-names></name><name name-style="western"><surname>He</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name><name name-style="western"><surname>Popek</surname><given-names>BI</given-names></name><name name-style="western"><surname>Graves</surname><given-names>DT</given-names></name></person-group><article-title>Lipopolysaccharides indirectly stimulate apoptosis and global induction of apoptotic genes in fibroblasts</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>52901</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1074/jbc.M307638200</pub-id><pub-id pub-id-type="pmid">14551216</pub-id></element-citation></ref><ref id="CR980"><label>980.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarid</surname><given-names>R</given-names></name><name name-style="western"><surname>Ben-Moshe</surname><given-names>T</given-names></name><name name-style="western"><surname>Kazimirsky</surname><given-names>G</given-names></name><name name-style="western"><surname>Weisberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Appel</surname><given-names>E</given-names></name><name name-style="western"><surname>Kobiler</surname><given-names>D</given-names></name><etal/></person-group><article-title>vFLIP protects PC-12 cells from apoptosis induced by Sindbis virus: implications for the role of TNF-alpha</article-title><source>Cell Death Differ</source><year>2001</year><volume>8</volume><fpage>1224</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400926</pub-id><pub-id pub-id-type="pmid">11753570</pub-id></element-citation></ref><ref id="CR981"><label>981.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shuying</surname><given-names>W</given-names></name><name name-style="western"><surname>Ranran</surname><given-names>D</given-names></name></person-group><article-title>Inhibitory effects of JQ1 on listeria monocytogenes-induced acute liver injury by blocking BRD4/RIPK1 axis</article-title><source>Biomed Pharmacother</source><year>2020</year><volume>125</volume><fpage>109818</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2020.109818</pub-id><pub-id pub-id-type="pmid">32106368</pub-id></element-citation></ref><ref id="CR982"><label>982.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Pothoulakis</surname><given-names>C</given-names></name><name name-style="western"><surname>Lamont</surname><given-names>JT</given-names></name></person-group><article-title>Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand</article-title><source>Gastroenterology</source><year>2007</year><volume>133</volume><fpage>875</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2007.06.063</pub-id><pub-id pub-id-type="pmid">17854595</pub-id></element-citation></ref><ref id="CR983"><label>983.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>BL</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Yang</surname><given-names>LY</given-names></name><name name-style="western"><surname>Xie</surname><given-names>JF</given-names></name><name name-style="western"><surname>Weng</surname><given-names>SP</given-names></name><name name-style="western"><surname>Yu</surname><given-names>XQ</given-names></name><etal/></person-group><article-title>The viral TRAF protein (ORF111L) from infectious spleen and kidney necrosis virus interacts with TRADD and induces caspase 8-mediated apoptosis</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e37001</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0037001</pub-id><pub-id pub-id-type="pmid">22615868</pub-id><pub-id pub-id-type="pmcid">PMC3352826</pub-id></element-citation></ref><ref id="CR984"><label>984.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandal</surname><given-names>P</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lyons</surname><given-names>JD</given-names></name><name name-style="western"><surname>Berger</surname><given-names>SB</given-names></name><name name-style="western"><surname>Otani</surname><given-names>S</given-names></name><name name-style="western"><surname>DeLaney</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-8 collaborates with caspase-11 to drive tissue damage and execution of endotoxic shock</article-title><source>Immunity</source><year>2018</year><volume>49</volume><fpage>42</fpage><lpage>55.e46</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.06.011</pub-id><pub-id pub-id-type="pmid">30021146</pub-id><pub-id pub-id-type="pmcid">PMC6064639</pub-id></element-citation></ref><ref id="CR985"><label>985.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karki</surname><given-names>R</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>BR</given-names></name><name name-style="western"><surname>Tuladhar</surname><given-names>S</given-names></name><name name-style="western"><surname>Williams</surname><given-names>EP</given-names></name><name name-style="western"><surname>Zalduondo</surname><given-names>L</given-names></name><name name-style="western"><surname>Samir</surname><given-names>P</given-names></name><etal/></person-group><article-title>Synergism of TNF-&#945; and IFN-&#947; triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>149</fpage><lpage>168.e117</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.025</pub-id><pub-id pub-id-type="pmid">33278357</pub-id><pub-id pub-id-type="pmcid">PMC7674074</pub-id></element-citation></ref><ref id="CR986"><label>986.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langen</surname><given-names>RC</given-names></name><name name-style="western"><surname>Van Der Velden</surname><given-names>JL</given-names></name><name name-style="western"><surname>Schols</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kelders</surname><given-names>MC</given-names></name><name name-style="western"><surname>Wouters</surname><given-names>EF</given-names></name><name name-style="western"><surname>Janssen-Heininger</surname><given-names>YM</given-names></name></person-group><article-title>Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization</article-title><source>FASEB J</source><year>2004</year><volume>18</volume><fpage>227</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1096/fj.03-0251com</pub-id><pub-id pub-id-type="pmid">14769817</pub-id></element-citation></ref><ref id="CR987"><label>987.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Waldemer-Streyer</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>MS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Muscle-derived TRAIL negatively regulates myogenic differentiation</article-title><source>Exp Cell Res</source><year>2020</year><volume>394</volume><fpage>112165</fpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2020.112165</pub-id><pub-id pub-id-type="pmid">32645396</pub-id><pub-id pub-id-type="pmcid">PMC7434709</pub-id></element-citation></ref><ref id="CR988"><label>988.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B</given-names></name><name name-style="western"><surname>Yao</surname><given-names>C</given-names></name><name name-style="western"><surname>Du</surname><given-names>P</given-names></name><etal/></person-group><article-title>Fas-associated protein with death domain regulates notch signaling during muscle regeneration</article-title><source>Cells Tissues Organs</source><year>2014</year><volume>200</volume><fpage>253</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1159/000437258</pub-id><pub-id pub-id-type="pmid">26303234</pub-id></element-citation></ref><ref id="CR989"><label>989.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>SE</given-names></name><name name-style="western"><surname>Jin</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>YP</given-names></name></person-group><article-title>TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK</article-title><source>Am J Physiol Cell Physiol</source><year>2007</year><volume>292</volume><fpage>C1660</fpage><lpage>1671</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00486.2006</pub-id><pub-id pub-id-type="pmid">17151142</pub-id><pub-id pub-id-type="pmcid">PMC3099536</pub-id></element-citation></ref><ref id="CR990"><label>990.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>SE</given-names></name><name name-style="western"><surname>Gerken</surname><given-names>E</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>M</given-names></name><name name-style="western"><surname>Mohan</surname><given-names>RK</given-names></name><name name-style="western"><surname>Li</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle</article-title><source>Am J Physiol Cell Physiol</source><year>2005</year><volume>289</volume><fpage>C1179</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00062.2005</pub-id><pub-id pub-id-type="pmid">16079187</pub-id><pub-id pub-id-type="pmcid">PMC3099530</pub-id></element-citation></ref><ref id="CR991"><label>991.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dufresne</surname><given-names>SS</given-names></name><name name-style="western"><surname>Boulanger-Piette</surname><given-names>A</given-names></name><name name-style="western"><surname>Boss&#233;</surname><given-names>S</given-names></name><name name-style="western"><surname>Argaw</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamoudi</surname><given-names>D</given-names></name><name name-style="western"><surname>Marcadet</surname><given-names>L</given-names></name><etal/></person-group><article-title>Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy</article-title><source>Acta Neuropathol Commun</source><year>2018</year><volume>6</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s40478-018-0533-1</pub-id><pub-id pub-id-type="pmid">29699580</pub-id><pub-id pub-id-type="pmcid">PMC5922009</pub-id></element-citation></ref><ref id="CR992"><label>992.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alger</surname><given-names>HM</given-names></name><name name-style="western"><surname>Raben</surname><given-names>N</given-names></name><name name-style="western"><surname>Pistilli</surname><given-names>E</given-names></name><name name-style="western"><surname>Francia</surname><given-names>DL</given-names></name><name name-style="western"><surname>Rawat</surname><given-names>R</given-names></name><name name-style="western"><surname>Getnet</surname><given-names>D</given-names></name><etal/></person-group><article-title>The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage</article-title><source>Arthritis Rheum</source><year>2011</year><volume>63</volume><fpage>3448</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1002/art.30530</pub-id><pub-id pub-id-type="pmid">21769834</pub-id><pub-id pub-id-type="pmcid">PMC3203318</pub-id></element-citation></ref><ref id="CR993"><label>993.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kondo</surname><given-names>M</given-names></name><name name-style="western"><surname>Murakawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Harashima</surname><given-names>N</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Harada</surname><given-names>M</given-names></name></person-group><article-title>Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathies</article-title><source>Immunology</source><year>2009</year><volume>128</volume><fpage>e589</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2008.03039.x</pub-id><pub-id pub-id-type="pmid">19740320</pub-id><pub-id pub-id-type="pmcid">PMC2753936</pub-id></element-citation></ref><ref id="CR994"><label>994.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del Sorbo</surname><given-names>L</given-names></name><name name-style="western"><surname>Costamagna</surname><given-names>A</given-names></name><name name-style="western"><surname>Muraca</surname><given-names>G</given-names></name><name name-style="western"><surname>Rotondo</surname><given-names>G</given-names></name><name name-style="western"><surname>Civiletti</surname><given-names>F</given-names></name><name name-style="western"><surname>Vizio</surname><given-names>B</given-names></name><etal/></person-group><article-title>Intratracheal Administration of Small Interfering RNA Targeting Fas Reduces Lung Ischemia-Reperfusion Injury</article-title><source>Crit Care Med</source><year>2016</year><volume>44</volume><fpage>e604</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000001601</pub-id><pub-id pub-id-type="pmid">26963318</pub-id></element-citation></ref><ref id="CR995"><label>995.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>S</given-names></name><name name-style="western"><surname>Hishikawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Koji</surname><given-names>T</given-names></name></person-group><article-title>Lung injury after ischemia-reperfusion of small intestine in rats involves apoptosis of type II alveolar epithelial cells mediated by TNF-alpha and activation of Bid pathway</article-title><source>Apoptosis</source><year>2007</year><volume>12</volume><fpage>1989</fpage><lpage>2001</lpage><pub-id pub-id-type="doi">10.1007/s10495-007-0125-1</pub-id><pub-id pub-id-type="pmid">17786556</pub-id></element-citation></ref><ref id="CR996"><label>996.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>BV</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>MR</given-names></name><name name-style="western"><surname>O&#8217;Dea</surname><given-names>KP</given-names></name><name name-style="western"><surname>Takata</surname><given-names>M</given-names></name></person-group><article-title>TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><fpage>4274</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202437</pub-id><pub-id pub-id-type="pmid">23487422</pub-id><pub-id pub-id-type="pmcid">PMC3701855</pub-id></element-citation></ref><ref id="CR997"><label>997.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wakabayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Bertok</surname><given-names>S</given-names></name><name name-style="western"><surname>Oakley</surname><given-names>CM</given-names></name><name name-style="western"><surname>Patel</surname><given-names>BV</given-names></name><name name-style="western"><surname>O&#8217;Dea</surname><given-names>KP</given-names></name><etal/></person-group><article-title>Inhibition of TNF Receptor p55 By a Domain Antibody Attenuates the Initial Phase of Acid-Induced Lung Injury in Mice</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>128</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00128</pub-id><pub-id pub-id-type="pmid">28243236</pub-id><pub-id pub-id-type="pmcid">PMC5304467</pub-id></element-citation></ref><ref id="CR998"><label>998.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohr</surname><given-names>A</given-names></name><name name-style="western"><surname>Tsapis</surname><given-names>N</given-names></name><name name-style="western"><surname>Foged</surname><given-names>C</given-names></name><name name-style="western"><surname>Andreana</surname><given-names>I</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Fattal</surname><given-names>E</given-names></name></person-group><article-title>Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-&#945; siRNA with PAMAM dendrimers in a murine model</article-title><source>Eur J Pharm Biopharm</source><year>2020</year><volume>156</volume><fpage>114</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2020.08.009</pub-id><pub-id pub-id-type="pmid">32798665</pub-id><pub-id pub-id-type="pmcid">PMC7425770</pub-id></element-citation></ref><ref id="CR999"><label>999.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>WY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JW</given-names></name><name name-style="western"><surname>Huang</surname><given-names>BT</given-names></name><name name-style="western"><surname>Lin</surname><given-names>EP</given-names></name><name name-style="western"><surname>Yang</surname><given-names>PC</given-names></name></person-group><article-title>A novel TNF-&#945;-targeting aptamer for TNF-&#945;-mediated acute lung injury and acute liver failure</article-title><source>Theranostics</source><year>2019</year><volume>9</volume><fpage>1741</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.7150/thno.30972</pub-id><pub-id pub-id-type="pmid">31037135</pub-id><pub-id pub-id-type="pmcid">PMC6485186</pub-id></element-citation></ref><ref id="CR1000"><label>1000.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proudfoot</surname><given-names>A</given-names></name><name name-style="western"><surname>Bayliffe</surname><given-names>A</given-names></name><name name-style="western"><surname>O&#8217;Kane</surname><given-names>CM</given-names></name><name name-style="western"><surname>Wright</surname><given-names>T</given-names></name><name name-style="western"><surname>Serone</surname><given-names>A</given-names></name><name name-style="western"><surname>Bareille</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury</article-title><source>Thorax</source><year>2018</year><volume>73</volume><fpage>723</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2017-210305</pub-id><pub-id pub-id-type="pmid">29382797</pub-id><pub-id pub-id-type="pmcid">PMC6204954</pub-id></element-citation></ref><ref id="CR1001"><label>1001.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohr</surname><given-names>A</given-names></name><name name-style="western"><surname>Tsapis</surname><given-names>N</given-names></name><name name-style="western"><surname>Andreana</surname><given-names>I</given-names></name><name name-style="western"><surname>Chamarat</surname><given-names>A</given-names></name><name name-style="western"><surname>Foged</surname><given-names>C</given-names></name><name name-style="western"><surname>Delomenie</surname><given-names>C</given-names></name><etal/></person-group><article-title>Anti-inflammatory effect of anti-TNF-&#945; SiRNA cationic phosphorus dendrimer nanocomplexes administered intranasally in a murine acute lung injury model</article-title><source>Biomacromolecules</source><year>2017</year><volume>18</volume><fpage>2379</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1021/acs.biomac.7b00572</pub-id><pub-id pub-id-type="pmid">28639789</pub-id></element-citation></ref><ref id="CR1002"><label>1002.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weifeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Yujie</surname><given-names>H</given-names></name><name name-style="western"><surname>Weifeng</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhenhui</surname><given-names>G</given-names></name><name name-style="western"><surname>Wenjie</surname><given-names>H</given-names></name></person-group><article-title>Inhibition of acute lung injury by TNFR-Fc through regulation of an inflammation-oxidative stress pathway</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0151672</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0151672</pub-id><pub-id pub-id-type="pmid">26990441</pub-id><pub-id pub-id-type="pmcid">PMC4798551</pub-id></element-citation></ref><ref id="CR1003"><label>1003.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cakarova</surname><given-names>L</given-names></name><name name-style="western"><surname>Marsh</surname><given-names>LM</given-names></name><name name-style="western"><surname>Wilhelm</surname><given-names>J</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>K</given-names></name><name name-style="western"><surname>Grimminger</surname><given-names>F</given-names></name><name name-style="western"><surname>Seeger</surname><given-names>W</given-names></name><etal/></person-group><article-title>Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>180</volume><fpage>521</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1164/rccm.200812-1837OC</pub-id><pub-id pub-id-type="pmid">19590023</pub-id></element-citation></ref><ref id="CR1004"><label>1004.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matute-Bello</surname><given-names>G</given-names></name><name name-style="western"><surname>Winn</surname><given-names>RK</given-names></name><name name-style="western"><surname>Martin</surname><given-names>TR</given-names></name><name name-style="western"><surname>Liles</surname><given-names>WC</given-names></name></person-group><article-title>Sustained lipopolysaccharide-induced lung inflammation in mice is attenuated by functional deficiency of the Fas/Fas ligand system</article-title><source>Clin Diagn Lab Immunol</source><year>2004</year><volume>11</volume><fpage>358</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">15013988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CDLI.11.2.358-361.2004</pub-id><pub-id pub-id-type="pmcid">PMC371192</pub-id></element-citation></ref><ref id="CR1005"><label>1005.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janssen</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Barthel</surname><given-names>L</given-names></name><name name-style="western"><surname>Muldrow</surname><given-names>A</given-names></name><name name-style="western"><surname>Oberley-Deegan</surname><given-names>RE</given-names></name><name name-style="western"><surname>Kearns</surname><given-names>MT</given-names></name><name name-style="western"><surname>Jakubzick</surname><given-names>C</given-names></name><etal/></person-group><article-title>Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury</article-title><source>Am J Respir Crit Care Med</source><year>2011</year><volume>184</volume><fpage>547</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1164/rccm.201011-1891OC</pub-id><pub-id pub-id-type="pmid">21471090</pub-id><pub-id pub-id-type="pmcid">PMC3175550</pub-id></element-citation></ref><ref id="CR1006"><label>1006.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>L</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X</given-names></name><name name-style="western"><surname>Ji</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-&#945; small interfering RNA alveolar epithelial cell-targeting nanoparticles reduce lung injury in C57BL/6J mice with sepsis</article-title><source>J Int Med Res</source><year>2021</year><volume>49</volume><fpage>300060520984652</fpage><pub-id pub-id-type="doi">10.1177/0300060520984652</pub-id><pub-id pub-id-type="pmid">33435767</pub-id><pub-id pub-id-type="pmcid">PMC7809319</pub-id></element-citation></ref><ref id="CR1007"><label>1007.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weckbach</surname><given-names>S</given-names></name><name name-style="western"><surname>Hohmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Denk</surname><given-names>S</given-names></name><name name-style="western"><surname>Kellermann</surname><given-names>P</given-names></name><name name-style="western"><surname>Huber-Lang</surname><given-names>MS</given-names></name><name name-style="western"><surname>Baumann</surname><given-names>B</given-names></name><etal/></person-group><article-title>Apoptotic and inflammatory signaling via Fas and tumor necrosis factor receptor I contribute to the development of chest trauma-induced septic acute lung injury</article-title><source>J Trauma Acute Care Surg</source><year>2013</year><volume>74</volume><fpage>792</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1097/TA.0b013e31827a3655</pub-id><pub-id pub-id-type="pmid">23425737</pub-id></element-citation></ref><ref id="CR1008"><label>1008.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thakkar</surname><given-names>RK</given-names></name><name name-style="western"><surname>Chung</surname><given-names>CS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Monaghan</surname><given-names>SF</given-names></name><name name-style="western"><surname>Lomas-Neira</surname><given-names>J</given-names></name><name name-style="western"><surname>Heffernan</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Local tissue expression of the cell death ligand, fas ligand, plays a central role in the development of extrapulmonary acute lung injury</article-title><source>Shock</source><year>2011</year><volume>36</volume><fpage>138</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e31821c236d</pub-id><pub-id pub-id-type="pmid">21451443</pub-id><pub-id pub-id-type="pmcid">PMC3139824</pub-id></element-citation></ref><ref id="CR1009"><label>1009.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perl</surname><given-names>M</given-names></name><name name-style="western"><surname>Chung</surname><given-names>CS</given-names></name><name name-style="western"><surname>Perl</surname><given-names>U</given-names></name><name name-style="western"><surname>Lomas-Neira</surname><given-names>J</given-names></name><name name-style="western"><surname>de Paepe</surname><given-names>M</given-names></name><name name-style="western"><surname>Cioffi</surname><given-names>WG</given-names></name><etal/></person-group><article-title>Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury</article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>176</volume><fpage>591</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1164/rccm.200611-1743OC</pub-id><pub-id pub-id-type="pmid">17600273</pub-id><pub-id pub-id-type="pmcid">PMC1994224</pub-id></element-citation></ref><ref id="CR1010"><label>1010.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perl</surname><given-names>M</given-names></name><name name-style="western"><surname>Chung</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lomas-Neira</surname><given-names>J</given-names></name><name name-style="western"><surname>Rachel</surname><given-names>TM</given-names></name><name name-style="western"><surname>Biffl</surname><given-names>WL</given-names></name><name name-style="western"><surname>Cioffi</surname><given-names>WG</given-names></name><etal/></person-group><article-title>Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis</article-title><source>Am J Pathol</source><year>2005</year><volume>167</volume><fpage>1545</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)61240-0</pub-id><pub-id pub-id-type="pmid">16314469</pub-id><pub-id pub-id-type="pmcid">PMC1613198</pub-id></element-citation></ref><ref id="CR1011"><label>1011.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Messer</surname><given-names>MP</given-names></name><name name-style="western"><surname>Kellermann</surname><given-names>P</given-names></name><name name-style="western"><surname>Weber</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Hohmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Denk</surname><given-names>S</given-names></name><name name-style="western"><surname>Klohs</surname><given-names>B</given-names></name><etal/></person-group><article-title>Silencing of fas, fas-associated via death domain, or caspase 3 differentially affects lung inflammation, apoptosis, and development of trauma-induced septic acute lung injury</article-title><source>Shock</source><year>2013</year><volume>39</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e318277d856</pub-id><pub-id pub-id-type="pmid">23247118</pub-id></element-citation></ref><ref id="CR1012"><label>1012.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuda</surname><given-names>N</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Takano</surname><given-names>K</given-names></name><name name-style="western"><surname>Kageyama</surname><given-names>S</given-names></name><name name-style="western"><surname>Kurobe</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yoshihara</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>179</volume><fpage>806</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1164/rccm.200804-534OC</pub-id><pub-id pub-id-type="pmid">19201926</pub-id></element-citation></ref><ref id="CR1013"><label>1013.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehrhardt</surname><given-names>H</given-names></name><name name-style="western"><surname>Pritzke</surname><given-names>T</given-names></name><name name-style="western"><surname>Oak</surname><given-names>P</given-names></name><name name-style="western"><surname>Kossert</surname><given-names>M</given-names></name><name name-style="western"><surname>Biebach</surname><given-names>L</given-names></name><name name-style="western"><surname>F&#246;rster</surname><given-names>K</given-names></name><etal/></person-group><article-title>Absence of TNF-&#945; enhances inflammatory response in the newborn lung undergoing mechanical ventilation</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2016</year><volume>310</volume><fpage>L909</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00367.2015</pub-id><pub-id pub-id-type="pmid">27016588</pub-id><pub-id pub-id-type="pmcid">PMC4896101</pub-id></element-citation></ref><ref id="CR1014"><label>1014.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Gundavarapu</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>C</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>A</given-names></name><name name-style="western"><surname>Luks</surname><given-names>FI</given-names></name><name name-style="western"><surname>De Paepe</surname><given-names>ME</given-names></name></person-group><article-title>The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice</article-title><source>Am J Respir Cell Mol Biol</source><year>2008</year><volume>39</volume><fpage>717</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2008-0052OC</pub-id><pub-id pub-id-type="pmid">18587053</pub-id><pub-id pub-id-type="pmcid">PMC2586047</pub-id></element-citation></ref><ref id="CR1015"><label>1015.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guthmann</surname><given-names>F</given-names></name><name name-style="western"><surname>Wissel</surname><given-names>H</given-names></name><name name-style="western"><surname>R&#252;stow</surname><given-names>B</given-names></name></person-group><article-title>Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injury</article-title><source>Exp Lung Res</source><year>2009</year><volume>35</volume><fpage>770</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.3109/01902140902887430</pub-id><pub-id pub-id-type="pmid">19916860</pub-id></element-citation></ref><ref id="CR1016"><label>1016.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaya</surname><given-names>G</given-names></name><name name-style="western"><surname>Saldir</surname><given-names>M</given-names></name><name name-style="western"><surname>Polat</surname><given-names>A</given-names></name><name name-style="western"><surname>Fidanci</surname><given-names>MK</given-names></name><name name-style="western"><surname>Erdem</surname><given-names>A</given-names></name><name name-style="western"><surname>Erdem</surname><given-names>G</given-names></name><etal/></person-group><article-title>Evaluation of Etanercept Treatment in Newborn Rat Model with Hyperoxic Lung Injury</article-title><source>Fetal Pediatr Pathol</source><year>2016</year><volume>35</volume><fpage>327</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1080/15513815.2016.1189018</pub-id><pub-id pub-id-type="pmid">27309384</pub-id></element-citation></ref><ref id="CR1017"><label>1017.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolthuis</surname><given-names>EK</given-names></name><name name-style="western"><surname>Vlaar</surname><given-names>AP</given-names></name><name name-style="western"><surname>Choi</surname><given-names>G</given-names></name><name name-style="western"><surname>Roelofs</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Haitsma</surname><given-names>JJ</given-names></name><name name-style="western"><surname>van der Poll</surname><given-names>T</given-names></name><etal/></person-group><article-title>Recombinant human soluble tumor necrosis factor-alpha receptor fusion protein partly attenuates ventilator-induced lung injury</article-title><source>Shock</source><year>2009</year><volume>31</volume><fpage>262</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e31817d42dd</pub-id><pub-id pub-id-type="pmid">18650784</pub-id></element-citation></ref><ref id="CR1018"><label>1018.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pryhuber</surname><given-names>GS</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>DP</given-names></name><name name-style="western"><surname>Baggs</surname><given-names>R</given-names></name><name name-style="western"><surname>Phipps</surname><given-names>R</given-names></name><name name-style="western"><surname>Huyck</surname><given-names>H</given-names></name><name name-style="western"><surname>Sanz</surname><given-names>I</given-names></name><etal/></person-group><article-title>Ablation of tumor necrosis factor receptor type I (p55) alters oxygen-induced lung injury</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2000</year><volume>278</volume><fpage>L1082</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1152/ajplung.2000.278.5.L1082</pub-id><pub-id pub-id-type="pmid">10781441</pub-id></element-citation></ref><ref id="CR1019"><label>1019.</label><mixed-citation publication-type="other">Redente EF, Chakraborty S, Sajuthi S, Black BP, Edelman BL, Seibold MA, et al. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis. JCI Insight. 2020;6:e141618.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/jci.insight.141618</pub-id><pub-id pub-id-type="pmcid">PMC7821600</pub-id><pub-id pub-id-type="pmid">33290280</pub-id></mixed-citation></ref><ref id="CR1020"><label>1020.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hampel</surname><given-names>B</given-names></name><name name-style="western"><surname>Yagita</surname><given-names>H</given-names></name><name name-style="western"><surname>Rajewsky</surname><given-names>K</given-names></name></person-group><article-title>T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis</article-title><source>J Exp Med</source><year>2004</year><volume>199</volume><fpage>1355</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1084/jem.20032196</pub-id><pub-id pub-id-type="pmid">15148335</pub-id><pub-id pub-id-type="pmcid">PMC2211818</pub-id></element-citation></ref><ref id="CR1021"><label>1021.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aoshiba</surname><given-names>K</given-names></name><name name-style="western"><surname>Yasui</surname><given-names>S</given-names></name><name name-style="western"><surname>Tamaoki</surname><given-names>J</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>A</given-names></name></person-group><article-title>The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>162</volume><fpage>695</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.162.2.9907012</pub-id><pub-id pub-id-type="pmid">10934108</pub-id></element-citation></ref><ref id="CR1022"><label>1022.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuwano</surname><given-names>K</given-names></name><name name-style="western"><surname>Hagimoto</surname><given-names>N</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Yatomi</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>N</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>S</given-names></name><etal/></person-group><article-title>Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis</article-title><source>J Clin Investig</source><year>1999</year><volume>104</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1172/JCI5628</pub-id><pub-id pub-id-type="pmid">10393694</pub-id><pub-id pub-id-type="pmcid">PMC408400</pub-id></element-citation></ref><ref id="CR1023"><label>1023.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Redente</surname><given-names>EF</given-names></name><name name-style="western"><surname>Keith</surname><given-names>RC</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>W</given-names></name><name name-style="western"><surname>Henson</surname><given-names>PM</given-names></name><name name-style="western"><surname>Ortiz</surname><given-names>LA</given-names></name><name name-style="western"><surname>Downey</surname><given-names>GP</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-&#945; accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages</article-title><source>Am J Respir Cell Mol Biol</source><year>2014</year><volume>50</volume><fpage>825</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2013-0386OC</pub-id><pub-id pub-id-type="pmid">24325577</pub-id><pub-id pub-id-type="pmcid">PMC4068926</pub-id></element-citation></ref><ref id="CR1024"><label>1024.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oikonomou</surname><given-names>N</given-names></name><name name-style="western"><surname>Harokopos</surname><given-names>V</given-names></name><name name-style="western"><surname>Zalevsky</surname><given-names>J</given-names></name><name name-style="western"><surname>Valavanis</surname><given-names>C</given-names></name><name name-style="western"><surname>Kotanidou</surname><given-names>A</given-names></name><name name-style="western"><surname>Szymkowski</surname><given-names>DE</given-names></name><etal/></person-group><article-title>Soluble TNF mediates the transition from pulmonary inflammation to fibrosis</article-title><source>PLoS ONE</source><year>2006</year><volume>1</volume><fpage>e108</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0000108</pub-id><pub-id pub-id-type="pmid">17205112</pub-id><pub-id pub-id-type="pmcid">PMC1762410</pub-id></element-citation></ref><ref id="CR1025"><label>1025.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuroki</surname><given-names>M</given-names></name><name name-style="western"><surname>Noguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shimono</surname><given-names>M</given-names></name><name name-style="western"><surname>Tomono</surname><given-names>K</given-names></name><name name-style="western"><surname>Tashiro</surname><given-names>T</given-names></name><name name-style="western"><surname>Obata</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Repression of bleomycin-induced pneumopathy by TNF</article-title><source>J Immunol</source><year>2003</year><volume>170</volume><fpage>567</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.170.1.567</pub-id><pub-id pub-id-type="pmid">12496444</pub-id></element-citation></ref><ref id="CR1026"><label>1026.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collison</surname><given-names>AM</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>de Siqueira</surname><given-names>AP</given-names></name><name name-style="western"><surname>Lv</surname><given-names>X</given-names></name><name name-style="western"><surname>Toop</surname><given-names>HD</given-names></name><name name-style="western"><surname>Morris</surname><given-names>JC</given-names></name><etal/></person-group><article-title>TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis</article-title><source>BMC Pulm Med</source><year>2019</year><volume>19</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s12890-019-0786-x</pub-id><pub-id pub-id-type="pmid">30732588</pub-id><pub-id pub-id-type="pmcid">PMC6367767</pub-id></element-citation></ref><ref id="CR1027"><label>1027.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGrath</surname><given-names>EE</given-names></name><name name-style="western"><surname>Lawrie</surname><given-names>A</given-names></name><name name-style="western"><surname>Marriott</surname><given-names>HM</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>P</given-names></name><name name-style="western"><surname>Cross</surname><given-names>SS</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>N</given-names></name><etal/></person-group><article-title>Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis</article-title><source>Thorax</source><year>2012</year><volume>67</volume><fpage>796</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2011-200863</pub-id><pub-id pub-id-type="pmid">22496351</pub-id><pub-id pub-id-type="pmcid">PMC3426075</pub-id></element-citation></ref><ref id="CR1028"><label>1028.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malaviya</surname><given-names>R</given-names></name><name name-style="western"><surname>Sunil</surname><given-names>VR</given-names></name><name name-style="western"><surname>Venosa</surname><given-names>A</given-names></name><name name-style="western"><surname>Verissimo</surname><given-names>VL</given-names></name><name name-style="western"><surname>Cervelli</surname><given-names>JA</given-names></name><name name-style="western"><surname>Vayas</surname><given-names>KN</given-names></name><etal/></person-group><article-title>Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-&#945; Antibody</article-title><source>Toxicol Sci</source><year>2015</year><volume>148</volume><fpage>71</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfv161</pub-id><pub-id pub-id-type="pmid">26243812</pub-id><pub-id pub-id-type="pmcid">PMC4659692</pub-id></element-citation></ref><ref id="CR1029"><label>1029.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>J</given-names></name><name name-style="western"><surname>Ni</surname><given-names>X</given-names></name></person-group><article-title>TNF-&#945; antagonist may not be suitable for severe rituximab-induced interstitial lung disease</article-title><source>J Clin Pharm Ther</source><year>2015</year><volume>40</volume><fpage>249</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1111/jcpt.12252</pub-id><pub-id pub-id-type="pmid">25809984</pub-id></element-citation></ref><ref id="CR1030"><label>1030.</label><mixed-citation publication-type="other">Santos LD, Antunes KH, Muraro SP, de Souza GF, da Silva AG, Felipe JS, et al. TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection. The Eur Respir J. 2021;57:2003764.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.03764-2020</pub-id><pub-id pub-id-type="pmcid">PMC8209485</pub-id><pub-id pub-id-type="pmid">33303545</pub-id></mixed-citation></ref><ref id="CR1031"><label>1031.</label><mixed-citation publication-type="other">Morris DR, Ansar M, Ivanciuc T, Qu Y, Casola A, Garofalo RP. Selective blockade of TNFR1 improves clinical disease and bronchoconstriction in experimental RSV infection. Viruses. 2020;12:1176.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v12101176</pub-id><pub-id pub-id-type="pmcid">PMC7588931</pub-id><pub-id pub-id-type="pmid">33080861</pub-id></mixed-citation></ref><ref id="CR1032"><label>1032.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>TH</given-names></name><name name-style="western"><surname>Maltby</surname><given-names>S</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>JL</given-names></name><name name-style="western"><surname>Eyers</surname><given-names>F</given-names></name><name name-style="western"><surname>Baines</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>PG</given-names></name><etal/></person-group><article-title>TNF-&#945; and macrophages are critical for respiratory syncytial virus-induced exacerbations in a mouse model of allergic airways disease</article-title><source>J Immunol</source><year>2016</year><volume>196</volume><fpage>3547</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1502339</pub-id><pub-id pub-id-type="pmid">27036916</pub-id></element-citation></ref><ref id="CR1033"><label>1033.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van den Berg</surname><given-names>E</given-names></name><name name-style="western"><surname>van Woensel</surname><given-names>JB</given-names></name><name name-style="western"><surname>Bos</surname><given-names>AP</given-names></name><name name-style="western"><surname>Bem</surname><given-names>RA</given-names></name><name name-style="western"><surname>Altemeier</surname><given-names>WA</given-names></name><name name-style="western"><surname>Gill</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Role of the Fas/FasL system in a model of RSV infection in mechanically ventilated mice</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2011</year><volume>301</volume><fpage>L451</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00368.2010</pub-id><pub-id pub-id-type="pmid">21743025</pub-id><pub-id pub-id-type="pmcid">PMC3191752</pub-id></element-citation></ref><ref id="CR1034"><label>1034.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopez</surname><given-names>AD</given-names></name><name name-style="western"><surname>Avasarala</surname><given-names>S</given-names></name><name name-style="western"><surname>Grewal</surname><given-names>S</given-names></name><name name-style="western"><surname>Murali</surname><given-names>AK</given-names></name><name name-style="western"><surname>London</surname><given-names>L</given-names></name></person-group><article-title>Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome</article-title><source>J Immunol</source><year>2009</year><volume>183</volume><fpage>8244</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901958</pub-id><pub-id pub-id-type="pmid">20007588</pub-id><pub-id pub-id-type="pmcid">PMC2814248</pub-id></element-citation></ref><ref id="CR1035"><label>1035.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bem</surname><given-names>RA</given-names></name><name name-style="western"><surname>Bos</surname><given-names>AP</given-names></name><name name-style="western"><surname>W&#246;sten-van Asperen</surname><given-names>RM</given-names></name><name name-style="western"><surname>Bruijn</surname><given-names>M</given-names></name><name name-style="western"><surname>Lutter</surname><given-names>R</given-names></name><name name-style="western"><surname>Sprick</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection</article-title><source>Am J Respir Cell Mol Biol</source><year>2010</year><volume>42</volume><fpage>697</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2009-0100OC</pub-id><pub-id pub-id-type="pmid">19635930</pub-id></element-citation></ref><ref id="CR1036"><label>1036.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neuzil</surname><given-names>KM</given-names></name><name name-style="western"><surname>Tang</surname><given-names>YW</given-names></name><name name-style="western"><surname>Graham</surname><given-names>BS</given-names></name></person-group><article-title>Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo</article-title><source>Am J Med Sci</source><year>1996</year><volume>311</volume><fpage>201</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8615393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000441-199605000-00001</pub-id></element-citation></ref><ref id="CR1037"><label>1037.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pant</surname><given-names>K</given-names></name><name name-style="western"><surname>Chandrasekaran</surname><given-names>A</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Vageesh</surname><given-names>A</given-names></name><name name-style="western"><surname>Popkov</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>JB</given-names></name></person-group><article-title>Effects of tumor necrosis factor on viral replication and pulmonary inflammation during acute mouse adenovirus type 1 respiratory infection</article-title><source>Virology</source><year>2020</year><volume>547</volume><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2020.05.004</pub-id><pub-id pub-id-type="pmid">32560900</pub-id><pub-id pub-id-type="pmcid">PMC7306826</pub-id></element-citation></ref><ref id="CR1038"><label>1038.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adkins</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Molloy</surname><given-names>CT</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>JB</given-names></name></person-group><article-title>Fas activity mediates airway inflammation during mouse adenovirus type 1 respiratory infection</article-title><source>Virology</source><year>2018</year><volume>521</volume><fpage>129</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2018.06.002</pub-id><pub-id pub-id-type="pmid">29908447</pub-id></element-citation></ref><ref id="CR1039"><label>1039.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>XM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Gu</surname><given-names>W</given-names></name><name name-style="western"><surname>Guo</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J</given-names></name><etal/></person-group><article-title>Impaired TNF/TNFR2 signaling enhances Th2 and Th17 polarization and aggravates allergic airway inflammation</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2017</year><volume>313</volume><fpage>L592</fpage><lpage>l601</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00409.2016</pub-id><pub-id pub-id-type="pmid">28619762</pub-id></element-citation></ref><ref id="CR1040"><label>1040.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Starkhammar</surname><given-names>M</given-names></name><name name-style="western"><surname>Kumlien Geor&#233;n</surname><given-names>S</given-names></name><name name-style="western"><surname>Dahl&#233;n</surname><given-names>SE</given-names></name><name name-style="western"><surname>Cardell</surname><given-names>LO</given-names></name><name name-style="western"><surname>Adner</surname><given-names>M</given-names></name></person-group><article-title>TNF&#945;-blockade stabilizes local airway hyperresponsiveness during TLR-induced exacerbations in murine model of asthma</article-title><source>Respir Res</source><year>2015</year><volume>16</volume><fpage>129</fpage><pub-id pub-id-type="doi">10.1186/s12931-015-0292-5</pub-id><pub-id pub-id-type="pmid">26494305</pub-id><pub-id pub-id-type="pmcid">PMC4618779</pub-id></element-citation></ref><ref id="CR1041"><label>1041.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faustino</surname><given-names>L</given-names></name><name name-style="western"><surname>Fonseca</surname><given-names>DM</given-names></name><name name-style="western"><surname>Florsheim</surname><given-names>EB</given-names></name><name name-style="western"><surname>Resende</surname><given-names>RR</given-names></name><name name-style="western"><surname>Lepique</surname><given-names>AP</given-names></name><name name-style="western"><surname>Faquim-Mauro</surname><given-names>E</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation</article-title><source>Mucosal Immunol</source><year>2014</year><volume>7</volume><fpage>1199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/mi.2014.9</pub-id><pub-id pub-id-type="pmid">24569802</pub-id></element-citation></ref><ref id="CR1042"><label>1042.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yilmaz</surname><given-names>O</given-names></name><name name-style="western"><surname>Karaman</surname><given-names>M</given-names></name><name name-style="western"><surname>Bagriyanik</surname><given-names>HA</given-names></name><name name-style="western"><surname>Firinci</surname><given-names>F</given-names></name><name name-style="western"><surname>Kiray</surname><given-names>M</given-names></name><name name-style="western"><surname>Turkeli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma</article-title><source>Int Immunopharmacol</source><year>2013</year><volume>17</volume><fpage>768</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2013.08.021</pub-id><pub-id pub-id-type="pmid">24063972</pub-id></element-citation></ref><ref id="CR1043"><label>1043.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>SK</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>FA</given-names></name><name name-style="western"><surname>Kierstein</surname><given-names>S</given-names></name><name name-style="western"><surname>Hortobagyi</surname><given-names>L</given-names></name><name name-style="western"><surname>Lin</surname><given-names>T</given-names></name><name name-style="western"><surname>Larkin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma</article-title><source>Allergy</source><year>2012</year><volume>67</volume><fpage>328</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/j.1398-9995.2011.02763.x</pub-id><pub-id pub-id-type="pmid">22175699</pub-id><pub-id pub-id-type="pmcid">PMC3278510</pub-id></element-citation></ref><ref id="CR1044"><label>1044.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name><name name-style="western"><surname>Chung</surname><given-names>DH</given-names></name></person-group><article-title>Fas/Fas ligand-mediated apoptosis promotes hypersensitivity pneumonitis in mice by enhancing maturation of dendritic cells</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>181</volume><fpage>1250</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1164/rccm.200909-1337OC</pub-id><pub-id pub-id-type="pmid">20194815</pub-id></element-citation></ref><ref id="CR1045"><label>1045.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weckmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Collison</surname><given-names>A</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>JL</given-names></name><name name-style="western"><surname>Kopp</surname><given-names>MV</given-names></name><name name-style="western"><surname>Wark</surname><given-names>PA</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease</article-title><source>Nat Med</source><year>2007</year><volume>13</volume><fpage>1308</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/nm1660</pub-id><pub-id pub-id-type="pmid">17934471</pub-id></element-citation></ref><ref id="CR1046"><label>1046.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuang</surname><given-names>YH</given-names></name><name name-style="western"><surname>Suen</surname><given-names>JL</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>BL</given-names></name></person-group><article-title>Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma</article-title><source>J Mol Med</source><year>2006</year><volume>84</volume><fpage>595</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1007/s00109-006-0047-3</pub-id><pub-id pub-id-type="pmid">16565865</pub-id></element-citation></ref><ref id="CR1047"><label>1047.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broide</surname><given-names>DH</given-names></name><name name-style="western"><surname>Stachnick</surname><given-names>G</given-names></name><name name-style="western"><surname>Castaneda</surname><given-names>D</given-names></name><name name-style="western"><surname>Nayar</surname><given-names>J</given-names></name><name name-style="western"><surname>Sriramarao</surname><given-names>P</given-names></name></person-group><article-title>Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75-and TNF receptor p55-deficient mice</article-title><source>Am J Respir Cell Mol Biol</source><year>2001</year><volume>24</volume><fpage>304</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb.24.3.4071</pub-id><pub-id pub-id-type="pmid">11245629</pub-id></element-citation></ref><ref id="CR1048"><label>1048.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitehead</surname><given-names>GS</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>SY</given-names></name><name name-style="western"><surname>Shalaby</surname><given-names>KH</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>K</given-names></name><name name-style="western"><surname>Moran</surname><given-names>TP</given-names></name><name name-style="western"><surname>Ward</surname><given-names>JM</given-names></name><etal/></person-group><article-title>TNF is required for TLR ligand-mediated but not protease-mediated allergic airway inflammation</article-title><source>J Clin Investig</source><year>2017</year><volume>127</volume><fpage>3313</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1172/JCI90890</pub-id><pub-id pub-id-type="pmid">28758900</pub-id><pub-id pub-id-type="pmcid">PMC5669552</pub-id></element-citation></ref><ref id="CR1049"><label>1049.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maillet</surname><given-names>I</given-names></name><name name-style="western"><surname>Schnyder-Candrian</surname><given-names>S</given-names></name><name name-style="western"><surname>Couillin</surname><given-names>I</given-names></name><name name-style="western"><surname>Quesniaux</surname><given-names>VF</given-names></name><name name-style="western"><surname>Erard</surname><given-names>F</given-names></name><name name-style="western"><surname>Moser</surname><given-names>R</given-names></name><etal/></person-group><article-title>Allergic lung inflammation is mediated by soluble tumor necrosis factor (TNF) and attenuated by dominant-negative TNF biologics</article-title><source>Am J Respir Cell Mol Biol</source><year>2011</year><volume>45</volume><fpage>731</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2010-0512OC</pub-id><pub-id pub-id-type="pmid">21297077</pub-id></element-citation></ref><ref id="CR1050"><label>1050.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>IW</given-names></name><name name-style="western"><surname>Sun</surname><given-names>K</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YS</given-names></name><name name-style="western"><surname>Ko</surname><given-names>HM</given-names></name><name name-style="western"><surname>Im</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><etal/></person-group><article-title>TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation</article-title><source>J Allergy Clin Immunol</source><year>2005</year><volume>116</volume><fpage>537</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2005.05.034</pub-id><pub-id pub-id-type="pmid">16159621</pub-id></element-citation></ref><ref id="CR1051"><label>1051.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hildebrandt</surname><given-names>GC</given-names></name><name name-style="western"><surname>Olkiewicz</surname><given-names>KM</given-names></name><name name-style="western"><surname>Corrion</surname><given-names>L</given-names></name><name name-style="western"><surname>Clouthier</surname><given-names>SG</given-names></name><name name-style="western"><surname>Pierce</surname><given-names>EM</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><article-title>A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome</article-title><source>Biol Blood Marrow Transplant</source><year>2008</year><volume>14</volume><fpage>385</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.bbmt.2008.01.004</pub-id><pub-id pub-id-type="pmid">18342780</pub-id><pub-id pub-id-type="pmcid">PMC2390587</pub-id></element-citation></ref><ref id="CR1052"><label>1052.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wan</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients</article-title><source>Int J Chronic Obstr Pulm Dis</source><year>2015</year><volume>10</volume><fpage>2405</fpage><lpage>12</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/COPD.S92260</pub-id><pub-id pub-id-type="pmcid">PMC4644161</pub-id><pub-id pub-id-type="pmid">26609227</pub-id></element-citation></ref><ref id="CR1053"><label>1053.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haw</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Starkey</surname><given-names>MR</given-names></name><name name-style="western"><surname>Nair</surname><given-names>PM</given-names></name><name name-style="western"><surname>Pavlidis</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>DH</given-names></name><etal/></person-group><article-title>A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease</article-title><source>Mucosal Immunol</source><year>2016</year><volume>9</volume><fpage>859</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/mi.2015.111</pub-id><pub-id pub-id-type="pmid">26555706</pub-id></element-citation></ref><ref id="CR1054"><label>1054.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Kepp</surname><given-names>O</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Mitochondrial regulation of cell death: a phylogenetically conserved control</article-title><source>Microb Cell</source><year>2016</year><volume>3</volume><fpage>101</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.15698/mic2016.03.483</pub-id><pub-id pub-id-type="pmid">28357340</pub-id><pub-id pub-id-type="pmcid">PMC5349020</pub-id></element-citation></ref><ref id="CR1055"><label>1055.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dadsena</surname><given-names>S</given-names></name><name name-style="western"><surname>Zollo</surname><given-names>C</given-names></name><name name-style="western"><surname>Garc&#237;a-S&#225;ez</surname><given-names>AJ</given-names></name></person-group><article-title>Mechanisms of mitochondrial cell death</article-title><source>Biochem Soc Trans</source><year>2021</year><volume>49</volume><fpage>663</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1042/BST20200522</pub-id><pub-id pub-id-type="pmid">33704419</pub-id></element-citation></ref><ref id="CR1056"><label>1056.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Czabotar</surname><given-names>PE</given-names></name><name name-style="western"><surname>Lessene</surname><given-names>G</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name></person-group><article-title>Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</article-title><source>Nat Rev Mol Cell Biol</source><year>2014</year><volume>15</volume><fpage>49</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nrm3722</pub-id><pub-id pub-id-type="pmid">24355989</pub-id></element-citation></ref><ref id="CR1057"><label>1057.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shamas-Din</surname><given-names>A</given-names></name><name name-style="western"><surname>Kale</surname><given-names>J</given-names></name><name name-style="western"><surname>Leber</surname><given-names>B</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>DW</given-names></name></person-group><article-title>Mechanisms of action of Bcl-2 family proteins</article-title><source>Cold Spring Harb Perspect Biol</source><year>2013</year><volume>5</volume><fpage>a008714</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a008714</pub-id><pub-id pub-id-type="pmid">23545417</pub-id><pub-id pub-id-type="pmcid">PMC3683897</pub-id></element-citation></ref><ref id="CR1058"><label>1058.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalkavan</surname><given-names>H</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>MOMP, cell suicide as a BCL-2 family business</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>46</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.179</pub-id><pub-id pub-id-type="pmid">29053143</pub-id><pub-id pub-id-type="pmcid">PMC5729535</pub-id></element-citation></ref><ref id="CR1059"><label>1059.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birkinshaw</surname><given-names>RW</given-names></name><name name-style="western"><surname>Czabotar</surname><given-names>PE</given-names></name></person-group><article-title>The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation</article-title><source>Semin Cell Dev Biol</source><year>2017</year><volume>72</volume><fpage>152</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.04.001</pub-id><pub-id pub-id-type="pmid">28396106</pub-id></element-citation></ref><ref id="CR1060"><label>1060.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Youle</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>The BCL-2 protein family: opposing activities that mediate cell death</article-title><source>Nat Rev Mol Cell Biol</source><year>2008</year><volume>9</volume><fpage>47</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1038/nrm2308</pub-id><pub-id pub-id-type="pmid">18097445</pub-id></element-citation></ref><ref id="CR1061"><label>1061.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Julien</surname><given-names>O</given-names></name><name name-style="western"><surname>Wells</surname><given-names>JA</given-names></name></person-group><article-title>Caspases and their substrates</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>1380</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.44</pub-id><pub-id pub-id-type="pmid">28498362</pub-id><pub-id pub-id-type="pmcid">PMC5520456</pub-id></element-citation></ref><ref id="CR1062"><label>1062.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shalini</surname><given-names>S</given-names></name><name name-style="western"><surname>Dorstyn</surname><given-names>L</given-names></name><name name-style="western"><surname>Dawar</surname><given-names>S</given-names></name></person-group><article-title>Kumar S. Old, new and emerging functions of caspases</article-title><source>Cell Death Differ</source><year>2015</year><volume>22</volume><fpage>526</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.216</pub-id><pub-id pub-id-type="pmid">25526085</pub-id><pub-id pub-id-type="pmcid">PMC4356345</pub-id></element-citation></ref><ref id="CR1063"><label>1063.</label><mixed-citation publication-type="other">Green DR. Caspases and their substrates. Cold Spring Harb Perspect Biol. 2022;14:a041012.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/cshperspect.a041012</pub-id><pub-id pub-id-type="pmcid">PMC8886984</pub-id><pub-id pub-id-type="pmid">35232877</pub-id></mixed-citation></ref><ref id="CR1064"><label>1064.</label><mixed-citation publication-type="other">Moldoveanu T, Czabotar PE. BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins. Cold Spring Harb Perspect Biol. 2020;12:a036319.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/cshperspect.a036319</pub-id><pub-id pub-id-type="pmcid">PMC7111251</pub-id><pub-id pub-id-type="pmid">31570337</pub-id></mixed-citation></ref><ref id="CR1065"><label>1065.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Llambi</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YM</given-names></name><name name-style="western"><surname>Victor</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>DM</given-names></name><name name-style="western"><surname>Gingras</surname><given-names>S</given-names></name><etal/></person-group><article-title>BOK is a non-canonical BCL-2 family effector of apoptosis regulated by ER-associated degradation</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>421</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.02.026</pub-id><pub-id pub-id-type="pmid">26949185</pub-id><pub-id pub-id-type="pmcid">PMC5018360</pub-id></element-citation></ref><ref id="CR1066"><label>1066.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bleicken</surname><given-names>S</given-names></name><name name-style="western"><surname>Landeta</surname><given-names>O</given-names></name><name name-style="western"><surname>Landajuela</surname><given-names>A</given-names></name><name name-style="western"><surname>Basa&#241;ez</surname><given-names>G</given-names></name><name name-style="western"><surname>Garc&#237;a-S&#225;ez</surname><given-names>AJ</given-names></name></person-group><article-title>Proapoptotic Bax and Bak proteins form stable protein-permeable pores of tunable size</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>33241</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.512087</pub-id><pub-id pub-id-type="pmid">24100034</pub-id><pub-id pub-id-type="pmcid">PMC3829170</pub-id></element-citation></ref><ref id="CR1067"><label>1067.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bleicken</surname><given-names>S</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>C</given-names></name><name name-style="western"><surname>Garc&#237;a-S&#225;ez</surname><given-names>AJ</given-names></name></person-group><article-title>Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis</article-title><source>Biophys J</source><year>2013</year><volume>104</volume><fpage>421</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2012.12.010</pub-id><pub-id pub-id-type="pmid">23442864</pub-id><pub-id pub-id-type="pmcid">PMC3552256</pub-id></element-citation></ref><ref id="CR1068"><label>1068.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name><name name-style="western"><surname>Kratina</surname><given-names>T</given-names></name><name name-style="western"><surname>Czabotar</surname><given-names>P</given-names></name><name name-style="western"><surname>Day</surname><given-names>CL</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kluck</surname><given-names>RM</given-names></name></person-group><article-title>Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices</article-title><source>Mol Cell</source><year>2009</year><volume>36</volume><fpage>696</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.11.008</pub-id><pub-id pub-id-type="pmid">19941828</pub-id></element-citation></ref><ref id="CR1069"><label>1069.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name><name name-style="western"><surname>Kluck</surname><given-names>RM</given-names></name></person-group><article-title>Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis</article-title><source>J cell Sci</source><year>2009</year><volume>122</volume><fpage>2801</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1242/jcs.038166</pub-id><pub-id pub-id-type="pmid">19795525</pub-id><pub-id pub-id-type="pmcid">PMC2736138</pub-id></element-citation></ref><ref id="CR1070"><label>1070.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verhagen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ekert</surname><given-names>PG</given-names></name><name name-style="western"><surname>Pakusch</surname><given-names>M</given-names></name><name name-style="western"><surname>Silke</surname><given-names>J</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>LM</given-names></name><name name-style="western"><surname>Reid</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</article-title><source>Cell</source><year>2000</year><volume>102</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)00009-X</pub-id><pub-id pub-id-type="pmid">10929712</pub-id></element-citation></ref><ref id="CR1071"><label>1071.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorstyn</surname><given-names>L</given-names></name><name name-style="western"><surname>Akey</surname><given-names>CW</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>New insights into apoptosome structure and function</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>1194</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/s41418-017-0025-z</pub-id><pub-id pub-id-type="pmid">29765111</pub-id><pub-id pub-id-type="pmcid">PMC6030056</pub-id></element-citation></ref><ref id="CR1072"><label>1072.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiozaki</surname><given-names>EN</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology</article-title><source>Trends Biochem Sci</source><year>2004</year><volume>29</volume><fpage>486</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2004.07.003</pub-id><pub-id pub-id-type="pmid">15337122</pub-id></element-citation></ref><ref id="CR1073"><label>1073.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>BH3-Only proteins-essential initiators of apoptotic cell death</article-title><source>Cell</source><year>2000</year><volume>103</volume><fpage>839</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)00187-2</pub-id><pub-id pub-id-type="pmid">11136969</pub-id></element-citation></ref><ref id="CR1074"><label>1074.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kale</surname><given-names>J</given-names></name><name name-style="western"><surname>Osterlund</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>DW</given-names></name></person-group><article-title>BCL-2 family proteins: changing partners in the dance towards death</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>65</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.186</pub-id><pub-id pub-id-type="pmid">29149100</pub-id><pub-id pub-id-type="pmcid">PMC5729540</pub-id></element-citation></ref><ref id="CR1075"><label>1075.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giam</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name></person-group><article-title>BH3-only proteins and their roles in programmed cell death</article-title><source>Oncogene</source><year>2008</year><volume>27</volume><fpage>S128</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/onc.2009.50</pub-id><pub-id pub-id-type="pmid">19641498</pub-id></element-citation></ref><ref id="CR1076"><label>1076.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gavathiotis</surname><given-names>E</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>M</given-names></name><name name-style="western"><surname>Davis</surname><given-names>ML</given-names></name><name name-style="western"><surname>Pitter</surname><given-names>K</given-names></name><name name-style="western"><surname>Bird</surname><given-names>GH</given-names></name><name name-style="western"><surname>Katz</surname><given-names>SG</given-names></name><etal/></person-group><article-title>BAX activation is initiated at a novel interaction site</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>1076</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/nature07396</pub-id><pub-id pub-id-type="pmid">18948948</pub-id><pub-id pub-id-type="pmcid">PMC2597110</pub-id></element-citation></ref><ref id="CR1077"><label>1077.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gavathiotis</surname><given-names>E</given-names></name><name name-style="western"><surname>Reyna</surname><given-names>DE</given-names></name><name name-style="western"><surname>Davis</surname><given-names>ML</given-names></name><name name-style="western"><surname>Bird</surname><given-names>GH</given-names></name><name name-style="western"><surname>Walensky</surname><given-names>LD</given-names></name></person-group><article-title>BH3-triggered structural reorganization drives the activation of proapoptotic BAX</article-title><source>Mol Cell</source><year>2010</year><volume>40</volume><fpage>481</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.10.019</pub-id><pub-id pub-id-type="pmid">21070973</pub-id><pub-id pub-id-type="pmcid">PMC3050027</pub-id></element-citation></ref><ref id="CR1078"><label>1078.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Tu</surname><given-names>HC</given-names></name><name name-style="western"><surname>Ren</surname><given-names>D</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>O</given-names></name><name name-style="western"><surname>Jeffers</surname><given-names>JR</given-names></name><name name-style="western"><surname>Zambetti</surname><given-names>GP</given-names></name><etal/></person-group><article-title>Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis</article-title><source>Mol Cell</source><year>2009</year><volume>36</volume><fpage>487</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.09.030</pub-id><pub-id pub-id-type="pmid">19917256</pub-id><pub-id pub-id-type="pmcid">PMC3163439</pub-id></element-citation></ref><ref id="CR1079"><label>1079.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>MC</given-names></name><name name-style="western"><surname>Zong</surname><given-names>WX</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>EH</given-names></name><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><name name-style="western"><surname>Panoutsakopoulou</surname><given-names>V</given-names></name><name name-style="western"><surname>Ross</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death</article-title><source>Science</source><year>2001</year><volume>292</volume><fpage>727</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1126/science.1059108</pub-id><pub-id pub-id-type="pmid">11326099</pub-id><pub-id pub-id-type="pmcid">PMC3049805</pub-id></element-citation></ref><ref id="CR1080"><label>1080.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Rafiuddin-Shah</surname><given-names>M</given-names></name><name name-style="western"><surname>Tu</surname><given-names>HC</given-names></name><name name-style="western"><surname>Jeffers</surname><given-names>JR</given-names></name><name name-style="western"><surname>Zambetti</surname><given-names>GP</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies</article-title><source>Nat Cell Biol</source><year>2006</year><volume>8</volume><fpage>1348</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/ncb1499</pub-id><pub-id pub-id-type="pmid">17115033</pub-id></element-citation></ref><ref id="CR1081"><label>1081.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>H</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Meng</surname><given-names>XW</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>PA</given-names></name><name name-style="western"><surname>Pang</surname><given-names>YP</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization</article-title><source>J Cell Biol</source><year>2011</year><volume>194</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1083/jcb.201102027</pub-id><pub-id pub-id-type="pmid">21727192</pub-id><pub-id pub-id-type="pmcid">PMC3135403</pub-id></element-citation></ref><ref id="CR1082"><label>1082.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>HC</given-names></name><name name-style="western"><surname>Kanai</surname><given-names>M</given-names></name><name name-style="western"><surname>Inoue-Yamauchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Tu</surname><given-names>HC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ren</surname><given-names>D</given-names></name><etal/></person-group><article-title>An interconnected hierarchical model of cell death regulation by the BCL-2 family</article-title><source>Nat Cell Biol</source><year>2015</year><volume>17</volume><fpage>1270</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/ncb3236</pub-id><pub-id pub-id-type="pmid">26344567</pub-id><pub-id pub-id-type="pmcid">PMC4589531</pub-id></element-citation></ref><ref id="CR1083"><label>1083.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Neill</surname><given-names>KL</given-names></name><name name-style="western"><surname>Huang</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name></person-group><article-title>Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane</article-title><source>Genes Dev</source><year>2016</year><volume>30</volume><fpage>973</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1101/gad.276725.115</pub-id><pub-id pub-id-type="pmid">27056669</pub-id><pub-id pub-id-type="pmcid">PMC4840302</pub-id></element-citation></ref><ref id="CR1084"><label>1084.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Letai</surname><given-names>A</given-names></name><name name-style="western"><surname>Bassik</surname><given-names>MC</given-names></name><name name-style="western"><surname>Walensky</surname><given-names>LD</given-names></name><name name-style="western"><surname>Sorcinelli</surname><given-names>MD</given-names></name><name name-style="western"><surname>Weiler</surname><given-names>S</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics</article-title><source>Cancer Cell</source><year>2002</year><volume>2</volume><fpage>183</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/S1535-6108(02)00127-7</pub-id><pub-id pub-id-type="pmid">12242151</pub-id></element-citation></ref><ref id="CR1085"><label>1085.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuwana</surname><given-names>T</given-names></name><name name-style="western"><surname>Bouchier-Hayes</surname><given-names>L</given-names></name><name name-style="western"><surname>Chipuk</surname><given-names>JE</given-names></name><name name-style="western"><surname>Bonzon</surname><given-names>C</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>BA</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name><etal/></person-group><article-title>BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly</article-title><source>Mol Cell</source><year>2005</year><volume>17</volume><fpage>525</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.02.003</pub-id><pub-id pub-id-type="pmid">15721256</pub-id></element-citation></ref><ref id="CR1086"><label>1086.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Willis</surname><given-names>SN</given-names></name><name name-style="western"><surname>Wei</surname><given-names>A</given-names></name><name name-style="western"><surname>Smith</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>JI</given-names></name><name name-style="western"><surname>Hinds</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</article-title><source>Mol Cell</source><year>2005</year><volume>17</volume><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.12.030</pub-id><pub-id pub-id-type="pmid">15694340</pub-id></element-citation></ref><ref id="CR1087"><label>1087.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeng</surname><given-names>PS</given-names></name><name name-style="western"><surname>Inoue-Yamauchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>EH</given-names></name></person-group><article-title>BH3-Dependent and Independent Activation of BAX and BAK in Mitochondrial</article-title><source>Apoptosis Curr Opin Physiol</source><year>2018</year><volume>3</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.cophys.2018.03.005</pub-id><pub-id pub-id-type="pmid">30334018</pub-id><pub-id pub-id-type="pmcid">PMC6186458</pub-id></element-citation></ref><ref id="CR1088"><label>1088.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaseva</surname><given-names>AV</given-names></name><name name-style="western"><surname>Moll</surname><given-names>UM</given-names></name></person-group><article-title>The mitochondrial p53 pathway</article-title><source>Biochim Biophys Acta</source><year>2009</year><volume>1787</volume><fpage>414</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2008.10.005</pub-id><pub-id pub-id-type="pmid">19007744</pub-id><pub-id pub-id-type="pmcid">PMC2819081</pub-id></element-citation></ref><ref id="CR1089"><label>1089.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mihara</surname><given-names>M</given-names></name><name name-style="western"><surname>Erster</surname><given-names>S</given-names></name><name name-style="western"><surname>Zaika</surname><given-names>A</given-names></name><name name-style="western"><surname>Petrenko</surname><given-names>O</given-names></name><name name-style="western"><surname>Chittenden</surname><given-names>T</given-names></name><name name-style="western"><surname>Pancoska</surname><given-names>P</given-names></name><etal/></person-group><article-title>p53 has a direct apoptogenic role at the mitochondria</article-title><source>Mol Cell</source><year>2003</year><volume>11</volume><fpage>577</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(03)00050-9</pub-id><pub-id pub-id-type="pmid">12667443</pub-id></element-citation></ref><ref id="CR1090"><label>1090.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>ZX</given-names></name><name name-style="western"><surname>Pervaiz</surname><given-names>S</given-names></name></person-group><article-title>Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>408</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.132</pub-id><pub-id pub-id-type="pmid">19834492</pub-id></element-citation></ref><ref id="CR1091"><label>1091.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chong</surname><given-names>SJF</given-names></name><name name-style="western"><surname>Iskandar</surname><given-names>K</given-names></name><name name-style="western"><surname>Lai</surname><given-names>JXH</given-names></name><name name-style="western"><surname>Qu</surname><given-names>J</given-names></name><name name-style="western"><surname>Raman</surname><given-names>D</given-names></name><name name-style="western"><surname>Valentin</surname><given-names>R</given-names></name><etal/></person-group><article-title>Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism</article-title><source>Nucleic Acids Res</source><year>2020</year><volume>48</volume><fpage>12727</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1110</pub-id><pub-id pub-id-type="pmid">33245769</pub-id><pub-id pub-id-type="pmcid">PMC7736805</pub-id></element-citation></ref><ref id="CR1092"><label>1092.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cl&#233;ment</surname><given-names>MV</given-names></name><name name-style="western"><surname>Hirpara</surname><given-names>JL</given-names></name><name name-style="western"><surname>Pervaiz</surname><given-names>S</given-names></name></person-group><article-title>Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced apoptosis independent of the mitochondria</article-title><source>Cell Death Differ</source><year>2003</year><volume>10</volume><fpage>1273</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401302</pub-id><pub-id pub-id-type="pmid">12894215</pub-id></element-citation></ref><ref id="CR1093"><label>1093.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Low</surname><given-names>IC</given-names></name><name name-style="western"><surname>Loh</surname><given-names>T</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Virshup</surname><given-names>DM</given-names></name><name name-style="western"><surname>Pervaiz</surname><given-names>S</given-names></name></person-group><article-title>Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56&#948; stabilizes its antiapoptotic activity</article-title><source>Blood</source><year>2014</year><volume>124</volume><fpage>2223</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-03-563296</pub-id><pub-id pub-id-type="pmid">25082878</pub-id></element-citation></ref><ref id="CR1094"><label>1094.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Tung</surname><given-names>KS</given-names></name><name name-style="western"><surname>Tourtellotte</surname><given-names>WG</given-names></name><name name-style="western"><surname>Brown</surname><given-names>GA</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Bax-deficient mice with lymphoid hyperplasia and male germ cell death</article-title><source>Science</source><year>1995</year><volume>270</volume><fpage>96</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1126/science.270.5233.96</pub-id><pub-id pub-id-type="pmid">7569956</pub-id></element-citation></ref><ref id="CR1095"><label>1095.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><name name-style="western"><surname>Ross</surname><given-names>AJ</given-names></name><name name-style="western"><surname>King</surname><given-names>A</given-names></name><name name-style="western"><surname>Zong</surname><given-names>WX</given-names></name><name name-style="western"><surname>Rathmell</surname><given-names>JC</given-names></name><name name-style="western"><surname>Shiels</surname><given-names>HA</given-names></name><etal/></person-group><article-title>The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues</article-title><source>Mol Cell</source><year>2000</year><volume>6</volume><fpage>1389</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)00136-2</pub-id><pub-id pub-id-type="pmid">11163212</pub-id><pub-id pub-id-type="pmcid">PMC3057227</pub-id></element-citation></ref><ref id="CR1096"><label>1096.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>F</given-names></name><name name-style="western"><surname>Voss</surname><given-names>A</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>JB</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Tai</surname><given-names>L</given-names></name><name name-style="western"><surname>Echeverry</surname><given-names>N</given-names></name><etal/></person-group><article-title>BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice</article-title><source>Cell Death Differ</source><year>2012</year><volume>19</volume><fpage>915</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.210</pub-id><pub-id pub-id-type="pmid">22281706</pub-id><pub-id pub-id-type="pmcid">PMC3354060</pub-id></element-citation></ref><ref id="CR1097"><label>1097.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>DH</given-names></name><name name-style="western"><surname>Soygur</surname><given-names>B</given-names></name><name name-style="western"><surname>Peng</surname><given-names>SP</given-names></name><name name-style="western"><surname>Malki</surname><given-names>S</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G</given-names></name><name name-style="western"><surname>Laird</surname><given-names>DJ</given-names></name></person-group><article-title>Apoptosis in the fetal testis eliminates developmentally defective germ cell clones</article-title><source>Nat Cell Biol</source><year>2020</year><volume>22</volume><fpage>1423</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-00603-8</pub-id><pub-id pub-id-type="pmid">33199844</pub-id><pub-id pub-id-type="pmcid">PMC8389187</pub-id></element-citation></ref><ref id="CR1098"><label>1098.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>LD</given-names></name><name name-style="western"><surname>Chiarini-Garcia</surname><given-names>H</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name></person-group><article-title>Bax-dependent spermatogonia apoptosis is required for testicular development and spermatogenesis</article-title><source>Biol Reprod</source><year>2002</year><volume>66</volume><fpage>950</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1095/biolreprod66.4.950</pub-id><pub-id pub-id-type="pmid">11906913</pub-id></element-citation></ref><ref id="CR1099"><label>1099.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>I</given-names></name><name name-style="western"><surname>Ody</surname><given-names>C</given-names></name><name name-style="western"><surname>Araki</surname><given-names>K</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>I</given-names></name><name name-style="western"><surname>Vassalli</surname><given-names>P</given-names></name></person-group><article-title>An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis</article-title><source>EMBO J</source><year>1997</year><volume>16</volume><fpage>2262</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1093/emboj/16.9.2262</pub-id><pub-id pub-id-type="pmid">9171341</pub-id><pub-id pub-id-type="pmcid">PMC1169828</pub-id></element-citation></ref><ref id="CR1100"><label>1100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>FA</given-names></name><name name-style="western"><surname>Keller-Peck</surname><given-names>CR</given-names></name><name name-style="western"><surname>Knudson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Snider</surname><given-names>WD</given-names></name></person-group><article-title>Widespread elimination of naturally occurring neuronal death in Bax-deficient mice</article-title><source>J Neurosci</source><year>1998</year><volume>18</volume><fpage>1428</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-04-01428.1998</pub-id><pub-id pub-id-type="pmid">9454852</pub-id><pub-id pub-id-type="pmcid">PMC6792725</pub-id></element-citation></ref><ref id="CR1101"><label>1101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>H</given-names></name><name name-style="western"><surname>Favero</surname><given-names>M</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>MW</given-names></name></person-group><article-title>Elimination of Bax expression in mice increases cerebellar purkinje cell numbers but not the number of granule cells</article-title><source>J Comp Neurol</source><year>2001</year><volume>436</volume><fpage>82</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1002/cne.1055</pub-id><pub-id pub-id-type="pmid">11413548</pub-id></element-citation></ref><ref id="CR1102"><label>1102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>AR</given-names></name><name name-style="western"><surname>Kim</surname><given-names>TW</given-names></name><name name-style="western"><surname>Rhyu</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YD</given-names></name><name name-style="western"><surname>Vinsant</surname><given-names>S</given-names></name><etal/></person-group><article-title>Misplacement of Purkinje cells during postnatal development in Bax knock-out mice: a novel role for programmed cell death in the nervous system?</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>2941</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3897-07.2008</pub-id><pub-id pub-id-type="pmid">18337425</pub-id><pub-id pub-id-type="pmcid">PMC6670685</pub-id></element-citation></ref><ref id="CR1103"><label>1103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Winseck</surname><given-names>A</given-names></name><name name-style="western"><surname>Vinsant</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>OH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Oppenheim</surname><given-names>RW</given-names></name></person-group><article-title>Programmed cell death of adult-generated hippocampal neurons is mediated by the proapoptotic gene Bax</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>11205</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1436-04.2004</pub-id><pub-id pub-id-type="pmid">15590937</pub-id><pub-id pub-id-type="pmcid">PMC6730275</pub-id></element-citation></ref><ref id="CR1104"><label>1104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>MY</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Ochiai</surname><given-names>W</given-names></name><name name-style="western"><surname>Nakashima</surname><given-names>K</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SY</given-names></name><name name-style="western"><surname>Park</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Bcl-XL/Bax proteins direct the fate of embryonic cortical precursor cells</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>4293</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1128/MCB.00031-07</pub-id><pub-id pub-id-type="pmid">17438128</pub-id><pub-id pub-id-type="pmcid">PMC1900045</pub-id></element-citation></ref><ref id="CR1105"><label>1105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Southwell</surname><given-names>DG</given-names></name><name name-style="western"><surname>Paredes</surname><given-names>MF</given-names></name><name name-style="western"><surname>Galvao</surname><given-names>RP</given-names></name><name name-style="western"><surname>Jones</surname><given-names>DL</given-names></name><name name-style="western"><surname>Froemke</surname><given-names>RC</given-names></name><name name-style="western"><surname>Sebe</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Intrinsically determined cell death of developing cortical interneurons</article-title><source>Nature</source><year>2012</year><volume>491</volume><fpage>109</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/nature11523</pub-id><pub-id pub-id-type="pmid">23041929</pub-id><pub-id pub-id-type="pmcid">PMC3726009</pub-id></element-citation></ref><ref id="CR1106"><label>1106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jyotika</surname><given-names>J</given-names></name><name name-style="western"><surname>McCutcheon</surname><given-names>J</given-names></name><name name-style="western"><surname>Laroche</surname><given-names>J</given-names></name><name name-style="western"><surname>Blaustein</surname><given-names>JD</given-names></name><name name-style="western"><surname>Forger</surname><given-names>NG</given-names></name></person-group><article-title>Deletion of the Bax gene disrupts sexual behavior and modestly impairs motor function in mice</article-title><source>Dev Neurobiol</source><year>2007</year><volume>67</volume><fpage>1511</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/dneu.20525</pub-id><pub-id pub-id-type="pmid">17525992</pub-id></element-citation></ref><ref id="CR1107"><label>1107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luedke</surname><given-names>AC</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>PO</given-names></name><name name-style="western"><surname>Niel</surname><given-names>L</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>MM</given-names></name></person-group><article-title>Altered anxiety and defensive behaviors in Bax knockout mice</article-title><source>Behav Brain Res</source><year>2013</year><volume>239</volume><fpage>115</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2012.10.056</pub-id><pub-id pub-id-type="pmid">23142367</pub-id></element-citation></ref><ref id="CR1108"><label>1108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krahe</surname><given-names>TE</given-names></name><name name-style="western"><surname>Medina</surname><given-names>AE</given-names></name><name name-style="western"><surname>Lantz</surname><given-names>CL</given-names></name><name name-style="western"><surname>Filgueiras</surname><given-names>CC</given-names></name></person-group><article-title>Hyperactivity and depression-like traits in Bax KO mice</article-title><source>Brain Res</source><year>2015</year><volume>1625</volume><fpage>246</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.09.002</pub-id><pub-id pub-id-type="pmid">26363094</pub-id><pub-id pub-id-type="pmcid">PMC5806998</pub-id></element-citation></ref><ref id="CR1109"><label>1109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanahan</surname><given-names>D</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><year>2011</year><volume>144</volume><fpage>646</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="CR1110"><label>1110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>F</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>J</given-names></name><name name-style="western"><surname>Voss</surname><given-names>AK</given-names></name></person-group><article-title>Consequences of the combined loss of BOK and BAK or BOK and BAX</article-title><source>Cell Death Dis</source><year>2013</year><volume>4</volume><fpage>e650</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.176</pub-id><pub-id pub-id-type="pmid">23744350</pub-id><pub-id pub-id-type="pmcid">PMC3698543</pub-id></element-citation></ref><ref id="CR1111"><label>1111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arakawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsujioka</surname><given-names>M</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name><name name-style="western"><surname>Tajima-Sakurai</surname><given-names>H</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>Y</given-names></name><name name-style="western"><surname>Matsuoka</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Role of Atg5-dependent cell death in the embryonic development of Bax/Bak double-knockout mice</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>1598</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.84</pub-id><pub-id pub-id-type="pmid">28574506</pub-id><pub-id pub-id-type="pmcid">PMC5563990</pub-id></element-citation></ref><ref id="CR1112"><label>1112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rybstein</surname><given-names>MD</given-names></name><name name-style="western"><surname>Bravo-San Pedro</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name></person-group><article-title>The autophagic network and cancer</article-title><source>Nat Cell Biol</source><year>2018</year><volume>20</volume><fpage>243</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0042-2</pub-id><pub-id pub-id-type="pmid">29476153</pub-id></element-citation></ref><ref id="CR1113"><label>1113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>Autophagy-independent functions of the autophagy machinery</article-title><source>Cell</source><year>2019</year><volume>177</volume><fpage>1682</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.026</pub-id><pub-id pub-id-type="pmid">31199916</pub-id><pub-id pub-id-type="pmcid">PMC7173070</pub-id></element-citation></ref><ref id="CR1114"><label>1114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>DR</given-names></name><name name-style="western"><surname>Cramer</surname><given-names>SD</given-names></name><name name-style="western"><surname>Thorburn</surname><given-names>A</given-names></name></person-group><article-title>The interplay of autophagy and non-apoptotic cell death pathways</article-title><source>Int Rev Cell Mol Biol</source><year>2020</year><volume>352</volume><fpage>159</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/bs.ircmb.2019.12.004</pub-id><pub-id pub-id-type="pmid">32334815</pub-id><pub-id pub-id-type="pmcid">PMC8185908</pub-id></element-citation></ref><ref id="CR1115"><label>1115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fairlie</surname><given-names>WD</given-names></name><name name-style="western"><surname>Tran</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>EF</given-names></name></person-group><article-title>Crosstalk between apoptosis and autophagy signaling pathways</article-title><source>Int Rev Cell Mol Biol</source><year>2020</year><volume>352</volume><fpage>115</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/bs.ircmb.2020.01.003</pub-id><pub-id pub-id-type="pmid">32334814</pub-id></element-citation></ref><ref id="CR1116"><label>1116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Serradj</surname><given-names>N</given-names></name><name name-style="western"><surname>Ueno</surname><given-names>M</given-names></name><name name-style="western"><surname>Liang</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Baccei</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Skilled movements require non-apoptotic Bax/Bak pathway-mediated corticospinal circuit reorganization</article-title><source>Neuron</source><year>2017</year><volume>94</volume><fpage>626</fpage><lpage>641.e624</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.019</pub-id><pub-id pub-id-type="pmid">28472660</pub-id><pub-id pub-id-type="pmcid">PMC5510485</pub-id></element-citation></ref><ref id="CR1117"><label>1117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hahn</surname><given-names>P</given-names></name><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><name name-style="western"><surname>Ying</surname><given-names>GS</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>J</given-names></name><name name-style="western"><surname>Milam</surname><given-names>AH</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Proapoptotic bcl-2 family members, Bax and Bak, are essential for developmental photoreceptor apoptosis</article-title><source>Investig Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>3598</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1167/iovs.02-1113</pub-id><pub-id pub-id-type="pmid">12882813</pub-id></element-citation></ref><ref id="CR1118"><label>1118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hahn</surname><given-names>P</given-names></name><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><name name-style="western"><surname>Tolentino</surname><given-names>M</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>J</given-names></name><name name-style="western"><surname>Dunaief</surname><given-names>JL</given-names></name></person-group><article-title>Persistent fetal ocular vasculature in mice deficient in bax and bak</article-title><source>Arch Ophthalmol</source><year>2005</year><volume>123</volume><fpage>797</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1001/archopht.123.6.797</pub-id><pub-id pub-id-type="pmid">15955981</pub-id></element-citation></ref><ref id="CR1119"><label>1119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>FS</given-names></name><name name-style="western"><surname>Holloway</surname><given-names>S</given-names></name><name name-style="western"><surname>Uren</surname><given-names>RT</given-names></name><name name-style="western"><surname>Wong</surname><given-names>AW</given-names></name><name name-style="western"><surname>Little</surname><given-names>MH</given-names></name><name name-style="western"><surname>Kluck</surname><given-names>RM</given-names></name><etal/></person-group><article-title>The BCL-2 family member BID plays a role during embryonic development in addition to its BH3-only protein function by acting in parallel to BAX, BAK and BOK</article-title><source>EMBO J</source><year>2022</year><volume>41</volume><fpage>e110300</fpage><pub-id pub-id-type="doi">10.15252/embj.2021110300</pub-id><pub-id pub-id-type="pmid">35758142</pub-id><pub-id pub-id-type="pmcid">PMC9340487</pub-id></element-citation></ref><ref id="CR1120"><label>1120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Romero</surname><given-names>H</given-names></name><name name-style="western"><surname>Hohorst</surname><given-names>L</given-names></name><name name-style="western"><surname>John</surname><given-names>M</given-names></name><name name-style="western"><surname>Albert</surname><given-names>MC</given-names></name><name name-style="western"><surname>King</surname><given-names>LE</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>L</given-names></name><etal/></person-group><article-title>BCL-2-family protein tBID can act as a BAX-like effector of apoptosis</article-title><source>EMBO J</source><year>2022</year><volume>41</volume><fpage>e108690</fpage><pub-id pub-id-type="doi">10.15252/embj.2021108690</pub-id><pub-id pub-id-type="pmid">34931711</pub-id><pub-id pub-id-type="pmcid">PMC8762556</pub-id></element-citation></ref><ref id="CR1121"><label>1121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>M</given-names></name><name name-style="western"><surname>Youle</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Tjandra</surname><given-names>N</given-names></name></person-group><article-title>Structure of Bax: coregulation of dimer formation and intracellular localization</article-title><source>Cell</source><year>2000</year><volume>103</volume><fpage>645</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)00167-7</pub-id><pub-id pub-id-type="pmid">11106734</pub-id></element-citation></ref><ref id="CR1122"><label>1122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDonnell</surname><given-names>JM</given-names></name><name name-style="western"><surname>Fushman</surname><given-names>D</given-names></name><name name-style="western"><surname>Milliman</surname><given-names>CL</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Cowburn</surname><given-names>D</given-names></name></person-group><article-title>Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists</article-title><source>Cell</source><year>1999</year><volume>96</volume><fpage>625</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80573-5</pub-id><pub-id pub-id-type="pmid">10089878</pub-id></element-citation></ref><ref id="CR1123"><label>1123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Salvesen</surname><given-names>GS</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>G</given-names></name></person-group><article-title>Solution structure of BID, an intracellular amplifier of apoptotic signaling</article-title><source>Cell</source><year>1999</year><volume>96</volume><fpage>615</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80572-3</pub-id><pub-id pub-id-type="pmid">10089877</pub-id></element-citation></ref><ref id="CR1124"><label>1124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>J</given-names></name><name name-style="western"><surname>Suh</surname><given-names>H</given-names></name><name name-style="western"><surname>Harada</surname><given-names>H</given-names></name><name name-style="western"><surname>Malynn</surname><given-names>BA</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>11272</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.0504783102</pub-id><pub-id pub-id-type="pmid">16055554</pub-id><pub-id pub-id-type="pmcid">PMC1183578</pub-id></element-citation></ref><ref id="CR1125"><label>1125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biswas</surname><given-names>S</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name><name name-style="western"><surname>Matise</surname><given-names>L</given-names></name><name name-style="western"><surname>Cleveland</surname><given-names>S</given-names></name><name name-style="western"><surname>Dave</surname><given-names>U</given-names></name><name name-style="western"><surname>Zinkel</surname><given-names>S</given-names></name></person-group><article-title>A role for proapoptotic Bax and Bak in T-cell differentiation and transformation</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>5237</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-04-279687</pub-id><pub-id pub-id-type="pmid">20813900</pub-id><pub-id pub-id-type="pmcid">PMC3012541</pub-id></element-citation></ref><ref id="CR1126"><label>1126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kodama</surname><given-names>T</given-names></name><name name-style="western"><surname>Hikita</surname><given-names>H</given-names></name><name name-style="western"><surname>Kawaguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Shigekawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages</article-title><source>Cell Death Differ</source><year>2012</year><volume>19</volume><fpage>1856</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/cdd.2012.88</pub-id><pub-id pub-id-type="pmid">22790873</pub-id><pub-id pub-id-type="pmcid">PMC3469054</pub-id></element-citation></ref><ref id="CR1127"><label>1127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pleines</surname><given-names>I</given-names></name><name name-style="western"><surname>Lebois</surname><given-names>M</given-names></name><name name-style="western"><surname>Gangatirkar</surname><given-names>P</given-names></name><name name-style="western"><surname>Au</surname><given-names>AE</given-names></name><name name-style="western"><surname>Lane</surname><given-names>RM</given-names></name><name name-style="western"><surname>Henley</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Intrinsic apoptosis circumvents the functional decline of circulating platelets but does not cause the storage lesion</article-title><source>Blood</source><year>2018</year><volume>132</volume><fpage>197</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1182/blood-2017-11-816355</pub-id><pub-id pub-id-type="pmid">29784641</pub-id></element-citation></ref><ref id="CR1128"><label>1128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>F</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>GL</given-names></name><name name-style="western"><surname>Lin</surname><given-names>A</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Impact of the combined loss of BOK, BAX and BAK on the hematopoietic system is slightly more severe than compound loss of BAX and BAK</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1938</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.304</pub-id><pub-id pub-id-type="pmid">26492371</pub-id><pub-id pub-id-type="pmcid">PMC4632322</pub-id></element-citation></ref><ref id="CR1129"><label>1129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathmell</surname><given-names>JC</given-names></name><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><name name-style="western"><surname>Zong</surname><given-names>WX</given-names></name><name name-style="western"><surname>Cinalli</surname><given-names>RM</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name></person-group><article-title>Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis</article-title><source>Nat Immunol</source><year>2002</year><volume>3</volume><fpage>932</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/ni834</pub-id><pub-id pub-id-type="pmid">12244308</pub-id></element-citation></ref><ref id="CR1130"><label>1130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>RG</given-names></name><name name-style="western"><surname>Bui</surname><given-names>T</given-names></name><name name-style="western"><surname>White</surname><given-names>C</given-names></name><name name-style="western"><surname>Madesh</surname><given-names>M</given-names></name><name name-style="western"><surname>Krawczyk</surname><given-names>CM</given-names></name><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><etal/></person-group><article-title>The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis</article-title><source>Immunity</source><year>2007</year><volume>27</volume><fpage>268</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.05.023</pub-id><pub-id pub-id-type="pmid">17692540</pub-id><pub-id pub-id-type="pmcid">PMC2714273</pub-id></element-citation></ref><ref id="CR1131"><label>1131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watson</surname><given-names>EC</given-names></name><name name-style="western"><surname>Koenig</surname><given-names>MN</given-names></name><name name-style="western"><surname>Grant</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>L</given-names></name><name name-style="western"><surname>Trounson</surname><given-names>E</given-names></name><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name><etal/></person-group><article-title>Apoptosis regulates endothelial cell number and capillary vessel diameter but not vessel regression during retinal angiogenesis</article-title><source>Devlopment</source><year>2016</year><volume>143</volume><fpage>2973</fpage><lpage>82</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/dev.137513</pub-id><pub-id pub-id-type="pmid">27471260</pub-id></element-citation></ref><ref id="CR1132"><label>1132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>YM</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>GY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Sawyer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Exacerbation of spontaneous autoimmune nephritis following regulatory T cell depletion in B cell lymphoma 2-interacting mediator knock-out mice</article-title><source>Clin Exp Immunol</source><year>2017</year><volume>188</volume><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1111/cei.12937</pub-id><pub-id pub-id-type="pmid">28152566</pub-id><pub-id pub-id-type="pmcid">PMC5383436</pub-id></element-citation></ref><ref id="CR1133"><label>1133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puthalakath</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Gunn</surname><given-names>P</given-names></name><name name-style="western"><surname>Lee</surname><given-names>L</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><name name-style="western"><surname>Huntington</surname><given-names>ND</given-names></name><etal/></person-group><article-title>ER stress triggers apoptosis by activating BH3-only protein Bim</article-title><source>Cell</source><year>2007</year><volume>129</volume><fpage>1337</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.04.027</pub-id><pub-id pub-id-type="pmid">17604722</pub-id></element-citation></ref><ref id="CR1134"><label>1134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hutcheson</surname><given-names>J</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>H</given-names></name></person-group><article-title>Loss of Bim results in abnormal accumulation of mature CD4-CD8-CD44-CD25- thymocytes</article-title><source>Immunobiology</source><year>2007</year><volume>212</volume><fpage>629</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2007.05.003</pub-id><pub-id pub-id-type="pmid">17869640</pub-id><pub-id pub-id-type="pmcid">PMC2074878</pub-id></element-citation></ref><ref id="CR1135"><label>1135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chougnet</surname><given-names>CA</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>P</given-names></name><name name-style="western"><surname>Lages</surname><given-names>CS</given-names></name><name name-style="western"><surname>Raynor</surname><given-names>J</given-names></name><name name-style="western"><surname>Sholl</surname><given-names>A</given-names></name><name name-style="western"><surname>Fink</surname><given-names>P</given-names></name><etal/></person-group><article-title>A major role for Bim in regulatory T cell homeostasis</article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>156</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1001505</pub-id><pub-id pub-id-type="pmid">21098226</pub-id><pub-id pub-id-type="pmcid">PMC3066029</pub-id></element-citation></ref><ref id="CR1136"><label>1136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Purton</surname><given-names>JF</given-names></name><name name-style="western"><surname>Godfrey</surname><given-names>DI</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>LC</given-names></name><name name-style="western"><surname>Coultas</surname><given-names>L</given-names></name><name name-style="western"><surname>Puthalakath</surname><given-names>H</given-names></name><etal/></person-group><article-title>BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes</article-title><source>Nature</source><year>2002</year><volume>415</volume><fpage>922</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/415922a</pub-id><pub-id pub-id-type="pmid">11859372</pub-id></element-citation></ref><ref id="CR1137"><label>1137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Enders</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Puthalakath</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><fpage>1119</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1084/jem.20030411</pub-id><pub-id pub-id-type="pmid">14517273</pub-id><pub-id pub-id-type="pmcid">PMC2194219</pub-id></element-citation></ref><ref id="CR1138"><label>1138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gray</surname><given-names>D</given-names></name><name name-style="western"><surname>Carrington</surname><given-names>EM</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Ko</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Defects in the Bcl-2-regulated apoptotic pathway lead to preferential increase of CD25 low Foxp3+ anergic CD4+ T cells</article-title><source>J Immunol</source><year>2011</year><volume>187</volume><fpage>1566</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100027</pub-id><pub-id pub-id-type="pmid">21742968</pub-id><pub-id pub-id-type="pmcid">PMC3150360</pub-id></element-citation></ref><ref id="CR1139"><label>1139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pellegrini</surname><given-names>M</given-names></name><name name-style="western"><surname>Belz</surname><given-names>G</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>14175</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1073/pnas.2336198100</pub-id><pub-id pub-id-type="pmid">14623954</pub-id><pub-id pub-id-type="pmcid">PMC283565</pub-id></element-citation></ref><ref id="CR1140"><label>1140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hildeman</surname><given-names>DA</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>TC</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Kappler</surname><given-names>J</given-names></name><etal/></person-group><article-title>Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim</article-title><source>Immunity</source><year>2002</year><volume>16</volume><fpage>759</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00322-9</pub-id><pub-id pub-id-type="pmid">12121658</pub-id></element-citation></ref><ref id="CR1141"><label>1141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fischer</surname><given-names>SF</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>K</given-names></name><name name-style="western"><surname>Light</surname><given-names>A</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells</article-title><source>Blood</source><year>2007</year><volume>110</volume><fpage>3978</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-05-091306</pub-id><pub-id pub-id-type="pmid">17720882</pub-id><pub-id pub-id-type="pmcid">PMC2190612</pub-id></element-citation></ref><ref id="CR1142"><label>1142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sugimoto-Ishige</surname><given-names>A</given-names></name><name name-style="western"><surname>Harada</surname><given-names>M</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Terooatea</surname><given-names>T</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Bim establishes the B-cell repertoire from early to late in the immune response</article-title><source>Int Immunol</source><year>2021</year><volume>33</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxaa060</pub-id><pub-id pub-id-type="pmid">32889526</pub-id></element-citation></ref><ref id="CR1143"><label>1143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>PM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>White</surname><given-names>J</given-names></name><name name-style="western"><surname>Kappler</surname><given-names>J</given-names></name><name name-style="western"><surname>Marrack</surname><given-names>P</given-names></name></person-group><article-title>Loss of Bim allows precursor B cell survival but not precursor B cell differentiation in the absence of interleukin 7</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>1179</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1084/jem.20041129</pub-id><pub-id pub-id-type="pmid">15520248</pub-id><pub-id pub-id-type="pmcid">PMC2211863</pub-id></element-citation></ref><ref id="CR1144"><label>1144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name><name name-style="western"><surname>Scott</surname><given-names>C</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival</article-title><source>Blood</source><year>2003</year><volume>101</volume><fpage>2393</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-07-2132</pub-id><pub-id pub-id-type="pmid">12433687</pub-id></element-citation></ref><ref id="CR1145"><label>1145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mailleux</surname><given-names>AA</given-names></name><name name-style="western"><surname>Overholtzer</surname><given-names>M</given-names></name><name name-style="western"><surname>Schmelzle</surname><given-names>T</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Brugge</surname><given-names>JS</given-names></name></person-group><article-title>BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms</article-title><source>Dev Cell</source><year>2007</year><volume>12</volume><fpage>221</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.12.003</pub-id><pub-id pub-id-type="pmid">17276340</pub-id><pub-id pub-id-type="pmcid">PMC2698712</pub-id></element-citation></ref><ref id="CR1146"><label>1146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuler</surname><given-names>F</given-names></name><name name-style="western"><surname>Baumgartner</surname><given-names>F</given-names></name><name name-style="western"><surname>Klepsch</surname><given-names>V</given-names></name><name name-style="western"><surname>Chamson</surname><given-names>M</given-names></name><name name-style="western"><surname>M&#252;ller-Holzner</surname><given-names>E</given-names></name><name name-style="western"><surname>Watson</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>The BH3-only protein BIM contributes to late-stage involution in the mouse mammary gland</article-title><source>Cell Death Differ</source><year>2016</year><volume>23</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.61</pub-id><pub-id pub-id-type="pmid">26045049</pub-id><pub-id pub-id-type="pmcid">PMC4815977</pub-id></element-citation></ref><ref id="CR1147"><label>1147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohgushi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kuroki</surname><given-names>S</given-names></name><name name-style="western"><surname>Fukamachi</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><etal/></person-group><article-title>Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>10017</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.22.10017-10028.2005</pub-id><pub-id pub-id-type="pmid">16260615</pub-id><pub-id pub-id-type="pmcid">PMC1280259</pub-id></element-citation></ref><ref id="CR1148"><label>1148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doonan</surname><given-names>F</given-names></name><name name-style="western"><surname>Donovan</surname><given-names>M</given-names></name><name name-style="western"><surname>Gomez-Vicente</surname><given-names>V</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Cotter</surname><given-names>TG</given-names></name></person-group><article-title>Bim expression indicates the pathway to retinal cell death in development and degeneration</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>10887</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0903-07.2007</pub-id><pub-id pub-id-type="pmid">17913922</pub-id><pub-id pub-id-type="pmcid">PMC6672824</pub-id></element-citation></ref><ref id="CR1149"><label>1149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wali</surname><given-names>JA</given-names></name><name name-style="western"><surname>Galic</surname><given-names>S</given-names></name><name name-style="western"><surname>Tan</surname><given-names>CY</given-names></name><name name-style="western"><surname>Gurzov</surname><given-names>EN</given-names></name><name name-style="western"><surname>Frazier</surname><given-names>AE</given-names></name><name name-style="western"><surname>Connor</surname><given-names>T</given-names></name><etal/></person-group><article-title>Loss of BIM increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice</article-title><source>Cell Death Differ</source><year>2018</year><volume>25</volume><fpage>217</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.168</pub-id><pub-id pub-id-type="pmid">29053141</pub-id><pub-id pub-id-type="pmcid">PMC5729528</pub-id></element-citation></ref><ref id="CR1150"><label>1150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hutcheson</surname><given-names>J</given-names></name><name name-style="western"><surname>Scatizzi</surname><given-names>JC</given-names></name><name name-style="western"><surname>Bickel</surname><given-names>E</given-names></name><name name-style="western"><surname>Brown</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><etal/></person-group><article-title>Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis</article-title><source>J Exp Med</source><year>2005</year><volume>201</volume><fpage>1949</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1084/jem.20041484</pub-id><pub-id pub-id-type="pmid">15967824</pub-id><pub-id pub-id-type="pmcid">PMC2212027</pub-id></element-citation></ref><ref id="CR1151"><label>1151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name><name name-style="western"><surname>King</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Heierhorst</surname><given-names>J</given-names></name><name name-style="western"><surname>Proapoptotic</surname><given-names>BIM</given-names></name></person-group><article-title>Impacts B lymphoid homeostasis by limiting the survival of mature B cells in a cell-autonomous manner</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>592</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00592</pub-id><pub-id pub-id-type="pmid">29623080</pub-id><pub-id pub-id-type="pmcid">PMC5874283</pub-id></element-citation></ref><ref id="CR1152"><label>1152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Stuchbery</surname><given-names>R</given-names></name><name name-style="western"><surname>M&#233;rino</surname><given-names>D</given-names></name><name name-style="western"><surname>Willson</surname><given-names>T</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Hildeman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Impact of conditional deletion of the pro-apoptotic BCL-2 family member BIM in mice</article-title><source>Cell Death Dis</source><year>2014</year><volume>5</volume><fpage>e1446</fpage><pub-id pub-id-type="doi">10.1038/cddis.2014.409</pub-id><pub-id pub-id-type="pmid">25299771</pub-id><pub-id pub-id-type="pmcid">PMC4237241</pub-id></element-citation></ref><ref id="CR1153"><label>1153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huntington</surname><given-names>ND</given-names></name><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Cumano</surname><given-names>A</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name><etal/></person-group><article-title>Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim sustains B lymphopoiesis in the absence of IL-7</article-title><source>Int Immunol</source><year>2009</year><volume>21</volume><fpage>715</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxp043</pub-id><pub-id pub-id-type="pmid">19454543</pub-id><pub-id pub-id-type="pmcid">PMC2980998</pub-id></element-citation></ref><ref id="CR1154"><label>1154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ludwig</surname><given-names>LM</given-names></name><name name-style="western"><surname>Roach</surname><given-names>LE</given-names></name><name name-style="western"><surname>Katz</surname><given-names>SG</given-names></name><name name-style="western"><surname>LaBelle</surname><given-names>JL</given-names></name></person-group><article-title>Loss of BIM in T cells results in BCL-2 family BH3-member compensation but incomplete cell death sensitivity normalization</article-title><source>Apoptosis</source><year>2020</year><volume>25</volume><fpage>247</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1007/s10495-020-01593-6</pub-id><pub-id pub-id-type="pmid">31993851</pub-id><pub-id pub-id-type="pmcid">PMC8265391</pub-id></element-citation></ref><ref id="CR1155"><label>1155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunk</surname><given-names>EC</given-names></name><name name-style="western"><surname>K&#246;nig</surname><given-names>HG</given-names></name><name name-style="western"><surname>Bernas</surname><given-names>T</given-names></name><name name-style="western"><surname>Engel</surname><given-names>T</given-names></name><name name-style="western"><surname>Henshall</surname><given-names>DC</given-names></name><name name-style="western"><surname>Kirby</surname><given-names>BP</given-names></name><etal/></person-group><article-title>BH3-only proteins BIM and PUMA in the regulation of survival and neuronal differentiation of newly generated cells in the adult mouse hippocampus</article-title><source>Cell Death Dis</source><year>2010</year><volume>1</volume><fpage>e15</fpage><pub-id pub-id-type="doi">10.1038/cddis.2009.13</pub-id><pub-id pub-id-type="pmid">21364616</pub-id><pub-id pub-id-type="pmcid">PMC3039291</pub-id></element-citation></ref><ref id="CR1156"><label>1156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>F</given-names></name><name name-style="western"><surname>Homan</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>H</given-names></name><name name-style="western"><surname>Misharin</surname><given-names>AV</given-names></name><name name-style="western"><surname>Abdala-Valencia</surname><given-names>H</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names><suffix>3rd</suffix></name><etal/></person-group><article-title>Bim suppresses the development of SLE by limiting myeloid inflammatory responses</article-title><source>J Exp Med</source><year>2017</year><volume>214</volume><fpage>3753</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1084/jem.20170479</pub-id><pub-id pub-id-type="pmid">29114065</pub-id><pub-id pub-id-type="pmcid">PMC5716039</pub-id></element-citation></ref><ref id="CR1157"><label>1157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leonard</surname><given-names>JR</given-names></name><name name-style="western"><surname>D&#8217;Sa</surname><given-names>C</given-names></name><name name-style="western"><surname>Cahn</surname><given-names>BR</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name></person-group><article-title>Bid regulation of neuronal apoptosis</article-title><source>Brain Res Dev Brain Res</source><year>2001</year><volume>128</volume><fpage>187</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/S0165-3806(01)00174-2</pub-id><pub-id pub-id-type="pmid">11412905</pub-id></element-citation></ref><ref id="CR1158"><label>1158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeffers</surname><given-names>JR</given-names></name><name name-style="western"><surname>Parganas</surname><given-names>E</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Puma is an essential mediator of p53-dependent and -independent apoptotic pathways</article-title><source>Cancer Cell</source><year>2003</year><volume>4</volume><fpage>321</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S1535-6108(03)00244-7</pub-id><pub-id pub-id-type="pmid">14585359</pub-id></element-citation></ref><ref id="CR1159"><label>1159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKenzie</surname><given-names>MD</given-names></name><name name-style="western"><surname>Carrington</surname><given-names>EM</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Kay</surname><given-names>TW</given-names></name><etal/></person-group><article-title>Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><fpage>1284</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.2337/db07-1692</pub-id><pub-id pub-id-type="pmid">18252892</pub-id></element-citation></ref><ref id="CR1160"><label>1160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jost</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Gray</surname><given-names>D</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>MD</given-names></name><name name-style="western"><surname>Nachbur</surname><given-names>U</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><etal/></person-group><article-title>XIAP discriminates between type I and type II FAS-induced apoptosis</article-title><source>Nature</source><year>2009</year><volume>460</volume><fpage>1035</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nature08229</pub-id><pub-id pub-id-type="pmid">19626005</pub-id><pub-id pub-id-type="pmcid">PMC2956120</pub-id></element-citation></ref><ref id="CR1161"><label>1161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zinkel</surname><given-names>SS</given-names></name><name name-style="western"><surname>Ong</surname><given-names>CC</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>DO</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Akashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Bronson</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Proapoptotic BID is required for myeloid homeostasis and tumor suppression</article-title><source>Genes Dev</source><year>2003</year><volume>17</volume><fpage>229</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1101/gad.1045603</pub-id><pub-id pub-id-type="pmid">12533511</pub-id><pub-id pub-id-type="pmcid">PMC195974</pub-id></element-citation></ref><ref id="CR1162"><label>1162.</label><mixed-citation publication-type="other">Salisbury-Ruf CT, Bertram CC, Vergeade A, Lark DS, Shi Q, Heberling ML, et al. Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. eLife. 2018;7:e40907.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.40907</pub-id><pub-id pub-id-type="pmcid">PMC6234033</pub-id><pub-id pub-id-type="pmid">30281024</pub-id></mixed-citation></ref><ref id="CR1163"><label>1163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tischner</surname><given-names>D</given-names></name><name name-style="western"><surname>Gaggl</surname><given-names>I</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>I</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Tuzlak</surname><given-names>S</given-names></name><name name-style="western"><surname>Drach</surname><given-names>M</given-names></name><etal/></person-group><article-title>Defective cell death signalling along the Bcl-2 regulated apoptosis pathway compromises Treg cell development and limits their functionality in mice</article-title><source>J Autoimmun</source><year>2012</year><volume>38</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2011.12.008</pub-id><pub-id pub-id-type="pmid">22257939</pub-id><pub-id pub-id-type="pmcid">PMC3314992</pub-id></element-citation></ref><ref id="CR1164"><label>1164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Myers</surname><given-names>M</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>FH</given-names></name><name name-style="western"><surname>Liew</surname><given-names>SH</given-names></name><name name-style="western"><surname>Zerafa</surname><given-names>N</given-names></name><name name-style="western"><surname>Gamage</surname><given-names>TU</given-names></name><name name-style="western"><surname>Sarraj</surname><given-names>M</given-names></name><etal/></person-group><article-title>PUMA regulates germ cell loss and primordial follicle endowment in mice</article-title><source>Reproduction</source><year>2014</year><volume>148</volume><fpage>211</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1530/REP-13-0666</pub-id><pub-id pub-id-type="pmid">24859845</pub-id></element-citation></ref><ref id="CR1165"><label>1165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erlacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Michalak</surname><given-names>EM</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Niederegger</surname><given-names>H</given-names></name><name name-style="western"><surname>Coultas</surname><given-names>L</given-names></name><etal/></person-group><article-title>BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo</article-title><source>Blood</source><year>2005</year><volume>106</volume><fpage>4131</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-04-1595</pub-id><pub-id pub-id-type="pmid">16118324</pub-id><pub-id pub-id-type="pmcid">PMC1895232</pub-id></element-citation></ref><ref id="CR1166"><label>1166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>HR</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yeo</surname><given-names>NCF</given-names></name><name name-style="western"><surname>Scott</surname><given-names>HE</given-names></name><name name-style="western"><surname>Dang</surname><given-names>N</given-names></name><etal/></person-group><article-title>Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis</article-title><source>Cell Death Dis</source><year>2021</year><volume>12</volume><fpage>659</fpage><pub-id pub-id-type="doi">10.1038/s41419-021-03902-6</pub-id><pub-id pub-id-type="pmid">34193827</pub-id><pub-id pub-id-type="pmcid">PMC8245518</pub-id></element-citation></ref><ref id="CR1167"><label>1167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerr</surname><given-names>JB</given-names></name><name name-style="western"><surname>Hutt</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Michalak</surname><given-names>EM</given-names></name><name name-style="western"><surname>Cook</surname><given-names>M</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Liew</surname><given-names>SH</given-names></name><etal/></person-group><article-title>DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa</article-title><source>Mol Cell</source><year>2012</year><volume>48</volume><fpage>343</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.08.017</pub-id><pub-id pub-id-type="pmid">23000175</pub-id><pub-id pub-id-type="pmcid">PMC3496022</pub-id></element-citation></ref><ref id="CR1168"><label>1168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naik</surname><given-names>E</given-names></name><name name-style="western"><surname>Michalak</surname><given-names>EM</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa</article-title><source>J Cell Biol</source><year>2007</year><volume>176</volume><fpage>415</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1083/jcb.200608070</pub-id><pub-id pub-id-type="pmid">17283183</pub-id><pub-id pub-id-type="pmcid">PMC2063977</pub-id></element-citation></ref><ref id="CR1169"><label>1169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wensveen</surname><given-names>FM</given-names></name><name name-style="western"><surname>Geest</surname><given-names>CR</given-names></name><name name-style="western"><surname>Libregts</surname><given-names>S</given-names></name><name name-style="western"><surname>Derks</surname><given-names>IAM</given-names></name><name name-style="western"><surname>Ekert</surname><given-names>PG</given-names></name><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><etal/></person-group><article-title>BH3-only protein Noxa contributes to apoptotic control of stress-erythropoiesis</article-title><source>Apoptosis</source><year>2013</year><volume>18</volume><fpage>1306</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/s10495-013-0890-y</pub-id><pub-id pub-id-type="pmid">23975731</pub-id><pub-id pub-id-type="pmcid">PMC3825139</pub-id></element-citation></ref><ref id="CR1170"><label>1170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clybouw</surname><given-names>C</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>S</given-names></name><name name-style="western"><surname>Auffredou</surname><given-names>MT</given-names></name><name name-style="western"><surname>Hugues</surname><given-names>P</given-names></name><name name-style="western"><surname>Alexia</surname><given-names>C</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><etal/></person-group><article-title>Regulation of memory B-cell survival by the BH3-only protein Puma</article-title><source>Blood</source><year>2011</year><volume>118</volume><fpage>4120</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-04-347096</pub-id><pub-id pub-id-type="pmid">21868573</pub-id><pub-id pub-id-type="pmcid">PMC3204730</pub-id></element-citation></ref><ref id="CR1171"><label>1171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wensveen</surname><given-names>FM</given-names></name><name name-style="western"><surname>Derks</surname><given-names>IA</given-names></name><name name-style="western"><surname>van Gisbergen</surname><given-names>KP</given-names></name><name name-style="western"><surname>de Bruin</surname><given-names>AM</given-names></name><name name-style="western"><surname>Meijers</surname><given-names>JC</given-names></name><name name-style="western"><surname>Yigittop</surname><given-names>H</given-names></name><etal/></person-group><article-title>BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>1440</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-09-378877</pub-id><pub-id pub-id-type="pmid">22144184</pub-id></element-citation></ref><ref id="CR1172"><label>1172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michalak</surname><given-names>EM</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute</article-title><source>Cell Death Differ</source><year>2008</year><volume>15</volume><fpage>1019</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/cdd.2008.16</pub-id><pub-id pub-id-type="pmid">18259198</pub-id><pub-id pub-id-type="pmcid">PMC2974267</pub-id></element-citation></ref><ref id="CR1173"><label>1173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erlacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Manzl</surname><given-names>C</given-names></name><name name-style="western"><surname>B&#246;ck</surname><given-names>G</given-names></name><name name-style="western"><surname>Tzankov</surname><given-names>A</given-names></name><name name-style="western"><surname>H&#228;cker</surname><given-names>G</given-names></name><etal/></person-group><article-title>Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><fpage>2939</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1084/jem.20061552</pub-id><pub-id pub-id-type="pmid">17178918</pub-id><pub-id pub-id-type="pmcid">PMC2118188</pub-id></element-citation></ref><ref id="CR1174"><label>1174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>DH</given-names></name><name name-style="western"><surname>Kupresanin</surname><given-names>F</given-names></name><name name-style="western"><surname>Berzins</surname><given-names>SP</given-names></name><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><etal/></person-group><article-title>The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens</article-title><source>Immunity</source><year>2012</year><volume>37</volume><fpage>451</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.05.030</pub-id><pub-id pub-id-type="pmid">22960223</pub-id><pub-id pub-id-type="pmcid">PMC3500635</pub-id></element-citation></ref><ref id="CR1175"><label>1175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Happo</surname><given-names>L</given-names></name><name name-style="western"><surname>Cragg</surname><given-names>MS</given-names></name><name name-style="western"><surname>Phipson</surname><given-names>B</given-names></name><name name-style="western"><surname>Haga</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>ES</given-names></name><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>5256</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-04-280818</pub-id><pub-id pub-id-type="pmid">20829369</pub-id><pub-id pub-id-type="pmcid">PMC3012543</pub-id></element-citation></ref><ref id="CR1176"><label>1176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>D</given-names></name><name name-style="western"><surname>Tu</surname><given-names>HC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>GX</given-names></name><name name-style="western"><surname>Bean</surname><given-names>GR</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>O</given-names></name><etal/></person-group><article-title>BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program</article-title><source>Science</source><year>2010</year><volume>330</volume><fpage>1390</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1126/science.1190217</pub-id><pub-id pub-id-type="pmid">21127253</pub-id><pub-id pub-id-type="pmcid">PMC3163443</pub-id></element-citation></ref><ref id="CR1177"><label>1177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ranger</surname><given-names>AM</given-names></name><name name-style="western"><surname>Zha</surname><given-names>J</given-names></name><name name-style="western"><surname>Harada</surname><given-names>H</given-names></name><name name-style="western"><surname>Datta</surname><given-names>SR</given-names></name><name name-style="western"><surname>Danial</surname><given-names>NN</given-names></name><name name-style="western"><surname>Gilmore</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Bad-deficient mice develop diffuse large B cell lymphoma</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>9324</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.1533446100</pub-id><pub-id pub-id-type="pmid">12876200</pub-id><pub-id pub-id-type="pmcid">PMC170917</pub-id></element-citation></ref><ref id="CR1178"><label>1178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Erlacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Kiessling</surname><given-names>S</given-names></name><name name-style="western"><surname>Manzl</surname><given-names>C</given-names></name><name name-style="western"><surname>Frenzel</surname><given-names>A</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>L</given-names></name><etal/></person-group><article-title>Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development</article-title><source>J Exp Med</source><year>2008</year><volume>205</volume><fpage>641</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1084/jem.20071658</pub-id><pub-id pub-id-type="pmid">18299399</pub-id><pub-id pub-id-type="pmcid">PMC2275386</pub-id></element-citation></ref><ref id="CR1179"><label>1179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coultas</surname><given-names>L</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Stanley</surname><given-names>EG</given-names></name><name name-style="western"><surname>Brodnicki</surname><given-names>TC</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>1570</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.4.1570-1581.2004</pub-id><pub-id pub-id-type="pmid">14749373</pub-id><pub-id pub-id-type="pmcid">PMC344198</pub-id></element-citation></ref><ref id="CR1180"><label>1180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>PN</given-names></name><name name-style="western"><surname>White</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Goschnick</surname><given-names>MW</given-names></name><name name-style="western"><surname>Fairfax</surname><given-names>KA</given-names></name><name name-style="western"><surname>Tarlinton</surname><given-names>DM</given-names></name><name name-style="western"><surname>Kinkel</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>1655</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/cdd.2010.43</pub-id><pub-id pub-id-type="pmid">20431598</pub-id><pub-id pub-id-type="pmcid">PMC2953537</pub-id></element-citation></ref><ref id="CR1181"><label>1181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>H&#252;bner</surname><given-names>A</given-names></name><name name-style="western"><surname>Cavanagh-Kyros</surname><given-names>J</given-names></name><name name-style="western"><surname>Rincon</surname><given-names>M</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>RJ</given-names></name></person-group><article-title>Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo</article-title><source>Mol Cell Biol</source><year>2010</year><volume>30</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1128/MCB.01155-09</pub-id><pub-id pub-id-type="pmid">19841067</pub-id><pub-id pub-id-type="pmcid">PMC2798311</pub-id></element-citation></ref><ref id="CR1182"><label>1182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaithiyanathan</surname><given-names>K</given-names></name><name name-style="western"><surname>Liew</surname><given-names>SH</given-names></name><name name-style="western"><surname>Zerafa</surname><given-names>N</given-names></name><name name-style="western"><surname>Gamage</surname><given-names>T</given-names></name><name name-style="western"><surname>Cook</surname><given-names>M</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><etal/></person-group><article-title>BCL2-modifying factor promotes germ cell loss during murine oogenesis</article-title><source>Reproduction</source><year>2016</year><volume>151</volume><fpage>553</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1530/REP-15-0561</pub-id><pub-id pub-id-type="pmid">26917450</pub-id></element-citation></ref><ref id="CR1183"><label>1183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>SH</given-names></name><name name-style="western"><surname>Vaithiyanathan</surname><given-names>K</given-names></name><name name-style="western"><surname>Cook</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Loss of the proapoptotic BH3-only protein BCL-2 modifying factor prolongs the fertile life span in female mice</article-title><source>Biol Reprod</source><year>2014</year><volume>90</volume><fpage>77</fpage><pub-id pub-id-type="doi">10.1095/biolreprod.113.116947</pub-id><pub-id pub-id-type="pmid">24571986</pub-id></element-citation></ref><ref id="CR1184"><label>1184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baumgartner</surname><given-names>F</given-names></name><name name-style="western"><surname>Woess</surname><given-names>C</given-names></name><name name-style="western"><surname>Pedit</surname><given-names>V</given-names></name><name name-style="western"><surname>Tzankov</surname><given-names>A</given-names></name><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name></person-group><article-title>Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf</article-title><source>Oncogene</source><year>2013</year><volume>32</volume><fpage>621</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/onc.2012.78</pub-id><pub-id pub-id-type="pmid">22430207</pub-id><pub-id pub-id-type="pmcid">PMC3428852</pub-id></element-citation></ref><ref id="CR1185"><label>1185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coultas</surname><given-names>L</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Loveland</surname><given-names>KL</given-names></name><name name-style="western"><surname>Meachem</surname><given-names>S</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>H</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis</article-title><source>EMBO J</source><year>2005</year><volume>24</volume><fpage>3963</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600857</pub-id><pub-id pub-id-type="pmid">16270031</pub-id><pub-id pub-id-type="pmcid">PMC1283956</pub-id></element-citation></ref><ref id="CR1186"><label>1186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Woess</surname><given-names>C</given-names></name><name name-style="western"><surname>Tuzlak</surname><given-names>S</given-names></name><name name-style="western"><surname>Erlacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><etal/></person-group><article-title>Deregulated cell death and lymphocyte homeostasis cause premature lethality in mice lacking the BH3-only proteins Bim and Bmf</article-title><source>Blood</source><year>2014</year><volume>123</volume><fpage>2652</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-11-537217</pub-id><pub-id pub-id-type="pmid">24632712</pub-id><pub-id pub-id-type="pmcid">PMC3999752</pub-id></element-citation></ref><ref id="CR1187"><label>1187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woess</surname><given-names>C</given-names></name><name name-style="western"><surname>Tuzlak</surname><given-names>S</given-names></name><name name-style="western"><surname>Labi</surname><given-names>V</given-names></name><name name-style="western"><surname>Drach</surname><given-names>M</given-names></name><name name-style="western"><surname>Bertele</surname><given-names>D</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>P</given-names></name><etal/></person-group><article-title>Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice</article-title><source>Cell Death Differ</source><year>2015</year><volume>22</volume><fpage>1477</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.8</pub-id><pub-id pub-id-type="pmid">25698446</pub-id><pub-id pub-id-type="pmcid">PMC4532784</pub-id></element-citation></ref><ref id="CR1188"><label>1188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rinkenberger</surname><given-names>JL</given-names></name><name name-style="western"><surname>Horning</surname><given-names>S</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>B</given-names></name><name name-style="western"><surname>Roth</surname><given-names>K</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Mcl-1 deficiency results in peri-implantation embryonic lethality</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>23</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1101/gad.14.1.23</pub-id><pub-id pub-id-type="pmid">10640272</pub-id><pub-id pub-id-type="pmcid">PMC316347</pub-id></element-citation></ref><ref id="CR1189"><label>1189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Haydar</surname><given-names>TF</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>CY</given-names></name><name name-style="western"><surname>Gu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Taya</surname><given-names>C</given-names></name><name name-style="western"><surname>Karasuyama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>325</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81476-2</pub-id><pub-id pub-id-type="pmid">9708735</pub-id></element-citation></ref><ref id="CR1190"><label>1190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Motoyama</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name><name name-style="western"><surname>Sawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice</article-title><source>Science</source><year>1995</year><volume>267</volume><fpage>1506</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1126/science.7878471</pub-id><pub-id pub-id-type="pmid">7878471</pub-id></element-citation></ref><ref id="CR1191"><label>1191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaidi</surname><given-names>AU</given-names></name><name name-style="western"><surname>D&#8217;Sa-Eipper</surname><given-names>C</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>J</given-names></name><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>TS</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Bcl-X(L)-caspase-9 interactions in the developing nervous system: evidence for multiple death pathways</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>169</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-01-00169.2001</pub-id><pub-id pub-id-type="pmid">11150333</pub-id><pub-id pub-id-type="pmcid">PMC6762421</pub-id></element-citation></ref><ref id="CR1192"><label>1192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shindler</surname><given-names>KS</given-names></name><name name-style="western"><surname>Latham</surname><given-names>CB</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name></person-group><article-title>Bax deficiency prevents the increased cell death of immature neurons in bcl-x-deficient mice</article-title><source>J Neurosci</source><year>1997</year><volume>17</volume><fpage>3112</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-09-03112.1997</pub-id><pub-id pub-id-type="pmid">9096145</pub-id><pub-id pub-id-type="pmcid">PMC6573662</pub-id></element-citation></ref><ref id="CR1193"><label>1193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akhtar</surname><given-names>RS</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name></person-group><article-title>Loss of BH3-only protein Bim inhibits apoptosis of hemopoietic cells in the fetal liver and male germ cells but not neuronal cells in bcl-x-deficient mice</article-title><source>J Histochem Cytochem</source><year>2008</year><volume>56</volume><fpage>921</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1369/jhc.2008.951749</pub-id><pub-id pub-id-type="pmid">18606610</pub-id><pub-id pub-id-type="pmcid">PMC2544614</pub-id></element-citation></ref><ref id="CR1194"><label>1194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>LC</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name></person-group><article-title>Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim</article-title><source>Dev Cell</source><year>2001</year><volume>1</volume><fpage>645</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/S1534-5807(01)00083-1</pub-id><pub-id pub-id-type="pmid">11709185</pub-id></element-citation></ref><ref id="CR1195"><label>1195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veis</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Sorenson</surname><given-names>CM</given-names></name><name name-style="western"><surname>Shutter</surname><given-names>JR</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair</article-title><source>Cell</source><year>1993</year><volume>75</volume><fpage>229</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)80065-M</pub-id><pub-id pub-id-type="pmid">8402909</pub-id></element-citation></ref><ref id="CR1196"><label>1196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Negishi</surname><given-names>I</given-names></name><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Shinkai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Louie</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice</article-title><source>Science</source><year>1993</year><volume>261</volume><fpage>1584</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1126/science.8372353</pub-id><pub-id pub-id-type="pmid">8372353</pub-id></element-citation></ref><ref id="CR1197"><label>1197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamada</surname><given-names>S</given-names></name><name name-style="western"><surname>Shimono</surname><given-names>A</given-names></name><name name-style="western"><surname>Shinto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tsujimura</surname><given-names>T</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Noda</surname><given-names>T</given-names></name><etal/></person-group><article-title>bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine</article-title><source>Cancer Res</source><year>1995</year><volume>55</volume><fpage>354</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7812968</pub-id></element-citation></ref><ref id="CR1198"><label>1198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michaelidis</surname><given-names>TM</given-names></name><name name-style="western"><surname>Sendtner</surname><given-names>M</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>JD</given-names></name><name name-style="western"><surname>Airaksinen</surname><given-names>MS</given-names></name><name name-style="western"><surname>Holtmann</surname><given-names>B</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development</article-title><source>Neuron</source><year>1996</year><volume>17</volume><fpage>75</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80282-2</pub-id><pub-id pub-id-type="pmid">8755480</pub-id></element-citation></ref><ref id="CR1199"><label>1199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manzl</surname><given-names>C</given-names></name><name name-style="western"><surname>Baumgartner</surname><given-names>F</given-names></name><name name-style="western"><surname>Peintner</surname><given-names>L</given-names></name><name name-style="western"><surname>Schuler</surname><given-names>F</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name></person-group><article-title>Possible pitfalls investigating cell death responses in genetically engineered mouse models and derived cell lines</article-title><source>Methods</source><year>2013</year><volume>61</volume><fpage>130</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.02.012</pub-id><pub-id pub-id-type="pmid">23454286</pub-id><pub-id pub-id-type="pmcid">PMC3693039</pub-id></element-citation></ref><ref id="CR1200"><label>1200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carpinelli</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wise</surname><given-names>AK</given-names></name><name name-style="western"><surname>Arhatari</surname><given-names>BD</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><name name-style="western"><surname>Manji</surname><given-names>SS</given-names></name><name name-style="western"><surname>Manning</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Anti-apoptotic gene Bcl2 is required for stapes development and hearing</article-title><source>Cell Death Dis</source><year>2012</year><volume>3</volume><fpage>e362</fpage><pub-id pub-id-type="doi">10.1038/cddis.2012.100</pub-id><pub-id pub-id-type="pmid">22874999</pub-id><pub-id pub-id-type="pmcid">PMC3434664</pub-id></element-citation></ref><ref id="CR1201"><label>1201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamasaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Sendo</surname><given-names>F</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Ishida</surname><given-names>N</given-names></name><name name-style="western"><surname>Negishi</surname><given-names>I</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>1985</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1084/jem.188.11.1985</pub-id><pub-id pub-id-type="pmid">9841913</pub-id><pub-id pub-id-type="pmcid">PMC2212378</pub-id></element-citation></ref><ref id="CR1202"><label>1202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>AA</given-names></name><name name-style="western"><surname>M&#246;ller</surname><given-names>C</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Hatakeyama</surname><given-names>S</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>G</given-names></name></person-group><article-title>Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation</article-title><source>J Exp Med</source><year>2001</year><volume>194</volume><fpage>1561</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1084/jem.194.11.1561</pub-id><pub-id pub-id-type="pmid">11733571</pub-id><pub-id pub-id-type="pmcid">PMC2193528</pub-id></element-citation></ref><ref id="CR1203"><label>1203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schenk</surname><given-names>RL</given-names></name><name name-style="western"><surname>Tuzlak</surname><given-names>S</given-names></name><name name-style="western"><surname>Carrington</surname><given-names>EM</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Heinzel</surname><given-names>S</given-names></name><name name-style="western"><surname>Teh</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>534</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.156</pub-id><pub-id pub-id-type="pmid">28085150</pub-id><pub-id pub-id-type="pmcid">PMC5344213</pub-id></element-citation></ref><ref id="CR1204"><label>1204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuzlak</surname><given-names>S</given-names></name><name name-style="western"><surname>Schenk</surname><given-names>RL</given-names></name><name name-style="western"><surname>Vasanthakumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Preston</surname><given-names>SP</given-names></name><name name-style="western"><surname>Haschka</surname><given-names>MD</given-names></name><name name-style="western"><surname>Zotos</surname><given-names>D</given-names></name><etal/></person-group><article-title>The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>523</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.155</pub-id><pub-id pub-id-type="pmid">28085151</pub-id><pub-id pub-id-type="pmcid">PMC5344212</pub-id></element-citation></ref><ref id="CR1205"><label>1205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Print</surname><given-names>CG</given-names></name><name name-style="western"><surname>Loveland</surname><given-names>KL</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>L</given-names></name><name name-style="western"><surname>Meehan</surname><given-names>T</given-names></name><name name-style="western"><surname>Stylianou</surname><given-names>A</given-names></name><name name-style="western"><surname>Wreford</surname><given-names>N</given-names></name><etal/></person-group><article-title>Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>12424</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.21.12424</pub-id><pub-id pub-id-type="pmid">9770502</pub-id><pub-id pub-id-type="pmcid">PMC22847</pub-id></element-citation></ref><ref id="CR1206"><label>1206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Waymire</surname><given-names>KG</given-names></name><name name-style="western"><surname>Moss</surname><given-names>JE</given-names></name><name name-style="western"><surname>Parlow</surname><given-names>AF</given-names></name><name name-style="western"><surname>Skinner</surname><given-names>MK</given-names></name><name name-style="western"><surname>Russell</surname><given-names>LD</given-names></name><etal/></person-group><article-title>Testicular degeneration in Bclw-deficient mice</article-title><source>Nat Genet</source><year>1998</year><volume>18</volume><fpage>251</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/ng0398-251</pub-id><pub-id pub-id-type="pmid">9500547</pub-id></element-citation></ref><ref id="CR1207"><label>1207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>LD</given-names></name><name name-style="western"><surname>Warren</surname><given-names>J</given-names></name><name name-style="western"><surname>Debeljuk</surname><given-names>L</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>LL</given-names></name><name name-style="western"><surname>Mahar</surname><given-names>PL</given-names></name><name name-style="western"><surname>Waymire</surname><given-names>KG</given-names></name><etal/></person-group><article-title>Spermatogenesis in Bclw-deficient mice</article-title><source>Biol Reprod</source><year>2001</year><volume>65</volume><fpage>318</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1095/biolreprod65.1.318</pub-id><pub-id pub-id-type="pmid">11420255</pub-id><pub-id pub-id-type="pmcid">PMC3049812</pub-id></element-citation></ref><ref id="CR1208"><label>1208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinkmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Hyland</surname><given-names>CD</given-names></name><name name-style="western"><surname>Teh</surname><given-names>CE</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>WS</given-names></name><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>2032</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.125</pub-id><pub-id pub-id-type="pmid">28800129</pub-id><pub-id pub-id-type="pmcid">PMC5686343</pub-id></element-citation></ref><ref id="CR1209"><label>1209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delbridge</surname><given-names>AR</given-names></name><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Antagonism between MCL-1 and PUMA governs stem/progenitor cell survival during hematopoietic recovery from stress</article-title><source>Blood</source><year>2015</year><volume>125</volume><fpage>3273</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1182/blood-2015-01-621250</pub-id><pub-id pub-id-type="pmid">25847014</pub-id><pub-id pub-id-type="pmcid">PMC4440882</pub-id></element-citation></ref><ref id="CR1210"><label>1210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kasai</surname><given-names>S</given-names></name><name name-style="western"><surname>Chuma</surname><given-names>S</given-names></name><name name-style="western"><surname>Motoyama</surname><given-names>N</given-names></name><name name-style="western"><surname>Nakatsuji</surname><given-names>N</given-names></name></person-group><article-title>Haploinsufficiency of Bcl-x leads to male-specific defects in fetal germ cells: differential regulation of germ cell apoptosis between the sexes</article-title><source>Dev Biol</source><year>2003</year><volume>264</volume><fpage>202</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/S0012-1606(03)00400-7</pub-id><pub-id pub-id-type="pmid">14623242</pub-id></element-citation></ref><ref id="CR1211"><label>1211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mason</surname><given-names>KD</given-names></name><name name-style="western"><surname>Carpinelli</surname><given-names>MR</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>JI</given-names></name><name name-style="western"><surname>Collinge</surname><given-names>JE</given-names></name><name name-style="western"><surname>Hilton</surname><given-names>AA</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>S</given-names></name><etal/></person-group><article-title>Programmed anuclear cell death delimits platelet life span</article-title><source>Cell</source><year>2007</year><volume>128</volume><fpage>1173</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.01.037</pub-id><pub-id pub-id-type="pmid">17382885</pub-id></element-citation></ref><ref id="CR1212"><label>1212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schenk</surname><given-names>RL</given-names></name><name name-style="western"><surname>Gangoda</surname><given-names>L</given-names></name><name name-style="western"><surname>Lawlor</surname><given-names>KE</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></name></person-group><article-title>The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophils</article-title><source>Cell Death Dis</source><year>2020</year><volume>11</volume><fpage>474</fpage><pub-id pub-id-type="doi">10.1038/s41419-020-2676-9</pub-id><pub-id pub-id-type="pmid">32555150</pub-id><pub-id pub-id-type="pmcid">PMC7303176</pub-id></element-citation></ref><ref id="CR1213"><label>1213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Kueh</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ke</surname><given-names>F</given-names></name><name name-style="western"><surname>Vanyai</surname><given-names>HK</given-names></name><name name-style="western"><surname>Sheikh</surname><given-names>BN</given-names></name><name name-style="western"><surname>Dengler</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Subtle Changes in the Levels of BCL-2 proteins cause severe craniofacial abnormalities</article-title><source>Cell Rep</source><year>2018</year><volume>24</volume><fpage>3285</fpage><lpage>3295.e3284</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.048</pub-id><pub-id pub-id-type="pmid">30232009</pub-id></element-citation></ref><ref id="CR1214"><label>1214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ke</surname><given-names>F</given-names></name><name name-style="western"><surname>Lancaster</surname><given-names>GI</given-names></name><name name-style="western"><surname>Grabow</surname><given-names>S</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Combined reduction in the expression of MCL-1 and BCL-2 reduces organismal size in mice</article-title><source>Cell Death Dis</source><year>2020</year><volume>11</volume><fpage>185</fpage><pub-id pub-id-type="doi">10.1038/s41419-020-2376-5</pub-id><pub-id pub-id-type="pmid">32170090</pub-id><pub-id pub-id-type="pmcid">PMC7070015</pub-id></element-citation></ref><ref id="CR1215"><label>1215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Ong</surname><given-names>CC</given-names></name><name name-style="western"><surname>Suh</surname><given-names>H</given-names></name><name name-style="western"><surname>Mizuno</surname><given-names>S</given-names></name><name name-style="western"><surname>Akashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells</article-title><source>Science</source><year>2005</year><volume>307</volume><fpage>1101</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1126/science.1106114</pub-id><pub-id pub-id-type="pmid">15718471</pub-id></element-citation></ref><ref id="CR1216"><label>1216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name><name name-style="western"><surname>Letai</surname><given-names>A</given-names></name><name name-style="western"><surname>Beard</surname><given-names>C</given-names></name><name name-style="western"><surname>Sorcinelli</surname><given-names>MD</given-names></name><name name-style="western"><surname>Ong</surname><given-names>CC</given-names></name><name name-style="western"><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1</article-title><source>Nature</source><year>2003</year><volume>426</volume><fpage>671</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nature02067</pub-id><pub-id pub-id-type="pmid">14668867</pub-id></element-citation></ref><ref id="CR1217"><label>1217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pierson</surname><given-names>W</given-names></name><name name-style="western"><surname>Cauwe</surname><given-names>B</given-names></name><name name-style="western"><surname>Policheni</surname><given-names>A</given-names></name><name name-style="western"><surname>Schlenner</surname><given-names>SM</given-names></name><name name-style="western"><surname>Franckaert</surname><given-names>D</given-names></name><name name-style="western"><surname>Berges</surname><given-names>J</given-names></name><etal/></person-group><article-title>Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3<sup>+</sup> regulatory T cells</article-title><source>Nat Immunol</source><year>2013</year><volume>14</volume><fpage>959</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/ni.2649</pub-id><pub-id pub-id-type="pmid">23852275</pub-id><pub-id pub-id-type="pmcid">PMC4128388</pub-id></element-citation></ref><ref id="CR1218"><label>1218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vikstrom</surname><given-names>I</given-names></name><name name-style="western"><surname>Carotta</surname><given-names>S</given-names></name><name name-style="western"><surname>L&#252;thje</surname><given-names>K</given-names></name><name name-style="western"><surname>Peperzak</surname><given-names>V</given-names></name><name name-style="western"><surname>Jost</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mcl-1 is essential for germinal center formation and B cell memory</article-title><source>Science</source><year>2010</year><volume>330</volume><fpage>1095</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1126/science.1191793</pub-id><pub-id pub-id-type="pmid">20929728</pub-id><pub-id pub-id-type="pmcid">PMC2991396</pub-id></element-citation></ref><ref id="CR1219"><label>1219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tripathi</surname><given-names>P</given-names></name><name name-style="western"><surname>Koss</surname><given-names>B</given-names></name><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name><name name-style="western"><surname>Hildeman</surname><given-names>DA</given-names></name></person-group><article-title>Mcl-1 antagonizes Bax/Bak to promote effector CD4(+) and CD8(+) T-cell responses</article-title><source>Cell Death Differ</source><year>2013</year><volume>20</volume><fpage>998</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1038/cdd.2013.25</pub-id><pub-id pub-id-type="pmid">23558951</pub-id><pub-id pub-id-type="pmcid">PMC3705594</pub-id></element-citation></ref><ref id="CR1220"><label>1220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunkle</surname><given-names>A</given-names></name><name name-style="western"><surname>Dzhagalov</surname><given-names>I</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name></person-group><article-title>Mcl-1 promotes survival of thymocytes by inhibition of Bak in a pathway separate from Bcl-2</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>994</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.201</pub-id><pub-id pub-id-type="pmid">20057504</pub-id><pub-id pub-id-type="pmcid">PMC2866813</pub-id></element-citation></ref><ref id="CR1221"><label>1221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathe</surname><given-names>P</given-names></name><name name-style="western"><surname>Delconte</surname><given-names>RB</given-names></name><name name-style="western"><surname>Souza-Fonseca-Guimaraes</surname><given-names>F</given-names></name><name name-style="western"><surname>Seillet</surname><given-names>C</given-names></name><name name-style="western"><surname>Chopin</surname><given-names>M</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><fpage>4539</fpage><pub-id pub-id-type="doi">10.1038/ncomms5539</pub-id><pub-id pub-id-type="pmid">25119382</pub-id></element-citation></ref><ref id="CR1222"><label>1222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dzhagalov</surname><given-names>I</given-names></name><name name-style="western"><surname>St John</surname><given-names>A</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name></person-group><article-title>The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages</article-title><source>Blood</source><year>2007</year><volume>109</volume><fpage>1620</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-03-013771</pub-id><pub-id pub-id-type="pmid">17062731</pub-id><pub-id pub-id-type="pmcid">PMC1794052</pub-id></element-citation></ref><ref id="CR1223"><label>1223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steimer</surname><given-names>DA</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>K</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>O</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>JK</given-names></name><name name-style="western"><surname>Zambetti</surname><given-names>GP</given-names></name><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name></person-group><article-title>Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>2805</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-05-159145</pub-id><pub-id pub-id-type="pmid">19064728</pub-id><pub-id pub-id-type="pmcid">PMC2661864</pub-id></element-citation></ref><ref id="CR1224"><label>1224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lilla</surname><given-names>JN</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CC</given-names></name><name name-style="western"><surname>Mukai</surname><given-names>K</given-names></name><name name-style="western"><surname>BenBarak</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Franco</surname><given-names>CB</given-names></name><name name-style="western"><surname>Kalesnikoff</surname><given-names>J</given-names></name><etal/></person-group><article-title>Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice</article-title><source>Blood</source><year>2011</year><volume>118</volume><fpage>6930</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-03-343962</pub-id><pub-id pub-id-type="pmid">22001390</pub-id><pub-id pub-id-type="pmcid">PMC3245213</pub-id></element-citation></ref><ref id="CR1225"><label>1225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slomp</surname><given-names>A</given-names></name><name name-style="western"><surname>Peperzak</surname><given-names>V</given-names></name></person-group><article-title>Role and regulation of pro-survival BCL-2 Proteins in Multiple Myeloma</article-title><source>Front Oncol</source><year>2018</year><volume>8</volume><fpage>533</fpage><pub-id pub-id-type="doi">10.3389/fonc.2018.00533</pub-id><pub-id pub-id-type="pmid">30524962</pub-id><pub-id pub-id-type="pmcid">PMC6256118</pub-id></element-citation></ref><ref id="CR1226"><label>1226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peperzak</surname><given-names>V</given-names></name><name name-style="western"><surname>Vikstr&#246;m</surname><given-names>I</given-names></name><name name-style="western"><surname>Walker</surname><given-names>J</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>SP</given-names></name><name name-style="western"><surname>LePage</surname><given-names>M</given-names></name><name name-style="western"><surname>Coquery</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Mcl-1 is essential for the survival of plasma cells</article-title><source>Nat Immunol</source><year>2013</year><volume>14</volume><fpage>290</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/ni.2527</pub-id><pub-id pub-id-type="pmid">23377201</pub-id><pub-id pub-id-type="pmcid">PMC4041127</pub-id></element-citation></ref><ref id="CR1227"><label>1227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrington</surname><given-names>EM</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Brady</surname><given-names>JL</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>JG</given-names></name><name name-style="western"><surname>Sutherland</surname><given-names>RM</given-names></name><name name-style="western"><surname>Anstee</surname><given-names>NS</given-names></name><etal/></person-group><article-title>Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>878</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.30</pub-id><pub-id pub-id-type="pmid">28362427</pub-id><pub-id pub-id-type="pmcid">PMC5423112</pub-id></element-citation></ref><ref id="CR1228"><label>1228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dzhagalov</surname><given-names>I</given-names></name><name name-style="western"><surname>Dunkle</surname><given-names>A</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name></person-group><article-title>The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>521</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.1.521</pub-id><pub-id pub-id-type="pmid">18566418</pub-id><pub-id pub-id-type="pmcid">PMC2561902</pub-id></element-citation></ref><ref id="CR1229"><label>1229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malin</surname><given-names>S</given-names></name><name name-style="western"><surname>McManus</surname><given-names>S</given-names></name><name name-style="western"><surname>Cobaleda</surname><given-names>C</given-names></name><name name-style="western"><surname>Novatchkova</surname><given-names>M</given-names></name><name name-style="western"><surname>Delogu</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name><etal/></person-group><article-title>Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development</article-title><source>Nat Immunol</source><year>2010</year><volume>11</volume><fpage>171</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/ni.1827</pub-id><pub-id pub-id-type="pmid">19946273</pub-id><pub-id pub-id-type="pmcid">PMC2956121</pub-id></element-citation></ref><ref id="CR1230"><label>1230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debrincat</surname><given-names>MA</given-names></name><name name-style="western"><surname>Josefsson</surname><given-names>EC</given-names></name><name name-style="western"><surname>James</surname><given-names>C</given-names></name><name name-style="western"><surname>Henley</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>S</given-names></name><name name-style="western"><surname>Lebois</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>5850</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-12-398834</pub-id><pub-id pub-id-type="pmid">22374700</pub-id></element-citation></ref><ref id="CR1231"><label>1231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Josefsson</surname><given-names>EC</given-names></name><name name-style="western"><surname>James</surname><given-names>C</given-names></name><name name-style="western"><surname>Henley</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Debrincat</surname><given-names>MA</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>KL</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets</article-title><source>J Exp Med</source><year>2011</year><volume>208</volume><fpage>2017</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1084/jem.20110750</pub-id><pub-id pub-id-type="pmid">21911424</pub-id><pub-id pub-id-type="pmcid">PMC3182050</pub-id></element-citation></ref><ref id="CR1232"><label>1232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wagner</surname><given-names>KU</given-names></name><name name-style="western"><surname>Claudio</surname><given-names>E</given-names></name><name name-style="western"><surname>Rucker</surname><given-names>EB</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Riedlinger</surname><given-names>G</given-names></name><name name-style="western"><surname>Broussard</surname><given-names>C</given-names></name><name name-style="western"><surname>Schwartzberg</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>4949</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1242/dev.127.22.4949</pub-id><pub-id pub-id-type="pmid">11044408</pub-id></element-citation></ref><ref id="CR1233"><label>1233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vikstr&#246;m</surname><given-names>IB</given-names></name><name name-style="western"><surname>Slomp</surname><given-names>A</given-names></name><name name-style="western"><surname>Carrington</surname><given-names>EM</given-names></name><name name-style="western"><surname>Moesbergen</surname><given-names>LM</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>GL</given-names></name><etal/></person-group><article-title>MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2345</fpage><pub-id pub-id-type="doi">10.1038/cddis.2016.237</pub-id><pub-id pub-id-type="pmid">27560714</pub-id><pub-id pub-id-type="pmcid">PMC5108322</pub-id></element-citation></ref><ref id="CR1234"><label>1234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sochalska</surname><given-names>M</given-names></name><name name-style="western"><surname>Ottina</surname><given-names>E</given-names></name><name name-style="western"><surname>Tuzlak</surname><given-names>S</given-names></name><name name-style="western"><surname>Herzog</surname><given-names>S</given-names></name><name name-style="western"><surname>Herold</surname><given-names>M</given-names></name><name name-style="western"><surname>Villunger</surname><given-names>A</given-names></name></person-group><article-title>Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival</article-title><source>Cell Death Differ</source><year>2016</year><volume>23</volume><fpage>628</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.130</pub-id><pub-id pub-id-type="pmid">26450454</pub-id><pub-id pub-id-type="pmcid">PMC4986635</pub-id></element-citation></ref><ref id="CR1235"><label>1235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debrincat</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pleines</surname><given-names>I</given-names></name><name name-style="western"><surname>Lebois</surname><given-names>M</given-names></name><name name-style="western"><surname>Lane</surname><given-names>RM</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>ML</given-names></name><name name-style="western"><surname>Corbin</surname><given-names>J</given-names></name><etal/></person-group><article-title>BCL-2 is dispensable for thrombopoiesis and platelet survival</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1721</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.97</pub-id><pub-id pub-id-type="pmid">25880088</pub-id><pub-id pub-id-type="pmcid">PMC4650559</pub-id></element-citation></ref><ref id="CR1236"><label>1236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>A</given-names></name><name name-style="western"><surname>Pena</surname><given-names>JC</given-names></name><name name-style="western"><surname>Chang</surname><given-names>B</given-names></name><name name-style="western"><surname>Margosian</surname><given-names>E</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>L</given-names></name><name name-style="western"><surname>Alt</surname><given-names>FW</given-names></name><etal/></person-group><article-title>Bclx regulates the survival of double-positive thymocytes</article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>4763</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.11.4763</pub-id><pub-id pub-id-type="pmid">7761398</pub-id><pub-id pub-id-type="pmcid">PMC41787</pub-id></element-citation></ref><ref id="CR1237"><label>1237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuzaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Tomita</surname><given-names>T</given-names></name><name name-style="western"><surname>Isoda</surname><given-names>M</given-names></name><name name-style="western"><surname>Loh</surname><given-names>DY</given-names></name><etal/></person-group><article-title>Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell</article-title><source>Blood</source><year>1997</year><volume>89</volume><fpage>853</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1182/blood.V89.3.853</pub-id><pub-id pub-id-type="pmid">9028316</pub-id></element-citation></ref><ref id="CR1238"><label>1238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geueke</surname><given-names>A</given-names></name><name name-style="western"><surname>Mantellato</surname><given-names>G</given-names></name><name name-style="western"><surname>Kuester</surname><given-names>F</given-names></name><name name-style="western"><surname>Schettina</surname><given-names>P</given-names></name><name name-style="western"><surname>Nelles</surname><given-names>M</given-names></name><name name-style="western"><surname>Seeger</surname><given-names>JM</given-names></name><etal/></person-group><article-title>The anti-apoptotic Bcl-2 protein regulates hair follicle stem cell function</article-title><source>EMBO Rep</source><year>2021</year><volume>22</volume><fpage>e52301</fpage><pub-id pub-id-type="doi">10.15252/embr.202052301</pub-id><pub-id pub-id-type="pmid">34342114</pub-id><pub-id pub-id-type="pmcid">PMC8490995</pub-id></element-citation></ref><ref id="CR1239"><label>1239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>RL</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>AB</given-names></name></person-group><article-title>MCL1 is critical for mitochondrial function and autophagy in the heart</article-title><source>Autophagy</source><year>2013</year><volume>9</volume><fpage>1902</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.4161/auto.26168</pub-id><pub-id pub-id-type="pmid">24165322</pub-id><pub-id pub-id-type="pmcid">PMC4028340</pub-id></element-citation></ref><ref id="CR1240"><label>1240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Bathina</surname><given-names>M</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>J</given-names></name><name name-style="western"><surname>Koss</surname><given-names>B</given-names></name><name name-style="western"><surname>Calabrese</surname><given-names>C</given-names></name><name name-style="western"><surname>Frase</surname><given-names>S</given-names></name><etal/></person-group><article-title>Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction</article-title><source>Genes Dev</source><year>2013</year><volume>27</volume><fpage>1351</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1101/gad.215855.113</pub-id><pub-id pub-id-type="pmid">23788622</pub-id><pub-id pub-id-type="pmcid">PMC3701191</pub-id></element-citation></ref><ref id="CR1241"><label>1241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arbour</surname><given-names>N</given-names></name><name name-style="western"><surname>Vanderluit</surname><given-names>JL</given-names></name><name name-style="western"><surname>Le Grand</surname><given-names>JN</given-names></name><name name-style="western"><surname>Jahani-Asl</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruzhynsky</surname><given-names>VA</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>EC</given-names></name><etal/></person-group><article-title>Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>6068</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4940-07.2008</pub-id><pub-id pub-id-type="pmid">18550749</pub-id><pub-id pub-id-type="pmcid">PMC2681190</pub-id></element-citation></ref><ref id="CR1242"><label>1242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Germain</surname><given-names>M</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>AP</given-names></name><name name-style="western"><surname>Le Grand</surname><given-names>JN</given-names></name><name name-style="western"><surname>Arbour</surname><given-names>N</given-names></name><name name-style="western"><surname>Vanderluit</surname><given-names>JL</given-names></name><name name-style="western"><surname>Park</surname><given-names>DS</given-names></name><etal/></person-group><article-title>MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner</article-title><source>EMBO J</source><year>2011</year><volume>30</volume><fpage>395</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.327</pub-id><pub-id pub-id-type="pmid">21139567</pub-id><pub-id pub-id-type="pmcid">PMC3025469</pub-id></element-citation></ref><ref id="CR1243"><label>1243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malone</surname><given-names>CD</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>SM</given-names></name><name name-style="western"><surname>Roome</surname><given-names>RB</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>J</given-names></name><name name-style="western"><surname>Furlong</surname><given-names>M</given-names></name><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Mcl-1 regulates the survival of adult neural precursor cells</article-title><source>Mol Cell Neurosci</source><year>2012</year><volume>49</volume><fpage>439</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2012.02.003</pub-id><pub-id pub-id-type="pmid">22357134</pub-id></element-citation></ref><ref id="CR1244"><label>1244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>A</given-names></name><name name-style="western"><surname>Swahari</surname><given-names>V</given-names></name><name name-style="western"><surname>Plestant</surname><given-names>C</given-names></name><name name-style="western"><surname>Smith</surname><given-names>I</given-names></name><name name-style="western"><surname>McCoy</surname><given-names>E</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bcl-xL is essential for the survival and function of differentiated neurons in the cortex that control complex behaviors</article-title><source>J Neurosci</source><year>2016</year><volume>36</volume><fpage>5448</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4247-15.2016</pub-id><pub-id pub-id-type="pmid">27194326</pub-id><pub-id pub-id-type="pmcid">PMC4871982</pub-id></element-citation></ref><ref id="CR1245"><label>1245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savitt</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jang</surname><given-names>SS</given-names></name><name name-style="western"><surname>Mu</surname><given-names>W</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>VL</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>TM</given-names></name></person-group><article-title>Bcl-x is required for proper development of the mouse substantia nigra</article-title><source>J Neurosci</source><year>2005</year><volume>25</volume><fpage>6721</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0760-05.2005</pub-id><pub-id pub-id-type="pmid">16033881</pub-id><pub-id pub-id-type="pmcid">PMC6725345</pub-id></element-citation></ref><ref id="CR1246"><label>1246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fogarty</surname><given-names>LC</given-names></name><name name-style="western"><surname>Song</surname><given-names>B</given-names></name><name name-style="western"><surname>Suppiah</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>SMM</given-names></name><name name-style="western"><surname>Martin</surname><given-names>HC</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Bcl-xL dependency coincides with the onset of neurogenesis in the developing mammalian spinal cord</article-title><source>Mol Cell Neurosci</source><year>2016</year><volume>77</volume><fpage>34</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2016.09.001</pub-id><pub-id pub-id-type="pmid">27665712</pub-id></element-citation></ref><ref id="CR1247"><label>1247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fogarty</surname><given-names>LC</given-names></name><name name-style="western"><surname>Flemmer</surname><given-names>RT</given-names></name><name name-style="western"><surname>Geizer</surname><given-names>BA</given-names></name><name name-style="western"><surname>Licursi</surname><given-names>M</given-names></name><name name-style="western"><surname>Karunanithy</surname><given-names>A</given-names></name><name name-style="western"><surname>Opferman</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Mcl-1 and Bcl-xL are essential for survival of the developing nervous system</article-title><source>Cell Death Differ</source><year>2019</year><volume>26</volume><fpage>1501</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/s41418-018-0225-1</pub-id><pub-id pub-id-type="pmid">30361616</pub-id><pub-id pub-id-type="pmcid">PMC6748126</pub-id></element-citation></ref><ref id="CR1248"><label>1248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veleta</surname><given-names>KA</given-names></name><name name-style="western"><surname>Cleveland</surname><given-names>AH</given-names></name><name name-style="western"><surname>Babcock</surname><given-names>BR</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>D</given-names></name><name name-style="western"><surname>Sokolsky-Papkov</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antiapoptotic Bcl-2 family proteins BCL-xL and MCL-1 integrate neural progenitor survival and proliferation during postnatal cerebellar neurogenesis</article-title><source>Cell Death Differ</source><year>2021</year><volume>28</volume><fpage>1579</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-00687-7</pub-id><pub-id pub-id-type="pmid">33293647</pub-id><pub-id pub-id-type="pmcid">PMC8166857</pub-id></element-citation></ref><ref id="CR1249"><label>1249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hikita</surname><given-names>H</given-names></name><name name-style="western"><surname>Takehara</surname><given-names>T</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Kodama</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Miyagi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver</article-title><source>Hepatology</source><year>2009</year><volume>50</volume><fpage>1217</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1002/hep.23126</pub-id><pub-id pub-id-type="pmid">19676108</pub-id><pub-id pub-id-type="pmcid">PMC3560852</pub-id></element-citation></ref><ref id="CR1250"><label>1250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takehara</surname><given-names>T</given-names></name><name name-style="western"><surname>Tatsumi</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Rucker</surname><given-names>EB</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Hennighausen</surname><given-names>L</given-names></name><name name-style="western"><surname>Jinushi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses</article-title><source>Gastroenterology</source><year>2004</year><volume>127</volume><fpage>1189</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2004.07.019</pub-id><pub-id pub-id-type="pmid">15480996</pub-id></element-citation></ref><ref id="CR1251"><label>1251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vick</surname><given-names>B</given-names></name><name name-style="western"><surname>Weber</surname><given-names>A</given-names></name><name name-style="western"><surname>Urbanik</surname><given-names>T</given-names></name><name name-style="western"><surname>Maass</surname><given-names>T</given-names></name><name name-style="western"><surname>Teufel</surname><given-names>A</given-names></name><name name-style="western"><surname>Krammer</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes</article-title><source>Hepatology</source><year>2009</year><volume>49</volume><fpage>627</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1002/hep.22664</pub-id><pub-id pub-id-type="pmid">19127517</pub-id><pub-id pub-id-type="pmcid">PMC2753874</pub-id></element-citation></ref><ref id="CR1252"><label>1252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watson</surname><given-names>EC</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>L</given-names></name><name name-style="western"><surname>Adams</surname><given-names>RH</given-names></name><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name><name name-style="western"><surname>Coultas</surname><given-names>L</given-names></name></person-group><article-title>Endothelial cell survival during angiogenesis requires the pro-survival protein MCL1</article-title><source>Cell Death Differ</source><year>2016</year><volume>23</volume><fpage>1371</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.20</pub-id><pub-id pub-id-type="pmid">26943318</pub-id><pub-id pub-id-type="pmcid">PMC4947668</pub-id></element-citation></ref><ref id="CR1253"><label>1253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>R</given-names></name><name name-style="western"><surname>Sheridan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Policheni</surname><given-names>A</given-names></name><name name-style="western"><surname>Heinlein</surname><given-names>M</given-names></name><name name-style="western"><surname>Gandolfo</surname><given-names>LC</given-names></name><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name><etal/></person-group><article-title>A critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice</article-title><source>Blood</source><year>2017</year><volume>130</volume><fpage>2504</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1182/blood-2017-03-771576</pub-id><pub-id pub-id-type="pmid">28972012</pub-id><pub-id pub-id-type="pmcid">PMC6207344</pub-id></element-citation></ref><ref id="CR1254"><label>1254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Healy</surname><given-names>ME</given-names></name><name name-style="western"><surname>Boege</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hodder</surname><given-names>MC</given-names></name><name name-style="western"><surname>B&#246;hm</surname><given-names>F</given-names></name><name name-style="western"><surname>Malehmir</surname><given-names>M</given-names></name><name name-style="western"><surname>Scherr</surname><given-names>AL</given-names></name><etal/></person-group><article-title>MCL1 is required for maintenance of intestinal homeostasis and prevention of carcinogenesis in mice</article-title><source>Gastroenterology</source><year>2020</year><volume>159</volume><fpage>183</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2020.03.017</pub-id><pub-id pub-id-type="pmid">32179094</pub-id><pub-id pub-id-type="pmcid">PMC7397524</pub-id></element-citation></ref><ref id="CR1255"><label>1255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walton</surname><given-names>KD</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>KU</given-names></name><name name-style="western"><surname>Rucker</surname><given-names>EB</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Shillingford</surname><given-names>JM</given-names></name><name name-style="western"><surname>Miyoshi</surname><given-names>K</given-names></name><name name-style="western"><surname>Hennighausen</surname><given-names>L</given-names></name></person-group><article-title>Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation</article-title><source>Mech Dev</source><year>2001</year><volume>109</volume><fpage>281</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/S0925-4773(01)00549-4</pub-id><pub-id pub-id-type="pmid">11731240</pub-id></element-citation></ref><ref id="CR1256"><label>1256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>NY</given-names></name><name name-style="western"><surname>Rios</surname><given-names>AC</given-names></name><name name-style="western"><surname>Pal</surname><given-names>B</given-names></name><name name-style="western"><surname>Soetanto</surname><given-names>R</given-names></name><name name-style="western"><surname>Lun</surname><given-names>AT</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K</given-names></name><etal/></person-group><article-title>EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival</article-title><source>Nat Cell Biol</source><year>2015</year><volume>17</volume><fpage>365</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1038/ncb3117</pub-id><pub-id pub-id-type="pmid">25730472</pub-id></element-citation></ref><ref id="CR1257"><label>1257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staversky</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Vitiello</surname><given-names>PF</given-names></name><name name-style="western"><surname>Yee</surname><given-names>M</given-names></name><name name-style="western"><surname>Callahan</surname><given-names>LM</given-names></name><name name-style="western"><surname>Dean</surname><given-names>DA</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>MA</given-names></name></person-group><article-title>Epithelial ablation of Bcl-XL increases sensitivity to oxygen without disrupting lung development</article-title><source>Am J Respir Cell Mol Biol</source><year>2010</year><volume>43</volume><fpage>376</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2009-0165OC</pub-id><pub-id pub-id-type="pmid">19880821</pub-id><pub-id pub-id-type="pmcid">PMC2933553</pub-id></element-citation></ref><ref id="CR1258"><label>1258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turnis</surname><given-names>ME</given-names></name><name name-style="western"><surname>Kaminska</surname><given-names>E</given-names></name><name name-style="western"><surname>Smith</surname><given-names>KH</given-names></name><name name-style="western"><surname>Kartchner</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>P</given-names></name><name name-style="western"><surname>Laxton</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Requirement for antiapoptotic MCL-1 during early erythropoiesis</article-title><source>Blood</source><year>2021</year><volume>137</volume><fpage>1945</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1182/blood.2020006916</pub-id><pub-id pub-id-type="pmid">33512417</pub-id><pub-id pub-id-type="pmcid">PMC8033457</pub-id></element-citation></ref><ref id="CR1259"><label>1259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teh</surname><given-names>CE</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>AK</given-names></name><name name-style="western"><surname>Henstridge</surname><given-names>DC</given-names></name><name name-style="western"><surname>Dewson</surname><given-names>G</given-names></name><name name-style="western"><surname>Diepstraten</surname><given-names>ST</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>G</given-names></name><etal/></person-group><article-title>MCL-1 is essential for survival but dispensable for metabolic fitness of FOXP3(+) regulatory T cells</article-title><source>Cell Death Differ</source><year>2020</year><volume>27</volume><fpage>3374</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-0585-1</pub-id><pub-id pub-id-type="pmid">32612106</pub-id><pub-id pub-id-type="pmcid">PMC7853142</pub-id></element-citation></ref><ref id="CR1260"><label>1260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hikita</surname><given-names>H</given-names></name><name name-style="western"><surname>Takehara</surname><given-names>T</given-names></name><name name-style="western"><surname>Kodama</surname><given-names>T</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Hosui</surname><given-names>A</given-names></name><name name-style="western"><surname>Miyagi</surname><given-names>T</given-names></name><etal/></person-group><article-title>BH3-only protein bid participates in the Bcl-2 network in healthy liver cells</article-title><source>Hepatology</source><year>2009</year><volume>50</volume><fpage>1972</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1002/hep.23207</pub-id><pub-id pub-id-type="pmid">19839062</pub-id><pub-id pub-id-type="pmcid">PMC3560855</pub-id></element-citation></ref><ref id="CR1261"><label>1261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kodama</surname><given-names>T</given-names></name><name name-style="western"><surname>Hikita</surname><given-names>H</given-names></name><name name-style="western"><surname>Kawaguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Saito</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Shigekawa</surname><given-names>M</given-names></name><etal/></person-group><article-title>The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>30009</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.443093</pub-id><pub-id pub-id-type="pmid">23986435</pub-id><pub-id pub-id-type="pmcid">PMC3798470</pub-id></element-citation></ref><ref id="CR1262"><label>1262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weber</surname><given-names>A</given-names></name><name name-style="western"><surname>Boger</surname><given-names>R</given-names></name><name name-style="western"><surname>Vick</surname><given-names>B</given-names></name><name name-style="western"><surname>Urbanik</surname><given-names>T</given-names></name><name name-style="western"><surname>Haybaeck</surname><given-names>J</given-names></name><name name-style="western"><surname>Zoller</surname><given-names>S</given-names></name><etal/></person-group><article-title>Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice</article-title><source>Hepatology</source><year>2010</year><volume>51</volume><fpage>1226</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1002/hep.23479</pub-id><pub-id pub-id-type="pmid">20099303</pub-id><pub-id pub-id-type="pmcid">PMC2936921</pub-id></element-citation></ref><ref id="CR1263"><label>1263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coussens</surname><given-names>LM</given-names></name><name name-style="western"><surname>Zitvogel</surname><given-names>L</given-names></name><name name-style="western"><surname>Palucka</surname><given-names>AK</given-names></name></person-group><article-title>Neutralizing tumor-promoting chronic inflammation: a magic bullet?</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>286</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1126/science.1232227</pub-id><pub-id pub-id-type="pmid">23329041</pub-id><pub-id pub-id-type="pmcid">PMC3591506</pub-id></element-citation></ref><ref id="CR1264"><label>1264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cecconi</surname><given-names>F</given-names></name><name name-style="western"><surname>Alvarez-Bolado</surname><given-names>G</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>BI</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name><name name-style="western"><surname>Gruss</surname><given-names>P</given-names></name></person-group><article-title>Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>727</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81732-8</pub-id><pub-id pub-id-type="pmid">9753320</pub-id></element-citation></ref><ref id="CR1265"><label>1265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honarpour</surname><given-names>N</given-names></name><name name-style="western"><surname>Du</surname><given-names>C</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>RE</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Herz</surname><given-names>J</given-names></name></person-group><article-title>Adult Apaf-1-deficient mice exhibit male infertility</article-title><source>Dev Biol</source><year>2000</year><volume>218</volume><fpage>248</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9585</pub-id><pub-id pub-id-type="pmid">10656767</pub-id></element-citation></ref><ref id="CR1266"><label>1266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name><name name-style="western"><surname>Kong</surname><given-names>YY</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>R</given-names></name><name name-style="western"><surname>Elia</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>A</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>R</given-names></name><etal/></person-group><article-title>Apaf1 is required for mitochondrial pathways of apoptosis and brain development</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>739</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81733-X</pub-id><pub-id pub-id-type="pmid">9753321</pub-id></element-citation></ref><ref id="CR1267"><label>1267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cecconi</surname><given-names>F</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name><name name-style="western"><surname>Dolgov</surname><given-names>O</given-names></name><name name-style="western"><surname>Munarriz</surname><given-names>E</given-names></name><name name-style="western"><surname>Anokhin</surname><given-names>K</given-names></name><name name-style="western"><surname>Gruss</surname><given-names>P</given-names></name><etal/></person-group><article-title>Apaf1-dependent programmed cell death is required for inner ear morphogenesis and growth</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>2125</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1242/dev.01082</pub-id><pub-id pub-id-type="pmid">15105372</pub-id></element-citation></ref><ref id="CR1268"><label>1268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>AB</given-names></name><name name-style="western"><surname>Kaiser</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Mocarski</surname><given-names>ES</given-names></name><name name-style="western"><surname>Caspary</surname><given-names>T</given-names></name></person-group><article-title>Apaf1 apoptotic function critically limits Sonic hedgehog signaling during craniofacial development</article-title><source>Cell Death Differ</source><year>2013</year><volume>20</volume><fpage>1510</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/cdd.2013.97</pub-id><pub-id pub-id-type="pmid">23892366</pub-id><pub-id pub-id-type="pmcid">PMC3792442</pub-id></element-citation></ref><ref id="CR1269"><label>1269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohsawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Hamada</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name><name name-style="western"><surname>Igaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Miura</surname><given-names>M</given-names></name></person-group><article-title>Maturation of the olfactory sensory neurons by Apaf-1/caspase-9-mediated caspase activity</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>13366</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1073/pnas.0910488107</pub-id><pub-id pub-id-type="pmid">20624980</pub-id><pub-id pub-id-type="pmcid">PMC2922127</pub-id></element-citation></ref><ref id="CR1270"><label>1270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hakem</surname><given-names>R</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>A</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>GS</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>JT</given-names></name><name name-style="western"><surname>Woo</surname><given-names>M</given-names></name><name name-style="western"><surname>Soengas</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Differential requirement for caspase 9 in apoptotic pathways in vivo</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>339</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81477-4</pub-id><pub-id pub-id-type="pmid">9708736</pub-id></element-citation></ref><ref id="CR1271"><label>1271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marsden</surname><given-names>VS</given-names></name><name name-style="western"><surname>Ekert</surname><given-names>PG</given-names></name><name name-style="western"><surname>Van Delft</surname><given-names>M</given-names></name><name name-style="western"><surname>Vaux</surname><given-names>DL</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9</article-title><source>J Cell Biol</source><year>2004</year><volume>165</volume><fpage>775</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1083/jcb.200312030</pub-id><pub-id pub-id-type="pmid">15210727</pub-id><pub-id pub-id-type="pmcid">PMC2172407</pub-id></element-citation></ref><ref id="CR1272"><label>1272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spellicy</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Norris</surname><given-names>J</given-names></name><name name-style="western"><surname>Bend</surname><given-names>R</given-names></name><name name-style="western"><surname>Bupp</surname><given-names>C</given-names></name><name name-style="western"><surname>Mester</surname><given-names>P</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>T</given-names></name><etal/></person-group><article-title>Key apoptotic genes APAF1 and CASP9 implicated in recurrent folate-resistant neural tube defects</article-title><source>Eur J Hum Genet</source><year>2018</year><volume>26</volume><fpage>420</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41431-017-0025-y</pub-id><pub-id pub-id-type="pmid">29358613</pub-id><pub-id pub-id-type="pmcid">PMC5838979</pub-id></element-citation></ref><ref id="CR1273"><label>1273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Wei</surname><given-names>G</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Rare mutations in apoptosis related genes APAF1, CASP9, and CASP3 contribute to human neural tube defects</article-title><source>Cell Death Dis</source><year>2018</year><volume>9</volume><fpage>43</fpage><pub-id pub-id-type="doi">10.1038/s41419-017-0096-2</pub-id><pub-id pub-id-type="pmid">29352212</pub-id><pub-id pub-id-type="pmcid">PMC5833651</pub-id></element-citation></ref><ref id="CR1274"><label>1274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>JM</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>E</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZJ</given-names></name><etal/></person-group><article-title>Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis</article-title><source>Cell</source><year>2000</year><volume>101</volume><fpage>389</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80849-1</pub-id><pub-id pub-id-type="pmid">10830166</pub-id></element-citation></ref><ref id="CR1275"><label>1275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narisawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Hecht</surname><given-names>NB</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>E</given-names></name><name name-style="western"><surname>Boatright</surname><given-names>KM</given-names></name><name name-style="western"><surname>Reed</surname><given-names>JC</given-names></name><name name-style="western"><surname>Mill&#225;n</surname><given-names>JL</given-names></name></person-group><article-title>Testis-specific cytochrome c-null mice produce functional sperm but undergo early testicular atrophy</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>5554</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.15.5554-5562.2002</pub-id><pub-id pub-id-type="pmid">12101247</pub-id><pub-id pub-id-type="pmcid">PMC133957</pub-id></element-citation></ref><ref id="CR1276"><label>1276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinto</surname><given-names>M</given-names></name><name name-style="western"><surname>Vempati</surname><given-names>UD</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>F</given-names></name><name name-style="western"><surname>Peralta</surname><given-names>S</given-names></name><name name-style="western"><surname>Moraes</surname><given-names>CT</given-names></name></person-group><article-title>Ablation of cytochrome c in Adult Forebrain Neurons Impairs Oxidative Phosphorylation Without Detectable Apoptosis</article-title><source>Mol Neurobiol</source><year>2019</year><volume>56</volume><fpage>3722</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s12035-018-1335-y</pub-id><pub-id pub-id-type="pmid">30191381</pub-id><pub-id pub-id-type="pmcid">PMC6942697</pub-id></element-citation></ref><ref id="CR1277"><label>1277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>GS</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Elia</surname><given-names>A</given-names></name><name name-style="western"><surname>Fang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wakeham</surname><given-names>A</given-names></name><etal/></person-group><article-title>Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis</article-title><source>Cell</source><year>2005</year><volume>121</volume><fpage>579</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.03.016</pub-id><pub-id pub-id-type="pmid">15907471</pub-id></element-citation></ref><ref id="CR1278"><label>1278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>M</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>R</given-names></name><name name-style="western"><surname>Soengas</surname><given-names>MS</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>GS</given-names></name><name name-style="western"><surname>Shahinian</surname><given-names>A</given-names></name><name name-style="western"><surname>K&#228;gi</surname><given-names>D</given-names></name><etal/></person-group><article-title>Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes</article-title><source>Genes Dev</source><year>1998</year><volume>12</volume><fpage>806</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1101/gad.12.6.806</pub-id><pub-id pub-id-type="pmid">9512515</pub-id><pub-id pub-id-type="pmcid">PMC316633</pub-id></element-citation></ref><ref id="CR1279"><label>1279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>TS</given-names></name><name name-style="western"><surname>Na</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Karasuyama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>368</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/384368a0</pub-id><pub-id pub-id-type="pmid">8934524</pub-id></element-citation></ref><ref id="CR1280"><label>1280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leonard</surname><given-names>JR</given-names></name><name name-style="western"><surname>Klocke</surname><given-names>BJ</given-names></name><name name-style="western"><surname>D&#8217;Sa</surname><given-names>C</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name></person-group><article-title>Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice</article-title><source>J Neuropathol Exp Neurol</source><year>2002</year><volume>61</volume><fpage>673</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1093/jnen/61.8.673</pub-id><pub-id pub-id-type="pmid">12152782</pub-id></element-citation></ref><ref id="CR1281"><label>1281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>KA</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>C</given-names></name><name name-style="western"><surname>Haydar</surname><given-names>TF</given-names></name><name name-style="western"><surname>D&#8217;Sa-Eipper</surname><given-names>C</given-names></name><name name-style="western"><surname>Shindler</surname><given-names>KS</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>TS</given-names></name><etal/></person-group><article-title>Epistatic and independent functions of caspase-3 and Bcl-X(L) in developmental programmed cell death</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>466</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.1.466</pub-id><pub-id pub-id-type="pmid">10618441</pub-id><pub-id pub-id-type="pmcid">PMC26686</pub-id></element-citation></ref><ref id="CR1282"><label>1282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hamachi</surname><given-names>M</given-names></name><name name-style="western"><surname>Nonomura</surname><given-names>K</given-names></name><name name-style="western"><surname>Muramatsu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name><etal/></person-group><article-title>Apoptosis is involved in maintaining the character of the midbrain and the diencephalon roof plate after neural tube closure</article-title><source>Dev Biol</source><year>2020</year><volume>468</volume><fpage>101</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2020.09.015</pub-id><pub-id pub-id-type="pmid">32979334</pub-id></element-citation></ref><ref id="CR1283"><label>1283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okamoto</surname><given-names>H</given-names></name><name name-style="western"><surname>Shiraishi</surname><given-names>H</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name></person-group><article-title>Histological analyses of normally grown, fertile Apaf1-deficient mice</article-title><source>Cell Death Differ</source><year>2006</year><volume>13</volume><fpage>668</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401806</pub-id><pub-id pub-id-type="pmid">16294213</pub-id></element-citation></ref><ref id="CR1284"><label>1284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>SC</given-names></name><name name-style="western"><surname>Scearce-Levie</surname><given-names>K</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name></person-group><article-title>Characterization of social behaviors in caspase-3 deficient mice</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>18335</fpage><pub-id pub-id-type="doi">10.1038/srep18335</pub-id><pub-id pub-id-type="pmid">26783106</pub-id><pub-id pub-id-type="pmcid">PMC4726076</pub-id></element-citation></ref><ref id="CR1285"><label>1285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>SC</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Weber</surname><given-names>M</given-names></name><name name-style="western"><surname>Larson</surname><given-names>JL</given-names></name><name name-style="western"><surname>Scearce-Levie</surname><given-names>K</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>M</given-names></name></person-group><article-title>Caspase-3 deficiency results in disrupted synaptic homeostasis and impaired attention control</article-title><source>J Neurosci</source><year>2015</year><volume>35</volume><fpage>2118</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3280-14.2015</pub-id><pub-id pub-id-type="pmid">25653368</pub-id><pub-id pub-id-type="pmcid">PMC6705356</pub-id></element-citation></ref><ref id="CR1286"><label>1286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Kamiya</surname><given-names>K</given-names></name><name name-style="western"><surname>Urase</surname><given-names>K</given-names></name><name name-style="western"><surname>Suga</surname><given-names>M</given-names></name><name name-style="western"><surname>Takizawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Mori</surname><given-names>H</given-names></name><etal/></person-group><article-title>Caspase-3-deficiency induces hyperplasia of supporting cells and degeneration of sensory cells resulting in the hearing loss</article-title><source>Brain Res</source><year>2001</year><volume>894</volume><fpage>359</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(01)02123-0</pub-id><pub-id pub-id-type="pmid">11251216</pub-id></element-citation></ref><ref id="CR1287"><label>1287.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morishita</surname><given-names>H</given-names></name><name name-style="western"><surname>Makishima</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaneko</surname><given-names>C</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YS</given-names></name><name name-style="western"><surname>Segil</surname><given-names>N</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Deafness due to degeneration of cochlear neurons in caspase-3-deficient mice</article-title><source>Biochem Biophys Res Commun</source><year>2001</year><volume>284</volume><fpage>142</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.4939</pub-id><pub-id pub-id-type="pmid">11374883</pub-id></element-citation></ref><ref id="CR1288"><label>1288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>A</given-names></name><name name-style="western"><surname>Hardisty-Hughes</surname><given-names>RE</given-names></name><name name-style="western"><surname>Wisby</surname><given-names>L</given-names></name><name name-style="western"><surname>Joyce</surname><given-names>S</given-names></name><name name-style="western"><surname>Brown</surname><given-names>SD</given-names></name></person-group><article-title>Melody, an ENU mutation in Caspase 3, alters the catalytic cysteine residue and causes sensorineural hearing loss in mice</article-title><source>Mamm Genome</source><year>2010</year><volume>21</volume><fpage>565</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/s00335-010-9306-2</pub-id><pub-id pub-id-type="pmid">21116635</pub-id><pub-id pub-id-type="pmcid">PMC3002157</pub-id></element-citation></ref><ref id="CR1289"><label>1289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>PA</given-names></name><name name-style="western"><surname>Wood</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>N</given-names></name><name name-style="western"><surname>Kuster</surname><given-names>K</given-names></name><name name-style="western"><surname>Perachio</surname><given-names>A</given-names></name><name name-style="western"><surname>Makishima</surname><given-names>T</given-names></name></person-group><article-title>Preserved otolith organ function in caspase-3-deficient mice with impaired horizontal semicircular canal function</article-title><source>Exp Brain Res</source><year>2015</year><volume>233</volume><fpage>1825</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s00221-015-4254-4</pub-id><pub-id pub-id-type="pmid">25827332</pub-id><pub-id pub-id-type="pmcid">PMC4439373</pub-id></element-citation></ref><ref id="CR1290"><label>1290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makishima</surname><given-names>T</given-names></name><name name-style="western"><surname>Hochman</surname><given-names>L</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>P</given-names></name><name name-style="western"><surname>Rosenberger</surname><given-names>E</given-names></name><name name-style="western"><surname>Ridley</surname><given-names>R</given-names></name><name name-style="western"><surname>Woo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inner ear dysfunction in caspase-3 deficient mice</article-title><source>BMC Neurosci</source><year>2011</year><volume>12</volume><fpage>102</fpage><pub-id pub-id-type="doi">10.1186/1471-2202-12-102</pub-id><pub-id pub-id-type="pmid">21988729</pub-id><pub-id pub-id-type="pmcid">PMC3208590</pub-id></element-citation></ref><ref id="CR1291"><label>1291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Ichii</surname><given-names>O</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>T</given-names></name><name name-style="western"><surname>Horino</surname><given-names>T</given-names></name><name name-style="western"><surname>Elewa</surname><given-names>YHA</given-names></name><name name-style="western"><surname>Kon</surname><given-names>Y</given-names></name></person-group><article-title>Immune-associated renal disease found in caspase 3-deficient mice</article-title><source>Cell tissue Res</source><year>2020</year><volume>379</volume><fpage>323</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s00441-019-03084-w</pub-id><pub-id pub-id-type="pmid">31440817</pub-id></element-citation></ref><ref id="CR1292"><label>1292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houde</surname><given-names>C</given-names></name><name name-style="western"><surname>Banks</surname><given-names>KG</given-names></name><name name-style="western"><surname>Coulombe</surname><given-names>N</given-names></name><name name-style="western"><surname>Rasper</surname><given-names>D</given-names></name><name name-style="western"><surname>Grimm</surname><given-names>E</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><etal/></person-group><article-title>Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>9977</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3356-04.2004</pub-id><pub-id pub-id-type="pmid">15525783</pub-id><pub-id pub-id-type="pmcid">PMC6730247</pub-id></element-citation></ref><ref id="CR1293"><label>1293.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lakhani</surname><given-names>SA</given-names></name><name name-style="western"><surname>Masud</surname><given-names>A</given-names></name><name name-style="western"><surname>Kuida</surname><given-names>K</given-names></name><name name-style="western"><surname>Porter</surname><given-names>GA</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Booth</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Mehal</surname><given-names>WZ</given-names></name><etal/></person-group><article-title>Caspases 3 and 7: key mediators of mitochondrial events of apoptosis</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>847</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1126/science.1115035</pub-id><pub-id pub-id-type="pmid">16469926</pub-id><pub-id pub-id-type="pmcid">PMC3738210</pub-id></element-citation></ref><ref id="CR1294"><label>1294.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McComb</surname><given-names>S</given-names></name><name name-style="western"><surname>Chan</surname><given-names>PK</given-names></name><name name-style="western"><surname>Guinot</surname><given-names>A</given-names></name><name name-style="western"><surname>Hartmannsdottir</surname><given-names>H</given-names></name><name name-style="western"><surname>Jenni</surname><given-names>S</given-names></name><name name-style="western"><surname>Dobay</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7</article-title><source>Sci Adv</source><year>2019</year><volume>5</volume><fpage>eaau9433</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aau9433</pub-id><pub-id pub-id-type="pmid">31392262</pub-id><pub-id pub-id-type="pmcid">PMC6669006</pub-id></element-citation></ref><ref id="CR1295"><label>1295.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>JG</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>SP</given-names></name><name name-style="western"><surname>Sheridan</surname><given-names>C</given-names></name><name name-style="western"><surname>L&#252;thi</surname><given-names>AU</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>C</given-names></name><name name-style="western"><surname>Martin</surname><given-names>SJ</given-names></name></person-group><article-title>Executioner caspase-3 and caspase-7 are functionally distinct proteases</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>12815</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.0707715105</pub-id><pub-id pub-id-type="pmid">18723680</pub-id><pub-id pub-id-type="pmcid">PMC2529079</pub-id></element-citation></ref><ref id="CR1296"><label>1296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>A</given-names></name><name name-style="western"><surname>Kawata</surname><given-names>D</given-names></name><name name-style="western"><surname>Shinotsuka</surname><given-names>N</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Miura</surname><given-names>M</given-names></name></person-group><article-title>Evidence for the involvement of caspases in establishing proper cerebrospinal fluid hydrodynamics</article-title><source>Neurosci Res</source><year>2021</year><volume>170</volume><fpage>145</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.neures.2020.12.006</pub-id><pub-id pub-id-type="pmid">33417971</pub-id></element-citation></ref><ref id="CR1297"><label>1297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demon</surname><given-names>D</given-names></name><name name-style="western"><surname>Van Damme</surname><given-names>P</given-names></name><name name-style="western"><surname>Vanden Berghe</surname><given-names>T</given-names></name><name name-style="western"><surname>Deceuninck</surname><given-names>A</given-names></name><name name-style="western"><surname>Van Durme</surname><given-names>J</given-names></name><name name-style="western"><surname>Verspurten</surname><given-names>J</given-names></name><etal/></person-group><article-title>Proteome-wide substrate analysis indicates substrate exclusion as a mechanism to generate caspase-7 versus caspase-3 specificity</article-title><source>Mol Cell Proteom</source><year>2009</year><volume>8</volume><fpage>2700</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1074/mcp.M900310-MCP200</pub-id><pub-id pub-id-type="pmcid">PMC2816020</pub-id><pub-id pub-id-type="pmid">19759058</pub-id></element-citation></ref><ref id="CR1298"><label>1298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nozaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Maltez</surname><given-names>VI</given-names></name><name name-style="western"><surname>Rayamajhi</surname><given-names>M</given-names></name><name name-style="western"><surname>Tubbs</surname><given-names>AL</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>JE</given-names></name><name name-style="western"><surname>Lacey</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Caspase-7 activates ASM to repair gasdermin and perforin pores</article-title><source>Nature</source><year>2022</year><volume>606</volume><fpage>960</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04825-8</pub-id><pub-id pub-id-type="pmid">35705808</pub-id><pub-id pub-id-type="pmcid">PMC9247046</pub-id></element-citation></ref><ref id="CR1299"><label>1299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okada</surname><given-names>H</given-names></name><name name-style="western"><surname>Suh</surname><given-names>WK</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J</given-names></name><name name-style="western"><surname>Woo</surname><given-names>M</given-names></name><name name-style="western"><surname>Du</surname><given-names>C</given-names></name><name name-style="western"><surname>Elia</surname><given-names>A</given-names></name><etal/></person-group><article-title>Generation and characterization of Smac/DIABLO-deficient mice</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>3509</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.10.3509-3517.2002</pub-id><pub-id pub-id-type="pmid">11971981</pub-id><pub-id pub-id-type="pmcid">PMC133802</pub-id></element-citation></ref><ref id="CR1300"><label>1300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martins</surname><given-names>LM</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>A</given-names></name><name name-style="western"><surname>Klupsch</surname><given-names>K</given-names></name><name name-style="western"><surname>Fedele</surname><given-names>V</given-names></name><name name-style="western"><surname>Moisoi</surname><given-names>N</given-names></name><name name-style="western"><surname>Teismann</surname><given-names>P</given-names></name><etal/></person-group><article-title>Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>9848</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.22.9848-9862.2004</pub-id><pub-id pub-id-type="pmid">15509788</pub-id><pub-id pub-id-type="pmcid">PMC525490</pub-id></element-citation></ref><ref id="CR1301"><label>1301.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hui</surname><given-names>KK</given-names></name><name name-style="western"><surname>Kanungo</surname><given-names>AK</given-names></name><name name-style="western"><surname>Elia</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>JT</given-names></name></person-group><article-title>Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO in regulating programmed cell death</article-title><source>Cell Death Differ</source><year>2011</year><volume>18</volume><fpage>1780</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.50</pub-id><pub-id pub-id-type="pmid">21597464</pub-id><pub-id pub-id-type="pmcid">PMC3190114</pub-id></element-citation></ref><ref id="CR1302"><label>1302.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olayioye</surname><given-names>MA</given-names></name><name name-style="western"><surname>Kaufmann</surname><given-names>H</given-names></name><name name-style="western"><surname>Pakusch</surname><given-names>M</given-names></name><name name-style="western"><surname>Vaux</surname><given-names>DL</given-names></name><name name-style="western"><surname>Lindeman</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Visvader</surname><given-names>JE</given-names></name></person-group><article-title>XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland</article-title><source>Cell Death Differ</source><year>2005</year><volume>12</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401524</pub-id><pub-id pub-id-type="pmid">15540113</pub-id></element-citation></ref><ref id="CR1303"><label>1303.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harlin</surname><given-names>H</given-names></name><name name-style="western"><surname>Reffey</surname><given-names>SB</given-names></name><name name-style="western"><surname>Duckett</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lindsten</surname><given-names>T</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>CB</given-names></name></person-group><article-title>Characterization of XIAP-deficient mice</article-title><source>Mol Cell Biol</source><year>2001</year><volume>21</volume><fpage>3604</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1128/MCB.21.10.3604-3608.2001</pub-id><pub-id pub-id-type="pmid">11313486</pub-id><pub-id pub-id-type="pmcid">PMC100282</pub-id></element-citation></ref><ref id="CR1304"><label>1304.</label><mixed-citation publication-type="other">Morrish E, Brumatti G, Silke J. Future therapeutic directions for smac-mimetics. Cells. 2020;9:406.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells9020406</pub-id><pub-id pub-id-type="pmcid">PMC7072318</pub-id><pub-id pub-id-type="pmid">32053868</pub-id></mixed-citation></ref><ref id="CR1305"><label>1305.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prakash</surname><given-names>H</given-names></name><name name-style="western"><surname>Albrecht</surname><given-names>M</given-names></name><name name-style="western"><surname>Becker</surname><given-names>D</given-names></name><name name-style="western"><surname>Kuhlmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Rudel</surname><given-names>T</given-names></name></person-group><article-title>Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>20291</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.096297</pub-id><pub-id pub-id-type="pmid">20427267</pub-id><pub-id pub-id-type="pmcid">PMC2888442</pub-id></element-citation></ref><ref id="CR1306"><label>1306.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yabal</surname><given-names>M</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>N</given-names></name><name name-style="western"><surname>Adler</surname><given-names>H</given-names></name><name name-style="western"><surname>Knies</surname><given-names>N</given-names></name><name name-style="western"><surname>Gro&#223;</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Damgaard</surname><given-names>RB</given-names></name><etal/></person-group><article-title>XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation</article-title><source>Cell Rep</source><year>2014</year><volume>7</volume><fpage>1796</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.05.008</pub-id><pub-id pub-id-type="pmid">24882010</pub-id></element-citation></ref><ref id="CR1307"><label>1307.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>WC</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>YT</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>IH</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>SC</given-names></name><name name-style="western"><surname>Miaw</surname><given-names>SC</given-names></name><name name-style="western"><surname>Lai</surname><given-names>MZ</given-names></name></person-group><article-title>Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap&#8722;/&#8722; mice</article-title><source>Blood</source><year>2014</year><volume>124</volume><fpage>2847</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-03-564609</pub-id><pub-id pub-id-type="pmid">25190756</pub-id></element-citation></ref><ref id="CR1308"><label>1308.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cardona</surname><given-names>M</given-names></name><name name-style="western"><surname>L&#243;pez</surname><given-names>JA</given-names></name><name name-style="western"><surname>Seraf&#237;n</surname><given-names>A</given-names></name><name name-style="western"><surname>Rongvaux</surname><given-names>A</given-names></name><name name-style="western"><surname>Inserte</surname><given-names>J</given-names></name><name name-style="western"><surname>Garc&#237;a-Dorado</surname><given-names>D</given-names></name><etal/></person-group><article-title>Executioner caspase-3 and 7 deficiency reduces myocyte number in the developing mouse heart</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0131411</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0131411</pub-id><pub-id pub-id-type="pmid">26121671</pub-id><pub-id pub-id-type="pmcid">PMC4487935</pub-id></element-citation></ref><ref id="CR1309"><label>1309.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Schoenwaelder</surname><given-names>SM</given-names></name><name name-style="western"><surname>Josefsson</surname><given-names>EC</given-names></name><name name-style="western"><surname>Jarman</surname><given-names>KE</given-names></name><name name-style="western"><surname>Henley</surname><given-names>KJ</given-names></name><name name-style="western"><surname>James</surname><given-names>C</given-names></name><etal/></person-group><article-title>Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>4283</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-11-394858</pub-id><pub-id pub-id-type="pmid">22294729</pub-id></element-citation></ref><ref id="CR1310"><label>1310.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Delft</surname><given-names>MF</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DP</given-names></name><name name-style="western"><surname>Lahoud</surname><given-names>MH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Adams</surname><given-names>JM</given-names></name></person-group><article-title>Apoptosis and non-inflammatory phagocytosis can be induced by mitochondrial damage without caspases</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>821</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.166</pub-id><pub-id pub-id-type="pmid">19911005</pub-id><pub-id pub-id-type="pmcid">PMC3005563</pub-id></element-citation></ref><ref id="CR1311"><label>1311.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woo</surname><given-names>M</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>R</given-names></name><name name-style="western"><surname>Furlonger</surname><given-names>C</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>A</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>GS</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>T</given-names></name><etal/></person-group><article-title>Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity</article-title><source>Nat Immunol</source><year>2003</year><volume>4</volume><fpage>1016</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/ni976</pub-id><pub-id pub-id-type="pmid">12970760</pub-id></element-citation></ref><ref id="CR1312"><label>1312.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miura</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>XD</given-names></name><name name-style="western"><surname>Allen</surname><given-names>MR</given-names></name><name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gronthos</surname><given-names>S</given-names></name><name name-style="western"><surname>Seo</surname><given-names>BM</given-names></name><etal/></person-group><article-title>A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells</article-title><source>J Clin Investig</source><year>2004</year><volume>114</volume><fpage>1704</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1172/JCI20427</pub-id><pub-id pub-id-type="pmid">15599395</pub-id><pub-id pub-id-type="pmcid">PMC535063</pub-id></element-citation></ref><ref id="CR1313"><label>1313.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>H</given-names></name><name name-style="western"><surname>Miyake</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mi-Ichi</surname><given-names>F</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hara</surname><given-names>H</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name></person-group><article-title>Apaf1 plays a negative regulatory role in T cell responses by suppressing activation of antigen-stimulated T cells</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><fpage>e0195119</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0195119</pub-id><pub-id pub-id-type="pmid">29596528</pub-id><pub-id pub-id-type="pmcid">PMC5875858</pub-id></element-citation></ref><ref id="CR1314"><label>1314.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hara</surname><given-names>H</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>A</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Wakeham</surname><given-names>AC</given-names></name><name name-style="western"><surname>Iti&#233;</surname><given-names>A</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>2288</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.5.2288</pub-id><pub-id pub-id-type="pmid">11859117</pub-id></element-citation></ref><ref id="CR1315"><label>1315.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagasaka</surname><given-names>A</given-names></name><name name-style="western"><surname>Kawane</surname><given-names>K</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>S</given-names></name></person-group><article-title>Apaf-1-independent programmed cell death in mouse development</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>931</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.186</pub-id><pub-id pub-id-type="pmid">19960021</pub-id></element-citation></ref><ref id="CR1316"><label>1316.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doerfler</surname><given-names>P</given-names></name><name name-style="western"><surname>Forbush</surname><given-names>KA</given-names></name><name name-style="western"><surname>Perlmutter</surname><given-names>RM</given-names></name></person-group><article-title>Caspase enzyme activity is not essential for apoptosis during thymocyte development</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>4071</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.8.4071</pub-id><pub-id pub-id-type="pmid">10754300</pub-id></element-citation></ref><ref id="CR1317"><label>1317.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izquierdo</surname><given-names>M</given-names></name><name name-style="western"><surname>Grandien</surname><given-names>A</given-names></name><name name-style="western"><surname>Criado</surname><given-names>LM</given-names></name><name name-style="western"><surname>Robles</surname><given-names>S</given-names></name><name name-style="western"><surname>Leonardo</surname><given-names>E</given-names></name><name name-style="western"><surname>Albar</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor</article-title><source>EMBO J</source><year>1999</year><volume>18</volume><fpage>156</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1093/emboj/18.1.156</pub-id><pub-id pub-id-type="pmid">9878059</pub-id><pub-id pub-id-type="pmcid">PMC1171111</pub-id></element-citation></ref><ref id="CR1318"><label>1318.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>EP</given-names></name><name name-style="western"><surname>McLellan</surname><given-names>M</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L</given-names></name><name name-style="western"><surname>Fulton</surname><given-names>R</given-names></name><name name-style="western"><surname>Mardis</surname><given-names>ER</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>RK</given-names></name><etal/></person-group><article-title>Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice</article-title><source>Blood</source><year>2014</year><volume>124</volume><fpage>3887</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-06-582551</pub-id><pub-id pub-id-type="pmid">25349173</pub-id><pub-id pub-id-type="pmcid">PMC4271179</pub-id></element-citation></ref><ref id="CR1319"><label>1319.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oppenheim</surname><given-names>RW</given-names></name><name name-style="western"><surname>Blomgren</surname><given-names>K</given-names></name><name name-style="western"><surname>Ethell</surname><given-names>DW</given-names></name><name name-style="western"><surname>Koike</surname><given-names>M</given-names></name><name name-style="western"><surname>Komatsu</surname><given-names>M</given-names></name><name name-style="western"><surname>Prevette</surname><given-names>D</given-names></name><etal/></person-group><article-title>Developing postmitotic mammalian neurons in vivo lacking Apaf-1 undergo programmed cell death by a caspase-independent, nonapoptotic pathway involving autophagy</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>1490</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4575-07.2008</pub-id><pub-id pub-id-type="pmid">18256270</pub-id><pub-id pub-id-type="pmcid">PMC6671586</pub-id></element-citation></ref><ref id="CR1320"><label>1320.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oppenheim</surname><given-names>RW</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><name name-style="western"><surname>Vinsant</surname><given-names>S</given-names></name><name name-style="western"><surname>Prevette</surname><given-names>D</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>CY</given-names></name><name name-style="western"><surname>Rakic</surname><given-names>P</given-names></name></person-group><article-title>Programmed cell death of developing mammalian neurons after genetic deletion of caspases</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>4752</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-13-04752.2001</pub-id><pub-id pub-id-type="pmid">11425902</pub-id><pub-id pub-id-type="pmcid">PMC6762357</pub-id></element-citation></ref><ref id="CR1321"><label>1321.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yaginuma</surname><given-names>H</given-names></name><name name-style="western"><surname>Shiraiwa</surname><given-names>N</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>T</given-names></name><name name-style="western"><surname>Nishiyama</surname><given-names>K</given-names></name><name name-style="western"><surname>Hong</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Caspase activity is involved in, but is dispensable for, early motoneuron death in the chick embryo cervical spinal cord</article-title><source>Mol Cell Neurosci</source><year>2001</year><volume>18</volume><fpage>168</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1006/mcne.2001.1009</pub-id><pub-id pub-id-type="pmid">11520178</pub-id></element-citation></ref><ref id="CR1322"><label>1322.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honarpour</surname><given-names>N</given-names></name><name name-style="western"><surname>Tabuchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Stark</surname><given-names>JM</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>RE</given-names></name><name name-style="western"><surname>S&#252;dhof</surname><given-names>TC</given-names></name><name name-style="western"><surname>Parada</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Embryonic neuronal death due to neurotrophin and neurotransmitter deprivation occurs independent of Apaf-1</article-title><source>Neuroscience</source><year>2001</year><volume>106</volume><fpage>263</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(01)00275-5</pub-id><pub-id pub-id-type="pmid">11566499</pub-id></element-citation></ref><ref id="CR1323"><label>1323.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aggarwal</surname><given-names>BB</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>SC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name></person-group><article-title>Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey</article-title><source>Blood</source><year>2012</year><volume>119</volume><fpage>651</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-04-325225</pub-id><pub-id pub-id-type="pmid">22053109</pub-id><pub-id pub-id-type="pmcid">PMC3265196</pub-id></element-citation></ref><ref id="CR1324"><label>1324.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Jost</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>S</given-names></name></person-group><article-title>The many roles of FAS receptor signaling in the immune system</article-title><source>Immunity</source><year>2009</year><volume>30</volume><fpage>180</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.01.001</pub-id><pub-id pub-id-type="pmid">19239902</pub-id><pub-id pub-id-type="pmcid">PMC2956119</pub-id></element-citation></ref><ref id="CR1325"><label>1325.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wajant</surname><given-names>H</given-names></name></person-group><article-title>The Fas signaling pathway: more than a paradigm</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>1635</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1126/science.1071553</pub-id><pub-id pub-id-type="pmid">12040174</pub-id></element-citation></ref><ref id="CR1326"><label>1326.</label><mixed-citation publication-type="other">Wallach D. The tumor necrosis factor family: family conventions and private idiosyncrasies. Cold Spring Harbor Perspect Biol. 2018;10:a028431.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/cshperspect.a028431</pub-id><pub-id pub-id-type="pmcid">PMC6169814</pub-id><pub-id pub-id-type="pmid">28847899</pub-id></mixed-citation></ref><ref id="CR1327"><label>1327.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Karstedt</surname><given-names>S</given-names></name><name name-style="western"><surname>Montinaro</surname><given-names>A</given-names></name><name name-style="western"><surname>Walczak</surname><given-names>H</given-names></name></person-group><article-title>Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy</article-title><source>Nat Rev Cancer</source><year>2017</year><volume>17</volume><fpage>352</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1038/nrc.2017.28</pub-id><pub-id pub-id-type="pmid">28536452</pub-id></element-citation></ref><ref id="CR1328"><label>1328.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kischkel</surname><given-names>FC</given-names></name><name name-style="western"><surname>Hellbardt</surname><given-names>S</given-names></name><name name-style="western"><surname>Behrmann</surname><given-names>I</given-names></name><name name-style="western"><surname>Germer</surname><given-names>M</given-names></name><name name-style="western"><surname>Pawlita</surname><given-names>M</given-names></name><name name-style="western"><surname>Krammer</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor</article-title><source>EMBO J</source><year>1995</year><volume>14</volume><fpage>5579</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb00245.x</pub-id><pub-id pub-id-type="pmid">8521815</pub-id><pub-id pub-id-type="pmcid">PMC394672</pub-id></element-citation></ref><ref id="CR1329"><label>1329.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boldin</surname><given-names>MP</given-names></name><name name-style="western"><surname>Goncharov</surname><given-names>TM</given-names></name><name name-style="western"><surname>Goltsev</surname><given-names>YV</given-names></name><name name-style="western"><surname>Wallach</surname><given-names>D</given-names></name></person-group><article-title>Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death</article-title><source>Cell</source><year>1996</year><volume>85</volume><fpage>803</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81265-9</pub-id><pub-id pub-id-type="pmid">8681376</pub-id></element-citation></ref><ref id="CR1330"><label>1330.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dickens</surname><given-names>LS</given-names></name><name name-style="western"><surname>Powley</surname><given-names>IR</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>MA</given-names></name><name name-style="western"><surname>MacFarlane</surname><given-names>M</given-names></name></person-group><article-title>The &#8216;complexities&#8217; of life and death: death receptor signalling platforms</article-title><source>Exp cell Res</source><year>2012</year><volume>318</volume><fpage>1269</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2012.04.005</pub-id><pub-id pub-id-type="pmid">22542855</pub-id></element-citation></ref><ref id="CR1331"><label>1331.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muzio</surname><given-names>M</given-names></name><name name-style="western"><surname>Chinnaiyan</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kischkel</surname><given-names>FC</given-names></name><name name-style="western"><surname>O&#8217;Rourke</surname><given-names>K</given-names></name><name name-style="western"><surname>Shevchenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Ni</surname><given-names>J</given-names></name><etal/></person-group><article-title>FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex</article-title><source>Cell</source><year>1996</year><volume>85</volume><fpage>817</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81266-0</pub-id><pub-id pub-id-type="pmid">8681377</pub-id></element-citation></ref><ref id="CR1332"><label>1332.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boldin</surname><given-names>MP</given-names></name><name name-style="western"><surname>Varfolomeev</surname><given-names>EE</given-names></name><name name-style="western"><surname>Pancer</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mett</surname><given-names>IL</given-names></name><name name-style="western"><surname>Camonis</surname><given-names>JH</given-names></name><name name-style="western"><surname>Wallach</surname><given-names>D</given-names></name></person-group><article-title>A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>7795</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.14.7795</pub-id><pub-id pub-id-type="pmid">7536190</pub-id></element-citation></ref><ref id="CR1333"><label>1333.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chinnaiyan</surname><given-names>AM</given-names></name><name name-style="western"><surname>O&#8217;Rourke</surname><given-names>K</given-names></name><name name-style="western"><surname>Tewari</surname><given-names>M</given-names></name><name name-style="western"><surname>Dixit</surname><given-names>VM</given-names></name></person-group><article-title>FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis</article-title><source>Cell</source><year>1995</year><volume>81</volume><fpage>505</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90071-3</pub-id><pub-id pub-id-type="pmid">7538907</pub-id></element-citation></ref><ref id="CR1334"><label>1334.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kischkel</surname><given-names>FC</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>DA</given-names></name><name name-style="western"><surname>Chuntharapai</surname><given-names>A</given-names></name><name name-style="western"><surname>Schow</surname><given-names>P</given-names></name><name name-style="western"><surname>Kim</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Ashkenazi</surname><given-names>A</given-names></name></person-group><article-title>Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5</article-title><source>Immunity</source><year>2000</year><volume>12</volume><fpage>611</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80212-5</pub-id><pub-id pub-id-type="pmid">10894161</pub-id></element-citation></ref><ref id="CR1335"><label>1335.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>FL</given-names></name><name name-style="western"><surname>Stec</surname><given-names>B</given-names></name><name name-style="western"><surname>Pop</surname><given-names>C</given-names></name><name name-style="western"><surname>Dobaczewska</surname><given-names>MK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Monosov</surname><given-names>E</given-names></name><etal/></person-group><article-title>The Fas-FADD death domain complex structure unravels signalling by receptor clustering</article-title><source>Nature</source><year>2009</year><volume>457</volume><fpage>1019</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/nature07606</pub-id><pub-id pub-id-type="pmid">19118384</pub-id><pub-id pub-id-type="pmcid">PMC2661029</pub-id></element-citation></ref><ref id="CR1336"><label>1336.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>FK</given-names></name><name name-style="western"><surname>Chun</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RM</given-names></name><name name-style="western"><surname>Bui</surname><given-names>KL</given-names></name><name name-style="western"><surname>Lenardo</surname><given-names>MJ</given-names></name></person-group><article-title>A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>2351</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1126/science.288.5475.2351</pub-id><pub-id pub-id-type="pmid">10875917</pub-id></element-citation></ref><ref id="CR1337"><label>1337.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Fu</surname><given-names>TM</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>AC</given-names></name><name name-style="western"><surname>Sengupta</surname><given-names>P</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>SK</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title>StructuraL Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 death receptor</article-title><source>Mol Cell</source><year>2016</year><volume>61</volume><fpage>602</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.01.009</pub-id><pub-id pub-id-type="pmid">26853147</pub-id><pub-id pub-id-type="pmcid">PMC4761300</pub-id></element-citation></ref><ref id="CR1338"><label>1338.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>D</given-names></name><name name-style="western"><surname>Blaser</surname><given-names>H</given-names></name><name name-style="western"><surname>Mak</surname><given-names>TW</given-names></name></person-group><article-title>Regulation of tumour necrosis factor signalling: live or let die</article-title><source>Nat Rev Immunol</source><year>2015</year><volume>15</volume><fpage>362</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nri3834</pub-id><pub-id pub-id-type="pmid">26008591</pub-id></element-citation></ref><ref id="CR1339"><label>1339.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name><name name-style="western"><surname>Kepp</surname><given-names>O</given-names></name><name name-style="western"><surname>Chan</surname><given-names>FK</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Necroptosis: Mechanisms and Relevance to Disease</article-title><source>Annu Rev Pathol</source><year>2017</year><volume>12</volume><fpage>103</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-052016-100247</pub-id><pub-id pub-id-type="pmid">27959630</pub-id><pub-id pub-id-type="pmcid">PMC5786374</pub-id></element-citation></ref><ref id="CR1340"><label>1340.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tummers</surname><given-names>B</given-names></name><name name-style="western"><surname>Green</surname><given-names>DR</given-names></name></person-group><article-title>Caspase-8: regulating life and death</article-title><source>Immunol Rev</source><year>2017</year><volume>277</volume><fpage>76</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1111/imr.12541</pub-id><pub-id pub-id-type="pmid">28462525</pub-id><pub-id pub-id-type="pmcid">PMC5417704</pub-id></element-citation></ref><ref id="CR1341"><label>1341.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnhart</surname><given-names>BC</given-names></name><name name-style="western"><surname>Alappat</surname><given-names>EC</given-names></name><name name-style="western"><surname>Peter</surname><given-names>ME</given-names></name></person-group><article-title>The CD95 type I/type II model</article-title><source>Semin Immunol</source><year>2003</year><volume>15</volume><fpage>185</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/S1044-5323(03)00031-9</pub-id><pub-id pub-id-type="pmid">14563117</pub-id></element-citation></ref><ref id="CR1342"><label>1342.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AW</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Krammer</surname><given-names>PH</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name></person-group><article-title>Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis</article-title><source>EMBO J</source><year>1995</year><volume>14</volume><fpage>6136</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb00304.x</pub-id><pub-id pub-id-type="pmid">8557033</pub-id><pub-id pub-id-type="pmcid">PMC394738</pub-id></element-citation></ref><ref id="CR1343"><label>1343.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81590-1</pub-id><pub-id pub-id-type="pmid">9727492</pub-id></element-citation></ref><ref id="CR1344"><label>1344.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name><name name-style="western"><surname>Budihardjo</surname><given-names>I</given-names></name><name name-style="western"><surname>Zou</surname><given-names>H</given-names></name><name name-style="western"><surname>Slaughter</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>481</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81589-5</pub-id><pub-id pub-id-type="pmid">9727491</pub-id></element-citation></ref><ref id="CR1345"><label>1345.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gross</surname><given-names>A</given-names></name><name name-style="western"><surname>Yin</surname><given-names>XM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wei</surname><given-names>MC</given-names></name><name name-style="western"><surname>Jockel</surname><given-names>J</given-names></name><name name-style="western"><surname>Milliman</surname><given-names>C</given-names></name><etal/></person-group><article-title>Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>1156</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.2.1156</pub-id><pub-id pub-id-type="pmid">9873064</pub-id></element-citation></ref><ref id="CR1346"><label>1346.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>O&#8217;Neill</surname><given-names>KL</given-names></name><name name-style="western"><surname>Gurumurthy</surname><given-names>CB</given-names></name><name name-style="western"><surname>Quadros</surname><given-names>RM</given-names></name><name name-style="western"><surname>Tu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cleavage by caspase 8 and mitochondrial membrane association activate the BH3-only protein bid during TRAIL-induced apoptosis</article-title><source>J Biol Chem</source><year>2016</year><volume>291</volume><fpage>11843</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.711051</pub-id><pub-id pub-id-type="pmid">27053107</pub-id><pub-id pub-id-type="pmcid">PMC4882451</pub-id></element-citation></ref><ref id="CR1347"><label>1347.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalaoui</surname><given-names>N</given-names></name><name name-style="western"><surname>Boyden</surname><given-names>SE</given-names></name><name name-style="western"><surname>Oda</surname><given-names>H</given-names></name><name name-style="western"><surname>Wood</surname><given-names>GM</given-names></name><name name-style="western"><surname>Stone</surname><given-names>DL</given-names></name><name name-style="western"><surname>Chau</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>103</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1828-5</pub-id><pub-id pub-id-type="pmid">31827281</pub-id><pub-id pub-id-type="pmcid">PMC6930849</pub-id></element-citation></ref><ref id="CR1348"><label>1348.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayden</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></name></person-group><article-title>Regulation of NF-&#954;B by TNF family cytokines</article-title><source>Semin Immunol</source><year>2014</year><volume>26</volume><fpage>253</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2014.05.004</pub-id><pub-id pub-id-type="pmid">24958609</pub-id><pub-id pub-id-type="pmcid">PMC4156877</pub-id></element-citation></ref><ref id="CR1349"><label>1349.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bertheloot</surname><given-names>D</given-names></name><name name-style="western"><surname>Latz</surname><given-names>E</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>BS</given-names></name></person-group><article-title>Necroptosis, pyroptosis and apoptosis: an intricate game of cell death</article-title><source>Cell Mol Immunol</source><year>2021</year><volume>18</volume><fpage>1106</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/s41423-020-00630-3</pub-id><pub-id pub-id-type="pmid">33785842</pub-id><pub-id pub-id-type="pmcid">PMC8008022</pub-id></element-citation></ref><ref id="CR1350"><label>1350.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>CM</given-names></name><name name-style="western"><surname>Martin</surname><given-names>SJ</given-names></name></person-group><article-title>Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory &#8220;FADDosome&#8221; Complex upon TRAIL Stimulation</article-title><source>Mol Cell</source><year>2017</year><volume>65</volume><fpage>715</fpage><lpage>729.e715</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.01.022</pub-id><pub-id pub-id-type="pmid">28212752</pub-id></element-citation></ref><ref id="CR1351"><label>1351.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibert</surname><given-names>B</given-names></name><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name></person-group><article-title>Dependence receptors and cancer: addiction to trophic ligands</article-title><source>Cancer Res</source><year>2015</year><volume>75</volume><fpage>5171</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-3652</pub-id><pub-id pub-id-type="pmid">26627011</pub-id></element-citation></ref><ref id="CR1352"><label>1352.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name><name name-style="western"><surname>Bredesen</surname><given-names>DE</given-names></name></person-group><article-title>Dependence receptors: from basic research to drug development</article-title><source>Sci Signal</source><year>2011</year><volume>4</volume><fpage>mr2</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2001521</pub-id><pub-id pub-id-type="pmid">21266712</pub-id></element-citation></ref><ref id="CR1353"><label>1353.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brisset</surname><given-names>M</given-names></name><name name-style="western"><surname>Grandin</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernet</surname><given-names>A</given-names></name><name name-style="western"><surname>Mehlen</surname><given-names>P</given-names></name><name name-style="western"><surname>Hollande</surname><given-names>F</given-names></name></person-group><article-title>Dependence receptors: new targets for cancer therapy</article-title><source>EMBO Mol Med</source><year>2021</year><volume>13</volume><fpage>e14495</fpage><pub-id pub-id-type="doi">10.15252/emmm.202114495</pub-id><pub-id pub-id-type="pmid">34542930</pub-id><pub-id pub-id-type="pmcid">PMC8573599</pub-id></element-citation></ref><ref id="CR1354"><label>1354.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dillon</surname><given-names>CP</given-names></name><name name-style="western"><surname>Oberst</surname><given-names>A</given-names></name><name name-style="western"><surname>Weinlich</surname><given-names>R</given-names></name><name name-style="western"><surname>Janke</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Ben-Moshe</surname><given-names>T</given-names></name><etal/></person-group><article-title>Survival function of the FADD-CASPASE-8-cFLIP(L) complex</article-title><source>Cell Rep</source><year>2012</year><volume>1</volume><fpage>401</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.03.010</pub-id><pub-id pub-id-type="pmid">22675671</pub-id><pub-id pub-id-type="pmcid">PMC3366463</pub-id></element-citation></ref><ref id="CR1355"><label>1355.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dillon</surname><given-names>CP</given-names></name><name name-style="western"><surname>Weinlich</surname><given-names>R</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>DA</given-names></name><name name-style="western"><surname>Cripps</surname><given-names>JG</given-names></name><name name-style="western"><surname>Quarato</surname><given-names>G</given-names></name><name name-style="western"><surname>Gurung</surname><given-names>P</given-names></name><etal/></person-group><article-title>RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3</article-title><source>Cell</source><year>2014</year><volume>157</volume><fpage>1189</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.04.018</pub-id><pub-id pub-id-type="pmid">24813850</pub-id><pub-id pub-id-type="pmcid">PMC4068710</pub-id></element-citation></ref><ref id="CR1356"><label>1356.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Daley-Bauer</surname><given-names>LP</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>P</given-names></name><name name-style="western"><surname>Berger</surname><given-names>SB</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><etal/></person-group><article-title>RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>7753</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.1401857111</pub-id><pub-id pub-id-type="pmid">24821786</pub-id><pub-id pub-id-type="pmcid">PMC4040608</pub-id></element-citation></ref><ref id="CR1357"><label>1357.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rickard</surname><given-names>JA</given-names></name><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>JA</given-names></name><name name-style="western"><surname>Evans</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lalaoui</surname><given-names>N</given-names></name><name name-style="western"><surname>Poh</surname><given-names>AR</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>T</given-names></name><etal/></person-group><article-title>RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis</article-title><source>Cell</source><year>2014</year><volume>157</volume><fpage>1175</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.04.019</pub-id><pub-id pub-id-type="pmid">24813849</pub-id></element-citation></ref><ref id="CR1358"><label>1358.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lynch</surname><given-names>DH</given-names></name><name name-style="western"><surname>Watson</surname><given-names>ML</given-names></name><name name-style="western"><surname>Alderson</surname><given-names>MR</given-names></name><name name-style="western"><surname>Baum</surname><given-names>PR</given-names></name><name name-style="western"><surname>Miller</surname><given-names>RE</given-names></name><name name-style="western"><surname>Tough</surname><given-names>T</given-names></name><etal/></person-group><article-title>The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster</article-title><source>Immunity</source><year>1994</year><volume>1</volume><fpage>131</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/1074-7613(94)90106-6</pub-id><pub-id pub-id-type="pmid">7889405</pub-id></element-citation></ref><ref id="CR1359"><label>1359.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roths</surname><given-names>JB</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>ED</given-names></name><name name-style="western"><surname>Eicher</surname><given-names>EM</given-names></name></person-group><article-title>A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice</article-title><source>J Exp Med</source><year>1984</year><volume>159</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1084/jem.159.1.1</pub-id><pub-id pub-id-type="pmid">6693832</pub-id><pub-id pub-id-type="pmcid">PMC2187205</pub-id></element-citation></ref><ref id="CR1360"><label>1360.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuzawa</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriyama</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaneko</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>M</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>H</given-names></name><etal/></person-group><article-title>A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse</article-title><source>J Exp Med</source><year>1990</year><volume>171</volume><fpage>519</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1084/jem.171.2.519</pub-id><pub-id pub-id-type="pmid">2406366</pub-id><pub-id pub-id-type="pmcid">PMC2187722</pub-id></element-citation></ref><ref id="CR1361"><label>1361.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adachi</surname><given-names>M</given-names></name><name name-style="western"><surname>Suematsu</surname><given-names>S</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>T</given-names></name><name name-style="western"><surname>Ogasawara</surname><given-names>J</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>N</given-names></name><etal/></person-group><article-title>Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver</article-title><source>Nat Genet</source><year>1995</year><volume>11</volume><fpage>294</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1038/ng1195-294</pub-id><pub-id pub-id-type="pmid">7581453</pub-id></element-citation></ref><ref id="CR1362"><label>1362.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anstee</surname><given-names>NS</given-names></name><name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>PD</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Cory</surname><given-names>S</given-names></name></person-group><article-title>Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice</article-title><source>Cell Death Differ</source><year>2017</year><volume>24</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.125</pub-id><pub-id pub-id-type="pmid">27813531</pub-id><pub-id pub-id-type="pmcid">PMC5344201</pub-id></element-citation></ref><ref id="CR1363"><label>1363.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>PD</given-names></name><name name-style="western"><surname>Belz</surname><given-names>GT</given-names></name><name name-style="western"><surname>Fortner</surname><given-names>KA</given-names></name><name name-style="western"><surname>Budd</surname><given-names>RC</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouillet</surname><given-names>P</given-names></name></person-group><article-title>Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity</article-title><source>Immunity</source><year>2008</year><volume>28</volume><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.12.017</pub-id><pub-id pub-id-type="pmid">18275830</pub-id><pub-id pub-id-type="pmcid">PMC2270348</pub-id></element-citation></ref><ref id="CR1364"><label>1364.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karray</surname><given-names>S</given-names></name><name name-style="western"><surname>Kress</surname><given-names>C</given-names></name><name name-style="western"><surname>Cuvellier</surname><given-names>S</given-names></name><name name-style="western"><surname>Hue-Beauvais</surname><given-names>C</given-names></name><name name-style="western"><surname>Damotte</surname><given-names>D</given-names></name><name name-style="western"><surname>Babinet</surname><given-names>C</given-names></name><etal/></person-group><article-title>Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>2118</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.4.2118</pub-id><pub-id pub-id-type="pmid">14764677</pub-id></element-citation></ref><ref id="CR1365"><label>1365.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>MH</given-names></name><name name-style="western"><surname>Eubanks</surname><given-names>JP</given-names></name><name name-style="western"><surname>Powers</surname><given-names>MR</given-names></name></person-group><article-title>Increased retinal neovascularization in Fas ligand-deficient mice</article-title><source>Investig Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>3202</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1167/iovs.03-0050</pub-id><pub-id pub-id-type="pmid">12824272</pub-id></element-citation></ref><ref id="CR1366"><label>1366.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schumann</surname><given-names>DM</given-names></name><name name-style="western"><surname>Maedler</surname><given-names>K</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>I</given-names></name><name name-style="western"><surname>Konrad</surname><given-names>D</given-names></name><name name-style="western"><surname>St&#248;rling</surname><given-names>J</given-names></name><name name-style="western"><surname>B&#246;ni-Schnetzler</surname><given-names>M</given-names></name><etal/></person-group><article-title>The Fas pathway is involved in pancreatic beta cell secretory function</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>2861</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.0611487104</pub-id><pub-id pub-id-type="pmid">17299038</pub-id><pub-id pub-id-type="pmcid">PMC1815272</pub-id></element-citation></ref><ref id="CR1367"><label>1367.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trumpi</surname><given-names>K</given-names></name><name name-style="western"><surname>Steller</surname><given-names>EJ</given-names></name><name name-style="western"><surname>de Leng</surname><given-names>WW</given-names></name><name name-style="western"><surname>Raats</surname><given-names>DA</given-names></name><name name-style="western"><surname>Nijman</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Morsink</surname><given-names>FH</given-names></name><etal/></person-group><article-title>Mice lacking functional CD95-ligand display reduced proliferation of the intestinal epithelium without gross homeostatic alterations</article-title><source>Med Mol Morphol</source><year>2016</year><volume>49</volume><fpage>110</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s00795-015-0129-9</pub-id><pub-id pub-id-type="pmid">26700225</pub-id></element-citation></ref><ref id="CR1368"><label>1368.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukuyama</surname><given-names>H</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>M</given-names></name><name name-style="western"><surname>Suematsu</surname><given-names>S</given-names></name><name name-style="western"><surname>Miwa</surname><given-names>K</given-names></name><name name-style="western"><surname>Suda</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>N</given-names></name><etal/></person-group><article-title>Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice</article-title><source>J Immunol</source><year>1998</year><volume>160</volume><fpage>3805</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.160.8.3805</pub-id><pub-id pub-id-type="pmid">9558084</pub-id></element-citation></ref><ref id="CR1369"><label>1369.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komano</surname><given-names>H</given-names></name><name name-style="western"><surname>Ikegami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>R</given-names></name><name name-style="western"><surname>Yonehara</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamasaki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells</article-title><source>Int Immunol</source><year>1999</year><volume>11</volume><fpage>1035</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1093/intimm/11.7.1035</pub-id><pub-id pub-id-type="pmid">10383935</pub-id></element-citation></ref><ref id="CR1370"><label>1370.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stranges</surname><given-names>PB</given-names></name><name name-style="western"><surname>Watson</surname><given-names>J</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Choisy-Rossi</surname><given-names>CM</given-names></name><name name-style="western"><surname>Stonebraker</surname><given-names>AC</given-names></name><name name-style="western"><surname>Beighton</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity</article-title><source>Immunity</source><year>2007</year><volume>26</volume><fpage>629</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.03.016</pub-id><pub-id pub-id-type="pmid">17509906</pub-id><pub-id pub-id-type="pmcid">PMC2575811</pub-id></element-citation></ref><ref id="CR1371"><label>1371.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathmell</surname><given-names>JC</given-names></name><name name-style="western"><surname>Cooke</surname><given-names>MP</given-names></name><name name-style="western"><surname>Ho</surname><given-names>WY</given-names></name><name name-style="western"><surname>Grein</surname><given-names>J</given-names></name><name name-style="western"><surname>Townsend</surname><given-names>SE</given-names></name><name name-style="western"><surname>Davis</surname><given-names>MM</given-names></name><etal/></person-group><article-title>CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells</article-title><source>Nature</source><year>1995</year><volume>376</volume><fpage>181</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/376181a0</pub-id><pub-id pub-id-type="pmid">7603571</pub-id></element-citation></ref><ref id="CR1372"><label>1372.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>JQ</given-names></name><name name-style="western"><surname>Okumura</surname><given-names>C</given-names></name><name name-style="western"><surname>McCarty</surname><given-names>T</given-names></name><name name-style="western"><surname>Shin</surname><given-names>MS</given-names></name><name name-style="western"><surname>Mukhopadhyay</surname><given-names>P</given-names></name><name name-style="western"><surname>Hori</surname><given-names>M</given-names></name><etal/></person-group><article-title>Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>1467</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1084/jem.20041575</pub-id><pub-id pub-id-type="pmid">15583018</pub-id><pub-id pub-id-type="pmcid">PMC2211944</pub-id></element-citation></ref><ref id="CR1373"><label>1373.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>SL</given-names></name><name name-style="western"><surname>Robert</surname><given-names>ME</given-names></name><name name-style="western"><surname>Hayday</surname><given-names>AC</given-names></name><name name-style="western"><surname>Craft</surname><given-names>J</given-names></name></person-group><article-title>A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice</article-title><source>J Exp Med</source><year>1996</year><volume>184</volume><fpage>1149</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1084/jem.184.3.1149</pub-id><pub-id pub-id-type="pmid">9064331</pub-id><pub-id pub-id-type="pmcid">PMC2192794</pub-id></element-citation></ref><ref id="CR1374"><label>1374.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sedger</surname><given-names>LM</given-names></name><name name-style="western"><surname>Glaccum</surname><given-names>MB</given-names></name><name name-style="western"><surname>Schuh</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kanaly</surname><given-names>ST</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>E</given-names></name><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><etal/></person-group><article-title>Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice</article-title><source>Eur J Immunol</source><year>2002</year><volume>32</volume><fpage>2246</fpage><lpage>54</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1521-4141(200208)32:8&amp;#x0003c;2246::AID-IMMU2246&amp;#x0003e;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">12209637</pub-id></element-citation></ref><ref id="CR1375"><label>1375.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diehl</surname><given-names>GE</given-names></name><name name-style="western"><surname>Yue</surname><given-names>HH</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>AA</given-names></name><name name-style="western"><surname>Ho</surname><given-names>M</given-names></name><name name-style="western"><surname>Morici</surname><given-names>LA</given-names></name><etal/></person-group><article-title>TRAIL-R as a negative regulator of innate immune cell responses</article-title><source>Immunity</source><year>2004</year><volume>21</volume><fpage>877</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.11.008</pub-id><pub-id pub-id-type="pmid">15589175</pub-id></element-citation></ref><ref id="CR1376"><label>1376.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finnberg</surname><given-names>N</given-names></name><name name-style="western"><surname>Gruber</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Fei</surname><given-names>P</given-names></name><name name-style="western"><surname>Rudolph</surname><given-names>D</given-names></name><name name-style="western"><surname>Bric</surname><given-names>A</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><etal/></person-group><article-title>DR5 knockout mice are compromised in radiation-induced apoptosis</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>2000</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.5.2000-2013.2005</pub-id><pub-id pub-id-type="pmid">15713653</pub-id><pub-id pub-id-type="pmcid">PMC549384</pub-id></element-citation></ref><ref id="CR1377"><label>1377.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehnert</surname><given-names>C</given-names></name><name name-style="western"><surname>Weiswange</surname><given-names>M</given-names></name><name name-style="western"><surname>Jeremias</surname><given-names>I</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>C</given-names></name><name name-style="western"><surname>Grunert</surname><given-names>M</given-names></name><name name-style="western"><surname>Debatin</surname><given-names>KM</given-names></name><etal/></person-group><article-title>TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation</article-title><source>J Immunol</source><year>2014</year><volume>193</volume><fpage>4021</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1303242</pub-id><pub-id pub-id-type="pmid">25217163</pub-id></element-citation></ref><ref id="CR1378"><label>1378.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGrath</surname><given-names>EE</given-names></name><name name-style="western"><surname>Marriott</surname><given-names>HM</given-names></name><name name-style="western"><surname>Lawrie</surname><given-names>A</given-names></name><name name-style="western"><surname>Francis</surname><given-names>SE</given-names></name><name name-style="western"><surname>Sabroe</surname><given-names>I</given-names></name><name name-style="western"><surname>Renshaw</surname><given-names>SA</given-names></name><etal/></person-group><article-title>TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation</article-title><source>J Leukoc Biol</source><year>2011</year><volume>90</volume><fpage>855</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1189/jlb.0211062</pub-id><pub-id pub-id-type="pmid">21562052</pub-id><pub-id pub-id-type="pmcid">PMC3644175</pub-id></element-citation></ref><ref id="CR1379"><label>1379.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sacks</surname><given-names>JA</given-names></name><name name-style="western"><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><article-title>TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>4570</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.7.4570</pub-id><pub-id pub-id-type="pmid">18354179</pub-id><pub-id pub-id-type="pmcid">PMC2776088</pub-id></element-citation></ref><ref id="CR1380"><label>1380.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cretney</surname><given-names>E</given-names></name><name name-style="western"><surname>Uldrich</surname><given-names>AP</given-names></name><name name-style="western"><surname>Berzins</surname><given-names>SP</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name><name name-style="western"><surname>Godfrey</surname><given-names>DI</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>MJ</given-names></name></person-group><article-title>Normal thymocyte negative selection in TRAIL-deficient mice</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><fpage>491</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1084/jem.20030634</pub-id><pub-id pub-id-type="pmid">12900523</pub-id><pub-id pub-id-type="pmcid">PMC2194098</pub-id></element-citation></ref><ref id="CR1381"><label>1381.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marino</surname><given-names>MW</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>A</given-names></name><name name-style="western"><surname>Grail</surname><given-names>D</given-names></name><name name-style="western"><surname>Inglese</surname><given-names>M</given-names></name><name name-style="western"><surname>Noguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Richards</surname><given-names>E</given-names></name><etal/></person-group><article-title>Characterization of tumor necrosis factor-deficient mice</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>8093</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.15.8093</pub-id><pub-id pub-id-type="pmid">9223320</pub-id><pub-id pub-id-type="pmcid">PMC21562</pub-id></element-citation></ref><ref id="CR1382"><label>1382.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasparakis</surname><given-names>M</given-names></name><name name-style="western"><surname>Alexopoulou</surname><given-names>L</given-names></name><name name-style="western"><surname>Episkopou</surname><given-names>V</given-names></name><name name-style="western"><surname>Kollias</surname><given-names>G</given-names></name></person-group><article-title>Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response</article-title><source>J Exp Med</source><year>1996</year><volume>184</volume><fpage>1397</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1084/jem.184.4.1397</pub-id><pub-id pub-id-type="pmid">8879212</pub-id><pub-id pub-id-type="pmcid">PMC2192824</pub-id></element-citation></ref><ref id="CR1383"><label>1383.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasparakis</surname><given-names>M</given-names></name><name name-style="western"><surname>Alexopoulou</surname><given-names>L</given-names></name><name name-style="western"><surname>Grell</surname><given-names>M</given-names></name><name name-style="western"><surname>Pfizenmaier</surname><given-names>K</given-names></name><name name-style="western"><surname>Bluethmann</surname><given-names>H</given-names></name><name name-style="western"><surname>Kollias</surname><given-names>G</given-names></name></person-group><article-title>Peyer&#8217;s patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>6319</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.12.6319</pub-id><pub-id pub-id-type="pmid">9177215</pub-id><pub-id pub-id-type="pmcid">PMC21047</pub-id></element-citation></ref><ref id="CR1384"><label>1384.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#246;rner</surname><given-names>H</given-names></name><name name-style="western"><surname>Cook</surname><given-names>M</given-names></name><name name-style="western"><surname>Riminton</surname><given-names>DS</given-names></name><name name-style="western"><surname>Lemckert</surname><given-names>FA</given-names></name><name name-style="western"><surname>Hoek</surname><given-names>RM</given-names></name><name name-style="western"><surname>Ledermann</surname><given-names>B</given-names></name><etal/></person-group><article-title>Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue</article-title><source>Eur J Immunol</source><year>1997</year><volume>27</volume><fpage>2600</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/eji.1830271020</pub-id><pub-id pub-id-type="pmid">9368616</pub-id></element-citation></ref><ref id="CR1385"><label>1385.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oishi</surname><given-names>N</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>HW</given-names></name><name name-style="western"><surname>Hill</surname><given-names>K</given-names></name><name name-style="western"><surname>Schacht</surname><given-names>J</given-names></name><name name-style="western"><surname>Sha</surname><given-names>SH</given-names></name></person-group><article-title>Tumor necrosis factor-alpha-mutant mice exhibit high frequency hearing loss</article-title><source>J Assoc Res Otolaryngology</source><year>2013</year><volume>14</volume><fpage>801</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s10162-013-0410-3</pub-id><pub-id pub-id-type="pmcid">PMC3825018</pub-id><pub-id pub-id-type="pmid">23996384</pub-id></element-citation></ref><ref id="CR1386"><label>1386.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfeffer</surname><given-names>K</given-names></name><name name-style="western"><surname>Matsuyama</surname><given-names>T</given-names></name><name name-style="western"><surname>K&#252;ndig</surname><given-names>TM</given-names></name><name name-style="western"><surname>Wakeham</surname><given-names>A</given-names></name><name name-style="western"><surname>Kishihara</surname><given-names>K</given-names></name><name name-style="western"><surname>Shahinian</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection</article-title><source>Cell</source><year>1993</year><volume>73</volume><fpage>457</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90134-C</pub-id><pub-id pub-id-type="pmid">8387893</pub-id></element-citation></ref><ref id="CR1387"><label>1387.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothe</surname><given-names>J</given-names></name><name name-style="western"><surname>Lesslauer</surname><given-names>W</given-names></name><name name-style="western"><surname>L&#246;tscher</surname><given-names>H</given-names></name><name name-style="western"><surname>Lang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Koebel</surname><given-names>P</given-names></name><name name-style="western"><surname>K&#246;ntgen</surname><given-names>F</given-names></name><etal/></person-group><article-title>Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes</article-title><source>Nature</source><year>1993</year><volume>364</volume><fpage>798</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1038/364798a0</pub-id><pub-id pub-id-type="pmid">8395024</pub-id></element-citation></ref><ref id="CR1388"><label>1388.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubota</surname><given-names>T</given-names></name><name name-style="western"><surname>McTiernan</surname><given-names>CF</given-names></name><name name-style="western"><surname>Frye</surname><given-names>CS</given-names></name><name name-style="western"><surname>Demetris</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>AM</given-names></name></person-group><article-title>Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice</article-title><source>J Card Fail</source><year>1997</year><volume>3</volume><fpage>117</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/S1071-9164(97)90045-2</pub-id><pub-id pub-id-type="pmid">9220311</pub-id></element-citation></ref><ref id="CR1389"><label>1389.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubota</surname><given-names>T</given-names></name><name name-style="western"><surname>McTiernan</surname><given-names>CF</given-names></name><name name-style="western"><surname>Frye</surname><given-names>CS</given-names></name><name name-style="western"><surname>Slawson</surname><given-names>SE</given-names></name><name name-style="western"><surname>Lemster</surname><given-names>BH</given-names></name><name name-style="western"><surname>Koretsky</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha</article-title><source>Circ Res</source><year>1997</year><volume>81</volume><fpage>627</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1161/01.RES.81.4.627</pub-id><pub-id pub-id-type="pmid">9314845</pub-id></element-citation></ref><ref id="CR1390"><label>1390.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lacey</surname><given-names>D</given-names></name><name name-style="western"><surname>Hickey</surname><given-names>P</given-names></name><name name-style="western"><surname>Arhatari</surname><given-names>BD</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>LA</given-names></name><name name-style="western"><surname>Rohrbeck</surname><given-names>L</given-names></name><name name-style="western"><surname>Kiriazis</surname><given-names>H</given-names></name><etal/></person-group><article-title>Spontaneous retrotransposon insertion into TNF 3&#8217;UTR causes heart valve disease and chronic polyarthritis</article-title><source>Proc Natl Acad Sci USA</source><year>2015</year><volume>112</volume><fpage>9698</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1073/pnas.1508399112</pub-id><pub-id pub-id-type="pmid">26195802</pub-id><pub-id pub-id-type="pmcid">PMC4534232</pub-id></element-citation></ref><ref id="CR1391"><label>1391.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sedger</surname><given-names>LM</given-names></name><name name-style="western"><surname>Katewa</surname><given-names>A</given-names></name><name name-style="western"><surname>Pettersen</surname><given-names>AK</given-names></name><name name-style="western"><surname>Osvath</surname><given-names>SR</given-names></name><name name-style="western"><surname>Farrell</surname><given-names>GC</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>Extreme lymphoproliferative disease and fatal autoimmune thrombocytopenia in FasL and TRAIL double-deficient mice</article-title><source>Blood</source><year>2010</year><volume>115</volume><fpage>3258</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-11-255497</pub-id><pub-id pub-id-type="pmid">20185587</pub-id><pub-id pub-id-type="pmcid">PMC2858490</pub-id></element-citation></ref><ref id="CR1392"><label>1392.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>K&#246;rner</surname><given-names>H</given-names></name><name name-style="western"><surname>Cretney</surname><given-names>E</given-names></name><name name-style="western"><surname>Wilhelm</surname><given-names>P</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>JM</given-names></name><name name-style="western"><surname>R&#246;llinghoff</surname><given-names>M</given-names></name><name name-style="western"><surname>Sedgwick</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1084/jem.191.1.89</pub-id><pub-id pub-id-type="pmid">10620607</pub-id><pub-id pub-id-type="pmcid">PMC2195803</pub-id></element-citation></ref><ref id="CR1393"><label>1393.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meynier</surname><given-names>S</given-names></name><name name-style="western"><surname>Rieux-Laucat</surname><given-names>F</given-names></name></person-group><article-title>FAS and RAS related apoptosis defects: from autoimmunity to leukemia</article-title><source>Immunol Rev</source><year>2019</year><volume>287</volume><fpage>50</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1111/imr.12720</pub-id><pub-id pub-id-type="pmid">30565243</pub-id></element-citation></ref><ref id="CR1394"><label>1394.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rieux-Laucat</surname><given-names>F</given-names></name><name name-style="western"><surname>Mag&#233;rus-Chatinet</surname><given-names>A</given-names></name><name name-style="western"><surname>Neven</surname><given-names>B</given-names></name></person-group><article-title>The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions</article-title><source>J Clin Immunol</source><year>2018</year><volume>38</volume><fpage>558</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1007/s10875-018-0523-x</pub-id><pub-id pub-id-type="pmid">29911256</pub-id></element-citation></ref><ref id="CR1395"><label>1395.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del-Rey</surname><given-names>M</given-names></name><name name-style="western"><surname>Ruiz-Contreras</surname><given-names>J</given-names></name><name name-style="western"><surname>Bosque</surname><given-names>A</given-names></name><name name-style="western"><surname>Calleja</surname><given-names>S</given-names></name><name name-style="western"><surname>Gomez-Rial</surname><given-names>J</given-names></name><name name-style="western"><surname>Roldan</surname><given-names>E</given-names></name><etal/></person-group><article-title>A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome</article-title><source>Blood</source><year>2006</year><volume>108</volume><fpage>1306</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-04-015776</pub-id><pub-id pub-id-type="pmid">16627752</pub-id></element-citation></ref><ref id="CR1396"><label>1396.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>GH</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Straus</surname><given-names>SE</given-names></name><name name-style="western"><surname>Dale</surname><given-names>JK</given-names></name><name name-style="western"><surname>Middleton</surname><given-names>LA</given-names></name><name name-style="western"><surname>Lin</surname><given-names>AY</given-names></name><etal/></person-group><article-title>Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome</article-title><source>Cell</source><year>1995</year><volume>81</volume><fpage>935</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90013-6</pub-id><pub-id pub-id-type="pmid">7540117</pub-id></element-citation></ref><ref id="CR1397"><label>1397.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magerus-Chatinet</surname><given-names>A</given-names></name><name name-style="western"><surname>Stolzenberg</surname><given-names>MC</given-names></name><name name-style="western"><surname>Loffredo</surname><given-names>MS</given-names></name><name name-style="western"><surname>Neven</surname><given-names>B</given-names></name><name name-style="western"><surname>Schaffner</surname><given-names>C</given-names></name><name name-style="western"><surname>Ducrot</surname><given-names>N</given-names></name><etal/></person-group><article-title>FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>3027</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-09-179630</pub-id><pub-id pub-id-type="pmid">19176318</pub-id></element-citation></ref><ref id="CR1398"><label>1398.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rensing-Ehl</surname><given-names>A</given-names></name><name name-style="western"><surname>V&#246;lkl</surname><given-names>S</given-names></name><name name-style="western"><surname>Speckmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Lorenz</surname><given-names>MR</given-names></name><name name-style="western"><surname>Ritter</surname><given-names>J</given-names></name><name name-style="western"><surname>Janda</surname><given-names>A</given-names></name><etal/></person-group><article-title>Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency</article-title><source>Blood</source><year>2014</year><volume>124</volume><fpage>851</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-03-564286</pub-id><pub-id pub-id-type="pmid">24894771</pub-id></element-citation></ref><ref id="CR1399"><label>1399.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>S</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>PA</given-names></name><name name-style="western"><surname>Seitz</surname><given-names>A</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>G</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J</given-names></name><name name-style="western"><surname>Niemela</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations</article-title><source>Blood</source><year>2014</year><volume>123</volume><fpage>1989</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-10-535393</pub-id><pub-id pub-id-type="pmid">24398331</pub-id><pub-id pub-id-type="pmcid">PMC3968385</pub-id></element-citation></ref><ref id="CR1400"><label>1400.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bi</surname><given-names>LL</given-names></name><name name-style="western"><surname>Pan</surname><given-names>G</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>TP</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Dale</surname><given-names>JK</given-names></name><name name-style="western"><surname>Makris</surname><given-names>C</given-names></name><etal/></person-group><article-title>Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib</article-title><source>BMC Med Genet</source><year>2007</year><volume>8</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/1471-2350-8-41</pub-id><pub-id pub-id-type="pmid">17605793</pub-id><pub-id pub-id-type="pmcid">PMC1931585</pub-id></element-citation></ref><ref id="CR1401"><label>1401.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Venkataraman</surname><given-names>G</given-names></name><name name-style="western"><surname>McClain</surname><given-names>KL</given-names></name><name name-style="western"><surname>Pittaluga</surname><given-names>S</given-names></name><name name-style="western"><surname>Rao</surname><given-names>VK</given-names></name><name name-style="western"><surname>Jaffe</surname><given-names>ES</given-names></name></person-group><article-title>Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease</article-title><source>Am J Surg Pathol</source><year>2010</year><volume>34</volume><fpage>589</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1097/PAS.0b013e3181d5ddf8</pub-id><pub-id pub-id-type="pmid">20216376</pub-id><pub-id pub-id-type="pmcid">PMC2861546</pub-id></element-citation></ref><ref id="CR1402"><label>1402.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haas</surname><given-names>SL</given-names></name><name name-style="western"><surname>Lohse</surname><given-names>P</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>WH</given-names></name><name name-style="western"><surname>Hildenbrand</surname><given-names>R</given-names></name><name name-style="western"><surname>Karaorman</surname><given-names>M</given-names></name><name name-style="western"><surname>Singer</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution</article-title><source>Gastroenterology</source><year>2006</year><volume>130</volume><fpage>172</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2005.09.014</pub-id><pub-id pub-id-type="pmid">16401480</pub-id></element-citation></ref><ref id="CR1403"><label>1403.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsuji</surname><given-names>S</given-names></name><name name-style="western"><surname>Matsuzaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Iseki</surname><given-names>M</given-names></name><name name-style="western"><surname>Nagasu</surname><given-names>A</given-names></name><name name-style="western"><surname>Hirano</surname><given-names>H</given-names></name><name name-style="western"><surname>Ishihara</surname><given-names>K</given-names></name><etal/></person-group><article-title>Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome</article-title><source>Clin Exp Immunol</source><year>2019</year><volume>198</volume><fpage>416</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1111/cei.13365</pub-id><pub-id pub-id-type="pmid">31429073</pub-id><pub-id pub-id-type="pmcid">PMC6857086</pub-id></element-citation></ref><ref id="CR1404"><label>1404.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDermott</surname><given-names>MF</given-names></name><name name-style="western"><surname>Aksentijevich</surname><given-names>I</given-names></name><name name-style="western"><surname>Galon</surname><given-names>J</given-names></name><name name-style="western"><surname>McDermott</surname><given-names>EM</given-names></name><name name-style="western"><surname>Ogunkolade</surname><given-names>BW</given-names></name><name name-style="western"><surname>Centola</surname><given-names>M</given-names></name><etal/></person-group><article-title>Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes</article-title><source>Cell</source><year>1999</year><volume>97</volume><fpage>133</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80721-7</pub-id><pub-id pub-id-type="pmid">10199409</pub-id></element-citation></ref><ref id="CR1405"><label>1405.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeh</surname><given-names>WC</given-names></name><name name-style="western"><surname>de la Pompa</surname><given-names>JL</given-names></name><name name-style="western"><surname>McCurrach</surname><given-names>ME</given-names></name><name name-style="western"><surname>Shu</surname><given-names>HB</given-names></name><name name-style="western"><surname>Elia</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Shahinian</surname><given-names>A</given-names></name><etal/></person-group><article-title>FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis</article-title><source>Science</source><year>1998</year><volume>279</volume><fpage>1954</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1126/science.279.5358.1954</pub-id><pub-id pub-id-type="pmid">9506948</pub-id></element-citation></ref><ref id="CR1406"><label>1406.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imtiyaz</surname><given-names>HZ</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Hu</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>9917</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1074/jbc.M900249200</pub-id><pub-id pub-id-type="pmid">19203997</pub-id><pub-id pub-id-type="pmcid">PMC2665115</pub-id></element-citation></ref><ref id="CR1407"><label>1407.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>McQuade</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Chan</surname><given-names>FK</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Functional complementation between FADD and RIP1 in embryos and lymphocytes</article-title><source>Nature</source><year>2011</year><volume>471</volume><fpage>373</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nature09878</pub-id><pub-id pub-id-type="pmid">21368761</pub-id><pub-id pub-id-type="pmcid">PMC3072026</pub-id></element-citation></ref><ref id="CR1408"><label>1408.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varfolomeev</surname><given-names>EE</given-names></name><name name-style="western"><surname>Schuchmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Luria</surname><given-names>V</given-names></name><name name-style="western"><surname>Chiannilkulchai</surname><given-names>N</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mett</surname><given-names>IL</given-names></name><etal/></person-group><article-title>Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally</article-title><source>Immunity</source><year>1998</year><volume>9</volume><fpage>267</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80609-3</pub-id><pub-id pub-id-type="pmid">9729047</pub-id></element-citation></ref><ref id="CR1409"><label>1409.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakamaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>T</given-names></name><name name-style="western"><surname>Asano</surname><given-names>M</given-names></name><name name-style="western"><surname>Sudo</surname><given-names>K</given-names></name><name name-style="western"><surname>Kazama</surname><given-names>H</given-names></name><name name-style="western"><surname>Sakagami</surname><given-names>J</given-names></name><etal/></person-group><article-title>Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart</article-title><source>Cell Death Differ</source><year>2002</year><volume>9</volume><fpage>1196</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401090</pub-id><pub-id pub-id-type="pmid">12404118</pub-id></element-citation></ref><ref id="CR1410"><label>1410.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeh</surname><given-names>WC</given-names></name><name name-style="western"><surname>Itie</surname><given-names>A</given-names></name><name name-style="western"><surname>Elia</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ng</surname><given-names>M</given-names></name><name name-style="western"><surname>Shu</surname><given-names>HB</given-names></name><name name-style="western"><surname>Wakeham</surname><given-names>A</given-names></name><etal/></person-group><article-title>Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development</article-title><source>Immunity</source><year>2000</year><volume>12</volume><fpage>633</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80214-9</pub-id><pub-id pub-id-type="pmid">10894163</pub-id></element-citation></ref><ref id="CR1411"><label>1411.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Chio</surname><given-names>II</given-names></name><name name-style="western"><surname>Lin</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>G</given-names></name><name name-style="western"><surname>Chau</surname><given-names>H</given-names></name><name name-style="western"><surname>Katz</surname><given-names>D</given-names></name><etal/></person-group><article-title>Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>12429</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1073/pnas.0806585105</pub-id><pub-id pub-id-type="pmid">18719121</pub-id><pub-id pub-id-type="pmcid">PMC2518828</pub-id></element-citation></ref><ref id="CR1412"><label>1412.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ermolaeva</surname><given-names>MA</given-names></name><name name-style="western"><surname>Michallet</surname><given-names>MC</given-names></name><name name-style="western"><surname>Papadopoulou</surname><given-names>N</given-names></name><name name-style="western"><surname>Uterm&#246;hlen</surname><given-names>O</given-names></name><name name-style="western"><surname>Kranidioti</surname><given-names>K</given-names></name><name name-style="western"><surname>Kollias</surname><given-names>G</given-names></name><etal/></person-group><article-title>Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses</article-title><source>Nat Immunol</source><year>2008</year><volume>9</volume><fpage>1037</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/ni.1638</pub-id><pub-id pub-id-type="pmid">18641654</pub-id></element-citation></ref><ref id="CR1413"><label>1413.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pobezinskaya</surname><given-names>YL</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YS</given-names></name><name name-style="western"><surname>Choksi</surname><given-names>S</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><article-title>The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors</article-title><source>Nat Immunol</source><year>2008</year><volume>9</volume><fpage>1047</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1038/ni.1639</pub-id><pub-id pub-id-type="pmid">18641653</pub-id><pub-id pub-id-type="pmcid">PMC2577920</pub-id></element-citation></ref><ref id="CR1414"><label>1414.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelliher</surname><given-names>MA</given-names></name><name name-style="western"><surname>Grimm</surname><given-names>S</given-names></name><name name-style="western"><surname>Ishida</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>F</given-names></name><name name-style="western"><surname>Stanger</surname><given-names>BZ</given-names></name><name name-style="western"><surname>Leder</surname><given-names>P</given-names></name></person-group><article-title>The death domain kinase RIP mediates the TNF-induced NF-kappaB signal</article-title><source>Immunity</source><year>1998</year><volume>8</volume><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80535-X</pub-id><pub-id pub-id-type="pmid">9529147</pub-id></element-citation></ref><ref id="CR1415"><label>1415.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roderick</surname><given-names>JE</given-names></name><name name-style="western"><surname>Hermance</surname><given-names>N</given-names></name><name name-style="western"><surname>Zelic</surname><given-names>M</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Polykratis</surname><given-names>A</given-names></name><name name-style="western"><surname>Pasparakis</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>14436</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1073/pnas.1409389111</pub-id><pub-id pub-id-type="pmid">25246544</pub-id><pub-id pub-id-type="pmcid">PMC4209989</pub-id></element-citation></ref><ref id="CR1416"><label>1416.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moulin</surname><given-names>M</given-names></name><name name-style="western"><surname>Anderton</surname><given-names>H</given-names></name><name name-style="western"><surname>Voss</surname><given-names>AK</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>T</given-names></name><name name-style="western"><surname>Wong</surname><given-names>WW</given-names></name><name name-style="western"><surname>Bankovacki</surname><given-names>A</given-names></name><etal/></person-group><article-title>IAPs limit activation of RIP kinases by TNF receptor 1 during development</article-title><source>EMBO J</source><year>2012</year><volume>31</volume><fpage>1679</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.18</pub-id><pub-id pub-id-type="pmid">22327219</pub-id><pub-id pub-id-type="pmcid">PMC3321198</pub-id></element-citation></ref><ref id="CR1417"><label>1417.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heard</surname><given-names>KN</given-names></name><name name-style="western"><surname>Bertrand</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Barker</surname><given-names>PA</given-names></name></person-group><article-title>cIAP2 supports viability of mice lacking cIAP1 and XIAP</article-title><source>EMBO J</source><year>2015</year><volume>34</volume><fpage>2393</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.15252/embj.201592060</pub-id><pub-id pub-id-type="pmid">26427758</pub-id><pub-id pub-id-type="pmcid">PMC4601659</pub-id></element-citation></ref><ref id="CR1418"><label>1418.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><etal/></person-group><article-title>RIPK3 mediates necroptosis during embryonic development and postnatal inflammation in Fadd-deficient mice</article-title><source>Cell Rep</source><year>2017</year><volume>19</volume><fpage>798</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.011</pub-id><pub-id pub-id-type="pmid">28445730</pub-id></element-citation></ref><ref id="CR1419"><label>1419.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newton</surname><given-names>K</given-names></name><name name-style="western"><surname>Wickliffe</surname><given-names>KE</given-names></name><name name-style="western"><surname>Dugger</surname><given-names>DL</given-names></name><name name-style="western"><surname>Maltzman</surname><given-names>A</given-names></name><name name-style="western"><surname>Roose-Girma</surname><given-names>M</given-names></name><name name-style="western"><surname>Dohse</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis</article-title><source>Nature</source><year>2019</year><volume>574</volume><fpage>428</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1548-x</pub-id><pub-id pub-id-type="pmid">31511692</pub-id></element-citation></ref><ref id="CR1420"><label>1420.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>JP</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development</article-title><source>Cell Death Dis</source><year>2019</year><volume>10</volume><fpage>245</fpage><pub-id pub-id-type="doi">10.1038/s41419-019-1490-8</pub-id><pub-id pub-id-type="pmid">30867408</pub-id><pub-id pub-id-type="pmcid">PMC6416317</pub-id></element-citation></ref><ref id="CR1421"><label>1421.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderton</surname><given-names>H</given-names></name><name name-style="western"><surname>Bandala-Sanchez</surname><given-names>E</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>DS</given-names></name><name name-style="western"><surname>Rickard</surname><given-names>JA</given-names></name><name name-style="western"><surname>Ng</surname><given-names>AP</given-names></name><name name-style="western"><surname>Di Rago</surname><given-names>L</given-names></name><etal/></person-group><article-title>RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development</article-title><source>Cell Death Differ</source><year>2019</year><volume>26</volume><fpage>877</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/s41418-018-0166-8</pub-id><pub-id pub-id-type="pmid">30185824</pub-id><pub-id pub-id-type="pmcid">PMC6461919</pub-id></element-citation></ref><ref id="CR1422"><label>1422.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowling</surname><given-names>JP</given-names></name><name name-style="western"><surname>Alsabbagh</surname><given-names>M</given-names></name><name name-style="western"><surname>Del Casale</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><fpage>705</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-08584-5</pub-id><pub-id pub-id-type="pmid">30741936</pub-id><pub-id pub-id-type="pmcid">PMC6370879</pub-id></element-citation></ref><ref id="CR1423"><label>1423.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Oh</surname><given-names>GS</given-names></name><name name-style="western"><surname>Scandella</surname><given-names>E</given-names></name><name name-style="western"><surname>Bolinger</surname><given-names>B</given-names></name><name name-style="western"><surname>Ludewig</surname><given-names>B</given-names></name><name name-style="western"><surname>Kovalenko</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>2522</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.4.2522</pub-id><pub-id pub-id-type="pmid">18684943</pub-id></element-citation></ref><ref id="CR1424"><label>1424.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fritsch</surname><given-names>M</given-names></name><name name-style="western"><surname>G&#252;nther</surname><given-names>SD</given-names></name><name name-style="western"><surname>Schwarzer</surname><given-names>R</given-names></name><name name-style="western"><surname>Albert</surname><given-names>MC</given-names></name><name name-style="western"><surname>Schorn</surname><given-names>F</given-names></name><name name-style="western"><surname>Werthenbach</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis</article-title><source>Nature</source><year>2019</year><volume>575</volume><fpage>683</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1770-6</pub-id><pub-id pub-id-type="pmid">31748744</pub-id></element-citation></ref><ref id="CR1425"><label>1425.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tummers</surname><given-names>B</given-names></name><name name-style="western"><surname>Mari</surname><given-names>L</given-names></name><name name-style="western"><surname>Guy</surname><given-names>CS</given-names></name><name name-style="western"><surname>Heckmann</surname><given-names>BL</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>DA</given-names></name><name name-style="western"><surname>R&#252;hl</surname><given-names>S</given-names></name><etal/></person-group><article-title>Caspase-8-dependent inflammatory responses are controlled by its adaptor, FADD, and necroptosis</article-title><source>Immunity</source><year>2020</year><volume>52</volume><fpage>994</fpage><lpage>1006.e1008</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.04.010</pub-id><pub-id pub-id-type="pmid">32428502</pub-id><pub-id pub-id-type="pmcid">PMC7306001</pub-id></element-citation></ref><ref id="CR1426"><label>1426.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newton</surname><given-names>K</given-names></name><name name-style="western"><surname>Wickliffe</surname><given-names>KE</given-names></name><name name-style="western"><surname>Maltzman</surname><given-names>A</given-names></name><name name-style="western"><surname>Dugger</surname><given-names>DL</given-names></name><name name-style="western"><surname>Reja</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Activity of caspase-8 determines plasticity between cell death pathways</article-title><source>Nature</source><year>2019</year><volume>575</volume><fpage>679</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1752-8</pub-id><pub-id pub-id-type="pmid">31723262</pub-id></element-citation></ref><ref id="CR1427"><label>1427.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>C</given-names></name><name name-style="western"><surname>Pu</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>B</given-names></name><etal/></person-group><article-title>Lack of FADD in Tie-2 expressing cells causes RIPK3-mediated embryonic lethality</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2351</fpage><pub-id pub-id-type="doi">10.1038/cddis.2016.251</pub-id><pub-id pub-id-type="pmid">27584790</pub-id><pub-id pub-id-type="pmcid">PMC5059855</pub-id></element-citation></ref><ref id="CR1428"><label>1428.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Z&#246;rnig</surname><given-names>M</given-names></name><name name-style="western"><surname>Hueber</surname><given-names>AO</given-names></name><name name-style="western"><surname>Evan</surname><given-names>G</given-names></name></person-group><article-title>p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice</article-title><source>Curr Biol</source><year>1998</year><volume>8</volume><fpage>467</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(98)70182-4</pub-id><pub-id pub-id-type="pmid">9550704</pub-id></element-citation></ref><ref id="CR1429"><label>1429.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Cado</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A</given-names></name><name name-style="western"><surname>Kabra</surname><given-names>NH</given-names></name><name name-style="western"><surname>Winoto</surname><given-names>A</given-names></name></person-group><article-title>Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1</article-title><source>Nature</source><year>1998</year><volume>392</volume><fpage>296</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1038/32681</pub-id><pub-id pub-id-type="pmid">9521326</pub-id></element-citation></ref><ref id="CR1430"><label>1430.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><article-title>FADD regulates thymocyte development at the &#946;-selection checkpoint by modulating Notch signaling</article-title><source>Cell Death Dis</source><year>2014</year><volume>5</volume><fpage>e1273</fpage><pub-id pub-id-type="doi">10.1038/cddis.2014.198</pub-id><pub-id pub-id-type="pmid">24901044</pub-id><pub-id pub-id-type="pmcid">PMC4611708</pub-id></element-citation></ref><ref id="CR1431"><label>1431.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newton</surname><given-names>K</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AW</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>931</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.5.931</pub-id><pub-id pub-id-type="pmid">10698935</pub-id><pub-id pub-id-type="pmcid">PMC305633</pub-id></element-citation></ref><ref id="CR1432"><label>1432.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kabra</surname><given-names>NH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>C</given-names></name><name name-style="western"><surname>Hsing</surname><given-names>LC</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Winoto</surname><given-names>A</given-names></name></person-group><article-title>T cell-specific FADD-deficient mice: FADD is required for early T cell development</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>6307</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1073/pnas.111158698</pub-id><pub-id pub-id-type="pmid">11353862</pub-id><pub-id pub-id-type="pmcid">PMC33464</pub-id></element-citation></ref><ref id="CR1433"><label>1433.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Imtiyaz</surname><given-names>HZ</given-names></name><name name-style="western"><surname>Hou</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>3033</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.5.3033</pub-id><pub-id pub-id-type="pmid">16116191</pub-id><pub-id pub-id-type="pmcid">PMC3110086</pub-id></element-citation></ref><ref id="CR1434"><label>1434.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osborn</surname><given-names>SL</given-names></name><name name-style="western"><surname>Diehl</surname><given-names>G</given-names></name><name name-style="western"><surname>Han</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Xue</surname><given-names>L</given-names></name><name name-style="western"><surname>Kurd</surname><given-names>N</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>K</given-names></name><etal/></person-group><article-title>Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>13034</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.1005997107</pub-id><pub-id pub-id-type="pmid">20615958</pub-id><pub-id pub-id-type="pmcid">PMC2919948</pub-id></element-citation></ref><ref id="CR1435"><label>1435.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XY</given-names></name><name name-style="western"><surname>Yang</surname><given-names>BY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Mo</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Hua</surname><given-names>ZC</given-names></name></person-group><article-title>FADD is essential for glucose uptake and survival of thymocytes</article-title><source>Biochem Biophys Res Commun</source><year>2014</year><volume>451</volume><fpage>202</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2014.07.092</pub-id><pub-id pub-id-type="pmid">25078620</pub-id></element-citation></ref><ref id="CR1436"><label>1436.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>CM</given-names></name><name name-style="western"><surname>Wen</surname><given-names>BG</given-names></name><name name-style="western"><surname>Chinnaiyan</surname><given-names>AM</given-names></name><name name-style="western"><surname>O&#8217;Rourke</surname><given-names>K</given-names></name><name name-style="western"><surname>Dixit</surname><given-names>VM</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>SM</given-names></name></person-group><article-title>A role for FADD in T cell activation and development</article-title><source>Immunity</source><year>1998</year><volume>8</volume><fpage>439</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80549-X</pub-id><pub-id pub-id-type="pmid">9586634</pub-id></element-citation></ref><ref id="CR1437"><label>1437.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newton</surname><given-names>K</given-names></name><name name-style="western"><surname>Kurts</surname><given-names>C</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AW</given-names></name><name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name></person-group><article-title>Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells</article-title><source>Curr Biol</source><year>2001</year><volume>11</volume><fpage>273</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(01)00067-7</pub-id><pub-id pub-id-type="pmid">11250157</pub-id></element-citation></ref><ref id="CR1438"><label>1438.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imtiyaz</surname><given-names>HZ</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Hou</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Manser</surname><given-names>T</given-names></name><etal/></person-group><article-title>The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><fpage>6852</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.11.6852</pub-id><pub-id pub-id-type="pmid">16709845</pub-id><pub-id pub-id-type="pmcid">PMC3110081</pub-id></element-citation></ref><ref id="CR1439"><label>1439.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name><name name-style="western"><surname>Lemmers</surname><given-names>B</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>A</given-names></name><name name-style="western"><surname>Matysiak-Zablocki</surname><given-names>E</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>K</given-names></name><name name-style="western"><surname>Au</surname><given-names>PY</given-names></name><etal/></person-group><article-title>Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity</article-title><source>Genes Dev</source><year>2003</year><volume>17</volume><fpage>883</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1101/gad.1063703</pub-id><pub-id pub-id-type="pmid">12654726</pub-id><pub-id pub-id-type="pmcid">PMC196031</pub-id></element-citation></ref><ref id="CR1440"><label>1440.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beisner</surname><given-names>DR</given-names></name><name name-style="western"><surname>Ch&#8217;en</surname><given-names>IL</given-names></name><name name-style="western"><surname>Kolla</surname><given-names>RV</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>SM</given-names></name></person-group><article-title>Cutting edge: innate immunity conferred by B cells is regulated by caspase-8</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>3469</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.6.3469</pub-id><pub-id pub-id-type="pmid">16148088</pub-id></element-citation></ref><ref id="CR1441"><label>1441.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lemmers</surname><given-names>B</given-names></name><name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name><name name-style="western"><surname>Bid&#232;re</surname><given-names>N</given-names></name><name name-style="western"><surname>Su</surname><given-names>H</given-names></name><name name-style="western"><surname>Matysiak-Zablocki</surname><given-names>E</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>K</given-names></name><etal/></person-group><article-title>Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>7416</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1074/jbc.M606721200</pub-id><pub-id pub-id-type="pmid">17213198</pub-id></element-citation></ref><ref id="CR1442"><label>1442.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>N</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name></person-group><article-title>An essential role for c-FLIP in the efficient development of mature T lymphocytes</article-title><source>J Exp Med</source><year>2005</year><volume>202</volume><fpage>395</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1084/jem.20050117</pub-id><pub-id pub-id-type="pmid">16043517</pub-id><pub-id pub-id-type="pmcid">PMC2213074</pub-id></element-citation></ref><ref id="CR1443"><label>1443.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chau</surname><given-names>H</given-names></name><name name-style="western"><surname>Wong</surname><given-names>V</given-names></name><name name-style="western"><surname>Chen</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Huang</surname><given-names>HL</given-names></name><name name-style="western"><surname>Lin</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Mirtsos</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cellular FLICE-inhibitory protein is required for T cell survival and cycling</article-title><source>J Exp Med</source><year>2005</year><volume>202</volume><fpage>405</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1084/jem.20050118</pub-id><pub-id pub-id-type="pmid">16043518</pub-id><pub-id pub-id-type="pmcid">PMC2213079</pub-id></element-citation></ref><ref id="CR1444"><label>1444.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Coffey</surname><given-names>FJ</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name><name name-style="western"><surname>Manser</surname><given-names>T</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>RR</given-names></name><etal/></person-group><article-title>A role for cFLIP in B cell proliferation and stress MAPK regulation</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><fpage>207</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.182.1.207</pub-id><pub-id pub-id-type="pmid">19109151</pub-id><pub-id pub-id-type="pmcid">PMC2720129</pub-id></element-citation></ref><ref id="CR1445"><label>1445.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kennedy</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Kataoka</surname><given-names>T</given-names></name><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name><name name-style="western"><surname>Budd</surname><given-names>RC</given-names></name></person-group><article-title>Caspase activation is required for T cell proliferation</article-title><source>J Exp Med</source><year>1999</year><volume>190</volume><fpage>1891</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1084/jem.190.12.1891</pub-id><pub-id pub-id-type="pmid">10601363</pub-id><pub-id pub-id-type="pmcid">PMC2195711</pub-id></element-citation></ref><ref id="CR1446"><label>1446.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohgaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Mozo</surname><given-names>J</given-names></name><name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name><name name-style="western"><surname>Matysiak-Zablocki</surname><given-names>E</given-names></name><name name-style="western"><surname>Bohgaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanchez</surname><given-names>O</given-names></name><etal/></person-group><article-title>Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim&#8722;/&#8722; mice</article-title><source>J Cell Biol</source><year>2011</year><volume>195</volume><fpage>277</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1083/jcb.201103053</pub-id><pub-id pub-id-type="pmid">22006951</pub-id><pub-id pub-id-type="pmcid">PMC3198166</pub-id></element-citation></ref><ref id="CR1447"><label>1447.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name><name name-style="western"><surname>Hakem</surname><given-names>R</given-names></name></person-group><article-title>Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder</article-title><source>J Exp Med</source><year>2005</year><volume>202</volume><fpage>727</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1084/jem.20050683</pub-id><pub-id pub-id-type="pmid">16157684</pub-id><pub-id pub-id-type="pmcid">PMC2212954</pub-id></element-citation></ref><ref id="CR1448"><label>1448.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>FADD deficiency impairs early hematopoiesis in the bone marrow</article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>203</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000648</pub-id><pub-id pub-id-type="pmid">21115735</pub-id><pub-id pub-id-type="pmcid">PMC3119601</pub-id></element-citation></ref><ref id="CR1449"><label>1449.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pellegrini</surname><given-names>M</given-names></name><name name-style="western"><surname>Bath</surname><given-names>S</given-names></name><name name-style="western"><surname>Marsden</surname><given-names>VS</given-names></name><name name-style="western"><surname>Huang</surname><given-names>DC</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>D</given-names></name><name name-style="western"><surname>Harris</surname><given-names>AW</given-names></name><etal/></person-group><article-title>FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells</article-title><source>Blood</source><year>2005</year><volume>106</volume><fpage>1581</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-01-0284</pub-id><pub-id pub-id-type="pmid">15905188</pub-id><pub-id pub-id-type="pmcid">PMC1895211</pub-id></element-citation></ref><ref id="CR1450"><label>1450.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schock</surname><given-names>SN</given-names></name><name name-style="western"><surname>Young</surname><given-names>JA</given-names></name><name name-style="western"><surname>He</surname><given-names>TH</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Winoto</surname><given-names>A</given-names></name></person-group><article-title>Deletion of FADD in macrophages and granulocytes results in RIP3- and MyD88-dependent systemic inflammation</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0124391</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0124391</pub-id><pub-id pub-id-type="pmid">25874713</pub-id><pub-id pub-id-type="pmcid">PMC4395384</pub-id></element-citation></ref><ref id="CR1451"><label>1451.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuda</surname><given-names>CM</given-names></name><name name-style="western"><surname>Misharin</surname><given-names>AV</given-names></name><name name-style="western"><surname>Khare</surname><given-names>S</given-names></name><name name-style="western"><surname>Saber</surname><given-names>R</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>F</given-names></name><name name-style="western"><surname>Archer</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner</article-title><source>Arthritis Res Ther</source><year>2015</year><volume>17</volume><fpage>291</fpage><pub-id pub-id-type="doi">10.1186/s13075-015-0794-z</pub-id><pub-id pub-id-type="pmid">26471282</pub-id><pub-id pub-id-type="pmcid">PMC4608154</pub-id></element-citation></ref><ref id="CR1452"><label>1452.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitale</surname><given-names>I</given-names></name><name name-style="western"><surname>Manic</surname><given-names>G</given-names></name><name name-style="western"><surname>Coussens</surname><given-names>LM</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name><name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></name></person-group><article-title>Macrophages and metabolism in the tumor microenvironment</article-title><source>Cell Metab</source><year>2019</year><volume>30</volume><fpage>36</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2019.06.001</pub-id><pub-id pub-id-type="pmid">31269428</pub-id></element-citation></ref><ref id="CR1453"><label>1453.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuda</surname><given-names>CM</given-names></name><name name-style="western"><surname>Misharin</surname><given-names>AV</given-names></name><name name-style="western"><surname>Gierut</surname><given-names>AK</given-names></name><name name-style="western"><surname>Saber</surname><given-names>R</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Hutcheson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation</article-title><source>J Immunol</source><year>2014</year><volume>192</volume><fpage>5548</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1400122</pub-id><pub-id pub-id-type="pmid">24808358</pub-id><pub-id pub-id-type="pmcid">PMC4074511</pub-id></element-citation></ref><ref id="CR1454"><label>1454.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>QQ</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>H</given-names></name><name name-style="western"><surname>Birkett</surname><given-names>R</given-names></name><name name-style="western"><surname>Doyle</surname><given-names>R</given-names></name><name name-style="western"><surname>Fang</surname><given-names>D</given-names></name><name name-style="western"><surname>Haines</surname><given-names>GK</given-names></name><etal/></person-group><article-title>CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><fpage>7086</fpage><pub-id pub-id-type="doi">10.1038/ncomms8086</pub-id><pub-id pub-id-type="pmid">25963626</pub-id><pub-id pub-id-type="pmcid">PMC4429912</pub-id></element-citation></ref><ref id="CR1455"><label>1455.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>YH</given-names></name><name name-style="western"><surname>Mo</surname><given-names>ST</given-names></name><name name-style="western"><surname>Hsiao</surname><given-names>HW</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name><name name-style="western"><surname>Lai</surname><given-names>MZ</given-names></name></person-group><article-title>Cellular FLIP inhibits myeloid cell activation by suppressing selective innate signaling</article-title><source>J Immunol</source><year>2015</year><volume>195</volume><fpage>2612</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1402944</pub-id><pub-id pub-id-type="pmid">26238491</pub-id></element-citation></ref><ref id="CR1456"><label>1456.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ch&#8217;en</surname><given-names>IL</given-names></name><name name-style="western"><surname>Tsau</surname><given-names>JS</given-names></name><name name-style="western"><surname>Molkentin</surname><given-names>JD</given-names></name><name name-style="western"><surname>Komatsu</surname><given-names>M</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>SM</given-names></name></person-group><article-title>Mechanisms of necroptosis in T cells</article-title><source>J Exp Med</source><year>2011</year><volume>208</volume><fpage>633</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1084/jem.20110251</pub-id><pub-id pub-id-type="pmid">21402742</pub-id><pub-id pub-id-type="pmcid">PMC3135356</pub-id></element-citation></ref><ref id="CR1457"><label>1457.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bell</surname><given-names>BD</given-names></name><name name-style="western"><surname>Leverrier</surname><given-names>S</given-names></name><name name-style="western"><surname>Weist</surname><given-names>BM</given-names></name><name name-style="western"><surname>Newton</surname><given-names>RH</given-names></name><name name-style="western"><surname>Arechiga</surname><given-names>AF</given-names></name><name name-style="western"><surname>Luhrs</surname><given-names>KA</given-names></name><etal/></person-group><article-title>FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>16677</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808597105</pub-id><pub-id pub-id-type="pmid">18946037</pub-id><pub-id pub-id-type="pmcid">PMC2575479</pub-id></element-citation></ref><ref id="CR1458"><label>1458.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ch&#8217;en</surname><given-names>IL</given-names></name><name name-style="western"><surname>Beisner</surname><given-names>DR</given-names></name><name name-style="western"><surname>Degterev</surname><given-names>A</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>C</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antigen-mediated T cell expansion regulated by parallel pathways of death</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>17463</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808043105</pub-id><pub-id pub-id-type="pmid">18981423</pub-id><pub-id pub-id-type="pmcid">PMC2582294</pub-id></element-citation></ref><ref id="CR1459"><label>1459.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolze</surname><given-names>A</given-names></name><name name-style="western"><surname>Byun</surname><given-names>M</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>D</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>NV</given-names></name><name name-style="western"><surname>Abhyankar</surname><given-names>A</given-names></name><name name-style="western"><surname>Premkumar</surname><given-names>L</given-names></name><etal/></person-group><article-title>Whole-exome-sequencing-based discovery of human FADD deficiency</article-title><source>Am J Hum Genet</source><year>2010</year><volume>87</volume><fpage>873</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2010.10.028</pub-id><pub-id pub-id-type="pmid">21109225</pub-id><pub-id pub-id-type="pmcid">PMC2997374</pub-id></element-citation></ref><ref id="CR1460"><label>1460.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuehn</surname><given-names>HS</given-names></name><name name-style="western"><surname>Caminha</surname><given-names>I</given-names></name><name name-style="western"><surname>Niemela</surname><given-names>JE</given-names></name><name name-style="western"><surname>Rao</surname><given-names>VK</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J</given-names></name><name name-style="western"><surname>Fleisher</surname><given-names>TA</given-names></name><etal/></person-group><article-title>FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome</article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>6035</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100021</pub-id><pub-id pub-id-type="pmid">21490157</pub-id><pub-id pub-id-type="pmcid">PMC3725553</pub-id></element-citation></ref><ref id="CR1461"><label>1461.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohn</surname><given-names>LA</given-names></name><name name-style="western"><surname>Long</surname><given-names>JD</given-names></name><name name-style="western"><surname>Trope</surname><given-names>EC</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>CY</given-names></name></person-group><article-title>Novel compound heterozygote variations in FADD identified to cause FAS-associated protein with death domain deficiency</article-title><source>J Clin Immunol</source><year>2020</year><volume>40</volume><fpage>658</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/s10875-020-00779-6</pub-id><pub-id pub-id-type="pmid">32350755</pub-id><pub-id pub-id-type="pmcid">PMC7253512</pub-id></element-citation></ref><ref id="CR1462"><label>1462.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savic</surname><given-names>S</given-names></name><name name-style="western"><surname>Parry</surname><given-names>D</given-names></name><name name-style="western"><surname>Carter</surname><given-names>C</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name><name name-style="western"><surname>Logan</surname><given-names>C</given-names></name><name name-style="western"><surname>Gutierrez</surname><given-names>BM</given-names></name><etal/></person-group><article-title>A new case of Fas-associated death domain protein deficiency and update on treatment outcomes</article-title><source>J allergy Clin Immunol</source><year>2015</year><volume>136</volume><fpage>502</fpage><lpage>505.e504</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2015.02.002</pub-id><pub-id pub-id-type="pmid">25794656</pub-id></element-citation></ref><ref id="CR1463"><label>1463.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chun</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Speirs</surname><given-names>CK</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency</article-title><source>Nature</source><year>2002</year><volume>419</volume><fpage>395</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nature01063</pub-id><pub-id pub-id-type="pmid">12353035</pub-id></element-citation></ref><ref id="CR1464"><label>1464.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Lobito</surname><given-names>A</given-names></name><name name-style="western"><surname>Chan</surname><given-names>FK</given-names></name><name name-style="western"><surname>Dale</surname><given-names>J</given-names></name><name name-style="western"><surname>Sneller</surname><given-names>M</given-names></name><etal/></person-group><article-title>Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II</article-title><source>Cell</source><year>1999</year><volume>98</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80605-4</pub-id><pub-id pub-id-type="pmid">10412980</pub-id></element-citation></ref><ref id="CR1465"><label>1465.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez-Feito</surname><given-names>A</given-names></name><name name-style="western"><surname>Melero</surname><given-names>J</given-names></name><name name-style="western"><surname>Mora-D&#237;az</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Vigil</surname><given-names>C</given-names></name><name name-style="western"><surname>Elduayen</surname><given-names>R</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Granado</surname><given-names>LI</given-names></name><etal/></person-group><article-title>Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation</article-title><source>Immunobiology</source><year>2016</year><volume>221</volume><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2015.08.004</pub-id><pub-id pub-id-type="pmid">26323380</pub-id></element-citation></ref><ref id="CR1466"><label>1466.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dechant</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Scheuerpflug</surname><given-names>CG</given-names></name><name name-style="western"><surname>Pauly</surname><given-names>E</given-names></name><name name-style="western"><surname>van der Werff Ten Bosch</surname><given-names>J</given-names></name><name name-style="western"><surname>Debatin</surname><given-names>KM</given-names></name><name name-style="western"><surname>Fellenberg</surname><given-names>J</given-names></name></person-group><article-title>Screening, identification, and functional analysis of three novel missense mutations in the TRADD gene in children with ALL and ALPS</article-title><source>Pediatr Blood Cancer</source><year>2008</year><volume>51</volume><fpage>616</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/pbc.21672</pub-id><pub-id pub-id-type="pmid">18661484</pub-id></element-citation></ref><ref id="CR1467"><label>1467.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehle</surname><given-names>AS</given-names></name><name name-style="western"><surname>Farin</surname><given-names>HF</given-names></name><name name-style="western"><surname>Marquardt</surname><given-names>B</given-names></name><name name-style="western"><surname>Michels</surname><given-names>BE</given-names></name><name name-style="western"><surname>Magg</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency</article-title><source>Gastroenterology</source><year>2019</year><volume>156</volume><fpage>275</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2018.09.041</pub-id><pub-id pub-id-type="pmid">30267714</pub-id></element-citation></ref><ref id="CR1468"><label>1468.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niemela</surname><given-names>J</given-names></name><name name-style="western"><surname>Kuehn</surname><given-names>HS</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Davies</surname><given-names>J</given-names></name><name name-style="western"><surname>Melendez</surname><given-names>J</given-names></name><etal/></person-group><article-title>Caspase-8 deficiency presenting as late-onset multi-organ lymphocytic infiltration with granulomas in two adult siblings</article-title><source>J Clin Immunol</source><year>2015</year><volume>35</volume><fpage>348</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1007/s10875-015-0150-8</pub-id><pub-id pub-id-type="pmid">25814141</pub-id><pub-id pub-id-type="pmcid">PMC4439260</pub-id></element-citation></ref><ref id="CR1469"><label>1469.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanderova</surname><given-names>V</given-names></name><name name-style="western"><surname>Grombirikova</surname><given-names>H</given-names></name><name name-style="western"><surname>Zentsova</surname><given-names>I</given-names></name><name name-style="western"><surname>Reblova</surname><given-names>K</given-names></name><name name-style="western"><surname>Klocperk</surname><given-names>A</given-names></name><name name-style="western"><surname>Fejtkova</surname><given-names>M</given-names></name><etal/></person-group><article-title>Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in Caspase 8</article-title><source>Haematologica</source><year>2019</year><volume>104</volume><fpage>e32</fpage><lpage>e34</lpage><pub-id pub-id-type="doi">10.3324/haematol.2018.201673</pub-id><pub-id pub-id-type="pmid">30337362</pub-id><pub-id pub-id-type="pmcid">PMC6312013</pub-id></element-citation></ref><ref id="CR1470"><label>1470.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piao</surname><given-names>X</given-names></name><name name-style="western"><surname>Komazawa-Sakon</surname><given-names>S</given-names></name><name name-style="western"><surname>Nishina</surname><given-names>T</given-names></name><name name-style="western"><surname>Koike</surname><given-names>M</given-names></name><name name-style="western"><surname>Piao</surname><given-names>JH</given-names></name><name name-style="western"><surname>Ehlken</surname><given-names>H</given-names></name><etal/></person-group><article-title>c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis</article-title><source>Sci Signal</source><year>2012</year><volume>5</volume><fpage>ra93</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2003558</pub-id><pub-id pub-id-type="pmid">23250397</pub-id><pub-id pub-id-type="pmcid">PMC4465294</pub-id></element-citation></ref><ref id="CR1471"><label>1471.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panayotova-Dimitrova</surname><given-names>D</given-names></name><name name-style="western"><surname>Feoktistova</surname><given-names>M</given-names></name><name name-style="western"><surname>Ploesser</surname><given-names>M</given-names></name><name name-style="western"><surname>Kellert</surname><given-names>B</given-names></name><name name-style="western"><surname>Hupe</surname><given-names>M</given-names></name><name name-style="western"><surname>Horn</surname><given-names>S</given-names></name><etal/></person-group><article-title>cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis</article-title><source>Cell Rep</source><year>2013</year><volume>5</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.09.035</pub-id><pub-id pub-id-type="pmid">24209745</pub-id></element-citation></ref><ref id="CR1472"><label>1472.</label><mixed-citation publication-type="other">Feoktistova M, Makarov R, Leverkus M, Yazdi AS, Panayotova-Dimitrova D. TNF is partially required for cell-death-triggered skin inflammation upon acute loss of cFLIP. Int J Mol Sci. 2020;21:8859.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21228859</pub-id><pub-id pub-id-type="pmcid">PMC7700656</pub-id><pub-id pub-id-type="pmid">33238518</pub-id></mixed-citation></ref><ref id="CR1473"><label>1473.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wittkopf</surname><given-names>N</given-names></name><name name-style="western"><surname>G&#252;nther</surname><given-names>C</given-names></name><name name-style="western"><surname>Martini</surname><given-names>E</given-names></name><name name-style="western"><surname>He</surname><given-names>G</given-names></name><name name-style="western"><surname>Amann</surname><given-names>K</given-names></name><name name-style="western"><surname>He</surname><given-names>YW</given-names></name><etal/></person-group><article-title>Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8</article-title><source>Gastroenterology</source><year>2013</year><volume>145</volume><fpage>1369</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.08.059</pub-id><pub-id pub-id-type="pmid">24036366</pub-id></element-citation></ref><ref id="CR1474"><label>1474.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gehrke</surname><given-names>N</given-names></name><name name-style="western"><surname>Garcia-Bardon</surname><given-names>D</given-names></name><name name-style="western"><surname>Mann</surname><given-names>A</given-names></name><name name-style="western"><surname>Schad</surname><given-names>A</given-names></name><name name-style="western"><surname>Alt</surname><given-names>Y</given-names></name><name name-style="western"><surname>W&#246;rns</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors</article-title><source>Cell Death Differ</source><year>2015</year><volume>22</volume><fpage>826</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.178</pub-id><pub-id pub-id-type="pmid">25342470</pub-id><pub-id pub-id-type="pmcid">PMC4392079</pub-id></element-citation></ref><ref id="CR1475"><label>1475.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonnet</surname><given-names>MC</given-names></name><name name-style="western"><surname>Preukschat</surname><given-names>D</given-names></name><name name-style="western"><surname>Welz</surname><given-names>PS</given-names></name><name name-style="western"><surname>van Loo</surname><given-names>G</given-names></name><name name-style="western"><surname>Ermolaeva</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bloch</surname><given-names>W</given-names></name><etal/></person-group><article-title>The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>572</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.08.014</pub-id><pub-id pub-id-type="pmid">22000287</pub-id></element-citation></ref><ref id="CR1476"><label>1476.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Welz</surname><given-names>PS</given-names></name><name name-style="western"><surname>Wullaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Vlantis</surname><given-names>K</given-names></name><name name-style="western"><surname>Kondylis</surname><given-names>V</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Majada</surname><given-names>V</given-names></name><name name-style="western"><surname>Ermolaeva</surname><given-names>M</given-names></name><etal/></person-group><article-title>FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation</article-title><source>Nature</source><year>2011</year><volume>477</volume><fpage>330</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1038/nature10273</pub-id><pub-id pub-id-type="pmid">21804564</pub-id></element-citation></ref><ref id="CR1477"><label>1477.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kovalenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kang</surname><given-names>TB</given-names></name><name name-style="western"><surname>Rajput</surname><given-names>A</given-names></name><name name-style="western"><surname>Bogdanov</surname><given-names>K</given-names></name><name name-style="western"><surname>Dittrich-Breiholz</surname><given-names>O</given-names></name><etal/></person-group><article-title>Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease</article-title><source>J Exp Med</source><year>2009</year><volume>206</volume><fpage>2161</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1084/jem.20090616</pub-id><pub-id pub-id-type="pmid">19720838</pub-id><pub-id pub-id-type="pmcid">PMC2757876</pub-id></element-citation></ref><ref id="CR1478"><label>1478.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#252;nther</surname><given-names>C</given-names></name><name name-style="western"><surname>Martini</surname><given-names>E</given-names></name><name name-style="western"><surname>Wittkopf</surname><given-names>N</given-names></name><name name-style="western"><surname>Amann</surname><given-names>K</given-names></name><name name-style="western"><surname>Weigmann</surname><given-names>B</given-names></name><name name-style="western"><surname>Neumann</surname><given-names>H</given-names></name><etal/></person-group><article-title>Caspase-8 regulates TNF-&#945;-induced epithelial necroptosis and terminal ileitis</article-title><source>Nature</source><year>2011</year><volume>477</volume><fpage>335</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nature10400</pub-id><pub-id pub-id-type="pmid">21921917</pub-id><pub-id pub-id-type="pmcid">PMC3373730</pub-id></element-citation></ref><ref id="CR1479"><label>1479.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Lasse</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P</given-names></name><name name-style="western"><surname>Nakasaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SW</given-names></name><name name-style="western"><surname>Yamasaki</surname><given-names>K</given-names></name><etal/></person-group><article-title>Development of atopic dermatitis-like skin disease from the chronic loss of epidermal caspase-8</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>22249</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1073/pnas.1009751108</pub-id><pub-id pub-id-type="pmid">21135236</pub-id><pub-id pub-id-type="pmcid">PMC3009816</pub-id></element-citation></ref><ref id="CR1480"><label>1480.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaden-Volynets</surname><given-names>V</given-names></name><name name-style="western"><surname>G&#252;nther</surname><given-names>C</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>J</given-names></name><name name-style="western"><surname>Beisner</surname><given-names>J</given-names></name><name name-style="western"><surname>Becker</surname><given-names>C</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>SC</given-names></name></person-group><article-title>Deletion of the Casp8 gene in mice results in ileocolitis, gut barrier dysfunction, and malassimilation, which can be partially attenuated by inulin or sodium butyrate</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2019</year><volume>317</volume><fpage>G493</fpage><lpage>g507</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00297.2018</pub-id><pub-id pub-id-type="pmid">31411503</pub-id></element-citation></ref><ref id="CR1481"><label>1481.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinlich</surname><given-names>R</given-names></name><name name-style="western"><surname>Oberst</surname><given-names>A</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>CP</given-names></name><name name-style="western"><surname>Janke</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Milasta</surname><given-names>S</given-names></name><name name-style="western"><surname>Lukens</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Protective roles for caspase-8 and cFLIP in adult homeostasis</article-title><source>Cell Rep</source><year>2013</year><volume>5</volume><fpage>340</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.08.045</pub-id><pub-id pub-id-type="pmid">24095739</pub-id><pub-id pub-id-type="pmcid">PMC3843376</pub-id></element-citation></ref><ref id="CR1482"><label>1482.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stolzer</surname><given-names>I</given-names></name><name name-style="western"><surname>Kaden-Volynets</surname><given-names>V</given-names></name><name name-style="western"><surname>Ruder</surname><given-names>B</given-names></name><name name-style="western"><surname>Letizia</surname><given-names>M</given-names></name><name name-style="western"><surname>Bittel</surname><given-names>M</given-names></name><name name-style="western"><surname>Rausch</surname><given-names>P</given-names></name><etal/></person-group><article-title>Environmental microbial factors determine the pattern of inflammatory lesions in a murine model of Crohn&#8217;s disease-like inflammation</article-title><source>Inflamm Bowel Dis</source><year>2020</year><volume>26</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1093/ibd/izz142</pub-id><pub-id pub-id-type="pmid">31276162</pub-id></element-citation></ref><ref id="CR1483"><label>1483.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaemmerer</surname><given-names>E</given-names></name><name name-style="western"><surname>Kuhn</surname><given-names>P</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>U</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>MK</given-names></name><name name-style="western"><surname>Klaus</surname><given-names>C</given-names></name><name name-style="western"><surname>Schiffer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Intestinal genetic inactivation of caspase-8 diminishes migration of enterocytes</article-title><source>World J Gastroenterol</source><year>2015</year><volume>21</volume><fpage>4499</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.3748/wjg.v21.i15.4499</pub-id><pub-id pub-id-type="pmid">25914458</pub-id><pub-id pub-id-type="pmcid">PMC4402296</pub-id></element-citation></ref><ref id="CR1484"><label>1484.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tisch</surname><given-names>N</given-names></name><name name-style="western"><surname>Mogler</surname><given-names>C</given-names></name><name name-style="western"><surname>Stojanovic</surname><given-names>A</given-names></name><name name-style="western"><surname>Luck</surname><given-names>R</given-names></name><name name-style="western"><surname>Korhonen</surname><given-names>EA</given-names></name><name name-style="western"><surname>Ellerkmann</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-8 in endothelial cells maintains gut homeostasis and prevents small bowel inflammation in mice</article-title><source>EMBO Mol Med</source><year>2022</year><volume>14</volume><fpage>e14121</fpage><pub-id pub-id-type="doi">10.15252/emmm.202114121</pub-id><pub-id pub-id-type="pmid">35491615</pub-id><pub-id pub-id-type="pmcid">PMC9174885</pub-id></element-citation></ref><ref id="CR1485"><label>1485.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarzer</surname><given-names>R</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>H</given-names></name><name name-style="western"><surname>Wachsmuth</surname><given-names>L</given-names></name><name name-style="western"><surname>Tresch</surname><given-names>A</given-names></name><name name-style="western"><surname>Pasparakis</surname><given-names>M</given-names></name></person-group><article-title>FADD and caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells</article-title><source>Immunity</source><year>2020</year><volume>52</volume><fpage>978</fpage><lpage>993.e976</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.04.002</pub-id><pub-id pub-id-type="pmid">32362323</pub-id></element-citation></ref><ref id="CR1486"><label>1486.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karki</surname><given-names>R</given-names></name><name name-style="western"><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><article-title>Diverging inflammasome signals in tumorigenesis and potential targeting</article-title><source>Nat Rev Cancer</source><year>2019</year><volume>19</volume><fpage>197</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0123-y</pub-id><pub-id pub-id-type="pmid">30842595</pub-id><pub-id pub-id-type="pmcid">PMC6953422</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>